{ "meta": { "tracker_site_url": "https://psilocybin-research.com", "publication_tracker_url": "https://psilocybin-research.com/", "generated_at_utc": "2026-07-11 16:51:14", "record_count": 1689, "schema_variant": "rights-safe-core-v1", "text_redistribution": "Source-derived abstracts, descriptions, keywords, and unrestricted payload text are not redistributed." }, "papers": [ { "id": 301, "title": "Contribution of the Serotonin 5-HT2A Receptor to the Therapeutic Effect of Psilocin on Social Behavior Deficits in Mice Repeatedly Exposed to Social Defeat Stress", "authors": "Ibi Daisuke, Takaba Rika, Yoshida Keisuke, Kawase Ririna, Kitagawa Hiroko, Matsushita Momoko, Ito Kana, Uno Shoya, Nishimura Fumiya, Kitagaki Shinji, Hiramatsu Masayuki", "journal": "Neuropsychopharmacology Reports", "publication_date": "2026-08-31", "publication_year": 2026, "doi": "10.1002/npr2.70152", "pubmed_id": "42379141", "openalex_id": "https://openalex.org/W7166665532", "source_url": "https://doi.org/10.1002/npr2.70152", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Anxiety,Receptor Pharmacology,Resilience,Animal Study,Treatment-Resistant Depression", "study_type": "Animal Study", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-07-01 06:48:03", "last_checked": "2026-07-07 01:20:41", "bibtex": null, "source_record_id": "PMID:42379141", "abstract_available": true, "abstract_source": "Crossref", "abstract_source_url": "https://doi.org/10.1002/npr2.70152", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "PMID:42379141", "source_url": "https://doi.org/10.1002/npr2.70152", "doi": "10.1002/npr2.70152", "pmid": "42379141", "publication_date": "2026-08-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3502, "title": "PSilocybin Microdose for psYCHological and Existential Distress in PALliative Care (PSYCHED-PAL): A Multi-site Phase 3 Double-blind, Placebo-controlled, Parallel-arm Clinical Trial", "authors": "Bruyère Health Research Institute.", "journal": "ClinicalTrials.gov", "publication_date": "2026-07-09", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07063862", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,End-of-Life Distress,Receptor Pharmacology,Default Mode Network,Aging,Microdosing,Clinical Trial,Randomized Controlled Trial,Observational Study,Cancer Patients,Healthcare Workers,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-07-11 01:24:11", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07063862", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07063862", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07063862", "source_url": "https://clinicaltrials.gov/study/NCT07063862", "doi": "", "pmid": "", "publication_date": "2026-07-09", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3467, "title": "PSilocybin for psYCHological and Existential Distress in PALliative Care (PSYCHED-PAL): A Multi-site, Open-label, Single Arm Phase I/II Proof-of-concept, Dose-finding, and Feasibility Clinical Trial", "authors": "Ottawa Hospital Research Institute", "journal": "ClinicalTrials.gov", "publication_date": "2026-07-09", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT04754061", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Receptor Pharmacology,Aging,Microdosing,Wellbeing,Emotional Processing,Clinical Trial,Randomized Controlled Trial,Cancer Patients,Healthcare Workers,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-07-11 01:24:10", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT04754061", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT04754061", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT04754061", "source_url": "https://clinicaltrials.gov/study/NCT04754061", "doi": "", "pmid": "", "publication_date": "2026-07-09", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3610, "title": "Psilocybin-Assisted Psychotherapy for Treatment-Resistant Depression: A Randomized Phase II Clinical Trial Comparing One Versus Two Psychedelic Doses of Psilocybin (PSI-1V2)", "authors": "University Health Network, Toronto", "journal": "ClinicalTrials.gov", "publication_date": "2026-07-08", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06341426", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Observational Study,Treatment-Resistant Depression,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-11 01:24:11", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06341426", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06341426", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06341426", "source_url": "https://clinicaltrials.gov/study/NCT06341426", "doi": "", "pmid": "", "publication_date": "2026-07-08", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3537, "title": "Computationally, Electrophysiologically, and Qualitatively Characterizing Serotonergic Psychedelics; Transdiagnostic Therapeutic and Pro-Psychotic Effects", "authors": "Yale University", "journal": "ClinicalTrials.gov", "publication_date": "2026-07-08", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06624137", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Addiction,OCD,Headache / Migraine,Brain Imaging,Aging,Wellbeing,Clinical Trial,Observational Study,Healthy Volunteers,Adverse Events", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-11 01:24:10", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06624137", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06624137", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06624137", "source_url": "https://clinicaltrials.gov/study/NCT06624137", "doi": "", "pmid": "", "publication_date": "2026-07-08", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 5677, "title": "CSF galanin and noradrenaline downregulation by psilocybin therapy in major depressive disorder.", "authors": "Paslawski W, Doyon D, Ekman CJ, Yngwe H, Mamula D, Zareba-Paslawska J, Beckman M, Xu ZD, Hökfelt T, Tiger M, Lundberg J, Svenningsson P.", "journal": "Neuropsychopharmacology", "publication_date": "2026-07-06", "publication_year": 2026, "doi": "10.1038/s41386-026-02490-3", "pubmed_id": "42414566", "openalex_id": "https://openalex.org/W7167637338", "source_url": "https://doi.org/10.1038/s41386-026-02490-3", "substance_tags": "psilocybin", "topic_tags": "Depression,Pharmacology,Mechanism of Action,Biomarkers", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-08 01:20:22", "last_checked": "2026-07-11 01:20:14", "bibtex": null, "source_record_id": "PMID:42414566", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1038/s41386-026-02490-3", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:42414566", "source_url": "https://doi.org/10.1038/s41386-026-02490-3", "doi": "10.1038/s41386-026-02490-3", "pmid": "42414566", "publication_date": "2026-07-06", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 5674, "title": "Psilocybe Poisoning: Pathophysiology, Classification and Treatment. A Clinical Case Review", "authors": "Omar Azuara-Antonio, Erika Rubí De La Cruz-Elizaldeb, José Eduardo Carmona-Rodriguez, Lesly Idaliht Hernandez-Martinez", "journal": "Mexican Journal of Medical Research ICSA", "publication_date": "2026-07-04", "publication_year": 2026, "doi": "10.29057/mjmr.v14i28.16493", "pubmed_id": null, "openalex_id": "https://openalex.org/W7167422156", "source_url": "https://doi.org/10.29057/mjmr.v14i28.16493", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Pharmacology,Receptor Pharmacology,Consciousness,Review Article,Adverse Events,Toxicity", "study_type": "Review Article", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-07 01:20:41", "last_checked": "2026-07-11 01:20:14", "bibtex": null, "source_record_id": "DOI:10.29057/mjmr.v14i28.16493", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.29057/mjmr.v14i28.16493", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.29057/mjmr.v14i28.16493", "source_url": "https://doi.org/10.29057/mjmr.v14i28.16493", "doi": "10.29057/mjmr.v14i28.16493", "pmid": "", "publication_date": "2026-07-04", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3978, "title": "Trajectories of psychedelic-assisted change: An observational study of a psilocybin retreat program followed by psychotherapeutic interventions", "authors": "Whitfield Henry J., Schepers Jan, Mason Natasha L., Luca Maria, Kuypers Kim P. C.", "journal": "Journal of Psychedelic Studies", "publication_date": "2026-07-02", "publication_year": 2026, "doi": "10.1556/2054.2026.00530", "pubmed_id": null, "openalex_id": "https://openalex.org/W7167262029", "source_url": "https://doi.org/10.1556/2054.2026.00530", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Wellbeing,Psychological Flexibility,Observational Study,Drug Interactions", "study_type": "Clinical Trial", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-07-04 01:20:27", "last_checked": "2026-07-10 01:20:13", "bibtex": null, "source_record_id": "DOI:10.1556/2054.2026.00530", "abstract_available": true, "abstract_source": "Crossref", "abstract_source_url": "https://doi.org/10.1556/2054.2026.00530", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "DOI:10.1556/2054.2026.00530", "source_url": "https://doi.org/10.1556/2054.2026.00530", "doi": "10.1556/2054.2026.00530", "pmid": "", "publication_date": "2026-07-02", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3982, "title": "Policy Considerations for Psychedelics in Research and Medicine - What’s Next on the Schedule?", "authors": "Matthew A. Boehm, Oriana Mayorga", "journal": "Journal of Science Policy & Governance", "publication_date": "2026-07-01", "publication_year": 2026, "doi": "10.38126/jspg280103", "pubmed_id": null, "openalex_id": "https://openalex.org/W7167073096", "source_url": "https://doi.org/10.38126/jspg280103", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Mechanism of Action,Clinical Trial,Review Article,Treatment-Resistant Depression,Safety,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 01:20:30", "last_checked": "2026-07-09 01:20:16", "bibtex": null, "source_record_id": "DOI:10.38126/jspg280103", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.38126/jspg280103", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.38126/jspg280103", "source_url": "https://doi.org/10.38126/jspg280103", "doi": "10.38126/jspg280103", "pmid": "", "publication_date": "2026-07-01", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3975, "title": "Sexual identity as a moderator of associations between lifetime MDMA/ecstasy or psilocybin use and mental health outcomes: An exploratory analysis of a nationally representative sample using NSDUH 2015-2019", "authors": "Seale M.", "journal": "Research Square", "publication_date": "2026-07-01", "publication_year": 2026, "doi": "10.21203/rs.3.rs-10208910/v1", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.21203/rs.3.rs-10208910/v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Observational Study,Drug Interactions", "study_type": "Observational Study", "source_name": "Europe PMC", "publication_status": "preprint", "date_added": "2026-07-03 01:20:31", "last_checked": "2026-07-09 01:20:12", "bibtex": null, "source_record_id": "DOI:10.21203/rs.3.rs-10208910/v1", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.21203/rs.3.rs-10208910/v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "DOI:10.21203/rs.3.rs-10208910/v1", "source_url": "https://doi.org/10.21203/rs.3.rs-10208910/v1", "doi": "10.21203/rs.3.rs-10208910/v1", "pmid": "", "publication_date": "2026-07-01", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3812, "title": "Past-Year Psilocybin and Alcohol Co-Use: Associations With Mental Health Symptoms", "authors": "Hummel Haley M., Obrochta Alexia N., Kerr David C. R., Cservenka Anita", "journal": "Journal of Drug Issues", "publication_date": "2026-06-30", "publication_year": 2026, "doi": "10.1177/00220426261466154", "pubmed_id": null, "openalex_id": "https://openalex.org/W7166830239", "source_url": "https://doi.org/10.1177/00220426261466154", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Observational Study", "study_type": "Observational Study", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-07-02 06:54:51", "last_checked": "2026-07-08 01:20:28", "bibtex": null, "source_record_id": "DOI:10.1177/00220426261466154", "abstract_available": true, "abstract_source": "Crossref", "abstract_source_url": "https://doi.org/10.1177/00220426261466154", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "DOI:10.1177/00220426261466154", "source_url": "https://doi.org/10.1177/00220426261466154", "doi": "10.1177/00220426261466154", "pmid": "", "publication_date": "2026-06-30", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3811, "title": "Investigating the impact of serotonergic psychedelic drugs, MDMA and ketamine on social cognition in psychiatric disorders: A scoping review.", "authors": "Smith SA, Mohammad H, Lee LHN, Dennett L, Smith S, Burback L, Winkler O, Greenshaw A, Jetly R, Kennedy SH, Bhat V, Swainson J, Vermetten E, Cao B, Li XM, Zhang Y.", "journal": null, "publication_date": "2026-06-30", "publication_year": 2026, "doi": "10.1007/s00213-026-07110-y", "pubmed_id": "42380668", "openalex_id": null, "source_url": "https://doi.org/10.1007/s00213-026-07110-y", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Emotional Processing,Clinical Trial,Review Article", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 13:00:05", "last_checked": "2026-07-08 01:20:23", "bibtex": null, "source_record_id": "PMID:42380668", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1007/s00213-026-07110-y", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:42380668", "source_url": "https://doi.org/10.1007/s00213-026-07110-y", "doi": "10.1007/s00213-026-07110-y", "pmid": "42380668", "publication_date": "2026-06-30", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3662, "title": "Efficacy in Relapse Prevention: Psilocybin in Alcohol Use Disorder With Depressive Symptoms", "authors": "Centre Hospitalier Universitaire de Nīmes", "journal": "ClinicalTrials.gov", "publication_date": "2026-06-30", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07638553", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Safety", "study_type": "Other", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-07 01:23:04", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07638553", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07638553", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07638553", "source_url": "https://clinicaltrials.gov/study/NCT07638553", "doi": "", "pmid": "", "publication_date": "2026-06-30", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3002, "title": "Modeled Long-Term Effects of Psilocybin on Dynamic Activity and Effective Connectivity of Fronto-Striatal-Thalamic Circuits.", "authors": "Pasquini L, Vohryzek J, Escrichs A, Perl YS, Ponce-Alvarez A, Idesis S, Girn M, Roseman L, Mitchell JM, Gazzaley A, Kringelbach M, Nutt DJ, Lyons T, Carhart-Harris RL, Deco G.", "journal": null, "publication_date": "2026-06-30", "publication_year": 2026, "doi": "10.1002/hbm.70596", "pubmed_id": "42381187", "openalex_id": null, "source_url": "https://doi.org/10.1002/hbm.70596", "substance_tags": "psilocybin", "topic_tags": "Depression,Eating Disorders,Brain Imaging,Mechanism of Action,Receptor Pharmacology,Aging,Healthy Volunteers", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 11:03:06", "last_checked": "2026-07-08 01:20:22", "bibtex": null, "source_record_id": "PMID:42381187", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1002/hbm.70596", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:42381187", "source_url": "https://doi.org/10.1002/hbm.70596", "doi": "10.1002/hbm.70596", "pmid": "42381187", "publication_date": "2026-06-30", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 58, "title": "MFCC-DFT mapping of ligand recognition at the 5-HT2A receptor: energetic analysis of the interactions between serotonin, psychedelics, and antipsychotics.", "authors": "Junior WSC, Bezerra KS, Matias EGC, Oliveira JIN, Fulco UL.", "journal": null, "publication_date": "2026-06-30", "publication_year": 2026, "doi": "10.1039/d6cp00943c", "pubmed_id": "42300394", "openalex_id": null, "source_url": "https://doi.org/10.1039/d6cp00943c", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Receptor Pharmacology,Drug Interactions", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-08 01:20:23", "bibtex": null, "source_record_id": "PMID:42300394", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1039/d6cp00943c", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:42300394", "source_url": "https://doi.org/10.1039/d6cp00943c", "doi": "10.1039/d6cp00943c", "pmid": "42300394", "publication_date": "2026-06-30", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 20, "title": "Psilocybin as a novel treatment for chronic pain.", "authors": "Askey T, Lasrado R, Maiarú M, Stephens GJ", "journal": "British journal of pharmacology", "publication_date": "2026-06-30", "publication_year": 2026, "doi": "10.1111/bph.17420", "pubmed_id": "39614355", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/39614355/", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Emotional Processing,Review Article,Animal Study,Inflammation", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-08 01:20:06", "bibtex": null, "source_record_id": "PMID:39614355", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39614355/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39614355", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39614355/", "doi": "10.1111/bph.17420", "pmid": "39614355", "publication_date": "2026-06-30", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 19, "title": "The Australia story: Current status and future challenges for the clinical applications of psychedelics.", "authors": "Nutt DJ, Hunt P, Schlag AK, Fitzgerald P", "journal": "British journal of pharmacology", "publication_date": "2026-06-30", "publication_year": 2026, "doi": "10.1111/bph.17398", "pubmed_id": "39701143", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/39701143/", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Mechanism of Action,Review Article,Treatment-Resistant Depression", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-08 01:20:06", "bibtex": null, "source_record_id": "PMID:39701143", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39701143/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39701143", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39701143/", "doi": "10.1111/bph.17398", "pmid": "39701143", "publication_date": "2026-06-30", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 18, "title": "Neuropsychopharmacology of hallucinogenic and non-hallucinogenic 5-HT receptor agonists.", "authors": "Sharp T, Ippolito A", "journal": "British journal of pharmacology", "publication_date": "2026-06-30", "publication_year": 2026, "doi": "10.1111/bph.70050", "pubmed_id": "40405723", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/40405723/", "substance_tags": "psilocin", "topic_tags": "Depression,Anxiety,Addiction,Neuroplasticity,Pharmacology,Receptor Pharmacology", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-08 01:20:06", "bibtex": null, "source_record_id": "PMID:40405723", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40405723/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40405723", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40405723/", "doi": "10.1111/bph.70050", "pmid": "40405723", "publication_date": "2026-06-30", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 17, "title": "Psychedelics, entactogens and psychoplastogens for depression and related disorders.", "authors": "Hoyer D", "journal": "British journal of pharmacology", "publication_date": "2026-06-30", "publication_year": 2026, "doi": "10.1111/bph.70088", "pubmed_id": "40518133", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/40518133/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Neuroplasticity,Brain Imaging,Mechanism of Action,Receptor Pharmacology,Biomarkers,Aging,Clinical Trial,Treatment-Resistant Depression,Inflammation,Immune Function", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-08 01:20:06", "bibtex": null, "source_record_id": "PMID:40518133", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40518133/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40518133", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40518133/", "doi": "10.1111/bph.70088", "pmid": "40518133", "publication_date": "2026-06-30", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 16, "title": "Evidence that 5-HT receptor signalling efficacy and not biased agonism differentiates serotonergic psychedelic from non-psychedelic drugs.", "authors": "Ippolito A, Vasudevan S, Hurley S, Gilmour G, Westhorpe F, Churchill G, Sharp T", "journal": "British journal of pharmacology", "publication_date": "2026-06-30", "publication_year": 2026, "doi": "10.1111/bph.70109", "pubmed_id": "40545270", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/40545270/", "substance_tags": "psilocin", "topic_tags": "Depression,Pharmacology,Mechanism of Action,Receptor Pharmacology,Animal Study", "study_type": "Animal Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-08 01:20:06", "bibtex": null, "source_record_id": "PMID:40545270", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40545270/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40545270", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40545270/", "doi": "10.1111/bph.70109", "pmid": "40545270", "publication_date": "2026-06-30", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 14, "title": "Psychedelics as pharmacotherapeutics for substance use disorders: A scoping review on clinical trials and perspectives on underlying neurobiology.", "authors": "Wittenkeller L, Gudelsky G, Winhusen TJ, Amato D", "journal": "British journal of pharmacology", "publication_date": "2026-06-30", "publication_year": 2026, "doi": "10.1111/bph.70181", "pubmed_id": "40891276", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/40891276/", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Mechanism of Action,Consciousness,Clinical Trial,Review Article,Treatment-Resistant Depression", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-08 01:20:06", "bibtex": null, "source_record_id": "PMID:40891276", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40891276/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40891276", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40891276/", "doi": "10.1111/bph.70181", "pmid": "40891276", "publication_date": "2026-06-30", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 8, "title": "Acute dose-dependent effects of 4-bromo-2,5-dimethoxyphenethylamine (2C-B) compared with 3,4-methylenedioxymethamphetamine (MDMA) and psilocybin in a double-blind, placebo-controlled study in healthy participants.", "authors": "Arikci D, Borgulya J, Straumann I, Vizeli P, Luethi D, Thomann J, Rudin D, Vukalovic I, Eckert A, Liechti ME, Holze F", "journal": "Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology", "publication_date": "2026-06-30", "publication_year": 2026, "doi": "10.1038/s41386-026-02428-9", "pubmed_id": "42049943", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/42049943/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Pharmacology,Consciousness,Emotional Processing,In Vitro Study,Healthy Volunteers", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-08 01:20:05", "bibtex": null, "source_record_id": "PMID:42049943", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/42049943/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:42049943", "source_url": "https://pubmed.ncbi.nlm.nih.gov/42049943/", "doi": "10.1038/s41386-026-02428-9", "pmid": "42049943", "publication_date": "2026-06-30", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 302, "title": "Chronic psilocin microdosing produces limited behavioral effects and does not enhance neurogenesis in rats.", "authors": "Ladislavová L, Kútná V, Mazochová K, Šíchová K, Danda H, Lhotková E, Uttl L, Brejtr V, Syrová K, Mazoch V, Horsley R, Páleníček T.", "journal": null, "publication_date": "2026-06-29", "publication_year": 2026, "doi": "10.1016/j.pbb.2026.174231", "pubmed_id": "42379524", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.pbb.2026.174231", "substance_tags": "psilocin", "topic_tags": "Depression,Neurogenesis,Receptor Pharmacology,Biomarkers,Microdosing,Creativity,Animal Study,Drug Interactions", "study_type": "Animal Study", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:03", "last_checked": "2026-07-07 01:20:35", "bibtex": null, "source_record_id": "PMID:42379524", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.pbb.2026.174231", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:42379524", "source_url": "https://doi.org/10.1016/j.pbb.2026.174231", "doi": "10.1016/j.pbb.2026.174231", "pmid": "42379524", "publication_date": "2026-06-29", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 22, "title": "Psychedelics in treatment-resistant depression: a comprehensive review of mechanisms, clinical evidence, and recommendations.", "authors": "Estela-Fernandez CA, Mohamed Yousif Elsheikh R, Beatrice DB, A Alhendal A, Irene Ewe C, Montesinos SY, Wensel J, Mishra AP, Yousif AA, Ali HT.", "journal": null, "publication_date": "2026-06-29", "publication_year": 2026, "doi": "10.1007/s40211-026-00584-4", "pubmed_id": "42377806", "openalex_id": null, "source_url": "https://doi.org/10.1007/s40211-026-00584-4", "substance_tags": "psilocybin", "topic_tags": "Depression,Pharmacology,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Review Article,Treatment-Resistant Depression,Toxicity", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-07 01:20:36", "bibtex": null, "source_record_id": "PMID:42377806", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1007/s40211-026-00584-4", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:42377806", "source_url": "https://doi.org/10.1007/s40211-026-00584-4", "doi": "10.1007/s40211-026-00584-4", "pmid": "42377806", "publication_date": "2026-06-29", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3561, "title": "The Efficacy of Psilocybin Therapy for Depression in Parkinson's Disease", "authors": "Yale University", "journal": "ClinicalTrials.gov", "publication_date": "2026-06-28", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07610369", "substance_tags": "psilocybin", "topic_tags": "Depression,Microdosing,Randomized Controlled Trial,Safety", "study_type": "Randomized Controlled Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-05 01:22:40", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07610369", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07610369", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07610369", "source_url": "https://clinicaltrials.gov/study/NCT07610369", "doi": "", "pmid": "", "publication_date": "2026-06-28", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 24, "title": "Psilocybin reduces fear memory and restores neuroplasticity in the hippocampus and medial prefrontal cortex.", "authors": "Du Y, Zhao X, Yao Y, Li Y, Wang G, Zhang L.", "journal": "Journal of Psychopharmacology", "publication_date": "2026-06-27", "publication_year": 2026, "doi": "10.1177/02698811261453819", "pubmed_id": "42365496", "openalex_id": "https://openalex.org/W7166436963", "source_url": "https://doi.org/10.1177/02698811261453819", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Neuroplasticity,Neurogenesis,Mechanism of Action,Biomarkers,Animal Study", "study_type": "Animal Study", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-05 01:20:22", "bibtex": null, "source_record_id": "PMID:42365496", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1177/02698811261453819", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:42365496", "source_url": "https://doi.org/10.1177/02698811261453819", "doi": "10.1177/02698811261453819", "pmid": "42365496", "publication_date": "2026-06-27", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3522, "title": "Psilocybin-Assisted Therapy for Physician Well-Being and Burnout: Feasibility, Safety, Clinical Effectiveness and Biomarkers of Response [PAT-B (Psilocybin-Assisted Therapy for Physician Well-Being and Burnout)]", "authors": "University of California, San Diego", "journal": "ClinicalTrials.gov", "publication_date": "2026-06-25", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06814522", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Brain Imaging,Biomarkers,Wellbeing,Emotional Processing,Healthcare Workers,Safety", "study_type": "Other", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-07-02 23:06:03", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06814522", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06814522", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06814522", "source_url": "https://clinicaltrials.gov/study/NCT06814522", "doi": "", "pmid": "", "publication_date": "2026-06-25", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3026, "title": "Divergent changes in perturbation-induced brain reconfiguration following depression treatment with psilocybin and escitalopram", "authors": "Dagnino, P. C.; Acero-Pousa, I.; Carhart-Harris, R.; Erritzoe, D.; Nutt, D. J.; Kringelbach, M. L.; Sanz Perl, Y.; Deco, G.", "journal": "bioRxiv", "publication_date": "2026-06-25", "publication_year": 2026, "doi": "10.64898/2026.06.22.733731", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.64898/2026.06.22.733731", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging,Aging", "study_type": "Other", "source_name": "bioRxiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:45", "last_checked": "2026-07-03 01:22:13", "bibtex": null, "source_record_id": "DOI:10.64898/2026.06.22.733731", "abstract_available": true, "abstract_source": "bioRxiv", "abstract_source_url": "https://doi.org/10.64898/2026.06.22.733731", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "bioRxiv", "source_record_id": "DOI:10.64898/2026.06.22.733731", "source_url": "https://doi.org/10.64898/2026.06.22.733731", "doi": "10.64898/2026.06.22.733731", "pmid": "", "publication_date": "2026-06-25", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3595, "title": "Acute Effects of MDMA Co-administration on the Response to Psilocybin in Healthy Subjects", "authors": "University Hospital, Basel, Switzerland", "journal": "ClinicalTrials.gov", "publication_date": "2026-06-24", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06884514", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Receptor Pharmacology,Consciousness,Wellbeing,Personality Change,Emotional Processing,Safety", "study_type": "Qualitative Study", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 23:13:10", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06884514", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06884514", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06884514", "source_url": "https://clinicaltrials.gov/study/NCT06884514", "doi": "", "pmid": "", "publication_date": "2026-06-24", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3560, "title": "A Pilot Mechanistic RCT of Psilocybin With Mindfulness-based Therapy vs Support for Posttraumatic Stress Disorder (PTSD)", "authors": "Anthony P King", "journal": "ClinicalTrials.gov", "publication_date": "2026-06-24", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07104916", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Neuroplasticity,Brain Imaging,Mechanism of Action,Biomarkers,Aging,Randomized Controlled Trial,Healthcare Workers,Drug Interactions", "study_type": "Randomized Controlled Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 23:13:10", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07104916", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07104916", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07104916", "source_url": "https://clinicaltrials.gov/study/NCT07104916", "doi": "", "pmid": "", "publication_date": "2026-06-24", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 30, "title": "The intersection between psychedelics and schizophrenia spectrum disorders: Reevaluating risk and therapeutic potential.", "authors": "Brar PS, Price RB, Ross S, Tofighi B, Sarpal DK", "journal": "Journal of psychopharmacology (Oxford, England)", "publication_date": "2026-06-24", "publication_year": 2026, "doi": "10.1177/02698811261456191", "pubmed_id": "42345450", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/42345450/", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Review Article,Safety", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-02 23:03:18", "bibtex": null, "source_record_id": "PMID:42345450", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/42345450/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:42345450", "source_url": "https://pubmed.ncbi.nlm.nih.gov/42345450/", "doi": "10.1177/02698811261456191", "pmid": "42345450", "publication_date": "2026-06-24", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 29, "title": "Novel approaches in depression treatment: from rapid-acting antidepressants to personalized interventions.", "authors": "Guidetti C, Fava M, Papakostas GI.", "journal": null, "publication_date": "2026-06-24", "publication_year": 2026, "doi": "10.1038/s41380-026-03722-0", "pubmed_id": "42350785", "openalex_id": null, "source_url": "https://doi.org/10.1038/s41380-026-03722-0", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging,Biomarkers,Clinical Trial,Review Article,Treatment-Resistant Depression", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-02 23:03:30", "bibtex": null, "source_record_id": "PMID:42350785", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1038/s41380-026-03722-0", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:42350785", "source_url": "https://doi.org/10.1038/s41380-026-03722-0", "doi": "10.1038/s41380-026-03722-0", "pmid": "42350785", "publication_date": "2026-06-24", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3986, "title": "Mechanistic insights toward dissociating therapeutic from psychedelic effects: bridging the gap between psychedelic research and mental health care", "authors": "Mauro Pettorruso, Giacomo d’Andrea, Antonio Inserra, Clara Cavallotto, Stefano Censi, Étienne Billard, Antonio Di Stefano, Luisa De Risio, Maria Giulia Tullo, Claudio D’Addario, Giorgio Di Lorenzo, Richard G. Wise, Stefano L. Sensi, Francesca Zoratto, Giovanni Martinotti", "journal": "Translational Psychiatry", "publication_date": "2026-06-23", "publication_year": 2026, "doi": "10.1038/s41398-026-04203-2", "pubmed_id": "42342649", "openalex_id": "https://openalex.org/W7165728379", "source_url": "https://doi.org/10.1038/s41398-026-04203-2", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Chronic Pain,Pharmacology,Mechanism of Action,Receptor Pharmacology,Default Mode Network,Consciousness,Personality Change,Mystical Experience,Clinical Trial,Animal Study,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:34", "last_checked": "2026-07-04 06:34:34", "bibtex": null, "source_record_id": "PMID:42342649", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1038/s41398-026-04203-2", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:42342649", "source_url": "https://doi.org/10.1038/s41398-026-04203-2", "doi": "10.1038/s41398-026-04203-2", "pmid": "42342649", "publication_date": "2026-06-23", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3684, "title": "TRIP - TReatment to Improve Depression and/or Anxiety Using Psilocybin-Assisted Psychotherapy in Patients With Advanced Cancer on Maintenance Therapy", "authors": "M.D. Anderson Cancer Center", "journal": "ClinicalTrials.gov", "publication_date": "2026-06-23", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06200155", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Chronic Pain,Neuroplasticity,Brain Imaging,Receptor Pharmacology,Biomarkers,Wellbeing,Mystical Experience,Healthcare Workers,Safety,Inflammation,Immune Function", "study_type": "Other", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:34", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06200155", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06200155", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06200155", "source_url": "https://clinicaltrials.gov/study/NCT06200155", "doi": "", "pmid": "", "publication_date": "2026-06-23", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3674, "title": "TRIPS - Treatment to Improve Depression and/or Anxiety Using Psilocybin-assisted Psychotherapy in Cancer Survivors", "authors": "M.D. Anderson Cancer Center", "journal": "ClinicalTrials.gov", "publication_date": "2026-06-23", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06801041", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Chronic Pain,Neuroplasticity,Brain Imaging,Receptor Pharmacology,Biomarkers,Wellbeing,Mystical Experience,Healthcare Workers,Safety,Inflammation,Immune Function", "study_type": "Other", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:34", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06801041", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06801041", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06801041", "source_url": "https://clinicaltrials.gov/study/NCT06801041", "doi": "", "pmid": "", "publication_date": "2026-06-23", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3705, "title": "Effects of Psilocybin Microdosing on Cognition, Mood and Quality of Life: A Pilot Study", "authors": "Yale University", "journal": "ClinicalTrials.gov", "publication_date": "2026-06-22", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07449351", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging,Mechanism of Action,Aging,Longevity,Microdosing,Wellbeing,Treatment-Resistant Depression,Safety", "study_type": "Other", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:34", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07449351", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07449351", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07449351", "source_url": "https://clinicaltrials.gov/study/NCT07449351", "doi": "", "pmid": "", "publication_date": "2026-06-22", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3650, "title": "Psilocybin-assisted Existential, Attachment and Relational (PEARL) Therapy for Caregivers of Patients With Advanced Cancer: A Phase II Open-Label Trial", "authors": "University Health Network, Toronto", "journal": "ClinicalTrials.gov", "publication_date": "2026-06-22", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07048743", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Spirituality,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:34", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07048743", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07048743", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07048743", "source_url": "https://clinicaltrials.gov/study/NCT07048743", "doi": "", "pmid": "", "publication_date": "2026-06-22", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 34, "title": "Blocking 5-HT2B receptors abolishes psilocybin’s efficacy in the rat forced swim test", "authors": "Lenka Seillier, Alexandre Seillier, Morgan A. Zvolska, Romana Šlamberová", "journal": "Journal of Psychopharmacology", "publication_date": "2026-06-22", "publication_year": 2026, "doi": "10.1177/02698811261458349", "pubmed_id": "42334341", "openalex_id": "https://openalex.org/W7165643590", "source_url": "https://doi.org/10.1177/02698811261458349", "substance_tags": "psilocybin", "topic_tags": "Depression,Pharmacology,Mechanism of Action,Receptor Pharmacology,Animal Study,Toxicity", "study_type": "Animal Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "PMID:42334341", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1177/02698811261458349", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:42334341", "source_url": "https://doi.org/10.1177/02698811261458349", "doi": "10.1177/02698811261458349", "pmid": "42334341", "publication_date": "2026-06-22", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3024, "title": "Sex-Specific Effects of Psilocybin Versus Escitalopram on Anxiety and Anhedonia: A Bayesian Reanalysis of Antidepressant Treatment Outcomes", "authors": "Frick A, Blest-Hopley G, Grin M, Erritzoe D, Nutt D, Carhart-Harris R.", "journal": "Research Square", "publication_date": "2026-06-18", "publication_year": 2026, "doi": "10.21203/rs.3.rs-9880403/v1", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.21203/rs.3.rs-9880403/v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Wellbeing,Clinical Trial,Randomized Controlled Trial,Drug Interactions", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "preprint", "date_added": "2026-07-01 11:03:45", "last_checked": "2026-07-01 11:22:00", "bibtex": null, "source_record_id": "DOI:10.21203/rs.3.rs-9880403/v1", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.21203/rs.3.rs-9880403/v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "DOI:10.21203/rs.3.rs-9880403/v1", "source_url": "https://doi.org/10.21203/rs.3.rs-9880403/v1", "doi": "10.21203/rs.3.rs-9880403/v1", "pmid": "", "publication_date": "2026-06-18", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 38, "title": "Psychedelic Use, Microdosing, Motives, and Information and Product Sources Among Young Adults in the United States", "authors": "Carla J. Berg, Darcey M. McCready, Cassidy R. LoParco, Laura C. Schubel, Katelyn F. Romm, Shriya Thakkar, Jessica Williams, Patricia Cavazos-Rehg, Y. Tony Yang", "journal": "Journal of Psychoactive Drugs", "publication_date": "2026-06-18", "publication_year": 2026, "doi": "10.1080/02791072.2026.2685527", "pubmed_id": "42318842", "openalex_id": "https://openalex.org/W7165130491", "source_url": "https://doi.org/10.1080/02791072.2026.2685527", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Microdosing,Observational Study,Toxicity", "study_type": "Observational Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "PMID:42318842", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1080/02791072.2026.2685527", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:42318842", "source_url": "https://doi.org/10.1080/02791072.2026.2685527", "doi": "10.1080/02791072.2026.2685527", "pmid": "42318842", "publication_date": "2026-06-18", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1923, "title": "Psilocybin-assisted therapy in treatment-resistant depression: rapid remission, uncertain durability, and the next phase of clinical evidence", "authors": "Astrit Sabani, Adnan Khatak", "journal": "Annals of Medicine and Surgery", "publication_date": "2026-06-17", "publication_year": 2026, "doi": "10.1097/ms9.0000000000005244", "pubmed_id": null, "openalex_id": "https://openalex.org/W7165127045", "source_url": "https://doi.org/10.1097/ms9.0000000000005244", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Chronic Pain,Receptor Pharmacology,Aging,Clinical Trial,Randomized Controlled Trial,Treatment-Resistant Depression,Safety,Toxicity", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:49:23", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "DOI:10.1097/ms9.0000000000005244", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1097/ms9.0000000000005244", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1097/ms9.0000000000005244", "source_url": "https://doi.org/10.1097/ms9.0000000000005244", "doi": "10.1097/ms9.0000000000005244", "pmid": "", "publication_date": "2026-06-17", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 43, "title": "Short- and Long-Acting Psychedelics: Structure-Activity Relationships, Pharmacology, and Implications for Neuropsychiatric Therapeutics.", "authors": "Bhat A, Zolali E, Sakib MA, Rahimian M, McMahon LR, German N, Obeng S", "journal": "ACS chemical neuroscience", "publication_date": "2026-06-16", "publication_year": 2026, "doi": "10.1021/acschemneuro.6c00202", "pubmed_id": "42257400", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/42257400/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Pharmacology,Receptor Pharmacology,Review Article", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-01 11:20:34", "bibtex": null, "source_record_id": "PMID:42257400", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/42257400/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:42257400", "source_url": "https://pubmed.ncbi.nlm.nih.gov/42257400/", "doi": "10.1021/acschemneuro.6c00202", "pmid": "42257400", "publication_date": "2026-06-16", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3023, "title": "Distinct brain responses to psilocybin and escitalopram in depression captured by the Fluctuation-Dissipation Theorem", "authors": "Dagnino PC, Acero-Pousa I, Zamora-López G, Escrichs A, Erritzoe D, Nutt DJ, Carhart-Harris RL, Sanz Perl Y, Kringelbach ML, Deco G.", "journal": "bioRxiv", "publication_date": "2026-06-15", "publication_year": 2026, "doi": "10.64898/2026.06.12.731811", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.64898/2026.06.12.731811", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging,Mechanism of Action,Biomarkers,Aging,Randomized Controlled Trial", "study_type": "Randomized Controlled Trial", "source_name": "bioRxiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:45", "last_checked": "2026-07-01 11:22:00", "bibtex": null, "source_record_id": "DOI:10.64898/2026.06.12.731811", "abstract_available": true, "abstract_source": "bioRxiv", "abstract_source_url": "https://doi.org/10.64898/2026.06.12.731811", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "bioRxiv", "source_record_id": "DOI:10.64898/2026.06.12.731811", "source_url": "https://doi.org/10.64898/2026.06.12.731811", "doi": "10.64898/2026.06.12.731811", "pmid": "", "publication_date": "2026-06-15", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1927, "title": "Psilocybin and Mental Health Outcomes: Scoping Review with ☸SAIMSARA", "authors": "SAIMSARA", "journal": "SAIMSARA Journal", "publication_date": "2026-06-14", "publication_year": 2026, "doi": "10.62487/saimsara7a54f680", "pubmed_id": null, "openalex_id": "https://openalex.org/W7164845889", "source_url": "https://doi.org/10.62487/saimsara7a54f680", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,End-of-Life Distress,Chronic Pain,Mechanism of Action,Clinical Trial,Review Article,Observational Study,Treatment-Resistant Depression,Safety,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:49:23", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "DOI:10.62487/saimsara7a54f680", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.62487/saimsara7a54f680", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.62487/saimsara7a54f680", "source_url": "https://doi.org/10.62487/saimsara7a54f680", "doi": "10.62487/saimsara7a54f680", "pmid": "", "publication_date": "2026-06-14", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1926, "title": "Efficacy of Psilocybin-Assisted Therapy in Major Depressive Disorder: A Systematic Review and Meta-Analysis", "authors": "Angel Labra-Lorenzana, Dania Nimbe Lima Sanchez, Christian Alejandro Delaflor-Wagner, Diana Martínez-Hernández, Christian Ramos-Jiménez, Christian Gabriel Toledo-Lozano", "journal": "Psychiatry International", "publication_date": "2026-06-14", "publication_year": 2026, "doi": "10.3390/psychiatryint7030137", "pubmed_id": null, "openalex_id": "https://openalex.org/W7164820747", "source_url": "https://doi.org/10.3390/psychiatryint7030137", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Clinical Trial,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Safety,Adverse Events,Toxicity", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:49:23", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "DOI:10.3390/psychiatryint7030137", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.3390/psychiatryint7030137", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.3390/psychiatryint7030137", "source_url": "https://doi.org/10.3390/psychiatryint7030137", "doi": "10.3390/psychiatryint7030137", "pmid": "", "publication_date": "2026-06-14", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 46, "title": "Music Playlist Use in Clinical Trials of Psychedelic Assisted Psychotherapy: A Systematic Review", "authors": "Lucas Cruz, Fernando R. Beserra, Julia M.K. Freind, Sandro E. Rodrigues, Daniel C. Mograbi", "journal": "Journal of Clinical Psychology", "publication_date": "2026-06-14", "publication_year": 2026, "doi": "10.1002/jclp.70167", "pubmed_id": "42296474", "openalex_id": "https://openalex.org/W7164838909", "source_url": "https://doi.org/10.1002/jclp.70167", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Chronic Pain,Clinical Trial,Systematic Review,Review Article,Toxicity", "study_type": "Systematic Review", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "PMID:42296474", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1002/jclp.70167", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:42296474", "source_url": "https://doi.org/10.1002/jclp.70167", "doi": "10.1002/jclp.70167", "pmid": "42296474", "publication_date": "2026-06-14", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 54, "title": "Pharmacokinetic and pharmacodynamic rational for expanding the therapeutic landscape of psilocybin beyond depression", "authors": "J. Mingardi, R. Molteni, F. Bifari", "journal": "Pharmacological Research", "publication_date": "2026-06-10", "publication_year": 2026, "doi": "10.1016/j.phrs.2026.108290", "pubmed_id": "42276399", "openalex_id": "https://openalex.org/W7164387819", "source_url": "https://doi.org/10.1016/j.phrs.2026.108290", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Pharmacology,Receptor Pharmacology", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "PMID:42276399", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:42276399", "source_url": "https://doi.org/10.1016/j.phrs.2026.108290", "doi": "10.1016/j.phrs.2026.108290", "pmid": "42276399", "publication_date": "2026-06-10", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3210, "title": "Aquahenosis: A non-pharmacological altered state of consciousness induced by Floatation-REST in individuals with anxiety and depression", "authors": "", "journal": "PsyArXiv", "publication_date": "2026-06-09", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://osf.io/preprints/psyarxiv/6mj8n_v2", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Mechanism of Action,Consciousness,Randomized Controlled Trial", "study_type": "Randomized Controlled Trial", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:48", "last_checked": "2026-07-01 11:22:30", "bibtex": null, "source_record_id": "https://osf.io/preprints/psyarxiv/6mj8n_v2", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/6mj8n_v2", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "https://osf.io/preprints/psyarxiv/6mj8n_v2", "source_url": "https://osf.io/preprints/psyarxiv/6mj8n_v2", "doi": "", "pmid": "", "publication_date": "2026-06-09", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 56, "title": "The effects of psychedelics on attention deficit and hyperactivity disorder - a systematic review", "authors": "Helerin Raikkerus, Andrea Bujour, Mark Kennedy, Jari Tiihonen", "journal": "Acta Neuropsychiatrica", "publication_date": "2026-06-09", "publication_year": 2026, "doi": "10.1017/neu.2026.10088", "pubmed_id": "42265057", "openalex_id": "https://openalex.org/W7164031094", "source_url": "https://doi.org/10.1017/neu.2026.10088", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Randomized Controlled Trial,Systematic Review,Review Article,Toxicity", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "PMID:42265057", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1017/neu.2026.10088", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:42265057", "source_url": "https://doi.org/10.1017/neu.2026.10088", "doi": "10.1017/neu.2026.10088", "pmid": "42265057", "publication_date": "2026-06-09", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3472, "title": "A Multi-site Randomized Controlled Trial of Psilocybin for Treatment-Resistant Depression (TRD) in Veterans", "authors": "VA Office of Research and Development", "journal": "ClinicalTrials.gov", "publication_date": "2026-06-04", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07226232", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Randomized Controlled Trial,Treatment-Resistant Depression,Veterans,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07226232", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07226232", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07226232", "source_url": "https://clinicaltrials.gov/study/NCT07226232", "doi": "", "pmid": "", "publication_date": "2026-06-04", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 62, "title": "Correction to: Preliminary Evidence of Sleep Improvements Following Psilocybin Administration, and their Involvement in Antidepressant Therapeutic Action", "authors": "Matthew J. Reid, Hannes Kettner, Tessa F. Blanken, Brandon Weiss, Robin Carhart-Harris", "journal": "Current Psychiatry Reports", "publication_date": "2026-06-04", "publication_year": 2026, "doi": "10.1007/s11920-026-01685-1", "pubmed_id": "42243392", "openalex_id": "https://openalex.org/W7163564850", "source_url": "https://doi.org/10.1007/s11920-026-01685-1", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "PMID:42243392", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:42243392", "source_url": "https://doi.org/10.1007/s11920-026-01685-1", "doi": "10.1007/s11920-026-01685-1", "pmid": "42243392", "publication_date": "2026-06-04", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 64, "title": "Changes in anxiety, quality of life, and functioning following psilocybin-assisted therapy in veterans with treatment-resistant depression", "authors": "Cecelia Kelly, Mathieu Fradet, Catherine M. Bostian, Anna Donnelly, Sara Ellis, Michael Ostacher, Scott Aaronson, Trisha Suppes", "journal": "Journal of Affective Disorders", "publication_date": "2026-06-03", "publication_year": 2026, "doi": "10.1016/j.jad.2026.122063", "pubmed_id": "42248535", "openalex_id": "https://openalex.org/W7163510976", "source_url": "https://doi.org/10.1016/j.jad.2026.122063", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Chronic Pain,Clinical Trial,Randomized Controlled Trial,Treatment-Resistant Depression,Veterans,Toxicity", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "PMID:42248535", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:42248535", "source_url": "https://doi.org/10.1016/j.jad.2026.122063", "doi": "10.1016/j.jad.2026.122063", "pmid": "42248535", "publication_date": "2026-06-03", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3367, "title": "Prolonged Grief Symptom Outcomes During At-Home Ketamine-Assisted Therapy: A Real-World Retrospective Analysis of 503 Adults", "authors": "Carter D, Reardon I, Swain J, Vando L.", "journal": "Research Square", "publication_date": "2026-06-01", "publication_year": 2026, "doi": "10.21203/rs.3.rs-9839240/v1", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.21203/rs.3.rs-9839240/v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Emotional Processing,Randomized Controlled Trial,Observational Study,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "preprint", "date_added": "2026-07-01 11:03:51", "last_checked": "2026-07-01 11:22:05", "bibtex": null, "source_record_id": "DOI:10.21203/rs.3.rs-9839240/v1", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.21203/rs.3.rs-9839240/v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "DOI:10.21203/rs.3.rs-9839240/v1", "source_url": "https://doi.org/10.21203/rs.3.rs-9839240/v1", "doi": "10.21203/rs.3.rs-9839240/v1", "pmid": "", "publication_date": "2026-06-01", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 69, "title": "Time to embrace the whole: considering the replacement of psilocybin with Psilocybe spp. in psychedelic research and therapy", "authors": "Genís Oña, Cristina Llagostera, Oscar Alvarez, Rosa M. Dueñas, Débora González, Óscar Soto-Angona", "journal": "Natural Product Research", "publication_date": "2026-06-01", "publication_year": 2026, "doi": "10.1080/14786419.2026.2683121", "pubmed_id": "42228759", "openalex_id": "https://openalex.org/W7163160532", "source_url": "https://doi.org/10.1080/14786419.2026.2683121", "substance_tags": "psilocybin", "topic_tags": "Depression,OCD,Neuroplasticity,Pharmacology,Review Article,Animal Study,Toxicity,Metabolomics", "study_type": "Review Article", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "PMID:42228759", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1080/14786419.2026.2683121", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:42228759", "source_url": "https://doi.org/10.1080/14786419.2026.2683121", "doi": "10.1080/14786419.2026.2683121", "pmid": "42228759", "publication_date": "2026-06-01", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3647, "title": "Imaging the Effects of Serotonin 2A Receptor Modulation on Synaptic Density in Treatment-resistant Depression (SYNVEST)", "authors": "Centre for Addiction and Mental Health", "journal": "ClinicalTrials.gov", "publication_date": "2026-05-31", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06512220", "substance_tags": "psilocybin", "topic_tags": "Depression,Neuroplasticity,Brain Imaging,Receptor Pharmacology,Aging,Clinical Trial,Randomized Controlled Trial,Healthy Volunteers,Treatment-Resistant Depression", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:34", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06512220", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06512220", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06512220", "source_url": "https://clinicaltrials.gov/study/NCT06512220", "doi": "", "pmid": "", "publication_date": "2026-05-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3615, "title": "A Phase 3, Randomized, Double-Blind, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Psilocybin in Adults With Major Depressive Disorder (MDD)", "authors": "Usona Institute", "journal": "ClinicalTrials.gov", "publication_date": "2026-05-31", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06308653", "substance_tags": "psilocybin", "topic_tags": "Depression,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:34", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06308653", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06308653", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06308653", "source_url": "https://clinicaltrials.gov/study/NCT06308653", "doi": "", "pmid": "", "publication_date": "2026-05-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1930, "title": "EE341 COST-EFFECTIVENESS OF PSILOCYBIN-ASSISTED THERAPY (PAT) FOR PATIENTS WITH TREATMENT-RESISTANT DEPRESSION", "authors": "Yosr Ziadi, Taehwan Park", "journal": "Value in Health", "publication_date": "2026-05-31", "publication_year": 2026, "doi": "10.1016/j.jval.2026.03.635", "pubmed_id": null, "openalex_id": "https://openalex.org/W7166194446", "source_url": "https://doi.org/10.1016/j.jval.2026.03.635", "substance_tags": "psilocybin", "topic_tags": "Depression,Personality Change,Treatment-Resistant Depression", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:49:23", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "DOI:10.1016/j.jval.2026.03.635", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.jval.2026.03.635", "source_url": "https://doi.org/10.1016/j.jval.2026.03.635", "doi": "10.1016/j.jval.2026.03.635", "pmid": "", "publication_date": "2026-05-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 75, "title": "Hallucinogen-Assisted Psychotherapy for Trauma Disorders: A Bionian Lens", "authors": "Christopher W. T. Miller, Zofia Kozak", "journal": "Psychodynamic Psychiatry", "publication_date": "2026-05-31", "publication_year": 2026, "doi": "10.1521/pdps.2026.54.2.308", "pubmed_id": "42301163", "openalex_id": "https://openalex.org/W7164890397", "source_url": "https://doi.org/10.1521/pdps.2026.54.2.308", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Mechanism of Action,Spirituality,Toxicity", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "PMID:42301163", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1521/pdps.2026.54.2.308", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:42301163", "source_url": "https://doi.org/10.1521/pdps.2026.54.2.308", "doi": "10.1521/pdps.2026.54.2.308", "pmid": "42301163", "publication_date": "2026-05-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 74, "title": "Expectations and Motivations for Participation in Clinical Trials Utilizing Psychedelics for Treatment-Resistant Depression: A Qualitative Study", "authors": "C. Poppe, Liisa Lyck, Laura Bechtold, Dimitris Repantis", "journal": "Brain and Behavior", "publication_date": "2026-05-31", "publication_year": 2026, "doi": "10.1002/brb3.71544", "pubmed_id": "42304595", "openalex_id": "https://openalex.org/W7164930745", "source_url": "https://doi.org/10.1002/brb3.71544", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Mechanism of Action,Clinical Trial,Treatment-Resistant Depression,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "PMID:42304595", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1002/brb3.71544", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:42304595", "source_url": "https://doi.org/10.1002/brb3.71544", "doi": "10.1002/brb3.71544", "pmid": "42304595", "publication_date": "2026-05-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 53, "title": "Psilocybin restores behavior and 5-HT2A signaling while reducing microglial density after chronic traumatic brain injury in rats", "authors": "Josh Allen, Bianca Jupp, Tamara L. Baker, Mohammad B. Haskali, Robert Brkljača, Zoe Plummer, Mujun Sun, Justin Brand, Brian R. Christie, Chantel T. Debert, Stuart J. McDonald, Terence J. O’Brien, Pablo M. Casillas-Espinosa, Sandy R. Shultz", "journal": "Cell Reports Medicine", "publication_date": "2026-05-31", "publication_year": 2026, "doi": "10.1016/j.xcrm.2026.102867", "pubmed_id": "42285092", "openalex_id": "https://openalex.org/W7164582898", "source_url": "https://doi.org/10.1016/j.xcrm.2026.102867", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Neuroplasticity,Pharmacology,Mechanism of Action,Receptor Pharmacology,Safety,Toxicity,Inflammation", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "PMID:42285092", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1016/j.xcrm.2026.102867", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:42285092", "source_url": "https://doi.org/10.1016/j.xcrm.2026.102867", "doi": "10.1016/j.xcrm.2026.102867", "pmid": "42285092", "publication_date": "2026-05-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3576, "title": "A Phase 2a Study of Group Retreat Psilocybin Therapy for Cancer-Related Anxiety and Depression", "authors": "University of Washington", "journal": "ClinicalTrials.gov", "publication_date": "2026-05-28", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07336238", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Clinical Trial,Observational Study,Cancer Patients,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07336238", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07336238", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07336238", "source_url": "https://clinicaltrials.gov/study/NCT07336238", "doi": "", "pmid": "", "publication_date": "2026-05-28", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1940, "title": "Psilocybin shows rapid relief for depression symptoms", "authors": "Valerie A. Canady", "journal": "Mental Health Weekly", "publication_date": "2026-05-28", "publication_year": 2026, "doi": "10.1002/mhw.34890", "pubmed_id": null, "openalex_id": "https://openalex.org/W7162755829", "source_url": "https://doi.org/10.1002/mhw.34890", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Clinical Trial,Randomized Controlled Trial", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:49:23", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "DOI:10.1002/mhw.34890", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1002/mhw.34890", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1002/mhw.34890", "source_url": "https://doi.org/10.1002/mhw.34890", "doi": "10.1002/mhw.34890", "pmid": "", "publication_date": "2026-05-28", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1939, "title": "Psilocybin shows mixed results for patients with treatment-resistant depression", "authors": "", "journal": "The Brown University Psychopharmacology Update", "publication_date": "2026-05-28", "publication_year": 2026, "doi": "10.1002/pu.31461", "pubmed_id": null, "openalex_id": "https://openalex.org/W7162787347", "source_url": "https://doi.org/10.1002/pu.31461", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Clinical Trial,Randomized Controlled Trial,Treatment-Resistant Depression,Toxicity", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:49:23", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "DOI:10.1002/pu.31461", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1002/pu.31461", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1002/pu.31461", "source_url": "https://doi.org/10.1002/pu.31461", "doi": "10.1002/pu.31461", "pmid": "", "publication_date": "2026-05-28", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1937, "title": "Effect of psilocybin-assisted psychotherapy on anxiety symptoms: A systematic review and meta-analysis", "authors": "Alex Hood, Gary ELKINS", "journal": "Journal of Psychedelic Studies", "publication_date": "2026-05-28", "publication_year": 2026, "doi": "10.1556/2054.2026.00507", "pubmed_id": null, "openalex_id": "https://openalex.org/W7162785692", "source_url": "https://doi.org/10.1556/2054.2026.00507", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,End-of-Life Distress,Chronic Pain,Receptor Pharmacology,Clinical Trial,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Toxicity", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:49:23", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "DOI:10.1556/2054.2026.00507", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1556/2054.2026.00507", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1556/2054.2026.00507", "source_url": "https://doi.org/10.1556/2054.2026.00507", "doi": "10.1556/2054.2026.00507", "pmid": "", "publication_date": "2026-05-28", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 93, "title": "A systematic review of the pharmacokinetics of classical serotonergic psychedelic compounds in healthy adult subjects", "authors": "Elliot Hampsey, Kirsty Martin, Michail Kalfas, Louis Benson, Sirid Wihlborg, Luke Jelen, Allan H. Young, James Rucker", "journal": "Journal of Psychopharmacology", "publication_date": "2026-05-28", "publication_year": 2026, "doi": "10.1177/02698811261453938", "pubmed_id": "42212869", "openalex_id": "https://openalex.org/W7162805790", "source_url": "https://doi.org/10.1177/02698811261453938", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Pharmacology,Clinical Trial,Systematic Review,Review Article,Toxicity", "study_type": "Systematic Review", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "PMID:42212869", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1177/02698811261453938", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:42212869", "source_url": "https://doi.org/10.1177/02698811261453938", "doi": "10.1177/02698811261453938", "pmid": "42212869", "publication_date": "2026-05-28", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 90, "title": "Psychedelic-induced hypomania and mania: a systematic review and meta-analysis.", "authors": "Eskinazi M, Nasserdine R, Cusin RM, Baniotoupoulos P, Saccaro LF, De Pieri M, Corino T, Seragnoli F, Briefer JF, Aboulafia Brakha T, Richard-Lepouriel H, Penzenstadler L, Böge K, Kirchner M, Zullino D, Højlund M, Sapienza J, Bosia M, Catalan A, Vieta E, Solmi M, Sabé M.", "journal": null, "publication_date": "2026-05-28", "publication_year": 2026, "doi": "10.1038/s41380-026-03657-6", "pubmed_id": "42215638", "openalex_id": null, "source_url": "https://doi.org/10.1038/s41380-026-03657-6", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Meta-Analysis,Systematic Review,Review Article,Observational Study,Safety", "study_type": "Meta-Analysis", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-01 11:22:01", "bibtex": null, "source_record_id": "PMID:42215638", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1038/s41380-026-03657-6", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:42215638", "source_url": "https://doi.org/10.1038/s41380-026-03657-6", "doi": "10.1038/s41380-026-03657-6", "pmid": "42215638", "publication_date": "2026-05-28", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 97, "title": "Psilocybin-induced neurocardiogenic syncope: a case report", "authors": "Mazen A. Atiq, Eli Weisman, Rodrigo B. Guerra, Luis Luna Martinez, David B. Yaden, Frederick S. Barrett, Sandeep Nayak, Ceyda Sayalı", "journal": "Psychopharmacology", "publication_date": "2026-05-27", "publication_year": 2026, "doi": "10.1007/s00213-026-07079-8", "pubmed_id": "42207275", "openalex_id": "https://openalex.org/W7162662445", "source_url": "https://doi.org/10.1007/s00213-026-07079-8", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Chronic Pain,Brain Imaging,Consciousness,Aging,Emotional Processing,Clinical Trial,Case Report,Safety,Adverse Events,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "PMID:42207275", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1007/s00213-026-07079-8", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:42207275", "source_url": "https://doi.org/10.1007/s00213-026-07079-8", "doi": "10.1007/s00213-026-07079-8", "pmid": "42207275", "publication_date": "2026-05-27", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 99, "title": "Long-Term Efficacy of Psilocybin with Adjunct Psychotherapy in Treatment-Resistant Major Depression (EPIsoDE): 6- and 12-Month Naturalistic Follow-Up of a Phase 2b Trial", "authors": "Lea J. Mertens, Felix Betzler, Manuela Brand, Ricarda Evens, Andrea Jungaberle, Henrik Jungaberle, Laura Kärtner, Tomislav Majić, Christian N. Schmitz, Andreas Ströhle, Dennis Scharf, Moritz Spangemacher, Max Wolff, Zahra Assadi, Scharif Bahri, Lilith Becher, Luca V. Färber, Henry Harder, Niklas Kirchen, Eugenia Kulakova, Linda C. Kunz, Andy Meijer, Barbara Rohrmoser, Stefan Wellek, Moritz M. Berger, Michael Koslowski, Gerhard Gründer", "journal": "Psychotherapy and Psychosomatics", "publication_date": "2026-05-26", "publication_year": 2026, "doi": "10.1159/000552272", "pubmed_id": "42201843", "openalex_id": "https://openalex.org/W7162570449", "source_url": "https://doi.org/10.1159/000552272", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Clinical Trial,Randomized Controlled Trial,Treatment-Resistant Depression,Toxicity", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "PMID:42201843", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1159/000552272", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:42201843", "source_url": "https://doi.org/10.1159/000552272", "doi": "10.1159/000552272", "pmid": "42201843", "publication_date": "2026-05-26", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 98, "title": "Catatonia Associated With First-Time Psilocybin Exposure: A Case Report", "authors": "Jasbir Singh, Pranathi Mruthyunjaya", "journal": "Cureus", "publication_date": "2026-05-26", "publication_year": 2026, "doi": "10.7759/cureus.c439", "pubmed_id": "42211293", "openalex_id": "https://openalex.org/W7162551404", "source_url": "https://doi.org/10.7759/cureus.c439", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Brain Imaging,Aging,Case Report", "study_type": "Case Report", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "PMID:42211293", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.7759/cureus.c439", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:42211293", "source_url": "https://doi.org/10.7759/cureus.c439", "doi": "10.7759/cureus.c439", "pmid": "42211293", "publication_date": "2026-05-26", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3660, "title": "The Safety and Acceptability of Psilocybin With Support and With Massed Prolonged Exposure Therapy for PTSD", "authors": "Emory University", "journal": "ClinicalTrials.gov", "publication_date": "2026-05-25", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07332143", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:34", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07332143", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07332143", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07332143", "source_url": "https://clinicaltrials.gov/study/NCT07332143", "doi": "", "pmid": "", "publication_date": "2026-05-25", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 100, "title": "Epigenome-wide association study of psilocybin-induced methylome changes in alcohol use disorder.", "authors": "Urban MM, Zillich L, Rieser NM, Herdener M, Spanagel R, Vollenweider FX, Preller KH, Meinhardt MW.", "journal": null, "publication_date": "2026-05-25", "publication_year": 2026, "doi": "10.1038/s41398-026-03961-3", "pubmed_id": "42192100", "openalex_id": null, "source_url": "https://doi.org/10.1038/s41398-026-03961-3", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Neuroplasticity,Mechanism of Action,Epigenetics,Observational Study,Genomics,Immune Function", "study_type": "Observational Study", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-01 11:22:00", "bibtex": null, "source_record_id": "PMID:42192100", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1038/s41398-026-03961-3", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:42192100", "source_url": "https://doi.org/10.1038/s41398-026-03961-3", "doi": "10.1038/s41398-026-03961-3", "pmid": "42192100", "publication_date": "2026-05-25", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4012, "title": "Psilocybin for Treatment-Resistant Depression: A Comprehensive Review of Mechanisms and Therapeutic Potential", "authors": "Dallas T Mason", "journal": "Digital Showcase Research, Scholarship, & Creative Works (University of Lynchburg)", "publication_date": "2026-05-21", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": "https://openalex.org/W7162235135", "source_url": "https://digitalshowcase.lynchburg.edu/dmscjournal/vol8/iss1/6", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Brain Imaging,Mechanism of Action,Receptor Pharmacology,Default Mode Network,Aging,Emotional Processing,Clinical Trial,Randomized Controlled Trial,Systematic Review,Review Article,Treatment-Resistant Depression,Safety,Toxicity", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:35", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "https://digitalshowcase.lynchburg.edu/dmscjournal/vol8/iss1/6", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://digitalshowcase.lynchburg.edu/dmscjournal/vol8/iss1/6", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "https://digitalshowcase.lynchburg.edu/dmscjournal/vol8/iss1/6", "source_url": "https://digitalshowcase.lynchburg.edu/dmscjournal/vol8/iss1/6", "doi": "", "pmid": "", "publication_date": "2026-05-21", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4011, "title": "The Use of Psilocybin for Managing Refractory Behavioral Health Conditions: A New and Promising Approach", "authors": "Rachel N Clark", "journal": "Digital Showcase Research, Scholarship, & Creative Works (University of Lynchburg)", "publication_date": "2026-05-21", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": "https://openalex.org/W7162225828", "source_url": "https://digitalshowcase.lynchburg.edu/cgi/viewcontent.cgi?article=3694&context=dmscjournal", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Pharmacology,Receptor Pharmacology,Aging,Clinical Trial,Review Article,Safety,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:35", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "https://digitalshowcase.lynchburg.edu/cgi/viewcontent.cgi?article=3694&context=dmscjournal", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://digitalshowcase.lynchburg.edu/cgi/viewcontent.cgi?article=3694&context=dmscjournal", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "https://digitalshowcase.lynchburg.edu/cgi/viewcontent.cgi?article=3694&context=dmscjournal", "source_url": "https://digitalshowcase.lynchburg.edu/cgi/viewcontent.cgi?article=3694&context=dmscjournal", "doi": "", "pmid": "", "publication_date": "2026-05-21", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4010, "title": "Psilocybin-Assisted Therapy in the Management of Anxiety and Depression Among Cancer Patients", "authors": "Caleb Lemus", "journal": "Digital Showcase Research, Scholarship, & Creative Works (University of Lynchburg)", "publication_date": "2026-05-21", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": "https://openalex.org/W7162222410", "source_url": "https://digitalshowcase.lynchburg.edu/cgi/viewcontent.cgi?article=3713&context=dmscjournal", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Chronic Pain,Neuroplasticity,Aging,Wellbeing,Emotional Processing,Randomized Controlled Trial,Review Article,Cancer Patients,Safety", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:35", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "https://digitalshowcase.lynchburg.edu/cgi/viewcontent.cgi?article=3713&context=dmscjournal", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://digitalshowcase.lynchburg.edu/cgi/viewcontent.cgi?article=3713&context=dmscjournal", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "https://digitalshowcase.lynchburg.edu/cgi/viewcontent.cgi?article=3713&context=dmscjournal", "source_url": "https://digitalshowcase.lynchburg.edu/cgi/viewcontent.cgi?article=3713&context=dmscjournal", "doi": "", "pmid": "", "publication_date": "2026-05-21", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4009, "title": "A single dose of psilocybin eased depression symptoms for months, our study found", "authors": "Hampus Yngwe, J O Lundberg", "journal": null, "publication_date": "2026-05-21", "publication_year": 2026, "doi": "10.64628/ab.esysa7wnu", "pubmed_id": null, "openalex_id": "https://openalex.org/W7162100098", "source_url": "https://doi.org/10.64628/ab.esysa7wnu", "substance_tags": "psilocybin", "topic_tags": "Depression,Toxicity", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:35", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "DOI:10.64628/ab.esysa7wnu", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.64628/ab.esysa7wnu", "source_url": "https://doi.org/10.64628/ab.esysa7wnu", "doi": "10.64628/ab.esysa7wnu", "pmid": "", "publication_date": "2026-05-21", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3661, "title": "Effects of Psilocybin With Psychological Support on Anhedonia in Treatment-resistant Depression: a Randomized Controlled Pilot Trial", "authors": "University of Colorado, Denver", "journal": "ClinicalTrials.gov", "publication_date": "2026-05-21", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06230757", "substance_tags": "psilocybin", "topic_tags": "Depression,Randomized Controlled Trial,Treatment-Resistant Depression", "study_type": "Randomized Controlled Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:34", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06230757", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06230757", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06230757", "source_url": "https://clinicaltrials.gov/study/NCT06230757", "doi": "", "pmid": "", "publication_date": "2026-05-21", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3636, "title": "A Pilot Mechanistic Study of Psilocybin-Assisted Therapy as a Treatment for Depression", "authors": "Washington University School of Medicine", "journal": "ClinicalTrials.gov", "publication_date": "2026-05-19", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07582120", "substance_tags": "psilocybin", "topic_tags": "Depression,Biomarkers,Psychological Flexibility,Clinical Trial", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:34", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07582120", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07582120", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07582120", "source_url": "https://clinicaltrials.gov/study/NCT07582120", "doi": "", "pmid": "", "publication_date": "2026-05-19", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3514, "title": "Psilocybin-assisted Cognitive Behavioral Therapy for Depression", "authors": "University of California, Los Angeles", "journal": "ClinicalTrials.gov", "publication_date": "2026-05-18", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05227612", "substance_tags": "psilocybin", "topic_tags": "Depression", "study_type": "Other", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05227612", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05227612", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05227612", "source_url": "https://clinicaltrials.gov/study/NCT05227612", "doi": "", "pmid": "", "publication_date": "2026-05-18", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 123, "title": "Short-Term and Late-Term Effects of Psilocybin on Symptoms in Major Depression", "authors": "Hampus Yngwe, Pontus Plavén-Sigray, Carl Johan Ekman, Eva Henje, Anders Berglund, Mikael Tiger, Maria Beckman, J O Lundberg", "journal": "JAMA Network Open", "publication_date": "2026-05-14", "publication_year": 2026, "doi": "10.1001/jamanetworkopen.2026.12589", "pubmed_id": "42138922", "openalex_id": "https://openalex.org/W7161294763", "source_url": "https://doi.org/10.1001/jamanetworkopen.2026.12589", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Chronic Pain,Clinical Trial,Randomized Controlled Trial,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "PMID:42138922", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1001/jamanetworkopen.2026.12589", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:42138922", "source_url": "https://doi.org/10.1001/jamanetworkopen.2026.12589", "doi": "10.1001/jamanetworkopen.2026.12589", "pmid": "42138922", "publication_date": "2026-05-14", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3606, "title": "Exploring the Safety, Acceptability, and Efficacy of Psilocybin Among Non-Small Cell Lung Cancer Patients With Major Depressive Disorder: A Proof-of-Concept Trial (DREAM LUNG STUDY)", "authors": "Alan Davis", "journal": "ClinicalTrials.gov", "publication_date": "2026-05-13", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07216404", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Clinical Trial,Observational Study,Cancer Patients,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07216404", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07216404", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07216404", "source_url": "https://clinicaltrials.gov/study/NCT07216404", "doi": "", "pmid": "", "publication_date": "2026-05-13", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3511, "title": "Psilocybin-assisted Therapy for Post-Traumatic Stress Disorder in Survivors of Intimate Partner Violence", "authors": "University of Calgary", "journal": "ClinicalTrials.gov", "publication_date": "2026-05-13", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06885996", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Mechanism of Action,Biomarkers,Oxidative Stress,Emotional Processing,Randomized Controlled Trial,Inflammation", "study_type": "Randomized Controlled Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06885996", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06885996", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06885996", "source_url": "https://clinicaltrials.gov/study/NCT06885996", "doi": "", "pmid": "", "publication_date": "2026-05-13", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4017, "title": "Psychedelic Use and Missed Needed Mental Health Treatment: Gender Differences in Unmet Perceived Need for Care", "authors": "Sean M. Viña", "journal": "Psychoactives", "publication_date": "2026-05-11", "publication_year": 2026, "doi": "10.3390/psychoactives5020014", "pubmed_id": null, "openalex_id": "https://openalex.org/W7160952638", "source_url": "https://doi.org/10.3390/psychoactives5020014", "substance_tags": "psilocybin", "topic_tags": "Depression,Observational Study,Toxicity", "study_type": "Observational Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:35", "last_checked": "2026-07-04 06:34:35", "bibtex": null, "source_record_id": "DOI:10.3390/psychoactives5020014", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.3390/psychoactives5020014", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.3390/psychoactives5020014", "source_url": "https://doi.org/10.3390/psychoactives5020014", "doi": "10.3390/psychoactives5020014", "pmid": "", "publication_date": "2026-05-11", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1945, "title": "Rapid-acting interventions in treatment-resistant depression - a comparative review of esketamine and psilocybin", "authors": "Bartłomiej Kosiarski, Anna Skrzypek, Patrycja Markowicz, Mikołaj Zbrożek, Krzysztof Biłyk, Maciej Hutkowski, Zuzanna Chwostek, Hanna Maruchniak, Wiktoria Marzec, Paulina Biedroń", "journal": "Journal of Pre-Clinical and Clinical Research", "publication_date": "2026-05-11", "publication_year": 2026, "doi": "10.26444/jpccr/221219", "pubmed_id": null, "openalex_id": "https://openalex.org/W7160910785", "source_url": "https://doi.org/10.26444/jpccr/221219", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Randomized Controlled Trial,Systematic Review,Review Article,Case Report,Animal Study,Treatment-Resistant Depression,Safety,Toxicity", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:52:05", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "DOI:10.26444/jpccr/221219", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.26444/jpccr/221219", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.26444/jpccr/221219", "source_url": "https://doi.org/10.26444/jpccr/221219", "doi": "10.26444/jpccr/221219", "pmid": "", "publication_date": "2026-05-11", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 113, "title": "Efficacy and Safety of a Single Dose of Psilocybin for Chronic Suicidal Ideation", "authors": "Andrew van der Vaart, Jeffrey LaPratt, Kimberly Swartz, Audrey Shoultz, Margo Lauterbach, Trisha Suppes, Harold A. Sackeïm, Scott T. Aaronson", "journal": "The Journal of Clinical Psychiatry", "publication_date": "2026-05-11", "publication_year": 2026, "doi": "10.4088/jcp.26m16338", "pubmed_id": "42138588", "openalex_id": "https://openalex.org/W7160906477", "source_url": "https://doi.org/10.4088/jcp.26m16338", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Clinical Trial,Randomized Controlled Trial,Safety,Adverse Events,Toxicity", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "PMID:42138588", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.4088/jcp.26m16338", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:42138588", "source_url": "https://doi.org/10.4088/jcp.26m16338", "doi": "10.4088/jcp.26m16338", "pmid": "42138588", "publication_date": "2026-05-11", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4018, "title": "Treatment-Resistant Depression in the 21st Century: A Scoping Review of Psychedelics and Neuromodulation in Transforming Care", "authors": "Khadija Kamene", "journal": "Premier Journal of Neuroscience", "publication_date": "2026-05-10", "publication_year": 2026, "doi": "10.70389/pjn.100014", "pubmed_id": null, "openalex_id": "https://openalex.org/W7162007156", "source_url": "https://doi.org/10.70389/pjn.100014", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Chronic Pain,Mechanism of Action,Systematic Review,Review Article,Treatment-Resistant Depression,Toxicity", "study_type": "Systematic Review", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:35", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "DOI:10.70389/pjn.100014", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.70389/pjn.100014", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.70389/pjn.100014", "source_url": "https://doi.org/10.70389/pjn.100014", "doi": "10.70389/pjn.100014", "pmid": "", "publication_date": "2026-05-10", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3022, "title": "Safety and Efficacy of Psilocybin in the Management of Treatment-Resistant Depression: A Systematic Review", "authors": "Walters CK, Chetty S, Rants’o TA, Gossayn S, Lerotholi LJ.", "journal": "Research Square", "publication_date": "2026-05-10", "publication_year": 2026, "doi": "10.21203/rs.3.rs-9283280/v1", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.21203/rs.3.rs-9283280/v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Headache / Migraine,Clinical Trial,Systematic Review,Review Article,Observational Study,Treatment-Resistant Depression,Safety,Adverse Events,Toxicity", "study_type": "Systematic Review", "source_name": "Europe PMC", "publication_status": "preprint", "date_added": "2026-07-01 11:03:45", "last_checked": "2026-07-01 11:22:00", "bibtex": null, "source_record_id": "DOI:10.21203/rs.3.rs-9283280/v1", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.21203/rs.3.rs-9283280/v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "DOI:10.21203/rs.3.rs-9283280/v1", "source_url": "https://doi.org/10.21203/rs.3.rs-9283280/v1", "doi": "10.21203/rs.3.rs-9283280/v1", "pmid": "", "publication_date": "2026-05-10", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4019, "title": "From Trials to Clinics: Considerations for Implementing Psychedelic-Assisted Therapy Into Clinical Practice", "authors": "Jessie Kim, Liam Lochhead, Cory R. Weissman", "journal": "Pharmacology Research & Perspectives", "publication_date": "2026-05-09", "publication_year": 2026, "doi": "10.1002/prp2.70262", "pubmed_id": "42108552", "openalex_id": "https://openalex.org/W7160830727", "source_url": "https://doi.org/10.1002/prp2.70262", "substance_tags": "psilocybin", "topic_tags": "Depression,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Emotional Processing,Mystical Experience,Clinical Trial,Review Article,Treatment-Resistant Depression,Healthcare Workers,Safety,Adverse Events,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:35", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "PMID:42108552", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1002/prp2.70262", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:42108552", "source_url": "https://doi.org/10.1002/prp2.70262", "doi": "10.1002/prp2.70262", "pmid": "42108552", "publication_date": "2026-05-09", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 70, "title": "Trials, trips, and tribulations: pathways for implementing psychedelic therapy in Ireland", "authors": "John R. Kelly, Christopher Sheridan, Patricia Iusan, Lisa Coakley, Lisa Burke, C. Brennan, Annie Annie MacDonald, Jo-Hanna Ivers, Dominic Trepel, Garrath Tormey, Martha Finnegan, Gareth W. Young, Andrew Harkin", "journal": "The International Journal of Neuropsychopharmacology", "publication_date": "2026-05-08", "publication_year": 2026, "doi": "10.1093/ijnp/pyag028", "pubmed_id": "42113605", "openalex_id": "https://openalex.org/W7160867854", "source_url": "https://doi.org/10.1093/ijnp/pyag028", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Mechanism of Action,Aging,Clinical Trial,Treatment-Resistant Depression,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "PMID:42113605", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1093/ijnp/pyag028", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:42113605", "source_url": "https://doi.org/10.1093/ijnp/pyag028", "doi": "10.1093/ijnp/pyag028", "pmid": "42113605", "publication_date": "2026-05-08", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3570, "title": "The Safety and Efficacy of Psilocybin Therapy Compared to Low-dose Control in Reducing Depressive Symptoms in Patients With COPD, ALS, MS, or APD.", "authors": "University Medical Center Groningen", "journal": "ClinicalTrials.gov", "publication_date": "2026-05-07", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06782724", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Chronic Pain,Brain Imaging,Biomarkers,Spirituality,Clinical Trial,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06782724", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06782724", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06782724", "source_url": "https://clinicaltrials.gov/study/NCT06782724", "doi": "", "pmid": "", "publication_date": "2026-05-07", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 116, "title": "Exploring new avenues: Psychedelic-assisted therapy for young people", "authors": "Ioanna Artemis Vamvakopoulou, D. P. Nicholls, David J. Nutt, M. Di Simplicio", "journal": "British Journal of Clinical Pharmacology", "publication_date": "2026-05-07", "publication_year": 2026, "doi": "10.1002/bcp.70579", "pubmed_id": "42101062", "openalex_id": "https://openalex.org/W7160597817", "source_url": "https://doi.org/10.1002/bcp.70579", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Wellbeing,Review Article,Observational Study,Adolescents,Safety,Toxicity", "study_type": "Review Article", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "PMID:42101062", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1002/bcp.70579", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:42101062", "source_url": "https://doi.org/10.1002/bcp.70579", "doi": "10.1002/bcp.70579", "pmid": "42101062", "publication_date": "2026-05-07", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3496, "title": "Does Psilocybin Require Psychedelic Effects to Treat Depression? A4-Week, Double-Blind, Proof-of-Concept Randomized Controlled Trial", "authors": "Centre for Addiction and Mental Health", "journal": "ClinicalTrials.gov", "publication_date": "2026-05-06", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05710237", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Receptor Pharmacology,Clinical Trial,Randomized Controlled Trial,Healthy Volunteers,Treatment-Resistant Depression,Safety", "study_type": "Randomized Controlled Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05710237", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05710237", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05710237", "source_url": "https://clinicaltrials.gov/study/NCT05710237", "doi": "", "pmid": "", "publication_date": "2026-05-06", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1947, "title": "Psilocybin-Assisted Therapy in Depressive Disorders: Efficacy, Safety, and Persistence of Clinical Effects - A Narrative Review", "authors": "Kinga Zachar, Maksymilian Sito, Filip Jurkowski, Łukasz Wójcik, Natalia Gawron, Hubert Tomasz Bojanowski, Aleksandra Dobracka, Zuzanna Marczak, Monika Jarowicz, Jędrzej Czmyr", "journal": "Journal of Education Health and Sport", "publication_date": "2026-05-06", "publication_year": 2026, "doi": "10.12775/jehs.2026.91.70672", "pubmed_id": null, "openalex_id": "https://openalex.org/W7160694792", "source_url": "https://doi.org/10.12775/jehs.2026.91.70672", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Chronic Pain,Headache / Migraine,Clinical Trial,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Treatment-Resistant Depression,Safety", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:52:05", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "DOI:10.12775/jehs.2026.91.70672", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.12775/jehs.2026.91.70672", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.12775/jehs.2026.91.70672", "source_url": "https://doi.org/10.12775/jehs.2026.91.70672", "doi": "10.12775/jehs.2026.91.70672", "pmid": "", "publication_date": "2026-05-06", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4020, "title": "Announcement of special issue: ‘Behavioural pharmacology of ketamine and psychedelic drugs’", "authors": "Bart A. Ellenbroek, Gernot Riedel", "journal": "Behavioural Pharmacology", "publication_date": "2026-05-05", "publication_year": 2026, "doi": "10.1097/fbp.0000000000000878", "pubmed_id": "42100839", "openalex_id": "https://openalex.org/W7160630756", "source_url": "https://doi.org/10.1097/fbp.0000000000000878", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Pharmacology,Receptor Pharmacology,Review Article,Treatment-Resistant Depression,Safety,Toxicity", "study_type": "Review Article", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:35", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "PMID:42100839", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1097/fbp.0000000000000878", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:42100839", "source_url": "https://doi.org/10.1097/fbp.0000000000000878", "doi": "10.1097/fbp.0000000000000878", "pmid": "42100839", "publication_date": "2026-05-05", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3620, "title": "A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of up to Two Doses of Psilocybin for the Treatment of Major Depressive Disorder in Adults With Cancer", "authors": "Sunstone Medical", "journal": "ClinicalTrials.gov", "publication_date": "2026-05-05", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05947383", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Observational Study,Cancer Patients,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:34", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05947383", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05947383", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05947383", "source_url": "https://clinicaltrials.gov/study/NCT05947383", "doi": "", "pmid": "", "publication_date": "2026-05-05", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3613, "title": "Induction Protocol for Psilocybin-Assisted Therapy in Treatment-Resistant Depression (TRD): A Pilot Study", "authors": "University of North Carolina, Chapel Hill", "journal": "ClinicalTrials.gov", "publication_date": "2026-05-05", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06303739", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Observational Study,Treatment-Resistant Depression", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:34", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06303739", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06303739", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06303739", "source_url": "https://clinicaltrials.gov/study/NCT06303739", "doi": "", "pmid": "", "publication_date": "2026-05-05", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3536, "title": "A Phase 2 Randomized Study Examining the Safety, Feasibility, and Effectiveness of Masking Psilocybin Therapy With General Anesthesia in Major Depressive Disorder", "authors": "Stanford University", "journal": "ClinicalTrials.gov", "publication_date": "2026-05-05", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07479550", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Brain Imaging,Wellbeing,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07479550", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07479550", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07479550", "source_url": "https://clinicaltrials.gov/study/NCT07479550", "doi": "", "pmid": "", "publication_date": "2026-05-05", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 119, "title": "Human brain changes after first psilocybin use.", "authors": "Lyons T, Spriggs M, Kerkelä L, Rosas FE, Roseman L, Mediano PAM, Timmermann C, Oestreich L, Pagni BA, Zeifman RJ, Hampshire A, Trender W, Douglass HM, Girn M, Godfrey K, Kettner H, Sharif F, Espasiano L, Gazzaley A, Wall MB, Erritzoe D, Nutt DJ, Carhart-Harris RL.", "journal": null, "publication_date": "2026-05-04", "publication_year": 2026, "doi": "10.1038/s41467-026-71962-3", "pubmed_id": "42086570", "openalex_id": null, "source_url": "https://doi.org/10.1038/s41467-026-71962-3", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging,Aging,Wellbeing", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-01 11:22:00", "bibtex": null, "source_record_id": "PMID:42086570", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1038/s41467-026-71962-3", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:42086570", "source_url": "https://doi.org/10.1038/s41467-026-71962-3", "doi": "10.1038/s41467-026-71962-3", "pmid": "42086570", "publication_date": "2026-05-04", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3577, "title": "A One-Year Observational Follow-up Study of Participants With Major Depressive Disorder Following a Randomized, Double-Blind Single-Dose of Psilocybin or Niacin-Control", "authors": "Usona Institute", "journal": "ClinicalTrials.gov", "publication_date": "2026-05-03", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT04353921", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Observational Study", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT04353921", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT04353921", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT04353921", "source_url": "https://clinicaltrials.gov/study/NCT04353921", "doi": "", "pmid": "", "publication_date": "2026-05-03", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3559, "title": "A Phase 2 Sequential Dose-Finding Study of Preparation for Group Retreat Psilocybin Therapy for Healthcare Clinicians With Loss of Meaning in Their Work and Symptoms of Depression", "authors": "University of Washington", "journal": "ClinicalTrials.gov", "publication_date": "2026-05-03", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07565909", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Clinical Trial,Observational Study,Healthcare Workers,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07565909", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07565909", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07565909", "source_url": "https://clinicaltrials.gov/study/NCT07565909", "doi": "", "pmid": "", "publication_date": "2026-05-03", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3531, "title": "Safety, Tolerability, Outcomes of Psilocybin for Depression (STOP Depression) in Veterans With Spinal Cord Injury", "authors": "James J. Peters Veterans Affairs Medical Center", "journal": "ClinicalTrials.gov", "publication_date": "2026-05-03", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07251491", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Mechanism of Action,Receptor Pharmacology,Wellbeing,Veterans,Safety,Adverse Events", "study_type": "Other", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07251491", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07251491", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07251491", "source_url": "https://clinicaltrials.gov/study/NCT07251491", "doi": "", "pmid": "", "publication_date": "2026-05-03", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3516, "title": "Group Psilocybin-assisted Cognitive Behavioral Therapy for Major Depressive Disorder", "authors": "University of California, Los Angeles", "journal": "ClinicalTrials.gov", "publication_date": "2026-05-03", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07566104", "substance_tags": "psilocybin", "topic_tags": "Depression", "study_type": "Other", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07566104", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07566104", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07566104", "source_url": "https://clinicaltrials.gov/study/NCT07566104", "doi": "", "pmid": "", "publication_date": "2026-05-03", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1948, "title": "Effects of Psilocybin Treatment on Cognitive Effort Avoidance in Major Depressive Disorder and Co-Occurring Alcohol Use Disorder", "authors": "Ceyda Sayalı, Eli Weisman, Frederick Barrett", "journal": null, "publication_date": "2026-05-01", "publication_year": 2026, "doi": "10.21428/8e6ba8ef.31e358f9", "pubmed_id": null, "openalex_id": "https://openalex.org/W7160707086", "source_url": "https://doi.org/10.21428/8e6ba8ef.31e358f9", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Chronic Pain,Toxicity", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:52:05", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "DOI:10.21428/8e6ba8ef.31e358f9", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.21428/8e6ba8ef.31e358f9", "source_url": "https://doi.org/10.21428/8e6ba8ef.31e358f9", "doi": "10.21428/8e6ba8ef.31e358f9", "pmid": "", "publication_date": "2026-05-01", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3600, "title": "Psilocybin-Assisted Therapy for Treatment-Resistant Depression in Bipolar II Disorder: A Randomized Controlled Trial", "authors": "Lakshmi N Yatham", "journal": "ClinicalTrials.gov", "publication_date": "2026-04-30", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06943573", "substance_tags": "psilocybin", "topic_tags": "Depression,Wellbeing,Randomized Controlled Trial,Healthy Volunteers,Treatment-Resistant Depression,Safety", "study_type": "Randomized Controlled Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06943573", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06943573", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06943573", "source_url": "https://clinicaltrials.gov/study/NCT06943573", "doi": "", "pmid": "", "publication_date": "2026-04-30", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1957, "title": "Effects of Psilocybin on Attentional Set-Shifting Following Chronic Unpredictable Stress in Rats (Abstract ID: 231339)", "authors": "Joseph Hennessey, John Mantsch, John McCorvy", "journal": "Journal of Pharmacology and Experimental Therapeutics", "publication_date": "2026-04-30", "publication_year": 2026, "doi": "10.1016/j.jpet.2026.104291", "pubmed_id": null, "openalex_id": "https://openalex.org/W7160842269", "source_url": "https://doi.org/10.1016/j.jpet.2026.104291", "substance_tags": "psilocybin", "topic_tags": "Depression,Pharmacology,Receptor Pharmacology", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:52:05", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "DOI:10.1016/j.jpet.2026.104291", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.jpet.2026.104291", "source_url": "https://doi.org/10.1016/j.jpet.2026.104291", "doi": "10.1016/j.jpet.2026.104291", "pmid": "", "publication_date": "2026-04-30", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1955, "title": "1080 Psilocybin Elicits Non-Linear Night to Night Changes in Sleep Spectral Power", "authors": "Matthew Reid, Eli Weisman, Luis Luna Martinez, William Coon, Frederick Barrett", "journal": "SLEEP", "publication_date": "2026-04-30", "publication_year": 2026, "doi": "10.1093/sleep/zsag091.1079", "pubmed_id": null, "openalex_id": "https://openalex.org/W7160609961", "source_url": "https://doi.org/10.1093/sleep/zsag091.1079", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Chronic Pain,Brain Imaging,Pharmacology,Consciousness,Clinical Trial", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:52:05", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "DOI:10.1093/sleep/zsag091.1079", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1093/sleep/zsag091.1079", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1093/sleep/zsag091.1079", "source_url": "https://doi.org/10.1093/sleep/zsag091.1079", "doi": "10.1093/sleep/zsag091.1079", "pmid": "", "publication_date": "2026-04-30", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1950, "title": "0408 Insomnia Severity Differences by Psilocybin, LSD, and DMT Use Status Among Young Adult Daily Cannabis Consumers in the Herbal Heart Study", "authors": "Denise Vidot, Bria-Necole Diggs, Amrit Baral, Michelle Thompson, Girardin Jean-Louis", "journal": "SLEEP", "publication_date": "2026-04-30", "publication_year": 2026, "doi": "10.1093/sleep/zsag091.0408", "pubmed_id": null, "openalex_id": "https://openalex.org/W7160621769", "source_url": "https://doi.org/10.1093/sleep/zsag091.0408", "substance_tags": "psilocybin", "topic_tags": "Depression,Observational Study,Toxicity", "study_type": "Observational Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:52:05", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "DOI:10.1093/sleep/zsag091.0408", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1093/sleep/zsag091.0408", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1093/sleep/zsag091.0408", "source_url": "https://doi.org/10.1093/sleep/zsag091.0408", "doi": "10.1093/sleep/zsag091.0408", "pmid": "", "publication_date": "2026-04-30", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1949, "title": "Role of Psychological support in sustaining Antidepressants effects in Psilocybin - Assisted Clinical", "authors": "Gyandev Gupta, Ravina Yadav", "journal": "JOURNAL OF ADVANCE AND FUTURE RESEARCH", "publication_date": "2026-04-30", "publication_year": 2026, "doi": "10.56975/jaafr.v4i5.509087", "pubmed_id": null, "openalex_id": "https://openalex.org/W7160185913", "source_url": "https://doi.org/10.56975/jaafr.v4i5.509087", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Chronic Pain,Pharmacology,Receptor Pharmacology,Aging,Emotional Processing,Clinical Trial,Animal Study,Treatment-Resistant Depression,Healthcare Workers,Adverse Events,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:52:05", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "DOI:10.56975/jaafr.v4i5.509087", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.56975/jaafr.v4i5.509087", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.56975/jaafr.v4i5.509087", "source_url": "https://doi.org/10.56975/jaafr.v4i5.509087", "doi": "10.56975/jaafr.v4i5.509087", "pmid": "", "publication_date": "2026-04-30", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 147, "title": "Predictors of therapeutic response to psychedelic-assisted therapy: A systematic review.", "authors": "Viljoen G, Walter H, Bendau A, Koslowski M, Betzler F", "journal": "Journal of psychopharmacology (Oxford, England)", "publication_date": "2026-04-30", "publication_year": 2026, "doi": "10.1177/02698811251389581", "pubmed_id": "41388888", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/41388888/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,OCD,End-of-Life Distress,Mystical Experience,Systematic Review,Review Article", "study_type": "Systematic Review", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-01 11:20:34", "bibtex": null, "source_record_id": "PMID:41388888", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41388888/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41388888", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41388888/", "doi": "10.1177/02698811251389581", "pmid": "41388888", "publication_date": "2026-04-30", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 130, "title": "Trip killers: Addressing a critical knowledge gap in psychedelic research.", "authors": "O'Mahony B, Harrington C, Harkin A, Lally N", "journal": "Journal of psychopharmacology (Oxford, England)", "publication_date": "2026-04-30", "publication_year": 2026, "doi": "10.1177/02698811261431056", "pubmed_id": "41869862", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/41869862/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Pharmacology,Mechanism of Action,Receptor Pharmacology,Aging,Review Article,Safety,Adverse Events", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-01 11:20:34", "bibtex": null, "source_record_id": "PMID:41869862", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41869862/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41869862", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41869862/", "doi": "10.1177/02698811261431056", "pmid": "41869862", "publication_date": "2026-04-30", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 128, "title": "Effects of psychedelic use on authoritarian attitudes revisited", "authors": "Otto Simonsson, Taylor Lyons, Joseph Marks, Hannes Kettner, Leor Roseman, Eline Haijen, Mendel Kaelen, Robin Carhart-Harris", "journal": "Journal of Psychopharmacology", "publication_date": "2026-04-30", "publication_year": 2026, "doi": "10.1177/02698811261443677", "pubmed_id": "42068187", "openalex_id": "https://openalex.org/W7159826531", "source_url": "https://doi.org/10.1177/02698811261443677", "substance_tags": "psilocybin", "topic_tags": "Depression,Observational Study,Healthy Volunteers,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "PMID:42068187", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1177/02698811261443677", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:42068187", "source_url": "https://doi.org/10.1177/02698811261443677", "doi": "10.1177/02698811261443677", "pmid": "42068187", "publication_date": "2026-04-30", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 114, "title": "Microdosing psilocybin for major depressive disorder: study protocol for a phase II double-blind placebo-controlled randomised partial crossover trial - CORRIGENDUM", "authors": "Zeina Beidas, Anya Ragnhildstveit, Adam Blackman, Thomas Anderson, Emily Fewster, Omer A. Syed, Valentyne Sobolenko, Ismail Kaan Kanca, Tatiana Son, Norman Farb, Rotem Petranker", "journal": "BJPsych Open", "publication_date": "2026-04-30", "publication_year": 2026, "doi": "10.1192/bjo.2026.12000", "pubmed_id": "42125778", "openalex_id": "https://openalex.org/W7161014612", "source_url": "https://doi.org/10.1192/bjo.2026.12000", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Pharmacology,Microdosing,Clinical Trial", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "PMID:42125778", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:42125778", "source_url": "https://doi.org/10.1192/bjo.2026.12000", "doi": "10.1192/bjo.2026.12000", "pmid": "42125778", "publication_date": "2026-04-30", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 106, "title": "Psychedelic-assisted therapy: a survey on the clinical methods of Swiss physicians", "authors": "Kristian Beichmann, Polina Catzeflis, Helena D. Aicher, Federico Seragnoli, Abigail Calder, Adam Amrani, Gregor Hasler", "journal": "Therapeutic Advances in Psychopharmacology", "publication_date": "2026-04-30", "publication_year": 2026, "doi": "10.1177/20451253261448745", "pubmed_id": "42179908", "openalex_id": "https://openalex.org/W7161849392", "source_url": "https://doi.org/10.1177/20451253261448745", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Chronic Pain,Observational Study,Toxicity", "study_type": "Observational Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "PMID:42179908", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1177/20451253261448745", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:42179908", "source_url": "https://doi.org/10.1177/20451253261448745", "doi": "10.1177/20451253261448745", "pmid": "42179908", "publication_date": "2026-04-30", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3509, "title": "Lysergic Acid Diethylamide (LSD) in Palliative Care: a Randomised, Double-blind, Active-placebo Controlled Phase II Study (LPC-Study)", "authors": "University Hospital, Basel, Switzerland", "journal": "ClinicalTrials.gov", "publication_date": "2026-04-28", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05883540", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Chronic Pain,Clinical Trial", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05883540", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05883540", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05883540", "source_url": "https://clinicaltrials.gov/study/NCT05883540", "doi": "", "pmid": "", "publication_date": "2026-04-28", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3474, "title": "A Double-blind, Randomized Trial Examining the Preliminary Efficacy of Psilocybin Therapy for People With Chronic Low Back Pain", "authors": "Joshua Woolley, MD, PhD", "journal": "ClinicalTrials.gov", "publication_date": "2026-04-28", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05351541", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Emotional Processing", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05351541", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05351541", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05351541", "source_url": "https://clinicaltrials.gov/study/NCT05351541", "doi": "", "pmid": "", "publication_date": "2026-04-28", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 152, "title": "The Harmonious Dance: A Narrative Review on Psychedelics and Music in Therapeutic Settings.", "authors": "Wang H, Li X, Yu F, Wang X", "journal": "Current neuropharmacology", "publication_date": "2026-04-27", "publication_year": 2026, "doi": "10.2174/011570159x442471260422110855", "pubmed_id": "42083530", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/42083530/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Default Mode Network,Emotional Processing,Review Article,Drug Interactions", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-01 11:20:34", "bibtex": null, "source_record_id": "PMID:42083530", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/42083530/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:42083530", "source_url": "https://pubmed.ncbi.nlm.nih.gov/42083530/", "doi": "10.2174/011570159x442471260422110855", "pmid": "42083530", "publication_date": "2026-04-27", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1961, "title": "483. Acute Functional Brain Changes Associated With Psilocybin in Depression and Healthy Adults: A Systematic Review and Coordinate-Based Meta-Analysis", "authors": "Joshua Poulin, Nic Viulet, Ashley Liu, Bradley J. MacIntosh, Sean M. Nestor", "journal": "Biological Psychiatry", "publication_date": "2026-04-24", "publication_year": 2026, "doi": "10.1016/j.biopsych.2026.03.717", "pubmed_id": null, "openalex_id": "https://openalex.org/W7155645923", "source_url": "https://doi.org/10.1016/j.biopsych.2026.03.717", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Receptor Pharmacology,Meta-Analysis,Systematic Review,Review Article,Treatment-Resistant Depression,Toxicity", "study_type": "Meta-Analysis", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:52:05", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "DOI:10.1016/j.biopsych.2026.03.717", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.biopsych.2026.03.717", "source_url": "https://doi.org/10.1016/j.biopsych.2026.03.717", "doi": "10.1016/j.biopsych.2026.03.717", "pmid": "", "publication_date": "2026-04-24", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3596, "title": "A Randomized, Double-Blind Study of Single-Dose Psilocybin for Major Depressive Disorder (MDD)", "authors": "Usona Institute", "journal": "ClinicalTrials.gov", "publication_date": "2026-04-21", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT03866174", "substance_tags": "psilocybin", "topic_tags": "Depression,Healthy Volunteers,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT03866174", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT03866174", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT03866174", "source_url": "https://clinicaltrials.gov/study/NCT03866174", "doi": "", "pmid": "", "publication_date": "2026-04-21", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3567, "title": "Toward Patient-Tailored Care for Treatment-Resistant Depression: A Pilot Patient-Preference Clinical Trial of Music and Mindfulness in Psilocybin-Assisted Psychotherapy", "authors": "Kyle Greenway", "journal": "ClinicalTrials.gov", "publication_date": "2026-04-21", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07373535", "substance_tags": "psilocybin", "topic_tags": "Depression,Wellbeing,Clinical Trial,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07373535", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07373535", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07373535", "source_url": "https://clinicaltrials.gov/study/NCT07373535", "doi": "", "pmid": "", "publication_date": "2026-04-21", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1968, "title": "Psilocybin as an alternative to conventional treatments: A systematic review", "authors": "Deivid Antonio Cahuasqui-Mendoza", "journal": "Gaceta Médica de Caracas", "publication_date": "2026-04-21", "publication_year": 2026, "doi": "10.47307/gmc.2026.134.s2.32", "pubmed_id": null, "openalex_id": "https://openalex.org/W7155199454", "source_url": "https://doi.org/10.47307/gmc.2026.134.s2.32", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Chronic Pain,Neuroplasticity,Clinical Trial,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Safety", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:52:05", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "DOI:10.47307/gmc.2026.134.s2.32", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.47307/gmc.2026.134.s2.32", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.47307/gmc.2026.134.s2.32", "source_url": "https://doi.org/10.47307/gmc.2026.134.s2.32", "doi": "10.47307/gmc.2026.134.s2.32", "pmid": "", "publication_date": "2026-04-21", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 164, "title": "Prevalence and Correlates of Past-Year Psilocybin Use in the United States", "authors": "Kevin H. Yang, Avery Eun, Joseph J. Palamar", "journal": "American Journal of Psychiatry", "publication_date": "2026-04-21", "publication_year": 2026, "doi": "10.1176/appi.ajp.20251343", "pubmed_id": "42014961", "openalex_id": "https://openalex.org/W7155191260", "source_url": "https://doi.org/10.1176/appi.ajp.20251343", "substance_tags": "psilocybin", "topic_tags": "Depression,Toxicity", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "PMID:42014961", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:42014961", "source_url": "https://doi.org/10.1176/appi.ajp.20251343", "doi": "10.1176/appi.ajp.20251343", "pmid": "42014961", "publication_date": "2026-04-21", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3436, "title": "Study of Psilocybin Assisted Psychotherapy to Address Fear of Recurrence in Patients Diagnosed With Early-stage Breast Cancer and Ovarian Cancer in Remission", "authors": "University of Colorado, Denver", "journal": "ClinicalTrials.gov", "publication_date": "2026-04-20", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06430541", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Clinical Trial,Observational Study", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06430541", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06430541", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06430541", "source_url": "https://clinicaltrials.gov/study/NCT06430541", "doi": "", "pmid": "", "publication_date": "2026-04-20", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 2978, "title": "The efficacy and safety of psilocybin-assisted therapy for major depressive disorder: a meta-analytic review of clinical outcomes", "authors": "Mohsen Khosravi, Domenico De Berardis, Massimo Tusconi", "journal": "Mental Wellness", "publication_date": "2026-04-20", "publication_year": 2026, "doi": "10.4081/mw.2026.40", "pubmed_id": null, "openalex_id": "https://openalex.org/W7155066504", "source_url": "https://doi.org/10.4081/mw.2026.40", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Clinical Trial,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Observational Study,Treatment-Resistant Depression,Safety,Toxicity", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:55:42", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "DOI:10.4081/mw.2026.40", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.4081/mw.2026.40", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.4081/mw.2026.40", "source_url": "https://doi.org/10.4081/mw.2026.40", "doi": "10.4081/mw.2026.40", "pmid": "", "publication_date": "2026-04-20", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 2977, "title": "Efficacy and Safety of Psilocybin-Assisted Therapy for Depression: A Meta-Analysis of Randomised Controlled Trials", "authors": "Siti Nashria Rusdhy, Andrian Fajar Kusumadewi, Carla Raymondalexas Marchira, Mustika Suci Mahardikaningrum, Teresa Lalita Wiryarini, Devira Ayu Wulandari", "journal": "Open Access Indonesian Journal of Medical Reviews", "publication_date": "2026-04-20", "publication_year": 2026, "doi": "10.37275/oaijmr.v6i2.883", "pubmed_id": null, "openalex_id": "https://openalex.org/W7155091271", "source_url": "https://doi.org/10.37275/oaijmr.v6i2.883", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Chronic Pain,Clinical Trial,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Treatment-Resistant Depression,Safety,Toxicity", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:55:42", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "DOI:10.37275/oaijmr.v6i2.883", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.37275/oaijmr.v6i2.883", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.37275/oaijmr.v6i2.883", "source_url": "https://doi.org/10.37275/oaijmr.v6i2.883", "doi": "10.37275/oaijmr.v6i2.883", "pmid": "", "publication_date": "2026-04-20", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4033, "title": "Psychedelics: Historical Context, Emerging Science, and Future Clinical Frontiers", "authors": "Vipul Janardan, Amit Khanna, Om Prakash, Anadrika Debbarma, SK Mathur", "journal": "Journal of Mental Health Disorders", "publication_date": "2026-04-17", "publication_year": 2026, "doi": "10.33696/mentalhealth.6.068", "pubmed_id": null, "openalex_id": "https://openalex.org/W7166815336", "source_url": "https://doi.org/10.33696/mentalhealth.6.068", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Addiction,Consciousness,Treatment-Resistant Depression,Toxicity", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:35", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "DOI:10.33696/mentalhealth.6.068", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.33696/mentalhealth.6.068", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.33696/mentalhealth.6.068", "source_url": "https://doi.org/10.33696/mentalhealth.6.068", "doi": "10.33696/mentalhealth.6.068", "pmid": "", "publication_date": "2026-04-17", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 168, "title": "Psychedelics and Autism Therapy: A Review of Current Research and Future Directions", "authors": "Christopher S. Gondi, Manu Gnanamony, Tarun P. Gondi, Lilyt Nersesyan, Lusine Demirkhanyan", "journal": "Current Issues in Molecular Biology", "publication_date": "2026-04-17", "publication_year": 2026, "doi": "10.3390/cimb48040417", "pubmed_id": "42042077", "openalex_id": "https://openalex.org/W7154992046", "source_url": "https://doi.org/10.3390/cimb48040417", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Chronic Pain,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Consciousness,Emotional Processing,Psychological Flexibility,Clinical Trial,Review Article,Treatment-Resistant Depression,Toxicity,Drug Interactions", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "PMID:42042077", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.3390/cimb48040417", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:42042077", "source_url": "https://doi.org/10.3390/cimb48040417", "doi": "10.3390/cimb48040417", "pmid": "42042077", "publication_date": "2026-04-17", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3019, "title": "Psilocybin in Older Adults: Therapeutic Opportunities in Inflammation-Driven Disorders of Aging-From Depression to Neurodegeneration", "authors": "Jóźwiak-Bębenista M, Stasiak A, Sienkiewicz M, Kwiatkowski P, Kowalczyk E.", "journal": "Preprints.org", "publication_date": "2026-04-14", "publication_year": 2026, "doi": "10.20944/preprints202604.1125.v1", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.20944/preprints202604.1125.v1", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Pharmacology,Mechanism of Action,Receptor Pharmacology,Default Mode Network,Aging,Inflammaging,Review Article,Older Adults,Treatment-Resistant Depression,Safety,Drug Interactions,Inflammation,Immune Function", "study_type": "Review Article", "source_name": "Europe PMC", "publication_status": "preprint", "date_added": "2026-07-01 11:03:45", "last_checked": "2026-07-01 11:22:00", "bibtex": null, "source_record_id": "DOI:10.20944/preprints202604.1125.v1", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.20944/preprints202604.1125.v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "DOI:10.20944/preprints202604.1125.v1", "source_url": "https://doi.org/10.20944/preprints202604.1125.v1", "doi": "10.20944/preprints202604.1125.v1", "pmid": "", "publication_date": "2026-04-14", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 172, "title": "A phase 1 study of a second experience with Group Retreat Psilocybin Therapy for partial responders after a first experience", "authors": "Anthony L. Back, Bonnie A. McGregor, Leslie L. Thorn, Kalin Harvey, Dianna Blom, George Callan, John Guy, Sameet Kumar, Rob Hershberg, Melissa Layer, Jackie Levin, Susanna Myers, Juliana Perez, Kathy Salmonson, Peter Thompson, Joseph Whinney", "journal": "Frontiers in Public Health", "publication_date": "2026-04-13", "publication_year": 2026, "doi": "10.3389/fpubh.2026.1810904", "pubmed_id": "42058096", "openalex_id": "https://openalex.org/W7154396122", "source_url": "https://doi.org/10.3389/fpubh.2026.1810904", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Chronic Pain,Mystical Experience,Clinical Trial,Cancer Patients,Safety,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "PMID:42058096", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.3389/fpubh.2026.1810904", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:42058096", "source_url": "https://doi.org/10.3389/fpubh.2026.1810904", "doi": "10.3389/fpubh.2026.1810904", "pmid": "42058096", "publication_date": "2026-04-13", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3578, "title": "CAPSI - Cancer Related Major Depression Treated With a Single Dose of Psilocybin: A Multicenter Randomized Placebo Controlled Double Blind Clinical Trial", "authors": "Section for Affective Disorders; Northern Stockholm Psychiatry", "journal": "ClinicalTrials.gov", "publication_date": "2026-04-12", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06319378", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06319378", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06319378", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06319378", "source_url": "https://clinicaltrials.gov/study/NCT06319378", "doi": "", "pmid": "", "publication_date": "2026-04-12", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1970, "title": "Psilocybin for Treatment of Prolonged Grief Disorder: An Open-Label Feasibility Study Protocol", "authors": "J. Morgan Penberthy, Fatma Wise, Nicholas P. Cherup, Evaline Mitchell, Madeline Burns, Oluwafunmilayo Akinlade, David Chung, Harshit Parmar, Jonathan Singer", "journal": "Psychoactives", "publication_date": "2026-04-12", "publication_year": 2026, "doi": "10.3390/psychoactives5020012", "pubmed_id": null, "openalex_id": "https://openalex.org/W7153973756", "source_url": "https://doi.org/10.3390/psychoactives5020012", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Brain Imaging,Clinical Trial,Randomized Controlled Trial,Safety", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:52:05", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "DOI:10.3390/psychoactives5020012", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.3390/psychoactives5020012", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.3390/psychoactives5020012", "source_url": "https://doi.org/10.3390/psychoactives5020012", "doi": "10.3390/psychoactives5020012", "pmid": "", "publication_date": "2026-04-12", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4044, "title": "Additional file 1 of Evaluation of a facilitator training program in a randomized controlled trial of psilocybin treatment for depression", "authors": "Nikita Sanati Morel, Dea Siggaard Stenbaek, Johan Lundberg, Maria Beckman", "journal": "Figshare", "publication_date": "2026-04-08", "publication_year": 2026, "doi": "10.6084/m9.figshare.32048850", "pubmed_id": null, "openalex_id": "https://openalex.org/W7154853940", "source_url": "https://doi.org/10.6084/m9.figshare.32048850", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Randomized Controlled Trial", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:35", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "DOI:10.6084/m9.figshare.32048850", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.6084/m9.figshare.32048850", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.6084/m9.figshare.32048850", "source_url": "https://doi.org/10.6084/m9.figshare.32048850", "doi": "10.6084/m9.figshare.32048850", "pmid": "", "publication_date": "2026-04-08", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 178, "title": "Evaluation of a facilitator training program in a randomized controlled trial of psilocybin treatment for depression", "authors": "Nikita Sanati Morel, Dea Siggaard Stenbaek, Johan Lundberg, Maria Beckman", "journal": "BMC Medical Education", "publication_date": "2026-04-07", "publication_year": 2026, "doi": "10.1186/s12909-026-09124-8", "pubmed_id": "41952163", "openalex_id": "https://openalex.org/W7151958593", "source_url": "https://doi.org/10.1186/s12909-026-09124-8", "substance_tags": "psilocybin", "topic_tags": "Depression,End-of-Life Distress,Chronic Pain,Clinical Trial,Randomized Controlled Trial,Toxicity", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "PMID:41952163", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1186/s12909-026-09124-8", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41952163", "source_url": "https://doi.org/10.1186/s12909-026-09124-8", "doi": "10.1186/s12909-026-09124-8", "pmid": "41952163", "publication_date": "2026-04-07", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3249, "title": "Altered States of Consciousness and the Subconscious Mind: A Comprehensive Comparative Review of Disciplines, Neurobiological Mechanisms, Clinical Applications, and Philosophical Frameworks - Including Life Between Lives and Transpersonal Hypnotherapy", "authors": "Gallardo LM.", "journal": "Preprints.org", "publication_date": "2026-04-06", "publication_year": 2026, "doi": "10.20944/preprints202604.0415.v1", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.20944/preprints202604.0415.v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Neuroplasticity,Brain Imaging,Mechanism of Action,Default Mode Network,Consciousness,Aging,Randomized Controlled Trial,Systematic Review,Review Article,Case Report,Treatment-Resistant Depression", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "preprint", "date_added": "2026-07-01 11:03:49", "last_checked": "2026-07-01 11:22:03", "bibtex": null, "source_record_id": "DOI:10.20944/preprints202604.0415.v1", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.20944/preprints202604.0415.v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "DOI:10.20944/preprints202604.0415.v1", "source_url": "https://doi.org/10.20944/preprints202604.0415.v1", "doi": "10.20944/preprints202604.0415.v1", "pmid": "", "publication_date": "2026-04-06", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1971, "title": "A living systematic review, meta-analysis and open-data resource of randomized controlled trials of psilocybin treatment for symptoms of depression", "authors": "S. Parker Singleton, Brooke L. Sevchik, Analiese Lahey, Pim Cuijpers, Mathias Harrer, Megan T. Jones, Sandeep M. Nayak, Eric C. Strain, Simon Vandekar, Robert H. Dworkin, J. Cobb Scott, Theodore D. Satterthwaite", "journal": "Nature Mental Health", "publication_date": "2026-04-05", "publication_year": 2026, "doi": "10.1038/s44220-026-00630-8", "pubmed_id": null, "openalex_id": "https://openalex.org/W7151101131", "source_url": "https://doi.org/10.1038/s44220-026-00630-8", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Clinical Trial,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Toxicity", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:52:05", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "DOI:10.1038/s44220-026-00630-8", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1038/s44220-026-00630-8", "source_url": "https://doi.org/10.1038/s44220-026-00630-8", "doi": "10.1038/s44220-026-00630-8", "pmid": "", "publication_date": "2026-04-05", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3651, "title": "Effects of Psilocybin in Obsessive Compulsive Disorder", "authors": "Johns Hopkins University", "journal": "ClinicalTrials.gov", "publication_date": "2026-04-01", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05546658", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,OCD,Mechanism of Action,Safety", "study_type": "Other", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:34", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05546658", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05546658", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05546658", "source_url": "https://clinicaltrials.gov/study/NCT05546658", "doi": "", "pmid": "", "publication_date": "2026-04-01", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1972, "title": "Therapeutic Potential of Psilocybin in Psychiatric Disorders: Mechanisms, Efficacy, and Clinical Implications", "authors": "Shakila Meshkat, Manish K. Jha, Venkat Bhat", "journal": "FOCUS The Journal of Lifelong Learning in Psychiatry", "publication_date": "2026-03-31", "publication_year": 2026, "doi": "10.1176/appi.focus.20250043", "pubmed_id": null, "openalex_id": "https://openalex.org/W7154344405", "source_url": "https://doi.org/10.1176/appi.focus.20250043", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,OCD,Eating Disorders,End-of-Life Distress,Headache / Migraine,Neuroplasticity,Mechanism of Action,Aging,Emotional Processing,Clinical Trial,Review Article,Safety,Adverse Events,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:52:05", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "DOI:10.1176/appi.focus.20250043", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1176/appi.focus.20250043", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1176/appi.focus.20250043", "source_url": "https://doi.org/10.1176/appi.focus.20250043", "doi": "10.1176/appi.focus.20250043", "pmid": "", "publication_date": "2026-03-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 190, "title": "Clinical Characteristics of Emergency Visits Related to Recreational Psychedelic Use", "authors": "Kush V. Bhatt, Joseph Friedman, Lindsay Benster, Rekha Narasimhan, Ke Yang, Jyoti Mishra, Cory R. Weissman, Dhakshin Ramanathan", "journal": "Community Mental Health Journal", "publication_date": "2026-03-31", "publication_year": 2026, "doi": "10.1007/s10597-026-01620-x", "pubmed_id": "41920509", "openalex_id": "https://openalex.org/W7147451430", "source_url": "https://doi.org/10.1007/s10597-026-01620-x", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Review Article,Observational Study,Safety,Adverse Events,Toxicity", "study_type": "Review Article", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "PMID:41920509", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1007/s10597-026-01620-x", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41920509", "source_url": "https://doi.org/10.1007/s10597-026-01620-x", "doi": "10.1007/s10597-026-01620-x", "pmid": "41920509", "publication_date": "2026-03-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 188, "title": "Psychedelic Therapies for Comorbid Major Depressive Disorder and Chronic Pain: A Review of Putative Mechanisms of Action", "authors": "Jordana Kazdan, Karim S. Ladha, M. Ishrat Husain", "journal": "Pharmacology Research & Perspectives", "publication_date": "2026-03-31", "publication_year": 2026, "doi": "10.1002/prp2.70238", "pubmed_id": "41940853", "openalex_id": "https://openalex.org/W7150989008", "source_url": "https://doi.org/10.1002/prp2.70238", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Chronic Pain,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Default Mode Network,Clinical Trial,Review Article,Toxicity,Inflammation", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "PMID:41940853", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1002/prp2.70238", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41940853", "source_url": "https://doi.org/10.1002/prp2.70238", "doi": "10.1002/prp2.70238", "pmid": "41940853", "publication_date": "2026-03-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 185, "title": "An Open-Label Study of Single-Dose Psilocybin for Borderline Personality Disorder With Co-Occurring Major Depressive Disorder", "authors": "Jon E. Grant, Sophia Boutouis, Margaret O’Brien, Laurie Avila, Megha Neelapu, Dustin Ehsan", "journal": "Clinical Neuropharmacology", "publication_date": "2026-03-31", "publication_year": 2026, "doi": "10.1097/wnf.0000000000000683", "pubmed_id": "41973961", "openalex_id": "https://openalex.org/W7154114794", "source_url": "https://doi.org/10.1097/wnf.0000000000000683", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Personality Change,Clinical Trial", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "PMID:41973961", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1097/wnf.0000000000000683", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41973961", "source_url": "https://doi.org/10.1097/wnf.0000000000000683", "doi": "10.1097/wnf.0000000000000683", "pmid": "41973961", "publication_date": "2026-03-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4054, "title": "Therapeutic Potential of Classical Psychedelics and NonHallucinogenic Psychoplastogens in Psychiatric Disorders", "authors": "Kenji Hashimoto, Feyza Arıcıoğlu, Mesut Çetin", "journal": "Psychiatry and Clinical Psychopharmacology", "publication_date": "2026-03-29", "publication_year": 2026, "doi": "10.65801/pcp.3512", "pubmed_id": null, "openalex_id": "https://openalex.org/W7143411647", "source_url": "https://doi.org/10.65801/pcp.3512", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Neuroplasticity,Pharmacology,Mechanism of Action,Receptor Pharmacology,Consciousness,Mystical Experience,Clinical Trial,Randomized Controlled Trial,Review Article,Animal Study,Safety,Toxicity,Drug Interactions", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:36", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "DOI:10.65801/pcp.3512", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.65801/pcp.3512", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.65801/pcp.3512", "source_url": "https://doi.org/10.65801/pcp.3512", "doi": "10.65801/pcp.3512", "pmid": "", "publication_date": "2026-03-29", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3663, "title": "Engaging Mood Brain Circuits With Psilocybin: a Randomized Neuroimaging Trial in Depression", "authors": "Sunnybrook Health Sciences Centre", "journal": "ClinicalTrials.gov", "publication_date": "2026-03-29", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06072898", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging,Aging,Clinical Trial", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:34", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06072898", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06072898", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06072898", "source_url": "https://clinicaltrials.gov/study/NCT06072898", "doi": "", "pmid": "", "publication_date": "2026-03-29", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3478, "title": "Psilocybin Assisted Psychotherapy for Treatment Resistant Depression and Co-occurring Substance Use Disorder", "authors": "Indiana University", "journal": "ClinicalTrials.gov", "publication_date": "2026-03-29", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07499583", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Brain Imaging,Default Mode Network,Mystical Experience,Clinical Trial,Treatment-Resistant Depression,Veterans,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07499583", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07499583", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07499583", "source_url": "https://clinicaltrials.gov/study/NCT07499583", "doi": "", "pmid": "", "publication_date": "2026-03-29", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 2981, "title": "MedCheck: FDA Approves Novel Antipsychotic Milsaperidone; Designates Psilocybin Analogue as Breakthrough Therapy for Postpartum Depression, and More!", "authors": "Linda M. Richmond", "journal": "Psychiatric News", "publication_date": "2026-03-29", "publication_year": 2026, "doi": "10.1176/appi.pn.2026.04.4.3", "pubmed_id": null, "openalex_id": "https://openalex.org/W7143348770", "source_url": "https://doi.org/10.1176/appi.pn.2026.04.4.3", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Pharmacology,Clinical Trial", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:55:42", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "DOI:10.1176/appi.pn.2026.04.4.3", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1176/appi.pn.2026.04.4.3", "source_url": "https://doi.org/10.1176/appi.pn.2026.04.4.3", "doi": "10.1176/appi.pn.2026.04.4.3", "pmid": "", "publication_date": "2026-03-29", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1942, "title": "Strong alliance, weak conclusions: Comment on Goodwin et al. (2026) “The role of therapeutic alliance in psilocybin treatment for treatment-resistant depression”", "authors": "", "journal": "PsyArXiv", "publication_date": "2026-03-29", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://osf.io/preprints/psyarxiv/8s7xk_v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Pharmacology,Treatment-Resistant Depression", "study_type": "Other", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 06:52:05", "last_checked": "2026-07-01 11:22:30", "bibtex": null, "source_record_id": "https://osf.io/preprints/psyarxiv/8s7xk_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/8s7xk_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "https://osf.io/preprints/psyarxiv/8s7xk_v1", "source_url": "https://osf.io/preprints/psyarxiv/8s7xk_v1", "doi": "", "pmid": "", "publication_date": "2026-03-29", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 210, "title": "Psychedelics in NHS services: exploring a model for real-world implementation of psilocybin", "authors": "Katharine Smith, Edward Harcourt, Andrea Cipriani", "journal": "The British Journal of Psychiatry", "publication_date": "2026-03-29", "publication_year": 2026, "doi": "10.1192/bjp.2026.10612", "pubmed_id": "41906234", "openalex_id": "https://openalex.org/W7143417129", "source_url": "https://doi.org/10.1192/bjp.2026.10612", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Toxicity", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "PMID:41906234", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1192/bjp.2026.10612", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41906234", "source_url": "https://doi.org/10.1192/bjp.2026.10612", "doi": "10.1192/bjp.2026.10612", "pmid": "41906234", "publication_date": "2026-03-29", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 209, "title": "Unlocking ‘stuckness’ and catalysing change: A qualitative study of clinician and service leader perspectives on psychedelic-assisted therapy for substance use and mental health problems", "authors": "Sarah Catchlove, Katrin Oliver, Michael Savic, Shalini Arunogiri", "journal": "Addiction", "publication_date": "2026-03-29", "publication_year": 2026, "doi": "10.1111/add.70403", "pubmed_id": "41906885", "openalex_id": "https://openalex.org/W7143442364", "source_url": "https://doi.org/10.1111/add.70403", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Chronic Pain,Healthcare Workers,Toxicity", "study_type": "Qualitative Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "PMID:41906885", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1111/add.70403", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41906885", "source_url": "https://doi.org/10.1111/add.70403", "doi": "10.1111/add.70403", "pmid": "41906885", "publication_date": "2026-03-29", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3696, "title": "Psilocybe Cubensis Mushrooms With or Without Fluoxetine for Refractory Depression", "authors": "Federal University of Latin American Integration", "journal": "ClinicalTrials.gov", "publication_date": "2026-03-26", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06898606", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:34", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06898606", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06898606", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06898606", "source_url": "https://clinicaltrials.gov/study/NCT06898606", "doi": "", "pmid": "", "publication_date": "2026-03-26", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 2982, "title": "26-CCC-15854-ACC TALK ABOUT A BAD TRIP!: PSILOCYBIN USE WITH PRE-EXISTING CARDIOVASCULAR DISEASE, A CASE REPORT", "authors": "Christine Buchanan", "journal": "Journal of the American College of Cardiology", "publication_date": "2026-03-26", "publication_year": 2026, "doi": "10.1016/j.jacc.2026.02.3249", "pubmed_id": null, "openalex_id": "https://openalex.org/W7141271109", "source_url": "https://doi.org/10.1016/j.jacc.2026.02.3249", "substance_tags": "psilocybin", "topic_tags": "Depression,Case Report", "study_type": "Case Report", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:55:42", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "DOI:10.1016/j.jacc.2026.02.3249", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.jacc.2026.02.3249", "source_url": "https://doi.org/10.1016/j.jacc.2026.02.3249", "doi": "10.1016/j.jacc.2026.02.3249", "pmid": "", "publication_date": "2026-03-26", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 213, "title": "Psilocin fosters neuroplasticity in iPSC-derived human cortical neurons.", "authors": "Schmidt M, Hoffrichter A, Davoudi M, Horschitz S, Lau T, Meinhardt MW, Spanagel R, Ladewig J, Köhr G, Koch P.", "journal": null, "publication_date": "2026-03-26", "publication_year": 2026, "doi": "10.7554/elife.104006", "pubmed_id": "41891829", "openalex_id": null, "source_url": "https://doi.org/10.7554/elife.104006", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Anxiety,Neuroplasticity,Receptor Pharmacology,Biomarkers,Treatment-Resistant Depression,Transcriptomics", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-01 11:22:00", "bibtex": null, "source_record_id": "PMID:41891829", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.7554/elife.104006", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:41891829", "source_url": "https://doi.org/10.7554/elife.104006", "doi": "10.7554/elife.104006", "pmid": "41891829", "publication_date": "2026-03-26", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4057, "title": "Classic psychedelic medicines for adolescent refractory mental health disease", "authors": "Aly Shah Aziz", "journal": "Journal of Psychedelic Studies", "publication_date": "2026-03-25", "publication_year": 2026, "doi": "10.1556/2054.2026.00452", "pubmed_id": null, "openalex_id": "https://openalex.org/W7140928407", "source_url": "https://doi.org/10.1556/2054.2026.00452", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Clinical Trial,Observational Study,Adolescents,Safety,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:36", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "DOI:10.1556/2054.2026.00452", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1556/2054.2026.00452", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1556/2054.2026.00452", "source_url": "https://doi.org/10.1556/2054.2026.00452", "doi": "10.1556/2054.2026.00452", "pmid": "", "publication_date": "2026-03-25", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 214, "title": "Psilocybin in Neuropsychiatric Disorders: Seeking Valuable Evidence in History, Pure Science, Clinical Trials and Real-World Data (RWD)", "authors": "Piotr Skalski, Katarzyna Pękacka-Falkowska, Agnieszka Pluto-Prądzyńska, Michał K. Owecki", "journal": "Brain Sciences", "publication_date": "2026-03-25", "publication_year": 2026, "doi": "10.3390/brainsci16040358", "pubmed_id": "42041769", "openalex_id": "https://openalex.org/W7140611633", "source_url": "https://doi.org/10.3390/brainsci16040358", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,End-of-Life Distress,Chronic Pain,Clinical Trial,Randomized Controlled Trial,Systematic Review,Review Article,Treatment-Resistant Depression", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "PMID:42041769", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.3390/brainsci16040358", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:42041769", "source_url": "https://doi.org/10.3390/brainsci16040358", "doi": "10.3390/brainsci16040358", "pmid": "42041769", "publication_date": "2026-03-25", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3447, "title": "Elucidating the Relevance of the Psychedelic Experience to Psilocybin's Anti-Anhedonic Effects: A Randomized, Open-Label, Cross-Over Functional Magnetic Resonance Imaging Trial", "authors": "Medical University of Vienna", "journal": "ClinicalTrials.gov", "publication_date": "2026-03-23", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07490353", "substance_tags": "psilocybin", "topic_tags": "Depression,Neuroplasticity,Brain Imaging,Receptor Pharmacology,Aging,Wellbeing,Clinical Trial,Inflammation", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07490353", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07490353", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07490353", "source_url": "https://clinicaltrials.gov/study/NCT07490353", "doi": "", "pmid": "", "publication_date": "2026-03-23", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 217, "title": "Psilocybin: Chemical Foundations and Emerging Therapeutic Potential", "authors": "Shivaputra A. Patil, Holly C. Hunsberger", "journal": "Mini-Reviews in Medicinal Chemistry", "publication_date": "2026-03-23", "publication_year": 2026, "doi": "10.2174/0113895575429775260119043318", "pubmed_id": "41879500", "openalex_id": "https://openalex.org/W7140303704", "source_url": "https://doi.org/10.2174/0113895575429775260119043318", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Addiction,Neuroplasticity,Pharmacology,Receptor Pharmacology,Longevity,Clinical Trial,Review Article,Cancer Patients,Treatment-Resistant Depression", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "PMID:41879500", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.2174/0113895575429775260119043318", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41879500", "source_url": "https://doi.org/10.2174/0113895575429775260119043318", "doi": "10.2174/0113895575429775260119043318", "pmid": "41879500", "publication_date": "2026-03-23", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 186, "title": "Psychedelic-assisted pharmacotherapy: clinical applications and regulatory considerations", "authors": "Donatella Marazziti, Matteo Gambini, Riccardo Gurrieri, Gerardo Russomanno, Giorgia Sità, Elena Pescini, FRANCESCA RITA DIGIUSEPPE, Federico Mucci", "journal": "Expert Opinion on Pharmacotherapy", "publication_date": "2026-03-23", "publication_year": 2026, "doi": "10.1080/14656566.2026.2654682", "pubmed_id": "41944071", "openalex_id": "https://openalex.org/W7151630586", "source_url": "https://doi.org/10.1080/14656566.2026.2654682", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Mechanism of Action,Clinical Trial,Review Article,Treatment-Resistant Depression,Safety,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "PMID:41944071", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1080/14656566.2026.2654682", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41944071", "source_url": "https://doi.org/10.1080/14656566.2026.2654682", "doi": "10.1080/14656566.2026.2654682", "pmid": "41944071", "publication_date": "2026-03-23", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 218, "title": "Editorial: Psychedelic-assisted psychotherapies: from clinical trials to credibility", "authors": "Malkanthi Evans, Andrew Charrette", "journal": "Frontiers in Neuroscience", "publication_date": "2026-03-22", "publication_year": 2026, "doi": "10.3389/fnins.2026.1816932", "pubmed_id": "41947857", "openalex_id": "https://openalex.org/W7140128776", "source_url": "https://doi.org/10.3389/fnins.2026.1816932", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Eating Disorders,Chronic Pain,Headache / Migraine,Neuroplasticity,Brain Imaging,Pharmacology,Mechanism of Action,Aging,Emotional Processing,Clinical Trial,Systematic Review,Review Article,Treatment-Resistant Depression,Safety,Toxicity", "study_type": "Systematic Review", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "PMID:41947857", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.3389/fnins.2026.1816932", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41947857", "source_url": "https://doi.org/10.3389/fnins.2026.1816932", "doi": "10.3389/fnins.2026.1816932", "pmid": "41947857", "publication_date": "2026-03-22", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4, "title": "The role of therapeutic alliance in psilocybin treatment for treatment-resistant depression: A post hoc path analysis", "authors": "Guy M. Goodwin, Scott T. Aaronson, Oscar Alvarez, Robin Carhart-Harris, Megan Croal, David Feifel, David J. Hellerstein, Muhammad I. Husain, John R. Kelly, Namik Kirlić, Rasmus Wentzer Licht, Lindsey Marwood, Ania Nowakowska, Tomáš Páleníček, Dimitris Repantis, Robert A. Schoevers, Hollie Simmons, Jair C. Soares, Metten Somers, Joyce Tsai, Mourad Wahba, Ella Williams, Allan H. Young, Matthew B. Young, Sidney Zisook, Ekaterina Malievskaia", "journal": "Journal of Affective Disorders", "publication_date": "2026-03-22", "publication_year": 2026, "doi": "10.1016/j.jad.2026.121662", "pubmed_id": "41881122", "openalex_id": "https://openalex.org/W7140125435", "source_url": "https://doi.org/10.1016/j.jad.2026.121662", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Treatment-Resistant Depression,Toxicity", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "PMID:41881122", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41881122", "source_url": "https://doi.org/10.1016/j.jad.2026.121662", "doi": "10.1016/j.jad.2026.121662", "pmid": "41881122", "publication_date": "2026-03-22", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 2983, "title": "Psilocybin, Lp(a), CAC, Niere und Darmkrebs - Evidenz-Quickies KW12", "authors": "Denis Nößler", "journal": "EvidenzUpdate", "publication_date": "2026-03-21", "publication_year": 2026, "doi": "10.69156/quick/2026.03.00011", "pubmed_id": null, "openalex_id": "https://openalex.org/W7140105589", "source_url": "https://doi.org/10.69156/quick/2026.03.00011", "substance_tags": "psilocybin", "topic_tags": "Depression,Biomarkers,Randomized Controlled Trial,Review Article,Treatment-Resistant Depression", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:55:42", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "DOI:10.69156/quick/2026.03.00011", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.69156/quick/2026.03.00011", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.69156/quick/2026.03.00011", "source_url": "https://doi.org/10.69156/quick/2026.03.00011", "doi": "10.69156/quick/2026.03.00011", "pmid": "", "publication_date": "2026-03-21", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 5, "title": "Psilocybin-assisted therapy for major depressive disorder: Perspective from meta-analysis", "authors": "Taro Kishi, Kenji Sakuma, Masakazu Hatano, Hiroyuki Uchida, Nakao Iwata", "journal": "Journal of Affective Disorders", "publication_date": "2026-03-21", "publication_year": 2026, "doi": "10.1016/j.jad.2026.121675", "pubmed_id": "41876058", "openalex_id": "https://openalex.org/W7140041737", "source_url": "https://doi.org/10.1016/j.jad.2026.121675", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Clinical Trial,Randomized Controlled Trial,Meta-Analysis,Toxicity", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "PMID:41876058", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41876058", "source_url": "https://doi.org/10.1016/j.jad.2026.121675", "doi": "10.1016/j.jad.2026.121675", "pmid": "41876058", "publication_date": "2026-03-21", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3657, "title": "Precision Phenotyping of Behavioral Risk and Response to Electromagnetic and Psychedelic Therapies", "authors": "University of New Mexico", "journal": "ClinicalTrials.gov", "publication_date": "2026-03-19", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07484906", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Neuroplasticity,Brain Imaging,Mechanism of Action,Biomarkers,Aging,Emotional Processing,Observational Study,Veterans,Safety,Transcriptomics", "study_type": "Observational Study", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:34", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07484906", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07484906", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07484906", "source_url": "https://clinicaltrials.gov/study/NCT07484906", "doi": "", "pmid": "", "publication_date": "2026-03-19", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3582, "title": "Psilocybin for Treatment-Resistant Depression in Autism: a Pilot Trial With Pre-Post Brain and Cognitive Measurement to Understand Mechanism", "authors": "Centre for Addiction and Mental Health", "journal": "ClinicalTrials.gov", "publication_date": "2026-03-19", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06731621", "substance_tags": "psilocybin", "topic_tags": "Depression,Consciousness,Clinical Trial,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06731621", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06731621", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06731621", "source_url": "https://clinicaltrials.gov/study/NCT06731621", "doi": "", "pmid": "", "publication_date": "2026-03-19", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 221, "title": "Psychedelics and Mental Health in Endurance Athletes: A Cross-Sectional Study in Brazil.", "authors": "Portes MAM, Bertoglio LJ.", "journal": null, "publication_date": "2026-03-19", "publication_year": 2026, "doi": "10.1080/02791072.2026.2644865", "pubmed_id": "41860795", "openalex_id": null, "source_url": "https://doi.org/10.1080/02791072.2026.2644865", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Observational Study,Inflammation", "study_type": "Observational Study", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-01 11:22:02", "bibtex": null, "source_record_id": "PMID:41860795", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1080/02791072.2026.2644865", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:41860795", "source_url": "https://doi.org/10.1080/02791072.2026.2644865", "doi": "10.1080/02791072.2026.2644865", "pmid": "41860795", "publication_date": "2026-03-19", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1974, "title": "PSILOCYBIN AS AN ADJUNCTIVE TREATMENT FOR DEPRESSION AND PSYCHOLOGICAL DISTRESS IN ONCOLOGY: CURRENT EVIDENCE AND CLINICAL IMPLICATIONS", "authors": "Anna Komarczewska, Michał Kociński, Patryk Iglewski, Michał Pietrasz, Jakub Idziński, Anna Lubomska", "journal": "International Journal of Innovative Technologies in Social Science", "publication_date": "2026-03-18", "publication_year": 2026, "doi": "10.31435/ijitss.1(49).2026.5034", "pubmed_id": null, "openalex_id": "https://openalex.org/W7164003040", "source_url": "https://doi.org/10.31435/ijitss.1(49).2026.5034", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Chronic Pain,Neuroplasticity,Receptor Pharmacology,Wellbeing,Clinical Trial,Randomized Controlled Trial,Systematic Review,Review Article,Case Report,Cancer Patients,Safety", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:52:05", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "DOI:10.31435/ijitss.1(49).2026.5034", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.31435/ijitss.1(49).2026.5034", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.31435/ijitss.1(49).2026.5034", "source_url": "https://doi.org/10.31435/ijitss.1(49).2026.5034", "doi": "10.31435/ijitss.1(49).2026.5034", "pmid": "", "publication_date": "2026-03-18", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 225, "title": "Psilocybin effects on brain functional connectivity: a systematic review of fMRI studies", "authors": "Àlvar Farré-Colomés, Olga Rublinetska, Óscar Soto-Angona", "journal": "Discover Mental Health", "publication_date": "2026-03-18", "publication_year": 2026, "doi": "10.1007/s44192-026-00384-w", "pubmed_id": "41854988", "openalex_id": "https://openalex.org/W7139105479", "source_url": "https://doi.org/10.1007/s44192-026-00384-w", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Brain Imaging,Mechanism of Action,Default Mode Network,Aging,Systematic Review,Review Article,Toxicity", "study_type": "Systematic Review", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "PMID:41854988", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1007/s44192-026-00384-w", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41854988", "source_url": "https://doi.org/10.1007/s44192-026-00384-w", "doi": "10.1007/s44192-026-00384-w", "pmid": "41854988", "publication_date": "2026-03-18", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3641, "title": "Safety and Efficacy of Psilocybin-assisted Psychotherapy for Demoralization Syndrome in Patients Diagnosed With Advanced Stage Cancer: a Pilot Study", "authors": "Gustavo Vazquez", "journal": "ClinicalTrials.gov", "publication_date": "2026-03-17", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06818994", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Aging,Clinical Trial,Cancer Patients,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:34", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06818994", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06818994", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06818994", "source_url": "https://clinicaltrials.gov/study/NCT06818994", "doi": "", "pmid": "", "publication_date": "2026-03-17", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3540, "title": "Evaluating the Role of Psilocybin Monitors in Psilocybin Therapy for Treatment Resistant Depression: A Pilot Randomized Clinical Trial", "authors": "Centre for Addiction and Mental Health", "journal": "ClinicalTrials.gov", "publication_date": "2026-03-17", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07211438", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Randomized Controlled Trial,Treatment-Resistant Depression", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07211438", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07211438", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07211438", "source_url": "https://clinicaltrials.gov/study/NCT07211438", "doi": "", "pmid": "", "publication_date": "2026-03-17", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 133, "title": "Efficacy and Safety of Psilocybin in Treatment-Resistant Major Depression", "authors": "Lea J. Mertens, Michael Koslowski, Felix Betzler, Manuela Brand, Ricarda Evens, Laura Kärtner, Andrea Jungaberle, Henrik Jungaberle, Tomislav Majić, Christian N. Schmitz, Andreas Ströhle, Dennis Scharf, Moritz Spangemacher, Max Wolff, Zahra Assadi, Scharif Bahri, Lilith Becher, Luca V. Färber, Niklas Kirchen, Eugenia Kulakova, Linda C. Kunz, Andy Meijer, Barbara Rohrmoser, Stefan Wellek, Moritz Berger, Gerhard Gründer", "journal": "JAMA Psychiatry", "publication_date": "2026-03-17", "publication_year": 2026, "doi": "10.1001/jamapsychiatry.2026.0132", "pubmed_id": "41848690", "openalex_id": "https://openalex.org/W7138853109", "source_url": "https://doi.org/10.1001/jamapsychiatry.2026.0132", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Treatment-Resistant Depression,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "PMID:41848690", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1001/jamapsychiatry.2026.0132", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41848690", "source_url": "https://doi.org/10.1001/jamapsychiatry.2026.0132", "doi": "10.1001/jamapsychiatry.2026.0132", "pmid": "41848690", "publication_date": "2026-03-17", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 132, "title": "Enlightenment in a Pill-Testing the Efficacy of Psilocybin", "authors": "J. Cramer Hudson, Harrison G. Pope", "journal": "JAMA Psychiatry", "publication_date": "2026-03-17", "publication_year": 2026, "doi": "10.1001/jamapsychiatry.2026.0070", "pubmed_id": "41848717", "openalex_id": "https://openalex.org/W7138881137", "source_url": "https://doi.org/10.1001/jamapsychiatry.2026.0070", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Spirituality,Mystical Experience", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "PMID:41848717", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1001/jamapsychiatry.2026.0070", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41848717", "source_url": "https://doi.org/10.1001/jamapsychiatry.2026.0070", "doi": "10.1001/jamapsychiatry.2026.0070", "pmid": "41848717", "publication_date": "2026-03-17", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4065, "title": "Hallucinogens for Mood and Anxiety Disorders: A Critical Review of Psychedelic-Assisted Therapies", "authors": "Georgia Chlebek", "journal": "ThinkIR: The University of Louisville's Institutional Repository (University of Louisville)", "publication_date": "2026-03-15", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": "https://openalex.org/W7138827229", "source_url": "https://ir.library.louisville.edu/tce/vol3/iss1/11", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Review Article,Adolescents,Treatment-Resistant Depression,Adverse Events,Toxicity", "study_type": "Review Article", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:36", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "https://ir.library.louisville.edu/tce/vol3/iss1/11", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://ir.library.louisville.edu/tce/vol3/iss1/11", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "https://ir.library.louisville.edu/tce/vol3/iss1/11", "source_url": "https://ir.library.louisville.edu/tce/vol3/iss1/11", "doi": "", "pmid": "", "publication_date": "2026-03-15", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4064, "title": "Editorial: Psychedelic substances and neurological diseases: from basics to clinical application", "authors": "Alessandra Linardi, Ariadiny Lima Caetano, Rodrigo Portes Ureshino", "journal": "Frontiers in Pharmacology", "publication_date": "2026-03-15", "publication_year": 2026, "doi": "10.3389/fphar.2026.1816812", "pubmed_id": "41919223", "openalex_id": "https://openalex.org/W7136503554", "source_url": "https://doi.org/10.3389/fphar.2026.1816812", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Neuroplasticity,Pharmacology,Mechanism of Action,Receptor Pharmacology,Consciousness,Mitochondrial Function,Oxidative Stress,Wellbeing,Spirituality,Clinical Trial,Review Article,Animal Study,Toxicity,Proteomics,Inflammation", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:36", "last_checked": "2026-07-04 06:34:36", "bibtex": null, "source_record_id": "PMID:41919223", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.3389/fphar.2026.1816812", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41919223", "source_url": "https://doi.org/10.3389/fphar.2026.1816812", "doi": "10.3389/fphar.2026.1816812", "pmid": "41919223", "publication_date": "2026-03-15", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3604, "title": "Pilot Study of Serotonin 2A Receptor (5-HT2A) Agonist Psilocybin for Depression in Patients With Mild Cognitive Impairment or Early Alzheimer's Disease", "authors": "Johns Hopkins University", "journal": "ClinicalTrials.gov", "publication_date": "2026-03-15", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT04123314", "substance_tags": "psilocybin", "topic_tags": "Depression,Receptor Pharmacology", "study_type": "Other", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT04123314", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT04123314", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT04123314", "source_url": "https://clinicaltrials.gov/study/NCT04123314", "doi": "", "pmid": "", "publication_date": "2026-03-15", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1976, "title": "Explainable AI framework for psilocybin depression treatment optimization", "authors": "Akey Sungheetha, R. Rajesh Sharma, Oluwasegun Julius Aroba, Sheila Mahapatra, P. D. Mahendhiran", "journal": "Frontiers in Computer Science", "publication_date": "2026-03-15", "publication_year": 2026, "doi": "10.3389/fcomp.2025.1652190", "pubmed_id": null, "openalex_id": "https://openalex.org/W7136253679", "source_url": "https://doi.org/10.3389/fcomp.2025.1652190", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Brain Imaging,Pharmacology,Receptor Pharmacology,Aging,Clinical Trial,Randomized Controlled Trial,Safety", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:52:05", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "DOI:10.3389/fcomp.2025.1652190", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.3389/fcomp.2025.1652190", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.3389/fcomp.2025.1652190", "source_url": "https://doi.org/10.3389/fcomp.2025.1652190", "doi": "10.3389/fcomp.2025.1652190", "pmid": "", "publication_date": "2026-03-15", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3493, "title": "Psilocybin Treatment of Major Depressive Disorder With Co-occurring Alcohol Use Disorder", "authors": "Johns Hopkins University", "journal": "ClinicalTrials.gov", "publication_date": "2026-03-12", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT04620759", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Healthcare Workers", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT04620759", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT04620759", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT04620759", "source_url": "https://clinicaltrials.gov/study/NCT04620759", "doi": "", "pmid": "", "publication_date": "2026-03-12", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 231, "title": "The renaissance of research on psychedelics in child and adolescent psychopharmacology", "authors": "Marc-Antoine Crocq, Philippe Auby", "journal": "Child and Adolescent Psychiatry and Mental Health", "publication_date": "2026-03-12", "publication_year": 2026, "doi": "10.1186/s13034-026-01069-6", "pubmed_id": "41826990", "openalex_id": "https://openalex.org/W7135184973", "source_url": "https://doi.org/10.1186/s13034-026-01069-6", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,OCD,Eating Disorders,Neuroplasticity,Pharmacology,Receptor Pharmacology,Clinical Trial,Review Article,Adolescents,Safety,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "PMID:41826990", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1186/s13034-026-01069-6", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41826990", "source_url": "https://doi.org/10.1186/s13034-026-01069-6", "doi": "10.1186/s13034-026-01069-6", "pmid": "41826990", "publication_date": "2026-03-12", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 82, "title": "Psychedelics for treatment of negative symptoms and depressive symptoms in schizophrenia spectrum disorder: A narrative review", "authors": "Michel Sabé, Paul Grof, Nathan Sackett, Sara Tai, Pamela Kryskow, Anya K. Bershad, Douglas Turkington, Matteo Buonarroti, Marco De Pieri, Pantelis Baniotopoulos, Mickael Eskinazi, Kerem Böge, Stefan Leucht, Federico Seragnoli, Leonice Furtado, Tatiana Aboulafia Brakha, Logos Curtis, Matthias Kirschner, Stefan Kaiser, Louise Penzenstadler, Daniele Zullino, Mikkel Højlund, Jade Gallo, Marco Solmi, Jacopo Sapienza, Marta Bosia, Joseph La Torre", "journal": "Schizophrenia Research", "publication_date": "2026-03-12", "publication_year": 2026, "doi": "10.1016/j.schres.2026.03.003", "pubmed_id": "41830808", "openalex_id": "https://openalex.org/W7135185290", "source_url": "https://doi.org/10.1016/j.schres.2026.03.003", "substance_tags": "psilocybin", "topic_tags": "Depression,Neuroplasticity,Receptor Pharmacology,Default Mode Network,Review Article,Case Report,Animal Study,Treatment-Resistant Depression,Safety,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "PMID:41830808", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1016/j.schres.2026.03.003", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41830808", "source_url": "https://doi.org/10.1016/j.schres.2026.03.003", "doi": "10.1016/j.schres.2026.03.003", "pmid": "41830808", "publication_date": "2026-03-12", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3473, "title": "Safety, Feasibility, and Tolerability of Psilocybin Treatment for Individuals With Functional Impairment Related to Mood, Anxiety, Trauma and/or Addiction Symptoms: An Open-label Proof-of-concept Study", "authors": "Yale University", "journal": "ClinicalTrials.gov", "publication_date": "2026-03-10", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06442423", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,OCD,Receptor Pharmacology,Clinical Trial,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06442423", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06442423", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06442423", "source_url": "https://clinicaltrials.gov/study/NCT06442423", "doi": "", "pmid": "", "publication_date": "2026-03-10", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 233, "title": "Strategic Neurodelivery of Psychedelic Compounds: Bridging MolecularPharmacology with Therapeutic Innovation in CNS Disorders", "authors": "Shikha Baghel Chauhan, Naziya Akhtar, chirag Jain, Indu Singh", "journal": "CNS & Neurological Disorders - Drug Targets", "publication_date": "2026-03-10", "publication_year": 2026, "doi": "10.2174/0118715273434237251212095005", "pubmed_id": "41833044", "openalex_id": "https://openalex.org/W7135100807", "source_url": "https://doi.org/10.2174/0118715273434237251212095005", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Addiction,Neuroplasticity,Pharmacology,Mechanism of Action,Receptor Pharmacology,Safety,Toxicity", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "PMID:41833044", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.2174/0118715273434237251212095005", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41833044", "source_url": "https://doi.org/10.2174/0118715273434237251212095005", "doi": "10.2174/0118715273434237251212095005", "pmid": "41833044", "publication_date": "2026-03-10", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3228, "title": "Age moderates the relationship between psychedelics use and mental health in naturalistic settings", "authors": "Gregorio GD, Basset S, Manmohan H, Nixon WC, Pogaku A, Zhou J, Sanderson DJ, Lengieza ML, Bocchio M.", "journal": "Research Square", "publication_date": "2026-03-09", "publication_year": 2026, "doi": "10.21203/rs.3.rs-9022170/v1", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.21203/rs.3.rs-9022170/v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Aging,Longevity,Mystical Experience,Clinical Trial,Observational Study,Safety", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "preprint", "date_added": "2026-07-01 11:03:48", "last_checked": "2026-07-01 11:22:02", "bibtex": null, "source_record_id": "DOI:10.21203/rs.3.rs-9022170/v1", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.21203/rs.3.rs-9022170/v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "DOI:10.21203/rs.3.rs-9022170/v1", "source_url": "https://doi.org/10.21203/rs.3.rs-9022170/v1", "doi": "10.21203/rs.3.rs-9022170/v1", "pmid": "", "publication_date": "2026-03-09", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 237, "title": "The combination of exercise and psychedelics for the treatment of major depressive disorder.", "authors": "Fabiano N, Stubbs B, Lawrence DW, Rosenblat JD, Teixeira PJ, Wong S, Zhou C, Carhart-Harris R", "journal": "Discover mental health", "publication_date": "2026-03-06", "publication_year": 2026, "doi": "10.1007/s44192-026-00408-5", "pubmed_id": "41793582", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/41793582/", "substance_tags": "psilocybin", "topic_tags": "Depression,Neuroplasticity,Neurogenesis,Mechanism of Action,Receptor Pharmacology,Default Mode Network,Resilience,Emotional Processing,Psychological Flexibility,Safety,Inflammation", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-01 11:20:34", "bibtex": null, "source_record_id": "PMID:41793582", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41793582/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41793582", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41793582/", "doi": "10.1007/s44192-026-00408-5", "pmid": "41793582", "publication_date": "2026-03-06", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3016, "title": "Inhibition of cortico-amygdala projections underlies affective bias modification by psilocybin", "authors": "Claydon MDB, Hinchcliffe JK, Bartlett J, Golden CT, Thomas CW, Gilmour G, Mellor JR, Bortolotto ZA, Robinson ESJ.", "journal": "bioRxiv", "publication_date": "2026-03-03", "publication_year": 2026, "doi": "10.64898/2026.03.02.709133", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.64898/2026.03.02.709133", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Animal Study", "study_type": "Animal Study", "source_name": "bioRxiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:45", "last_checked": "2026-07-01 11:22:00", "bibtex": null, "source_record_id": "DOI:10.64898/2026.03.02.709133", "abstract_available": true, "abstract_source": "bioRxiv", "abstract_source_url": "https://doi.org/10.64898/2026.03.02.709133", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "bioRxiv", "source_record_id": "DOI:10.64898/2026.03.02.709133", "source_url": "https://doi.org/10.64898/2026.03.02.709133", "doi": "10.64898/2026.03.02.709133", "pmid": "", "publication_date": "2026-03-03", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3616, "title": "A Phase 2b Double-blind, Randomized, Low-dose Comparator-controlled Clinical Trial to Assess the Efficacy and Safety of NPX-5 in Psilocybin-assisted Psychotherapy for the Treatment of Adjustment Disorder Associated With Cancer.", "authors": "Psyence Australia Pty Ltd", "journal": "ClinicalTrials.gov", "publication_date": "2026-03-02", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07072728", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:34", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07072728", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07072728", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07072728", "source_url": "https://clinicaltrials.gov/study/NCT07072728", "doi": "", "pmid": "", "publication_date": "2026-03-02", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 230, "title": "Differential Effects of Acute and Chronic Fluoxetine on Psychedelic-Induced Behavior in Mice: Implications for Clinical Trials", "authors": "Bo Jarrett Wood, M. Frances Vest, Catharine Carfagno, Kyla Rose Bartley, Papori Sharma, Adam L. Halberstadt, Bruce E. Blough, Kevin S. Murnane", "journal": "ACS Pharmacology & Translational Science", "publication_date": "2026-03-02", "publication_year": 2026, "doi": "10.1021/acsptsci.5c00484", "pubmed_id": "41852641", "openalex_id": "https://openalex.org/W7133349014", "source_url": "https://doi.org/10.1021/acsptsci.5c00484", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Pharmacology,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Randomized Controlled Trial,Animal Study,Toxicity,Drug Interactions", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "PMID:41852641", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1021/acsptsci.5c00484", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41852641", "source_url": "https://doi.org/10.1021/acsptsci.5c00484", "doi": "10.1021/acsptsci.5c00484", "pmid": "41852641", "publication_date": "2026-03-02", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4075, "title": "A scoping review of mystical-type experiences and mood symptom outcomes in psychedelic therapy clinical trials: comparing life-threatening disease and depressive populations", "authors": "Ana Deutsch, Luis E. Contreras, Sarah Kratina, Leah M. Mayo", "journal": "Therapeutic Advances in Psychopharmacology", "publication_date": "2026-02-28", "publication_year": 2026, "doi": "10.1177/20451253261433836", "pubmed_id": "41918771", "openalex_id": "https://openalex.org/W7141801946", "source_url": "https://doi.org/10.1177/20451253261433836", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Chronic Pain,Mechanism of Action,Mystical Experience,Clinical Trial,Randomized Controlled Trial,Review Article,Toxicity", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:36", "last_checked": "2026-07-04 06:34:36", "bibtex": null, "source_record_id": "PMID:41918771", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1177/20451253261433836", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41918771", "source_url": "https://doi.org/10.1177/20451253261433836", "doi": "10.1177/20451253261433836", "pmid": "41918771", "publication_date": "2026-02-28", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4074, "title": "THE EFFECT OF PSILOCYBIN AND EUGENOL ON LIPOPOLYSACCHARIDE INDUCED INFLAMMATION IN SMALL AND LARGE INTESTINE OF MICE", "authors": "Zeinab Asghari, Gregory Robinson, Marta Gerasymchuk, Esmaeel Ghasemi Gojani, Timur Zanikov, Yasaman Rastamian, Olga Kovalchuk, Igor Kovalchuk*", "journal": "Zenodo (CERN European Organization for Nuclear Research)", "publication_date": "2026-02-28", "publication_year": 2026, "doi": "10.5281/zenodo.18796594", "pubmed_id": null, "openalex_id": "https://openalex.org/W7131870859", "source_url": "https://doi.org/10.5281/zenodo.18796594", "substance_tags": "psilocybin", "topic_tags": "Depression,Pharmacology,Animal Study,Microbiome,Inflammation,Immune Function", "study_type": "Animal Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:36", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "DOI:10.5281/zenodo.18796594", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.5281/zenodo.18796594", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.5281/zenodo.18796594", "source_url": "https://doi.org/10.5281/zenodo.18796594", "doi": "10.5281/zenodo.18796594", "pmid": "", "publication_date": "2026-02-28", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 227, "title": "Cost-Effectiveness of Psilocybin-Assisted Therapy Versus Standard of Care for Patients With Treatment-Resistant Depression", "authors": "Yosr Ziadi, Taehwan Park", "journal": "Value in Health Regional Issues", "publication_date": "2026-02-28", "publication_year": 2026, "doi": "10.1016/j.vhri.2026.101605", "pubmed_id": "41842876", "openalex_id": "https://openalex.org/W7138831903", "source_url": "https://doi.org/10.1016/j.vhri.2026.101605", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Randomized Controlled Trial,Treatment-Resistant Depression", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "PMID:41842876", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1016/j.vhri.2026.101605", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41842876", "source_url": "https://doi.org/10.1016/j.vhri.2026.101605", "doi": "10.1016/j.vhri.2026.101605", "pmid": "41842876", "publication_date": "2026-02-28", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 259, "title": "Psychedelics and the Extracellular Matrix: Rewiring Neuroplasticity and Metaplasticity for Next-Generation Psychiatric Therapies.", "authors": "Zhang J, Lin C, Lv X, Zhao H, Wang X.", "journal": null, "publication_date": "2026-02-27", "publication_year": 2026, "doi": "10.1016/j.biopsych.2026.02.011", "pubmed_id": "41765343", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.biopsych.2026.02.011", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Addiction,Neuroplasticity,Mechanism of Action,Receptor Pharmacology", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-01 11:22:03", "bibtex": null, "source_record_id": "PMID:41765343", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.biopsych.2026.02.011", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:41765343", "source_url": "https://doi.org/10.1016/j.biopsych.2026.02.011", "doi": "10.1016/j.biopsych.2026.02.011", "pmid": "41765343", "publication_date": "2026-02-27", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4076, "title": "Psilocybin-assisted therapy for major depressive disorder: implications for clinical effectiveness, health economics, and regulatory decision-making", "authors": "C Faria, Diana Dias da Silva, João José Sousa", "journal": "Instituto Politécnico do Porto", "publication_date": "2026-02-26", "publication_year": 2026, "doi": "10.26537/prpaeh.v4i3.7173", "pubmed_id": null, "openalex_id": "https://openalex.org/W7166641777", "source_url": "https://doi.org/10.26537/prpaeh.v4i3.7173", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Clinical Trial,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Treatment-Resistant Depression,Safety", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:36", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "DOI:10.26537/prpaeh.v4i3.7173", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.26537/prpaeh.v4i3.7173", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.26537/prpaeh.v4i3.7173", "source_url": "https://doi.org/10.26537/prpaeh.v4i3.7173", "doi": "10.26537/prpaeh.v4i3.7173", "pmid": "", "publication_date": "2026-02-26", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 260, "title": "Psychedelic therapy and cultural humility", "authors": "Alex Gearin, Jennifer Docherty, Xiaofan Sun, Emmanuel Hei-Lok Cheung, Peter Tanuseputro", "journal": "Translational Psychiatry", "publication_date": "2026-02-26", "publication_year": 2026, "doi": "10.1038/s41398-026-03913-x", "pubmed_id": "41748534", "openalex_id": "https://openalex.org/W7131675232", "source_url": "https://doi.org/10.1038/s41398-026-03913-x", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Pharmacology,Spirituality,Clinical Trial,Healthcare Workers", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "PMID:41748534", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1038/s41398-026-03913-x", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41748534", "source_url": "https://doi.org/10.1038/s41398-026-03913-x", "doi": "10.1038/s41398-026-03913-x", "pmid": "41748534", "publication_date": "2026-02-26", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 83, "title": "Psilocybin for psychiatric disorders: History, clinical trials, neuroimaging, and regulations", "authors": "Kengo Yonezawa, M. Hirata, Hiroaki Takano, Keisuke Kusudo, Sota Tomiyama, Lisa Harada, Kota Suzuki, DJ Nutt, H. Uchida, Hideaki Tani", "journal": "Psychiatry and Clinical Neurosciences", "publication_date": "2026-02-25", "publication_year": 2026, "doi": "10.1111/pcn.70042", "pubmed_id": "41749057", "openalex_id": "https://openalex.org/W7131868995", "source_url": "https://doi.org/10.1111/pcn.70042", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,OCD,End-of-Life Distress,Chronic Pain,Brain Imaging,Aging,Spirituality,Clinical Trial,Systematic Review,Review Article,Safety,Adverse Events", "study_type": "Systematic Review", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "PMID:41749057", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1111/pcn.70042", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41749057", "source_url": "https://doi.org/10.1111/pcn.70042", "doi": "10.1111/pcn.70042", "pmid": "41749057", "publication_date": "2026-02-25", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 263, "title": "Pilot study of psilocybin in patients with post-treatment lyme disease", "authors": "Albert Garcia-Romeu, Gideon P. Naudé, Alison W. Rebman, Sara So, Abigail Yaffe, Ian Geithner, Erica A. Kozero, Ting Yang, Mark J. Soloski, John N. Aucott", "journal": "Scientific Reports", "publication_date": "2026-02-24", "publication_year": 2026, "doi": "10.1038/s41598-026-38091-9", "pubmed_id": "41741501", "openalex_id": "https://openalex.org/W7131357000", "source_url": "https://doi.org/10.1038/s41598-026-38091-9", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Chronic Pain,Headache / Migraine,Receptor Pharmacology,Clinical Trial,Randomized Controlled Trial,Treatment-Resistant Depression,Adverse Events,Inflammation", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "PMID:41741501", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1038/s41598-026-38091-9", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41741501", "source_url": "https://doi.org/10.1038/s41598-026-38091-9", "doi": "10.1038/s41598-026-38091-9", "pmid": "41741501", "publication_date": "2026-02-24", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 136, "title": "Advancing cancer neuroscience through stress modulation: Interdisciplinary potential of psilocybin and ketamine", "authors": "Alan C. Courtes, Blake Myers, Noah Daly, Greg Jones, Jair C. Soares, Carlos A. Zarate, Rodrigo Machado-Vieira", "journal": "General Hospital Psychiatry", "publication_date": "2026-02-24", "publication_year": 2026, "doi": "10.1016/j.genhosppsych.2026.02.011", "pubmed_id": "41762772", "openalex_id": "https://openalex.org/W7131407394", "source_url": "https://doi.org/10.1016/j.genhosppsych.2026.02.011", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Neuroplasticity,Pharmacology,Cancer Patients,Treatment-Resistant Depression", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "PMID:41762772", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41762772", "source_url": "https://doi.org/10.1016/j.genhosppsych.2026.02.011", "doi": "10.1016/j.genhosppsych.2026.02.011", "pmid": "41762772", "publication_date": "2026-02-24", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3032, "title": "Safety and Efficacy of Microdosing Psilocybin over 8 Weeks for Major Depressive Disorder: A Randomized Clinical Trial", "authors": "Petranker R, Farb N, Syed O, Li E, Shore D, Anderson T, Blackman A.", "journal": "Research Square", "publication_date": "2026-02-22", "publication_year": 2026, "doi": "10.21203/rs.3.rs-8319478/v1", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.21203/rs.3.rs-8319478/v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Microdosing,Clinical Trial,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "preprint", "date_added": "2026-07-01 11:03:46", "last_checked": "2026-07-01 11:22:00", "bibtex": null, "source_record_id": "DOI:10.21203/rs.3.rs-8319478/v1", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.21203/rs.3.rs-8319478/v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "DOI:10.21203/rs.3.rs-8319478/v1", "source_url": "https://doi.org/10.21203/rs.3.rs-8319478/v1", "doi": "10.21203/rs.3.rs-8319478/v1", "pmid": "", "publication_date": "2026-02-22", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 264, "title": "Psychedelic medicine: mechanisms, evidence, and translation to practice", "authors": "Edward Jacobs, Zarmeen Zahid, Jared T. Hinkle, Sandeep M. Nayak, David B Yaden", "journal": "BMJ", "publication_date": "2026-02-22", "publication_year": 2026, "doi": "10.1136/bmj-2024-081723", "pubmed_id": "41730563", "openalex_id": "https://openalex.org/W7131088236", "source_url": "https://doi.org/10.1136/bmj-2024-081723", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Addiction,Mechanism of Action,Emotional Processing,Psychological Flexibility,Clinical Trial,Review Article,Adverse Events,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "PMID:41730563", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1136/bmj-2024-081723", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41730563", "source_url": "https://doi.org/10.1136/bmj-2024-081723", "doi": "10.1136/bmj-2024-081723", "pmid": "41730563", "publication_date": "2026-02-22", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1982, "title": "Effects of Psilocybin and Select Pharmaceutical Interactions", "authors": "Jordan McDowell, Jada Middleton, Alanna Bluett, Alisa Kozachenko, Bayan Attar, Yuvraj Singh Saini, Jennifer Burke, Cayden McPhee, Mutahera Mutahera, Talya Ahmed, Nabila Ibrahim, Gilbert Atukwatsibwe, Sulabha Adhikari, Mohammad Esmaili, Jean-Vital Yambayamba", "journal": "MacEwan University Student eJournal", "publication_date": "2026-02-17", "publication_year": 2026, "doi": "10.31542/bcek6t76", "pubmed_id": null, "openalex_id": "https://openalex.org/W7130340064", "source_url": "https://doi.org/10.31542/bcek6t76", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Pharmacology,Receptor Pharmacology,Aging,Clinical Trial,Older Adults,Toxicity,Drug Interactions", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:52:05", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "DOI:10.31542/bcek6t76", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.31542/bcek6t76", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.31542/bcek6t76", "source_url": "https://doi.org/10.31542/bcek6t76", "doi": "10.31542/bcek6t76", "pmid": "", "publication_date": "2026-02-17", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 154, "title": "Psilocybin-assisted psychotherapy for psycho-existential distress in advanced cancer: a narrative review", "authors": "Luca Magnani, Luca Ghirotto, Fabio Fesce, Tania Simona Re, Silvia Tanzi, Andrea Amerio, Alessandra Costanza", "journal": "BMJ Supportive & Palliative Care", "publication_date": "2026-02-17", "publication_year": 2026, "doi": "10.1136/spcare-2025-005689", "pubmed_id": "41708300", "openalex_id": "https://openalex.org/W7130337407", "source_url": "https://doi.org/10.1136/spcare-2025-005689", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Chronic Pain,Systematic Review,Review Article,Cancer Patients,Inflammation", "study_type": "Systematic Review", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "PMID:41708300", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1136/spcare-2025-005689", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41708300", "source_url": "https://doi.org/10.1136/spcare-2025-005689", "doi": "10.1136/spcare-2025-005689", "pmid": "41708300", "publication_date": "2026-02-17", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4900, "title": "Sense-Making Around Psilocybin in UK Women Experiencing Cancer-Related Existential Distress: An Interpretative Phenomenological Analysis", "authors": "Zaynab Khan, Sterre Weaver, Rachael V. Dando, Anne Katrin Schlag, Joanna C. Neill, Verity Wainwright", "journal": "Qualitative Health Research", "publication_date": "2026-02-16", "publication_year": 2026, "doi": "10.1177/10497323261419338", "pubmed_id": "41700878", "openalex_id": "https://openalex.org/W7129539813", "source_url": "https://doi.org/10.1177/10497323261419338", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Chronic Pain,Aging,Clinical Trial,Cancer Patients", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:51", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "PMID:41700878", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1177/10497323261419338", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41700878", "source_url": "https://doi.org/10.1177/10497323261419338", "doi": "10.1177/10497323261419338", "pmid": "41700878", "publication_date": "2026-02-16", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3520, "title": "Pilot Study of Psilocybin-Assisted Therapy for Demoralization in Patients Receiving Hospice Care - PATH Study", "authors": "Yvan Beaussant, MD, MSci", "journal": "ClinicalTrials.gov", "publication_date": "2026-02-16", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT04950608", "substance_tags": "psilocybin", "topic_tags": "Depression,End-of-Life Distress,Cancer Patients,Safety", "study_type": "Other", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT04950608", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT04950608", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT04950608", "source_url": "https://clinicaltrials.gov/study/NCT04950608", "doi": "", "pmid": "", "publication_date": "2026-02-16", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 265, "title": "Rebuttal to “Questioning the recovery of dissociated traumatic memories under psilocybin”", "authors": "Stéphanie Knatz Peck, Timothy D. Brewerton", "journal": "Journal of Eating Disorders", "publication_date": "2026-02-16", "publication_year": 2026, "doi": "10.1186/s40337-026-01532-x", "pubmed_id": "41703646", "openalex_id": "https://openalex.org/W7129385481", "source_url": "https://doi.org/10.1186/s40337-026-01532-x", "substance_tags": "psilocybin", "topic_tags": "Depression,Emotional Processing,Case Report,Toxicity", "study_type": "Case Report", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "PMID:41703646", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1186/s40337-026-01532-x", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41703646", "source_url": "https://doi.org/10.1186/s40337-026-01532-x", "doi": "10.1186/s40337-026-01532-x", "pmid": "41703646", "publication_date": "2026-02-16", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 269, "title": "Microdosing psilocybin for major depressive disorder: study protocol for a phase II double-blind placebo-controlled randomised partial crossover trial", "authors": "Zeina Beidas, Anya Ragnhildstveit, Adam Blackman, Thomas Anderson, Emily C. Fewster, Omer A. Syed, Valentyne Sobolenko, Ismail Kaan Kanca, Magdalena Jaglinska, Tatiana Son, Norman Farb, Rotem Petranker", "journal": "BJPsych Open", "publication_date": "2026-02-15", "publication_year": 2026, "doi": "10.1192/bjo.2025.10968", "pubmed_id": "41693474", "openalex_id": "https://openalex.org/W7129015437", "source_url": "https://doi.org/10.1192/bjo.2025.10968", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Pharmacology,Microdosing,Wellbeing,Creativity,Clinical Trial,Randomized Controlled Trial,Review Article,Observational Study,Safety", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "PMID:41693474", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1192/bjo.2025.10968", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41693474", "source_url": "https://doi.org/10.1192/bjo.2025.10968", "doi": "10.1192/bjo.2025.10968", "pmid": "41693474", "publication_date": "2026-02-15", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 47, "title": "Psilocybin-assisted cognitive behavioral therapy for major depressive disorder: A pilot trial", "authors": "Marc J. Weintraub, Jessica Jeffrey, Megan Ichinose, R. Lindsey Bergman, Benjamin Shapiro, Gregory Barnett, Hewa Artin, Marc Lynn, Anabel Salimian, Shelby Grody, Rahul Ramesh, Lauren Eales, Charles S. Grob, David J. Miklowitz", "journal": "Journal of Affective Disorders", "publication_date": "2026-02-15", "publication_year": 2026, "doi": "10.1016/j.jad.2026.121423", "pubmed_id": "41707717", "openalex_id": "https://openalex.org/W7129028447", "source_url": "https://doi.org/10.1016/j.jad.2026.121423", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Clinical Trial,Randomized Controlled Trial,Treatment-Resistant Depression", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "PMID:41707717", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41707717", "source_url": "https://doi.org/10.1016/j.jad.2026.121423", "doi": "10.1016/j.jad.2026.121423", "pmid": "41707717", "publication_date": "2026-02-15", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3541, "title": "A Phase 1 Translational Study to Assess Brain Activity Using Functional Magnetic Resonance Imaging (fMRI) and to Evaluate the Safety, Tolerability, and Pharmacokinetics of Multiple Doses of MLS101 (Psilocybin) in Healthy Volunteers", "authors": "MycoMedica Life Sciences PBC", "journal": "ClinicalTrials.gov", "publication_date": "2026-02-12", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07050368", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Brain Imaging,Pharmacology,Aging,Clinical Trial,Healthy Volunteers,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07050368", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07050368", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07050368", "source_url": "https://clinicaltrials.gov/study/NCT07050368", "doi": "", "pmid": "", "publication_date": "2026-02-12", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 137, "title": "Trip sitting or just sitting? Session facilitators substantially influence psychedelic experiences in clinical trials but not in healthy ones", "authors": "Sean P. Goldy, Nathan D. Sepeda, Samantha Hilbert, Bilal A. Bari, Albert Garcia-Romeu, Natalie Gukasyan, Frederick S. Barrett, David B. Yaden, Sandeep M. Nayak", "journal": "Psychiatry Research", "publication_date": "2026-02-12", "publication_year": 2026, "doi": "10.1016/j.psychres.2026.117010", "pubmed_id": "41747432", "openalex_id": "https://openalex.org/W7128814597", "source_url": "https://doi.org/10.1016/j.psychres.2026.117010", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Clinical Trial,Randomized Controlled Trial,Toxicity", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 06:34:36", "bibtex": null, "source_record_id": "PMID:41747432", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41747432", "source_url": "https://doi.org/10.1016/j.psychres.2026.117010", "doi": "10.1016/j.psychres.2026.117010", "pmid": "41747432", "publication_date": "2026-02-12", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3704, "title": "Single Dose Psilocybin for a Post-surgical Trauma Inpatient Population for Pain, Mood, and Opioid Use Disorder", "authors": "Trent Emerick", "journal": "ClinicalTrials.gov", "publication_date": "2026-02-11", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07406828", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Chronic Pain,Clinical Trial,Review Article,Observational Study,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:34", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07406828", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07406828", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07406828", "source_url": "https://clinicaltrials.gov/study/NCT07406828", "doi": "", "pmid": "", "publication_date": "2026-02-11", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3624, "title": "Psilocybin-assisted Therapy for Comorbid Major Depressive Disorder and Alcohol Use Disorder: A Pilot Randomized Clinical Trial", "authors": "Centre for Addiction and Mental Health", "journal": "ClinicalTrials.gov", "publication_date": "2026-02-11", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07405606", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Clinical Trial,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:34", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07405606", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07405606", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07405606", "source_url": "https://clinicaltrials.gov/study/NCT07405606", "doi": "", "pmid": "", "publication_date": "2026-02-11", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1983, "title": "Low-income group psilocybin assisted therapy for depression: An Oregon feasibility study", "authors": "Matthew Hicks, Olivia Hicks, Ryan Bradley, Heather Zwickey", "journal": "Journal of Psychedelic Studies", "publication_date": "2026-02-11", "publication_year": 2026, "doi": "10.1556/2054.2026.00485", "pubmed_id": null, "openalex_id": "https://openalex.org/W7128687864", "source_url": "https://doi.org/10.1556/2054.2026.00485", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Chronic Pain,Clinical Trial,Randomized Controlled Trial,Observational Study,Adverse Events,Toxicity", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:52:05", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "DOI:10.1556/2054.2026.00485", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1556/2054.2026.00485", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1556/2054.2026.00485", "source_url": "https://doi.org/10.1556/2054.2026.00485", "doi": "10.1556/2054.2026.00485", "pmid": "", "publication_date": "2026-02-11", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 275, "title": "Time-Dependent Effects of Rapid-Acting Antidepressants in iPSC-Derived Neurons from Treatment-Resistant Depression and Healthy Volunteers", "authors": "Johnston J, Jones G, Peng S, Yuan P, Yavi M, Kadriu B, Henter I, Quintanilla B, Elkahloun AG, Moaddel R, Schulmann A, Akula N, Kvarta M, McMahon F, Zarate C.", "journal": "Research Square", "publication_date": "2026-02-11", "publication_year": 2026, "doi": "10.21203/rs.3.rs-8733841/v1", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.21203/rs.3.rs-8733841/v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Neuroplasticity,Mechanism of Action,Clinical Trial,Healthy Volunteers,Treatment-Resistant Depression,Transcriptomics,Proteomics,Inflammation", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "preprint", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-01 11:22:03", "bibtex": null, "source_record_id": "DOI:10.21203/rs.3.rs-8733841/v1", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.21203/rs.3.rs-8733841/v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "DOI:10.21203/rs.3.rs-8733841/v1", "source_url": "https://doi.org/10.21203/rs.3.rs-8733841/v1", "doi": "10.21203/rs.3.rs-8733841/v1", "pmid": "", "publication_date": "2026-02-11", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 86, "title": "Therapeutic effects of psilocybin in major depressive disorder: a systematic review and meta-analysis exploring dose effects", "authors": "Ziping He, Yijie Wang, Jie Chen, Junzhe Cheng, Yuxin Feng, Shuliang Niu, J. Yan", "journal": "European Archives of Psychiatry and Clinical Neuroscience", "publication_date": "2026-02-11", "publication_year": 2026, "doi": "10.1007/s00406-025-02165-y", "pubmed_id": "41677823", "openalex_id": "https://openalex.org/W7128718542", "source_url": "https://doi.org/10.1007/s00406-025-02165-y", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Pharmacology,Clinical Trial,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Treatment-Resistant Depression,Safety,Toxicity", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "PMID:41677823", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41677823", "source_url": "https://doi.org/10.1007/s00406-025-02165-y", "doi": "10.1007/s00406-025-02165-y", "pmid": "41677823", "publication_date": "2026-02-11", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 48, "title": "Examining the effects of psilocybin-assisted psychotherapy on anhedonia in treatment-resistant depression", "authors": "Erica Kaczmarek, Nelson B. Rodrigues, Noah Chisamore, Zoe Doyle, Shakila Meshkat, Marc G. Blainey, Ryan M. Brudner, Shaun Ali, Kayla M. Teopiz, Roger S. McIntyre, Joshua D. Rosenblat", "journal": "Journal of Affective Disorders", "publication_date": "2026-02-11", "publication_year": 2026, "doi": "10.1016/j.jad.2026.121385", "pubmed_id": "41690631", "openalex_id": "https://openalex.org/W7128743161", "source_url": "https://doi.org/10.1016/j.jad.2026.121385", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Clinical Trial,Randomized Controlled Trial,Treatment-Resistant Depression", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "PMID:41690631", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1016/j.jad.2026.121385", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41690631", "source_url": "https://doi.org/10.1016/j.jad.2026.121385", "doi": "10.1016/j.jad.2026.121385", "pmid": "41690631", "publication_date": "2026-02-11", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3031, "title": "Mystical but Not Challenging Experiences Predict Symptom Improvement After Psilocybin for Treatment-Resistant OCD", "authors": "", "journal": "PsyArXiv", "publication_date": "2026-02-10", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://osf.io/preprints/psyarxiv/d94hb_v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,OCD,Mystical Experience", "study_type": "Clinical Trial", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:46", "last_checked": "2026-07-01 11:22:30", "bibtex": null, "source_record_id": "https://osf.io/preprints/psyarxiv/d94hb_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/d94hb_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "https://osf.io/preprints/psyarxiv/d94hb_v1", "source_url": "https://osf.io/preprints/psyarxiv/d94hb_v1", "doi": "", "pmid": "", "publication_date": "2026-02-10", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4086, "title": "Exploring a Decade of Microdosing Research: A Qualitative Meta-synthesis of Microdosing Literature", "authors": "Blake Beaton", "journal": "Deviant Behavior", "publication_date": "2026-02-08", "publication_year": 2026, "doi": "10.1080/01639625.2026.2624690", "pubmed_id": null, "openalex_id": "https://openalex.org/W7128430445", "source_url": "https://doi.org/10.1080/01639625.2026.2624690", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Microdosing", "study_type": "Qualitative Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:36", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "DOI:10.1080/01639625.2026.2624690", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1080/01639625.2026.2624690", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1080/01639625.2026.2624690", "source_url": "https://doi.org/10.1080/01639625.2026.2624690", "doi": "10.1080/01639625.2026.2624690", "pmid": "", "publication_date": "2026-02-08", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4089, "title": "Activity-Dependent Neural Rewiring by Psilocybin: A Monosynaptic Rabies Virus Tracing Study", "authors": "Zen Revista", "journal": "Zenodo (CERN European Organization for Nuclear Research)", "publication_date": "2026-02-05", "publication_year": 2026, "doi": "10.5281/zenodo.18501514", "pubmed_id": null, "openalex_id": "https://openalex.org/W7127925138", "source_url": "https://doi.org/10.5281/zenodo.18501514", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Neuroplasticity,Brain Imaging,Mechanism of Action,Aging,Review Article,Toxicity", "study_type": "Review Article", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:36", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "DOI:10.5281/zenodo.18501514", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.5281/zenodo.18501514", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.5281/zenodo.18501514", "source_url": "https://doi.org/10.5281/zenodo.18501514", "doi": "10.5281/zenodo.18501514", "pmid": "", "publication_date": "2026-02-05", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3690, "title": "Safety and Psychological Effects of Psilocybin and D-Serine Formulation in Healthy Volunteers", "authors": "Hadassah Medical Organization", "journal": "ClinicalTrials.gov", "publication_date": "2026-02-04", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07079930", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Neuroplasticity,Brain Imaging,Receptor Pharmacology,Consciousness,Biomarkers,Clinical Trial,Observational Study,Animal Study,Healthy Volunteers,Safety,Toxicity,Inflammation", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:34", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07079930", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07079930", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07079930", "source_url": "https://clinicaltrials.gov/study/NCT07079930", "doi": "", "pmid": "", "publication_date": "2026-02-04", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3550, "title": "A Phase 2a, Open-label, Pilot Study to Assess the Safety and Efficacy of Oral Psilocybin (TRP-8802) Administration in Concert With Psychotherapy Among Adult Patients With Irritable Bowel Syndrome: A Randomized Delayed Treatment Control Design", "authors": "TRYP Therapeutics", "journal": "ClinicalTrials.gov", "publication_date": "2026-02-04", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06206265", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Chronic Pain,Brain Imaging,Aging,Clinical Trial,Healthcare Workers,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06206265", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06206265", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06206265", "source_url": "https://clinicaltrials.gov/study/NCT06206265", "doi": "", "pmid": "", "publication_date": "2026-02-04", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 138, "title": "Challenges with clinical trial participants in studies with classical psychedelics: A position statement from the National Network of Depression Centers’ task group on psychedelics and related compounds", "authors": "Benjamin R. Lewis, M. Carrington Reid, Andrew M. Novick, Kevin Byrne, Mark J. Niciu, Gregory A. Fonzo, Thomas D. Meyer, David Feifel, Rif S. El-Mallakh, Jair Soares, Trisha Suppes, Frederick S. Barrett", "journal": "Journal of Psychopharmacology", "publication_date": "2026-02-04", "publication_year": 2026, "doi": "10.1177/02698811251413490", "pubmed_id": "41645048", "openalex_id": "https://openalex.org/W7128008256", "source_url": "https://doi.org/10.1177/02698811251413490", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Clinical Trial,Healthcare Workers,Safety,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "PMID:41645048", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1177/02698811251413490", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41645048", "source_url": "https://doi.org/10.1177/02698811251413490", "doi": "10.1177/02698811251413490", "pmid": "41645048", "publication_date": "2026-02-04", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 280, "title": "Acute psilocin increased cortical activity in rat", "authors": "Junhong Liu, Y. Lynn Wang, Ke Xia, Jia-Bin Wu, Danhao Zheng, Aoling Cai, Haitao Yan, Ruibin Su", "journal": "Frontiers in Neuroscience", "publication_date": "2026-02-03", "publication_year": 2026, "doi": "10.3389/fnins.2026.1593703", "pubmed_id": "41716660", "openalex_id": "https://openalex.org/W7127681443", "source_url": "https://doi.org/10.3389/fnins.2026.1593703", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Brain Imaging,Pharmacology,Mechanism of Action,Receptor Pharmacology,Aging,Clinical Trial,Animal Study", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "PMID:41716660", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.3389/fnins.2026.1593703", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41716660", "source_url": "https://doi.org/10.3389/fnins.2026.1593703", "doi": "10.3389/fnins.2026.1593703", "pmid": "41716660", "publication_date": "2026-02-03", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1985, "title": "Psilocybin exerts differential effects on social behavior and inflammation in mice in contexts of activity-based anorexia", "authors": "Sheida Shadani, Erika Greaves, Zane B. Andrews, Claire J. Foldi", "journal": "Psychedelics.", "publication_date": "2026-02-02", "publication_year": 2026, "doi": "10.61373/pp026a.0003", "pubmed_id": null, "openalex_id": "https://openalex.org/W7127440111", "source_url": "https://doi.org/10.61373/pp026a.0003", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,OCD,Eating Disorders,Mechanism of Action,Receptor Pharmacology,Emotional Processing,Animal Study,Toxicity,Inflammation,Immune Function", "study_type": "Animal Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:52:05", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "DOI:10.61373/pp026a.0003", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.61373/pp026a.0003", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.61373/pp026a.0003", "source_url": "https://doi.org/10.61373/pp026a.0003", "doi": "10.61373/pp026a.0003", "pmid": "", "publication_date": "2026-02-02", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 2984, "title": "Psilocybin wirkt bei therapieresistenter Depression", "authors": "Thomas Müller", "journal": "DNP - Die Neurologie & Psychiatrie", "publication_date": "2026-01-31", "publication_year": 2026, "doi": "10.1007/s15202-025-6636-1", "pubmed_id": null, "openalex_id": "https://openalex.org/W7127040761", "source_url": "https://doi.org/10.1007/s15202-025-6636-1", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Pharmacology,Toxicity", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:55:42", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "DOI:10.1007/s15202-025-6636-1", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1007/s15202-025-6636-1", "source_url": "https://doi.org/10.1007/s15202-025-6636-1", "doi": "10.1007/s15202-025-6636-1", "pmid": "", "publication_date": "2026-01-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1986, "title": "Attitudes and perceptions of Portuguese mental health professionals on the therapeutic use of psilocybin and methylenedioxymethamphetamine (MDMA).", "authors": "Jorge Encantado, Laura C. Carvalho, Pedro Mota, Catarina Cunha, Albert Garcia-Romeu, Matthew W. Johnson, Pedro J. Teixeira", "journal": "Professional Psychology Research and Practice", "publication_date": "2026-01-31", "publication_year": 2026, "doi": "10.1037/pro0000664", "pubmed_id": null, "openalex_id": "https://openalex.org/W7128674161", "source_url": "https://doi.org/10.1037/pro0000664", "substance_tags": "psilocybin", "topic_tags": "Depression,Toxicity", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:52:05", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "DOI:10.1037/pro0000664", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1037/pro0000664", "source_url": "https://doi.org/10.1037/pro0000664", "doi": "10.1037/pro0000664", "pmid": "", "publication_date": "2026-01-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 307, "title": "Ketamine, Psychedelics, and Psychotherapy: Reframing, Redefining, Renaming Treatment Models.", "authors": "Swainson J, Brietzke E, Khullar A, McIntyre RS, Soares CN", "journal": "Canadian journal of psychiatry. Revue canadienne de psychiatrie", "publication_date": "2026-01-31", "publication_year": 2026, "doi": "10.1177/07067437251389090", "pubmed_id": "41148143", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/41148143/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Mechanism of Action,Clinical Trial", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:20:35", "bibtex": null, "source_record_id": "PMID:41148143", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41148143/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41148143", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41148143/", "doi": "10.1177/07067437251389090", "pmid": "41148143", "publication_date": "2026-01-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 300, "title": "Placebo Effects in the Treatment of Depression-Implications for the Psychedelic Renaissance.", "authors": "Ansari M, Elliott SI, Holmes SE, Sanacora G", "journal": "Neurologic clinics", "publication_date": "2026-01-31", "publication_year": 2026, "doi": "10.1016/j.ncl.2025.08.009", "pubmed_id": "41232997", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/41232997/", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Mechanism of Action,Review Article", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-01 11:20:35", "bibtex": null, "source_record_id": "PMID:41232997", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41232997/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41232997", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41232997/", "doi": "10.1016/j.ncl.2025.08.009", "pmid": "41232997", "publication_date": "2026-01-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 287, "title": "Psychedelic- and Substance-Assisted Therapies in Global Mental Health: Bridging Cultures, Evidence, and Access", "authors": "Simon Halm", "journal": "Brain and Behavior", "publication_date": "2026-01-31", "publication_year": 2026, "doi": "10.1002/brb3.71265", "pubmed_id": "41699879", "openalex_id": "https://openalex.org/W7129286008", "source_url": "https://doi.org/10.1002/brb3.71265", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Mechanism of Action,Toxicity", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "PMID:41699879", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1002/brb3.71265", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41699879", "source_url": "https://doi.org/10.1002/brb3.71265", "doi": "10.1002/brb3.71265", "pmid": "41699879", "publication_date": "2026-01-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 284, "title": "Bioactive compounds from Psilocybe cubensis mycelial cultures with transient anxiolytic effects in mice.", "authors": "Kala K, Bederska-Lojewska D, Lazur J, Gasior K, Maslanka A, Szewczyk A, Sulkowska-Ziaja K, Turek J, Szewczyk B, Pilc A, Muszynska B.", "journal": null, "publication_date": "2026-01-31", "publication_year": 2026, "doi": "10.26402/jpp.2026.1.07", "pubmed_id": "41931735", "openalex_id": null, "source_url": "https://doi.org/10.26402/jpp.2026.1.07", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Microdosing,Animal Study,In Vitro Study", "study_type": "Animal Study", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-01 11:22:01", "bibtex": null, "source_record_id": "PMID:41931735", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.26402/jpp.2026.1.07", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:41931735", "source_url": "https://doi.org/10.26402/jpp.2026.1.07", "doi": "10.26402/jpp.2026.1.07", "pmid": "41931735", "publication_date": "2026-01-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1988, "title": "Psilocybin-Induced Neuroplasticity and Sustained Antidepressant Effects", "authors": "Anna Maria Komarczewska, Filip Matusiak, Klaudia Brzoza, Michał Kociński, Patryk Iglewski, Michał Pietrasz", "journal": "Quality in Sport", "publication_date": "2026-01-30", "publication_year": 2026, "doi": "10.12775/qs.2026.51.68216", "pubmed_id": null, "openalex_id": "https://openalex.org/W7126403964", "source_url": "https://doi.org/10.12775/qs.2026.51.68216", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Chronic Pain,Neuroplasticity,Brain Imaging,Pharmacology,Mechanism of Action,Receptor Pharmacology,Aging,Clinical Trial,Meta-Analysis,Review Article,Animal Study,Cancer Patients,Treatment-Resistant Depression,Toxicity", "study_type": "Meta-Analysis", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:52:05", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "DOI:10.12775/qs.2026.51.68216", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.12775/qs.2026.51.68216", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.12775/qs.2026.51.68216", "source_url": "https://doi.org/10.12775/qs.2026.51.68216", "doi": "10.12775/qs.2026.51.68216", "pmid": "", "publication_date": "2026-01-30", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 312, "title": "The Use of Psilocybin in the Treatment of Depressive Disorders: A Narrative Review", "authors": "Lukasz Siwek, Marta Nowocien, Barbara Balajewicz, Angelika Samborska, Sara Szukalska, Marta Karczewska, Karolina Lichwala, Kamil Wroblewski, Paulina Wróblewska", "journal": "Cureus", "publication_date": "2026-01-30", "publication_year": 2026, "doi": "10.7759/cureus.102694", "pubmed_id": "41777966", "openalex_id": "https://openalex.org/W7126444817", "source_url": "https://doi.org/10.7759/cureus.102694", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Receptor Pharmacology,Review Article,Treatment-Resistant Depression,Toxicity,Drug Interactions", "study_type": "Review Article", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "PMID:41777966", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.7759/cureus.102694", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41777966", "source_url": "https://doi.org/10.7759/cureus.102694", "doi": "10.7759/cureus.102694", "pmid": "41777966", "publication_date": "2026-01-30", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4097, "title": "Protecting patient autonomy in psychedelic-assisted psychotherapy: a nursing ethics perspective", "authors": "Aditi Kanwar, Nitin Jeengar, Pramod Kumar Ashaiya", "journal": "Zenodo (CERN European Organization for Nuclear Research)", "publication_date": "2026-01-29", "publication_year": 2026, "doi": "10.5281/zenodo.18425838", "pubmed_id": null, "openalex_id": "https://openalex.org/W7126227261", "source_url": "https://doi.org/10.5281/zenodo.18425838", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,End-of-Life Distress,Chronic Pain,Consciousness,Emotional Processing,Treatment-Resistant Depression,Safety,Toxicity", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:36", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "DOI:10.5281/zenodo.18425838", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.5281/zenodo.18425838", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.5281/zenodo.18425838", "source_url": "https://doi.org/10.5281/zenodo.18425838", "doi": "10.5281/zenodo.18425838", "pmid": "", "publication_date": "2026-01-29", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 194, "title": "PSilocybin for psYCHological and existential distress in PALliative care (PSYCHED-PAL): A single arm unblinded clinical trial", "authors": "James Downar, Julie Lapenskie, Koby Anderson, Gaelle Parsons, Nadia Polskaia, Genevieve Lalumiere, Peter G. Lawlor", "journal": "Palliative Medicine", "publication_date": "2026-01-29", "publication_year": 2026, "doi": "10.1177/02692163261416269", "pubmed_id": "41617652", "openalex_id": "https://openalex.org/W7126258550", "source_url": "https://doi.org/10.1177/02692163261416269", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Chronic Pain,Microdosing,Emotional Processing,Clinical Trial,Randomized Controlled Trial,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "PMID:41617652", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1177/02692163261416269", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41617652", "source_url": "https://doi.org/10.1177/02692163261416269", "doi": "10.1177/02692163261416269", "pmid": "41617652", "publication_date": "2026-01-29", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4098, "title": "Psychedelic research and sexuality: opportunities and pitfalls", "authors": "H. Knegtering, Thalia Herder, Nynke Boonstra, S. K. Spoelstra", "journal": "The Journal of Sexual Medicine", "publication_date": "2026-01-27", "publication_year": 2026, "doi": "10.1093/jsxmed/qdag025", "pubmed_id": "41722098", "openalex_id": "https://openalex.org/W7130838555", "source_url": "https://doi.org/10.1093/jsxmed/qdag025", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Addiction,Emotional Processing,Review Article,Toxicity,Drug Interactions", "study_type": "Review Article", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:36", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "PMID:41722098", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1093/jsxmed/qdag025", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41722098", "source_url": "https://doi.org/10.1093/jsxmed/qdag025", "doi": "10.1093/jsxmed/qdag025", "pmid": "41722098", "publication_date": "2026-01-27", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1989, "title": "PSILOCYBIN IN PSYCHIATRIC PRACTICE AND PSYCHEDELIC-ASSISTED THERAPY FOR TREATMENT-RESISTANT DEPRESSION", "authors": "Łukasz Deska, Cezary Kosmecki, Dawid Głaz, Natalia Kamińska, Wojciech Sołtys, Magdalena Stolarczyk, Maksymilian Głaz, Mateusz Stronczyński, Aleksandra Jagura-Sukiennik, Julia Wawerska", "journal": "International Journal of Innovative Technologies in Social Science", "publication_date": "2026-01-27", "publication_year": 2026, "doi": "10.31435/ijitss.1(49).2026.4711", "pubmed_id": null, "openalex_id": "https://openalex.org/W7125929049", "source_url": "https://doi.org/10.31435/ijitss.1(49).2026.4711", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Systematic Review,Review Article,Treatment-Resistant Depression,Safety,Adverse Events,Toxicity", "study_type": "Systematic Review", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:52:05", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "DOI:10.31435/ijitss.1(49).2026.4711", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.31435/ijitss.1(49).2026.4711", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.31435/ijitss.1(49).2026.4711", "source_url": "https://doi.org/10.31435/ijitss.1(49).2026.4711", "doi": "10.31435/ijitss.1(49).2026.4711", "pmid": "", "publication_date": "2026-01-27", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 316, "title": "A Promise Without Panacea: Psychedelic-Assisted Therapies in Modern Psychiatry", "authors": "Mohsin Raza, Jasleen Kaur", "journal": "Cureus", "publication_date": "2026-01-26", "publication_year": 2026, "doi": "10.7759/cureus.102421", "pubmed_id": "41769492", "openalex_id": "https://openalex.org/W7125808618", "source_url": "https://doi.org/10.7759/cureus.102421", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Addiction,Neuroplasticity,Emotional Processing,Clinical Trial,Treatment-Resistant Depression,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "PMID:41769492", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.7759/cureus.102421", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41769492", "source_url": "https://doi.org/10.7759/cureus.102421", "doi": "10.7759/cureus.102421", "pmid": "41769492", "publication_date": "2026-01-26", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4101, "title": "Psychedelics in psychiatric treatment: a literature review", "authors": "Adam Wolski, Ewa Szplit, Mikołaj Franciszek Patalong, Roman Cemaga, Mateusz Kubicki, Przemysław Kołodziej, Natalia Bruska, Bartłomiej Błaszkowski, Andrii Bilyk, Katarzyna Więckowska", "journal": "Quality in Sport", "publication_date": "2026-01-25", "publication_year": 2026, "doi": "10.12775/qs.2026.50.68013", "pubmed_id": null, "openalex_id": "https://openalex.org/W7125801196", "source_url": "https://doi.org/10.12775/qs.2026.50.68013", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Mechanism of Action,Clinical Trial,Systematic Review,Review Article,Safety,Toxicity", "study_type": "Systematic Review", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:36", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "DOI:10.12775/qs.2026.50.68013", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.12775/qs.2026.50.68013", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.12775/qs.2026.50.68013", "source_url": "https://doi.org/10.12775/qs.2026.50.68013", "doi": "10.12775/qs.2026.50.68013", "pmid": "", "publication_date": "2026-01-25", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4100, "title": "The therapeutic efficacy of psilocybin in major depressive disorder: A review of recent clinical and mechanistic evidence", "authors": "Fernando Mora López, Johynny Solís Solís, Ekaterina Daniela Hernández Baker, Olger Herrera Barboza, David Diaz Polo, Daniela Consumi Cordero", "journal": "Zenodo (CERN European Organization for Nuclear Research)", "publication_date": "2026-01-25", "publication_year": 2026, "doi": "10.5281/zenodo.18375715", "pubmed_id": null, "openalex_id": "https://openalex.org/W7125699554", "source_url": "https://doi.org/10.5281/zenodo.18375715", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Neuroplasticity,Brain Imaging,Mechanism of Action,Receptor Pharmacology,Default Mode Network,Biomarkers,Aging,Emotional Processing,Clinical Trial,Randomized Controlled Trial,Review Article,Treatment-Resistant Depression,Safety,Adverse Events,Toxicity", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:36", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "DOI:10.5281/zenodo.18375715", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.5281/zenodo.18375715", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.5281/zenodo.18375715", "source_url": "https://doi.org/10.5281/zenodo.18375715", "doi": "10.5281/zenodo.18375715", "pmid": "", "publication_date": "2026-01-25", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1991, "title": "The Evaluation of the Efficacy and Safety of the Use of Psilocybin in the Treatment of Adults with Treatment-Resistant Depression", "authors": "Rishika Scott, James Smith", "journal": "Emerging Minds Journal for Student Research", "publication_date": "2026-01-24", "publication_year": 2026, "doi": "10.59973/emjsr.317", "pubmed_id": null, "openalex_id": "https://openalex.org/W7125652025", "source_url": "https://doi.org/10.59973/emjsr.317", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Pharmacology,Receptor Pharmacology,Clinical Trial,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Treatment-Resistant Depression,Safety", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:52:05", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "DOI:10.59973/emjsr.317", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.59973/emjsr.317", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.59973/emjsr.317", "source_url": "https://doi.org/10.59973/emjsr.317", "doi": "10.59973/emjsr.317", "pmid": "", "publication_date": "2026-01-24", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 195, "title": "Methodological moderators of psilocybin-assisted therapy in depression: A systematic review and meta-analysis", "authors": "Omer A. Syed, Benjamin Tsang, Sean M. Nestor, Nir Lipsman, Muhammad Ishrat Husain, Fahad Alam, Peter Giacobbe", "journal": "Neuroscience & Biobehavioral Reviews", "publication_date": "2026-01-23", "publication_year": 2026, "doi": "10.1016/j.neubiorev.2026.106573", "pubmed_id": "41587629", "openalex_id": "https://openalex.org/W7125613611", "source_url": "https://doi.org/10.1016/j.neubiorev.2026.106573", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Clinical Trial,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Treatment-Resistant Depression,Healthcare Workers", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "PMID:41587629", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1016/j.neubiorev.2026.106573", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41587629", "source_url": "https://doi.org/10.1016/j.neubiorev.2026.106573", "doi": "10.1016/j.neubiorev.2026.106573", "pmid": "41587629", "publication_date": "2026-01-23", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1992, "title": "THE PSYCHEDELIC RENAISSANCE: A SYSTEMATIC REVIEW OF PSILOCYBIN AND LSD IN THE TREATMENT OF PSYCHIATRIC DISORDERS", "authors": "Jakub Klepacz, Radosław Swędrak, Marzena Swojnóg, Zuzanna Dobrakowska", "journal": "International Journal of Innovative Technologies in Social Science", "publication_date": "2026-01-22", "publication_year": 2026, "doi": "10.31435/ijitss.1(49).2026.4582", "pubmed_id": null, "openalex_id": "https://openalex.org/W7127606273", "source_url": "https://doi.org/10.31435/ijitss.1(49).2026.4582", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,End-of-Life Distress,Chronic Pain,Mechanism of Action,Receptor Pharmacology,Default Mode Network,Clinical Trial,Systematic Review,Review Article,Treatment-Resistant Depression,Safety,Toxicity", "study_type": "Systematic Review", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:52:05", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "DOI:10.31435/ijitss.1(49).2026.4582", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.31435/ijitss.1(49).2026.4582", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.31435/ijitss.1(49).2026.4582", "source_url": "https://doi.org/10.31435/ijitss.1(49).2026.4582", "doi": "10.31435/ijitss.1(49).2026.4582", "pmid": "", "publication_date": "2026-01-22", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4106, "title": "Does psilocybin help with mental health conditions?", "authors": "Tripdatabase", "journal": "Zenodo (CERN European Organization for Nuclear Research)", "publication_date": "2026-01-21", "publication_year": 2026, "doi": "10.5281/zenodo.18339283", "pubmed_id": null, "openalex_id": "https://openalex.org/W7125428177", "source_url": "https://doi.org/10.5281/zenodo.18339283", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Chronic Pain,Safety,Toxicity", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:36", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "DOI:10.5281/zenodo.18339283", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.5281/zenodo.18339283", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.5281/zenodo.18339283", "source_url": "https://doi.org/10.5281/zenodo.18339283", "doi": "10.5281/zenodo.18339283", "pmid": "", "publication_date": "2026-01-21", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4108, "title": "Psychological Therapy Quantity and Depressive Symptom Reduction in Psychedelic-Assisted Therapy: A Systematic Review and Meta-Analysis.", "authors": "Florineth, Gianluca Andri, Klima, Isabell, Boeker, Anna Laura, Catzeflis, Polina, Wopfner, Alexander, Denier, Niklaus, Bracht, Tobias, Adorjan, Kristina, Pfammatter, Mario, Müller, Felix, Soravia, Leila Maria", "journal": "Open Access CRIS of the University of Bern", "publication_date": "2026-01-20", "publication_year": 2026, "doi": "10.48620/94398", "pubmed_id": null, "openalex_id": "https://openalex.org/W7128014083", "source_url": "https://doi.org/10.48620/94398", "substance_tags": "psilocybin", "topic_tags": "Depression,Microdosing,Clinical Trial,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Case Report,Safety,Toxicity,Drug Interactions", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:36", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "DOI:10.48620/94398", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.48620/94398", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.48620/94398", "source_url": "https://doi.org/10.48620/94398", "doi": "10.48620/94398", "pmid": "", "publication_date": "2026-01-20", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 334, "title": "Psychological Therapy Quantity and Depressive Symptom Reduction in Psychedelic-Assisted Therapy", "authors": "Gianluca Andri Florineth, Isabell Klima, Anna Laura Boeker, Polina Catzeflis, Alexander Wopfner, Niklaus Denier, Tobias Bracht, Kristina Adorjan, Mario Pfammatter, Felix Müller, Leila Maria Soravia", "journal": "JAMA Network Open", "publication_date": "2026-01-20", "publication_year": 2026, "doi": "10.1001/jamanetworkopen.2025.54843", "pubmed_id": "41563753", "openalex_id": "https://openalex.org/W7125277592", "source_url": "https://doi.org/10.1001/jamanetworkopen.2025.54843", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Microdosing,Clinical Trial,Meta-Analysis,Systematic Review,Review Article,Case Report,Safety,Toxicity,Drug Interactions", "study_type": "Meta-Analysis", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "PMID:41563753", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1001/jamanetworkopen.2025.54843", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41563753", "source_url": "https://doi.org/10.1001/jamanetworkopen.2025.54843", "doi": "10.1001/jamanetworkopen.2025.54843", "pmid": "41563753", "publication_date": "2026-01-20", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 140, "title": "Psilocin mediates long-term synaptic depression in the prelimbic cortex through 5-HT2A receptor-independent mechanisms", "authors": "Ana Domi, Erika Lucente, Davide Cadeddu, Niklas Bengtsson, Erik Smedler, Louise Adermark", "journal": "Neuropharmacology", "publication_date": "2026-01-20", "publication_year": 2026, "doi": "10.1016/j.neuropharm.2026.110854", "pubmed_id": "41577180", "openalex_id": "https://openalex.org/W7125257065", "source_url": "https://doi.org/10.1016/j.neuropharm.2026.110854", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Neuroplasticity,Pharmacology,Mechanism of Action,Receptor Pharmacology,Animal Study,Toxicity,Drug Interactions", "study_type": "Animal Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "PMID:41577180", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1016/j.neuropharm.2026.110854", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41577180", "source_url": "https://doi.org/10.1016/j.neuropharm.2026.110854", "doi": "10.1016/j.neuropharm.2026.110854", "pmid": "41577180", "publication_date": "2026-01-20", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 141, "title": "Insights into psilocybin use among people with bipolar disorder: A thematic analysis of Reddit posts", "authors": "Laura Mills, Susan L. Rossell, Sean Carruthers", "journal": "Journal of Affective Disorders", "publication_date": "2026-01-19", "publication_year": 2026, "doi": "10.1016/j.jad.2026.121220", "pubmed_id": "41571194", "openalex_id": "https://openalex.org/W7124978464", "source_url": "https://doi.org/10.1016/j.jad.2026.121220", "substance_tags": "psilocybin", "topic_tags": "Depression,Safety", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "PMID:41571194", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1016/j.jad.2026.121220", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41571194", "source_url": "https://doi.org/10.1016/j.jad.2026.121220", "doi": "10.1016/j.jad.2026.121220", "pmid": "41571194", "publication_date": "2026-01-19", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 251, "title": "Early response to psilocybin in adults with treatment-resistant depression as a predictor for antidepressant efficacy", "authors": "Zoe Doyle, Noah Chisamore, Erica Kaczmarek, Danica E. Johnson, Ryan M. Brudner, Geneva Weiglein, Marc G. Blainey, Jordan Bawks, Jeremy Riva-Cambrin, Rickinder Sethi, Roger S. McIntyre, Joshua D. Rosenblat", "journal": "General Hospital Psychiatry", "publication_date": "2026-01-18", "publication_year": 2026, "doi": "10.1016/j.genhosppsych.2026.01.001", "pubmed_id": "41581334", "openalex_id": "https://openalex.org/W7124833468", "source_url": "https://doi.org/10.1016/j.genhosppsych.2026.01.001", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Clinical Trial,Treatment-Resistant Depression,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "PMID:41581334", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41581334", "source_url": "https://doi.org/10.1016/j.genhosppsych.2026.01.001", "doi": "10.1016/j.genhosppsych.2026.01.001", "pmid": "41581334", "publication_date": "2026-01-18", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 142, "title": "Insights from the psychedelic experience integration session: Verbatims differentiate 3-month abstinence in alcohol use disorder with depressive symptoms", "authors": "Maria Garcia Garcia, Dahbia Belahda, Carine Graux, Chris Serrand, Noe Igounenc, Felix Sergent, Thibault Mura, Amandine Luquiens", "journal": "Journal of Affective Disorders", "publication_date": "2026-01-18", "publication_year": 2026, "doi": "10.1016/j.jad.2026.121215", "pubmed_id": "41558304", "openalex_id": "https://openalex.org/W7124752751", "source_url": "https://doi.org/10.1016/j.jad.2026.121215", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Chronic Pain,Mechanism of Action,Biomarkers,Emotional Processing,Randomized Controlled Trial,Review Article", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "PMID:41558304", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1016/j.jad.2026.121215", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41558304", "source_url": "https://doi.org/10.1016/j.jad.2026.121215", "doi": "10.1016/j.jad.2026.121215", "pmid": "41558304", "publication_date": "2026-01-18", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1993, "title": "Group Retreat Psilocybin Therapy for People with Metastatic Cancer with Symptoms of Anxiety and Depression: Safety and Efficacy Outcomes of a Phase 1/2 Study", "authors": "Anthony L. Back, Bonnie A. McGregor, Leslie Lazar Thorn, Kelsey K. Baker, T. Gooley, Mendel Kaelen, Kalin Harvey, John M. Guy, Susanna Myers, Juliana Pérez, Peter Thompson, Lindsay Billingsley, Cheryl Sesnon", "journal": "Psychedelic Medicine", "publication_date": "2026-01-17", "publication_year": 2026, "doi": "10.1177/28314425251413856", "pubmed_id": null, "openalex_id": "https://openalex.org/W7124682544", "source_url": "https://doi.org/10.1177/28314425251413856", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Chronic Pain,Clinical Trial,Randomized Controlled Trial,Observational Study,Cancer Patients,Safety", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:52:05", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "DOI:10.1177/28314425251413856", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1177/28314425251413856", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1177/28314425251413856", "source_url": "https://doi.org/10.1177/28314425251413856", "doi": "10.1177/28314425251413856", "pmid": "", "publication_date": "2026-01-17", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 198, "title": "Bridging the reporting gap: Application of the ReSPCT guidelines in psilocybin clinical trial protocols", "authors": "Damian Świeczkowski, Aleksander Kwaśny, Krzysztof Sadko, Wiesław Jerzy Cubała", "journal": "European Neuropsychopharmacology", "publication_date": "2026-01-15", "publication_year": 2026, "doi": "10.1016/j.euroneuro.2025.112746", "pubmed_id": "41546918", "openalex_id": "https://openalex.org/W7124418318", "source_url": "https://doi.org/10.1016/j.euroneuro.2025.112746", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Clinical Trial,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "PMID:41546918", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41546918", "source_url": "https://doi.org/10.1016/j.euroneuro.2025.112746", "doi": "10.1016/j.euroneuro.2025.112746", "pmid": "41546918", "publication_date": "2026-01-15", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3261, "title": "Aquahenosis: A non-pharmacological altered state of consciousness induced by Floatation-REST", "authors": "", "journal": "PsyArXiv", "publication_date": "2026-01-14", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://osf.io/preprints/psyarxiv/6mj8n_v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Mechanism of Action,Consciousness,Spirituality,Randomized Controlled Trial", "study_type": "Randomized Controlled Trial", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:49", "last_checked": "2026-07-01 11:22:30", "bibtex": null, "source_record_id": "https://osf.io/preprints/psyarxiv/6mj8n_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/6mj8n_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "https://osf.io/preprints/psyarxiv/6mj8n_v1", "source_url": "https://osf.io/preprints/psyarxiv/6mj8n_v1", "doi": "", "pmid": "", "publication_date": "2026-01-14", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3038, "title": "Psilocybin rapidly, but not immediately, reverses reward learning deficits in a durable manner in an inflammatory rat model of depressive symptoms", "authors": "Hinchcliffe JK, Thomas CW, Gilmour G, Robinson ES.", "journal": "bioRxiv", "publication_date": "2026-01-14", "publication_year": 2026, "doi": "10.64898/2026.01.14.699553", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.64898/2026.01.14.699553", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Animal Study,Inflammation", "study_type": "Animal Study", "source_name": "bioRxiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:46", "last_checked": "2026-07-01 11:22:00", "bibtex": null, "source_record_id": "DOI:10.64898/2026.01.14.699553", "abstract_available": true, "abstract_source": "bioRxiv", "abstract_source_url": "https://doi.org/10.64898/2026.01.14.699553", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "bioRxiv", "source_record_id": "DOI:10.64898/2026.01.14.699553", "source_url": "https://doi.org/10.64898/2026.01.14.699553", "doi": "10.64898/2026.01.14.699553", "pmid": "", "publication_date": "2026-01-14", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3029, "title": "Psilocybin for Treatment-Resistant OCD: A Randomized Controlled Trial", "authors": "", "journal": "PsyArXiv", "publication_date": "2026-01-14", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://osf.io/preprints/psyarxiv/atfum_v1", "substance_tags": "psilocybin", "topic_tags": "Depression,OCD,Clinical Trial,Randomized Controlled Trial,Safety", "study_type": "Randomized Controlled Trial", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:46", "last_checked": "2026-07-01 11:22:30", "bibtex": null, "source_record_id": "https://osf.io/preprints/psyarxiv/atfum_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/atfum_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "https://osf.io/preprints/psyarxiv/atfum_v1", "source_url": "https://osf.io/preprints/psyarxiv/atfum_v1", "doi": "", "pmid": "", "publication_date": "2026-01-14", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 184, "title": "The Psychological Support Model in Psilocybin Research: Psychotherapy in Disguise?", "authors": "Celia Faye Jacobsen, Dea Siggaard Stenbæk, Stig Poulsen, Sophia Armand", "journal": "Psychiatric Research and Clinical Practice", "publication_date": "2026-01-13", "publication_year": 2026, "doi": "10.1176/appi.prcp.20250113", "pubmed_id": "42022021", "openalex_id": "https://openalex.org/W7123730053", "source_url": "https://doi.org/10.1176/appi.prcp.20250113", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Emotional Processing,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "PMID:42022021", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1176/appi.prcp.20250113", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:42022021", "source_url": "https://doi.org/10.1176/appi.prcp.20250113", "doi": "10.1176/appi.prcp.20250113", "pmid": "42022021", "publication_date": "2026-01-13", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3532, "title": "A Phase III, Multicentre, Randomised, Double-blind, Controlled Study to Investigate the Efficacy, Safety, and Tolerability of Two Administrations of COMP360 in Participants With Treatment-resistant Depression", "authors": "COMPASS Pathways", "journal": "ClinicalTrials.gov", "publication_date": "2026-01-11", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05711940", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05711940", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05711940", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05711940", "source_url": "https://clinicaltrials.gov/study/NCT05711940", "doi": "", "pmid": "", "publication_date": "2026-01-11", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3523, "title": "Effects of Psilocybin in Patients With Amyotrophic Lateral Sclerosis", "authors": "Johns Hopkins University", "journal": "ClinicalTrials.gov", "publication_date": "2026-01-11", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06656702", "substance_tags": "psilocybin", "topic_tags": "Depression", "study_type": "Other", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06656702", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06656702", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06656702", "source_url": "https://clinicaltrials.gov/study/NCT06656702", "doi": "", "pmid": "", "publication_date": "2026-01-11", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 266, "title": "Sense-making around psilocybin in UK women experiencing cancer-related existential distress: An Interpretative Phenomenological Analysis", "authors": "Zaynab Khan, Sterre Weaver, Rachael V. Dando, Anne Katrin Schlag, Joanna; id_orcid 0000-0002-2717-9739 Neill, Verity; id_orcid 0000-0002-9876-250X Wainwright", "journal": "Research Explorer (The University of Manchester)", "publication_date": "2026-01-08", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": "https://openalex.org/W7128133091", "source_url": "https://research.manchester.ac.uk/en/publications/6f070f13-96c6-4cc4-9e40-f2837bdb79b3", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Chronic Pain,Aging,Clinical Trial,Cancer Patients", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "https://research.manchester.ac.uk/en/publications/6f070f13-96c6-4cc4-9e40-f2837bdb79b3", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://research.manchester.ac.uk/en/publications/6f070f13-96c6-4cc4-9e40-f2837bdb79b3", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "https://research.manchester.ac.uk/en/publications/6f070f13-96c6-4cc4-9e40-f2837bdb79b3", "source_url": "https://research.manchester.ac.uk/en/publications/6f070f13-96c6-4cc4-9e40-f2837bdb79b3", "doi": "", "pmid": "", "publication_date": "2026-01-08", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3014, "title": "Psilocin fosters neuroplasticity in iPSC-derived human cortical neurons", "authors": "Koch P, Schmidt M, Hoffrichter A, Davoudi M, Horschitz S, Lau T, Meinhardt M, Spanagel R, Ladewig J, Köhr G.", "journal": "Research Square", "publication_date": "2026-01-06", "publication_year": 2026, "doi": "10.21203/rs.3.rs-4242829/v3", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.21203/rs.3.rs-4242829/v3", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Anxiety,Neuroplasticity,Receptor Pharmacology,Biomarkers,Treatment-Resistant Depression,Transcriptomics", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "preprint", "date_added": "2026-07-01 11:03:45", "last_checked": "2026-07-01 11:22:00", "bibtex": null, "source_record_id": "DOI:10.21203/rs.3.rs-4242829/v3", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.21203/rs.3.rs-4242829/v3", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "DOI:10.21203/rs.3.rs-4242829/v3", "source_url": "https://doi.org/10.21203/rs.3.rs-4242829/v3", "doi": "10.21203/rs.3.rs-4242829/v3", "pmid": "", "publication_date": "2026-01-06", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 291, "title": "Psilocybin and Bipolar Depression: Promise and Prudence", "authors": "Matheus G. Marques, Liliana Patarroyo-Rodríguez, Balwinder Singh", "journal": "CNS Drugs", "publication_date": "2026-01-03", "publication_year": 2026, "doi": "10.1007/s40263-025-01255-8", "pubmed_id": "41485178", "openalex_id": "https://openalex.org/W7118127068", "source_url": "https://doi.org/10.1007/s40263-025-01255-8", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Pharmacology,Clinical Trial,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "PMID:41485178", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41485178", "source_url": "https://doi.org/10.1007/s40263-025-01255-8", "doi": "10.1007/s40263-025-01255-8", "pmid": "41485178", "publication_date": "2026-01-03", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 333, "title": "An open-label pilot study of psilocybin-assisted therapy for binge eating disorder", "authors": "Jesse Dallery, Jennifer L. Miller, Jeff Boissoneault, Lauren Harvey, Lindsey Ives, Alexandra Knerr, Shelby Blaes, Morgan N. Ransom, Melissa S. Munson, James P. Gilligan, Michael H. Silverman, Peter R. Guzzo, Beverlee Loeser", "journal": "Journal of Eating Disorders", "publication_date": "2026-01-02", "publication_year": 2026, "doi": "10.1186/s40337-025-01508-3", "pubmed_id": "41485073", "openalex_id": "https://openalex.org/W7118124310", "source_url": "https://doi.org/10.1186/s40337-025-01508-3", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Eating Disorders,Brain Imaging,Biomarkers,Aging,Emotional Processing,Psychological Flexibility,Safety,Adverse Events", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "PMID:41485073", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1186/s40337-025-01508-3", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41485073", "source_url": "https://doi.org/10.1186/s40337-025-01508-3", "doi": "10.1186/s40337-025-01508-3", "pmid": "41485073", "publication_date": "2026-01-02", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 336, "title": "The effects of psilocybin on psychological distress in cancer patients: a systematic review and meta-analysis", "authors": "Reza Moshfeghinia, Sara Mostafavi, Kimia Jazi, Amir Reza Ghasemi, Yasamin Khosravaninezhad, Santhosshi Narayanan, Jamshid Ahmadi, Mehdi Pasalar", "journal": "BMC Psychology", "publication_date": "2026-01-01", "publication_year": 2026, "doi": "10.1186/s40359-025-03935-y", "pubmed_id": "41484687", "openalex_id": "https://openalex.org/W7118088637", "source_url": "https://doi.org/10.1186/s40359-025-03935-y", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Chronic Pain,Wellbeing,Emotional Processing,Spirituality,Clinical Trial,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Cancer Patients,Safety", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "PMID:41484687", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1186/s40359-025-03935-y", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41484687", "source_url": "https://doi.org/10.1186/s40359-025-03935-y", "doi": "10.1186/s40359-025-03935-y", "pmid": "41484687", "publication_date": "2026-01-01", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4183, "title": "Psychedelics and neuroanesthesia: A narrative review of converging mechanisms", "authors": "Kunal Kumar Sharma", "journal": "Journal of Scientific Innovations in Anesthesiology", "publication_date": "2025-12-31", "publication_year": 2025, "doi": "10.65929/jsia.2026.1.2.002", "pubmed_id": null, "openalex_id": "https://openalex.org/W7164804665", "source_url": "https://doi.org/10.65929/jsia.2026.1.2.002", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,End-of-Life Distress,Brain Imaging,Pharmacology,Mechanism of Action,Receptor Pharmacology,Consciousness,Review Article,Treatment-Resistant Depression,Toxicity,Drug Interactions", "study_type": "Review Article", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:37", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "DOI:10.65929/jsia.2026.1.2.002", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.65929/jsia.2026.1.2.002", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.65929/jsia.2026.1.2.002", "source_url": "https://doi.org/10.65929/jsia.2026.1.2.002", "doi": "10.65929/jsia.2026.1.2.002", "pmid": "", "publication_date": "2025-12-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4182, "title": "Motivation-based subtypes of psilocybin microdosers", "authors": "Ethan Klukas", "journal": "Open Collections", "publication_date": "2025-12-31", "publication_year": 2025, "doi": "10.14288/1.0452623", "pubmed_id": null, "openalex_id": "https://openalex.org/W7163695947", "source_url": "https://doi.org/10.14288/1.0452623", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Microdosing,Wellbeing,Creativity,Randomized Controlled Trial,Toxicity", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:37", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "DOI:10.14288/1.0452623", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.14288/1.0452623", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.14288/1.0452623", "source_url": "https://doi.org/10.14288/1.0452623", "doi": "10.14288/1.0452623", "pmid": "", "publication_date": "2025-12-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4181, "title": "COMBINATION OF PSILOCYBIN AND COGNITIVE BEHAVIORAL THERAPY IMPROVES OXYTOCIN LEVELS AND DEPRESSIVE SYMPTOMS IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER", "authors": "Mahvash Khan, Muhammad Omar Malik, Sara Sajjad, Muhammad Uzair, Inayat Shah, Muhammad Ismail Bhatti", "journal": "Genetics and Molecular Research", "publication_date": "2025-12-31", "publication_year": 2025, "doi": "10.4238/e91xh631", "pubmed_id": null, "openalex_id": "https://openalex.org/W7163017615", "source_url": "https://doi.org/10.4238/e91xh631", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,OCD,Pharmacology,Receptor Pharmacology,Emotional Processing,Randomized Controlled Trial,Drug Interactions", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:37", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "DOI:10.4238/e91xh631", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.4238/e91xh631", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.4238/e91xh631", "source_url": "https://doi.org/10.4238/e91xh631", "doi": "10.4238/e91xh631", "pmid": "", "publication_date": "2025-12-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4179, "title": "Psychedelics and Mental Health: Psilocybin and Depression. A Sistematic Review", "authors": "Marta Gómez Álvarez, Javier Calleja-Conde, Víctor Echeverry-Alzate", "journal": "Open Science Framework", "publication_date": "2025-12-31", "publication_year": 2025, "doi": "10.17605/osf.io/yu3n9", "pubmed_id": null, "openalex_id": "https://openalex.org/W7162447643", "source_url": "https://doi.org/10.17605/osf.io/yu3n9", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Chronic Pain,Clinical Trial,Randomized Controlled Trial,Systematic Review,Review Article,Treatment-Resistant Depression,Safety,Toxicity", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:37", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "DOI:10.17605/osf.io/yu3n9", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.17605/osf.io/yu3n9", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.17605/osf.io/yu3n9", "source_url": "https://doi.org/10.17605/osf.io/yu3n9", "doi": "10.17605/osf.io/yu3n9", "pmid": "", "publication_date": "2025-12-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4175, "title": "Cost-Effectiveness of Psilocybin-Assisted Therapy (PAT) for Patients with Treatment-Resistant Depression", "authors": "Yosr Ziadi, Taehwan Park", "journal": "Open MIND", "publication_date": "2025-12-31", "publication_year": 2025, "doi": "10.17605/osf.io/nrt59", "pubmed_id": null, "openalex_id": "https://openalex.org/W7161800164", "source_url": "https://osf.io/nrt59", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Clinical Trial,Treatment-Resistant Depression", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:37", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "DOI:10.17605/osf.io/nrt59", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://osf.io/nrt59", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.17605/osf.io/nrt59", "source_url": "https://osf.io/nrt59", "doi": "10.17605/osf.io/nrt59", "pmid": "", "publication_date": "2025-12-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4172, "title": "Optimization of Psilocybin Extraction from Psilocybe cubensis Mushrooms and Characterization of the Fungal Extract", "authors": "Mateus Araújo da Luz, Taynah Pereira Galdino, Lucas Matheus da S. Oliveira, H. Guedes, Anauara Silva, Victor I. Afonso, Suédina M. L. Silva, Antônio G. B. Lima, Marcus V. L. Fook, Maria C. M. Torres", "journal": "Journal of the Brazilian Chemical Society", "publication_date": "2025-12-31", "publication_year": 2025, "doi": "10.21577/0103-5053.20260049", "pubmed_id": null, "openalex_id": "https://openalex.org/W7138979953", "source_url": "https://doi.org/10.21577/0103-5053.20260049", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Anxiety,PTSD", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:37", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "DOI:10.21577/0103-5053.20260049", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.21577/0103-5053.20260049", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.21577/0103-5053.20260049", "source_url": "https://doi.org/10.21577/0103-5053.20260049", "doi": "10.21577/0103-5053.20260049", "pmid": "", "publication_date": "2025-12-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4171, "title": "Psychedelic-assisted psychotherapy: Clarifying the role of the \"psychotherapy\"", "authors": "Stefan Jerotić, Olga Čolović, Nađa Marić", "journal": "Medicinska istrazivanja", "publication_date": "2025-12-31", "publication_year": 2025, "doi": "10.5937/medi0-62051", "pubmed_id": null, "openalex_id": "https://openalex.org/W7130417929", "source_url": "https://doi.org/10.5937/medi0-62051", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Mechanism of Action,Clinical Trial,Randomized Controlled Trial,Review Article,Toxicity", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:37", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "DOI:10.5937/medi0-62051", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.5937/medi0-62051", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.5937/medi0-62051", "source_url": "https://doi.org/10.5937/medi0-62051", "doi": "10.5937/medi0-62051", "pmid": "", "publication_date": "2025-12-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4169, "title": "Exploring Psychedelics as Novel Therapeutics for Smoking Cessation: Mechanistic Insights from Animal Studies", "authors": "Belle Buzzi", "journal": "VCU Scholars Compass (Virginia Commonwealth University)", "publication_date": "2025-12-31", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": "https://openalex.org/W7127870091", "source_url": "https://scholarscompass.vcu.edu/etd/8246", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Neuroplasticity,Pharmacology,Mechanism of Action,Receptor Pharmacology,Animal Study", "study_type": "Animal Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:37", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "https://scholarscompass.vcu.edu/etd/8246", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://scholarscompass.vcu.edu/etd/8246", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "https://scholarscompass.vcu.edu/etd/8246", "source_url": "https://scholarscompass.vcu.edu/etd/8246", "doi": "", "pmid": "", "publication_date": "2025-12-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4163, "title": "Psilocybin-Therapie vorteilhaft für Stimmungsstörungen von Parkinsonkranken", "authors": "", "journal": "Fortschritte der Neurologie · Psychiatrie", "publication_date": "2025-12-31", "publication_year": 2025, "doi": "10.1055/a-2700-8978", "pubmed_id": null, "openalex_id": "https://openalex.org/W7124268562", "source_url": "https://doi.org/10.1055/a-2700-8978", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Clinical Trial,Randomized Controlled Trial,Safety", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:37", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "DOI:10.1055/a-2700-8978", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1055/a-2700-8978", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1055/a-2700-8978", "source_url": "https://doi.org/10.1055/a-2700-8978", "doi": "10.1055/a-2700-8978", "pmid": "", "publication_date": "2025-12-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4162, "title": "Effects of Serotonergic Psychedelics on Synaptic Function and Neuroplasticity", "authors": "Aneta Petrušková", "journal": "OPUS FAU - Online publication system of Friedrich-Alexander-Universität Erlangen-Nürnberg", "publication_date": "2025-12-31", "publication_year": 2025, "doi": "10.25593/open-fau-2619", "pubmed_id": null, "openalex_id": "https://openalex.org/W7121233275", "source_url": "https://open.fau.de/handle/openfau/38445", "substance_tags": "psilocin", "topic_tags": "Depression,Anxiety,Addiction,End-of-Life Distress,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Animal Study,Toxicity", "study_type": "Animal Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:37", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "DOI:10.25593/open-fau-2619", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://open.fau.de/handle/openfau/38445", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.25593/open-fau-2619", "source_url": "https://open.fau.de/handle/openfau/38445", "doi": "10.25593/open-fau-2619", "pmid": "", "publication_date": "2025-12-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4161, "title": "‘Shroom’ for concern: a case of psychedelic mushroom-induced acute kidney injury", "authors": "Maurice Lam, C. Khor, S. Hultin, J. J. Cheung, N. A. Shah", "journal": "Internal Medicine Journal", "publication_date": "2025-12-31", "publication_year": 2025, "doi": "10.1111/imj.70313", "pubmed_id": "41518153", "openalex_id": "https://openalex.org/W7119893738", "source_url": "https://doi.org/10.1111/imj.70313", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,OCD,Chronic Pain,Mechanism of Action,Receptor Pharmacology,Safety,Toxicity", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:37", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "PMID:41518153", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1111/imj.70313", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41518153", "source_url": "https://doi.org/10.1111/imj.70313", "doi": "10.1111/imj.70313", "pmid": "41518153", "publication_date": "2025-12-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4158, "title": "Efficacy and safety of psilocybin in treatment-resistant major depression (EPIsoDE): Results of a randomized active placebo-controlled trial", "authors": "L.J. Mertens, M. Koslowski, F. Betzler, M. Brand, R. Evens, L. Krätner, A. Jungaberle, H. Jungaberle, T. Majić, C.N. Schmitz, A. Ströhle, D. Scharf, M. Spangemacher, M. Wolff, Z. Assadi, B. Scharif, L. Becher, L.V. Färber, N. Kirchen, E. Kulakova, L. Kunz, A. Meijer, B. Rohrmoser, S. Wellek, M. Berger, G. Gründer", "journal": "Neuroscience Applied", "publication_date": "2025-12-31", "publication_year": 2025, "doi": "10.1016/j.nsa.2025.105779", "pubmed_id": null, "openalex_id": "https://openalex.org/W7118005769", "source_url": "https://doi.org/10.1016/j.nsa.2025.105779", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Chronic Pain,Clinical Trial,Randomized Controlled Trial,Treatment-Resistant Depression,Safety", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:37", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "DOI:10.1016/j.nsa.2025.105779", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.nsa.2025.105779", "source_url": "https://doi.org/10.1016/j.nsa.2025.105779", "doi": "10.1016/j.nsa.2025.105779", "pmid": "", "publication_date": "2025-12-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4155, "title": "An open-label study of single-dose COMP360 psilocybin for post-traumatic stress disorder: safety, tolerability, and secondary efficacy outcomes", "authors": "N. Mcgowan, J. Rucker, R. Yehuda, M. Agrawal, H. Simmons, S. Das, G. Goodwin", "journal": "Neuroscience Applied", "publication_date": "2025-12-31", "publication_year": 2025, "doi": "10.1016/j.nsa.2025.106821", "pubmed_id": null, "openalex_id": "https://openalex.org/W7117964120", "source_url": "https://doi.org/10.1016/j.nsa.2025.106821", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Chronic Pain,Pharmacology,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:37", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "DOI:10.1016/j.nsa.2025.106821", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.nsa.2025.106821", "source_url": "https://doi.org/10.1016/j.nsa.2025.106821", "doi": "10.1016/j.nsa.2025.106821", "pmid": "", "publication_date": "2025-12-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4153, "title": "Relationship between cardiovascular effects and psychedelic experiences under psilocybin in patients with treatment-resistant depression", "authors": "L. Puhl, L. Kunz, M. Berger, G. Gründer, L. Mertens, M. Spangemacher", "journal": "Neuroscience Applied", "publication_date": "2025-12-31", "publication_year": 2025, "doi": "10.1016/j.nsa.2025.106390", "pubmed_id": null, "openalex_id": "https://openalex.org/W7117961846", "source_url": "https://doi.org/10.1016/j.nsa.2025.106390", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Chronic Pain,Treatment-Resistant Depression,Toxicity", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:37", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "DOI:10.1016/j.nsa.2025.106390", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.nsa.2025.106390", "source_url": "https://doi.org/10.1016/j.nsa.2025.106390", "doi": "10.1016/j.nsa.2025.106390", "pmid": "", "publication_date": "2025-12-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4152, "title": "Psilocybin Treatment for Refractory Depression: A Clinical Review", "authors": "Jensen, Hailey A", "journal": "Digital Commons - Gardner-Webb University (Gardner-Webb University)", "publication_date": "2025-12-31", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": "https://openalex.org/W7110564344", "source_url": "https://digitalcommons.gardner-webb.edu/pa-department-journal-of-medical-science/63", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Pharmacology,Clinical Trial,Review Article,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:37", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "https://digitalcommons.gardner-webb.edu/pa-department-journal-of-medical-science/63", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://digitalcommons.gardner-webb.edu/pa-department-journal-of-medical-science/63", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "https://digitalcommons.gardner-webb.edu/pa-department-journal-of-medical-science/63", "source_url": "https://digitalcommons.gardner-webb.edu/pa-department-journal-of-medical-science/63", "doi": "", "pmid": "", "publication_date": "2025-12-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 372, "title": "Anxiety and Affective Symptoms Related to the Use of Classic Psychedelics: A Systematic Review.", "authors": "Viljoen G, Betzler F", "journal": "Current topics in behavioral neurosciences", "publication_date": "2025-12-31", "publication_year": 2025, "doi": "10.1007/7854_2024_534", "pubmed_id": "39436632", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/39436632/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Emotional Processing,Systematic Review,Review Article,Safety", "study_type": "Systematic Review", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:20:35", "bibtex": null, "source_record_id": "PMID:39436632", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39436632/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39436632", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39436632/", "doi": "10.1007/7854_2024_534", "pmid": "39436632", "publication_date": "2025-12-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 350, "title": "An exploration of the relationships between the effects of psilocybin on behavior, 5-HT2A receptor occupancy, and neuroplastic effects in mice", "authors": "Connor J. Maltby, Adam K. Klein, Enya Paschen, Jessica Pinto, Dino Dvořák, Joseph R. Hedde, Ashley N. Hanks, Massimiliano Bianchi, Zoe Hughes", "journal": "Journal of Psychopharmacology", "publication_date": "2025-12-31", "publication_year": 2025, "doi": "10.1177/02698811251395386", "pubmed_id": "41493065", "openalex_id": "https://openalex.org/W7118979083", "source_url": "https://doi.org/10.1177/02698811251395386", "substance_tags": "psilocybin", "topic_tags": "Depression,Neuroplasticity,Pharmacology,Mechanism of Action,Receptor Pharmacology,Biomarkers,Animal Study,Toxicity", "study_type": "Animal Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "PMID:41493065", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1177/02698811251395386", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41493065", "source_url": "https://doi.org/10.1177/02698811251395386", "doi": "10.1177/02698811251395386", "pmid": "41493065", "publication_date": "2025-12-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 349, "title": "The Effect of Magic Mushroom ( Psilocybe azurescens ) on Social Interaction, Anxiety- and Depressive-Like Behaviors in Male Rats; the Role of Neuroinflammation, Oxidative Stress, and Neurotrophic Factors", "authors": "Hediye Moghadam, Parisa Akbari, Elmira Beirami, Samaneh Nabavifard, Akram Ameli, Neda Valian", "journal": "Journal of Neuroscience Research", "publication_date": "2025-12-31", "publication_year": 2025, "doi": "10.1002/jnr.70107", "pubmed_id": "41493855", "openalex_id": "https://openalex.org/W7119167790", "source_url": "https://doi.org/10.1002/jnr.70107", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Anxiety,Pharmacology,Mechanism of Action,Receptor Pharmacology,Oxidative Stress,Toxicity,Drug Interactions,Inflammation", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "PMID:41493855", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1002/jnr.70107", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41493855", "source_url": "https://doi.org/10.1002/jnr.70107", "doi": "10.1002/jnr.70107", "pmid": "41493855", "publication_date": "2025-12-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 347, "title": "Pharmacological Management of Anxiety in End-of-Life Care: A Systematic Review of Benzodiazepines, Opioids, and Psilocybin", "authors": "Brunno Freitas da Costa, Paula Hartmann, Daniel Pagnin", "journal": "Human Psychopharmacology Clinical and Experimental", "publication_date": "2025-12-31", "publication_year": 2025, "doi": "10.1002/hup.70032", "pubmed_id": "41502021", "openalex_id": "https://openalex.org/W7118595574", "source_url": "https://doi.org/10.1002/hup.70032", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,End-of-Life Distress,Clinical Trial,Systematic Review,Review Article,Safety,Adverse Events", "study_type": "Systematic Review", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "PMID:41502021", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1002/hup.70032", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41502021", "source_url": "https://doi.org/10.1002/hup.70032", "doi": "10.1002/hup.70032", "pmid": "41502021", "publication_date": "2025-12-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 345, "title": "Single-dose psilocybin promotes cell-type-specific changes of neurons in the orbitofrontal cortex", "authors": "Ziran Huang, Xiaoyan Wei, Yihui Wang, Jin Tian, Jihui Dong, Bo Liang, Lin Lu, Wen Zhang", "journal": "Neurotherapeutics", "publication_date": "2025-12-31", "publication_year": 2025, "doi": "10.1016/j.neurot.2026.e00841", "pubmed_id": "41620327", "openalex_id": "https://openalex.org/W7126381155", "source_url": "https://doi.org/10.1016/j.neurot.2026.e00841", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Addiction,OCD,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Animal Study,Toxicity", "study_type": "Animal Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "PMID:41620327", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1016/j.neurot.2026.e00841", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41620327", "source_url": "https://doi.org/10.1016/j.neurot.2026.e00841", "doi": "10.1016/j.neurot.2026.e00841", "pmid": "41620327", "publication_date": "2025-12-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 340, "title": "New Antidepressant Development in the Treatment of Depression.", "authors": "Spiti A, Caldirola D, Perna G.", "journal": null, "publication_date": "2025-12-31", "publication_year": 2025, "doi": "10.1007/978-981-95-6872-7_23", "pubmed_id": "42036580", "openalex_id": null, "source_url": "https://doi.org/10.1007/978-981-95-6872-7_23", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Mechanism of Action,Receptor Pharmacology,Biomarkers,Clinical Trial,Animal Study,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:04", "bibtex": null, "source_record_id": "PMID:42036580", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1007/978-981-95-6872-7_23", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:42036580", "source_url": "https://doi.org/10.1007/978-981-95-6872-7_23", "doi": "10.1007/978-981-95-6872-7_23", "pmid": "42036580", "publication_date": "2025-12-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 339, "title": "Psychedelics: Future Therapeutics in Major Depression?", "authors": "Olivier B, Olivier JDA.", "journal": null, "publication_date": "2025-12-31", "publication_year": 2025, "doi": "10.1007/978-981-95-6872-7_25", "pubmed_id": "42036582", "openalex_id": null, "source_url": "https://doi.org/10.1007/978-981-95-6872-7_25", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Treatment-Resistant Depression,Adverse Events", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:01", "bibtex": null, "source_record_id": "PMID:42036582", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1007/978-981-95-6872-7_25", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:42036582", "source_url": "https://doi.org/10.1007/978-981-95-6872-7_25", "doi": "10.1007/978-981-95-6872-7_25", "pmid": "42036582", "publication_date": "2025-12-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 329, "title": "From trials to clinics: investigators’ perspectives on translating psychedelic research into clinical care", "authors": "Joshua Mitchell, Logan Neitzke-Spruill, David S. Mathai, Jill O. Robinson, Zuzana Kavan, Lynnette A Averil, Amy L McGuire", "journal": "Translational Behavioral Medicine", "publication_date": "2025-12-31", "publication_year": 2025, "doi": "10.1093/tbm/ibag027", "pubmed_id": "42152689", "openalex_id": "https://openalex.org/W7161692886", "source_url": "https://doi.org/10.1093/tbm/ibag027", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Addiction,Chronic Pain,Pharmacology,Clinical Trial,Treatment-Resistant Depression,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "PMID:42152689", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1093/tbm/ibag027", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:42152689", "source_url": "https://doi.org/10.1093/tbm/ibag027", "doi": "10.1093/tbm/ibag027", "pmid": "42152689", "publication_date": "2025-12-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 323, "title": "[Clinical application and mechanistic studies of psychedelics for treatment of depression: progress and future challenges].", "authors": "Xia K, Gao T.", "journal": null, "publication_date": "2025-12-31", "publication_year": 2025, "doi": "10.12122/j.issn.1673-4254.2026.01.01", "pubmed_id": "41540686", "openalex_id": null, "source_url": "https://doi.org/10.12122/j.issn.1673-4254.2026.01.01", "substance_tags": "psilocybin", "topic_tags": "Depression,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Biomarkers,Randomized Controlled Trial,Review Article,Treatment-Resistant Depression,Safety", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:03", "bibtex": null, "source_record_id": "PMID:41540686", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.12122/j.issn.1673-4254.2026.01.01", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:41540686", "source_url": "https://doi.org/10.12122/j.issn.1673-4254.2026.01.01", "doi": "10.12122/j.issn.1673-4254.2026.01.01", "pmid": "41540686", "publication_date": "2025-12-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 235, "title": "Psychedelic therapy and postpartum depression: priorities and prospects.", "authors": "Thuery G, Crossen F, Mc Loone D, Hinds C, Duffy R, Jairaj C, Harkin A, Kelly JR", "journal": "Therapeutic advances in psychopharmacology", "publication_date": "2025-12-31", "publication_year": 2025, "doi": "10.1177/20451253251408280", "pubmed_id": "41816502", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/41816502/", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Aging,Review Article,Safety,Immune Function", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-01 11:20:34", "bibtex": null, "source_record_id": "PMID:41816502", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41816502/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41816502", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41816502/", "doi": "10.1177/20451253251408280", "pmid": "41816502", "publication_date": "2025-12-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 176, "title": "Psilocybin elicits a conserved glucocorticoid-responsive gene signature across five 5-HT2A receptor-rich brain regions in rat", "authors": "Ashkan Veysi, Daniela Atanasovski, Maryam Ardalan, Nasrin Motamed, Elias Eriksson", "journal": "Acta Neuropsychiatrica", "publication_date": "2025-12-31", "publication_year": 2025, "doi": "10.1017/neu.2026.10075", "pubmed_id": "41958297", "openalex_id": "https://openalex.org/W7153263780", "source_url": "https://doi.org/10.1017/neu.2026.10075", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Neuroplasticity,Receptor Pharmacology,Animal Study,Toxicity,Transcriptomics", "study_type": "Animal Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "PMID:41958297", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1017/neu.2026.10075", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41958297", "source_url": "https://doi.org/10.1017/neu.2026.10075", "doi": "10.1017/neu.2026.10075", "pmid": "41958297", "publication_date": "2025-12-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 167, "title": "Correction: Characteristics and mental health of psychedelic mushroom and multi-psychedelic users relative to non-psychedelic users in American adults, 2020-2021.", "authors": "Abramsky-Sze S, Marseille E, Matzopoulos R, Morlock R, Lerer L", "journal": "Frontiers in psychiatry", "publication_date": "2025-12-31", "publication_year": 2025, "doi": "10.3389/fpsyt.2026.1834094", "pubmed_id": "42088004", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/42088004/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-01 11:20:34", "bibtex": null, "source_record_id": "PMID:42088004", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/42088004/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:42088004", "source_url": "https://pubmed.ncbi.nlm.nih.gov/42088004/", "doi": "10.3389/fpsyt.2026.1834094", "pmid": "42088004", "publication_date": "2025-12-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3464, "title": "Microdosing Psychedelics to Improve Mood", "authors": "Rotem Petranker", "journal": "ClinicalTrials.gov", "publication_date": "2025-12-29", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05259943", "substance_tags": "psilocybin", "topic_tags": "Depression,Microdosing,Clinical Trial,Observational Study,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05259943", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05259943", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05259943", "source_url": "https://clinicaltrials.gov/study/NCT05259943", "doi": "", "pmid": "", "publication_date": "2025-12-29", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3017, "title": "Psilocybin as a Serotonergic Therapy in Epilepsy: Narrative Review of Therapeutic Potentials and Seizure Risks", "authors": "Miguel Benjamín Cervera-Sánchez, Daniel San-Juan, Roberto Díaz-Peregrino, Evelin Zulema Camacho-Castillo, Sthefany Anahi Bringas-Ortiz, Christian Padilla-Cabezutd", "journal": null, "publication_date": "2025-12-28", "publication_year": 2025, "doi": "10.22541/au.176701186.65064859/v1", "pubmed_id": null, "openalex_id": "https://openalex.org/W7117461912", "source_url": "https://doi.org/10.22541/au.176701186.65064859/v1", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Chronic Pain,Receptor Pharmacology,Clinical Trial,Review Article,Observational Study,Animal Study,Safety,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 11:03:45", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "DOI:10.22541/au.176701186.65064859/v1", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.22541/au.176701186.65064859/v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.22541/au.176701186.65064859/v1", "source_url": "https://doi.org/10.22541/au.176701186.65064859/v1", "doi": "10.22541/au.176701186.65064859/v1", "pmid": "", "publication_date": "2025-12-28", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 377, "title": "Efficacy and Safety of Psychedelics in Mental Disorder Cases: An Umbrella Review of Meta-Analyses of Randomized Controlled Trials", "authors": "Monika Dominiak, Adam Gędek, Szymon Modrzejewski, Agnieszka Permoda-Osip, Anna Zofia Antosik", "journal": "Journal of Clinical Medicine", "publication_date": "2025-12-28", "publication_year": 2025, "doi": "10.3390/jcm15010253", "pubmed_id": "41517502", "openalex_id": "https://openalex.org/W7117705718", "source_url": "https://doi.org/10.3390/jcm15010253", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Addiction,Chronic Pain,Clinical Trial,Randomized Controlled Trial,Meta-Analysis,Review Article,Safety,Adverse Events,Toxicity", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "PMID:41517502", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.3390/jcm15010253", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41517502", "source_url": "https://doi.org/10.3390/jcm15010253", "doi": "10.3390/jcm15010253", "pmid": "41517502", "publication_date": "2025-12-28", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4190, "title": "A Nature-Themed Video Intervention Increases Nature Relatedness in Psilocybin-Assisted Psychotherapy for Alcohol Use Disorder", "authors": "Rhianna Rich, Kelsey T. Laird, Prabha Siddarth, Brittany Youssef, Grace M. Schwartz, Ashley Ramos, Karina Sergi, Micah Linton, L. Schwartzberg, Daniel F. Kelly, Keith G. Heinzerling", "journal": "Psychedelic Medicine", "publication_date": "2025-12-25", "publication_year": 2025, "doi": "10.1177/28314425251387655", "pubmed_id": null, "openalex_id": "https://openalex.org/W7117646156", "source_url": "https://doi.org/10.1177/28314425251387655", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Mechanism of Action,Wellbeing,Randomized Controlled Trial,Toxicity", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:37", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "DOI:10.1177/28314425251387655", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1177/28314425251387655", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1177/28314425251387655", "source_url": "https://doi.org/10.1177/28314425251387655", "doi": "10.1177/28314425251387655", "pmid": "", "publication_date": "2025-12-25", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 378, "title": "Knowledge, perceptions, and use of psychedelics for mental health among autistic adults: An online survey", "authors": "Sahba Afsharnia, Vivian Liang, Yona Lunsky, A Orsini, Ami Tint, Hsiang-yuan Lin", "journal": "PLOS mental health.", "publication_date": "2025-12-25", "publication_year": 2025, "doi": "10.1371/journal.pmen.0000514", "pubmed_id": "41662127", "openalex_id": "https://openalex.org/W7117295770", "source_url": "https://doi.org/10.1371/journal.pmen.0000514", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Chronic Pain,Clinical Trial,Observational Study,Safety,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "PMID:41662127", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1371/journal.pmen.0000514", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41662127", "source_url": "https://doi.org/10.1371/journal.pmen.0000514", "doi": "10.1371/journal.pmen.0000514", "pmid": "41662127", "publication_date": "2025-12-25", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3701, "title": "The Safety and Efficacy of Psilocybin in Patients With Treatment-resistant Depression and Chronic Suicidal Ideation", "authors": "Sheppard Pratt Health System", "journal": "ClinicalTrials.gov", "publication_date": "2025-12-23", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05220410", "substance_tags": "psilocybin", "topic_tags": "Depression,Treatment-Resistant Depression,Safety", "study_type": "Other", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:34", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05220410", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05220410", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05220410", "source_url": "https://clinicaltrials.gov/study/NCT05220410", "doi": "", "pmid": "", "publication_date": "2025-12-23", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3506, "title": "An Open Label Study of Single-Dose Psilocybin for Major Depressive Disorder With Co-occurring Borderline Personality Disorder", "authors": "University of Chicago", "journal": "ClinicalTrials.gov", "publication_date": "2025-12-22", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05399498", "substance_tags": "psilocybin", "topic_tags": "Depression,Personality Change,Safety", "study_type": "Other", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05399498", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05399498", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05399498", "source_url": "https://clinicaltrials.gov/study/NCT05399498", "doi": "", "pmid": "", "publication_date": "2025-12-22", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1990, "title": "Group Retreat Psilocybin Therapy for People with Metastatic Cancer with Anxiety and Depression: A Rite of Passage Facilitation Model for a Phase 1/2 Study", "authors": "Anthony L. Back, Bonnie A. McGregor, Lindsay Billingsley, Dianna Blom, George Callan, Susanna Myers, John Guy, Sameet Kumar, Melissa Layer, Jackie Levin, Juliana Pérez, Peter Thompson, Kathy Salmonson, Joseph Whinney, Leslie Lazar Thorn", "journal": "Psychedelic Medicine", "publication_date": "2025-12-22", "publication_year": 2025, "doi": "10.1177/28314425251404460", "pubmed_id": null, "openalex_id": "https://openalex.org/W7116873484", "source_url": "https://doi.org/10.1177/28314425251404460", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Chronic Pain,Emotional Processing,Clinical Trial,Randomized Controlled Trial,Cancer Patients,Safety,Toxicity", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:52:05", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "DOI:10.1177/28314425251404460", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1177/28314425251404460", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1177/28314425251404460", "source_url": "https://doi.org/10.1177/28314425251404460", "doi": "10.1177/28314425251404460", "pmid": "", "publication_date": "2025-12-22", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 380, "title": "Psychedelics as a Therapeutic Opportunity or Threat: A Narrative Review", "authors": "Paweł Liszka, Agata Ogórek, Klaudia M Olejnik-Chlewicka, Konrad Puchalski, Marta Zasiadła, Klaudia M Patrzykąt, Jakub Perediatkiewicz, Wojciech Urbański, Paweł M Łuczak, Jakub Brodowski", "journal": "Cureus", "publication_date": "2025-12-22", "publication_year": 2025, "doi": "10.7759/cureus.99942", "pubmed_id": "41583322", "openalex_id": "https://openalex.org/W7116864166", "source_url": "https://doi.org/10.7759/cureus.99942", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Pharmacology,Mechanism of Action,Receptor Pharmacology,Emotional Processing,Clinical Trial,Randomized Controlled Trial,Systematic Review,Review Article,Cancer Patients,Treatment-Resistant Depression,Safety,Toxicity,Drug Interactions", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "PMID:41583322", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.7759/cureus.99942", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41583322", "source_url": "https://doi.org/10.7759/cureus.99942", "doi": "10.7759/cureus.99942", "pmid": "41583322", "publication_date": "2025-12-22", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3052, "title": "Psilocybin modulates social behaviour in male and female mice in a time-dependent manner", "authors": "Shadani S, McCoy K, Ong L, Greaves E, Conn K, Andrews ZB, Foldi CJ.", "journal": "bioRxiv", "publication_date": "2025-12-21", "publication_year": 2025, "doi": "10.64898/2025.12.18.695064", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.64898/2025.12.18.695064", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Eating Disorders,Receptor Pharmacology,Animal Study", "study_type": "Animal Study", "source_name": "bioRxiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:46", "last_checked": "2026-07-01 11:22:00", "bibtex": null, "source_record_id": "DOI:10.64898/2025.12.18.695064", "abstract_available": true, "abstract_source": "bioRxiv", "abstract_source_url": "https://doi.org/10.64898/2025.12.18.695064", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "bioRxiv", "source_record_id": "DOI:10.64898/2025.12.18.695064", "source_url": "https://doi.org/10.64898/2025.12.18.695064", "doi": "10.64898/2025.12.18.695064", "pmid": "", "publication_date": "2025-12-21", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 344, "title": "Magic mushrooms and mood: exploring Psilocybin as a depression treatment", "authors": "M. Haseeb Ul Rasool, Taha Hannan, Muhammad Imam", "journal": "Journal of the Pakistan Medical Association", "publication_date": "2025-12-19", "publication_year": 2025, "doi": "10.47391/jpma.30858", "pubmed_id": "41736353", "openalex_id": "https://openalex.org/W7117257845", "source_url": "https://doi.org/10.47391/jpma.30858", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Pharmacology,Mechanism of Action,Receptor Pharmacology,Treatment-Resistant Depression,Toxicity", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "PMID:41736353", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.47391/jpma.30858", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41736353", "source_url": "https://doi.org/10.47391/jpma.30858", "doi": "10.47391/jpma.30858", "pmid": "41736353", "publication_date": "2025-12-19", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4195, "title": "Effects of LSD and Psilocybin on Heart Rate in Patients Receiving Psychedelic Treatment for Depressive and Anxiety Disorders: A Retrospective Observational Study", "authors": "Mylène Cheng, Tatiana Aboulafia Brakha, Albert Buchard, Raya Anastasova, Léa Girani, Anna Breitenmoser, Sylvie Alaux, Cédric Mabilais, Caroline Amberger, Federico Seragnoli, Leonice Furtado, Gabriel Thorens, Daniele Zullino, Louise Penzenstadler", "journal": "Psychology International", "publication_date": "2025-12-18", "publication_year": 2025, "doi": "10.3390/psycholint8010001", "pubmed_id": null, "openalex_id": "https://openalex.org/W4417497243", "source_url": "https://doi.org/10.3390/psycholint8010001", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Chronic Pain,Observational Study,Treatment-Resistant Depression,Adverse Events,Toxicity,Drug Interactions", "study_type": "Observational Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:37", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "DOI:10.3390/psycholint8010001", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.3390/psycholint8010001", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.3390/psycholint8010001", "source_url": "https://doi.org/10.3390/psycholint8010001", "doi": "10.3390/psycholint8010001", "pmid": "", "publication_date": "2025-12-18", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3521, "title": "A Phase III, Multicentre, Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy, Safety, and Tolerability of COMP360 in Participants With Treatment-resistant Depression", "authors": "COMPASS Pathways", "journal": "ClinicalTrials.gov", "publication_date": "2025-12-17", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05624268", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05624268", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05624268", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05624268", "source_url": "https://clinicaltrials.gov/study/NCT05624268", "doi": "", "pmid": "", "publication_date": "2025-12-17", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 392, "title": "Psilocybin reporting in media (PRiMe) for the treatment of depression", "authors": "Gurjot Brar, T. R. JUN. BURKE, Andrew Gribben, Colm Harrington, Guillaume Thuery, John R. Kelly", "journal": "Irish Journal of Psychological Medicine", "publication_date": "2025-12-17", "publication_year": 2025, "doi": "10.1017/ipm.2025.10142", "pubmed_id": "41410115", "openalex_id": "https://openalex.org/W4417453981", "source_url": "https://doi.org/10.1017/ipm.2025.10142", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Safety,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "PMID:41410115", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1017/ipm.2025.10142", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41410115", "source_url": "https://doi.org/10.1017/ipm.2025.10142", "doi": "10.1017/ipm.2025.10142", "pmid": "41410115", "publication_date": "2025-12-17", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 353, "title": "Psilocybin-assisted therapy for individuals with palliative care needs: A systematic review of safety and efficacy.", "authors": "Matos ARS, Silva AC, Rego L, Fernandes R, Gonçalves S.", "journal": null, "publication_date": "2025-12-17", "publication_year": 2025, "doi": "10.1177/02692163251383335", "pubmed_id": "41410211", "openalex_id": null, "source_url": "https://doi.org/10.1177/02692163251383335", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Clinical Trial,Randomized Controlled Trial,Systematic Review,Review Article,Observational Study,Safety,Adverse Events", "study_type": "Systematic Review", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:00", "bibtex": null, "source_record_id": "PMID:41410211", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1177/02692163251383335", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:41410211", "source_url": "https://doi.org/10.1177/02692163251383335", "doi": "10.1177/02692163251383335", "pmid": "41410211", "publication_date": "2025-12-17", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 294, "title": "Psilocybin in the real world: Regulatory, ethical, and operational challenges in Australia’s clinical landscape", "authors": "Megan Dutton, Paul Schwenn, Jules Mitchell, Per Hoffmann, Neil W. Bailey, Paul B. Fitzgerald, Jim Lagopoulos, Adem Can", "journal": "Australian & New Zealand Journal of Psychiatry", "publication_date": "2025-12-16", "publication_year": 2025, "doi": "10.1177/00048674251398677", "pubmed_id": "41405025", "openalex_id": "https://openalex.org/W4417431364", "source_url": "https://doi.org/10.1177/00048674251398677", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Mechanism of Action,Clinical Trial,Treatment-Resistant Depression,Safety,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "PMID:41405025", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1177/00048674251398677", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41405025", "source_url": "https://doi.org/10.1177/00048674251398677", "doi": "10.1177/00048674251398677", "pmid": "41405025", "publication_date": "2025-12-16", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 229, "title": "Breaking the chains of depression: A systematic review and meta-analysis of psilocybin therapy", "authors": "Faheem Ahmed Khan, Nuruliarizki Shinta Pandupuspitasari, Tewin Tencomnao, Siriporn Chuchawankul", "journal": "Journal of Affective Disorders", "publication_date": "2025-12-16", "publication_year": 2025, "doi": "10.1016/j.jad.2025.120882", "pubmed_id": "41419063", "openalex_id": "https://openalex.org/W4417535188", "source_url": "https://doi.org/10.1016/j.jad.2025.120882", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Chronic Pain,Meta-Analysis,Systematic Review,Review Article,Toxicity", "study_type": "Meta-Analysis", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "PMID:41419063", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41419063", "source_url": "https://doi.org/10.1016/j.jad.2025.120882", "doi": "10.1016/j.jad.2025.120882", "pmid": "41419063", "publication_date": "2025-12-16", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4201, "title": "Preadministration of Lorazepam Negates the Long-Term Antidepressant-Like Effects of Psilocybin in Male Wistar Kyoto Rats", "authors": "Sophie Woodruff, Meghan Hibicke, Charles D. Nichols", "journal": "Psychedelic Medicine", "publication_date": "2025-12-15", "publication_year": 2025, "doi": "10.1177/28314425251393186", "pubmed_id": null, "openalex_id": "https://openalex.org/W7116737777", "source_url": "https://doi.org/10.1177/28314425251393186", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Chronic Pain,Neuroplasticity,Pharmacology,Receptor Pharmacology,Longevity,Treatment-Resistant Depression", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:37", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "DOI:10.1177/28314425251393186", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1177/28314425251393186", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1177/28314425251393186", "source_url": "https://doi.org/10.1177/28314425251393186", "doi": "10.1177/28314425251393186", "pmid": "", "publication_date": "2025-12-15", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4200, "title": "Psychedelic-Assisted Therapy (Pat): A New Frontier in Mental Health Treatment", "authors": "M. H. M. Wickramasekara, G. D. M. C. Gonapaladeniya", "journal": "˜The œjournal of desk research review and analysis.", "publication_date": "2025-12-15", "publication_year": 2025, "doi": "10.4038/jdrra.v3i2.87", "pubmed_id": null, "openalex_id": "https://openalex.org/W7115587785", "source_url": "https://doi.org/10.4038/jdrra.v3i2.87", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Addiction,Mechanism of Action,Receptor Pharmacology,Aging,Clinical Trial,Review Article,Older Adults,Safety,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:37", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "DOI:10.4038/jdrra.v3i2.87", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.4038/jdrra.v3i2.87", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.4038/jdrra.v3i2.87", "source_url": "https://doi.org/10.4038/jdrra.v3i2.87", "doi": "10.4038/jdrra.v3i2.87", "pmid": "", "publication_date": "2025-12-15", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4199, "title": "Exploring Determinants of Psilocybin Acceptance as an Alternative Modality for Major Depressive Disorder: A Pilot Study", "authors": "Shannon Antoine-Hardy, D’Elia Bonilla", "journal": "Journal of Complementary and Alternative Medical Research", "publication_date": "2025-12-15", "publication_year": 2025, "doi": "10.9734/jocamr/2025/v26i11723", "pubmed_id": null, "openalex_id": "https://openalex.org/W4417387420", "source_url": "https://doi.org/10.9734/jocamr/2025/v26i11723", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:37", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "DOI:10.9734/jocamr/2025/v26i11723", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.9734/jocamr/2025/v26i11723", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.9734/jocamr/2025/v26i11723", "source_url": "https://doi.org/10.9734/jocamr/2025/v26i11723", "doi": "10.9734/jocamr/2025/v26i11723", "pmid": "", "publication_date": "2025-12-15", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 293, "title": "Psychedelic experiences elicited by serotonergic psychedelics: Molecular mechanisms and functional connectivity changes in the brain.", "authors": "Vollebregt R, Storm AEM, Lucassen PJ, Somers M.", "journal": null, "publication_date": "2025-12-15", "publication_year": 2025, "doi": "10.1016/j.neubiorev.2025.106529", "pubmed_id": "41412413", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.neubiorev.2025.106529", "substance_tags": "psilocybin", "topic_tags": "Depression,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Default Mode Network,Emotional Processing,Systematic Review,Review Article,Treatment-Resistant Depression,Drug Interactions", "study_type": "Systematic Review", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-01 11:22:03", "bibtex": null, "source_record_id": "PMID:41412413", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.neubiorev.2025.106529", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:41412413", "source_url": "https://doi.org/10.1016/j.neubiorev.2025.106529", "doi": "10.1016/j.neubiorev.2025.106529", "pmid": "41412413", "publication_date": "2025-12-15", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4203, "title": "COMPARATIVE EFFICACY AND ACCEPTABILITY OF PSILOCYBIN-KETAMINE AND TYPICAL ANTIDEPRESSANTS FOR MAJOR DEPRESSIVE DISORDER MANAGEMENT: A NETWORK META-ANALYSIS", "authors": "Pedro Rodrigues, Weliton Rodrigues dos Santos Júnior, Ivan de Sousa Araújo, Leonardo Maia Leony, Fernanda Adélia Almeida Custódio Pires Gomes, Tairone Matos de Lima Junior, Luís Felipe Freitas Moreira, Rafael Telles Santana, Manoel Carlos Matos Santos, R. Silva", "journal": null, "publication_date": "2025-12-10", "publication_year": 2025, "doi": "10.55905/edicon.978-65-83115-47-8_8", "pubmed_id": null, "openalex_id": "https://openalex.org/W4417258517", "source_url": "https://doi.org/10.55905/edicon.978-65-83115-47-8_8", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Clinical Trial,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Observational Study", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:37", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "DOI:10.55905/edicon.978-65-83115-47-8_8", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.55905/edicon.978-65-83115-47-8_8", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.55905/edicon.978-65-83115-47-8_8", "source_url": "https://doi.org/10.55905/edicon.978-65-83115-47-8_8", "doi": "10.55905/edicon.978-65-83115-47-8_8", "pmid": "", "publication_date": "2025-12-10", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3059, "title": "Age and cannabis co-use are associated with differences in experience and perceived benefits of psilocybin: a retrospective study", "authors": "", "journal": "PsyArXiv", "publication_date": "2025-12-09", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://osf.io/preprints/psyarxiv/dczw2_v2", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Mechanism of Action,Aging,Mystical Experience,Older Adults", "study_type": "Other", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:46", "last_checked": "2026-07-01 11:22:30", "bibtex": null, "source_record_id": "https://osf.io/preprints/psyarxiv/dczw2_v2", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/dczw2_v2", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "https://osf.io/preprints/psyarxiv/dczw2_v2", "source_url": "https://osf.io/preprints/psyarxiv/dczw2_v2", "doi": "", "pmid": "", "publication_date": "2025-12-09", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3048, "title": "Real-World Psilocybin Therapy for Treatment-Resistant Depression: a Retrospective Observational Study", "authors": "Jungwirth J, Westenhöfer S, Aicher H, Provaznikova B, Kronenberg G, Seifritz E, Prinz S, Olbrich S.", "journal": "Research Square", "publication_date": "2025-12-09", "publication_year": 2025, "doi": "10.21203/rs.3.rs-8079137/v1", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.21203/rs.3.rs-8079137/v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Observational Study,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "preprint", "date_added": "2026-07-01 11:03:46", "last_checked": "2026-07-01 11:22:00", "bibtex": null, "source_record_id": "DOI:10.21203/rs.3.rs-8079137/v1", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.21203/rs.3.rs-8079137/v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "DOI:10.21203/rs.3.rs-8079137/v1", "source_url": "https://doi.org/10.21203/rs.3.rs-8079137/v1", "doi": "10.21203/rs.3.rs-8079137/v1", "pmid": "", "publication_date": "2025-12-09", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 354, "title": "Psilocybin in late-life mental health: Addressing depression, loneliness, and existential anxiety", "authors": "Gerasimos Konstantinou, Joshua D. Rosenblat, Sarah Hales, Muhammad Ishrat Husain, Daniel M. Blumberger", "journal": "General Hospital Psychiatry", "publication_date": "2025-12-08", "publication_year": 2025, "doi": "10.1016/j.genhosppsych.2025.12.005", "pubmed_id": "41401486", "openalex_id": "https://openalex.org/W4417166023", "source_url": "https://doi.org/10.1016/j.genhosppsych.2025.12.005", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Chronic Pain,Neuroplasticity,Pharmacology,Mechanism of Action,Default Mode Network,Aging,Clinical Trial,Review Article,Safety,Toxicity,Drug Interactions", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "PMID:41401486", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1016/j.genhosppsych.2025.12.005", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41401486", "source_url": "https://doi.org/10.1016/j.genhosppsych.2025.12.005", "doi": "10.1016/j.genhosppsych.2025.12.005", "pmid": "41401486", "publication_date": "2025-12-08", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 256, "title": "The Relationship Between Participant Pretreatment Clinical Presentation and the Quality of Psilocybin Experience", "authors": "Namik Kirlić, Merve Atli, Sunil Mistry, Michael Gold, Guy M. Goodwin", "journal": "Journal of Clinical Psychopharmacology", "publication_date": "2025-12-08", "publication_year": 2025, "doi": "10.1097/jcp.0000000000002119", "pubmed_id": "41362124", "openalex_id": "https://openalex.org/W4417148678", "source_url": "https://doi.org/10.1097/jcp.0000000000002119", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Chronic Pain,Mechanism of Action,Consciousness,Personality Change,Emotional Processing,Clinical Trial,Treatment-Resistant Depression,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "PMID:41362124", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1097/jcp.0000000000002119", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41362124", "source_url": "https://doi.org/10.1097/jcp.0000000000002119", "doi": "10.1097/jcp.0000000000002119", "pmid": "41362124", "publication_date": "2025-12-08", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 79, "title": "Suggested Guidelines for Applying a Systemic Lens to Psychedelic-Assisted Psychotherapy", "authors": "Sara N. Lappan, Sean D. Davis", "journal": "Psychedelic Medicine", "publication_date": "2025-12-08", "publication_year": 2025, "doi": "10.1177/28314425251404021", "pubmed_id": "42131862", "openalex_id": "https://openalex.org/W7117297881", "source_url": "https://doi.org/10.1177/28314425251404021", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Emotional Processing,Toxicity", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "PMID:42131862", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1177/28314425251404021", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:42131862", "source_url": "https://doi.org/10.1177/28314425251404021", "doi": "10.1177/28314425251404021", "pmid": "42131862", "publication_date": "2025-12-08", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4205, "title": "Are Magic Mushrooms the Magic to Healing?", "authors": "Wohlfarth, Gale, Hardy, Susan, Ray, Herman", "journal": "DigitalCommons - Kennesaw State University (Kennesaw State University)", "publication_date": "2025-12-07", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": "https://openalex.org/W7113308122", "source_url": "https://digitalcommons.kennesaw.edu/undergradsymposiumksu/fall2025/fall2025/134", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,End-of-Life Distress,Headache / Migraine,Observational Study,Veterans,Toxicity", "study_type": "Observational Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:37", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "https://digitalcommons.kennesaw.edu/undergradsymposiumksu/fall2025/fall2025/134", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://digitalcommons.kennesaw.edu/undergradsymposiumksu/fall2025/fall2025/134", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "https://digitalcommons.kennesaw.edu/undergradsymposiumksu/fall2025/fall2025/134", "source_url": "https://digitalcommons.kennesaw.edu/undergradsymposiumksu/fall2025/fall2025/134", "doi": "", "pmid": "", "publication_date": "2025-12-07", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3625, "title": "Investigating the Effects of a Psychedelic-augmented Mental Imagery-based Intervention for Young People With Self-harm Behaviour: an Experimental Medicine Study", "authors": "Imperial College London", "journal": "ClinicalTrials.gov", "publication_date": "2025-12-04", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06798636", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Emotional Processing,Safety", "study_type": "Other", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:34", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06798636", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06798636", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06798636", "source_url": "https://clinicaltrials.gov/study/NCT06798636", "doi": "", "pmid": "", "publication_date": "2025-12-04", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4210, "title": "Psychedelics as neuroplasticity enhancers: Mechanisms, therapeutic applications, and translational challenges", "authors": "Taslim Uddin, Suma Akter, Kanak Yadab Ghosh", "journal": "Advanced Neurology", "publication_date": "2025-12-03", "publication_year": 2025, "doi": "10.36922/an025410095", "pubmed_id": null, "openalex_id": "https://openalex.org/W4417099564", "source_url": "https://doi.org/10.36922/an025410095", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Addiction,Neuroplasticity,Neurogenesis,Pharmacology,Mechanism of Action,Receptor Pharmacology,Review Article,Animal Study,Safety,Toxicity", "study_type": "Review Article", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:38", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "DOI:10.36922/an025410095", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.36922/an025410095", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.36922/an025410095", "source_url": "https://doi.org/10.36922/an025410095", "doi": "10.36922/an025410095", "pmid": "", "publication_date": "2025-12-03", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3513, "title": "A Phase 2b, Randomized, Double-blind, Placebo-controlled, Multi-center Study of the Effects of Psilocybin-assisted Psychotherapy on Psychiatric and Existential Distress in Advanced Cancer", "authors": "NYU Langone Health", "journal": "ClinicalTrials.gov", "publication_date": "2025-12-03", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05398484", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Mechanism of Action,Clinical Trial,Randomized Controlled Trial,Safety", "study_type": "Randomized Controlled Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05398484", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05398484", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05398484", "source_url": "https://clinicaltrials.gov/study/NCT05398484", "doi": "", "pmid": "", "publication_date": "2025-12-03", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 403, "title": "Questioning the recovery of dissociated traumatic memories under psilocybin: comment on “Therapeutic emergence of dissociated traumatic memories during psilocybin treatment for anorexia nervosa”", "authors": "Samuli Kangaslampi, Max Wolff, Manoj K. Doss, Lilian Kloft, Henry Otgaar", "journal": "Journal of Eating Disorders", "publication_date": "2025-12-03", "publication_year": 2025, "doi": "10.1186/s40337-025-01484-8", "pubmed_id": "41345723", "openalex_id": "https://openalex.org/W4416977442", "source_url": "https://doi.org/10.1186/s40337-025-01484-8", "substance_tags": "psilocybin", "topic_tags": "Depression,Eating Disorders,Emotional Processing,Case Report,Toxicity", "study_type": "Case Report", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "PMID:41345723", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1186/s40337-025-01484-8", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41345723", "source_url": "https://doi.org/10.1186/s40337-025-01484-8", "doi": "10.1186/s40337-025-01484-8", "pmid": "41345723", "publication_date": "2025-12-03", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4212, "title": "Magic Mushrooms as Medicine: What the United States Can Learn from Jamaica’s Unregulated Psilocybin Industry as FDA Approval Nears", "authors": "Spohn, Kyle", "journal": "eYLS (Yale Law School)", "publication_date": "2025-12-01", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": "https://openalex.org/W7112471464", "source_url": "https://repository.law.miami.edu/umialr/vol57/iss1/7", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Clinical Trial,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:38", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "https://repository.law.miami.edu/umialr/vol57/iss1/7", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://repository.law.miami.edu/umialr/vol57/iss1/7", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "https://repository.law.miami.edu/umialr/vol57/iss1/7", "source_url": "https://repository.law.miami.edu/umialr/vol57/iss1/7", "doi": "", "pmid": "", "publication_date": "2025-12-01", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4230, "title": "Efficacy of psilocybin on death anxiety in terminal patients: a narrative review", "authors": "Morris Lintong Barimbing, Dian Pritasari Jeger, Made Edwin Sridana", "journal": "Progress in Palliative Care", "publication_date": "2025-11-30", "publication_year": 2025, "doi": "10.1080/09699260.2026.2657096", "pubmed_id": null, "openalex_id": "https://openalex.org/W7152631097", "source_url": "https://doi.org/10.1080/09699260.2026.2657096", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Pharmacology,Mechanism of Action,Receptor Pharmacology,Default Mode Network,Randomized Controlled Trial,Review Article,Safety", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:38", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "DOI:10.1080/09699260.2026.2657096", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1080/09699260.2026.2657096", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1080/09699260.2026.2657096", "source_url": "https://doi.org/10.1080/09699260.2026.2657096", "doi": "10.1080/09699260.2026.2657096", "pmid": "", "publication_date": "2025-11-30", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4225, "title": "Psychedelic Assisted Psychotherapy (PAP): the Geneva University Hospital model", "authors": "F. Seragnoli", "journal": "Emerging Trends in Drugs Addictions and Health", "publication_date": "2025-11-30", "publication_year": 2025, "doi": "10.1016/j.etdah.2025.100256", "pubmed_id": null, "openalex_id": "https://openalex.org/W7115197406", "source_url": "https://doi.org/10.1016/j.etdah.2025.100256", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Toxicity", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:38", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "DOI:10.1016/j.etdah.2025.100256", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1016/j.etdah.2025.100256", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.etdah.2025.100256", "source_url": "https://doi.org/10.1016/j.etdah.2025.100256", "doi": "10.1016/j.etdah.2025.100256", "pmid": "", "publication_date": "2025-11-30", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4221, "title": "Psilocybin and Neuroplasticity: Mechanisms, Therapeutic Potential, and Future Directions", "authors": "S. Fereydouni", "journal": "Emerging Trends in Drugs Addictions and Health", "publication_date": "2025-11-30", "publication_year": 2025, "doi": "10.1016/j.etdah.2025.100215", "pubmed_id": null, "openalex_id": "https://openalex.org/W7115166480", "source_url": "https://doi.org/10.1016/j.etdah.2025.100215", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Chronic Pain,Neuroplasticity,Neurogenesis,Pharmacology,Mechanism of Action,Receptor Pharmacology,Wellbeing,Review Article,Animal Study,Toxicity", "study_type": "Review Article", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:38", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "DOI:10.1016/j.etdah.2025.100215", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1016/j.etdah.2025.100215", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.etdah.2025.100215", "source_url": "https://doi.org/10.1016/j.etdah.2025.100215", "doi": "10.1016/j.etdah.2025.100215", "pmid": "", "publication_date": "2025-11-30", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3166, "title": "Limited prognostic value of early maladaptive schemas for acute psychedelic experience and symptom improvement", "authors": "Buchard A, Seragnoli F, Sabe M, Eskinazi M, Aboulafia T, Furtado L, Briefer J, Roediger E, Penzenstadler L, Zullino D, Thorens G.", "journal": "Research Square", "publication_date": "2025-11-30", "publication_year": 2025, "doi": "10.21203/rs.3.rs-8214817/v1", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.21203/rs.3.rs-8214817/v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Emotional Processing", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "preprint", "date_added": "2026-07-01 11:03:47", "last_checked": "2026-07-01 11:22:01", "bibtex": null, "source_record_id": "DOI:10.21203/rs.3.rs-8214817/v1", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.21203/rs.3.rs-8214817/v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "DOI:10.21203/rs.3.rs-8214817/v1", "source_url": "https://doi.org/10.21203/rs.3.rs-8214817/v1", "doi": "10.21203/rs.3.rs-8214817/v1", "pmid": "", "publication_date": "2025-11-30", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3154, "title": "Real-World Effectiveness and Safety of Psychedelic-Assisted Psychotherapy: Outcomes from a Large-Scale Compassionate Use Cohort in Switzerland", "authors": "Aboulafia-Brakha T, Buchard A, Mabilais C, Alaux S, Amberger C, Furtado L, Seragnoli F, Briefer J, Thorens G, Sabé M, Szczesniak L, Iuga R, Zullino D, Penzenstadler L.", "journal": "medRxiv", "publication_date": "2025-11-30", "publication_year": 2025, "doi": "10.1101/2025.12.01.25341335", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.1101/2025.12.01.25341335", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Emotional Processing,Observational Study,Safety,Adverse Events", "study_type": "Observational Study", "source_name": "medRxiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:47", "last_checked": "2026-07-01 11:22:01", "bibtex": null, "source_record_id": "DOI:10.1101/2025.12.01.25341335", "abstract_available": true, "abstract_source": "medRxiv", "abstract_source_url": "https://doi.org/10.1101/2025.12.01.25341335", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "medRxiv", "source_record_id": "DOI:10.1101/2025.12.01.25341335", "source_url": "https://doi.org/10.1101/2025.12.01.25341335", "doi": "10.1101/2025.12.01.25341335", "pmid": "", "publication_date": "2025-11-30", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 406, "title": "Sudden Loss of Consciousness Following Psilocybin Ingestion", "authors": "Amanda E. Downey, Marlene Tai, Ellen Bradley, Josh Woolley", "journal": "American Journal of Psychiatry", "publication_date": "2025-11-30", "publication_year": 2025, "doi": "10.1176/appi.ajp.20250037", "pubmed_id": "41320824", "openalex_id": "https://openalex.org/W4416839507", "source_url": "https://doi.org/10.1176/appi.ajp.20250037", "substance_tags": "psilocybin", "topic_tags": "Depression,Consciousness,Toxicity", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "PMID:41320824", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41320824", "source_url": "https://doi.org/10.1176/appi.ajp.20250037", "doi": "10.1176/appi.ajp.20250037", "pmid": "41320824", "publication_date": "2025-11-30", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 405, "title": "Acute Blockade of the Serotonin Transporter With Low Doses of Escitalopram Does Not Alter the Behavioural Responses to Acute Psilocybin", "authors": "Nina Kleditzsch, James J Gattuso, Anthony J. Hannan, Thibault Renoir", "journal": "European Journal of Neuroscience", "publication_date": "2025-11-30", "publication_year": 2025, "doi": "10.1111/ejn.70351", "pubmed_id": "41365493", "openalex_id": "https://openalex.org/W4417176534", "source_url": "https://doi.org/10.1111/ejn.70351", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Anxiety,Pharmacology,Receptor Pharmacology,Animal Study,Treatment-Resistant Depression,Toxicity", "study_type": "Animal Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "PMID:41365493", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1111/ejn.70351", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41365493", "source_url": "https://doi.org/10.1111/ejn.70351", "doi": "10.1111/ejn.70351", "pmid": "41365493", "publication_date": "2025-11-30", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 401, "title": "Investigational psilocybin treatment for post-traumatic stress disorder: a qualitative study of participant experience, trauma engagement, and differences from standard treatment", "authors": "Nadav Liam Modlin, Victoria Williamson, Guy M. Goodwin, Ekaterina Malievskaia, Merve Atli, Zsofia Elek, Alice Gaillard, Don Koelpin, Anthony J. Cleare, Manish Agrawal, Rachel Yehuda, Namik Kirlić, James Rucker", "journal": "EClinicalMedicine", "publication_date": "2025-11-30", "publication_year": 2025, "doi": "10.1016/j.eclinm.2025.103692", "pubmed_id": "41497513", "openalex_id": "https://openalex.org/W4417031290", "source_url": "https://doi.org/10.1016/j.eclinm.2025.103692", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Chronic Pain,Mechanism of Action,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "PMID:41497513", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1016/j.eclinm.2025.103692", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41497513", "source_url": "https://doi.org/10.1016/j.eclinm.2025.103692", "doi": "10.1016/j.eclinm.2025.103692", "pmid": "41497513", "publication_date": "2025-11-30", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3681, "title": "Assessing the Safety, Tolerability, and Efficacy of Psilocybin Therapy Followed by Accelerated Intermittent Theta Burst (aiTBS) Repetitive Transcranial Magnetic Stimulation (rTMS) for Treatment-Resistant Major Depressive Disorder", "authors": "University of Texas at Austin", "journal": "ClinicalTrials.gov", "publication_date": "2025-11-25", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06132178", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging,Biomarkers,Aging,Clinical Trial,Safety,Inflammation", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:34", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06132178", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06132178", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06132178", "source_url": "https://clinicaltrials.gov/study/NCT06132178", "doi": "", "pmid": "", "publication_date": "2025-11-25", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 421, "title": "A comparative assessment of the antidepressant efficacy of ketamine, psilocybin, and fluoxetine in a chronic stress model", "authors": "Małgorzata Domżalska, Joanna Kwiatkowska, Iwona Cichoń, Ewa Sokołowska", "journal": "Scientific Reports", "publication_date": "2025-11-25", "publication_year": 2025, "doi": "10.1038/s41598-025-29642-7", "pubmed_id": "41290975", "openalex_id": "https://openalex.org/W4416669801", "source_url": "https://doi.org/10.1038/s41598-025-29642-7", "substance_tags": "psilocybin", "topic_tags": "Depression,Pharmacology,Receptor Pharmacology,Clinical Trial,Animal Study", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "PMID:41290975", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1038/s41598-025-29642-7", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41290975", "source_url": "https://doi.org/10.1038/s41598-025-29642-7", "doi": "10.1038/s41598-025-29642-7", "pmid": "41290975", "publication_date": "2025-11-25", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 407, "title": "Psilocybin reduces comorbid chronic pain and depression in mice", "authors": "Jorge Ferreira", "journal": "Lab Animal", "publication_date": "2025-11-25", "publication_year": 2025, "doi": "10.1038/s41684-025-01663-9", "pubmed_id": "41298885", "openalex_id": "https://openalex.org/W4416717006", "source_url": "https://doi.org/10.1038/s41684-025-01663-9", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Pharmacology,Receptor Pharmacology,Animal Study,Toxicity", "study_type": "Animal Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "PMID:41298885", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41298885", "source_url": "https://doi.org/10.1038/s41684-025-01663-9", "doi": "10.1038/s41684-025-01663-9", "pmid": "41298885", "publication_date": "2025-11-25", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3700, "title": "Pragmatic Trial of Psilocybin Therapy in Palliative Care (PT2PC): A Multicenter Triple-blind Phase 2 Randomized Controlled Trial of Psilocybin Therapy for Demoralized Adults Near the End of Life", "authors": "Charles S. Grob, M.D.", "journal": "ClinicalTrials.gov", "publication_date": "2025-11-24", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05403086", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Clinical Trial,Randomized Controlled Trial,Safety", "study_type": "Randomized Controlled Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:34", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05403086", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05403086", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05403086", "source_url": "https://clinicaltrials.gov/study/NCT05403086", "doi": "", "pmid": "", "publication_date": "2025-11-24", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4232, "title": "Qualitative Research on Psilocybin-Assisted Psychotherapy for the Treatment of Mental Disorders: A Scoping Review", "authors": "J Pincombe, M.L. Williams, Sean Carruthers, Susan L. Rossell", "journal": "Psychedelic Medicine", "publication_date": "2025-11-23", "publication_year": 2025, "doi": "10.1177/28314425251394012", "pubmed_id": null, "openalex_id": "https://openalex.org/W4416994935", "source_url": "https://doi.org/10.1177/28314425251394012", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,OCD,Eating Disorders,Chronic Pain,Systematic Review,Review Article,Healthcare Workers", "study_type": "Systematic Review", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:38", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "DOI:10.1177/28314425251394012", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1177/28314425251394012", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1177/28314425251394012", "source_url": "https://doi.org/10.1177/28314425251394012", "doi": "10.1177/28314425251394012", "pmid": "", "publication_date": "2025-11-23", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 348, "title": "Advancing treatment paradigms: the role of psilocybin in managing major depressive disorder", "authors": "Sana Rasheed, Rida Arif, Ahmed Asad Raza, Abedin Samadi", "journal": "Annals of Medicine and Surgery", "publication_date": "2025-11-23", "publication_year": 2025, "doi": "10.1097/ms9.0000000000004349", "pubmed_id": "41497122", "openalex_id": "https://openalex.org/W4416592848", "source_url": "https://doi.org/10.1097/ms9.0000000000004349", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Aging,Safety,Toxicity", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "PMID:41497122", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1097/ms9.0000000000004349", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41497122", "source_url": "https://doi.org/10.1097/ms9.0000000000004349", "doi": "10.1097/ms9.0000000000004349", "pmid": "41497122", "publication_date": "2025-11-23", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 390, "title": "Cognitive outcomes following psilocybin-assisted therapy in treatment-resistant depression: A post-hoc analysis of a randomized, waitlist-controlled trial", "authors": "Danica E. Johnson, Shakila Meshkat, Erica Kaczmarek, Jennifer S. Rabin, Ryan M. Brudner, Noah Chisamore, Zoe Doyle, Jordan Bawks, Jeremy Riva-Cambrin, Rodrigo B. Mansur, Orly Lipsitz, Roger S McIntyre, Krista L. Lanctôt, Joshua D. Rosenblat", "journal": "Progress in Neuro-Psychopharmacology and Biological Psychiatry", "publication_date": "2025-11-21", "publication_year": 2025, "doi": "10.1016/j.pnpbp.2025.111565", "pubmed_id": "41285295", "openalex_id": "https://openalex.org/W4416549169", "source_url": "https://doi.org/10.1016/j.pnpbp.2025.111565", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Randomized Controlled Trial,Treatment-Resistant Depression", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "PMID:41285295", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1016/j.pnpbp.2025.111565", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41285295", "source_url": "https://doi.org/10.1016/j.pnpbp.2025.111565", "doi": "10.1016/j.pnpbp.2025.111565", "pmid": "41285295", "publication_date": "2025-11-21", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4235, "title": "Self-reported improvement in depression, anxiety, and substance use in Spanish-speakers after a memorable psychedelic experience", "authors": "Stacey B. Armstrong, Meghan DellaCrosse, Jaime Fuentes-Balderrama, Rafaelle Lancelotta, Alan K. Davis", "journal": "Psychedelics", "publication_date": "2025-11-19", "publication_year": 2025, "doi": "10.1016/j.psyche.2025.100006", "pubmed_id": null, "openalex_id": "https://openalex.org/W7106133965", "source_url": "https://doi.org/10.1016/j.psyche.2025.100006", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Chronic Pain,Mystical Experience,Observational Study,Toxicity", "study_type": "Observational Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:38", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "DOI:10.1016/j.psyche.2025.100006", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1016/j.psyche.2025.100006", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.psyche.2025.100006", "source_url": "https://doi.org/10.1016/j.psyche.2025.100006", "doi": "10.1016/j.psyche.2025.100006", "pmid": "", "publication_date": "2025-11-19", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 425, "title": "Psilocybin and Chronic Pain: A New Perspective for Future Pain Therapists?", "authors": "Silvia Natoli, Arturo Cuomo, Maurizio Marchesini, Livio Luongo, Giuliano Lo Bianco, Vittorio Guardamagna, Shigeki Yamaguchi", "journal": "Medical Sciences", "publication_date": "2025-11-19", "publication_year": 2025, "doi": "10.3390/medsci13040277", "pubmed_id": "41283278", "openalex_id": "https://openalex.org/W4416407616", "source_url": "https://doi.org/10.3390/medsci13040277", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Chronic Pain,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Resilience,Emotional Processing,Clinical Trial,Randomized Controlled Trial,Review Article,Animal Study,Safety,Toxicity,Inflammation", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "PMID:41283278", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.3390/medsci13040277", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41283278", "source_url": "https://doi.org/10.3390/medsci13040277", "doi": "10.3390/medsci13040277", "pmid": "41283278", "publication_date": "2025-11-19", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3548, "title": "A Double-blind, Phase II Feasibility Study to Assess the Safety and Efficacy of Psilocybin Microdosing Combined With Psychotherapy in Treatment-resistant Depression", "authors": "Beersheva Mental Health Center", "journal": "ClinicalTrials.gov", "publication_date": "2025-11-18", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07183748", "substance_tags": "psilocybin", "topic_tags": "Depression,Biomarkers,Microdosing,Clinical Trial,Treatment-Resistant Depression,Safety,Inflammation", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07183748", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07183748", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07183748", "source_url": "https://clinicaltrials.gov/study/NCT07183748", "doi": "", "pmid": "", "publication_date": "2025-11-18", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3454, "title": "Open Label, Phase 2 Study for Evaluating the Feasibility, Safety and Efficacy of Psychotherapy Assisted Psilocybin for Treatment of Severe Obsessive Compulsive Disorder (OCD) in Drug and/or Psychotherapy Resistant Patients.", "authors": "Beersheva Mental Health Center", "journal": "ClinicalTrials.gov", "publication_date": "2025-11-18", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT04882839", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Anxiety,Addiction,OCD,End-of-Life Distress,Headache / Migraine,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Consciousness,Emotional Processing,Spirituality,Clinical Trial,Case Report,Animal Study,Cancer Patients,Safety,Adverse Events,Toxicity,Drug Interactions", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT04882839", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT04882839", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT04882839", "source_url": "https://clinicaltrials.gov/study/NCT04882839", "doi": "", "pmid": "", "publication_date": "2025-11-18", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3058, "title": "Microdosing Psilocybin for Major Depressive Disorder: Study Protocol for a Phase II Double-Blind Placebo-Controlled Randomized Partial Crossover Trial", "authors": "", "journal": "PsyArXiv", "publication_date": "2025-11-15", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://osf.io/preprints/psyarxiv/hmnsw_v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Microdosing,Wellbeing,Creativity,Clinical Trial,Observational Study,Safety", "study_type": "Clinical Trial", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:46", "last_checked": "2026-07-01 11:22:30", "bibtex": null, "source_record_id": "https://osf.io/preprints/psyarxiv/hmnsw_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/hmnsw_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "https://osf.io/preprints/psyarxiv/hmnsw_v1", "source_url": "https://osf.io/preprints/psyarxiv/hmnsw_v1", "doi": "", "pmid": "", "publication_date": "2025-11-15", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4241, "title": "Qualitative insights into psilocybin and LSD experiences: Enhanced connection and emotion processing reported by Spanish-speaking survey respondents", "authors": "Meghan DellaCrosse, Shoval Gilead, Rafael Lancelotta, Ana María Ortiz Bernal, Christopher Timmermann, Alan K. Davis", "journal": "Psychedelics", "publication_date": "2025-11-14", "publication_year": 2025, "doi": "10.1016/j.psyche.2025.100004", "pubmed_id": null, "openalex_id": "https://openalex.org/W4416229038", "source_url": "https://doi.org/10.1016/j.psyche.2025.100004", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Addiction,Receptor Pharmacology,Emotional Processing,Observational Study,Toxicity", "study_type": "Observational Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:38", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "DOI:10.1016/j.psyche.2025.100004", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1016/j.psyche.2025.100004", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.psyche.2025.100004", "source_url": "https://doi.org/10.1016/j.psyche.2025.100004", "doi": "10.1016/j.psyche.2025.100004", "pmid": "", "publication_date": "2025-11-14", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 436, "title": "Negative affective bias in depression following treatment with psilocybin or escitalopram - a secondary analysis from a randomized trial", "authors": "Marieke Martens, Bruna Giribaldi Cunha, David Erritzøe, David Nutt, Robin Carhart-Harris, Catherine J. Harmer", "journal": "Translational Psychiatry", "publication_date": "2025-11-12", "publication_year": 2025, "doi": "10.1038/s41398-025-03693-w", "pubmed_id": "41257994", "openalex_id": "https://openalex.org/W4416593366", "source_url": "https://doi.org/10.1038/s41398-025-03693-w", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Mechanism of Action,Emotional Processing,Clinical Trial,Randomized Controlled Trial,Meta-Analysis", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "PMID:41257994", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1038/s41398-025-03693-w", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41257994", "source_url": "https://doi.org/10.1038/s41398-025-03693-w", "doi": "10.1038/s41398-025-03693-w", "pmid": "41257994", "publication_date": "2025-11-12", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 356, "title": "‘Magic’ mechanisms underlie psilocybin’s effects in chronic pain", "authors": "Sian Lewis", "journal": "Nature reviews. Neuroscience", "publication_date": "2025-11-10", "publication_year": 2025, "doi": "10.1038/s41583-025-00999-y", "pubmed_id": "41219396", "openalex_id": "https://openalex.org/W4416111978", "source_url": "https://doi.org/10.1038/s41583-025-00999-y", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Chronic Pain,Mechanism of Action,Toxicity", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "PMID:41219396", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41219396", "source_url": "https://doi.org/10.1038/s41583-025-00999-y", "doi": "10.1038/s41583-025-00999-y", "pmid": "41219396", "publication_date": "2025-11-10", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 305, "title": "Pharmacodynamic biomarker - or psychotherapeutic process? Comment on “The role of the psychedelic experience in psilocybin treatment for treatment-resistant depression”", "authors": "Max Wolff, Samuli Kangaslampi", "journal": "Journal of Affective Disorders", "publication_date": "2025-11-10", "publication_year": 2025, "doi": "10.1016/j.jad.2025.120637", "pubmed_id": "41224017", "openalex_id": "https://openalex.org/W4416412154", "source_url": "https://doi.org/10.1016/j.jad.2025.120637", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Pharmacology,Biomarkers,Treatment-Resistant Depression,Toxicity", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "PMID:41224017", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41224017", "source_url": "https://doi.org/10.1016/j.jad.2025.120637", "doi": "10.1016/j.jad.2025.120637", "pmid": "41224017", "publication_date": "2025-11-10", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4245, "title": "Novel qNMR Methodto Quantify Psilocybin and Psilocinin Psychedelic Mushrooms", "authors": "Luisina Rodríguez (12333694), Guillermo Morera (22593717), Sandra Lupo (22593720), Danilo Davyt (2738347), Ignacio Carrera (1677175), Gonzalo Hernández Dossi (22593723)", "journal": "Figshare", "publication_date": "2025-11-09", "publication_year": 2025, "doi": "10.1021/acsomega.5c07092.s001", "pubmed_id": null, "openalex_id": "https://openalex.org/W7111180330", "source_url": "https://figshare.com/articles/journal_contribution/Novel_qNMR_Method_to_Quantify_Psilocybin_and_Psilocin_in_Psychedelic_Mushrooms/30584544", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:38", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "DOI:10.1021/acsomega.5c07092.s001", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://figshare.com/articles/journal_contribution/Novel_qNMR_Method_to_Quantify_Psilocybin_and_Psilocin_in_Psychedelic_Mushrooms/30584544", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1021/acsomega.5c07092.s001", "source_url": "https://figshare.com/articles/journal_contribution/Novel_qNMR_Method_to_Quantify_Psilocybin_and_Psilocin_in_Psychedelic_Mushrooms/30584544", "doi": "10.1021/acsomega.5c07092.s001", "pmid": "", "publication_date": "2025-11-09", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 422, "title": "Novel qNMR Method to Quantify Psilocybin and Psilocin in Psychedelic Mushrooms", "authors": "Luisina Castelli Rodríguez, Guillermo Morera, Sandra Lupo, Danilo Davyt, Ignacio Carrera, Gonzalo Hernández Dossi", "journal": "ACS Omega", "publication_date": "2025-11-09", "publication_year": 2025, "doi": "10.1021/acsomega.5c07092", "pubmed_id": "41322617", "openalex_id": "https://openalex.org/W4416673609", "source_url": "https://doi.org/10.1021/acsomega.5c07092", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "PMID:41322617", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1021/acsomega.5c07092", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41322617", "source_url": "https://doi.org/10.1021/acsomega.5c07092", "doi": "10.1021/acsomega.5c07092", "pmid": "41322617", "publication_date": "2025-11-09", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3033, "title": "Ketamine and Psilocybin Differentially Impact Sensory Learning During the Mismatch Negativity", "authors": "Allohverdi SG, Soltanzadeh M, Schmidt A, Charlton CE, Hauke DJ, Karvelis P, Vollenweider FX, Diaconescu AO.", "journal": "bioRxiv", "publication_date": "2025-11-06", "publication_year": 2025, "doi": "10.1101/2025.11.06.687023", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.1101/2025.11.06.687023", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging,Mechanism of Action", "study_type": "Other", "source_name": "bioRxiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:46", "last_checked": "2026-07-01 11:22:00", "bibtex": null, "source_record_id": "DOI:10.1101/2025.11.06.687023", "abstract_available": true, "abstract_source": "bioRxiv", "abstract_source_url": "https://doi.org/10.1101/2025.11.06.687023", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "bioRxiv", "source_record_id": "DOI:10.1101/2025.11.06.687023", "source_url": "https://doi.org/10.1101/2025.11.06.687023", "doi": "10.1101/2025.11.06.687023", "pmid": "", "publication_date": "2025-11-06", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 408, "title": "Efficacy, all-cause discontinuation, and safety of serotonergic psychedelics and MDMA to treat mental disorders: A living systematic review with meta-analysis.", "authors": "Højlund M, Kafali HY, Kırmızı B, Fusar-Poli P, Correll CU, Cortese S, Sabé M, Fiedorowicz J, Saraf G, Zein J, Berk M, Husain MI, Rosenblat JD, Rubaiyat R, Corace K, Wong S, Hatcher S, Kaluzienski M, Yatham LN, Cipriani A, Gosling CJ, Carhart-Harris R, Tanuseputro P, Myran DT, Fabiano N, Moher D, Mayo LM, Nicholls SG, White T, Prisco M, Radua J, Vieta E, Ladha KS, Katz J, Veroniki AA, Solmi M.", "journal": null, "publication_date": "2025-11-06", "publication_year": 2025, "doi": "10.1016/j.euroneuro.2025.09.011", "pubmed_id": "41205366", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.euroneuro.2025.09.011", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Receptor Pharmacology,Clinical Trial,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Safety", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:03", "bibtex": null, "source_record_id": "PMID:41205366", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.euroneuro.2025.09.011", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:41205366", "source_url": "https://doi.org/10.1016/j.euroneuro.2025.09.011", "doi": "10.1016/j.euroneuro.2025.09.011", "pmid": "41205366", "publication_date": "2025-11-06", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4246, "title": "A single dose of psilocybin alleviates chronic pain and associated anxiety and depression in mice", "authors": "AccessScience Editors", "journal": null, "publication_date": "2025-11-05", "publication_year": 2025, "doi": "10.1036/1097-8542.br2511031", "pubmed_id": null, "openalex_id": "https://openalex.org/W4415974900", "source_url": "https://doi.org/10.1036/1097-8542.br2511031", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Chronic Pain,Pharmacology,Animal Study", "study_type": "Animal Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:38", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "DOI:10.1036/1097-8542.br2511031", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1036/1097-8542.br2511031", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1036/1097-8542.br2511031", "source_url": "https://doi.org/10.1036/1097-8542.br2511031", "doi": "10.1036/1097-8542.br2511031", "pmid": "", "publication_date": "2025-11-05", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4248, "title": "Divergent effects of ketamine and psilocybin on EEG power spectral density in a mismatch negativity paradigm", "authors": "Milad Soltanzadeh, Zheng Wang, Shona G. Allohverdi, Colleen E. Charlton, André Schmidt, Franz Xaver Vollenweider, Andreea O. Diaconescu", "journal": "Universität Zürich, ZORA", "publication_date": "2025-11-04", "publication_year": 2025, "doi": "10.5167/uzh-292276", "pubmed_id": null, "openalex_id": "https://openalex.org/W7130720501", "source_url": "https://doi.org/10.5167/uzh-292276", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Brain Imaging,Receptor Pharmacology,Default Mode Network", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:38", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "DOI:10.5167/uzh-292276", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.5167/uzh-292276", "source_url": "https://doi.org/10.5167/uzh-292276", "doi": "10.5167/uzh-292276", "pmid": "", "publication_date": "2025-11-04", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4247, "title": "Classic psychedelics may treat depressive disorders, but more evidence and legislative changes are required", "authors": "Aisling McGuigan", "journal": "Drugs & Therapy Perspectives", "publication_date": "2025-11-04", "publication_year": 2025, "doi": "10.1007/s40267-025-01199-5", "pubmed_id": null, "openalex_id": "https://openalex.org/W4415932492", "source_url": "https://doi.org/10.1007/s40267-025-01199-5", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Chronic Pain,Clinical Trial,Randomized Controlled Trial,Treatment-Resistant Depression,Toxicity", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:38", "last_checked": "2026-07-04 06:34:38", "bibtex": null, "source_record_id": "DOI:10.1007/s40267-025-01199-5", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1007/s40267-025-01199-5", "source_url": "https://doi.org/10.1007/s40267-025-01199-5", "doi": "10.1007/s40267-025-01199-5", "pmid": "", "publication_date": "2025-11-04", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3510, "title": "Psilocybin - Induced Neuroplasticity in the Treatment of Major Depressive Disorder", "authors": "Yale University", "journal": "ClinicalTrials.gov", "publication_date": "2025-11-04", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT03554174", "substance_tags": "psilocybin", "topic_tags": "Depression,Neuroplasticity", "study_type": "Other", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT03554174", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT03554174", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT03554174", "source_url": "https://clinicaltrials.gov/study/NCT03554174", "doi": "", "pmid": "", "publication_date": "2025-11-04", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3489, "title": "A Phase 1/2 Study of a Group Model of Psilocybin-Assisted Therapy for Cancer-Related Anxiety in Patients With Metastatic Cancer", "authors": "University of Washington", "journal": "ClinicalTrials.gov", "publication_date": "2025-11-04", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05847686", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Receptor Pharmacology,Clinical Trial,Cancer Patients,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05847686", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05847686", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05847686", "source_url": "https://clinicaltrials.gov/study/NCT05847686", "doi": "", "pmid": "", "publication_date": "2025-11-04", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3067, "title": "Psilocybin reduces depressive-like behavior and improves cognition in healthy aging mice via epigenetic regulation of plasticity- and immune-related genes", "authors": "Mennenga S, Hanson T, Semple M, Lifshitz D, Flores B, Balducci J, Harker S, Ford A, Lewis C.", "journal": "Research Square", "publication_date": "2025-11-04", "publication_year": 2025, "doi": "10.21203/rs.3.rs-7890051/v1", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.21203/rs.3.rs-7890051/v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Neuroplasticity,Mechanism of Action,Aging,Epigenetics,Wellbeing,Resilience,Emotional Processing,Animal Study,Genomics,Inflammation,Immune Function", "study_type": "Animal Study", "source_name": "Europe PMC", "publication_status": "preprint", "date_added": "2026-07-01 11:03:46", "last_checked": "2026-07-01 11:22:00", "bibtex": null, "source_record_id": "DOI:10.21203/rs.3.rs-7890051/v1", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.21203/rs.3.rs-7890051/v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "DOI:10.21203/rs.3.rs-7890051/v1", "source_url": "https://doi.org/10.21203/rs.3.rs-7890051/v1", "doi": "10.21203/rs.3.rs-7890051/v1", "pmid": "", "publication_date": "2025-11-04", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4249, "title": "Hormonal Influences on Psilocybin Responsivity Across the Female Lifespan: Toward Personalized Psychedelic-Assisted Therapy", "authors": "Faith Ekoh, Shanice Rerrie, James Angud, Ersilia Mirabelli", "journal": "Psychoactives", "publication_date": "2025-11-01", "publication_year": 2025, "doi": "10.3390/psychoactives4040039", "pubmed_id": null, "openalex_id": "https://openalex.org/W4415817857", "source_url": "https://doi.org/10.3390/psychoactives4040039", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Neuroplasticity,Pharmacology,Receptor Pharmacology,Longevity,Review Article,Animal Study,Toxicity", "study_type": "Review Article", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:38", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "DOI:10.3390/psychoactives4040039", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.3390/psychoactives4040039", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.3390/psychoactives4040039", "source_url": "https://doi.org/10.3390/psychoactives4040039", "doi": "10.3390/psychoactives4040039", "pmid": "", "publication_date": "2025-11-01", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 84, "title": "Lifetime Psychedelic Use and Opioid Use Disorder Severity: Substance-Use Pattern Specific and Mental Health-Dependent Associations in a National Survey", "authors": "", "journal": "PsyArXiv", "publication_date": "2025-11-01", "publication_year": 2025, "doi": "10.1016/j.addbeh.2026.108652", "pubmed_id": null, "openalex_id": null, "source_url": "https://osf.io/preprints/psyarxiv/jd2rk_v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Observational Study,Safety", "study_type": "Observational Study", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-01 11:22:30", "bibtex": null, "source_record_id": "DOI:10.1016/j.addbeh.2026.108652", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/jd2rk_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "DOI:10.1016/j.addbeh.2026.108652", "source_url": "https://osf.io/preprints/psyarxiv/jd2rk_v1", "doi": "10.1016/j.addbeh.2026.108652", "pmid": "", "publication_date": "2025-11-01", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4251, "title": "Psilocybin bei Alkoholkonsumstörung", "authors": "", "journal": "Suchttherapie", "publication_date": "2025-10-31", "publication_year": 2025, "doi": "10.1055/a-2702-9616", "pubmed_id": null, "openalex_id": "https://openalex.org/W4416016336", "source_url": "https://doi.org/10.1055/a-2702-9616", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Pharmacology,Toxicity", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:38", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "DOI:10.1055/a-2702-9616", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1055/a-2702-9616", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1055/a-2702-9616", "source_url": "https://doi.org/10.1055/a-2702-9616", "doi": "10.1055/a-2702-9616", "pmid": "", "publication_date": "2025-10-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4250, "title": "Metaanalyse: Wirksamkeit und Sicherheit von Psilocybin bei Major Depressionen", "authors": "", "journal": "Fortschritte der Neurologie · Psychiatrie", "publication_date": "2025-10-31", "publication_year": 2025, "doi": "10.1055/a-2576-6069", "pubmed_id": null, "openalex_id": "https://openalex.org/W4415976738", "source_url": "https://doi.org/10.1055/a-2576-6069", "substance_tags": "psilocybin", "topic_tags": "Depression,Toxicity", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:38", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "DOI:10.1055/a-2576-6069", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1055/a-2576-6069", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1055/a-2576-6069", "source_url": "https://doi.org/10.1055/a-2576-6069", "doi": "10.1055/a-2576-6069", "pmid": "", "publication_date": "2025-10-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1987, "title": "Ketamine and psilocybin for athletes: A therapeutic breakthrough or a slippery slope?", "authors": "Thomas Zandonai, Sofia Venturini, Ornella Corazza", "journal": "Performance Enhancement & Health", "publication_date": "2025-10-31", "publication_year": 2025, "doi": "10.1016/j.peh.2025.100386", "pubmed_id": null, "openalex_id": "https://openalex.org/W4415757045", "source_url": "https://doi.org/10.1016/j.peh.2025.100386", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Chronic Pain,Receptor Pharmacology,Resilience,Safety,Toxicity", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:52:05", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "DOI:10.1016/j.peh.2025.100386", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1016/j.peh.2025.100386", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.peh.2025.100386", "source_url": "https://doi.org/10.1016/j.peh.2025.100386", "doi": "10.1016/j.peh.2025.100386", "pmid": "", "publication_date": "2025-10-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 460, "title": "The emotional architecture of the psychedelic brain.", "authors": "Moujaes F, Rieser NM, Belinger L, Herdener M, Zahid Z, Preller KH", "journal": "Trends in cognitive sciences", "publication_date": "2025-10-31", "publication_year": 2025, "doi": "10.1016/j.tics.2025.07.006", "pubmed_id": "40830011", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/40830011/", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Neuroplasticity,Mechanism of Action,Emotional Processing,Review Article", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:20:35", "bibtex": null, "source_record_id": "PMID:40830011", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40830011/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40830011", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40830011/", "doi": "10.1016/j.tics.2025.07.006", "pmid": "40830011", "publication_date": "2025-10-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 458, "title": "The therapeutic use of psychedelic drugs: Legal, policy, and neuroscientific perspectives.", "authors": "Rahmani S, Crupi R, Riley AL, Davidson T", "journal": "Pharmacology, biochemistry, and behavior", "publication_date": "2025-10-31", "publication_year": 2025, "doi": "10.1016/j.pbb.2025.174087", "pubmed_id": "40849009", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/40849009/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Mechanism of Action,Safety", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:20:35", "bibtex": null, "source_record_id": "PMID:40849009", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40849009/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40849009", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40849009/", "doi": "10.1016/j.pbb.2025.174087", "pmid": "40849009", "publication_date": "2025-10-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 449, "title": "Reporting of side-effects in clinical trials of psilocybin-assisted psychotherapy for psychiatric conditions: systematic review", "authors": "Jonathon Marinis, Sarah Clarke, Alexandre A. Guerin, Adam J. Guastella, Gillinder Bedi", "journal": "BJPsych Open", "publication_date": "2025-10-31", "publication_year": 2025, "doi": "10.1192/bjo.2025.10847", "pubmed_id": "41178084", "openalex_id": "https://openalex.org/W4415782096", "source_url": "https://doi.org/10.1192/bjo.2025.10847", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Chronic Pain,Clinical Trial,Randomized Controlled Trial,Systematic Review,Review Article,Safety,Toxicity", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "PMID:41178084", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1192/bjo.2025.10847", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41178084", "source_url": "https://doi.org/10.1192/bjo.2025.10847", "doi": "10.1192/bjo.2025.10847", "pmid": "41178084", "publication_date": "2025-10-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4254, "title": "“It Fueled the Fire to Who I Am Now”: Exploring Motivations for Microdosing Psychedelics", "authors": "Blake Beaton", "journal": "Journal of Drug Issues", "publication_date": "2025-10-30", "publication_year": 2025, "doi": "10.1177/00220426251395178", "pubmed_id": null, "openalex_id": "https://openalex.org/W4415749444", "source_url": "https://doi.org/10.1177/00220426251395178", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Microdosing,Wellbeing,Spirituality,Toxicity", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:38", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "DOI:10.1177/00220426251395178", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1177/00220426251395178", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1177/00220426251395178", "source_url": "https://doi.org/10.1177/00220426251395178", "doi": "10.1177/00220426251395178", "pmid": "", "publication_date": "2025-10-30", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 466, "title": "Psychedelics and ketamine/esketamine in depressive disorders: biological mechanisms and associated neuroimaging and clinical changes.", "authors": "d'Andrea G, Chiappini S, Ciavoni L, Tucci R, Martino F, Semeraro FM, Di Battista D, Mosca A, Miuli A, Di Carlo F, Russo M, Di Petta G, Fornaro M, Pettorruso M, Sensi SL, Martinotti G.", "journal": null, "publication_date": "2025-10-30", "publication_year": 2025, "doi": "10.1038/s41398-025-03654-3", "pubmed_id": "41173871", "openalex_id": null, "source_url": "https://doi.org/10.1038/s41398-025-03654-3", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Brain Imaging,Mechanism of Action,Receptor Pharmacology,Default Mode Network,Aging,Emotional Processing,Clinical Trial,Systematic Review,Review Article,Observational Study,Treatment-Resistant Depression", "study_type": "Systematic Review", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:02", "bibtex": null, "source_record_id": "PMID:41173871", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1038/s41398-025-03654-3", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:41173871", "source_url": "https://doi.org/10.1038/s41398-025-03654-3", "doi": "10.1038/s41398-025-03654-3", "pmid": "41173871", "publication_date": "2025-10-30", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 306, "title": "Psilocybin use in bipolar disorder: A comprehensive review.", "authors": "Do A, Cloutier L, Hébert-Tremblay L, Thauvin C.", "journal": null, "publication_date": "2025-10-30", "publication_year": 2025, "doi": "10.1016/j.jad.2025.120485", "pubmed_id": "41177271", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.jad.2025.120485", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Clinical Trial,Review Article,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:00", "bibtex": null, "source_record_id": "PMID:41177271", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.jad.2025.120485", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:41177271", "source_url": "https://doi.org/10.1016/j.jad.2025.120485", "doi": "10.1016/j.jad.2025.120485", "pmid": "41177271", "publication_date": "2025-10-30", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3566, "title": "A Randomized, Double-Blind, Placebo-Controlled Mechanistic Study to Assess a Single Oral Dose of CYB003 in Participants With Major Depressive Disorder (MDD) and Moderate to Severe Anxiety", "authors": "Ohio State University", "journal": "ClinicalTrials.gov", "publication_date": "2025-10-29", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06820723", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Anxiety,Neuroplasticity,Brain Imaging,Mechanism of Action,Biomarkers,Aging,Healthcare Workers", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06820723", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06820723", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06820723", "source_url": "https://clinicaltrials.gov/study/NCT06820723", "doi": "", "pmid": "", "publication_date": "2025-10-29", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 409, "title": "Psilocybin as a fast-acting and long-lasting antidepressant for adolescence: Proposing NeuroD1 as a biomarker of its long-term plasticity", "authors": "Rubén García-Cabrerizo, Itziar Beruete-Fresnillo, Pedro Bergas-Cladera, M. Julia García-Fuster", "journal": "Biomedicine & Pharmacotherapy", "publication_date": "2025-10-29", "publication_year": 2025, "doi": "10.1016/j.biopha.2025.118720", "pubmed_id": "41172953", "openalex_id": "https://openalex.org/W4415713367", "source_url": "https://doi.org/10.1016/j.biopha.2025.118720", "substance_tags": "psilocybin", "topic_tags": "Depression,Neuroplasticity,Neurogenesis,Pharmacology,Receptor Pharmacology,Biomarkers,Observational Study,Adolescents,Toxicity", "study_type": "Observational Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "PMID:41172953", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1016/j.biopha.2025.118720", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41172953", "source_url": "https://doi.org/10.1016/j.biopha.2025.118720", "doi": "10.1016/j.biopha.2025.118720", "pmid": "41172953", "publication_date": "2025-10-29", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3597, "title": "A Wellcome Leap for the Opioid Crisis: Can the 5HT2A Agonist Psilocybin Improve Brain, Behavioral, and Clinical Outcomes in Opioid Use Disorder (OUD)?", "authors": "Anna Rose Childress, Ph.D.", "journal": "ClinicalTrials.gov", "publication_date": "2025-10-28", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06786325", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,OCD,Receptor Pharmacology,Consciousness,Biomarkers,Emotional Processing,Spirituality,Mystical Experience,Clinical Trial,Observational Study,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06786325", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06786325", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06786325", "source_url": "https://clinicaltrials.gov/study/NCT06786325", "doi": "", "pmid": "", "publication_date": "2025-10-28", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4259, "title": "Psilocybin's effects on obsessive-compulsive behaviors: A systematic review of preclinical and clinical evidence", "authors": "James J Gattuso, Bilgenur Bezcioglu, Carey Wilson, Kato Havaux, Anthony J. Hannan, Thibault Renoir", "journal": "Psychedelics.", "publication_date": "2025-10-27", "publication_year": 2025, "doi": "10.61373/pp025i.0044", "pubmed_id": null, "openalex_id": "https://openalex.org/W4415615338", "source_url": "https://doi.org/10.61373/pp025i.0044", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Anxiety,OCD,Chronic Pain,Neuroplasticity,Brain Imaging,Pharmacology,Biomarkers,Aging,Clinical Trial,Randomized Controlled Trial,Systematic Review,Review Article,Animal Study,Toxicity", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:38", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "DOI:10.61373/pp025i.0044", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.61373/pp025i.0044", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.61373/pp025i.0044", "source_url": "https://doi.org/10.61373/pp025i.0044", "doi": "10.61373/pp025i.0044", "pmid": "", "publication_date": "2025-10-27", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 391, "title": "Adverse event reporting and management in psilocybin therapy clinical trials: A systematic review to guide clinical and research protocol development.", "authors": "Bukovsky D, Amaev A, Song J, Kyte S, Carmona-Torres E, Ueno F, Deluca V, Strafella AP, Husain MI, Graff-Guerrero A, Gerretsen P.", "journal": null, "publication_date": "2025-10-22", "publication_year": 2025, "doi": "10.1016/j.pnpbp.2025.111541", "pubmed_id": "41138900", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.pnpbp.2025.111541", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Headache / Migraine,Clinical Trial,Systematic Review,Review Article,Safety,Adverse Events", "study_type": "Systematic Review", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:00", "bibtex": null, "source_record_id": "PMID:41138900", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.pnpbp.2025.111541", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:41138900", "source_url": "https://doi.org/10.1016/j.pnpbp.2025.111541", "doi": "10.1016/j.pnpbp.2025.111541", "pmid": "41138900", "publication_date": "2025-10-22", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4260, "title": "Psychedelics and time: Exploring altered temporal perception and its implications for consciousness, neuroscience, and therapy", "authors": "Pu Jiang, Cong Lin, Xiaohui Wang", "journal": "Psychedelics.", "publication_date": "2025-10-20", "publication_year": 2025, "doi": "10.61373/pp025p.0041", "pubmed_id": null, "openalex_id": "https://openalex.org/W4415381295", "source_url": "https://doi.org/10.61373/pp025p.0041", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Mechanism of Action,Consciousness", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:38", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "DOI:10.61373/pp025p.0041", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.61373/pp025p.0041", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.61373/pp025p.0041", "source_url": "https://doi.org/10.61373/pp025p.0041", "doi": "10.61373/pp025p.0041", "pmid": "", "publication_date": "2025-10-20", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4262, "title": "Is there more to magic mushrooms than psilocybin?", "authors": "special to C EN Mara Johnson-Groh", "journal": "C&EN Global Enterprise", "publication_date": "2025-10-19", "publication_year": 2025, "doi": "10.1021/cen-10322-feature2", "pubmed_id": null, "openalex_id": "https://openalex.org/W4416285937", "source_url": "https://doi.org/10.1021/cen-10322-feature2", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Addiction,OCD,Receptor Pharmacology,Clinical Trial,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:38", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "DOI:10.1021/cen-10322-feature2", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1021/cen-10322-feature2", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1021/cen-10322-feature2", "source_url": "https://doi.org/10.1021/cen-10322-feature2", "doi": "10.1021/cen-10322-feature2", "pmid": "", "publication_date": "2025-10-19", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 473, "title": "Biological markers of treatment response to serotonergic psychedelic therapies: a systematic review.", "authors": "Wong S, Jones BDM, Thiyagarajah MT, Sabbah SG, Thompson C, Solmi M, Umer M, Zrenner C, Voineskos D, Rosenblat JD, Mulsant BH, Blumberger DM, Husain MI.", "journal": null, "publication_date": "2025-10-15", "publication_year": 2025, "doi": "10.1177/20451253251384513", "pubmed_id": "41122434", "openalex_id": null, "source_url": "https://doi.org/10.1177/20451253251384513", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging,Mechanism of Action,Biomarkers,Aging,Clinical Trial,Systematic Review,Review Article,Treatment-Resistant Depression", "study_type": "Systematic Review", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:04", "bibtex": null, "source_record_id": "PMID:41122434", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1177/20451253251384513", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:41122434", "source_url": "https://doi.org/10.1177/20451253251384513", "doi": "10.1177/20451253251384513", "pmid": "41122434", "publication_date": "2025-10-15", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 358, "title": "A novel psychedelic 5-HT2A receptor agonist GM-2505: The pharmacokinetic, safety, and pharmacodynamic profile from a randomized trial healthy volunteer", "authors": "Gerard J. Marek, Soma Makai-Bölöni, Daniel Umbricht, Edward P. Christian, Jason Winters, Dino Dvořák, Shane Raines, Zoë A. Hughes, Eric W. Austin, Adam K. Klein, William Leong, Fas J. Krol, Anne J. van der Graaf, Maria J. Juachon, Marije E. Otto, Laura Borghans, Gabriël E. Jacobs, Andrew C. Kruegel, Jonathan Sporn", "journal": "Journal of Psychopharmacology", "publication_date": "2025-10-15", "publication_year": 2025, "doi": "10.1177/02698811251378512", "pubmed_id": "41099491", "openalex_id": "https://openalex.org/W4415246252", "source_url": "https://doi.org/10.1177/02698811251378512", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging,Pharmacology,Receptor Pharmacology,Clinical Trial,Randomized Controlled Trial,Healthy Volunteers,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "PMID:41099491", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1177/02698811251378512", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41099491", "source_url": "https://doi.org/10.1177/02698811251378512", "doi": "10.1177/02698811251378512", "pmid": "41099491", "publication_date": "2025-10-15", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4267, "title": "Structure-GuidedDesign of Novel 5-HT2A Partial Agonists as PsychedelicAnalogues with Antidepressant Effects", "authors": "Rongyan Li (11403789), Haohan Yan (22432650), Yujin Chen (1412254), Yangyang Liu (807797), Lingjie Tang (9276407), Jing Yu (81085), Junjun Liu (674159), Huan Wang (109286), Sheng Wang (339979), Jianjun Cheng (646595)", "journal": "Figshare", "publication_date": "2025-10-14", "publication_year": 2025, "doi": "10.1021/acs.jmedchem.5c02045.s001", "pubmed_id": null, "openalex_id": "https://openalex.org/W7111070235", "source_url": "https://figshare.com/articles/journal_contribution/Structure-Guided_Design_of_Novel_5_HT_sub_2A_sub_Partial_Agonists_as_Psychedelic_Analogues_with_Antidepressant_Effects/30360072", "substance_tags": "psilocybin", "topic_tags": "Depression,Pharmacology,Receptor Pharmacology,Animal Study", "study_type": "Animal Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:38", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "DOI:10.1021/acs.jmedchem.5c02045.s001", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://figshare.com/articles/journal_contribution/Structure-Guided_Design_of_Novel_5_HT_sub_2A_sub_Partial_Agonists_as_Psychedelic_Analogues_with_Antidepressant_Effects/30360072", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1021/acs.jmedchem.5c02045.s001", "source_url": "https://figshare.com/articles/journal_contribution/Structure-Guided_Design_of_Novel_5_HT_sub_2A_sub_Partial_Agonists_as_Psychedelic_Analogues_with_Antidepressant_Effects/30360072", "doi": "10.1021/acs.jmedchem.5c02045.s001", "pmid": "", "publication_date": "2025-10-14", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3057, "title": "Psilocybin exerts differential effects on social behaviour and inflammation in mice in contexts of activity-based anorexia (ABA)", "authors": "Shadani S, Greaves E, Andrews ZB, Foldi CJ.", "journal": "bioRxiv", "publication_date": "2025-10-14", "publication_year": 2025, "doi": "10.1101/2025.10.14.682467", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.1101/2025.10.14.682467", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,OCD,Eating Disorders,Mechanism of Action,Emotional Processing,Animal Study,Inflammation,Immune Function", "study_type": "Animal Study", "source_name": "bioRxiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:46", "last_checked": "2026-07-01 11:22:00", "bibtex": null, "source_record_id": "DOI:10.1101/2025.10.14.682467", "abstract_available": true, "abstract_source": "bioRxiv", "abstract_source_url": "https://doi.org/10.1101/2025.10.14.682467", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "bioRxiv", "source_record_id": "DOI:10.1101/2025.10.14.682467", "source_url": "https://doi.org/10.1101/2025.10.14.682467", "doi": "10.1101/2025.10.14.682467", "pmid": "", "publication_date": "2025-10-14", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4268, "title": "Psychedelics in the context of stress and psychiatric disorders: A new horizon in mental health treatment", "authors": "Sha Jin, H.Y. Wang, Xiaohui Wang", "journal": "Psychedelics.", "publication_date": "2025-10-13", "publication_year": 2025, "doi": "10.61373/pp025v.0038", "pubmed_id": null, "openalex_id": "https://openalex.org/W4415151524", "source_url": "https://doi.org/10.61373/pp025v.0038", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Consciousness,Wellbeing,Emotional Processing", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:38", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "DOI:10.61373/pp025v.0038", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.61373/pp025v.0038", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.61373/pp025v.0038", "source_url": "https://doi.org/10.61373/pp025v.0038", "doi": "10.61373/pp025v.0038", "pmid": "", "publication_date": "2025-10-13", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3590, "title": "Psilocybin and Affective Function in Chronic Lower Back Pain Depression", "authors": "Johns Hopkins University", "journal": "ClinicalTrials.gov", "publication_date": "2025-10-13", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06355414", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Mechanism of Action,Observational Study,Safety", "study_type": "Observational Study", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06355414", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06355414", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06355414", "source_url": "https://clinicaltrials.gov/study/NCT06355414", "doi": "", "pmid": "", "publication_date": "2025-10-13", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 472, "title": "Structure-Guided Design of Novel 5-HT2A Partial Agonists as Psychedelic Analogues with Antidepressant Effects", "authors": "Rongyan Li, Haohan Yan, Yujin Chen, Yangyang Liu, Lingjie Tang, Jing Yu, Junjun Liu, Huan Wang, Sheng Wang, Jianjun Cheng", "journal": "Journal of Medicinal Chemistry", "publication_date": "2025-10-13", "publication_year": 2025, "doi": "10.1021/acs.jmedchem.5c02045", "pubmed_id": "41087124", "openalex_id": "https://openalex.org/W4415182565", "source_url": "https://doi.org/10.1021/acs.jmedchem.5c02045", "substance_tags": "psilocybin", "topic_tags": "Depression,Pharmacology,Receptor Pharmacology,Animal Study", "study_type": "Animal Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "PMID:41087124", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1021/acs.jmedchem.5c02045", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41087124", "source_url": "https://doi.org/10.1021/acs.jmedchem.5c02045", "doi": "10.1021/acs.jmedchem.5c02045", "pmid": "41087124", "publication_date": "2025-10-13", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 428, "title": "Zalsupindole is a Nondissociative, Nonhallucinogenic Neuroplastogen with Therapeutic Effects Comparable to Ketamine and Psychedelics", "authors": "Rajiv Agrawal, Daniel J. Gillie, Alison E. Mungenast, Milan Chytil, Sharon Engel, Michael C. Wu, Kurt Rasmussen, Eliseo Salinas, David E. Olson", "journal": "ACS Chemical Neuroscience", "publication_date": "2025-10-12", "publication_year": 2025, "doi": "10.1021/acschemneuro.5c00667", "pubmed_id": "41078264", "openalex_id": "https://openalex.org/W4415115279", "source_url": "https://doi.org/10.1021/acschemneuro.5c00667", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Neuroplasticity,Neurogenesis,Pharmacology,Receptor Pharmacology,Animal Study,Safety", "study_type": "Animal Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "PMID:41078264", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1021/acschemneuro.5c00667", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41078264", "source_url": "https://doi.org/10.1021/acschemneuro.5c00667", "doi": "10.1021/acschemneuro.5c00667", "pmid": "41078264", "publication_date": "2025-10-12", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 450, "title": "Set and setting in psilocybin-assisted therapy: A qualitative study of patients with cancer and depression", "authors": "Yvan Beaussant, Elise C. Tarbi, Kabir Nigam, Skye A. Miner, Zachary Sager, Justin J. Sanders, Michael Ljuslin, Benjamin Guérin, Roxanne Sholevar, Kimberly Roddy, James A. Tulsky, Manish Agrawal", "journal": "General Hospital Psychiatry", "publication_date": "2025-10-10", "publication_year": 2025, "doi": "10.1016/j.genhosppsych.2025.10.010", "pubmed_id": "41109203", "openalex_id": "https://openalex.org/W4415081303", "source_url": "https://doi.org/10.1016/j.genhosppsych.2025.10.010", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Toxicity", "study_type": "Qualitative Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "PMID:41109203", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41109203", "source_url": "https://doi.org/10.1016/j.genhosppsych.2025.10.010", "doi": "10.1016/j.genhosppsych.2025.10.010", "pmid": "41109203", "publication_date": "2025-10-10", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4272, "title": "Psychedelics in Practice: Science, Safety, and the Future of Healing", "authors": "Renee Ireland", "journal": "˜The œproceedings of sliit international conference on advancements in science and humanities", "publication_date": "2025-10-09", "publication_year": 2025, "doi": "10.54389/epsd8792", "pubmed_id": null, "openalex_id": "https://openalex.org/W7119484008", "source_url": "https://doi.org/10.54389/epsd8792", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,End-of-Life Distress,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Default Mode Network,Consciousness,Treatment-Resistant Depression,Safety,Toxicity,Contraindications", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:38", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "DOI:10.54389/epsd8792", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.54389/epsd8792", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.54389/epsd8792", "source_url": "https://doi.org/10.54389/epsd8792", "doi": "10.54389/epsd8792", "pmid": "", "publication_date": "2025-10-09", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4271, "title": "Control group improvement lower in psilocybin trials for depression", "authors": "", "journal": "The Brown University Psychopharmacology Update", "publication_date": "2025-10-09", "publication_year": 2025, "doi": "10.1002/pu.31371", "pubmed_id": null, "openalex_id": "https://openalex.org/W4415055785", "source_url": "https://doi.org/10.1002/pu.31371", "substance_tags": "psilocybin", "topic_tags": "Depression,Receptor Pharmacology,Clinical Trial,Randomized Controlled Trial,Meta-Analysis,Treatment-Resistant Depression", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:38", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "DOI:10.1002/pu.31371", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1002/pu.31371", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1002/pu.31371", "source_url": "https://doi.org/10.1002/pu.31371", "doi": "10.1002/pu.31371", "pmid": "", "publication_date": "2025-10-09", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 325, "title": "Corrigendum to \"The role of the psychedelic experience in psilocybin treatment for treatment-resistant depression\" [Journal of Affective Disorders, Volume 372 (2025), Pages 523-532].", "authors": "Goodwin GM, Aaronson ST, Alvarez O, Carhart-Harris R, Chai-Rees J, Croal M, DeBattista C, Dunlop BW, Feifel D, Hellerstein DJ, Husain MI, Kelly JR, Kirlic N, Licht RW, Marwood L, Meyer TD, Mistry S, Nowakowska A, Páleníček T, Repantis D, Schoevers RA, Simmons H, Somers M, Teoh E, Tsai J, Wahba M, Williams S, Young AH, Young MB, Zisook S, Malievskaia E.", "journal": null, "publication_date": "2025-10-09", "publication_year": 2025, "doi": "10.1016/j.jad.2025.120352", "pubmed_id": "41075579", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.jad.2025.120352", "substance_tags": "psilocybin", "topic_tags": "Depression,Treatment-Resistant Depression", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:03", "bibtex": null, "source_record_id": "PMID:41075579", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:41075579", "source_url": "https://doi.org/10.1016/j.jad.2025.120352", "doi": "10.1016/j.jad.2025.120352", "pmid": "41075579", "publication_date": "2025-10-09", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 429, "title": "Synaptic priming: A framework for pharmacotherapy in depression.", "authors": "Brown KA, Ajibola MI, Medeiros GC, Gould TD.", "journal": null, "publication_date": "2025-10-07", "publication_year": 2025, "doi": "10.1016/j.neuron.2025.09.010", "pubmed_id": "41067229", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.neuron.2025.09.010", "substance_tags": "psilocybin", "topic_tags": "Depression,Neuroplasticity,Pharmacology,Review Article", "study_type": "Review Article", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:03", "bibtex": null, "source_record_id": "PMID:41067229", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.neuron.2025.09.010", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:41067229", "source_url": "https://doi.org/10.1016/j.neuron.2025.09.010", "doi": "10.1016/j.neuron.2025.09.010", "pmid": "41067229", "publication_date": "2025-10-07", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3575, "title": "Efficacy of Psilocybin and Trazodone Combination in Treatment-resistant Depression: a Randomized Controlled Proof-of-concept Study (PSILOTRAZ)", "authors": "Centre Hospitalier St Anne", "journal": "ClinicalTrials.gov", "publication_date": "2025-10-06", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07210112", "substance_tags": "psilocybin", "topic_tags": "Depression,Receptor Pharmacology,Clinical Trial,Randomized Controlled Trial,Treatment-Resistant Depression,Safety", "study_type": "Randomized Controlled Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07210112", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07210112", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07210112", "source_url": "https://clinicaltrials.gov/study/NCT07210112", "doi": "", "pmid": "", "publication_date": "2025-10-06", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3065, "title": "Towards Novel Antidepressant Strategies: A Comparative Study of Ketamine, Psilocybin, and Fluoxetine in a Chronic Stress Model", "authors": "Domzalska M, Kwiatkowska J, Cichon I, Sokolowska E.", "journal": "Research Square", "publication_date": "2025-10-06", "publication_year": 2025, "doi": "10.21203/rs.3.rs-7269356/v1", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.21203/rs.3.rs-7269356/v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Receptor Pharmacology,Animal Study", "study_type": "Animal Study", "source_name": "Europe PMC", "publication_status": "preprint", "date_added": "2026-07-01 11:03:46", "last_checked": "2026-07-01 11:22:00", "bibtex": null, "source_record_id": "DOI:10.21203/rs.3.rs-7269356/v1", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.21203/rs.3.rs-7269356/v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "DOI:10.21203/rs.3.rs-7269356/v1", "source_url": "https://doi.org/10.21203/rs.3.rs-7269356/v1", "doi": "10.21203/rs.3.rs-7269356/v1", "pmid": "", "publication_date": "2025-10-06", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4275, "title": "Neurobiological and Therapeutic Potential of Psilocybin in Psychiatric Disorders", "authors": "M Loganathan, A Saravanakumar, P. Parthiban, G Anandharaj, S Gobika, D Dharshana, Mohamed Safir Ali", "journal": "Journal of Pharma Insights and Research.", "publication_date": "2025-10-04", "publication_year": 2025, "doi": "10.69613/thv1dn30", "pubmed_id": null, "openalex_id": "https://openalex.org/W4416779935", "source_url": "https://doi.org/10.69613/thv1dn30", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,End-of-Life Distress,Chronic Pain,Neuroplasticity,Pharmacology,Mechanism of Action,Receptor Pharmacology,Default Mode Network,Clinical Trial,Treatment-Resistant Depression,Healthcare Workers,Safety,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:38", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "DOI:10.69613/thv1dn30", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.69613/thv1dn30", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.69613/thv1dn30", "source_url": "https://doi.org/10.69613/thv1dn30", "doi": "10.69613/thv1dn30", "pmid": "", "publication_date": "2025-10-04", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3677, "title": "Retrospective Observational Study of Intensity Effects in Psychedelic-assisted Treatment", "authors": "University Hospital, Geneva", "journal": "ClinicalTrials.gov", "publication_date": "2025-10-01", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07164287", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Observational Study,Treatment-Resistant Depression,Safety", "study_type": "Observational Study", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:34", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07164287", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07164287", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07164287", "source_url": "https://clinicaltrials.gov/study/NCT07164287", "doi": "", "pmid": "", "publication_date": "2025-10-01", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 454, "title": "Single-dose psilocybin rapidly and sustainably relieves allodynia and anxiodepressive-like behaviors in mouse models of chronic pain", "authors": "Ahmad Hammo, Stephen Wisser, Joseph Cichon", "journal": "Nature Neuroscience", "publication_date": "2025-10-01", "publication_year": 2025, "doi": "10.1038/s41593-025-02068-0", "pubmed_id": "41039182", "openalex_id": "https://openalex.org/W4414747399", "source_url": "https://doi.org/10.1038/s41593-025-02068-0", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Chronic Pain,Brain Imaging,Pharmacology,Mechanism of Action,Receptor Pharmacology,Default Mode Network,Aging,Animal Study", "study_type": "Animal Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "PMID:41039182", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1038/s41593-025-02068-0", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41039182", "source_url": "https://doi.org/10.1038/s41593-025-02068-0", "doi": "10.1038/s41593-025-02068-0", "pmid": "41039182", "publication_date": "2025-10-01", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4283, "title": "3642 Down the rabbit hole: case reports of a hallucinogen-induced disorder of neuroperception", "authors": "Anneliese McConnell, Wei He, Harry McConnell, Sandro Sprendei, Paul F. Sowman", "journal": null, "publication_date": "2025-09-30", "publication_year": 2025, "doi": "10.1136/bmjno-2025-anzan.170", "pubmed_id": null, "openalex_id": "https://openalex.org/W4415496150", "source_url": "https://doi.org/10.1136/bmjno-2025-anzan.170", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Receptor Pharmacology,Microdosing,Clinical Trial,Systematic Review,Review Article,Case Report,Treatment-Resistant Depression", "study_type": "Systematic Review", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:38", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "DOI:10.1136/bmjno-2025-anzan.170", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1136/bmjno-2025-anzan.170", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1136/bmjno-2025-anzan.170", "source_url": "https://doi.org/10.1136/bmjno-2025-anzan.170", "doi": "10.1136/bmjno-2025-anzan.170", "pmid": "", "publication_date": "2025-09-30", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 498, "title": "Correction to: Incremental efficacy systematic review and meta-analysis of psilocybin-for-depression RCTs.", "authors": "Borgogna NC, Owen T, Petrovitch D, Vaughn J, Johnson DAL, Pagano LA, Aita SL, Hill BD.", "journal": null, "publication_date": "2025-09-30", "publication_year": 2025, "doi": "10.1007/s00213-025-06818-7", "pubmed_id": "40381005", "openalex_id": null, "source_url": "https://doi.org/10.1007/s00213-025-06818-7", "substance_tags": "psilocybin", "topic_tags": "Depression,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:03", "bibtex": null, "source_record_id": "PMID:40381005", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:40381005", "source_url": "https://doi.org/10.1007/s00213-025-06818-7", "doi": "10.1007/s00213-025-06818-7", "pmid": "40381005", "publication_date": "2025-09-30", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 485, "title": "[Role of psychedelics in psychiatry: a true therapeutic revolution or a trend?]", "authors": "Michel Sabé, Federico Seragnoli, Louise Penzenstadler, Gabriel Thorens", "journal": "PubMed", "publication_date": "2025-09-30", "publication_year": 2025, "doi": null, "pubmed_id": "41575100", "openalex_id": "https://openalex.org/W7125566383", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41575100", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,End-of-Life Distress,Consciousness,Clinical Trial,Treatment-Resistant Depression,Safety,Adverse Events,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "PMID:41575100", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41575100", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41575100", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41575100", "doi": "", "pmid": "41575100", "publication_date": "2025-09-30", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 505, "title": "Psilocybin during the postpartum period induces long-lasting adverse effects in both mothers and offspring", "authors": "Cassandra J. Hatzipantelis, Min Liu, A. H. G. Love, Sadie J. Leventhal, Hero Maera, Srinidhi Viswanathan, Emily Avetisyan, Liana Belinsky, McKenna M. Rangel, Nina J. Jain, Max Kelly, C. Copeland, Yara A. Khatib, Oliver Fiehn, David E. Olson, Danielle S. Stolzenberg", "journal": "Nature Communications", "publication_date": "2025-09-29", "publication_year": 2025, "doi": "10.1038/s41467-025-64371-5", "pubmed_id": "41027992", "openalex_id": "https://openalex.org/W4414669838", "source_url": "https://doi.org/10.1038/s41467-025-64371-5", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Pharmacology,Receptor Pharmacology,Animal Study,Safety", "study_type": "Animal Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "PMID:41027992", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1038/s41467-025-64371-5", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41027992", "source_url": "https://doi.org/10.1038/s41467-025-64371-5", "doi": "10.1038/s41467-025-64371-5", "pmid": "41027992", "publication_date": "2025-09-29", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4289, "title": "Novel perspectives for glutamatergic strategies, psychedelics and antipsychotic augmentation in Treatment Resistant Depression: A narrative review", "authors": "Stefania Chiappini, Clara Cavallotto, Andrea Miuli, Giacomo d’Andrea, Alessio Mosca, Carlotta Marrangone, Rita Allegretti, Serena Panichella, Antonio d'Attilio, Giovanna Mammarella, Luca Persico, Alessia Santeusanio, Gianfranco Tamagnini, Mauro Pettorruso, Giovanni Martinotti", "journal": "Clinical Neuropsychopharmacology and Addiction", "publication_date": "2025-09-24", "publication_year": 2025, "doi": "10.53941/cna.2025.100006", "pubmed_id": null, "openalex_id": "https://openalex.org/W4414523550", "source_url": "https://doi.org/10.53941/cna.2025.100006", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Pharmacology,Biomarkers,Aging,Review Article,Animal Study,Treatment-Resistant Depression,Safety,Inflammation", "study_type": "Review Article", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:38", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "DOI:10.53941/cna.2025.100006", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.53941/cna.2025.100006", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.53941/cna.2025.100006", "source_url": "https://doi.org/10.53941/cna.2025.100006", "doi": "10.53941/cna.2025.100006", "pmid": "", "publication_date": "2025-09-24", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3588, "title": "Observational Pilot Study to Explore the Social and Health Impacts of a New Model of Care in Oregon: Psilocybin Services on Alcoholism", "authors": "Healing Advocacy Fund", "journal": "ClinicalTrials.gov", "publication_date": "2025-09-23", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07189988", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Wellbeing,Clinical Trial,Observational Study,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07189988", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07189988", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07189988", "source_url": "https://clinicaltrials.gov/study/NCT07189988", "doi": "", "pmid": "", "publication_date": "2025-09-23", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4290, "title": "With great power comes great responsibility: Promise and caution in the new psychedelic renaissance", "authors": "Matthew Halma, R. Levy, Joseph Varón", "journal": "Brain Disorders", "publication_date": "2025-09-22", "publication_year": 2025, "doi": "10.1016/j.dscb.2025.100286", "pubmed_id": null, "openalex_id": "https://openalex.org/W4414440106", "source_url": "https://doi.org/10.1016/j.dscb.2025.100286", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Consciousness,Aging,Clinical Trial,Review Article,Treatment-Resistant Depression,Healthcare Workers,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:38", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "DOI:10.1016/j.dscb.2025.100286", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1016/j.dscb.2025.100286", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.dscb.2025.100286", "source_url": "https://doi.org/10.1016/j.dscb.2025.100286", "doi": "10.1016/j.dscb.2025.100286", "pmid": "", "publication_date": "2025-09-22", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 484, "title": "Psilocybin-assisted psychotherapy in adults with depression - A literature review.", "authors": "Dorczok MC, Mittmann G, Ettl T, Steiner-Hofbauer V.", "journal": null, "publication_date": "2025-09-22", "publication_year": 2025, "doi": "10.1016/j.pnpbp.2025.111508", "pubmed_id": "40998282", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.pnpbp.2025.111508", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Review Article,Treatment-Resistant Depression", "study_type": "Review Article", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:00", "bibtex": null, "source_record_id": "PMID:40998282", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.pnpbp.2025.111508", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:40998282", "source_url": "https://doi.org/10.1016/j.pnpbp.2025.111508", "doi": "10.1016/j.pnpbp.2025.111508", "pmid": "40998282", "publication_date": "2025-09-22", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 453, "title": "Considerations and cautions for the integration of psilocybin into routine clinical care: a consensus statement from the US National Network of Depression Centers' Task Group on Psychedelics and Related Compounds.", "authors": "Hosein MM, Reid MJ, Walser S, Charney S, Fonzo GA, Lewis BR, Yaden DB, Suppes T, Cordner ZA, Barrett FS.", "journal": null, "publication_date": "2025-09-22", "publication_year": 2025, "doi": "10.1016/j.eclinm.2025.103517", "pubmed_id": "41048658", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.eclinm.2025.103517", "substance_tags": "psilocybin", "topic_tags": "Depression,Safety", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:00", "bibtex": null, "source_record_id": "PMID:41048658", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.eclinm.2025.103517", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:41048658", "source_url": "https://doi.org/10.1016/j.eclinm.2025.103517", "doi": "10.1016/j.eclinm.2025.103517", "pmid": "41048658", "publication_date": "2025-09-22", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 311, "title": "Compassionate use of psilocybin for treatment-resistant depression in Germany", "authors": "Gerhard Gründer, Lea J. Mertens, Andrea Jungaberle, Henrik Jungaberle, Moritz Spangemacher", "journal": "The Lancet Psychiatry", "publication_date": "2025-09-22", "publication_year": 2025, "doi": "10.1016/s2215-0366(25)00277-9", "pubmed_id": "40976246", "openalex_id": "https://openalex.org/W4414422524", "source_url": "https://doi.org/10.1016/s2215-0366(25)00277-9", "substance_tags": "psilocybin", "topic_tags": "Depression,Treatment-Resistant Depression", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "PMID:40976246", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:40976246", "source_url": "https://doi.org/10.1016/s2215-0366(25)00277-9", "doi": "10.1016/s2215-0366(25)00277-9", "pmid": "40976246", "publication_date": "2025-09-22", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 149, "title": "High dose of psilocybin induces acute behavioral changes without inducing conditioned place preference in Sprague-Dawley rats", "authors": "Vítor Bruno, Martha López-Canul, Brandon Richardson, Rosana Camarini, Tânia Marcourakis, Gabriella Gobbi", "journal": "Journal of Psychopharmacology", "publication_date": "2025-09-21", "publication_year": 2025, "doi": "10.1177/02698811251368361", "pubmed_id": "40984017", "openalex_id": "https://openalex.org/W4414414148", "source_url": "https://doi.org/10.1177/02698811251368361", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Chronic Pain,Pharmacology,Animal Study,Toxicity", "study_type": "Animal Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "PMID:40984017", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1177/02698811251368361", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:40984017", "source_url": "https://doi.org/10.1177/02698811251368361", "doi": "10.1177/02698811251368361", "pmid": "40984017", "publication_date": "2025-09-21", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 509, "title": "Psilocybin-assisted psychotherapy for methamphetamine use disorder: A pilot open-label safety and feasibility study", "authors": "Elizabeth Knock, Krista J. Siefried, Gillinder Bedi, Steven M. Albert, Richard O. Day, Nadine Ezard, Margaret Ross, Paul Liknaitzky, Jonathan Brett", "journal": "Addiction", "publication_date": "2025-09-19", "publication_year": 2025, "doi": "10.1111/add.70187", "pubmed_id": "40974259", "openalex_id": "https://openalex.org/W4414374510", "source_url": "https://doi.org/10.1111/add.70187", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Chronic Pain,Headache / Migraine,Clinical Trial,Randomized Controlled Trial,Safety,Adverse Events,Toxicity", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "PMID:40974259", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1111/add.70187", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:40974259", "source_url": "https://doi.org/10.1111/add.70187", "doi": "10.1111/add.70187", "pmid": "40974259", "publication_date": "2025-09-19", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4292, "title": "S1 Appendix - Psilocybin-assisted group psychotherapy and mindfulness-based stress reduction for frontline healthcare provider COVID-19-related depression and burnout: A randomized controlled trial", "authors": "Benjamin R. Lewis (22279166), John Hendrick (22279169), Kevin Byrne (1610821), Madeleine Odette (22279172), Chaorong Wu (8444343), Eric L. Garland (4666660)", "journal": "Figshare", "publication_date": "2025-09-18", "publication_year": 2025, "doi": "10.1371/journal.pmed.1004519.s001", "pubmed_id": null, "openalex_id": "https://openalex.org/W7110952270", "source_url": "https://figshare.com/articles/journal_contribution/S1_Appendix_-_Psilocybin-assisted_group_psychotherapy_and_mindfulness-based_stress_reduction_for_frontline_healthcare_provider_COVID-19-related_depression_and_burnout_A_randomized_controlled_trial/30170132", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Chronic Pain,Clinical Trial,Randomized Controlled Trial,Drug Interactions", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:39", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "DOI:10.1371/journal.pmed.1004519.s001", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://figshare.com/articles/journal_contribution/S1_Appendix_-_Psilocybin-assisted_group_psychotherapy_and_mindfulness-based_stress_reduction_for_frontline_healthcare_provider_COVID-19-related_depression_and_burnout_A_randomized_controlled_trial/30170132", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1371/journal.pmed.1004519.s001", "source_url": "https://figshare.com/articles/journal_contribution/S1_Appendix_-_Psilocybin-assisted_group_psychotherapy_and_mindfulness-based_stress_reduction_for_frontline_healthcare_provider_COVID-19-related_depression_and_burnout_A_randomized_controlled_trial/30170132", "doi": "10.1371/journal.pmed.1004519.s001", "pmid": "", "publication_date": "2025-09-18", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 513, "title": "Reappraisal of the hype and hope offered by psilocybin treatment of depression.", "authors": "Beaglehole B, Manuel J.", "journal": null, "publication_date": "2025-09-18", "publication_year": 2025, "doi": "10.26635/6965.7138", "pubmed_id": "40966702", "openalex_id": null, "source_url": "https://doi.org/10.26635/6965.7138", "substance_tags": "psilocybin", "topic_tags": "Depression,Review Article,Treatment-Resistant Depression,Safety,Adverse Events", "study_type": "Review Article", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:00", "bibtex": null, "source_record_id": "PMID:40966702", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.26635/6965.7138", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:40966702", "source_url": "https://doi.org/10.26635/6965.7138", "doi": "10.26635/6965.7138", "pmid": "40966702", "publication_date": "2025-09-18", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 512, "title": "Psilocybin-assisted group psychotherapy and mindfulness-based stress reduction for frontline healthcare provider COVID-19-related depression and burnout: A randomized controlled trial", "authors": "Benjamin R. Lewis, John Hendrick, Kevin Byrne, Madeleine Odette, Chaorong Wu, Eric L. Garland", "journal": "PLoS Medicine", "publication_date": "2025-09-18", "publication_year": 2025, "doi": "10.1371/journal.pmed.1004519", "pubmed_id": "40972137", "openalex_id": "https://openalex.org/W4414366251", "source_url": "https://doi.org/10.1371/journal.pmed.1004519", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Clinical Trial,Randomized Controlled Trial,Observational Study,Healthcare Workers,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "PMID:40972137", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1371/journal.pmed.1004519", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:40972137", "source_url": "https://doi.org/10.1371/journal.pmed.1004519", "doi": "10.1371/journal.pmed.1004519", "pmid": "40972137", "publication_date": "2025-09-18", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4293, "title": "Efficacy of Psychedelics Therapy Across Psychiatric Disorders: An Umbrella Review of Meta-Analyses", "authors": "Lopez, Alissa A, Salloum, Ihsan, Lopez-Alvarenga, Juan C", "journal": "ScholarWorks @ UTRGV (The University of Texas Rio Grande Valley)", "publication_date": "2025-09-16", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": "https://openalex.org/W7110568410", "source_url": "https://scholarworks.utrgv.edu/colloquium/2025/talks/1", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Clinical Trial,Meta-Analysis,Systematic Review,Review Article,Toxicity", "study_type": "Meta-Analysis", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:39", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "https://scholarworks.utrgv.edu/colloquium/2025/talks/1", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://scholarworks.utrgv.edu/colloquium/2025/talks/1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "https://scholarworks.utrgv.edu/colloquium/2025/talks/1", "source_url": "https://scholarworks.utrgv.edu/colloquium/2025/talks/1", "doi": "", "pmid": "", "publication_date": "2025-09-16", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 515, "title": "Preliminary validation and refinement of the psychedelic aesthetic experience questionnaire", "authors": "Jake F. Hooper, Jarrod M. Ellingson, Kent E. Hutchison", "journal": "Frontiers in Psychology", "publication_date": "2025-09-14", "publication_year": 2025, "doi": "10.3389/fpsyg.2025.1648968", "pubmed_id": "41030347", "openalex_id": "https://openalex.org/W4414189000", "source_url": "https://doi.org/10.3389/fpsyg.2025.1648968", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Chronic Pain,Consciousness,Emotional Processing,Observational Study", "study_type": "Observational Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "PMID:41030347", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.3389/fpsyg.2025.1648968", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41030347", "source_url": "https://doi.org/10.3389/fpsyg.2025.1648968", "doi": "10.3389/fpsyg.2025.1648968", "pmid": "41030347", "publication_date": "2025-09-14", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 456, "title": "Emerging mechanisms of psilocybin-induced neuroplasticity.", "authors": "Sonda S, Pendin D, Comai S, De Martin S, Manfredi P, Mattarei A.", "journal": null, "publication_date": "2025-09-14", "publication_year": 2025, "doi": "10.1016/j.tips.2025.08.012", "pubmed_id": "40957728", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.tips.2025.08.012", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Review Article,Safety", "study_type": "Review Article", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:00", "bibtex": null, "source_record_id": "PMID:40957728", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.tips.2025.08.012", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:40957728", "source_url": "https://doi.org/10.1016/j.tips.2025.08.012", "doi": "10.1016/j.tips.2025.08.012", "pmid": "40957728", "publication_date": "2025-09-14", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 326, "title": "Temporal dynamics in neuroimaging as correlates of therapeutic response to psilocybin in major depressive disorder: A systematic review and critical appraisal.", "authors": "Sabbah SG, Li S, Wong S, Le GH, Badulescu S, Hawco C, Rosenblat JD, McIntyre RS.", "journal": null, "publication_date": "2025-09-14", "publication_year": 2025, "doi": "10.1016/j.jad.2025.120335", "pubmed_id": "40962065", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.jad.2025.120335", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging,Mechanism of Action,Default Mode Network,Aging,Systematic Review,Review Article,Treatment-Resistant Depression,Safety", "study_type": "Systematic Review", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:01", "bibtex": null, "source_record_id": "PMID:40962065", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.jad.2025.120335", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:40962065", "source_url": "https://doi.org/10.1016/j.jad.2025.120335", "doi": "10.1016/j.jad.2025.120335", "pmid": "40962065", "publication_date": "2025-09-14", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 5626, "title": "Serotonin 5-HT2C Receptor SignalingAnalysis Reveals Psychedelic Biased Agonism", "authors": "Emma M. Bonniwell (14267047), Rana Alabdali (22241286), Joseph J. Hennessey (22241289), John L. McKee (22179170), Natalie G. Cavalco (20388684), Josie C. Lammers (22241292), Ethan J. Moore (22241295), Luca Franchini (10578054), Cesare Orlandi (204175), John D. McCorvy (1416910)", "journal": "Figshare", "publication_date": "2025-09-12", "publication_year": 2025, "doi": "10.1021/acschemneuro.5c00647.s001", "pubmed_id": null, "openalex_id": "https://openalex.org/W7111383702", "source_url": "https://figshare.com/articles/journal_contribution/Serotonin_5_HT_sub_2C_sub_Receptor_Signaling_Analysis_Reveals_Psychedelic_Biased_Agonism/30120024", "substance_tags": "psilocin", "topic_tags": "Depression,Pharmacology,Mechanism of Action,Receptor Pharmacology,Safety", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:52:10", "last_checked": "2026-07-04 06:52:10", "bibtex": null, "source_record_id": "DOI:10.1021/acschemneuro.5c00647.s001", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://figshare.com/articles/journal_contribution/Serotonin_5_HT_sub_2C_sub_Receptor_Signaling_Analysis_Reveals_Psychedelic_Biased_Agonism/30120024", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1021/acschemneuro.5c00647.s001", "source_url": "https://figshare.com/articles/journal_contribution/Serotonin_5_HT_sub_2C_sub_Receptor_Signaling_Analysis_Reveals_Psychedelic_Biased_Agonism/30120024", "doi": "10.1021/acschemneuro.5c00647.s001", "pmid": "", "publication_date": "2025-09-12", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 488, "title": "Serotonin 5-HT2C Receptor Signaling Analysis Reveals Psychedelic Biased Agonism.", "authors": "Bonniwell EM, Alabdali R, Hennessey JJ, McKee JL, Cavalco NG, Lammers JC, Moore EJ, Franchini L, Orlandi C, McCorvy JD.", "journal": null, "publication_date": "2025-09-12", "publication_year": 2025, "doi": "10.1021/acschemneuro.5c00647", "pubmed_id": "40944639", "openalex_id": "https://openalex.org/W4414162276", "source_url": "https://doi.org/10.1021/acschemneuro.5c00647", "substance_tags": "psilocin", "topic_tags": "Depression,Mechanism of Action,Receptor Pharmacology,Safety", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:03", "bibtex": null, "source_record_id": "PMID:40944639", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1021/acschemneuro.5c00647", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:40944639", "source_url": "https://doi.org/10.1021/acschemneuro.5c00647", "doi": "10.1021/acschemneuro.5c00647", "pmid": "40944639", "publication_date": "2025-09-12", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 489, "title": "Concomitant use of antidepressants and classic psychedelics: A scoping review.", "authors": "Tap SC, Thomas K, Páleníček T, Stenbæk DS, Oliveira-Maia AJ, van Dalfsen JH, Schoevers RA.", "journal": null, "publication_date": "2025-09-11", "publication_year": 2025, "doi": "10.1177/02698811251368360", "pubmed_id": "40937732", "openalex_id": null, "source_url": "https://doi.org/10.1177/02698811251368360", "substance_tags": "psilocybin", "topic_tags": "Depression,Receptor Pharmacology,Review Article,Safety", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:04", "bibtex": null, "source_record_id": "PMID:40937732", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1177/02698811251368360", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:40937732", "source_url": "https://doi.org/10.1177/02698811251368360", "doi": "10.1177/02698811251368360", "pmid": "40937732", "publication_date": "2025-09-11", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 518, "title": "Correction: Therapeutic and legal aspects of psilocybin in cancer-related depression.", "authors": "Wierzbicka M, Kopczyk R, Gerlach A, Rymaszewska J.", "journal": null, "publication_date": "2025-09-10", "publication_year": 2025, "doi": "10.3389/fpsyt.2025.1698185", "pubmed_id": "41019591", "openalex_id": null, "source_url": "https://doi.org/10.3389/fpsyt.2025.1698185", "substance_tags": "psilocybin", "topic_tags": "Depression,Cancer Patients", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:02", "bibtex": null, "source_record_id": "PMID:41019591", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.3389/fpsyt.2025.1698185", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:41019591", "source_url": "https://doi.org/10.3389/fpsyt.2025.1698185", "doi": "10.3389/fpsyt.2025.1698185", "pmid": "41019591", "publication_date": "2025-09-10", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 476, "title": "Psilocybin Enhances Cued Fear Extinction and Extinction Recall in Stress-Naïve, Acutely Stressed, and Chronically Stressed Mice", "authors": "John A. Razidlo, Noelle Cataldo, Cody J. Wenthur", "journal": "ACS Pharmacology & Translational Science", "publication_date": "2025-09-10", "publication_year": 2025, "doi": "10.1021/acsptsci.5c00462", "pubmed_id": "41244305", "openalex_id": "https://openalex.org/W4414130775", "source_url": "https://doi.org/10.1021/acsptsci.5c00462", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Animal Study", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "PMID:41244305", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1021/acsptsci.5c00462", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41244305", "source_url": "https://doi.org/10.1021/acsptsci.5c00462", "doi": "10.1021/acsptsci.5c00462", "pmid": "41244305", "publication_date": "2025-09-10", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3699, "title": "Measurement of Serum Cytokine Levels in Samples Collected as Part of a Clinical Trial of Psilocybin for Treatment-resistant Depression.", "authors": "King's College London", "journal": "ClinicalTrials.gov", "publication_date": "2025-09-09", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07164755", "substance_tags": "psilocybin", "topic_tags": "Depression,Receptor Pharmacology,Biomarkers,Clinical Trial,Animal Study,In Vitro Study,Treatment-Resistant Depression,Safety,Inflammation,Immune Function", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:34", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07164755", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07164755", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07164755", "source_url": "https://clinicaltrials.gov/study/NCT07164755", "doi": "", "pmid": "", "publication_date": "2025-09-09", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3562, "title": "Processing Intergenerational Trauma With Psilocybin-Assisted Therapy", "authors": "Rachel Yehuda", "journal": "ClinicalTrials.gov", "publication_date": "2025-09-07", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06899165", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Biomarkers,Wellbeing,Resilience,Healthcare Workers,Safety", "study_type": "Other", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06899165", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06899165", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06899165", "source_url": "https://clinicaltrials.gov/study/NCT06899165", "doi": "", "pmid": "", "publication_date": "2025-09-07", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 521, "title": "Effect of psilocybin therapy on suicidal ideation, attempts, and deaths in people with psychiatric diagnoses: a systematic review and meta-analysis.", "authors": "Wong S, Meckling G, Fabiano N, Lee S, Jones BDM, Shorr R, Dargel A, Davis AK, Fiedorowicz JG, Solmi M, Rosenblat JD, Mulsant BH, Blumberger DM, Husain MI.", "journal": null, "publication_date": "2025-09-06", "publication_year": 2025, "doi": "10.1177/20451253251372449", "pubmed_id": "40933784", "openalex_id": null, "source_url": "https://doi.org/10.1177/20451253251372449", "substance_tags": "psilocybin", "topic_tags": "Depression,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Treatment-Resistant Depression,Safety", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:00", "bibtex": null, "source_record_id": "PMID:40933784", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1177/20451253251372449", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:40933784", "source_url": "https://doi.org/10.1177/20451253251372449", "doi": "10.1177/20451253251372449", "pmid": "40933784", "publication_date": "2025-09-06", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4297, "title": "Five-year outcomes of psilocybin-assisted therapy for Major Depressive Disorder", "authors": "Alan K. Davis, Meghan DellaCrosse, Nathan D. Sepeda, Adam W. Levin, Mary P Cosimano, Hillary Shaub, Washington Taylor, Peter M. Gooch, Shoval Gilead, Skylar J. Gaughan, Stacey B. Armstrong, Frederick S. Barrett", "journal": "Journal of Psychedelic Studies", "publication_date": "2025-09-03", "publication_year": 2025, "doi": "10.1556/2054.2025.00461", "pubmed_id": null, "openalex_id": "https://openalex.org/W4413975912", "source_url": "https://doi.org/10.1556/2054.2025.00461", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Mechanism of Action,Emotional Processing,Randomized Controlled Trial,Healthcare Workers,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:39", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "DOI:10.1556/2054.2025.00461", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1556/2054.2025.00461", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1556/2054.2025.00461", "source_url": "https://doi.org/10.1556/2054.2025.00461", "doi": "10.1556/2054.2025.00461", "pmid": "", "publication_date": "2025-09-03", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 524, "title": "Therapeutic Use of Psilocybin in Depression: a Systematic Review of Clinical Evidence.", "authors": "Andrade FRT, Buchborn T, Thalheimer G, Meinhardt MW, Joca S, de Almeida RMM.", "journal": null, "publication_date": "2025-09-02", "publication_year": 2025, "doi": "10.1017/neu.2025.10039", "pubmed_id": "40899152", "openalex_id": null, "source_url": "https://doi.org/10.1017/neu.2025.10039", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Headache / Migraine,Mechanism of Action,Receptor Pharmacology,Randomized Controlled Trial,Systematic Review,Review Article,Treatment-Resistant Depression,Safety", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:00", "bibtex": null, "source_record_id": "PMID:40899152", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1017/neu.2025.10039", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:40899152", "source_url": "https://doi.org/10.1017/neu.2025.10039", "doi": "10.1017/neu.2025.10039", "pmid": "40899152", "publication_date": "2025-09-02", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 522, "title": "Psychedelics and mental health: reimagining care through science, insight, and compassion", "authors": "Georgios Mikellides, Marios Kyriazis", "journal": "Frontiers in Pharmacology", "publication_date": "2025-09-02", "publication_year": 2025, "doi": "10.3389/fphar.2025.1649929", "pubmed_id": "40969944", "openalex_id": "https://openalex.org/W4413961399", "source_url": "https://doi.org/10.3389/fphar.2025.1649929", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,OCD,End-of-Life Distress,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Default Mode Network,Consciousness,Aging,Wellbeing,Emotional Processing,Spirituality,Mystical Experience,Clinical Trial,Randomized Controlled Trial,Review Article,Treatment-Resistant Depression,Safety,Adverse Events,Toxicity", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "PMID:40969944", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.3389/fphar.2025.1649929", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:40969944", "source_url": "https://doi.org/10.3389/fphar.2025.1649929", "doi": "10.3389/fphar.2025.1649929", "pmid": "40969944", "publication_date": "2025-09-02", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4302, "title": "Therapeutic Effects of Psychedelics and their Non-Hallucinogenic Analogs on Depressive-Like Behaviour", "authors": "Kaylee Reid, Daniel Kot, Argel Aguilar-Valles", "journal": "Carleton undergraduate journal of science.", "publication_date": "2025-09-01", "publication_year": 2025, "doi": "10.22215/cujs.v5i1.5286", "pubmed_id": null, "openalex_id": "https://openalex.org/W4413920645", "source_url": "https://doi.org/10.22215/cujs.v5i1.5286", "substance_tags": "psilocybin", "topic_tags": "Depression,Neuroplasticity,Receptor Pharmacology,Animal Study,Treatment-Resistant Depression", "study_type": "Animal Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:39", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "DOI:10.22215/cujs.v5i1.5286", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.22215/cujs.v5i1.5286", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.22215/cujs.v5i1.5286", "source_url": "https://doi.org/10.22215/cujs.v5i1.5286", "doi": "10.22215/cujs.v5i1.5286", "pmid": "", "publication_date": "2025-09-01", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4300, "title": "Gregor Hasler: Three Guiding Questions - How do psychedelics shape the brain? How can they heal psychiatric disorders such as depression and PTSD? How can we ensure their safe and responsible use?", "authors": "Gregor Hasler", "journal": "Psychedelics.", "publication_date": "2025-09-01", "publication_year": 2025, "doi": "10.61373/pp025k.0032", "pubmed_id": null, "openalex_id": "https://openalex.org/W4413911705", "source_url": "https://doi.org/10.61373/pp025k.0032", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Addiction,Neuroplasticity,Pharmacology,Mechanism of Action,Biomarkers,Safety,Genomics", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:39", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "DOI:10.61373/pp025k.0032", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.61373/pp025k.0032", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.61373/pp025k.0032", "source_url": "https://doi.org/10.61373/pp025k.0032", "doi": "10.61373/pp025k.0032", "pmid": "", "publication_date": "2025-09-01", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4298, "title": "Neuroplasticity and Neuro-Generation: The Promise of Psychedelics in Dementia Care", "authors": "Kerem Kemal Soylemez, Emma Marie de Boo, Aysil Susuzlu, Joanne Lusher", "journal": "Psychoactives", "publication_date": "2025-09-01", "publication_year": 2025, "doi": "10.3390/psychoactives4030031", "pubmed_id": null, "openalex_id": "https://openalex.org/W4413908189", "source_url": "https://doi.org/10.3390/psychoactives4030031", "substance_tags": "psilocybin", "topic_tags": "Depression,Neuroplasticity,Receptor Pharmacology,Wellbeing,Resilience,Emotional Processing,Review Article,Safety,Inflammation", "study_type": "Review Article", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:39", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "DOI:10.3390/psychoactives4030031", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.3390/psychoactives4030031", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.3390/psychoactives4030031", "source_url": "https://doi.org/10.3390/psychoactives4030031", "doi": "10.3390/psychoactives4030031", "pmid": "", "publication_date": "2025-09-01", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3571, "title": "Effect of Psilocybin Only and Psilocybin Assisted Cognitive Behavioral Therapy in the Management of Major Depressive Disorder and Associated Metabolic, Immune, Inflammatory, Neuroplasticity and Electrical Activity Markers: a Randomized Controlled Trial", "authors": "Khyber Medical University Peshawar", "journal": "ClinicalTrials.gov", "publication_date": "2025-09-01", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06746441", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Neuroplasticity,Brain Imaging,Biomarkers,Clinical Trial,Randomized Controlled Trial,Inflammation,Immune Function", "study_type": "Randomized Controlled Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06746441", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06746441", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06746441", "source_url": "https://clinicaltrials.gov/study/NCT06746441", "doi": "", "pmid": "", "publication_date": "2025-09-01", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4308, "title": "We may know why psilocybin helps treat mental health conditions", "authors": "Chris Simms", "journal": "The New Scientist", "publication_date": "2025-08-31", "publication_year": 2025, "doi": "10.1016/s0262-4079(25)01446-0", "pubmed_id": null, "openalex_id": "https://openalex.org/W4414149661", "source_url": "https://doi.org/10.1016/s0262-4079(25)01446-0", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:39", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "DOI:10.1016/s0262-4079(25)01446-0", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/s0262-4079(25)01446-0", "source_url": "https://doi.org/10.1016/s0262-4079(25)01446-0", "doi": "10.1016/s0262-4079(25)01446-0", "pmid": "", "publication_date": "2025-08-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4305, "title": "Psilocybin-Assisted Psychotherapy for Chronic Somatoform Pain Disorder: A Case Report", "authors": "M Mercier, Cédric Mabilais, Vasileios Chytas, Leonice Furtado, Federico Seragnoli, Albert Buchard, Tatiana Aboulafia Brakha, Gabriel Thorens, Daniele Zullino, Louise Penzenstadler", "journal": "Psychoactives", "publication_date": "2025-08-31", "publication_year": 2025, "doi": "10.3390/psychoactives4030030", "pubmed_id": null, "openalex_id": "https://openalex.org/W4413893315", "source_url": "https://doi.org/10.3390/psychoactives4030030", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Chronic Pain,Mechanism of Action,Case Report,Safety", "study_type": "Case Report", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:39", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "DOI:10.3390/psychoactives4030030", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.3390/psychoactives4030030", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.3390/psychoactives4030030", "source_url": "https://doi.org/10.3390/psychoactives4030030", "doi": "10.3390/psychoactives4030030", "pmid": "", "publication_date": "2025-08-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4304, "title": "PSYCHEDELICS IN PSYCHIATRY - OVERVIEW OF PSILOCYBIN RESEARCH", "authors": "Anna Blazhkova, Magdalena Czaja, Hanna Sitka, Sven Solisch, Anna Susłow, Ewa Szczęsna", "journal": "International Journal of Innovative Technologies in Social Science", "publication_date": "2025-08-31", "publication_year": 2025, "doi": "10.31435/ijitss.3(47).2025.3650", "pubmed_id": null, "openalex_id": "https://openalex.org/W4413888032", "source_url": "https://doi.org/10.31435/ijitss.3(47).2025.3650", "substance_tags": "psilocybin", "topic_tags": "Depression,Eating Disorders,Neuroplasticity,Mechanism of Action,Clinical Trial,Randomized Controlled Trial", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:39", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "DOI:10.31435/ijitss.3(47).2025.3650", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.31435/ijitss.3(47).2025.3650", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.31435/ijitss.3(47).2025.3650", "source_url": "https://doi.org/10.31435/ijitss.3(47).2025.3650", "doi": "10.31435/ijitss.3(47).2025.3650", "pmid": "", "publication_date": "2025-08-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4303, "title": "A lexicon for psychedelic research and treatment", "authors": "David Nutt, David Erritzøe, Anne Katrin Schlag, David Luke, Deborah C. Mash, Hiroyuki Uchida, Jacob S. Aday, James Rucker, Liliana Galindo, Mark Sweeney, Matthew X. Lowe, Oliver Davis, Plinio Ferreira, Rayyan Zafar, Robin Carhart-Harris, Tadeusz Hawrot, Joanna C. Neill", "journal": "Drug Science Policy and Law", "publication_date": "2025-08-31", "publication_year": 2025, "doi": "10.1177/20503245251380511", "pubmed_id": null, "openalex_id": "https://openalex.org/W4414407628", "source_url": "https://doi.org/10.1177/20503245251380511", "substance_tags": "psilocybin", "topic_tags": "Depression,Pharmacology,Microdosing,Clinical Trial,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:39", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "DOI:10.1177/20503245251380511", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1177/20503245251380511", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1177/20503245251380511", "source_url": "https://doi.org/10.1177/20503245251380511", "doi": "10.1177/20503245251380511", "pmid": "", "publication_date": "2025-08-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 606, "title": "Biochemical Insights into Diverse Psilocybe Mushrooms and Their Metabolites as Sources of Neuroactive Agents: A Review", "authors": "Sudhakaran G, Chakraborty S, Aung San, Bharti SAK, Csaba V, Valan Arasu M, Namasivayam SKR, Arockiaraj J.", "journal": null, "publication_date": "2025-08-31", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://europepmc.org/article/AGR/IND609227368", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Headache / Migraine,Mechanism of Action,Review Article", "study_type": "Review Article", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:00", "bibtex": null, "source_record_id": "https://europepmc.org/article/AGR/IND609227368", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://europepmc.org/article/AGR/IND609227368", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "https://europepmc.org/article/AGR/IND609227368", "source_url": "https://europepmc.org/article/AGR/IND609227368", "doi": "", "pmid": "", "publication_date": "2025-08-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 483, "title": "Psilocybin with psychotherapeutic support for treatment-resistant depression: a pilot clinical trial", "authors": "Sally Meikle, Olivia Carter, Paul Liknaitzky, Lauren Johansen, Ravi Iyer, Nigel Strauss, M.L. Williams, David Castle, Susan L. Rossell", "journal": "Therapeutic Advances in Psychopharmacology", "publication_date": "2025-08-31", "publication_year": 2025, "doi": "10.1177/20451253251377187", "pubmed_id": "41050149", "openalex_id": "https://openalex.org/W4414745551", "source_url": "https://doi.org/10.1177/20451253251377187", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Spirituality,Clinical Trial,Treatment-Resistant Depression,Safety,Adverse Events,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "PMID:41050149", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1177/20451253251377187", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41050149", "source_url": "https://doi.org/10.1177/20451253251377187", "doi": "10.1177/20451253251377187", "pmid": "41050149", "publication_date": "2025-08-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 557, "title": "Psilocybin-assisted therapy for treatment-resistant depression in the US: a model-based cost-effectiveness analysis", "authors": "Anton L.V. Avanceña, Linh N. Vuong, James G. Kahn, Elliot Marseille", "journal": "Translational Psychiatry", "publication_date": "2025-08-28", "publication_year": 2025, "doi": "10.1038/s41398-025-03556-4", "pubmed_id": "40883271", "openalex_id": "https://openalex.org/W4413817374", "source_url": "https://doi.org/10.1038/s41398-025-03556-4", "substance_tags": "psilocybin", "topic_tags": "Depression,Receptor Pharmacology,Treatment-Resistant Depression,Safety", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "PMID:40883271", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1038/s41398-025-03556-4", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:40883271", "source_url": "https://doi.org/10.1038/s41398-025-03556-4", "doi": "10.1038/s41398-025-03556-4", "pmid": "40883271", "publication_date": "2025-08-28", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 361, "title": "Investigating the safety and tolerability of single-dose psilocybin for post-traumatic stress disorder: A nonrandomized open-label clinical trial", "authors": "Niall M. McGowan, James Rucker, Rachel Yehuda, Manish Agrawal, Nadav Liam Modlin, Hollie Simmons, Agata Tofil-Kaluza, Shriya Das, Guy M. Goodwin", "journal": "Journal of Psychopharmacology", "publication_date": "2025-08-28", "publication_year": 2025, "doi": "10.1177/02698811251362390", "pubmed_id": "40883964", "openalex_id": "https://openalex.org/W4413839750", "source_url": "https://doi.org/10.1177/02698811251362390", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Chronic Pain,Headache / Migraine,Pharmacology,Clinical Trial,Treatment-Resistant Depression,Healthcare Workers,Safety,Adverse Events,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "PMID:40883964", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1177/02698811251362390", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:40883964", "source_url": "https://doi.org/10.1177/02698811251362390", "doi": "10.1177/02698811251362390", "pmid": "40883964", "publication_date": "2025-08-28", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 558, "title": "Overview and Specificity of Psilocybin Use in the Treatment of Mental Disorders: A Scientometric Analysis.", "authors": "Fernandes-Nascimento MH, Viana-Ferreira K, Negrão AB.", "journal": null, "publication_date": "2025-08-27", "publication_year": 2025, "doi": "10.1089/psymed.2024.0031", "pubmed_id": "40933206", "openalex_id": null, "source_url": "https://doi.org/10.1089/psymed.2024.0031", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Clinical Trial", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:00", "bibtex": null, "source_record_id": "PMID:40933206", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1089/psymed.2024.0031", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:40933206", "source_url": "https://doi.org/10.1089/psymed.2024.0031", "doi": "10.1089/psymed.2024.0031", "pmid": "40933206", "publication_date": "2025-08-27", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3192, "title": "Psilocybin: Systematic review of its use in the treatment of depression", "authors": "Andres-Olivera P, de la Iglesia J, Dominguez-Alvarez E, Soto’Gonzalez P, Rodriguez C, Munaiz-Cossio C, Gonzalez-Bolaños R, Brito-Rey R, Marín-Lorenzo C, Arribas-Simon B.", "journal": null, "publication_date": "2025-08-25", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://europepmc.org/article/PMC/PMC12436869", "substance_tags": "psilocybin", "topic_tags": "Depression,Systematic Review,Review Article", "study_type": "Systematic Review", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 11:03:48", "last_checked": "2026-07-01 11:22:02", "bibtex": null, "source_record_id": "https://europepmc.org/article/PMC/PMC12436869", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "https://europepmc.org/article/PMC/PMC12436869", "source_url": "https://europepmc.org/article/PMC/PMC12436869", "doi": "", "pmid": "", "publication_date": "2025-08-25", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4314, "title": "“To Have the Encounter with Our Own Finiteness in that Existential Way”: Descriptions of Existential Experience in Patients with Cancer and Major Depression Participating in Psilocybin-Assisted Group Therapy", "authors": "Elise C. Tarbi, Skye A. Miner, Kabir Nigam, Zachary Sager, Justin J. Sanders, Michael Ljuslin, Benjamin Guérin, Kimberly Roddy, James A. Tulsky, Manish Agrawal, Yvan Beaussant", "journal": "Psychedelic Medicine", "publication_date": "2025-08-24", "publication_year": 2025, "doi": "10.1177/28314425251370303", "pubmed_id": null, "openalex_id": "https://openalex.org/W4414955208", "source_url": "https://doi.org/10.1177/28314425251370303", "substance_tags": "psilocybin", "topic_tags": "Depression,Spirituality,Clinical Trial,Cancer Patients,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:39", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "DOI:10.1177/28314425251370303", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1177/28314425251370303", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1177/28314425251370303", "source_url": "https://doi.org/10.1177/28314425251370303", "doi": "10.1177/28314425251370303", "pmid": "", "publication_date": "2025-08-24", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 416, "title": "Above the threshold, beyond the trip: the role of the 5-HT2A receptor in psychedelic-induced neuroplasticity and antidepressant effects.", "authors": "Drewko AJ, Habets RLP, Brunt TM.", "journal": null, "publication_date": "2025-08-22", "publication_year": 2025, "doi": "10.1038/s41380-025-03169-9", "pubmed_id": "40849544", "openalex_id": null, "source_url": "https://doi.org/10.1038/s41380-025-03169-9", "substance_tags": "psilocybin", "topic_tags": "Depression,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Review Article,Treatment-Resistant Depression", "study_type": "Review Article", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:03", "bibtex": null, "source_record_id": "PMID:40849544", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1038/s41380-025-03169-9", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:40849544", "source_url": "https://doi.org/10.1038/s41380-025-03169-9", "doi": "10.1038/s41380-025-03169-9", "pmid": "40849544", "publication_date": "2025-08-22", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 560, "title": "Psychedelic Therapy, Positive Emotional Experiences, and the Central Role of Self-Compassion", "authors": "Zeifman R, Danias G, Agin-Liebes G, Pagni B, Kettner H, Bhat V, Ross S, Erritzoe D, Carhart-Harris R.", "journal": "Research Square", "publication_date": "2025-08-21", "publication_year": 2025, "doi": "10.21203/rs.3.rs-7420529/v1", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.21203/rs.3.rs-7420529/v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Emotional Processing,Mystical Experience,Clinical Trial,Observational Study", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "preprint", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:01", "bibtex": null, "source_record_id": "DOI:10.21203/rs.3.rs-7420529/v1", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.21203/rs.3.rs-7420529/v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "DOI:10.21203/rs.3.rs-7420529/v1", "source_url": "https://doi.org/10.21203/rs.3.rs-7420529/v1", "doi": "10.21203/rs.3.rs-7420529/v1", "pmid": "", "publication_date": "2025-08-21", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 430, "title": "Chronic psilocybin administration increases sociability and alters the gut microbiome in male wild-type mice but not in a preclinical model of obsessive-compulsive disorder", "authors": "James J Gattuso, Geraldine Kong, Bilgenur Bezcioglu, Da Lu, Millicent N. Ekwudo, Carey Wilson, Carolina Gubert, Anthony J. Hannan, Thibault Renoir", "journal": "Neuropharmacology", "publication_date": "2025-08-20", "publication_year": 2025, "doi": "10.1016/j.neuropharm.2025.110648", "pubmed_id": "40849086", "openalex_id": "https://openalex.org/W4413389430", "source_url": "https://doi.org/10.1016/j.neuropharm.2025.110648", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,OCD,Mechanism of Action,Receptor Pharmacology,Animal Study,Microbiome", "study_type": "Animal Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "PMID:40849086", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1016/j.neuropharm.2025.110648", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:40849086", "source_url": "https://doi.org/10.1016/j.neuropharm.2025.110648", "doi": "10.1016/j.neuropharm.2025.110648", "pmid": "40849086", "publication_date": "2025-08-20", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3557, "title": "Effect of Psilocybin on the Positive Valence System in Treatment-resistant Depression: a Pilot Clinical Neuroimaging Study", "authors": "Centre Hospitalier Universitaire de Nīmes", "journal": "ClinicalTrials.gov", "publication_date": "2025-08-19", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06650800", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Brain Imaging,Mechanism of Action,Receptor Pharmacology,Aging,Treatment-Resistant Depression,Safety", "study_type": "Other", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06650800", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06650800", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06650800", "source_url": "https://clinicaltrials.gov/study/NCT06650800", "doi": "", "pmid": "", "publication_date": "2025-08-19", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 459, "title": "Psilocybin-assisted psychotherapy, combined antipsychotic and antidepressant treatment for bipolar depression, duration of birth control pill use and risk of depression, handgrip strength and cognitive function, mood disorders in epilepsy, and mental health issues among physicians.", "authors": "Koenig HG.", "journal": null, "publication_date": "2025-08-19", "publication_year": 2025, "doi": "10.1177/00912174251369880", "pubmed_id": "40833259", "openalex_id": null, "source_url": "https://doi.org/10.1177/00912174251369880", "substance_tags": "psilocybin", "topic_tags": "Depression,Safety", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:04", "bibtex": null, "source_record_id": "PMID:40833259", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:40833259", "source_url": "https://doi.org/10.1177/00912174251369880", "doi": "10.1177/00912174251369880", "pmid": "40833259", "publication_date": "2025-08-19", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3466, "title": "A Phase II, Multicentre, Randomised, Double-blind, Controlled Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of COMP360 in Participants With Recurrent Major Depressive Disorder", "authors": "COMPASS Pathways", "journal": "ClinicalTrials.gov", "publication_date": "2025-08-18", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05733546", "substance_tags": "psilocybin", "topic_tags": "Depression,Pharmacology,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05733546", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05733546", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05733546", "source_url": "https://clinicaltrials.gov/study/NCT05733546", "doi": "", "pmid": "", "publication_date": "2025-08-18", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 563, "title": "Exploring the Therapeutic Potential of Ketamine and Psilocybin in Comparison to Current Treatment Regimens for Treatment-Resistant Depression, Mood Disorders, and Post-traumatic Stress Disorder in the Pediatric Population: A Narrative Review.", "authors": "Hughes B, Mirza S, Ponamala M, Sagaser J, Paredes R, Hematillake N, Tailor C, Khan R, Pemminati S.", "journal": null, "publication_date": "2025-08-17", "publication_year": 2025, "doi": "10.7759/cureus.90425", "pubmed_id": "40970030", "openalex_id": null, "source_url": "https://doi.org/10.7759/cureus.90425", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Emotional Processing,Meta-Analysis,Systematic Review,Review Article,Adolescents,Treatment-Resistant Depression", "study_type": "Meta-Analysis", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:00", "bibtex": null, "source_record_id": "PMID:40970030", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.7759/cureus.90425", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:40970030", "source_url": "https://doi.org/10.7759/cureus.90425", "doi": "10.7759/cureus.90425", "pmid": "40970030", "publication_date": "2025-08-17", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3070, "title": "Psilocybin treatment for symptoms of depression: a living systematic review, meta-analysis, and data resource", "authors": "Singleton SP, Sevchik BL, Lahey A, Cuijpers P, Harrer M, Jones MT, Nayak SM, Strain EC, Vandekar SN, Dworkin RH, Scott JC, Satterthwaite TD.", "journal": "medRxiv", "publication_date": "2025-08-15", "publication_year": 2025, "doi": "10.1101/2025.08.13.25333530", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.1101/2025.08.13.25333530", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Safety", "study_type": "Randomized Controlled Trial", "source_name": "medRxiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:46", "last_checked": "2026-07-01 11:22:00", "bibtex": null, "source_record_id": "DOI:10.1101/2025.08.13.25333530", "abstract_available": true, "abstract_source": "medRxiv", "abstract_source_url": "https://doi.org/10.1101/2025.08.13.25333530", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "medRxiv", "source_record_id": "DOI:10.1101/2025.08.13.25333530", "source_url": "https://doi.org/10.1101/2025.08.13.25333530", "doi": "10.1101/2025.08.13.25333530", "pmid": "", "publication_date": "2025-08-15", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 519, "title": "Therapeutic Divergence in 5-HT2A Agonism: Psilocybin and Phenalkylamines for Demoralization Syndrome.", "authors": "Kargbo RB.", "journal": null, "publication_date": "2025-08-14", "publication_year": 2025, "doi": "10.1021/acsmedchemlett.5c00475", "pubmed_id": "40959252", "openalex_id": null, "source_url": "https://doi.org/10.1021/acsmedchemlett.5c00475", "substance_tags": "psilocybin", "topic_tags": "Depression,Receptor Pharmacology,Safety", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:00", "bibtex": null, "source_record_id": "PMID:40959252", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1021/acsmedchemlett.5c00475", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:40959252", "source_url": "https://doi.org/10.1021/acsmedchemlett.5c00475", "doi": "10.1021/acsmedchemlett.5c00475", "pmid": "40959252", "publication_date": "2025-08-14", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 829, "title": "Hallucinogen-Persisting Perception Disorder in a 16-Year-Old Adolescent", "authors": "Anna Mori-Kreiner, Arpit Aggarwal, Meelie Bordoloi", "journal": "Psychopharmacology Bulletin", "publication_date": "2025-08-11", "publication_year": 2025, "doi": "10.64719/pb.4525", "pubmed_id": "39935673", "openalex_id": "https://openalex.org/W4407426725", "source_url": "https://doi.org/10.64719/pb.4525", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Review Article,Case Report,Adolescents,Toxicity", "study_type": "Review Article", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "PMID:39935673", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.64719/pb.4525", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:39935673", "source_url": "https://doi.org/10.64719/pb.4525", "doi": "10.64719/pb.4525", "pmid": "39935673", "publication_date": "2025-08-11", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 530, "title": "Psilocybin-assisted psychotherapy for depression and anxiety associated with life threatening illness: A phase 2b randomized controlled trial", "authors": "Margaret Ross, Ravi Iyer, M.L. Williams, Mark Boughey, Clare O’Callaghan, Richard Hiscock, Justin Dwyer", "journal": "General Hospital Psychiatry", "publication_date": "2025-08-11", "publication_year": 2025, "doi": "10.1016/j.genhosppsych.2025.08.001", "pubmed_id": "40858059", "openalex_id": "https://openalex.org/W4413190735", "source_url": "https://doi.org/10.1016/j.genhosppsych.2025.08.001", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Chronic Pain,Wellbeing,Spirituality,Mystical Experience,Clinical Trial,Randomized Controlled Trial,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "PMID:40858059", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1016/j.genhosppsych.2025.08.001", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:40858059", "source_url": "https://doi.org/10.1016/j.genhosppsych.2025.08.001", "doi": "10.1016/j.genhosppsych.2025.08.001", "pmid": "40858059", "publication_date": "2025-08-11", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 567, "title": "Psychedelic-Assisted Therapy: Potential Benefits and Challenges in Mental Health Treatment.", "authors": "Silczuk A, Madejek RJ, Koweszko T, Mularczyk-Tomczewska P, Adamska E, Gujski M, Szulc A.", "journal": null, "publication_date": "2025-08-08", "publication_year": 2025, "doi": "10.12659/msm.948302", "pubmed_id": "40781763", "openalex_id": null, "source_url": "https://doi.org/10.12659/msm.948302", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Addiction,OCD,Neuroplasticity,Mechanism of Action,Clinical Trial,Review Article,Safety", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:04", "bibtex": null, "source_record_id": "PMID:40781763", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.12659/msm.948302", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:40781763", "source_url": "https://doi.org/10.12659/msm.948302", "doi": "10.12659/msm.948302", "pmid": "40781763", "publication_date": "2025-08-08", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4317, "title": "The psychedelic renaissance: psilocybin, a breakthrough for treatment resistant depression?", "authors": "Trevor R. Norman", "journal": "Exploration of neuroscience", "publication_date": "2025-08-06", "publication_year": 2025, "doi": "10.37349/en.2025.1006105", "pubmed_id": null, "openalex_id": "https://openalex.org/W4413121359", "source_url": "https://doi.org/10.37349/en.2025.1006105", "substance_tags": "psilocybin", "topic_tags": "Depression,Headache / Migraine,Emotional Processing,Treatment-Resistant Depression,Adverse Events", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:39", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "DOI:10.37349/en.2025.1006105", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.37349/en.2025.1006105", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.37349/en.2025.1006105", "source_url": "https://doi.org/10.37349/en.2025.1006105", "doi": "10.37349/en.2025.1006105", "pmid": "", "publication_date": "2025-08-06", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 571, "title": "Improved mental health outcomes and normalised spontaneous EEG activity in veterans reporting a history of traumatic brain injuries following participation in a psilocybin retreat", "authors": "Grace Blest-Hopley, Giuseppe Pasculli, Simon Ruffell, WaiFung Tsang, Olateju Emmanuel, Kathryn M. Pate, Hannes Kettner, Leor Roseman, David Erritzøe, Robin Carhart-Harris", "journal": "Frontiers in Psychiatry", "publication_date": "2025-08-05", "publication_year": 2025, "doi": "10.3389/fpsyt.2025.1594307", "pubmed_id": "40842948", "openalex_id": "https://openalex.org/W4413002573", "source_url": "https://doi.org/10.3389/fpsyt.2025.1594307", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Neuroplasticity,Brain Imaging,Emotional Processing,Veterans,Toxicity", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "PMID:40842948", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.3389/fpsyt.2025.1594307", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:40842948", "source_url": "https://doi.org/10.3389/fpsyt.2025.1594307", "doi": "10.3389/fpsyt.2025.1594307", "pmid": "40842948", "publication_date": "2025-08-05", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 574, "title": "Neurobiology of psilocybin: a comprehensive overview and comparative analysis of experimental models", "authors": "Dotun Adeleye Adeyinka, Dayna Forsyth, Suzanne Currie, Nicoletta Faraone", "journal": "Frontiers in Systems Neuroscience", "publication_date": "2025-08-04", "publication_year": 2025, "doi": "10.3389/fnsys.2025.1585367", "pubmed_id": "40894380", "openalex_id": "https://openalex.org/W4413969371", "source_url": "https://doi.org/10.3389/fnsys.2025.1585367", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Neuroplasticity,Neurogenesis,Pharmacology,Mechanism of Action,Aging,Animal Study,Safety,Drug Interactions", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "PMID:40894380", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.3389/fnsys.2025.1585367", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:40894380", "source_url": "https://doi.org/10.3389/fnsys.2025.1585367", "doi": "10.3389/fnsys.2025.1585367", "pmid": "40894380", "publication_date": "2025-08-04", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 531, "title": "A dose of therapy with psilocybin - A meta-analysis of the relationship between the amount of therapy hours and treatment outcomes in psychedelic-assisted therapy.", "authors": "Hultgren J, Hafsteinsson MH, Brulin JG.", "journal": null, "publication_date": "2025-08-04", "publication_year": 2025, "doi": "10.1016/j.genhosppsych.2025.07.020", "pubmed_id": "40782561", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.genhosppsych.2025.07.020", "substance_tags": "psilocybin", "topic_tags": "Depression,Meta-Analysis", "study_type": "Meta-Analysis", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:00", "bibtex": null, "source_record_id": "PMID:40782561", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.genhosppsych.2025.07.020", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:40782561", "source_url": "https://doi.org/10.1016/j.genhosppsych.2025.07.020", "doi": "10.1016/j.genhosppsych.2025.07.020", "pmid": "40782561", "publication_date": "2025-08-04", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4319, "title": "Response to emotional stimuli weaker in SSRI users compared with psilocybin", "authors": "", "journal": "The Brown University Psychopharmacology Update", "publication_date": "2025-08-03", "publication_year": 2025, "doi": "10.1002/pu.31349", "pubmed_id": null, "openalex_id": "https://openalex.org/W4412941980", "source_url": "https://doi.org/10.1002/pu.31349", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging,Mechanism of Action,Receptor Pharmacology,Aging,Emotional Processing", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:39", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "DOI:10.1002/pu.31349", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1002/pu.31349", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1002/pu.31349", "source_url": "https://doi.org/10.1002/pu.31349", "doi": "10.1002/pu.31349", "pmid": "", "publication_date": "2025-08-03", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 575, "title": "Therapeutic and legal aspects of psilocybin in cancer-related depression", "authors": "Małgorzata Wierzbicka, Renata Kopczyk, Aleksandra Gerlach, Joanna Rymaszewska", "journal": "Frontiers in Psychiatry", "publication_date": "2025-08-03", "publication_year": 2025, "doi": "10.3389/fpsyt.2025.1591864", "pubmed_id": "40831528", "openalex_id": "https://openalex.org/W4412939048", "source_url": "https://doi.org/10.3389/fpsyt.2025.1591864", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Anxiety,PTSD,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Observational Study,Cancer Patients,Treatment-Resistant Depression", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "PMID:40831528", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.3389/fpsyt.2025.1591864", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:40831528", "source_url": "https://doi.org/10.3389/fpsyt.2025.1591864", "doi": "10.3389/fpsyt.2025.1591864", "pmid": "40831528", "publication_date": "2025-08-03", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4335, "title": "577. CLINICAL EVIDENCE AND APPLICATIONS OF PSYCHEDELICS FOR MENTAL ILLNESSES", "authors": "Hiroe Tani", "journal": "The International Journal of Neuropsychopharmacology", "publication_date": "2025-07-31", "publication_year": 2025, "doi": "10.1093/ijnp/pyaf052.377", "pubmed_id": null, "openalex_id": "https://openalex.org/W4413284846", "source_url": "https://doi.org/10.1093/ijnp/pyaf052.377", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,OCD,End-of-Life Distress,Brain Imaging,Mechanism of Action,Receptor Pharmacology,Aging,Clinical Trial,Review Article,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:39", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "DOI:10.1093/ijnp/pyaf052.377", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1093/ijnp/pyaf052.377", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1093/ijnp/pyaf052.377", "source_url": "https://doi.org/10.1093/ijnp/pyaf052.377", "doi": "10.1093/ijnp/pyaf052.377", "pmid": "", "publication_date": "2025-07-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4333, "title": "544. MOLECULAR AND CELLULAR MECHANISMS OF THE LONG-LASTING EFFECTS OF PSYCHEDELICS AND THEIR NON-HALLUCINOGENIC DERIVATIVES", "authors": "Argel Aguilar-Valles, Dhiral Kot, Victor Lewis, Gianfilippo Coppola", "journal": "The International Journal of Neuropsychopharmacology", "publication_date": "2025-07-31", "publication_year": 2025, "doi": "10.1093/ijnp/pyaf052.363", "pubmed_id": null, "openalex_id": "https://openalex.org/W4413284752", "source_url": "https://doi.org/10.1093/ijnp/pyaf052.363", "substance_tags": "psilocybin", "topic_tags": "Depression,Neuroplasticity,Pharmacology,Mechanism of Action,Receptor Pharmacology,Animal Study,In Vitro Study,Treatment-Resistant Depression,Transcriptomics", "study_type": "Animal Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:39", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "DOI:10.1093/ijnp/pyaf052.363", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1093/ijnp/pyaf052.363", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1093/ijnp/pyaf052.363", "source_url": "https://doi.org/10.1093/ijnp/pyaf052.363", "doi": "10.1093/ijnp/pyaf052.363", "pmid": "", "publication_date": "2025-07-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4322, "title": "670. CAN WE RE-MEDICALISE THE PSYCHEDELIC EXPERIENCE?", "authors": "Guy M. Goodwin", "journal": "The International Journal of Neuropsychopharmacology", "publication_date": "2025-07-31", "publication_year": 2025, "doi": "10.1093/ijnp/pyaf052.159", "pubmed_id": null, "openalex_id": "https://openalex.org/W4413284175", "source_url": "https://doi.org/10.1093/ijnp/pyaf052.159", "substance_tags": "psilocybin", "topic_tags": "Depression,Randomized Controlled Trial,Treatment-Resistant Depression,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:39", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "DOI:10.1093/ijnp/pyaf052.159", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1093/ijnp/pyaf052.159", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1093/ijnp/pyaf052.159", "source_url": "https://doi.org/10.1093/ijnp/pyaf052.159", "doi": "10.1093/ijnp/pyaf052.159", "pmid": "", "publication_date": "2025-07-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3265, "title": "631. PSILOCYBIN AND KETANSERIN VS RTMS IN TREATMENT-RESISTANT DEPRESSION: ENHANCING TOLERABILITY BY MITIGATING PSYCHEDELIC EFFECTS", "authors": "", "journal": null, "publication_date": "2025-07-31", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://europepmc.org/article/PMC/PMC12359594", "substance_tags": "psilocybin", "topic_tags": "Depression,Treatment-Resistant Depression,Safety", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 11:03:49", "last_checked": "2026-07-01 11:22:03", "bibtex": null, "source_record_id": "https://europepmc.org/article/PMC/PMC12359594", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "https://europepmc.org/article/PMC/PMC12359594", "source_url": "https://europepmc.org/article/PMC/PMC12359594", "doi": "", "pmid": "", "publication_date": "2025-07-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3235, "title": "229. PSILOCYBIN WITH PSYCHOTHERAPEUTIC SUPPORT FOR TREATMENT-RESISTANT DEPRESSION: A PILOT CLINICAL TRIAL", "authors": "", "journal": null, "publication_date": "2025-07-31", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://europepmc.org/article/PMC/PMC12359778", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Treatment-Resistant Depression", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 11:03:48", "last_checked": "2026-07-01 11:22:02", "bibtex": null, "source_record_id": "https://europepmc.org/article/PMC/PMC12359778", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "https://europepmc.org/article/PMC/PMC12359778", "source_url": "https://europepmc.org/article/PMC/PMC12359778", "doi": "", "pmid": "", "publication_date": "2025-07-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3213, "title": "597. ARE SIDE EFFECTS NECESSARY FOR ANTIDEPRESSIVE TREATMENT: THE PSILOCYBIN EXPERIENCE", "authors": "", "journal": null, "publication_date": "2025-07-31", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://europepmc.org/article/PMC/PMC12359505", "substance_tags": "psilocybin", "topic_tags": "Depression,Adverse Events", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 11:03:48", "last_checked": "2026-07-01 11:22:02", "bibtex": null, "source_record_id": "https://europepmc.org/article/PMC/PMC12359505", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "https://europepmc.org/article/PMC/PMC12359505", "source_url": "https://europepmc.org/article/PMC/PMC12359505", "doi": "", "pmid": "", "publication_date": "2025-07-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 580, "title": "Psilocybin as Transformative Fast-Acting Antidepressant: Pharmacological Properties and Molecular Mechanisms.", "authors": "Adebo M, Bonnet M, Laouej O, Defaix C, McGowan JC, Butlen-Ducuing F, David DJ, Poupon E, Tritschler L, Gardier AM.", "journal": null, "publication_date": "2025-07-31", "publication_year": 2025, "doi": "10.1111/fcp.70038", "pubmed_id": "40670864", "openalex_id": null, "source_url": "https://doi.org/10.1111/fcp.70038", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Anxiety,Addiction,Neuroplasticity,Pharmacology,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Review Article,Animal Study", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:00", "bibtex": null, "source_record_id": "PMID:40670864", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1111/fcp.70038", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:40670864", "source_url": "https://doi.org/10.1111/fcp.70038", "doi": "10.1111/fcp.70038", "pmid": "40670864", "publication_date": "2025-07-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 579, "title": "Correction to \"Acceptability of psilocybin-assisted group therapy in patients with cancer and major depressive disorder: Qualitative analysis\".", "authors": "", "journal": null, "publication_date": "2025-07-31", "publication_year": 2025, "doi": "10.1002/cncr.70003", "pubmed_id": "40679122", "openalex_id": null, "source_url": "https://doi.org/10.1002/cncr.70003", "substance_tags": "psilocybin", "topic_tags": "Depression", "study_type": "Qualitative Study", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:03", "bibtex": null, "source_record_id": "PMID:40679122", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:40679122", "source_url": "https://doi.org/10.1002/cncr.70003", "doi": "10.1002/cncr.70003", "pmid": "40679122", "publication_date": "2025-07-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4342, "title": "Preparing Social Work for Psychedelic-Assisted Therapy", "authors": "Heidi Allen, B. Stott", "journal": "Social Work", "publication_date": "2025-07-29", "publication_year": 2025, "doi": "10.1093/sw/swaf031", "pubmed_id": "40803340", "openalex_id": "https://openalex.org/W4413116433", "source_url": "https://doi.org/10.1093/sw/swaf031", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Treatment-Resistant Depression", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:39", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "PMID:40803340", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1093/sw/swaf031", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:40803340", "source_url": "https://doi.org/10.1093/sw/swaf031", "doi": "10.1093/sw/swaf031", "pmid": "40803340", "publication_date": "2025-07-29", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4341, "title": "Psilocybin-assisted treatment of depression", "authors": "Barbara Anna Zapalska, Antonina Teresa Witkowska, Anna Cukrowska, Artur Galus", "journal": "Medical Science", "publication_date": "2025-07-29", "publication_year": 2025, "doi": "10.54905/disssi.v29i161.e110ms3657", "pubmed_id": null, "openalex_id": "https://openalex.org/W4412885037", "source_url": "https://doi.org/10.54905/disssi.v29i161.e110ms3657", "substance_tags": "psilocybin", "topic_tags": "Depression,Receptor Pharmacology,Review Article,Treatment-Resistant Depression,Adverse Events", "study_type": "Review Article", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:39", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "DOI:10.54905/disssi.v29i161.e110ms3657", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.54905/disssi.v29i161.e110ms3657", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.54905/disssi.v29i161.e110ms3657", "source_url": "https://doi.org/10.54905/disssi.v29i161.e110ms3657", "doi": "10.54905/disssi.v29i161.e110ms3657", "pmid": "", "publication_date": "2025-07-29", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 73, "title": "Meaning-Centered Psychotherapy for Psilocybin-Assisted Therapy Among Patients with Advanced Cancer and Depression: Rationale and Preliminary Evaluation of MCP-PSIL.", "authors": "Rosa WE, Napolitano S, McAndrew N, Jenkins B, Lichtenthal WG, Applebaum AJ, Breitbart W, Agrawal M.", "journal": null, "publication_date": "2025-07-29", "publication_year": 2025, "doi": "10.1177/28314425251363983", "pubmed_id": "42311441", "openalex_id": null, "source_url": "https://doi.org/10.1177/28314425251363983", "substance_tags": "psilocybin", "topic_tags": "Depression,Aging,Clinical Trial,Observational Study", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-01 11:22:00", "bibtex": null, "source_record_id": "PMID:42311441", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1177/28314425251363983", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:42311441", "source_url": "https://doi.org/10.1177/28314425251363983", "doi": "10.1177/28314425251363983", "pmid": "42311441", "publication_date": "2025-07-29", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 555, "title": "An overview of psilocybin, LSD, MDMA, and ketamine in revitalizing psychedelic-assisted therapy: Insights, limitations and future directions.", "authors": "Askariyan K, Joghataei MT, Dehghan S, Nohesara S, Riahi Pour L, Mohammadi MH, Ahmadirad N.", "journal": null, "publication_date": "2025-07-24", "publication_year": 2025, "doi": "10.1016/j.pnpbp.2025.111461", "pubmed_id": "40716639", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.pnpbp.2025.111461", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Addiction,Mechanism of Action,Receptor Pharmacology,Review Article,Observational Study", "study_type": "Review Article", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:00", "bibtex": null, "source_record_id": "PMID:40716639", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.pnpbp.2025.111461", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:40716639", "source_url": "https://doi.org/10.1016/j.pnpbp.2025.111461", "doi": "10.1016/j.pnpbp.2025.111461", "pmid": "40716639", "publication_date": "2025-07-24", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 602, "title": "Psilocybin in alcohol use disorder and comorbid depressive symptoms: Results from a feasibility randomized clinical trial", "authors": "Amandine Luquiens, Dahbia Belahda, Carine Graux, Noe Igounenc, Chris Serrand, Paul A. Rochefort, Thibault Mura, Felix Sergent", "journal": "Addiction", "publication_date": "2025-07-23", "publication_year": 2025, "doi": "10.1111/add.70152", "pubmed_id": "40702912", "openalex_id": "https://openalex.org/W4412642858", "source_url": "https://doi.org/10.1111/add.70152", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Chronic Pain,Clinical Trial,Randomized Controlled Trial,Safety,Adverse Events,Toxicity", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "PMID:40702912", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1111/add.70152", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:40702912", "source_url": "https://doi.org/10.1111/add.70152", "doi": "10.1111/add.70152", "pmid": "40702912", "publication_date": "2025-07-23", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3633, "title": "The Safety, Feasibility, and Acceptability of Psilocybin Combined With Multidisciplinary Palliative Care in Demoralized Cancer Survivors With Chronic Pain (P-PC)", "authors": "Emory University", "journal": "ClinicalTrials.gov", "publication_date": "2025-07-22", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05506982", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Chronic Pain,Mystical Experience,Clinical Trial,Cancer Patients,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:34", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05506982", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05506982", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05506982", "source_url": "https://clinicaltrials.gov/study/NCT05506982", "doi": "", "pmid": "", "publication_date": "2025-07-22", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 604, "title": "“I’ve learned that I’m open-minded to this possibility”: A qualitative study to evaluate the acceptability of a psilocybin-aided smoking cessation treatment for people with HIV who smoke", "authors": "Patricia A. Cioe, Garrett S Stang, Danish Azam, Sarah Dugal", "journal": "Addiction Science & Clinical Practice", "publication_date": "2025-07-20", "publication_year": 2025, "doi": "10.1186/s13722-025-00563-0", "pubmed_id": "40691651", "openalex_id": "https://openalex.org/W4412510542", "source_url": "https://doi.org/10.1186/s13722-025-00563-0", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Safety,Adverse Events,Toxicity", "study_type": "Qualitative Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "PMID:40691651", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1186/s13722-025-00563-0", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:40691651", "source_url": "https://doi.org/10.1186/s13722-025-00563-0", "doi": "10.1186/s13722-025-00563-0", "pmid": "40691651", "publication_date": "2025-07-20", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3581, "title": "Acceptability & Safety of Two Sequential Doses of Psilocybin in Bipolar Disorder II Depression and Suicidality", "authors": "The University of Texas Health Science Center, Houston", "journal": "ClinicalTrials.gov", "publication_date": "2025-07-17", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06706232", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06706232", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06706232", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06706232", "source_url": "https://clinicaltrials.gov/study/NCT06706232", "doi": "", "pmid": "", "publication_date": "2025-07-17", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3071, "title": "Epigenome-wide Association Study of Psilocybin-Induced Methylome Changes in Alcohol Use Disorder", "authors": "Urban MM, Zillich L, Rieser NM, Herdener M, Vollenweider FX, Spanagel R, Preller KH, Meinhardt MW.", "journal": "bioRxiv", "publication_date": "2025-07-17", "publication_year": 2025, "doi": "10.1101/2025.07.18.664368", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.1101/2025.07.18.664368", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Neuroplasticity,Mechanism of Action,Epigenetics,Observational Study,Genomics,Immune Function", "study_type": "Observational Study", "source_name": "bioRxiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:46", "last_checked": "2026-07-01 11:22:00", "bibtex": null, "source_record_id": "DOI:10.1101/2025.07.18.664368", "abstract_available": true, "abstract_source": "bioRxiv", "abstract_source_url": "https://doi.org/10.1101/2025.07.18.664368", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "bioRxiv", "source_record_id": "DOI:10.1101/2025.07.18.664368", "source_url": "https://doi.org/10.1101/2025.07.18.664368", "doi": "10.1101/2025.07.18.664368", "pmid": "", "publication_date": "2025-07-17", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 493, "title": "The polypharmacology of psychedelics reveals multiple targets for potential therapeutics.", "authors": "Jain MK, Gumpper RH, Slocum ST, Schmitz GP, Madsen JS, Tummino TA, Suomivuori CM, Huang XP, Shub L, DiBerto JF, Kim K, DeLeon C, Krumm BE, Fay JF, Keiser M, Hauser AS, Dror RO, Shoichet B, Gloriam DE, Nichols DE, Roth BL.", "journal": null, "publication_date": "2025-07-17", "publication_year": 2025, "doi": "10.1016/j.neuron.2025.06.012", "pubmed_id": "40683247", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.neuron.2025.06.012", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Headache / Migraine,Pharmacology,Receptor Pharmacology", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:03", "bibtex": null, "source_record_id": "PMID:40683247", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.neuron.2025.06.012", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:40683247", "source_url": "https://doi.org/10.1016/j.neuron.2025.06.012", "doi": "10.1016/j.neuron.2025.06.012", "pmid": "40683247", "publication_date": "2025-07-17", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 395, "title": "Mapping psilocybin therapy: A systematic review of therapeutic frameworks, adaptations, and standardization across contemporary clinical trials.", "authors": "Kittur ME, Burgos M LA, Jones BDM, Blumberger DM, Mulsant BH, Rosenblat JD, Husain MI.", "journal": null, "publication_date": "2025-07-17", "publication_year": 2025, "doi": "10.1016/j.jad.2025.119952", "pubmed_id": "40684956", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.jad.2025.119952", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,OCD,Eating Disorders,Mechanism of Action,Clinical Trial,Systematic Review,Review Article,Treatment-Resistant Depression", "study_type": "Systematic Review", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:00", "bibtex": null, "source_record_id": "PMID:40684956", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.jad.2025.119952", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:40684956", "source_url": "https://doi.org/10.1016/j.jad.2025.119952", "doi": "10.1016/j.jad.2025.119952", "pmid": "40684956", "publication_date": "2025-07-17", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 568, "title": "The Causal Role of Consciousness in Psychedelic Therapy for Treatment-Resistant Depression: Hypothesis and Proposal", "authors": "Tobías Fernández-Borkel, Lucas F. Borkel, Jaime Rojas-Hernández, Elisa Hernández-Álvarez, Domingo Jesús Quintana Hernández, Ludovica G. Ponti, Luis Alberto Henríquez-Hernández", "journal": "ACS Pharmacology & Translational Science", "publication_date": "2025-07-15", "publication_year": 2025, "doi": "10.1021/acsptsci.5c00445", "pubmed_id": "40894333", "openalex_id": "https://openalex.org/W4412475877", "source_url": "https://doi.org/10.1021/acsptsci.5c00445", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Brain Imaging,Receptor Pharmacology,Consciousness,Randomized Controlled Trial,Treatment-Resistant Depression", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "PMID:40894333", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1021/acsptsci.5c00445", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:40894333", "source_url": "https://doi.org/10.1021/acsptsci.5c00445", "doi": "10.1021/acsptsci.5c00445", "pmid": "40894333", "publication_date": "2025-07-15", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4345, "title": "Stronger visual surround suppression under psilocybin: A psychophysical and EEG pilot study", "authors": "Michael-Paul Schallmo, Sophia Jungers, Ranji Varghese, Kathryn R. Cullen, Michael D. Evans, Jessica L. Nielson, Link Swanson", "journal": "Journal of Vision", "publication_date": "2025-07-14", "publication_year": 2025, "doi": "10.1167/jov.25.9.2091", "pubmed_id": null, "openalex_id": "https://openalex.org/W4412459077", "source_url": "https://doi.org/10.1167/jov.25.9.2091", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging,Receptor Pharmacology", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:39", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "DOI:10.1167/jov.25.9.2091", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1167/jov.25.9.2091", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1167/jov.25.9.2091", "source_url": "https://doi.org/10.1167/jov.25.9.2091", "doi": "10.1167/jov.25.9.2091", "pmid": "", "publication_date": "2025-07-14", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3097, "title": "Biochemical Insights into Diverse Psilocybe Mushrooms and Their Metabolites as Sources of Neuroactive Agents: A Review.", "authors": "Sudhakaran G, Chakraborty S, Kumar A, Bharti SAK, Csaba V, Valan Arasu M, Namasivayam SKR, Arockiaraj J.", "journal": null, "publication_date": "2025-07-14", "publication_year": 2025, "doi": "10.1007/s00284-025-04379-8", "pubmed_id": "40663181", "openalex_id": null, "source_url": "https://doi.org/10.1007/s00284-025-04379-8", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Headache / Migraine,Mechanism of Action,Review Article", "study_type": "Review Article", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 11:03:46", "last_checked": "2026-07-01 11:22:00", "bibtex": null, "source_record_id": "PMID:40663181", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1007/s00284-025-04379-8", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:40663181", "source_url": "https://doi.org/10.1007/s00284-025-04379-8", "doi": "10.1007/s00284-025-04379-8", "pmid": "40663181", "publication_date": "2025-07-14", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 535, "title": "Attitudes toward psychedelics and psychedelic-assisted psychotherapy among Australian mental healthcare providers", "authors": "Zohaib Nadeem, Stephen Parker, Hugh McGovern, Bianca Sebben, Lena Oestreich", "journal": "Australian & New Zealand Journal of Psychiatry", "publication_date": "2025-07-14", "publication_year": 2025, "doi": "10.1177/00048674251346679", "pubmed_id": "40660894", "openalex_id": "https://openalex.org/W4412418522", "source_url": "https://doi.org/10.1177/00048674251346679", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Chronic Pain,Observational Study,Treatment-Resistant Depression,Healthcare Workers,Safety,Toxicity", "study_type": "Observational Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "PMID:40660894", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1177/00048674251346679", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:40660894", "source_url": "https://doi.org/10.1177/00048674251346679", "doi": "10.1177/00048674251346679", "pmid": "40660894", "publication_date": "2025-07-14", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 603, "title": "Exploring the Frontiers of Psychedelics: A New Chromatographic Method for Detection and Quantification of Psilocybin and Psilocin in Psilocybe cubensis Mushrooms", "authors": "Taynah Pereira Galdino, Lucas Cordeiro de Oliveira, Mateus Araújo da Luz, R.C.A. Barbosa, M. Torres, Kátia Sivieri, Paula A. Fernandes, Márcio Luiz dos Santos, Antônio Gilson Barbosa de Lima, Suédina Maria de Lima Silva, Marcus Vinícius Lia Fook", "journal": "ACS Omega", "publication_date": "2025-07-09", "publication_year": 2025, "doi": "10.1021/acsomega.5c02751", "pubmed_id": "40727727", "openalex_id": "https://openalex.org/W4412138274", "source_url": "https://doi.org/10.1021/acsomega.5c02751", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Anxiety,Pharmacology", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "PMID:40727727", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1021/acsomega.5c02751", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:40727727", "source_url": "https://doi.org/10.1021/acsomega.5c02751", "doi": "10.1021/acsomega.5c02751", "pmid": "40727727", "publication_date": "2025-07-09", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4347, "title": "The Medial PrefrontalCortex Modulates Psychedelic-likeEffects of Psilocin", "authors": "Miyuan Zhang (21677016), Haojiang Zhai (21677019), Longwei Yang (21677022), Haohong Li (5164970), Xiaohui Wang (19899)", "journal": "Figshare", "publication_date": "2025-07-07", "publication_year": 2025, "doi": "10.1021/acsptsci.5c00324.s001", "pubmed_id": null, "openalex_id": "https://openalex.org/W7111003529", "source_url": "https://figshare.com/articles/journal_contribution/The_Medial_Prefrontal_Cortex_Modulates_Psychedelic-like_Effects_of_Psilocin/29500347", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Animal Study,Safety,Toxicity", "study_type": "Animal Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:39", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "DOI:10.1021/acsptsci.5c00324.s001", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://figshare.com/articles/journal_contribution/The_Medial_Prefrontal_Cortex_Modulates_Psychedelic-like_Effects_of_Psilocin/29500347", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1021/acsptsci.5c00324.s001", "source_url": "https://figshare.com/articles/journal_contribution/The_Medial_Prefrontal_Cortex_Modulates_Psychedelic-like_Effects_of_Psilocin/29500347", "doi": "10.1021/acsptsci.5c00324.s001", "pmid": "", "publication_date": "2025-07-07", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 569, "title": "The Medial Prefrontal Cortex Modulates Psychedelic-like Effects of Psilocin", "authors": "Miyuan Zhang, Haiyan Zhai, Longwei Yang, Haohong Li, Xiaohui Wang", "journal": "ACS Pharmacology & Translational Science", "publication_date": "2025-07-07", "publication_year": 2025, "doi": "10.1021/acsptsci.5c00324", "pubmed_id": "40810162", "openalex_id": "https://openalex.org/W4412100010", "source_url": "https://doi.org/10.1021/acsptsci.5c00324", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Mechanism of Action,Receptor Pharmacology,Animal Study,Safety", "study_type": "Animal Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "PMID:40810162", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1021/acsptsci.5c00324", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:40810162", "source_url": "https://doi.org/10.1021/acsptsci.5c00324", "doi": "10.1021/acsptsci.5c00324", "pmid": "40810162", "publication_date": "2025-07-07", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 461, "title": "Unraveling the policies, legislations, and regulations of psychedelics in Australia, Canada, Netherlands, New Zealand, and India.", "authors": "Joga R, Yerram S, Patnam JD, Choudhary KK, Varpe P, Raghuvanshi RS, Srivastava S.", "journal": null, "publication_date": "2025-07-07", "publication_year": 2025, "doi": "10.1016/j.healthpol.2025.105392", "pubmed_id": "40694950", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.healthpol.2025.105392", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Clinical Trial,Review Article,Treatment-Resistant Depression,Adverse Events", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:04", "bibtex": null, "source_record_id": "PMID:40694950", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.healthpol.2025.105392", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:40694950", "source_url": "https://doi.org/10.1016/j.healthpol.2025.105392", "doi": "10.1016/j.healthpol.2025.105392", "pmid": "40694950", "publication_date": "2025-07-07", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3745, "title": "An open-label, dose-escalation trial of psilocybin-assisted therapy for bipolar 2 depression", "authors": "Szigeti B.", "journal": "PsyArXiv", "publication_date": "2025-07-06", "publication_year": 2025, "doi": "10.31234/osf.io/97cqx_v1", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.31234/osf.io/97cqx_v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Headache / Migraine,Safety,Adverse Events", "study_type": "Other", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:10:18", "last_checked": "2026-07-01 11:22:00", "bibtex": null, "source_record_id": "DOI:10.31234/osf.io/97cqx_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://doi.org/10.31234/osf.io/97cqx_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "DOI:10.31234/osf.io/97cqx_v1", "source_url": "https://doi.org/10.31234/osf.io/97cqx_v1", "doi": "10.31234/osf.io/97cqx_v1", "pmid": "", "publication_date": "2025-07-06", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3072, "title": "An open-label, dose-escalation trial of psilocybin-assisted therapy for bipolar 2 depression", "authors": "", "journal": "PsyArXiv", "publication_date": "2025-07-06", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://osf.io/preprints/psyarxiv/97cqx_v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Headache / Migraine,Safety,Adverse Events", "study_type": "Other", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:46", "last_checked": "2026-07-01 11:22:30", "bibtex": null, "source_record_id": "https://osf.io/preprints/psyarxiv/97cqx_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/97cqx_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "https://osf.io/preprints/psyarxiv/97cqx_v1", "source_url": "https://osf.io/preprints/psyarxiv/97cqx_v1", "doi": "", "pmid": "", "publication_date": "2025-07-06", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 496, "title": "The therapeutic potential of psilocybin beyond psychedelia through shared mechanisms with ketamine.", "authors": "Park D, Lee G, Lee WG, Kim B, Lee Y, Kim JW.", "journal": null, "publication_date": "2025-07-06", "publication_year": 2025, "doi": "10.1038/s41380-025-03100-2", "pubmed_id": "40624295", "openalex_id": null, "source_url": "https://doi.org/10.1038/s41380-025-03100-2", "substance_tags": "psilocybin", "topic_tags": "Depression,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Review Article,Animal Study", "study_type": "Review Article", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:00", "bibtex": null, "source_record_id": "PMID:40624295", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1038/s41380-025-03100-2", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:40624295", "source_url": "https://doi.org/10.1038/s41380-025-03100-2", "doi": "10.1038/s41380-025-03100-2", "pmid": "40624295", "publication_date": "2025-07-06", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4348, "title": "Explore the effect of psilocybin on depression and anxiety", "authors": "Yutong Song", "journal": "Arts Culture and Language", "publication_date": "2025-07-05", "publication_year": 2025, "doi": "10.61173/rcg8me57", "pubmed_id": null, "openalex_id": "https://openalex.org/W4412054280", "source_url": "https://doi.org/10.61173/rcg8me57", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,End-of-Life Distress,Headache / Migraine,Wellbeing,Spirituality,Safety", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:39", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "DOI:10.61173/rcg8me57", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.61173/rcg8me57", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.61173/rcg8me57", "source_url": "https://doi.org/10.61173/rcg8me57", "doi": "10.61173/rcg8me57", "pmid": "", "publication_date": "2025-07-05", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 615, "title": "Exploring Jordanian Physicians’ and Medical Students’ Perspectives on Ketamine and Psychedelic-Assisted Therapies: An Insight from the Middle East", "authors": "Khalid Ahmed, Dima Abu Nasrieh, Haneen A. Banihani, Mohammed Fadi Obaidat, Toni Mazzawi, Azzah Khalid Al-Tarawneh, Radwan Bani Mustafa, Zaid Al Kayed", "journal": "Journal of Psychoactive Drugs", "publication_date": "2025-07-05", "publication_year": 2025, "doi": "10.1080/02791072.2025.2526403", "pubmed_id": "40619866", "openalex_id": "https://openalex.org/W4412097474", "source_url": "https://doi.org/10.1080/02791072.2025.2526403", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Addiction,Observational Study,Safety,Toxicity", "study_type": "Observational Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "PMID:40619866", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1080/02791072.2025.2526403", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:40619866", "source_url": "https://doi.org/10.1080/02791072.2025.2526403", "doi": "10.1080/02791072.2025.2526403", "pmid": "40619866", "publication_date": "2025-07-05", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4350, "title": "Beyond prohibition: A public health analysis of naturalistic psychedelic use", "authors": "Mark Haden, Sarah A. Paschall, Birgitta Woods", "journal": "Journal of Psychedelic Studies", "publication_date": "2025-07-02", "publication_year": 2025, "doi": "10.1556/2054.2025.00450", "pubmed_id": null, "openalex_id": "https://openalex.org/W4411976075", "source_url": "https://doi.org/10.1556/2054.2025.00450", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Chronic Pain,Aging,Wellbeing,Emotional Processing,Spirituality,Psychological Flexibility,Review Article,Older Adults,Adolescents,Safety", "study_type": "Review Article", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:39", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "DOI:10.1556/2054.2025.00450", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1556/2054.2025.00450", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1556/2054.2025.00450", "source_url": "https://doi.org/10.1556/2054.2025.00450", "doi": "10.1556/2054.2025.00450", "pmid": "", "publication_date": "2025-07-02", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3216, "title": "Accurate and Interpretable Prediction of Antidepressant Treatment Response from Receptor-informed Neuroimaging", "authors": "Tolle HM, Luppi AI, Lawn T, Roseman L, Nutt D, Carhart-Harris RL, Mediano PAM.", "journal": "bioRxiv", "publication_date": "2025-07-02", "publication_year": 2025, "doi": "10.1101/2025.07.02.662710", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.1101/2025.07.02.662710", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging,Mechanism of Action,Receptor Pharmacology,Default Mode Network,Biomarkers,Aging,Clinical Trial", "study_type": "Clinical Trial", "source_name": "bioRxiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:48", "last_checked": "2026-07-01 11:22:02", "bibtex": null, "source_record_id": "DOI:10.1101/2025.07.02.662710", "abstract_available": true, "abstract_source": "bioRxiv", "abstract_source_url": "https://doi.org/10.1101/2025.07.02.662710", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "bioRxiv", "source_record_id": "DOI:10.1101/2025.07.02.662710", "source_url": "https://doi.org/10.1101/2025.07.02.662710", "doi": "10.1101/2025.07.02.662710", "pmid": "", "publication_date": "2025-07-02", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 497, "title": "Single-dose (10 mg) psilocybin reduces symptoms in adults with obsessive-compulsive disorder: A pharmacological challenge study", "authors": "Luca Pellegrini, Naomi Fineberg, Sorcha O'Connor, Ana Maria Frota Lisbôa Pereira de Souza, Kate Godfrey, Sara Reed, Joseph Peill, Mairead Healy, Cyrus Rohani-Shukla, Hakjun Lee, Robin Carhart-Harris, Trevor W. Robbins, David Nutt, David Erritzøe", "journal": "Comprehensive Psychiatry", "publication_date": "2025-07-01", "publication_year": 2025, "doi": "10.1016/j.comppsych.2025.152619", "pubmed_id": "40618640", "openalex_id": "https://openalex.org/W4411969620", "source_url": "https://doi.org/10.1016/j.comppsych.2025.152619", "substance_tags": "psilocybin", "topic_tags": "Depression,OCD,Chronic Pain,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Healthcare Workers,Adverse Events,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "PMID:40618640", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1016/j.comppsych.2025.152619", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:40618640", "source_url": "https://doi.org/10.1016/j.comppsych.2025.152619", "doi": "10.1016/j.comppsych.2025.152619", "pmid": "40618640", "publication_date": "2025-07-01", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4353, "title": "Psilocybin bei schwerer behandlungsresistenter Depression", "authors": "", "journal": "Fortschritte der Neurologie · Psychiatrie", "publication_date": "2025-06-30", "publication_year": 2025, "doi": "10.1055/a-2524-6277", "pubmed_id": null, "openalex_id": "https://openalex.org/W4411986809", "source_url": "https://doi.org/10.1055/a-2524-6277", "substance_tags": "psilocybin", "topic_tags": "Depression,Treatment-Resistant Depression", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:39", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "DOI:10.1055/a-2524-6277", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1055/a-2524-6277", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1055/a-2524-6277", "source_url": "https://doi.org/10.1055/a-2524-6277", "doi": "10.1055/a-2524-6277", "pmid": "", "publication_date": "2025-06-30", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 640, "title": "Disentangling the acute subjective effects of classic psychedelics from their enduring therapeutic properties.", "authors": "Atiq MA, Baker MR, Voort JLV, Vargas MV, Choi DS", "journal": "Psychopharmacology", "publication_date": "2025-06-30", "publication_year": 2025, "doi": "10.1007/s00213-024-06599-5", "pubmed_id": "38743110", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/38743110/", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Receptor Pharmacology,Mystical Experience,Clinical Trial,Review Article,Animal Study,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:20:35", "bibtex": null, "source_record_id": "PMID:38743110", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38743110/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38743110", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38743110/", "doi": "10.1007/s00213-024-06599-5", "pmid": "38743110", "publication_date": "2025-06-30", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 625, "title": "Correction: Dissociable effects of psilocybin and escitalopram for depression on processing of musical surprises.", "authors": "Harding R, Singer N, Wall MB, Hendler T, Erritzoe D, Nutt D, Carhart-Harris R, Roseman L.", "journal": null, "publication_date": "2025-06-30", "publication_year": 2025, "doi": "10.1038/s41380-025-03066-1", "pubmed_id": "40481249", "openalex_id": null, "source_url": "https://doi.org/10.1038/s41380-025-03066-1", "substance_tags": "psilocybin", "topic_tags": "Depression", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:03", "bibtex": null, "source_record_id": "PMID:40481249", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:40481249", "source_url": "https://doi.org/10.1038/s41380-025-03066-1", "doi": "10.1038/s41380-025-03066-1", "pmid": "40481249", "publication_date": "2025-06-30", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 623, "title": "Exploring the Therapeutic Effects of Psychedelics Administered to Military Veterans in Naturalistic Retreat Settings", "authors": "Megan Calnan, Grace Blest-Hopley, Chris Busch, Milly Adams, Simon Ruffell, Theodore Piper, Leor Roseman, Hannes Kettner, Robin Carhart-Harris", "journal": "Brain and Behavior", "publication_date": "2025-06-30", "publication_year": 2025, "doi": "10.1002/brb3.70660", "pubmed_id": "40619953", "openalex_id": "https://openalex.org/W4412096805", "source_url": "https://doi.org/10.1002/brb3.70660", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Chronic Pain,Wellbeing,Veterans,Safety,Toxicity", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "PMID:40619953", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1002/brb3.70660", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:40619953", "source_url": "https://doi.org/10.1002/brb3.70660", "doi": "10.1002/brb3.70660", "pmid": "40619953", "publication_date": "2025-06-30", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 618, "title": "Control Group Outcomes in Trials of Psilocybin, SSRIs, or Esketamine for Depression: A Meta-Analysis.", "authors": "Hieronymus F, López E, Werin Sjögren H, Lundberg J.", "journal": null, "publication_date": "2025-06-30", "publication_year": 2025, "doi": "10.1001/jamanetworkopen.2025.24119", "pubmed_id": "40736734", "openalex_id": null, "source_url": "https://doi.org/10.1001/jamanetworkopen.2025.24119", "substance_tags": "psilocybin", "topic_tags": "Depression,Receptor Pharmacology,Clinical Trial,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Treatment-Resistant Depression", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:00", "bibtex": null, "source_record_id": "PMID:40736734", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1001/jamanetworkopen.2025.24119", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:40736734", "source_url": "https://doi.org/10.1001/jamanetworkopen.2025.24119", "doi": "10.1001/jamanetworkopen.2025.24119", "pmid": "40736734", "publication_date": "2025-06-30", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 617, "title": "Synthesis of Psilocin, Psilocybin and 5-MeO-DMT Succinate, All Labelled With Carbon-14 at the Indole 2-Position", "authors": "Rodney D. Brown, Niall M. Hamilton, Connor Mallon, James Stevenson, Michael T. Faley, Robert B. Kargbo, Alexander M. Sherwood, Balasubramaniam Upeandran", "journal": "Journal of Labelled Compounds and Radiopharmaceuticals", "publication_date": "2025-06-30", "publication_year": 2025, "doi": "10.1002/jlcr.4155", "pubmed_id": "40743107", "openalex_id": "https://openalex.org/W4412793773", "source_url": "https://doi.org/10.1002/jlcr.4155", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Anxiety,PTSD,Pharmacology", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "PMID:40743107", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1002/jlcr.4155", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:40743107", "source_url": "https://doi.org/10.1002/jlcr.4155", "doi": "10.1002/jlcr.4155", "pmid": "40743107", "publication_date": "2025-06-30", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 595, "title": "Natural hallucinogens of fungal and animal origin: action and potentialapplications - a narrative review.", "authors": "Ciszowski K, Ziaja A, Niedzielska-Andres E, Pomierny-Chamioło L.", "journal": null, "publication_date": "2025-06-30", "publication_year": 2025, "doi": "10.24425/fmc.2025.156119", "pubmed_id": "41329968", "openalex_id": null, "source_url": "https://doi.org/10.24425/fmc.2025.156119", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Chronic Pain,Pharmacology,Mechanism of Action,Receptor Pharmacology,Systematic Review,Review Article,Animal Study,Treatment-Resistant Depression,Safety,Toxicity,Inflammation", "study_type": "Systematic Review", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:04", "bibtex": null, "source_record_id": "PMID:41329968", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.24425/fmc.2025.156119", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:41329968", "source_url": "https://doi.org/10.24425/fmc.2025.156119", "doi": "10.24425/fmc.2025.156119", "pmid": "41329968", "publication_date": "2025-06-30", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 540, "title": "Examining mystical experiences as a predictor of psilocybin-assisted psychotherapy for treatment-resistant depression", "authors": "Ryan M. Brudner, Erica Kaczmarek, Marc G. Blainey, Christian Schulz, Shakila Meshkat, Zoe Doyle, Orly Lipsitz, Hilary Offman, Rickinder Sethi, Geneva Weiglein, Roger S. McIntyre, Joshua D. Rosenblat", "journal": "Journal of Psychopharmacology", "publication_date": "2025-06-30", "publication_year": 2025, "doi": "10.1177/02698811251346697", "pubmed_id": "40590216", "openalex_id": "https://openalex.org/W4411880520", "source_url": "https://doi.org/10.1177/02698811251346697", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Chronic Pain,Mechanism of Action,Mystical Experience,Treatment-Resistant Depression,Toxicity", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "PMID:40590216", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1177/02698811251346697", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:40590216", "source_url": "https://doi.org/10.1177/02698811251346697", "doi": "10.1177/02698811251346697", "pmid": "40590216", "publication_date": "2025-06-30", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 644, "title": "Psychedelic-Assisted Therapies for Psychosocial Symptoms in Cancer: A Systematic Review and Meta-Analysis.", "authors": "Schuman HDM, Savard C, Mina R, Barkova S, Conradi HSW, Deleemans JM, Carlson LE.", "journal": null, "publication_date": "2025-06-29", "publication_year": 2025, "doi": "10.3390/curroncol32070380", "pubmed_id": "40710191", "openalex_id": null, "source_url": "https://doi.org/10.3390/curroncol32070380", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Cancer Patients,Safety", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:02", "bibtex": null, "source_record_id": "PMID:40710191", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.3390/curroncol32070380", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:40710191", "source_url": "https://doi.org/10.3390/curroncol32070380", "doi": "10.3390/curroncol32070380", "pmid": "40710191", "publication_date": "2025-06-29", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4356, "title": "Increasing the Evaluation and Reporting Rigor of Psychotherapy Interventions in Treatments Involving Psychedelics", "authors": "Mathieu Fradet", "journal": "Psychoactives", "publication_date": "2025-06-28", "publication_year": 2025, "doi": "10.3390/psychoactives4030021", "pubmed_id": null, "openalex_id": "https://openalex.org/W4411824807", "source_url": "https://doi.org/10.3390/psychoactives4030021", "substance_tags": "psilocybin", "topic_tags": "Depression,Receptor Pharmacology,Clinical Trial,Review Article", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:39", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "DOI:10.3390/psychoactives4030021", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.3390/psychoactives4030021", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.3390/psychoactives4030021", "source_url": "https://doi.org/10.3390/psychoactives4030021", "doi": "10.3390/psychoactives4030021", "pmid": "", "publication_date": "2025-06-28", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4358, "title": "Evaluating Psilocybin as a Treatment for Neuropsychiatric Symptoms in Parkinson’s Disease", "authors": "Nayiri Barton", "journal": "Global Journal of Medical Research", "publication_date": "2025-06-27", "publication_year": 2025, "doi": "10.34257/gjmravol25is1pg1", "pubmed_id": null, "openalex_id": "https://openalex.org/W4412955867", "source_url": "https://doi.org/10.34257/gjmravol25is1pg1", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Neuroplasticity,Receptor Pharmacology,Review Article,Safety,Inflammation", "study_type": "Review Article", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:39", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "DOI:10.34257/gjmravol25is1pg1", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.34257/gjmravol25is1pg1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.34257/gjmravol25is1pg1", "source_url": "https://doi.org/10.34257/gjmravol25is1pg1", "doi": "10.34257/gjmravol25is1pg1", "pmid": "", "publication_date": "2025-06-27", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4357, "title": "Exploring the integration of psychedelic-assisted therapy and digital mental health interventions in trauma recovery for underserved adults with high-functioning autism", "authors": "Paul Okugo Imoh, Aderonke Ajiboye, Tahir Kolawole Balogun, Amina Catherine Ijiga, Toyosi Motilola Olola, Emmanuel Oluwasayomi Ahmadu", "journal": "Magna Scientia Advanced Research and Reviews", "publication_date": "2025-06-27", "publication_year": 2025, "doi": "10.30574/msarr.2025.14.1.0079", "pubmed_id": null, "openalex_id": "https://openalex.org/W4411744352", "source_url": "https://doi.org/10.30574/msarr.2025.14.1.0079", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Addiction,Review Article,Treatment-Resistant Depression", "study_type": "Review Article", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:39", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "DOI:10.30574/msarr.2025.14.1.0079", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.30574/msarr.2025.14.1.0079", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.30574/msarr.2025.14.1.0079", "source_url": "https://doi.org/10.30574/msarr.2025.14.1.0079", "doi": "10.30574/msarr.2025.14.1.0079", "pmid": "", "publication_date": "2025-06-27", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 583, "title": "Australia’s psychedelic experiment: reflections from a psychiatrist clinical researcher", "authors": "Adam Bayes", "journal": "Australasian Psychiatry", "publication_date": "2025-06-25", "publication_year": 2025, "doi": "10.1177/10398562251347890", "pubmed_id": "40574457", "openalex_id": "https://openalex.org/W4411736916", "source_url": "https://doi.org/10.1177/10398562251347890", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Treatment-Resistant Depression,Healthcare Workers,Safety", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "PMID:40574457", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1177/10398562251347890", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:40574457", "source_url": "https://doi.org/10.1177/10398562251347890", "doi": "10.1177/10398562251347890", "pmid": "40574457", "publication_date": "2025-06-25", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 648, "title": "Serotonin 5-HT2A receptor expression is chronically decreased in the anterior cerebral cortex of male rats following repetitive low-level blast exposure", "authors": "Rita De Gasperi, Georgina Pérez Garcia, Miguel A. Gama Sosa, Gissel M. Perez, Rania Abutarboush, Usmah Kawoos, Patrick R. Hof, Carolyn W. Zhu, Stephen T. Ahlers, Gregory A. Elder", "journal": "Frontiers in Neurology", "publication_date": "2025-06-24", "publication_year": 2025, "doi": "10.3389/fneur.2025.1594335", "pubmed_id": "40635716", "openalex_id": "https://openalex.org/W4411662399", "source_url": "https://doi.org/10.3389/fneur.2025.1594335", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,PTSD,Receptor Pharmacology,Observational Study,Veterans,Toxicity", "study_type": "Observational Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "PMID:40635716", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.3389/fneur.2025.1594335", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:40635716", "source_url": "https://doi.org/10.3389/fneur.2025.1594335", "doi": "10.3389/fneur.2025.1594335", "pmid": "40635716", "publication_date": "2025-06-24", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 649, "title": "The Clinical Applications of Psilocybin Therapies and Post-COVID Syndrome: A Comprehensive Narrative Review.", "authors": "Mathew A, Dongre R, Kim SH, Turner J, Mathew A, Cherryholmes E, Mehrinfar M, Kamprath S.", "journal": null, "publication_date": "2025-06-23", "publication_year": 2025, "doi": "10.7759/cureus.86659", "pubmed_id": "40718283", "openalex_id": null, "source_url": "https://doi.org/10.7759/cureus.86659", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Wellbeing,Clinical Trial,Review Article,In Vitro Study", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:00", "bibtex": null, "source_record_id": "PMID:40718283", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.7759/cureus.86659", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:40718283", "source_url": "https://doi.org/10.7759/cureus.86659", "doi": "10.7759/cureus.86659", "pmid": "40718283", "publication_date": "2025-06-23", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 585, "title": "Use of Psychedelic Agents in Older Adults with Treatment-Resistant Major Depressive Disorder: What the Evidence Shows.", "authors": "Vinarcsik L, Smoller C, Grossberg G.", "journal": null, "publication_date": "2025-06-23", "publication_year": 2025, "doi": "10.1007/s40266-025-01221-5", "pubmed_id": "40553322", "openalex_id": null, "source_url": "https://doi.org/10.1007/s40266-025-01221-5", "substance_tags": "psilocybin", "topic_tags": "Depression,Receptor Pharmacology,Aging,Review Article,Older Adults,Safety", "study_type": "Review Article", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:04", "bibtex": null, "source_record_id": "PMID:40553322", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1007/s40266-025-01221-5", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:40553322", "source_url": "https://doi.org/10.1007/s40266-025-01221-5", "doi": "10.1007/s40266-025-01221-5", "pmid": "40553322", "publication_date": "2025-06-23", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 650, "title": "Assessing the Attitudes of Dutch Mental Health Care Professionals Toward Psychedelic-Assisted Psychotherapy: A Cross-Sectional Exploratory Study", "authors": "Martijn H.B. Koolen, Annika Wirsching, Erwin Krediet, Michiel van Elk", "journal": "Journal of Psychoactive Drugs", "publication_date": "2025-06-22", "publication_year": 2025, "doi": "10.1080/02791072.2025.2508156", "pubmed_id": "40551401", "openalex_id": "https://openalex.org/W4411571625", "source_url": "https://doi.org/10.1080/02791072.2025.2508156", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Pharmacology,Consciousness,Observational Study,Healthcare Workers,Safety", "study_type": "Observational Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "PMID:40551401", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1080/02791072.2025.2508156", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:40551401", "source_url": "https://doi.org/10.1080/02791072.2025.2508156", "doi": "10.1080/02791072.2025.2508156", "pmid": "40551401", "publication_date": "2025-06-22", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 150, "title": "The Music for Subanesthetic Infusions of Ketamine randomised clinical trial: ketamine as a psychedelic treatment for highly refractory depression", "authors": "Kyle T. Greenway, Nicolas Garel, Lê-Anh Dinh-Williams, Julien Thibault Lévesque, Mendel Kaelen, Vincent Dagenais-Beaulé, Sara de la Salle, David Erritzøe, Karl Looper, Gustavo Turecki, Soham Rej, Stéphane Richard-Devantoy", "journal": "The British Journal of Psychiatry", "publication_date": "2025-06-17", "publication_year": 2025, "doi": "10.1192/bjp.2025.102", "pubmed_id": "40528492", "openalex_id": "https://openalex.org/W4411430663", "source_url": "https://doi.org/10.1192/bjp.2025.102", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Mechanism of Action,Personality Change,Emotional Processing,Mystical Experience,Clinical Trial,Randomized Controlled Trial,Treatment-Resistant Depression,Healthcare Workers,Toxicity", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "PMID:40528492", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1192/bjp.2025.102", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:40528492", "source_url": "https://doi.org/10.1192/bjp.2025.102", "doi": "10.1192/bjp.2025.102", "pmid": "40528492", "publication_date": "2025-06-17", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 654, "title": "Long-term benefits of single-dose psilocybin in depressed patients with cancer", "authors": "Manish Agrawal, Kim Roddy, Betsy Jenkins, Celia Leeks, Ezekiel Emanuel", "journal": "Cancer", "publication_date": "2025-06-14", "publication_year": 2025, "doi": "10.1002/cncr.35889", "pubmed_id": "40518804", "openalex_id": "https://openalex.org/W4411327114", "source_url": "https://doi.org/10.1002/cncr.35889", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Chronic Pain,Clinical Trial,Cancer Patients,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "PMID:40518804", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1002/cncr.35889", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:40518804", "source_url": "https://doi.org/10.1002/cncr.35889", "doi": "10.1002/cncr.35889", "pmid": "40518804", "publication_date": "2025-06-14", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 656, "title": "Evaluation of behavioural and neurochemical effects of psilocybin in mice subjected to chronic unpredictable mild stress", "authors": "Ines Erkizia-Santamaría, Igor Horrillo, Nerea Martínez-Álvarez, Daniel Pérez-Martínez, Guadalupe Rivero, Amaia M. Erdozain, J. Javier Meana, Jorge E. Ortega", "journal": "Translational Psychiatry", "publication_date": "2025-06-13", "publication_year": 2025, "doi": "10.1038/s41398-025-03421-4", "pubmed_id": "40517150", "openalex_id": "https://openalex.org/W4411302754", "source_url": "https://doi.org/10.1038/s41398-025-03421-4", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Animal Study,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "PMID:40517150", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1038/s41398-025-03421-4", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:40517150", "source_url": "https://doi.org/10.1038/s41398-025-03421-4", "doi": "10.1038/s41398-025-03421-4", "pmid": "40517150", "publication_date": "2025-06-13", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4363, "title": "Stephen Ross: Psychedelic-assisted therapies for difficult-to-treat psychiatric and medical disorders", "authors": "Stephen Ross", "journal": "Psychedelics.", "publication_date": "2025-06-09", "publication_year": 2025, "doi": "10.61373/pp025k.0017", "pubmed_id": null, "openalex_id": "https://openalex.org/W4411182514", "source_url": "https://doi.org/10.61373/pp025k.0017", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Chronic Pain,Clinical Trial,Adolescents,Cancer Patients,Genomics,Inflammation", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:39", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "DOI:10.61373/pp025k.0017", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.61373/pp025k.0017", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.61373/pp025k.0017", "source_url": "https://doi.org/10.61373/pp025k.0017", "doi": "10.61373/pp025k.0017", "pmid": "", "publication_date": "2025-06-09", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4362, "title": "Is there mush-room to improve the environmental sustainability of psilocybin production?", "authors": "Luke Lanham, Alistair R. McTaggart, James R. Falconer", "journal": "Journal of CO2 Utilization", "publication_date": "2025-06-09", "publication_year": 2025, "doi": "10.1016/j.jcou.2025.103137", "pubmed_id": null, "openalex_id": "https://openalex.org/W4411163945", "source_url": "https://doi.org/10.1016/j.jcou.2025.103137", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Review Article,Treatment-Resistant Depression", "study_type": "Review Article", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:39", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "DOI:10.1016/j.jcou.2025.103137", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1016/j.jcou.2025.103137", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.jcou.2025.103137", "source_url": "https://doi.org/10.1016/j.jcou.2025.103137", "doi": "10.1016/j.jcou.2025.103137", "pmid": "", "publication_date": "2025-06-09", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 433, "title": "Long-term outcomes of single-dose psilocybin for U.S. military Veterans with severe treatment-resistant depression - 12-month data from an open-label pilot study", "authors": "Sara Ellis, Catherine Bostian, Anna J. Donnelly, Wendy Feng, Katherine Eisen, Melanie Lean, Elizabeth Conlan, Michael J. Ostacher, Scott T. Aaronson, Trisha Suppes", "journal": "Journal of Affective Disorders", "publication_date": "2025-06-08", "publication_year": 2025, "doi": "10.1016/j.jad.2025.119655", "pubmed_id": "40499827", "openalex_id": "https://openalex.org/W4411137642", "source_url": "https://doi.org/10.1016/j.jad.2025.119655", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Clinical Trial,Treatment-Resistant Depression,Veterans,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "PMID:40499827", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:40499827", "source_url": "https://doi.org/10.1016/j.jad.2025.119655", "doi": "10.1016/j.jad.2025.119655", "pmid": "40499827", "publication_date": "2025-06-08", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 663, "title": "Clinical conceptualisation of PTSD in psilocybin treatment: disrupting a pre-determined and over-determined maladaptive interpretive framework.", "authors": "Modlin NL, Williamson V, Maggio C, Stubley J, Kirlic N, Cleare A, Rucker J.", "journal": null, "publication_date": "2025-06-07", "publication_year": 2025, "doi": "10.1177/20451253251342319", "pubmed_id": "40492108", "openalex_id": null, "source_url": "https://doi.org/10.1177/20451253251342319", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Eating Disorders,End-of-Life Distress,Mechanism of Action,Review Article,Treatment-Resistant Depression,Safety", "study_type": "Review Article", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:00", "bibtex": null, "source_record_id": "PMID:40492108", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1177/20451253251342319", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:40492108", "source_url": "https://doi.org/10.1177/20451253251342319", "doi": "10.1177/20451253251342319", "pmid": "40492108", "publication_date": "2025-06-07", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 664, "title": "Enhanced meaning in life following psychedelic use: converging evidence from controlled and naturalistic studies", "authors": "William Roseby, Hannes Kettner, Leor Roseman, Meg J. Spriggs, Taylor Lyons, Joe Peill, Bruna Giribaldi, David Erritzøe, David Nutt, Robin Carhart-Harris", "journal": "Frontiers in Psychology", "publication_date": "2025-06-05", "publication_year": 2025, "doi": "10.3389/fpsyg.2025.1580663", "pubmed_id": "40547590", "openalex_id": "https://openalex.org/W4411107182", "source_url": "https://doi.org/10.3389/fpsyg.2025.1580663", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Mechanism of Action,Wellbeing,Emotional Processing,Mystical Experience,Clinical Trial,Observational Study,Healthy Volunteers,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "PMID:40547590", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.3389/fpsyg.2025.1580663", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:40547590", "source_url": "https://doi.org/10.3389/fpsyg.2025.1580663", "doi": "10.3389/fpsyg.2025.1580663", "pmid": "40547590", "publication_date": "2025-06-05", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 652, "title": "Classic Psychedelics in Pain Modulation: Mechanisms, Clinical Evidence, and Future Perspectives.", "authors": "Czopek A, Jończyk J, Fryc M, Kluzik D, Zagórska A.", "journal": null, "publication_date": "2025-06-05", "publication_year": 2025, "doi": "10.1021/acschemneuro.5c00152", "pubmed_id": "40474592", "openalex_id": null, "source_url": "https://doi.org/10.1021/acschemneuro.5c00152", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Chronic Pain,Headache / Migraine,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Randomized Controlled Trial,Review Article,Animal Study,Safety,Inflammation", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:03", "bibtex": null, "source_record_id": "PMID:40474592", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1021/acschemneuro.5c00152", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:40474592", "source_url": "https://doi.org/10.1021/acschemneuro.5c00152", "doi": "10.1021/acschemneuro.5c00152", "pmid": "40474592", "publication_date": "2025-06-05", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3672, "title": "Low-Income Group Psilocybin Assisted Therapy for Depression: A Feasibility Study", "authors": "Matthew Hicks", "journal": "ClinicalTrials.gov", "publication_date": "2025-06-04", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06372197", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Consciousness,Clinical Trial,Observational Study,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:34", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06372197", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06372197", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06372197", "source_url": "https://clinicaltrials.gov/study/NCT06372197", "doi": "", "pmid": "", "publication_date": "2025-06-04", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3480, "title": "Optimizing Microdosing and Meditation", "authors": "National University of Natural Medicine", "journal": "ClinicalTrials.gov", "publication_date": "2025-06-04", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06560658", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Consciousness,Microdosing,Wellbeing,Clinical Trial,Review Article,Observational Study,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06560658", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06560658", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06560658", "source_url": "https://clinicaltrials.gov/study/NCT06560658", "doi": "", "pmid": "", "publication_date": "2025-06-04", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 462, "title": "Psychedelics in the Treatment of Neurologic and Psychiatric Disorders: Coincidence or a New Point of View.", "authors": "Lashgari NA, Khalaji M, Rana P, Badrabadi F, Rahnama M, Nasoori H, Momeni Roudsari N, Khosravi Nia MM, Shafaroodi H.", "journal": null, "publication_date": "2025-06-03", "publication_year": 2025, "doi": "10.1007/s12035-025-05097-9", "pubmed_id": "40461729", "openalex_id": null, "source_url": "https://doi.org/10.1007/s12035-025-05097-9", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Review Article,Animal Study,In Vitro Study,Inflammation", "study_type": "Review Article", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:02", "bibtex": null, "source_record_id": "PMID:40461729", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1007/s12035-025-05097-9", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:40461729", "source_url": "https://doi.org/10.1007/s12035-025-05097-9", "doi": "10.1007/s12035-025-05097-9", "pmid": "40461729", "publication_date": "2025-06-03", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 541, "title": "Self-inflicted transorbital intracranial foreign body following ingestion of hallucinogenic psilocybin mushrooms", "authors": "Abigail M. Blanton, Pooja Parikh, Scott Zhou, Mohamed Mohamed, Rafael Ufret-Vincenty, Ronald Mancini", "journal": "American Journal of Ophthalmology Case Reports", "publication_date": "2025-06-01", "publication_year": 2025, "doi": "10.1016/j.ajoc.2025.102359", "pubmed_id": "40535325", "openalex_id": "https://openalex.org/W4410946123", "source_url": "https://doi.org/10.1016/j.ajoc.2025.102359", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Case Report,Safety,Toxicity", "study_type": "Case Report", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "PMID:40535325", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1016/j.ajoc.2025.102359", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:40535325", "source_url": "https://doi.org/10.1016/j.ajoc.2025.102359", "doi": "10.1016/j.ajoc.2025.102359", "pmid": "40535325", "publication_date": "2025-06-01", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 685, "title": "Correction to: Unraveling psilocybin's therapeutic potential: behavioral and neuroplasticity insights in Wistar-Kyoto and Wistar male rat models of treatment-resistant depression.", "authors": "Kolasa M, Nikiforuk A, Korlatowicz A, Solich J, Potasiewicz A, Dziedzicka-Wasylewska M, Bugno R, Hogendorf A, Bojarski A, Faron-Górecka A", "journal": "Psychopharmacology", "publication_date": "2025-05-31", "publication_year": 2025, "doi": "10.1007/s00213-024-06654-1", "pubmed_id": "39030424", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/39030424/", "substance_tags": "psilocybin", "topic_tags": "Depression,Neuroplasticity,Animal Study,Treatment-Resistant Depression", "study_type": "Animal Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:20:35", "bibtex": null, "source_record_id": "PMID:39030424", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39030424", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39030424/", "doi": "10.1007/s00213-024-06654-1", "pmid": "39030424", "publication_date": "2025-05-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 671, "title": "There's More Than One Way to Bring Health Back: Divergent Effects of Psilocybin and Escitalopram Treatment on Emotional Brain Function in Depression.", "authors": "Fonzo GA, Doss MK, Nemeroff CB.", "journal": null, "publication_date": "2025-05-31", "publication_year": 2025, "doi": "10.1176/appi.ajp.20250247", "pubmed_id": "40450555", "openalex_id": null, "source_url": "https://doi.org/10.1176/appi.ajp.20250247", "substance_tags": "psilocybin", "topic_tags": "Depression,Emotional Processing", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:04", "bibtex": null, "source_record_id": "PMID:40450555", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:40450555", "source_url": "https://doi.org/10.1176/appi.ajp.20250247", "doi": "10.1176/appi.ajp.20250247", "pmid": "40450555", "publication_date": "2025-05-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 587, "title": "Neurocognitive effects of psilocybin: A systematic and comprehensive review of neuroimaging studies in humans.", "authors": "Berkovitch L, Fauvel B, Preller KH, Gaillard R.", "journal": null, "publication_date": "2025-05-30", "publication_year": 2025, "doi": "10.1016/j.neubiorev.2025.106239", "pubmed_id": "40456393", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.neubiorev.2025.106239", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging,Mechanism of Action,Default Mode Network,Aging,Personality Change,Emotional Processing,Clinical Trial,Systematic Review,Review Article,Healthy Volunteers", "study_type": "Systematic Review", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:00", "bibtex": null, "source_record_id": "PMID:40456393", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.neubiorev.2025.106239", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:40456393", "source_url": "https://doi.org/10.1016/j.neubiorev.2025.106239", "doi": "10.1016/j.neubiorev.2025.106239", "pmid": "40456393", "publication_date": "2025-05-30", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3081, "title": "Converging pathways: shared brain circuitry engaged by monoaminergic antidepressants, ketamine and psilocybin", "authors": "Joseph K, Collins J, Genovese T, Maxwell M, Lieberman JA, Osten P.", "journal": "bioRxiv", "publication_date": "2025-05-29", "publication_year": 2025, "doi": "10.1101/2025.05.26.655791", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.1101/2025.05.26.655791", "substance_tags": "psilocybin", "topic_tags": "Depression,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Biomarkers,Microdosing,Animal Study", "study_type": "Animal Study", "source_name": "bioRxiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:46", "last_checked": "2026-07-01 11:22:00", "bibtex": null, "source_record_id": "DOI:10.1101/2025.05.26.655791", "abstract_available": true, "abstract_source": "bioRxiv", "abstract_source_url": "https://doi.org/10.1101/2025.05.26.655791", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "bioRxiv", "source_record_id": "DOI:10.1101/2025.05.26.655791", "source_url": "https://doi.org/10.1101/2025.05.26.655791", "doi": "10.1101/2025.05.26.655791", "pmid": "", "publication_date": "2025-05-29", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 688, "title": "Patients’ Attitudes Toward Hallucinogenic and Non-Hallucinogenic Psilocybin for Mental Health Treatment", "authors": "Araam Abboud, Clay M. Schiebrel, Ramzi W. Nahhas, Sam Durkin, Kyle Hua, Hannah Redding, Danielle Gainer", "journal": "Journal of Psychoactive Drugs", "publication_date": "2025-05-28", "publication_year": 2025, "doi": "10.1080/02791072.2025.2511752", "pubmed_id": "40443112", "openalex_id": "https://openalex.org/W4410874041", "source_url": "https://doi.org/10.1080/02791072.2025.2511752", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Addiction,Receptor Pharmacology,Personality Change,Observational Study", "study_type": "Observational Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "PMID:40443112", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1080/02791072.2025.2511752", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:40443112", "source_url": "https://doi.org/10.1080/02791072.2025.2511752", "doi": "10.1080/02791072.2025.2511752", "pmid": "40443112", "publication_date": "2025-05-28", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3708, "title": "Role of the Serotonin 2A Receptor in Psilocybin-induced Altered States of Consciousness (PDR-Study)", "authors": "University Hospital, Basel, Switzerland", "journal": "ClinicalTrials.gov", "publication_date": "2025-05-27", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06796361", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Anxiety,Addiction,Receptor Pharmacology,Consciousness,Personality Change,Spirituality,Healthy Volunteers", "study_type": "Other", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:34", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06796361", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06796361", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06796361", "source_url": "https://clinicaltrials.gov/study/NCT06796361", "doi": "", "pmid": "", "publication_date": "2025-05-27", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 365, "title": "Attitudes Toward Psychedelic Treatments by Individuals With Histories of Substance Use or Psychiatric Disorders: A Survey Study", "authors": "Sara Prostko, Alexander Wu, Samuel Maddams, Veronica Szpak, Naomi Rosenblum, Lori M. Hilt, Joji Suzuki", "journal": "Journal of Addiction Medicine", "publication_date": "2025-05-27", "publication_year": 2025, "doi": "10.1097/adm.0000000000001517", "pubmed_id": "40433994", "openalex_id": "https://openalex.org/W4410826214", "source_url": "https://doi.org/10.1097/adm.0000000000001517", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Observational Study,Safety,Toxicity", "study_type": "Observational Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "PMID:40433994", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1097/adm.0000000000001517", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:40433994", "source_url": "https://doi.org/10.1097/adm.0000000000001517", "doi": "10.1097/adm.0000000000001517", "pmid": "40433994", "publication_date": "2025-05-27", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 689, "title": "The Potential Role of Psilocybin in Traumatic Brain Injury Recovery: A Narrative Review.", "authors": "Palmer C, Ferber AT, Greenwald BD.", "journal": null, "publication_date": "2025-05-25", "publication_year": 2025, "doi": "10.3390/brainsci15060572", "pubmed_id": "40563744", "openalex_id": null, "source_url": "https://doi.org/10.3390/brainsci15060572", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Neuroplasticity,Clinical Trial,Review Article,Inflammation", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:00", "bibtex": null, "source_record_id": "PMID:40563744", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.3390/brainsci15060572", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:40563744", "source_url": "https://doi.org/10.3390/brainsci15060572", "doi": "10.3390/brainsci15060572", "pmid": "40563744", "publication_date": "2025-05-25", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 665, "title": "Role of endogenous serotonin in psychedelic-like effects of psilocybin in mice", "authors": "Ines Erkizia-Santamaría, Nerea Martínez-Álvarez, Leyre Salinas-Novoa, J. Javier Meana, Jorge E. Ortega", "journal": "The International Journal of Neuropsychopharmacology", "publication_date": "2025-05-24", "publication_year": 2025, "doi": "10.1093/ijnp/pyaf035", "pubmed_id": "40413648", "openalex_id": "https://openalex.org/W4410718370", "source_url": "https://doi.org/10.1093/ijnp/pyaf035", "substance_tags": "psilocybin", "topic_tags": "Depression,Neuroplasticity,Pharmacology,Mechanism of Action,Receptor Pharmacology,Animal Study,Toxicity,Drug Interactions", "study_type": "Animal Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "PMID:40413648", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1093/ijnp/pyaf035", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:40413648", "source_url": "https://doi.org/10.1093/ijnp/pyaf035", "doi": "10.1093/ijnp/pyaf035", "pmid": "40413648", "publication_date": "2025-05-24", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3642, "title": "An Investigation of Strategies to Understand and Optimize the Antidepressant Effects of Psilocybin (The OPTIMIZE Study)", "authors": "Charles Raison", "journal": "ClinicalTrials.gov", "publication_date": "2025-05-22", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06512194", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Aging,Wellbeing,Adverse Events", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:34", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06512194", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06512194", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06512194", "source_url": "https://clinicaltrials.gov/study/NCT06512194", "doi": "", "pmid": "", "publication_date": "2025-05-22", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3747, "title": "Age and cannabis co-use moderate experience and perceived benefits of psilocybin", "authors": "Hooper J, Williams S, Mueller R, Hutchison K.", "journal": "PsyArXiv", "publication_date": "2025-05-21", "publication_year": 2025, "doi": "10.31234/osf.io/dczw2_v1", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.31234/osf.io/dczw2_v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Mechanism of Action,Aging,Mystical Experience,Older Adults", "study_type": "Other", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:10:18", "last_checked": "2026-07-01 11:22:00", "bibtex": null, "source_record_id": "DOI:10.31234/osf.io/dczw2_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://doi.org/10.31234/osf.io/dczw2_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "DOI:10.31234/osf.io/dczw2_v1", "source_url": "https://doi.org/10.31234/osf.io/dczw2_v1", "doi": "10.31234/osf.io/dczw2_v1", "pmid": "", "publication_date": "2025-05-21", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3090, "title": "Age and cannabis co-use moderate experience and perceived benefits of psilocybin", "authors": "", "journal": "PsyArXiv", "publication_date": "2025-05-21", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://osf.io/preprints/psyarxiv/dczw2_v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Mechanism of Action,Aging,Mystical Experience,Older Adults", "study_type": "Other", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:46", "last_checked": "2026-07-01 11:22:30", "bibtex": null, "source_record_id": "https://osf.io/preprints/psyarxiv/dczw2_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/dczw2_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "https://osf.io/preprints/psyarxiv/dczw2_v1", "source_url": "https://osf.io/preprints/psyarxiv/dczw2_v1", "doi": "", "pmid": "", "publication_date": "2025-05-21", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 588, "title": "Lessons learned from the regulatory alignment in ketamine, esketamine and arketamine clinical trials: A cross-sectional analysis of protocols from ClinicalTrials.gov.", "authors": "Swieczkowski D, Kwaśny A, Sadko K, Pruc M, Gaca Z, Szarpak L, Cubała WJ.", "journal": null, "publication_date": "2025-05-21", "publication_year": 2025, "doi": "10.1016/j.psychres.2025.116559", "pubmed_id": "40440859", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.psychres.2025.116559", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Treatment-Resistant Depression,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:04", "bibtex": null, "source_record_id": "PMID:40440859", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.psychres.2025.116559", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:40440859", "source_url": "https://doi.org/10.1016/j.psychres.2025.116559", "doi": "10.1016/j.psychres.2025.116559", "pmid": "40440859", "publication_date": "2025-05-21", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 696, "title": "Can the gut-brain axis provide insight into psilocybin's therapeutic value in reducing stress?", "authors": "Kit A, Conway K, Makarowski S, O'Regan G, Allen J, Shultz SR, Bodnar TS, Christie BR.", "journal": null, "publication_date": "2025-05-18", "publication_year": 2025, "doi": "10.1016/j.ynstr.2025.100732", "pubmed_id": "40496249", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.ynstr.2025.100732", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,OCD,Mechanism of Action,Review Article,Animal Study,Microbiome,Inflammation", "study_type": "Review Article", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:01", "bibtex": null, "source_record_id": "PMID:40496249", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.ynstr.2025.100732", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:40496249", "source_url": "https://doi.org/10.1016/j.ynstr.2025.100732", "doi": "10.1016/j.ynstr.2025.100732", "pmid": "40496249", "publication_date": "2025-05-18", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3762, "title": "Under Pressure: Stronger depressive symptoms are associated with more positive expectations towards experimental treatments", "authors": "Basedow LA, Lottes L, Falkenberg I, Vogelbacher C, Yildiz C.", "journal": "PsyArXiv", "publication_date": "2025-05-15", "publication_year": 2025, "doi": "10.31234/osf.io/6hjkm_v1", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.31234/osf.io/6hjkm_v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Aging,Observational Study,Healthcare Workers,Safety,Adverse Events", "study_type": "Observational Study", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:10:19", "last_checked": "2026-07-01 11:22:02", "bibtex": null, "source_record_id": "DOI:10.31234/osf.io/6hjkm_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://doi.org/10.31234/osf.io/6hjkm_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "DOI:10.31234/osf.io/6hjkm_v1", "source_url": "https://doi.org/10.31234/osf.io/6hjkm_v1", "doi": "10.31234/osf.io/6hjkm_v1", "pmid": "", "publication_date": "2025-05-15", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3183, "title": "Under Pressure: Stronger depressive symptoms are associated with more positive expectations towards experimental treatments", "authors": "", "journal": "PsyArXiv", "publication_date": "2025-05-15", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://osf.io/preprints/psyarxiv/6hjkm_v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Aging,Observational Study,Healthcare Workers,Safety,Adverse Events", "study_type": "Observational Study", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:47", "last_checked": "2026-07-01 11:22:30", "bibtex": null, "source_record_id": "https://osf.io/preprints/psyarxiv/6hjkm_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/6hjkm_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "https://osf.io/preprints/psyarxiv/6hjkm_v1", "source_url": "https://osf.io/preprints/psyarxiv/6hjkm_v1", "doi": "", "pmid": "", "publication_date": "2025-05-15", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 698, "title": "Aesthetic quality of psychedelic experience is linked to insight and psychological outcomes", "authors": "Jake F. Hooper, Emily Gyongyosi, Kent E. Hutchison, Raeghan L. Mueller", "journal": "Frontiers in Psychology", "publication_date": "2025-05-14", "publication_year": 2025, "doi": "10.3389/fpsyg.2025.1533055", "pubmed_id": "40443723", "openalex_id": "https://openalex.org/W4410417211", "source_url": "https://doi.org/10.3389/fpsyg.2025.1533055", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Chronic Pain,Mechanism of Action,Emotional Processing,Mystical Experience,Observational Study", "study_type": "Observational Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "PMID:40443723", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.3389/fpsyg.2025.1533055", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:40443723", "source_url": "https://doi.org/10.3389/fpsyg.2025.1533055", "doi": "10.3389/fpsyg.2025.1533055", "pmid": "40443723", "publication_date": "2025-05-14", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3694, "title": "Investigating the Role of Serotonin in the Mechanism of Action of Psilocybin in Patients With Major Depressive Disorder", "authors": "Icahn School of Medicine at Mount Sinai", "journal": "ClinicalTrials.gov", "publication_date": "2025-05-13", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06592833", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Receptor Pharmacology", "study_type": "Other", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:34", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06592833", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06592833", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06592833", "source_url": "https://clinicaltrials.gov/study/NCT06592833", "doi": "", "pmid": "", "publication_date": "2025-05-13", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 885, "title": "Serotonergic psychedelics for depression: A comprehensive overview.", "authors": "Wingert AM, Agnorelli C, Peill J, Reed S, Nutt DJ, Erritzoe D.", "journal": null, "publication_date": "2025-05-13", "publication_year": 2025, "doi": "10.1016/bs.irn.2025.04.009", "pubmed_id": "40541312", "openalex_id": null, "source_url": "https://doi.org/10.1016/bs.irn.2025.04.009", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Review Article,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:02", "bibtex": null, "source_record_id": "PMID:40541312", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/bs.irn.2025.04.009", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:40541312", "source_url": "https://doi.org/10.1016/bs.irn.2025.04.009", "doi": "10.1016/bs.irn.2025.04.009", "pmid": "40541312", "publication_date": "2025-05-13", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 674, "title": "The pharmacological treatment of anxiety in people with eating disorders: A systematic review.", "authors": "Morris R, Keeler J, Treasure J, Himmerich H.", "journal": null, "publication_date": "2025-05-13", "publication_year": 2025, "doi": "10.1016/j.phrs.2025.107782", "pubmed_id": "40378942", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.phrs.2025.107782", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Eating Disorders,Randomized Controlled Trial,Systematic Review,Review Article,Case Report,Safety", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:04", "bibtex": null, "source_record_id": "PMID:40378942", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.phrs.2025.107782", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:40378942", "source_url": "https://doi.org/10.1016/j.phrs.2025.107782", "doi": "10.1016/j.phrs.2025.107782", "pmid": "40378942", "publication_date": "2025-05-13", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 630, "title": "The effect of psychedelic microdosing on animal behavior: A review with recommendations for the field.", "authors": "Syed OA, Petranker R, Tsang B.", "journal": null, "publication_date": "2025-05-08", "publication_year": 2025, "doi": "10.1016/j.neubiorev.2025.106204", "pubmed_id": "40348309", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.neubiorev.2025.106204", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,OCD,Microdosing,Wellbeing,Review Article,Animal Study,Safety", "study_type": "Review Article", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:04", "bibtex": null, "source_record_id": "PMID:40348309", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.neubiorev.2025.106204", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:40348309", "source_url": "https://doi.org/10.1016/j.neubiorev.2025.106204", "doi": "10.1016/j.neubiorev.2025.106204", "pmid": "40348309", "publication_date": "2025-05-08", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 629, "title": "Non-hallucinogenic psychedelics for mood and anxiety disorders: A systematic review.", "authors": "Chen MJQ, Chen-Li D, Chisamore N, Husain MI, Di Vincenzo JD, Mansur RB, Phan L, Johnson D, McIntyre RS, Rosenblat JD.", "journal": null, "publication_date": "2025-05-07", "publication_year": 2025, "doi": "10.1016/j.psychres.2025.116532", "pubmed_id": "40354769", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.psychres.2025.116532", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Consciousness,Clinical Trial,Systematic Review,Review Article,Case Report", "study_type": "Systematic Review", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:02", "bibtex": null, "source_record_id": "PMID:40354769", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.psychres.2025.116532", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:40354769", "source_url": "https://doi.org/10.1016/j.psychres.2025.116532", "doi": "10.1016/j.psychres.2025.116532", "pmid": "40354769", "publication_date": "2025-05-07", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4374, "title": "Psychedelic-assisted psychotherapy and its potential to manage demoralization: A brief exploration of an alternative approach to end of life care", "authors": "Jennifer Ong", "journal": null, "publication_date": "2025-05-06", "publication_year": 2025, "doi": "10.70462/acim.2025.1.001", "pubmed_id": null, "openalex_id": "https://openalex.org/W4410178457", "source_url": "https://doi.org/10.70462/acim.2025.1.001", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,End-of-Life Distress,Treatment-Resistant Depression", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:40", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "DOI:10.70462/acim.2025.1.001", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.70462/acim.2025.1.001", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.70462/acim.2025.1.001", "source_url": "https://doi.org/10.70462/acim.2025.1.001", "doi": "10.70462/acim.2025.1.001", "pmid": "", "publication_date": "2025-05-06", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 702, "title": "Exploring the Role of Psychedelics in Modulating Ego and Treating Neuropsychiatric Disorders.", "authors": "Wang H, Wang X", "journal": "ACS chemical neuroscience", "publication_date": "2025-05-06", "publication_year": 2025, "doi": "10.1021/acschemneuro.5c00247", "pubmed_id": "40254808", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/40254808/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Default Mode Network,Aging,Emotional Processing", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:20:35", "bibtex": null, "source_record_id": "PMID:40254808", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40254808/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40254808", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40254808/", "doi": "10.1021/acschemneuro.5c00247", "pmid": "40254808", "publication_date": "2025-05-06", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4375, "title": "Michael A. Wheeler: Psychedelics and neuroimmune circuits-what a strange trip, indeed", "authors": "Michael A. Wheeler", "journal": "Psychedelics.", "publication_date": "2025-05-05", "publication_year": 2025, "doi": "10.61373/pp025k.0011", "pubmed_id": null, "openalex_id": "https://openalex.org/W4410121503", "source_url": "https://doi.org/10.61373/pp025k.0011", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Mechanism of Action,Receptor Pharmacology,Emotional Processing,Genomics,Inflammation,Immune Function", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:40", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "DOI:10.61373/pp025k.0011", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.61373/pp025k.0011", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.61373/pp025k.0011", "source_url": "https://doi.org/10.61373/pp025k.0011", "doi": "10.61373/pp025k.0011", "pmid": "", "publication_date": "2025-05-05", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3539, "title": "The Effects of Psilocybin on Self-Focus and Self-Related Processing in Major Depressive Disorder", "authors": "Sharmin Ghaznavi", "journal": "ClinicalTrials.gov", "publication_date": "2025-05-05", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06247839", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging,Aging", "study_type": "Other", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06247839", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06247839", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06247839", "source_url": "https://clinicaltrials.gov/study/NCT06247839", "doi": "", "pmid": "", "publication_date": "2025-05-05", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3088, "title": "Psilocybin Mitigates Behavioral Despair and Cognitive Impairment in Treatment-resistant Depression Model using Wistar Kyoto Rats", "authors": "Wang Z, Robbins B, Zhuang R, Bruggen Rv, Sandini T, Li X, Zhang Y.", "journal": "Research Square", "publication_date": "2025-05-05", "publication_year": 2025, "doi": "10.21203/rs.3.rs-5493661/v1", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.21203/rs.3.rs-5493661/v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Receptor Pharmacology,Biomarkers,Animal Study,Treatment-Resistant Depression", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "preprint", "date_added": "2026-07-01 11:03:46", "last_checked": "2026-07-01 11:22:00", "bibtex": null, "source_record_id": "DOI:10.21203/rs.3.rs-5493661/v1", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.21203/rs.3.rs-5493661/v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "DOI:10.21203/rs.3.rs-5493661/v1", "source_url": "https://doi.org/10.21203/rs.3.rs-5493661/v1", "doi": "10.21203/rs.3.rs-5493661/v1", "pmid": "", "publication_date": "2025-05-05", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 703, "title": "A protocol for a scoping review of variations among psychedelic interventions for psychological suffering associated with the end-of-life.", "authors": "Kratina S, Strike C, Schwartz R, Nayfeh A, Jopling S, Lo C, Rush B.", "journal": null, "publication_date": "2025-05-05", "publication_year": 2025, "doi": "10.1371/journal.pone.0318343", "pubmed_id": "40327705", "openalex_id": null, "source_url": "https://doi.org/10.1371/journal.pone.0318343", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Mechanism of Action,Systematic Review,Review Article,Safety", "study_type": "Systematic Review", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:03", "bibtex": null, "source_record_id": "PMID:40327705", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1371/journal.pone.0318343", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:40327705", "source_url": "https://doi.org/10.1371/journal.pone.0318343", "doi": "10.1371/journal.pone.0318343", "pmid": "40327705", "publication_date": "2025-05-05", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4376, "title": "Psychedelic therapy as relational medicine: psychosocial mechanisms in clinical and naturalistic contexts", "authors": "Hannes Kettner", "journal": "Open MIND", "publication_date": "2025-05-03", "publication_year": 2025, "doi": "10.25560/125300", "pubmed_id": null, "openalex_id": "https://openalex.org/W7124428185", "source_url": "https://hdl.handle.net/10044/1/125300", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Mechanism of Action,Aging,Wellbeing,Randomized Controlled Trial", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:40", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "DOI:10.25560/125300", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://hdl.handle.net/10044/1/125300", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.25560/125300", "source_url": "https://hdl.handle.net/10044/1/125300", "doi": "10.25560/125300", "pmid": "", "publication_date": "2025-05-03", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4380, "title": "0391 Racial/Ethnic Differences in Psychedelic Use and Sleep Satisfaction: Preliminary Findings from the Herbal Heart Study", "authors": "Denise C. Vidot, Amrit Baral, Bria-Necole Diggs, Ranya Marrakchi El Fellah, Kylee Krivijanski, Albert Garcia-Romeu, Winston De La Haye, Clarence Locklear, Girardin Jean-Louis", "journal": "SLEEP", "publication_date": "2025-04-30", "publication_year": 2025, "doi": "10.1093/sleep/zsaf090.0391", "pubmed_id": null, "openalex_id": "https://openalex.org/W4410502978", "source_url": "https://doi.org/10.1093/sleep/zsaf090.0391", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Mechanism of Action", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:40", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "DOI:10.1093/sleep/zsaf090.0391", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1093/sleep/zsaf090.0391", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1093/sleep/zsaf090.0391", "source_url": "https://doi.org/10.1093/sleep/zsaf090.0391", "doi": "10.1093/sleep/zsaf090.0391", "pmid": "", "publication_date": "2025-04-30", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4378, "title": "Psilocybin-gestützte Therapie von Depression, Angst und Suchtstörungen: Neurobiologische Grundlagen und klinische Anwendung", "authors": "Anna Lasch, Timo Schweikert, Eva Dora, Theresa Kolb, Hanne Lilian Schurig, Andreas Walther", "journal": "Nervenheilkunde", "publication_date": "2025-04-30", "publication_year": 2025, "doi": "10.1055/a-2517-1621", "pubmed_id": null, "openalex_id": "https://openalex.org/W4409999287", "source_url": "https://doi.org/10.1055/a-2517-1621", "substance_tags": "psilocybin", "topic_tags": "Depression", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:40", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "DOI:10.1055/a-2517-1621", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1055/a-2517-1621", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1055/a-2517-1621", "source_url": "https://doi.org/10.1055/a-2517-1621", "doi": "10.1055/a-2517-1621", "pmid": "", "publication_date": "2025-04-30", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 706, "title": "Divergent Effects of Psilocybin for 2 Patients Participating in a Psilocybin-assisted Cognitive Behavioral Therapy Trial for Major Depressive Disorder.", "authors": "Weintraub MJ, Miklowitz DJ, Jeffrey JK.", "journal": null, "publication_date": "2025-04-30", "publication_year": 2025, "doi": "10.1097/pra.0000000000000853", "pubmed_id": "40440674", "openalex_id": null, "source_url": "https://doi.org/10.1097/pra.0000000000000853", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Healthcare Workers", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:00", "bibtex": null, "source_record_id": "PMID:40440674", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1097/pra.0000000000000853", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:40440674", "source_url": "https://doi.org/10.1097/pra.0000000000000853", "doi": "10.1097/pra.0000000000000853", "pmid": "40440674", "publication_date": "2025-04-30", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 705, "title": "From molecules to meaning: unpacking the antidepressant mechanisms of psychedelic drugs.", "authors": "Acero VP, Flatt TA, Gooch PM, Gaughan SJ, Levin AW, Davis AK", "journal": "Expert review of clinical pharmacology", "publication_date": "2025-04-30", "publication_year": 2025, "doi": "10.1080/17512433.2025.2515866", "pubmed_id": "40470809", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/40470809/", "substance_tags": "psilocybin", "topic_tags": "Depression,Pharmacology,Mechanism of Action,Spirituality,Review Article", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:20:35", "bibtex": null, "source_record_id": "PMID:40470809", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40470809/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40470809", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40470809/", "doi": "10.1080/17512433.2025.2515866", "pmid": "40470809", "publication_date": "2025-04-30", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4382, "title": "The benefits and harm of psychedelics in the treatment of patients with mental health and substance abuse disorders: an integrative literature review", "authors": "Saara Susan Sevander, Marja-Liisa Rissanen", "journal": null, "publication_date": "2025-04-29", "publication_year": 2025, "doi": "10.59476/hesdia.v0i1.700", "pubmed_id": null, "openalex_id": "https://openalex.org/W4411419984", "source_url": "https://doi.org/10.59476/hesdia.v0i1.700", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Neuroplasticity,Receptor Pharmacology,Clinical Trial,Review Article,Treatment-Resistant Depression", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:40", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "DOI:10.59476/hesdia.v0i1.700", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.59476/hesdia.v0i1.700", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.59476/hesdia.v0i1.700", "source_url": "https://doi.org/10.59476/hesdia.v0i1.700", "doi": "10.59476/hesdia.v0i1.700", "pmid": "", "publication_date": "2025-04-29", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4386, "title": "Psilocybin-assisted therapy shows range of benefits in cancer patients", "authors": "", "journal": "The Brown University Psychopharmacology Update", "publication_date": "2025-04-28", "publication_year": 2025, "doi": "10.1002/pu.31316", "pubmed_id": null, "openalex_id": "https://openalex.org/W4409945764", "source_url": "https://doi.org/10.1002/pu.31316", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Pharmacology,Receptor Pharmacology,Clinical Trial,Cancer Patients,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:40", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "DOI:10.1002/pu.31316", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1002/pu.31316", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1002/pu.31316", "source_url": "https://doi.org/10.1002/pu.31316", "doi": "10.1002/pu.31316", "pmid": "", "publication_date": "2025-04-28", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4385, "title": "Trial finds psilocybin improves symptoms in treatment-resistant depression", "authors": "", "journal": "The Brown University Psychopharmacology Update", "publication_date": "2025-04-28", "publication_year": 2025, "doi": "10.1002/pu.31317", "pubmed_id": null, "openalex_id": "https://openalex.org/W4409945649", "source_url": "https://doi.org/10.1002/pu.31317", "substance_tags": "psilocybin", "topic_tags": "Depression,Treatment-Resistant Depression", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:40", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "DOI:10.1002/pu.31317", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1002/pu.31317", "source_url": "https://doi.org/10.1002/pu.31317", "doi": "10.1002/pu.31317", "pmid": "", "publication_date": "2025-04-28", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 631, "title": "Dissociable effects of psilocybin and escitalopram for depression on processing of musical surprises", "authors": "Rebecca Harding, Neomi Singer, Matthew B. Wall, Talma Hendler, David Erritzøe, David Nutt, Robin Carhart-Harris, Leor Roseman", "journal": "Molecular Psychiatry", "publication_date": "2025-04-25", "publication_year": 2025, "doi": "10.1038/s41380-025-03035-8", "pubmed_id": "40281226", "openalex_id": "https://openalex.org/W4409788022", "source_url": "https://doi.org/10.1038/s41380-025-03035-8", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Brain Imaging,Mechanism of Action,Receptor Pharmacology,Aging,Emotional Processing", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "PMID:40281226", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1038/s41380-025-03035-8", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:40281226", "source_url": "https://doi.org/10.1038/s41380-025-03035-8", "doi": "10.1038/s41380-025-03035-8", "pmid": "40281226", "publication_date": "2025-04-25", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3591, "title": "Treatment With Psilocybin for Chronic Neuropathic Pain and Depression (TRANSCEND): An Open-Label Clinical Trial", "authors": "Centre for Addiction and Mental Health", "journal": "ClinicalTrials.gov", "publication_date": "2025-04-24", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06518720", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Clinical Trial,Randomized Controlled Trial,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06518720", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06518720", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06518720", "source_url": "https://clinicaltrials.gov/study/NCT06518720", "doi": "", "pmid": "", "publication_date": "2025-04-24", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 463, "title": "Psilocybin-assisted psychotherapy as a rapid-acting treatment for cancer-related depression and anxiety: Evidence from a network meta-analysis", "authors": "Damian Świeczkowski, Aleksander Kwaśny, Michał Pruc, Zuzanna Gaca, Łukasz Szarpak, Wiesław Jerzy Cubała", "journal": "The International Journal of Psychiatry in Medicine", "publication_date": "2025-04-24", "publication_year": 2025, "doi": "10.1177/00912174251337572", "pubmed_id": "40279353", "openalex_id": "https://openalex.org/W4409797469", "source_url": "https://doi.org/10.1177/00912174251337572", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Cancer Patients,Safety", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "PMID:40279353", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1177/00912174251337572", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:40279353", "source_url": "https://doi.org/10.1177/00912174251337572", "doi": "10.1177/00912174251337572", "pmid": "40279353", "publication_date": "2025-04-24", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 732, "title": "[Treatment with psychedelics: potential benefits in Parkinson's disease].", "authors": "Louise Penzenstadler, Sandra Baudois, Alma Lingenberg, Sabina Catalano Chiuvé, Emilie Tomkova, Vanessa Fleury", "journal": "PubMed", "publication_date": "2025-04-22", "publication_year": 2025, "doi": "10.53738/revmed.2025.21.915.47180", "pubmed_id": "40275842", "openalex_id": "https://openalex.org/W4409833807", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40275842", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,OCD,Neuroplasticity,Receptor Pharmacology,Clinical Trial,Safety,Inflammation", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "PMID:40275842", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40275842", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:40275842", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40275842", "doi": "10.53738/revmed.2025.21.915.47180", "pmid": "40275842", "publication_date": "2025-04-22", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 626, "title": "5-HT2A receptors: Pharmacology and functional selectivity.", "authors": "Cummins BR, Billac GB, Nichols DE, Nichols CD.", "journal": null, "publication_date": "2025-04-22", "publication_year": 2025, "doi": "10.1016/j.pharmr.2025.100059", "pubmed_id": "40418878", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.pharmr.2025.100059", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Pharmacology,Mechanism of Action,Receptor Pharmacology,Aging,Clinical Trial,Drug Interactions", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:04", "bibtex": null, "source_record_id": "PMID:40418878", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.pharmr.2025.100059", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:40418878", "source_url": "https://doi.org/10.1016/j.pharmr.2025.100059", "doi": "10.1016/j.pharmr.2025.100059", "pmid": "40418878", "publication_date": "2025-04-22", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 500, "title": "Incremental efficacy systematic review and meta-analysis of psilocybin-for-depression RCTs.", "authors": "Borgogna NC, Owen T, Petrovitch D, Vaughn J, Johnson DAL, Pagano LA, Aita SL, Hill BD.", "journal": null, "publication_date": "2025-04-22", "publication_year": 2025, "doi": "10.1007/s00213-025-06788-w", "pubmed_id": "40266291", "openalex_id": null, "source_url": "https://doi.org/10.1007/s00213-025-06788-w", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Healthcare Workers,Safety", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:00", "bibtex": null, "source_record_id": "PMID:40266291", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1007/s00213-025-06788-w", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:40266291", "source_url": "https://doi.org/10.1007/s00213-025-06788-w", "doi": "10.1007/s00213-025-06788-w", "pmid": "40266291", "publication_date": "2025-04-22", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4391, "title": "Regulatory Challenges of Integrating Psychedelics into Mental Health Sector", "authors": "Kerem Kemal Soylemez, Emma Marie de Boo, Joanne Lusher", "journal": "Psychoactives", "publication_date": "2025-04-21", "publication_year": 2025, "doi": "10.3390/psychoactives4020011", "pubmed_id": null, "openalex_id": "https://openalex.org/W4409667310", "source_url": "https://doi.org/10.3390/psychoactives4020011", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Receptor Pharmacology,Review Article", "study_type": "Review Article", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:40", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "DOI:10.3390/psychoactives4020011", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.3390/psychoactives4020011", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.3390/psychoactives4020011", "source_url": "https://doi.org/10.3390/psychoactives4020011", "doi": "10.3390/psychoactives4020011", "pmid": "", "publication_date": "2025-04-21", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 734, "title": "Evaluating the effectiveness of psilocybin in alleviating distress among cancer patients: A systematic review.", "authors": "Lapid MI, Pagali SR, Randall AL, Donovan KA, Bronars CA, Gauthier TA, Bock J, Lim SD, Carey EC, Sokolowski E, Ulrich AM, Hassett LC, Kung S, Whitford KJ, Olivier KR, D'Andre SD.", "journal": null, "publication_date": "2025-04-21", "publication_year": 2025, "doi": "10.1017/s147895152500032x", "pubmed_id": "40259688", "openalex_id": null, "source_url": "https://doi.org/10.1017/s147895152500032x", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Randomized Controlled Trial,Systematic Review,Review Article,Case Report,Cancer Patients,Safety", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:00", "bibtex": null, "source_record_id": "PMID:40259688", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1017/s147895152500032x", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:40259688", "source_url": "https://doi.org/10.1017/s147895152500032x", "doi": "10.1017/s147895152500032x", "pmid": "40259688", "publication_date": "2025-04-21", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 708, "title": "Rapid and sustained antidepressant effects of vaporized N,N-dimethyltryptamine: a phase 2a clinical trial in treatment-resistant depression.", "authors": "Falchi-Carvalho M, Palhano-Fontes F, Wießner I, Barros H, Bolcont R, Laborde S, Ruschi B Silva S, Montanini D, C Barbosa D, Teixeira E, Florence-Vilela R, Almeida R, K A de Macedo R, Arichelle F, J Pantrigo É, V Costa-Macedo J, da Cruz Nunes JA, de Araújo Costa Neto LA, Nunes Ferreira LF, Dantas Corrêa L, da Costa Bezerra RB, Arcoverde E, Galvão-Coelho N, B Araujo D.", "journal": null, "publication_date": "2025-04-21", "publication_year": 2025, "doi": "10.1038/s41386-025-02091-6", "pubmed_id": "40258990", "openalex_id": null, "source_url": "https://doi.org/10.1038/s41386-025-02091-6", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Treatment-Resistant Depression,Safety,Adverse Events,Drug Interactions", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:04", "bibtex": null, "source_record_id": "PMID:40258990", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1038/s41386-025-02091-6", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:40258990", "source_url": "https://doi.org/10.1038/s41386-025-02091-6", "doi": "10.1038/s41386-025-02091-6", "pmid": "40258990", "publication_date": "2025-04-21", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 736, "title": "Development of a PBPK model of psilocybin/psilocin from Psilocybe cubensis (magic mushroom) in mice, rats, and humans", "authors": "Nilubon Thaoboonruang, Ornrat Lohitnavy, Kimheang Ya, Manupat Lohitnavy", "journal": "Scientific Reports", "publication_date": "2025-04-20", "publication_year": 2025, "doi": "10.1038/s41598-025-98202-w", "pubmed_id": "40258947", "openalex_id": "https://openalex.org/W4409623005", "source_url": "https://doi.org/10.1038/s41598-025-98202-w", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Pharmacology,Clinical Trial,Animal Study", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "PMID:40258947", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1038/s41598-025-98202-w", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:40258947", "source_url": "https://doi.org/10.1038/s41598-025-98202-w", "doi": "10.1038/s41598-025-98202-w", "pmid": "40258947", "publication_date": "2025-04-20", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 737, "title": "Comparative Efficacy and Functional Outcomes of Psychedelic-Assisted Therapies in Treatment-Resistant Depression: A Systematic Review of Recent Clinical Trials.", "authors": "Mimms C, Sotelo K, Khaliq AS.", "journal": null, "publication_date": "2025-04-17", "publication_year": 2025, "doi": "10.7759/cureus.82532", "pubmed_id": "40385821", "openalex_id": null, "source_url": "https://doi.org/10.7759/cureus.82532", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Randomized Controlled Trial,Systematic Review,Review Article,Observational Study,Treatment-Resistant Depression,Safety", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:02", "bibtex": null, "source_record_id": "PMID:40385821", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.7759/cureus.82532", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:40385821", "source_url": "https://doi.org/10.7759/cureus.82532", "doi": "10.7759/cureus.82532", "pmid": "40385821", "publication_date": "2025-04-17", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 633, "title": "Regulatory Alignment of Psilocybin Clinical Trials in Major Depressive Disorder on ClinicalTrials.gov: A Cross-Sectional Analysis", "authors": "Damian Świeczkowski, Aleksander Kwaśny, Michał Pruc, Zuzanna Gaca, Łukasz Szarpak, Wiesław Jerzy Cubała", "journal": "Pharmacopsychiatry", "publication_date": "2025-04-16", "publication_year": 2025, "doi": "10.1055/a-2529-7029", "pubmed_id": "40245934", "openalex_id": "https://openalex.org/W4409534321", "source_url": "https://doi.org/10.1055/a-2529-7029", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Treatment-Resistant Depression,Safety,Drug Interactions", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "PMID:40245934", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1055/a-2529-7029", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:40245934", "source_url": "https://doi.org/10.1055/a-2529-7029", "doi": "10.1055/a-2529-7029", "pmid": "40245934", "publication_date": "2025-04-16", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3465, "title": "A Phase 2a, Open-label, Pilot Study to Assess the Safety and Efficacy of Psilocybin Administration in Concert With Psychotherapy Among Adult Patients With Fibromyalgia", "authors": "Kevin Boehnke", "journal": "ClinicalTrials.gov", "publication_date": "2025-04-15", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05128162", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Chronic Pain,Mechanism of Action,Clinical Trial,Review Article,Cancer Patients,Treatment-Resistant Depression,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05128162", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05128162", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05128162", "source_url": "https://clinicaltrials.gov/study/NCT05128162", "doi": "", "pmid": "", "publication_date": "2025-04-15", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 678, "title": "Exploring psilocybin's role in mental health and palliative medicine: a path to improved well-being.", "authors": "Umbacia MA, Leon MX, Quintero JM, Castro LM, Paez V, Dodd S, Bustos RH.", "journal": null, "publication_date": "2025-04-09", "publication_year": 2025, "doi": "10.1080/14728214.2025.2488786", "pubmed_id": "40178229", "openalex_id": null, "source_url": "https://doi.org/10.1080/14728214.2025.2488786", "substance_tags": "psilocybin", "topic_tags": "Depression,End-of-Life Distress,Mechanism of Action,Receptor Pharmacology,Wellbeing,Clinical Trial", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:02", "bibtex": null, "source_record_id": "PMID:40178229", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1080/14728214.2025.2488786", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:40178229", "source_url": "https://doi.org/10.1080/14728214.2025.2488786", "doi": "10.1080/14728214.2025.2488786", "pmid": "40178229", "publication_date": "2025-04-09", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4401, "title": "194. Improving Workplace and Psychosocial Function in Treatment-Resistant Depression: Exploratory Outcomes From an Open-Label Feasibility Trial of Psilocybin-Assisted Psychotherapy", "authors": "Orly Lipsitz, Joshua D. Rosenblat", "journal": "Biological Psychiatry", "publication_date": "2025-04-08", "publication_year": 2025, "doi": "10.1016/j.biopsych.2025.02.431", "pubmed_id": null, "openalex_id": "https://openalex.org/W4409281338", "source_url": "https://doi.org/10.1016/j.biopsych.2025.02.431", "substance_tags": "psilocybin", "topic_tags": "Depression,Randomized Controlled Trial,Treatment-Resistant Depression", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:40", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "DOI:10.1016/j.biopsych.2025.02.431", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.biopsych.2025.02.431", "source_url": "https://doi.org/10.1016/j.biopsych.2025.02.431", "doi": "10.1016/j.biopsych.2025.02.431", "pmid": "", "publication_date": "2025-04-08", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4400, "title": "187. Changes in Symptoms of Anhedonia With Psilocybin-Assisted Psychotherapy: A Secondary Analysis of a Randomized Clinical Trial for Treatment-Resistant Depression", "authors": "Erica Kaczmarek, Nelson B. Rodrigues, Noah Chisamore, Zoe Doyle, Roger S. McIntyre, Rodrigo B. Mansur, Joshua D. Rosenblat", "journal": "Biological Psychiatry", "publication_date": "2025-04-08", "publication_year": 2025, "doi": "10.1016/j.biopsych.2025.02.424", "pubmed_id": null, "openalex_id": "https://openalex.org/W4409281325", "source_url": "https://doi.org/10.1016/j.biopsych.2025.02.424", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Randomized Controlled Trial,Treatment-Resistant Depression", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:40", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "DOI:10.1016/j.biopsych.2025.02.424", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.biopsych.2025.02.424", "source_url": "https://doi.org/10.1016/j.biopsych.2025.02.424", "doi": "10.1016/j.biopsych.2025.02.424", "pmid": "", "publication_date": "2025-04-08", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4399, "title": "186. Assessing Cognitive Outcomes in Treatment-Resistant Depression Following Psilocybin-Assisted Psychotherapy", "authors": "Danica E. Johnson, Erica Kaczmarek, Noah Chisamore, Orly Lipitz, Zoe Doyle, Rodrigo B. Mansur, Roger S. McIntyre, Joshua D. Rosenblat", "journal": "Biological Psychiatry", "publication_date": "2025-04-08", "publication_year": 2025, "doi": "10.1016/j.biopsych.2025.02.423", "pubmed_id": null, "openalex_id": "https://openalex.org/W4409281322", "source_url": "https://doi.org/10.1016/j.biopsych.2025.02.423", "substance_tags": "psilocybin", "topic_tags": "Depression,Treatment-Resistant Depression", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:40", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "DOI:10.1016/j.biopsych.2025.02.423", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.biopsych.2025.02.423", "source_url": "https://doi.org/10.1016/j.biopsych.2025.02.423", "doi": "10.1016/j.biopsych.2025.02.423", "pmid": "", "publication_date": "2025-04-08", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4397, "title": "166. Dynamic Mediodorsal Thalamus Activity Predicts and Reflects Longitudinal Treatment Outcomes in Psilocybin Therapy for Treatment-Resistant Depression", "authors": "Xue Zhang, Emily Zhai, Claire Bertrand, Sara Ellis, Isabelle Wydler, Anna J. Donnelly, Trisha Suppes, Leanne M. Williams", "journal": "Biological Psychiatry", "publication_date": "2025-04-08", "publication_year": 2025, "doi": "10.1016/j.biopsych.2025.02.403", "pubmed_id": null, "openalex_id": "https://openalex.org/W4409280673", "source_url": "https://doi.org/10.1016/j.biopsych.2025.02.403", "substance_tags": "psilocybin", "topic_tags": "Depression,Treatment-Resistant Depression", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:40", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "DOI:10.1016/j.biopsych.2025.02.403", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.biopsych.2025.02.403", "source_url": "https://doi.org/10.1016/j.biopsych.2025.02.403", "doi": "10.1016/j.biopsych.2025.02.403", "pmid": "", "publication_date": "2025-04-08", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3446, "title": "Psilocybin-assisted Interpersonal Therapy for Depression", "authors": "University of Otago", "journal": "ClinicalTrials.gov", "publication_date": "2025-04-08", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05581797", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Emotional Processing,Clinical Trial,Review Article,Treatment-Resistant Depression,Healthcare Workers", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05581797", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05581797", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05581797", "source_url": "https://clinicaltrials.gov/study/NCT05581797", "doi": "", "pmid": "", "publication_date": "2025-04-08", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 745, "title": "The Emergence of Psilocybin in Psychiatry and Neuroscience.", "authors": "Omidian H, Omidian A.", "journal": null, "publication_date": "2025-04-08", "publication_year": 2025, "doi": "10.3390/ph18040555", "pubmed_id": "40283990", "openalex_id": null, "source_url": "https://doi.org/10.3390/ph18040555", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Pharmacology,Mechanism of Action,Clinical Trial,Review Article,Cancer Patients,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:00", "bibtex": null, "source_record_id": "PMID:40283990", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.3390/ph18040555", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:40283990", "source_url": "https://doi.org/10.3390/ph18040555", "doi": "10.3390/ph18040555", "pmid": "40283990", "publication_date": "2025-04-08", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 744, "title": "A multi-institutional investigation of psilocybin’s effects on mouse behavior", "authors": "Lu OD, White K, Raymond K, Liu C, Klein AS, Green N, Vaillancourt S, Gallagher A, Shindy L, Li A, Wallquist K, Li R, Zou M, Casey AB, Cameron LP, Pomrenze MB, Sohal V, Kheirbek MA, Gomez AM, Lammel S, Heifets BD, Malenka R.", "journal": "bioRxiv", "publication_date": "2025-04-08", "publication_year": 2025, "doi": "10.1101/2025.04.08.647810", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.1101/2025.04.08.647810", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Animal Study", "study_type": "Animal Study", "source_name": "bioRxiv", "publication_status": "preprint", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:02", "bibtex": null, "source_record_id": "DOI:10.1101/2025.04.08.647810", "abstract_available": true, "abstract_source": "bioRxiv", "abstract_source_url": "https://doi.org/10.1101/2025.04.08.647810", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "bioRxiv", "source_record_id": "DOI:10.1101/2025.04.08.647810", "source_url": "https://doi.org/10.1101/2025.04.08.647810", "doi": "10.1101/2025.04.08.647810", "pmid": "", "publication_date": "2025-04-08", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 693, "title": "In Vitro Psilocybin Synthesis by Co-Immobilized Enzymes", "authors": "Tim Schäfer, Alexander M. Sherwood, Thomas A. Kirkland, Thomas Krüger, Jakob Worbs, Olaf Kniemeyer, Markus Gressler, Dirk Hoffmeister", "journal": "Chemistry - A European Journal", "publication_date": "2025-04-08", "publication_year": 2025, "doi": "10.1002/chem.202501037", "pubmed_id": "40202903", "openalex_id": "https://openalex.org/W4409288174", "source_url": "https://doi.org/10.1002/chem.202501037", "substance_tags": "psilocybin", "topic_tags": "Depression,Pharmacology,Clinical Trial,In Vitro Study", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "PMID:40202903", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1002/chem.202501037", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:40202903", "source_url": "https://doi.org/10.1002/chem.202501037", "doi": "10.1002/chem.202501037", "pmid": "40202903", "publication_date": "2025-04-08", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 634, "title": "Psilocybin therapy for mood dysfunction in Parkinson’s disease: an open-label pilot trial", "authors": "Ellen Bradley, Kimberly Sakai, Gisele Fernandes-Osterhold, Balázs Szigeti, Connie Ludwig, Jill L. Ostrem, Caroline M. Tanner, Meredith Bock, Katiah Llerena, Patrick R. Finley, Aoife O’Donovan, José Rafael P. Zuzuárregui, Zachary Busby, Amber McKernan, Andrew Penn, Aliss C.C. Wang, Raymond C. Rosen, Joshua Woolley", "journal": "Neuropsychopharmacology", "publication_date": "2025-04-08", "publication_year": 2025, "doi": "10.1038/s41386-025-02097-0", "pubmed_id": "40205013", "openalex_id": "https://openalex.org/W4409286565", "source_url": "https://doi.org/10.1038/s41386-025-02097-0", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Receptor Pharmacology,Safety,Adverse Events", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "PMID:40205013", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1038/s41386-025-02097-0", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:40205013", "source_url": "https://doi.org/10.1038/s41386-025-02097-0", "doi": "10.1038/s41386-025-02097-0", "pmid": "40205013", "publication_date": "2025-04-08", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4404, "title": "Harnessing neuroplasticity with psychoplastogens: the essential role of psychotherapy in psychedelic treatment optimization", "authors": "Jennifer Jones", "journal": "Frontiers in Psychiatry", "publication_date": "2025-04-07", "publication_year": 2025, "doi": "10.3389/fpsyt.2025.1565852", "pubmed_id": "40264517", "openalex_id": "https://openalex.org/W4409274889", "source_url": "https://doi.org/10.3389/fpsyt.2025.1565852", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,OCD,Eating Disorders,Chronic Pain,Neuroplasticity,Brain Imaging,Pharmacology,Mechanism of Action,Receptor Pharmacology,Default Mode Network,Consciousness,Aging,Emotional Processing,Psychological Flexibility,Clinical Trial,Review Article,Animal Study,Veterans,Healthcare Workers,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:40", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "PMID:40264517", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.3389/fpsyt.2025.1565852", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:40264517", "source_url": "https://doi.org/10.3389/fpsyt.2025.1565852", "doi": "10.3389/fpsyt.2025.1565852", "pmid": "40264517", "publication_date": "2025-04-07", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4407, "title": "The neurons that mediate a psychedelic’s long-term antidepressive effects", "authors": "", "journal": "Nature", "publication_date": "2025-04-01", "publication_year": 2025, "doi": "10.1038/d41586-025-00979-3", "pubmed_id": "40175746", "openalex_id": "https://openalex.org/W4409087880", "source_url": "https://doi.org/10.1038/d41586-025-00979-3", "substance_tags": "psilocybin", "topic_tags": "Depression,Neuroplasticity,Receptor Pharmacology", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:40", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "PMID:40175746", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1038/d41586-025-00979-3", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:40175746", "source_url": "https://doi.org/10.1038/d41586-025-00979-3", "doi": "10.1038/d41586-025-00979-3", "pmid": "40175746", "publication_date": "2025-04-01", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 886, "title": "Potential therapeutic effects of psychedelics in small doses: Is there a role for microdosing in psychiatry?", "authors": "Totomanova I, Haijen ECHM, Hurks PPM, Ramaekers JG, Kuypers KPC.", "journal": null, "publication_date": "2025-04-01", "publication_year": 2025, "doi": "10.1016/bs.irn.2025.03.002", "pubmed_id": "40541311", "openalex_id": null, "source_url": "https://doi.org/10.1016/bs.irn.2025.03.002", "substance_tags": "psilocybin", "topic_tags": "Depression,OCD,Chronic Pain,Pharmacology,Microdosing,Clinical Trial,Review Article,Safety", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:03", "bibtex": null, "source_record_id": "PMID:40541311", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/bs.irn.2025.03.002", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:40541311", "source_url": "https://doi.org/10.1016/bs.irn.2025.03.002", "doi": "10.1016/bs.irn.2025.03.002", "pmid": "40541311", "publication_date": "2025-04-01", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4408, "title": "Minorities’ diminished psychedelic returns: Depression, suicide, distress, and serious mental illness", "authors": "Sean M. Viña", "journal": "Drug Science Policy and Law", "publication_date": "2025-03-31", "publication_year": 2025, "doi": "10.1177/20503245251337357", "pubmed_id": null, "openalex_id": "https://openalex.org/W4409677856", "source_url": "https://doi.org/10.1177/20503245251337357", "substance_tags": "psilocybin", "topic_tags": "Depression,Observational Study", "study_type": "Observational Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:40", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "DOI:10.1177/20503245251337357", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1177/20503245251337357", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1177/20503245251337357", "source_url": "https://doi.org/10.1177/20503245251337357", "doi": "10.1177/20503245251337357", "pmid": "", "publication_date": "2025-03-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 752, "title": "De Novo Biosynthesis of Antidepressant Psilocybin in Escherichia coli", "authors": "Zhangrao Huang, Yongpeng Yao, Rong Di, Jianchao Zhang, Yuanyuan Pan, Gang Liu", "journal": "Microbial Biotechnology", "publication_date": "2025-03-31", "publication_year": 2025, "doi": "10.1111/1751-7915.70135", "pubmed_id": "40177917", "openalex_id": "https://openalex.org/W4409148851", "source_url": "https://doi.org/10.1111/1751-7915.70135", "substance_tags": "psilocybin", "topic_tags": "Depression,End-of-Life Distress,Pharmacology,Mechanism of Action,Treatment-Resistant Depression", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "PMID:40177917", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1111/1751-7915.70135", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:40177917", "source_url": "https://doi.org/10.1111/1751-7915.70135", "doi": "10.1111/1751-7915.70135", "pmid": "40177917", "publication_date": "2025-03-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 739, "title": "Psilocybin-Assisted suppoRtive psychoTherapy IN the treatment of prolonged Grief (PARTING) trial: protocol for an open-label pilot trial for cancer-related bereavement", "authors": "Vanessa L. Beesley, Tom Kennedy, Fiona Maccallum, Margaret Ross, Renee Harvey, Susan L. Rossell, Jerome Sarris, Daniel Perkins, Rachel Ε. Neale, James Bennett-Levy, Shevaugn Johnson, Hanna Beebe, Natalie Roset, Jörg Strobel, Stephen Parker", "journal": "BMJ Open", "publication_date": "2025-03-31", "publication_year": 2025, "doi": "10.1136/bmjopen-2024-095992", "pubmed_id": "40233965", "openalex_id": "https://openalex.org/W4409449177", "source_url": "https://doi.org/10.1136/bmjopen-2024-095992", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Aging,Psychological Flexibility,Clinical Trial,Review Article,Cancer Patients,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "PMID:40233965", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1136/bmjopen-2024-095992", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:40233965", "source_url": "https://doi.org/10.1136/bmjopen-2024-095992", "doi": "10.1136/bmjopen-2024-095992", "pmid": "40233965", "publication_date": "2025-03-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3783, "title": "Ayahuasca in the treatment of the consequences of chronic childhood sexual abuse in a religious community", "authors": "Turkia M.", "journal": "PsyArXiv", "publication_date": "2025-03-26", "publication_year": 2025, "doi": "10.31234/osf.io/mzkyv_v1", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.31234/osf.io/mzkyv_v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Emotional Processing", "study_type": "Other", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:10:21", "last_checked": "2026-07-01 11:22:04", "bibtex": null, "source_record_id": "DOI:10.31234/osf.io/mzkyv_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://doi.org/10.31234/osf.io/mzkyv_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "DOI:10.31234/osf.io/mzkyv_v1", "source_url": "https://doi.org/10.31234/osf.io/mzkyv_v1", "doi": "10.31234/osf.io/mzkyv_v1", "pmid": "", "publication_date": "2025-03-26", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3308, "title": "Ayahuasca in the treatment of the consequences of chronic childhood sexual abuse in a religious community", "authors": "", "journal": "PsyArXiv", "publication_date": "2025-03-26", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://osf.io/preprints/psyarxiv/mzkyv_v1", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Personality Change,Emotional Processing,Spirituality", "study_type": "Other", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:50", "last_checked": "2026-07-01 11:22:30", "bibtex": null, "source_record_id": "https://osf.io/preprints/psyarxiv/mzkyv_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/mzkyv_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "https://osf.io/preprints/psyarxiv/mzkyv_v1", "source_url": "https://osf.io/preprints/psyarxiv/mzkyv_v1", "doi": "", "pmid": "", "publication_date": "2025-03-26", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 892, "title": "Existing evidence for the use of psychedelics in patients with cancer and other serious illness: A narrative review.", "authors": "Bires J.", "journal": null, "publication_date": "2025-03-25", "publication_year": 2025, "doi": "10.1080/07347332.2025.2482917", "pubmed_id": "40138527", "openalex_id": null, "source_url": "https://doi.org/10.1080/07347332.2025.2482917", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Clinical Trial,Randomized Controlled Trial,Review Article,Cancer Patients,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:03", "bibtex": null, "source_record_id": "PMID:40138527", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1080/07347332.2025.2482917", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:40138527", "source_url": "https://doi.org/10.1080/07347332.2025.2482917", "doi": "10.1080/07347332.2025.2482917", "pmid": "40138527", "publication_date": "2025-03-25", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 502, "title": "Comparing Antidepressant Effects of Psilocybin-Assisted Psychotherapy in Individuals That Were Unmedicated at Initial Screening Versus Individuals Discontinuing Medications for Study Participation: Comparaison des effets antidépresseurs de la psychothérapie assistée par la psilocybine (PAP) chez les personnes non médicamentées à la sélection initiale et les personnes ayant arrêté les médicaments pour participer à l’étude", "authors": "Noah Chisamore, Erica Kaczmarek, Zoe Doyle, Danica E. Johnson, Geneva Weiglein, Shakila Meshkat, Ryan M. Brudner, Marc G. Blainey, Jeremy Riva-Cambrin, Roger S. McIntyre, Joshua D. Rosenblat", "journal": "The Canadian Journal of Psychiatry", "publication_date": "2025-03-24", "publication_year": 2025, "doi": "10.1177/07067437251328316", "pubmed_id": "40129307", "openalex_id": "https://openalex.org/W4408813813", "source_url": "https://doi.org/10.1177/07067437251328316", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Chronic Pain,Mystical Experience,Clinical Trial,Randomized Controlled Trial,Treatment-Resistant Depression,Healthcare Workers,Toxicity", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:34", "bibtex": null, "source_record_id": "PMID:40129307", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1177/07067437251328316", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:40129307", "source_url": "https://doi.org/10.1177/07067437251328316", "doi": "10.1177/07067437251328316", "pmid": "40129307", "publication_date": "2025-03-24", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 713, "title": "Classic Psychedelics for the Treatment of Depression: Potential Benefits and Challenges.", "authors": "Ghaznavi S, Richter SG.", "journal": null, "publication_date": "2025-03-23", "publication_year": 2025, "doi": "10.1007/s40265-025-02172-2", "pubmed_id": "40128500", "openalex_id": null, "source_url": "https://doi.org/10.1007/s40265-025-02172-2", "substance_tags": "psilocybin", "topic_tags": "Depression,Treatment-Resistant Depression", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:03", "bibtex": null, "source_record_id": "PMID:40128500", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1007/s40265-025-02172-2", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:40128500", "source_url": "https://doi.org/10.1007/s40265-025-02172-2", "doi": "10.1007/s40265-025-02172-2", "pmid": "40128500", "publication_date": "2025-03-23", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 772, "title": "Structural basis for psilocybin biosynthesis", "authors": "Chunyan Meng, Wenting Guo, Xiao Chuan, Yan Wen, Xudong Zhu, Qingrong Zhang, Yuxuan Liang, Hongwei Li, Sha Xu, Yuntan Qiu, Haitao Chen, Wei-Jye Lin, Baixing Wu", "journal": "Nature Communications", "publication_date": "2025-03-21", "publication_year": 2025, "doi": "10.1038/s41467-025-58239-x", "pubmed_id": "40121242", "openalex_id": "https://openalex.org/W4408739043", "source_url": "https://doi.org/10.1038/s41467-025-58239-x", "substance_tags": "psilocybin", "topic_tags": "Depression,Pharmacology,Mechanism of Action,Animal Study", "study_type": "Animal Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:34", "bibtex": null, "source_record_id": "PMID:40121242", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1038/s41467-025-58239-x", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:40121242", "source_url": "https://doi.org/10.1038/s41467-025-58239-x", "doi": "10.1038/s41467-025-58239-x", "pmid": "40121242", "publication_date": "2025-03-21", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3104, "title": "The effects of psilocybin therapy versus escitalopram on cognitive bias: A secondary analysis of a randomized controlled trial", "authors": "Henry J, Giribaldi B, Nutt DJ, Erritzoe D, Carhart-Harris R, Lyons T.", "journal": "medRxiv", "publication_date": "2025-03-20", "publication_year": 2025, "doi": "10.1101/2025.03.17.25324123", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.1101/2025.03.17.25324123", "substance_tags": "psilocybin", "topic_tags": "Depression,Randomized Controlled Trial", "study_type": "Randomized Controlled Trial", "source_name": "medRxiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:46", "last_checked": "2026-07-01 11:22:01", "bibtex": null, "source_record_id": "DOI:10.1101/2025.03.17.25324123", "abstract_available": true, "abstract_source": "medRxiv", "abstract_source_url": "https://doi.org/10.1101/2025.03.17.25324123", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "medRxiv", "source_record_id": "DOI:10.1101/2025.03.17.25324123", "source_url": "https://doi.org/10.1101/2025.03.17.25324123", "doi": "10.1101/2025.03.17.25324123", "pmid": "", "publication_date": "2025-03-20", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 773, "title": "Is there a place for psychedelics in sports practice?", "authors": "Portes MAM, Werle I, Bertoglio LJ.", "journal": null, "publication_date": "2025-03-20", "publication_year": 2025, "doi": "10.1017/neu.2025.13", "pubmed_id": "40116762", "openalex_id": null, "source_url": "https://doi.org/10.1017/neu.2025.13", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Pharmacology,Animal Study,Inflammation", "study_type": "Animal Study", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:01", "bibtex": null, "source_record_id": "PMID:40116762", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1017/neu.2025.13", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:40116762", "source_url": "https://doi.org/10.1017/neu.2025.13", "doi": "10.1017/neu.2025.13", "pmid": "40116762", "publication_date": "2025-03-20", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 756, "title": "Psychedelic Drugs in Mental Disorders: Current Clinical Scope and Deep Learning-Based Advanced Perspectives.", "authors": "Kim SH, Yang S, Jung J, Choi J, Kang M, Joo JY.", "journal": null, "publication_date": "2025-03-19", "publication_year": 2025, "doi": "10.1002/advs.202413786", "pubmed_id": "40112231", "openalex_id": null, "source_url": "https://doi.org/10.1002/advs.202413786", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Pharmacology,Mechanism of Action,Epigenetics,Review Article,Transcriptomics,Microbiome", "study_type": "Review Article", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:03", "bibtex": null, "source_record_id": "PMID:40112231", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1002/advs.202413786", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:40112231", "source_url": "https://doi.org/10.1002/advs.202413786", "doi": "10.1002/advs.202413786", "pmid": "40112231", "publication_date": "2025-03-19", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3457, "title": "Psilocybin in Alcohol Use Disorder With Comorbid Depression", "authors": "Centre Hospitalier Universitaire de Nīmes", "journal": "ClinicalTrials.gov", "publication_date": "2025-03-18", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06235411", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Mechanism of Action,Clinical Trial,Observational Study,Safety,Inflammation,Immune Function", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06235411", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06235411", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06235411", "source_url": "https://clinicaltrials.gov/study/NCT06235411", "doi": "", "pmid": "", "publication_date": "2025-03-18", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3530, "title": "A Randomized, Placebo-controlled Trial of Psychedelic-assisted Psychotherapy With Single Dose Psilocybin for Frontline Clinicians Experiencing COVID-related Symptoms of Depression and Burnout", "authors": "University of Washington", "journal": "ClinicalTrials.gov", "publication_date": "2025-03-17", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05163496", "substance_tags": "psilocybin", "topic_tags": "Depression,Healthcare Workers", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05163496", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05163496", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05163496", "source_url": "https://clinicaltrials.gov/study/NCT05163496", "doi": "", "pmid": "", "publication_date": "2025-03-17", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 750, "title": "Exploring the potential of psychedelic-assisted psychotherapy for moral injury: A scoping review.", "authors": "Kurkova V, Winkler O, Greenshaw A, Jetly R, Swainson J, Lodewyk K, Saghafi P, Dennett E, Burback L.", "journal": null, "publication_date": "2025-03-17", "publication_year": 2025, "doi": "10.1016/j.pnpbp.2025.111333", "pubmed_id": "40113127", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.pnpbp.2025.111333", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,End-of-Life Distress,Personality Change,Review Article", "study_type": "Review Article", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:04", "bibtex": null, "source_record_id": "PMID:40113127", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.pnpbp.2025.111333", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:40113127", "source_url": "https://doi.org/10.1016/j.pnpbp.2025.111333", "doi": "10.1016/j.pnpbp.2025.111333", "pmid": "40113127", "publication_date": "2025-03-17", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 778, "title": "A Modern Overview of the Potential Therapeutic Effects of Psilocybin in the Treatment of Depressive Disorders, Treatment-Resistant Depression, and End-of-Life Distress.", "authors": "Dino F.", "journal": null, "publication_date": "2025-03-16", "publication_year": 2025, "doi": "10.7759/cureus.80707", "pubmed_id": "40242672", "openalex_id": null, "source_url": "https://doi.org/10.7759/cureus.80707", "substance_tags": "psilocybin", "topic_tags": "Depression,End-of-Life Distress,Pharmacology,Review Article,Treatment-Resistant Depression,Safety,Drug Interactions,Contraindications", "study_type": "Review Article", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:01", "bibtex": null, "source_record_id": "PMID:40242672", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.7759/cureus.80707", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:40242672", "source_url": "https://doi.org/10.7759/cureus.80707", "doi": "10.7759/cureus.80707", "pmid": "40242672", "publication_date": "2025-03-16", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4426, "title": "The renaissance of psychedelics in modern psychiatry: a new breakthrough or the myth of a “magic bullet”?", "authors": "Valentin Yurievich Skryabin", "journal": "Neurology Bulletin", "publication_date": "2025-03-13", "publication_year": 2025, "doi": "10.17816/nb639991", "pubmed_id": null, "openalex_id": "https://openalex.org/W4408435134", "source_url": "https://doi.org/10.17816/nb639991", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,OCD,Review Article", "study_type": "Review Article", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:40", "last_checked": "2026-07-04 07:00:34", "bibtex": null, "source_record_id": "DOI:10.17816/nb639991", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.17816/nb639991", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.17816/nb639991", "source_url": "https://doi.org/10.17816/nb639991", "doi": "10.17816/nb639991", "pmid": "", "publication_date": "2025-03-13", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 783, "title": "Therapeutic Potential of Psilocybin for Treating Neuropsychiatric Long COVID Symptoms: A Reddit Investigation", "authors": "Lukas Bobak, Ian Dorney, Alexsandra Kovacevich, Brian S. Barnett", "journal": "Journal of Psychoactive Drugs", "publication_date": "2025-03-13", "publication_year": 2025, "doi": "10.1080/02791072.2025.2478097", "pubmed_id": "40084630", "openalex_id": "https://openalex.org/W4408456788", "source_url": "https://doi.org/10.1080/02791072.2025.2478097", "substance_tags": "psilocybin", "topic_tags": "Depression,Observational Study", "study_type": "Observational Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:34", "bibtex": null, "source_record_id": "PMID:40084630", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1080/02791072.2025.2478097", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:40084630", "source_url": "https://doi.org/10.1080/02791072.2025.2478097", "doi": "10.1080/02791072.2025.2478097", "pmid": "40084630", "publication_date": "2025-03-13", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3649, "title": "Effects of Psilocybin in Advanced-Stage Cancer Patients With Anxiety", "authors": "Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center", "journal": "ClinicalTrials.gov", "publication_date": "2025-03-12", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT00302744", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Chronic Pain,Consciousness,Spirituality,Cancer Patients", "study_type": "Other", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:34", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT00302744", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT00302744", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT00302744", "source_url": "https://clinicaltrials.gov/study/NCT00302744", "doi": "", "pmid": "", "publication_date": "2025-03-12", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4430, "title": "PSYCHEDELIC PHARMACOLOGY IN PSYCHIATRY: THE MECHANISMS AND THERAPEUTIC POTENTIAL OF PSILOCYBIN, MDMA, AND LSD IN MENTAL HEALTH DISORDERS", "authors": "Dr Hafiz Shafique Ahmad, Muhammad Waqar Ali, Usman Ul Haq", "journal": "Journal of medical & health sciences review.", "publication_date": "2025-03-10", "publication_year": 2025, "doi": "10.62019/r713mw08", "pubmed_id": null, "openalex_id": "https://openalex.org/W4408376371", "source_url": "https://doi.org/10.62019/r713mw08", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Neuroplasticity,Pharmacology,Mechanism of Action,Receptor Pharmacology,Default Mode Network,Consciousness,Aging,Emotional Processing,Treatment-Resistant Depression", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:40", "last_checked": "2026-07-04 07:00:34", "bibtex": null, "source_record_id": "DOI:10.62019/r713mw08", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.62019/r713mw08", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.62019/r713mw08", "source_url": "https://doi.org/10.62019/r713mw08", "doi": "10.62019/r713mw08", "pmid": "", "publication_date": "2025-03-10", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3116, "title": "Revealing Changes in Linear and Nonlinear Functional Connectivity After Psilocybin and Escitalopram Treatment in Patients with Depression", "authors": "Quah S, Glick C, Roseman L, Pasquini L, Carhart-Harris R, Saggar M.", "journal": "bioRxiv", "publication_date": "2025-03-09", "publication_year": 2025, "doi": "10.1101/2025.03.05.641592", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.1101/2025.03.05.641592", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging,Mechanism of Action,Default Mode Network,Drug Interactions", "study_type": "Other", "source_name": "bioRxiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:46", "last_checked": "2026-07-01 11:22:01", "bibtex": null, "source_record_id": "DOI:10.1101/2025.03.05.641592", "abstract_available": true, "abstract_source": "bioRxiv", "abstract_source_url": "https://doi.org/10.1101/2025.03.05.641592", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "bioRxiv", "source_record_id": "DOI:10.1101/2025.03.05.641592", "source_url": "https://doi.org/10.1101/2025.03.05.641592", "doi": "10.1101/2025.03.05.641592", "pmid": "", "publication_date": "2025-03-09", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 565, "title": "Current Evidence for the Role of Rapid-Acting Antidepressants in Bipolar Depression: A Perspective and Plan for Action.", "authors": "Repple J, Bayas M, Möser C, Kobayashi NF, Reif A.", "journal": null, "publication_date": "2025-03-07", "publication_year": 2025, "doi": "10.1016/j.biopsych.2025.02.903", "pubmed_id": "40064389", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.biopsych.2025.02.903", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Review Article,Safety", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:04", "bibtex": null, "source_record_id": "PMID:40064389", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.biopsych.2025.02.903", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:40064389", "source_url": "https://doi.org/10.1016/j.biopsych.2025.02.903", "doi": "10.1016/j.biopsych.2025.02.903", "pmid": "40064389", "publication_date": "2025-03-07", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4431, "title": "Risks of using psilocybin in treatment of treatment-resistant depression", "authors": "Michał Orzechowski, Joanna Orzechowska, Paulina Fijałek, Jan Karczmarz, Aleksandra Paprocka, Marika Gutowska, Agnieszka Kosińska, Urszula Świrk, Wiktoria Belcarz, Katarzyna Kalinowska", "journal": "Journal of Education Health and Sport", "publication_date": "2025-03-05", "publication_year": 2025, "doi": "10.12775/jehs.2025.79.58319", "pubmed_id": null, "openalex_id": "https://openalex.org/W4408197223", "source_url": "https://doi.org/10.12775/jehs.2025.79.58319", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Review Article,Treatment-Resistant Depression,Safety", "study_type": "Review Article", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:40", "last_checked": "2026-07-04 07:00:34", "bibtex": null, "source_record_id": "DOI:10.12775/jehs.2025.79.58319", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.12775/jehs.2025.79.58319", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.12775/jehs.2025.79.58319", "source_url": "https://doi.org/10.12775/jehs.2025.79.58319", "doi": "10.12775/jehs.2025.79.58319", "pmid": "", "publication_date": "2025-03-05", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3666, "title": "Acute Effects of 2C-B Compared With MDMA and Psilocybin in Healthy Subjects", "authors": "University Hospital, Basel, Switzerland", "journal": "ClinicalTrials.gov", "publication_date": "2025-03-04", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05523401", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,PTSD,Pharmacology,Receptor Pharmacology,Clinical Trial,In Vitro Study,Safety,Drug Interactions", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:34", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05523401", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05523401", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05523401", "source_url": "https://clinicaltrials.gov/study/NCT05523401", "doi": "", "pmid": "", "publication_date": "2025-03-04", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 788, "title": "Further education in psychedelic-assisted therapy - experiences from Switzerland.", "authors": "Aicher HD, Müller F, Gasser P.", "journal": null, "publication_date": "2025-03-04", "publication_year": 2025, "doi": "10.1186/s12909-025-06871-y", "pubmed_id": "40045361", "openalex_id": null, "source_url": "https://doi.org/10.1186/s12909-025-06871-y", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Consciousness,Clinical Trial,Treatment-Resistant Depression", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:04", "bibtex": null, "source_record_id": "PMID:40045361", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1186/s12909-025-06871-y", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:40045361", "source_url": "https://doi.org/10.1186/s12909-025-06871-y", "doi": "10.1186/s12909-025-06871-y", "pmid": "40045361", "publication_date": "2025-03-04", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4433, "title": "Could psilocin rescue chronic, stress-accelerated, transcriptional aging in brain?", "authors": "Craig, Danny R, Blalock, Eric M.", "journal": "UKnowledge (University of Kentucky)", "publication_date": "2025-03-03", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": "https://openalex.org/W7110662772", "source_url": "https://uknowledge.uky.edu/jpns/vol2/iss1/1", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Neuroplasticity,Pharmacology,Mechanism of Action,Receptor Pharmacology,Aging,Cellular Senescence,Resilience,Clinical Trial,Randomized Controlled Trial,Animal Study,Older Adults,Adolescents,Treatment-Resistant Depression,Safety,Drug Interactions,Transcriptomics,Inflammation", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:40", "last_checked": "2026-07-04 07:00:34", "bibtex": null, "source_record_id": "https://uknowledge.uky.edu/jpns/vol2/iss1/1", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://uknowledge.uky.edu/jpns/vol2/iss1/1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "https://uknowledge.uky.edu/jpns/vol2/iss1/1", "source_url": "https://uknowledge.uky.edu/jpns/vol2/iss1/1", "doi": "", "pmid": "", "publication_date": "2025-03-03", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4434, "title": "Psilocybin therapy might help frontline pandemic workers", "authors": "", "journal": "The Brown University Psychopharmacology Update", "publication_date": "2025-03-02", "publication_year": 2025, "doi": "10.1002/pu.31292", "pubmed_id": null, "openalex_id": "https://openalex.org/W4408154898", "source_url": "https://doi.org/10.1002/pu.31292", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Addiction,Pharmacology,Clinical Trial,Healthcare Workers,Adverse Events", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:40", "last_checked": "2026-07-04 07:00:34", "bibtex": null, "source_record_id": "DOI:10.1002/pu.31292", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1002/pu.31292", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1002/pu.31292", "source_url": "https://doi.org/10.1002/pu.31292", "doi": "10.1002/pu.31292", "pmid": "", "publication_date": "2025-03-02", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 792, "title": "Psychedelic-assisted therapy: An overview for the internist.", "authors": "Barnett BS, Mauney EE, King F.", "journal": null, "publication_date": "2025-03-02", "publication_year": 2025, "doi": "10.3949/ccjm.92a.24032", "pubmed_id": "40032306", "openalex_id": null, "source_url": "https://doi.org/10.3949/ccjm.92a.24032", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Addiction,Healthcare Workers", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:02", "bibtex": null, "source_record_id": "PMID:40032306", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.3949/ccjm.92a.24032", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:40032306", "source_url": "https://doi.org/10.3949/ccjm.92a.24032", "doi": "10.3949/ccjm.92a.24032", "pmid": "40032306", "publication_date": "2025-03-02", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 790, "title": "Results From a Long-Term Observational Follow-Up Study of a Single Dose of Psilocybin for a Treatment-Resistant Episode of Major Depressive Disorder", "authors": "Guy M. Goodwin, Ania Nowakowska, Merve Atli, Boadie W. Dunlop, David Feifel, David J. Hellerstein, Lindsey Marwood, Zainib Shabir, Sunil Mistry, S. C. Stansfield, Emma Teoh, Joyce Tsai, Matthew B. Young, Ekaterina Malievskaia", "journal": "The Journal of Clinical Psychiatry", "publication_date": "2025-03-02", "publication_year": 2025, "doi": "10.4088/jcp.24m15449", "pubmed_id": "40047545", "openalex_id": "https://openalex.org/W4408151066", "source_url": "https://doi.org/10.4088/jcp.24m15449", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Mechanism of Action,Observational Study,Treatment-Resistant Depression,Adverse Events,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:34", "bibtex": null, "source_record_id": "PMID:40047545", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.4088/jcp.24m15449", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:40047545", "source_url": "https://doi.org/10.4088/jcp.24m15449", "doi": "10.4088/jcp.24m15449", "pmid": "40047545", "publication_date": "2025-03-02", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 797, "title": "Psychedelics for Cancer Pain and Associated Psychological Distress: A Narrative Review of a Potential Strategy.", "authors": "Belitzky E, Ravani Carvalho LV, Taylor M, Ortiz CN, Baum L, Fiellin DA, Lustberg MB.", "journal": null, "publication_date": "2025-02-28", "publication_year": 2025, "doi": "10.1002/cam4.70586", "pubmed_id": "40052631", "openalex_id": null, "source_url": "https://doi.org/10.1002/cam4.70586", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Chronic Pain,Clinical Trial,Review Article,Cancer Patients,Safety", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:04", "bibtex": null, "source_record_id": "PMID:40052631", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1002/cam4.70586", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:40052631", "source_url": "https://doi.org/10.1002/cam4.70586", "doi": "10.1002/cam4.70586", "pmid": "40052631", "publication_date": "2025-02-28", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3764, "title": "Sociodemographic and mental-health characteristics of psychedelic-assisted therapy participants: Latent class analysis of a cross-sectional, purposive online sample", "authors": "Petrovitch D, Hosford S, Littlefield AK, Austin-Robillard H.", "journal": "PsyArXiv", "publication_date": "2025-02-27", "publication_year": 2025, "doi": "10.31234/osf.io/26tz7_v1", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.31234/osf.io/26tz7_v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Clinical Trial", "study_type": "Clinical Trial", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:10:19", "last_checked": "2026-07-01 11:22:02", "bibtex": null, "source_record_id": "DOI:10.31234/osf.io/26tz7_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://doi.org/10.31234/osf.io/26tz7_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "DOI:10.31234/osf.io/26tz7_v1", "source_url": "https://doi.org/10.31234/osf.io/26tz7_v1", "doi": "10.31234/osf.io/26tz7_v1", "pmid": "", "publication_date": "2025-02-27", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3196, "title": "Sociodemographic and mental-health characteristics of psychedelic-assisted therapy participants: Latent class analysis of a cross-sectional, purposive online sample", "authors": "", "journal": "PsyArXiv", "publication_date": "2025-02-27", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://osf.io/preprints/psyarxiv/26tz7_v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Pharmacology,Clinical Trial", "study_type": "Clinical Trial", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:48", "last_checked": "2026-07-01 11:22:30", "bibtex": null, "source_record_id": "https://osf.io/preprints/psyarxiv/26tz7_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/26tz7_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "https://osf.io/preprints/psyarxiv/26tz7_v1", "source_url": "https://osf.io/preprints/psyarxiv/26tz7_v1", "doi": "", "pmid": "", "publication_date": "2025-02-27", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 800, "title": "Serotonergic Psychedelics Rapidly Modulate Evoked Glutamate Release in Cultured Cortical Neurons", "authors": "Aneta Petrušková, Debarpan Guhathakurta, Enes Yağız Akdaş, Bartomeu Perelló-Amorós, Renato Frischknecht, Eva-Maria Weiss, Tomáš Páleníček, Anna Fejtová", "journal": "Journal of Neurochemistry", "publication_date": "2025-02-27", "publication_year": 2025, "doi": "10.1111/jnc.70020", "pubmed_id": "40022486", "openalex_id": "https://openalex.org/W4408089796", "source_url": "https://doi.org/10.1111/jnc.70020", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Anxiety,Addiction,End-of-Life Distress,Neuroplasticity,Brain Imaging,Pharmacology,Mechanism of Action,Receptor Pharmacology,Aging,Animal Study", "study_type": "Animal Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:34", "bibtex": null, "source_record_id": "PMID:40022486", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1111/jnc.70020", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:40022486", "source_url": "https://doi.org/10.1111/jnc.70020", "doi": "10.1111/jnc.70020", "pmid": "40022486", "publication_date": "2025-02-27", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 815, "title": "A review of psychedelics trials completed in depression, informed by European regulatory perspectives.", "authors": "Silva F, Butlen-Ducuing F, Guizzaro L, Balabanov P.", "journal": null, "publication_date": "2025-02-25", "publication_year": 2025, "doi": "10.1016/j.nsa.2025.105516", "pubmed_id": "40654583", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.nsa.2025.105516", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Review Article,Treatment-Resistant Depression,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:04", "bibtex": null, "source_record_id": "PMID:40654583", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.nsa.2025.105516", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:40654583", "source_url": "https://doi.org/10.1016/j.nsa.2025.105516", "doi": "10.1016/j.nsa.2025.105516", "pmid": "40654583", "publication_date": "2025-02-25", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 719, "title": "Psychedelic-assisted Therapy as a Promising Treatment for Irritable Bowel Syndrome.", "authors": "Mauney E, King F, Burton-Murray H, Kuo B.", "journal": null, "publication_date": "2025-02-16", "publication_year": 2025, "doi": "10.1097/mcg.0000000000002149", "pubmed_id": "39998940", "openalex_id": null, "source_url": "https://doi.org/10.1097/mcg.0000000000002149", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Chronic Pain,Headache / Migraine,Neuroplasticity,Mechanism of Action,Default Mode Network,Drug Interactions", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:04", "bibtex": null, "source_record_id": "PMID:39998940", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1097/mcg.0000000000002149", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:39998940", "source_url": "https://doi.org/10.1097/mcg.0000000000002149", "doi": "10.1097/mcg.0000000000002149", "pmid": "39998940", "publication_date": "2025-02-16", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 822, "title": "CORRECTION: Efficacy of psilocybin for treating symptoms of depression: systematic review and meta-analysis.", "authors": "", "journal": null, "publication_date": "2025-02-09", "publication_year": 2025, "doi": "10.1136/bmj.r111", "pubmed_id": "39929528", "openalex_id": null, "source_url": "https://doi.org/10.1136/bmj.r111", "substance_tags": "psilocybin", "topic_tags": "Depression,Meta-Analysis,Systematic Review,Review Article", "study_type": "Meta-Analysis", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:03", "bibtex": null, "source_record_id": "PMID:39929528", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:39929528", "source_url": "https://doi.org/10.1136/bmj.r111", "doi": "10.1136/bmj.r111", "pmid": "39929528", "publication_date": "2025-02-09", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 826, "title": "Emerging Medications for Treatment-Resistant Depression: A Review with Perspective on Mechanisms and Challenges.", "authors": "Lucido MJ, Dunlop BW.", "journal": null, "publication_date": "2025-02-05", "publication_year": 2025, "doi": "10.3390/brainsci15020161", "pubmed_id": "40002494", "openalex_id": null, "source_url": "https://doi.org/10.3390/brainsci15020161", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Review Article,Treatment-Resistant Depression,Inflammation,Immune Function", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:05", "bibtex": null, "source_record_id": "PMID:40002494", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.3390/brainsci15020161", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:40002494", "source_url": "https://doi.org/10.3390/brainsci15020161", "doi": "10.3390/brainsci15020161", "pmid": "40002494", "publication_date": "2025-02-05", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4443, "title": "Psilocybin mushroom stewardship: A qualitative inquiry into practices and priorities of “underground” psilocybin mushroom practitioners", "authors": "Shannon Hughes, Lucia Terpak, Reilly Capps, Pam Peters, Nicole Lilly, Dylan Rivard", "journal": "Journal of Psychedelic Studies", "publication_date": "2025-02-04", "publication_year": 2025, "doi": "10.1556/2054.2025.00375", "pubmed_id": null, "openalex_id": "https://openalex.org/W4407157019", "source_url": "https://doi.org/10.1556/2054.2025.00375", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,OCD,Receptor Pharmacology,Personality Change,Mystical Experience,Safety", "study_type": "Qualitative Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:41", "last_checked": "2026-07-04 07:00:34", "bibtex": null, "source_record_id": "DOI:10.1556/2054.2025.00375", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1556/2054.2025.00375", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1556/2054.2025.00375", "source_url": "https://doi.org/10.1556/2054.2025.00375", "doi": "10.1556/2054.2025.00375", "pmid": "", "publication_date": "2025-02-04", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 827, "title": "Psychedelics assisting therapy, or therapy assisting psychedelics? The importance of psychotherapy in psychedelic-assisted therapy", "authors": "Joseph A. Zamaria, Gisele Fernandes-Osterhold, Jonathan Shedler, Rachel Yehuda", "journal": "Frontiers in Psychology", "publication_date": "2025-02-04", "publication_year": 2025, "doi": "10.3389/fpsyg.2025.1505894", "pubmed_id": "39973948", "openalex_id": "https://openalex.org/W4407181198", "source_url": "https://doi.org/10.3389/fpsyg.2025.1505894", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Addiction,Consciousness,Emotional Processing,Clinical Trial,Observational Study,Treatment-Resistant Depression,Healthcare Workers,Safety,Drug Interactions", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:34", "bibtex": null, "source_record_id": "PMID:39973948", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.3389/fpsyg.2025.1505894", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:39973948", "source_url": "https://doi.org/10.3389/fpsyg.2025.1505894", "doi": "10.3389/fpsyg.2025.1505894", "pmid": "39973948", "publication_date": "2025-02-04", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 830, "title": "Investigating novel pharmacological strategies for treatment-resistant depression: focus on new mechanisms and approaches.", "authors": "de Miranda AS, C B Toscano E, Venna VR, Graeff FG, Teixeira AL.", "journal": null, "publication_date": "2025-02-02", "publication_year": 2025, "doi": "10.1080/17460441.2025.2460674", "pubmed_id": "39885729", "openalex_id": null, "source_url": "https://doi.org/10.1080/17460441.2025.2460674", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Mechanism of Action,Clinical Trial,Treatment-Resistant Depression,Healthcare Workers", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:04", "bibtex": null, "source_record_id": "PMID:39885729", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1080/17460441.2025.2460674", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:39885729", "source_url": "https://doi.org/10.1080/17460441.2025.2460674", "doi": "10.1080/17460441.2025.2460674", "pmid": "39885729", "publication_date": "2025-02-02", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 802, "title": "Psilocybin-assisted psychotherapy for Parkinson's disease without depression: A case-report", "authors": "Vanessa Fleury, Emilie Tomkova, Sabina Catalano Chiuvé, Louise Penzenstadler", "journal": "Journal of Parkinson s Disease", "publication_date": "2025-02-01", "publication_year": 2025, "doi": "10.1177/1877718x241312604", "pubmed_id": "39973494", "openalex_id": "https://openalex.org/W4407078896", "source_url": "https://doi.org/10.1177/1877718x241312604", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Receptor Pharmacology,Wellbeing,Emotional Processing,Treatment-Resistant Depression", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:34", "bibtex": null, "source_record_id": "PMID:39973494", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1177/1877718x241312604", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:39973494", "source_url": "https://doi.org/10.1177/1877718x241312604", "doi": "10.1177/1877718x241312604", "pmid": "39973494", "publication_date": "2025-02-01", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4455, "title": "BEHAVIORAL ANALYSES OF ANTIDEPRESSANT-LIKE EFFECT OF SEROTONERGIC PSYCHEDELICS IN MICE", "authors": "Daisuke Ibi, Rika Takaba, Keisuke Yoshida, Takayoshi Mamiya, Shinji Kitagaki, Masayuki Hiramatsu", "journal": "The International Journal of Neuropsychopharmacology", "publication_date": "2025-01-31", "publication_year": 2025, "doi": "10.1093/ijnp/pyae059.584", "pubmed_id": null, "openalex_id": "https://openalex.org/W4407387174", "source_url": "https://doi.org/10.1093/ijnp/pyae059.584", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Anxiety,Pharmacology,Receptor Pharmacology,Animal Study", "study_type": "Animal Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:41", "last_checked": "2026-07-04 07:00:34", "bibtex": null, "source_record_id": "DOI:10.1093/ijnp/pyae059.584", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1093/ijnp/pyae059.584", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1093/ijnp/pyae059.584", "source_url": "https://doi.org/10.1093/ijnp/pyae059.584", "doi": "10.1093/ijnp/pyae059.584", "pmid": "", "publication_date": "2025-01-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4450, "title": "Latent Class Analysis of Changes in Substance Use and Depressive Symptoms following Naturalistic Psilocybin Use: Results from a Prospective Longitudinal Survey", "authors": "Jérémie Richard, Sandeep M. Nayak, Nathan D. Sepeda, Albert Garcia-Romeu", "journal": "Drug and Alcohol Dependence", "publication_date": "2025-01-31", "publication_year": 2025, "doi": "10.1016/j.drugalcdep.2024.112184", "pubmed_id": null, "openalex_id": "https://openalex.org/W4407076188", "source_url": "https://doi.org/10.1016/j.drugalcdep.2024.112184", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Observational Study", "study_type": "Observational Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:41", "last_checked": "2026-07-04 07:00:34", "bibtex": null, "source_record_id": "DOI:10.1016/j.drugalcdep.2024.112184", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.drugalcdep.2024.112184", "source_url": "https://doi.org/10.1016/j.drugalcdep.2024.112184", "doi": "10.1016/j.drugalcdep.2024.112184", "pmid": "", "publication_date": "2025-01-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3292, "title": "BEHAVIORAL PHENOTYPING AND METABOLOMIC COMPARISON OF CHEMICALLY SYNTHESIZED PSILOCYBIN AND PSYCHEDELIC MUSHROOM EXTRACT IN A ZEBRAFISH DEPRESSION MODEL", "authors": "", "journal": null, "publication_date": "2025-01-31", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://europepmc.org/article/PMC/PMC11815225", "substance_tags": "psilocybin", "topic_tags": "Depression,Metabolomics", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 11:03:50", "last_checked": "2026-07-01 11:22:03", "bibtex": null, "source_record_id": "https://europepmc.org/article/PMC/PMC11815225", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "https://europepmc.org/article/PMC/PMC11815225", "source_url": "https://europepmc.org/article/PMC/PMC11815225", "doi": "", "pmid": "", "publication_date": "2025-01-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3291, "title": "ASSOCIATIONS BETWEEN ESCITALOPRAM AND PSILOCYBIN THERAPY AND BRAIN RESTING-STATE FUNCTIONAL CONNECTIVITY IN MAJOR DEPRESSIVE DISORDER", "authors": "", "journal": null, "publication_date": "2025-01-31", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://europepmc.org/article/PMC/PMC11814992", "substance_tags": "psilocybin", "topic_tags": "Depression", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 11:03:50", "last_checked": "2026-07-01 11:22:03", "bibtex": null, "source_record_id": "https://europepmc.org/article/PMC/PMC11814992", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "https://europepmc.org/article/PMC/PMC11814992", "source_url": "https://europepmc.org/article/PMC/PMC11814992", "doi": "", "pmid": "", "publication_date": "2025-01-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 832, "title": "The Acceptability of Psychedelic-Assisted Therapy Amongst Mental Health Consumers: Utilising the Theory of Planned Behaviour", "authors": "Eva Louie, Ellen Towers, Alyssa R. Morse, Joshua Watt, Zachary Bryant, Paul Haber, Kirsten C. Morley", "journal": "International Journal of Mental Health Nursing", "publication_date": "2025-01-31", "publication_year": 2025, "doi": "10.1111/inm.70010", "pubmed_id": "39952893", "openalex_id": "https://openalex.org/W4407570589", "source_url": "https://doi.org/10.1111/inm.70010", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Observational Study,Treatment-Resistant Depression,Safety", "study_type": "Observational Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:34", "bibtex": null, "source_record_id": "PMID:39952893", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1111/inm.70010", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:39952893", "source_url": "https://doi.org/10.1111/inm.70010", "doi": "10.1111/inm.70010", "pmid": "39952893", "publication_date": "2025-01-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 831, "title": "Among Psychedelics, Only Psilocybin Has Demonstrated Benefit to Treat Depression.", "authors": "Allen F. Shaughnessy", "journal": "PubMed", "publication_date": "2025-01-31", "publication_year": 2025, "doi": null, "pubmed_id": "39964936", "openalex_id": "https://openalex.org/W4407760123", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39964936", "substance_tags": "psilocybin", "topic_tags": "Depression", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:34", "bibtex": null, "source_record_id": "PMID:39964936", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:39964936", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39964936", "doi": "", "pmid": "39964936", "publication_date": "2025-01-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 775, "title": "Psychedelics in neuroinflammation: Mechanisms and therapeutic potential.", "authors": "de Deus JL, Maia JM, Soriano RN, Amorim MR, Branco LGS.", "journal": null, "publication_date": "2025-01-30", "publication_year": 2025, "doi": "10.1016/j.pnpbp.2025.111278", "pubmed_id": "39892847", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.pnpbp.2025.111278", "substance_tags": "psilocybin", "topic_tags": "Depression,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Review Article,Drug Interactions,Inflammation", "study_type": "Review Article", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:04", "bibtex": null, "source_record_id": "PMID:39892847", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.pnpbp.2025.111278", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:39892847", "source_url": "https://doi.org/10.1016/j.pnpbp.2025.111278", "doi": "10.1016/j.pnpbp.2025.111278", "pmid": "39892847", "publication_date": "2025-01-30", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 847, "title": "Mushrooms, Microdosing, and Mental Illness: The Effect of Psilocybin on Neurotransmitters, Neuroinflammation, and Neuroplasticity.", "authors": "Kinderlehrer DA.", "journal": null, "publication_date": "2025-01-28", "publication_year": 2025, "doi": "10.2147/ndt.s500337", "pubmed_id": "39897712", "openalex_id": null, "source_url": "https://doi.org/10.2147/ndt.s500337", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Neuroplasticity,Receptor Pharmacology,Default Mode Network,Microdosing,Inflammation", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:00", "bibtex": null, "source_record_id": "PMID:39897712", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.2147/ndt.s500337", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:39897712", "source_url": "https://doi.org/10.2147/ndt.s500337", "doi": "10.2147/ndt.s500337", "pmid": "39897712", "publication_date": "2025-01-28", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 817, "title": "Psychiatric Treatments with Short-Duration Psychedelics and AI-Driven Behavioral Monitoring.", "authors": "Kargbo RB.", "journal": null, "publication_date": "2025-01-28", "publication_year": 2025, "doi": "10.1021/acsmedchemlett.5c00031", "pubmed_id": "39967620", "openalex_id": null, "source_url": "https://doi.org/10.1021/acsmedchemlett.5c00031", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Receptor Pharmacology,Review Article,Animal Study,Treatment-Resistant Depression", "study_type": "Review Article", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:03", "bibtex": null, "source_record_id": "PMID:39967620", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1021/acsmedchemlett.5c00031", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:39967620", "source_url": "https://doi.org/10.1021/acsmedchemlett.5c00031", "doi": "10.1021/acsmedchemlett.5c00031", "pmid": "39967620", "publication_date": "2025-01-28", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 804, "title": "Suicide of a patient shortly after psilocybin-assisted psychedelic therapy: A case report", "authors": "Felix Müller, Thomas Sauer, Corina Hänny, Markus Mühlhauser, Undine E. Lang", "journal": "Psychiatry Research", "publication_date": "2025-01-28", "publication_year": 2025, "doi": "10.1016/j.psychres.2025.116381", "pubmed_id": "39889565", "openalex_id": "https://openalex.org/W4407011158", "source_url": "https://doi.org/10.1016/j.psychres.2025.116381", "substance_tags": "psilocybin", "topic_tags": "Depression,Emotional Processing,Case Report,Toxicity", "study_type": "Case Report", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:34", "bibtex": null, "source_record_id": "PMID:39889565", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1016/j.psychres.2025.116381", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:39889565", "source_url": "https://doi.org/10.1016/j.psychres.2025.116381", "doi": "10.1016/j.psychres.2025.116381", "pmid": "39889565", "publication_date": "2025-01-28", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 668, "title": "Effects of Psilocybin on Mouse Brain Microstructure", "authors": "Paloma C. Frautschi, Ajay Paul Singh, Nicholas A. Stowe, Sean M. Grady, Zarmeen Zahid, Matthew I. Banks, John-Paul J. Yu", "journal": "American Journal of Neuroradiology", "publication_date": "2025-01-28", "publication_year": 2025, "doi": "10.3174/ajnr.a8634", "pubmed_id": "39880687", "openalex_id": "https://openalex.org/W4406946828", "source_url": "https://doi.org/10.3174/ajnr.a8634", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging,Pharmacology,Mechanism of Action,Aging,Animal Study,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:34", "bibtex": null, "source_record_id": "PMID:39880687", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.3174/ajnr.a8634", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:39880687", "source_url": "https://doi.org/10.3174/ajnr.a8634", "doi": "10.3174/ajnr.a8634", "pmid": "39880687", "publication_date": "2025-01-28", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3679, "title": "A Phase II Randomized, Double-blind, Active Placebo-controlled Parallel Group Trial to Examine the Efficacy and Safety of Psilocybin in Treatment-resistant Major Depression", "authors": "Central Institute of Mental Health, Mannheim", "journal": "ClinicalTrials.gov", "publication_date": "2025-01-19", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT04670081", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:34", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT04670081", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT04670081", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT04670081", "source_url": "https://clinicaltrials.gov/study/NCT04670081", "doi": "", "pmid": "", "publication_date": "2025-01-19", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 722, "title": "Catalyst for change: Psilocybin's antidepressant mechanisms-A systematic review.", "authors": "Liebnau J, Betzler F, Kerber A.", "journal": null, "publication_date": "2025-01-19", "publication_year": 2025, "doi": "10.1177/02698811241312866", "pubmed_id": "39829391", "openalex_id": null, "source_url": "https://doi.org/10.1177/02698811241312866", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging,Mechanism of Action,Default Mode Network,Aging,Emotional Processing,Clinical Trial,Meta-Analysis,Systematic Review,Review Article", "study_type": "Meta-Analysis", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:02", "bibtex": null, "source_record_id": "PMID:39829391", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1177/02698811241312866", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:39829391", "source_url": "https://doi.org/10.1177/02698811241312866", "doi": "10.1177/02698811241312866", "pmid": "39829391", "publication_date": "2025-01-19", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 854, "title": "Uncovering Psychedelics: From Neural Circuits to Therapeutic Applications.", "authors": "Melani A, Bonaso M, Biso L, Zucchini B, Conversano C, Scarselli M.", "journal": null, "publication_date": "2025-01-18", "publication_year": 2025, "doi": "10.3390/ph18010130", "pubmed_id": "39861191", "openalex_id": null, "source_url": "https://doi.org/10.3390/ph18010130", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Neuroplasticity,Brain Imaging,Mechanism of Action,Default Mode Network,Consciousness,Aging,Emotional Processing,Spirituality,Clinical Trial,Review Article,Safety", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:04", "bibtex": null, "source_record_id": "PMID:39861191", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.3390/ph18010130", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:39861191", "source_url": "https://doi.org/10.3390/ph18010130", "doi": "10.3390/ph18010130", "pmid": "39861191", "publication_date": "2025-01-18", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 911, "title": "Transformative Therapies for Depression: Postpartum Depression, Major Depressive Disorder, and Treatment-Resistant Depression.", "authors": "Richardson E, Patterson R, Meltzer-Brody S, McClure R, Tow A.", "journal": null, "publication_date": "2025-01-15", "publication_year": 2025, "doi": "10.1146/annurev-med-050423-095712", "pubmed_id": "39527720", "openalex_id": null, "source_url": "https://doi.org/10.1146/annurev-med-050423-095712", "substance_tags": "psilocybin", "topic_tags": "Depression,Review Article,Treatment-Resistant Depression", "study_type": "Review Article", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:03", "bibtex": null, "source_record_id": "PMID:39527720", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1146/annurev-med-050423-095712", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:39527720", "source_url": "https://doi.org/10.1146/annurev-med-050423-095712", "doi": "10.1146/annurev-med-050423-095712", "pmid": "39527720", "publication_date": "2025-01-15", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4462, "title": "What are the benefits and harms of classical psychedelics (psilocybin and LSD) for treating anxiety, depression, and existential distress in people with life-threatening diseases?", "authors": "Amin Sharifan", "journal": "Cochrane Clinical Answers", "publication_date": "2025-01-12", "publication_year": 2025, "doi": "10.1002/cca.4512", "pubmed_id": null, "openalex_id": "https://openalex.org/W4406299512", "source_url": "https://doi.org/10.1002/cca.4512", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:41", "last_checked": "2026-07-04 07:00:34", "bibtex": null, "source_record_id": "DOI:10.1002/cca.4512", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1002/cca.4512", "source_url": "https://doi.org/10.1002/cca.4512", "doi": "10.1002/cca.4512", "pmid": "", "publication_date": "2025-01-12", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4463, "title": "Study finds encouraging results in psilocybin treatment for TRD patients", "authors": "Valerie A. Canady", "journal": "Mental Health Weekly", "publication_date": "2025-01-09", "publication_year": 2025, "doi": "10.1002/mhw.34292", "pubmed_id": null, "openalex_id": "https://openalex.org/W4406243180", "source_url": "https://doi.org/10.1002/mhw.34292", "substance_tags": "psilocybin", "topic_tags": "Depression,Pharmacology,Aging,Treatment-Resistant Depression,Safety", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:41", "last_checked": "2026-07-04 07:00:34", "bibtex": null, "source_record_id": "DOI:10.1002/mhw.34292", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1002/mhw.34292", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1002/mhw.34292", "source_url": "https://doi.org/10.1002/mhw.34292", "doi": "10.1002/mhw.34292", "pmid": "", "publication_date": "2025-01-09", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4464, "title": "PSYCHEDELICS IN THE TREATMENT OF MENTAL DISORDERS", "authors": "Eduardo d’Avila Lins Lacerda, Bianca Medeiros Ferraz da Nóbrega, Yasmin Mesquita Dias Franca Gadelha, Liliane Reis Teixeira, Manolo Altieri Espinar, Bruna Trigueiro Carlini, Gabriel Santa Cruz Lins, Anthonielly Leinat Lima, Isabel Azevedo, Paulo Heinrich Soares Bomtempo", "journal": "Health and Society", "publication_date": "2025-01-07", "publication_year": 2025, "doi": "10.51249/hs.v5i01.2377", "pubmed_id": null, "openalex_id": "https://openalex.org/W4406161181", "source_url": "https://doi.org/10.51249/hs.v5i01.2377", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Neuroplasticity,Receptor Pharmacology,Review Article,Safety,Drug Interactions", "study_type": "Review Article", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:41", "last_checked": "2026-07-04 07:00:34", "bibtex": null, "source_record_id": "DOI:10.51249/hs.v5i01.2377", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.51249/hs.v5i01.2377", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.51249/hs.v5i01.2377", "source_url": "https://doi.org/10.51249/hs.v5i01.2377", "doi": "10.51249/hs.v5i01.2377", "pmid": "", "publication_date": "2025-01-07", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 862, "title": "Neurobiological mechanisms of antidepressant properties of psilocybin: A systematic review of blood biomarkers.", "authors": "Constantino JL, van Dalfsen JH, Massetti S, Kamphuis J, Schoevers RA.", "journal": null, "publication_date": "2025-01-06", "publication_year": 2025, "doi": "10.1016/j.pnpbp.2025.111251", "pubmed_id": "39788410", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.pnpbp.2025.111251", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Receptor Pharmacology,Biomarkers,Clinical Trial,Systematic Review,Review Article,Animal Study,Healthy Volunteers", "study_type": "Systematic Review", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:01", "bibtex": null, "source_record_id": "PMID:39788410", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.pnpbp.2025.111251", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:39788410", "source_url": "https://doi.org/10.1016/j.pnpbp.2025.111251", "doi": "10.1016/j.pnpbp.2025.111251", "pmid": "39788410", "publication_date": "2025-01-06", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 760, "title": "Moderating factors in psilocybin-assisted treatment affecting mood and personality: A naturalistic, open-label investigation", "authors": "Mona Irrmischer, Drew Puxty, Barış Onur Yıldırım, J.B. Deijen, Hessel Engelbregt", "journal": "Psychopharmacology", "publication_date": "2025-01-06", "publication_year": 2025, "doi": "10.1007/s00213-024-06733-3", "pubmed_id": "39775022", "openalex_id": "https://openalex.org/W4406141686", "source_url": "https://doi.org/10.1007/s00213-024-06733-3", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Chronic Pain,Personality Change,Emotional Processing,Mystical Experience,Toxicity", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:34", "bibtex": null, "source_record_id": "PMID:39775022", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1007/s00213-024-06733-3", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:39775022", "source_url": "https://doi.org/10.1007/s00213-024-06733-3", "doi": "10.1007/s00213-024-06733-3", "pmid": "39775022", "publication_date": "2025-01-06", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 863, "title": "Clinical and preclinical evidence of psilocybin as antidepressant. A narrative review.", "authors": "Erkizia-Santamaría I, Horrillo I, Meana JJ, Ortega JE.", "journal": null, "publication_date": "2025-01-05", "publication_year": 2025, "doi": "10.1016/j.pnpbp.2025.111249", "pubmed_id": "39778644", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.pnpbp.2025.111249", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Anxiety,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Review Article,Animal Study,Safety,Toxicity", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:00", "bibtex": null, "source_record_id": "PMID:39778644", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.pnpbp.2025.111249", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:39778644", "source_url": "https://doi.org/10.1016/j.pnpbp.2025.111249", "doi": "10.1016/j.pnpbp.2025.111249", "pmid": "39778644", "publication_date": "2025-01-05", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 761, "title": "Psychedelic Treatments in Adolescent Psychopharmacology: Considering Safety, Ethics, and Scientific Rigor.", "authors": "Sutherland I, Ho MF, Croarkin PE.", "journal": null, "publication_date": "2025-01-05", "publication_year": 2025, "doi": "10.1089/cap.2024.0082", "pubmed_id": "39761065", "openalex_id": null, "source_url": "https://doi.org/10.1089/cap.2024.0082", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Pharmacology,Adolescents,Treatment-Resistant Depression,Safety", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:03", "bibtex": null, "source_record_id": "PMID:39761065", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1089/cap.2024.0082", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:39761065", "source_url": "https://doi.org/10.1089/cap.2024.0082", "doi": "10.1089/cap.2024.0082", "pmid": "39761065", "publication_date": "2025-01-05", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3201, "title": "Perturbing whole-brain models of brain hierarchy: an application for depression following pharmacological treatment", "authors": "Socoró Garrigosa M, Sanz Perl Y, Kringelbach ML, Carhart-Harris R, Vohryzek J, Deco G.", "journal": "bioRxiv", "publication_date": "2025-01-01", "publication_year": 2025, "doi": "10.1101/2025.01.01.631011", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.1101/2025.01.01.631011", "substance_tags": "psilocybin", "topic_tags": "Depression,Neuroplasticity,Clinical Trial", "study_type": "Clinical Trial", "source_name": "bioRxiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:48", "last_checked": "2026-07-01 11:22:02", "bibtex": null, "source_record_id": "DOI:10.1101/2025.01.01.631011", "abstract_available": true, "abstract_source": "bioRxiv", "abstract_source_url": "https://doi.org/10.1101/2025.01.01.631011", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "bioRxiv", "source_record_id": "DOI:10.1101/2025.01.01.631011", "source_url": "https://doi.org/10.1101/2025.01.01.631011", "doi": "10.1101/2025.01.01.631011", "pmid": "", "publication_date": "2025-01-01", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4494, "title": "Comparative Efficacy of Hallucinogens in Treating Mood Disorders Through a Meta-Analysis of Symptom Reduction, Dosage, and Duration", "authors": "Muniz, John Marco D.F.", "journal": "Journal of International Crisis and Risk Communication Research", "publication_date": "2024-12-31", "publication_year": 2024, "doi": null, "pubmed_id": null, "openalex_id": "https://openalex.org/W7112971088", "source_url": "https://stars.library.ucf.edu/hut2024/268", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Chronic Pain,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Aging,Clinical Trial,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Treatment-Resistant Depression", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:41", "last_checked": "2026-07-04 07:00:34", "bibtex": null, "source_record_id": "https://stars.library.ucf.edu/hut2024/268", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://stars.library.ucf.edu/hut2024/268", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "https://stars.library.ucf.edu/hut2024/268", "source_url": "https://stars.library.ucf.edu/hut2024/268", "doi": "", "pmid": "", "publication_date": "2024-12-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4488, "title": "Psilocybin-Assisted Therapy for Trauma-Related Disorders: A Scoping Review of a Depression-Dominated Evidence Base with Implications for Intimate Partner Violence-Related PTSD", "authors": "Hancock, Mackenzie, Shambhu Prasad Adhikari, Getz, Nicole", "journal": "Open Science Framework", "publication_date": "2024-12-31", "publication_year": 2024, "doi": "10.17605/osf.io/ar2s4", "pubmed_id": null, "openalex_id": "https://openalex.org/W7106330185", "source_url": "https://doi.org/10.17605/osf.io/ar2s4", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Clinical Trial,Systematic Review,Review Article,Safety", "study_type": "Systematic Review", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:41", "last_checked": "2026-07-04 07:00:34", "bibtex": null, "source_record_id": "DOI:10.17605/osf.io/ar2s4", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.17605/osf.io/ar2s4", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.17605/osf.io/ar2s4", "source_url": "https://doi.org/10.17605/osf.io/ar2s4", "doi": "10.17605/osf.io/ar2s4", "pmid": "", "publication_date": "2024-12-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4484, "title": "Alternative therapy for neurological and psychiatric disorders using psilocybin", "authors": "Henrique Tofoli Vieira Machado, GEOVANA MENDES DE SEIXAS, L. Silva, Mariana Duarte Garcia Brito, Gabriella Assink de Castro", "journal": null, "publication_date": "2024-12-31", "publication_year": 2024, "doi": "10.5327/1516-3180.cpn.1123", "pubmed_id": null, "openalex_id": "https://openalex.org/W4417514861", "source_url": "https://doi.org/10.5327/1516-3180.cpn.1123", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Chronic Pain,Mechanism of Action,Wellbeing,Emotional Processing,Clinical Trial,Randomized Controlled Trial,Systematic Review,Review Article,Treatment-Resistant Depression,Safety", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:41", "last_checked": "2026-07-04 07:00:34", "bibtex": null, "source_record_id": "DOI:10.5327/1516-3180.cpn.1123", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.5327/1516-3180.cpn.1123", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.5327/1516-3180.cpn.1123", "source_url": "https://doi.org/10.5327/1516-3180.cpn.1123", "doi": "10.5327/1516-3180.cpn.1123", "pmid": "", "publication_date": "2024-12-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4483, "title": "In Silico Evaluation of Tryptamine-Derived Schiff Bases as Modulators of the Serotonin 5-HT₂A Receptor", "authors": "Marina D. Kostić, Jana Nedić, Jovana S. Dragojević, Vera M. Divac", "journal": null, "publication_date": "2024-12-31", "publication_year": 2024, "doi": "10.46793/iccbikg25.477k", "pubmed_id": null, "openalex_id": "https://openalex.org/W4416739362", "source_url": "https://doi.org/10.46793/iccbikg25.477k", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Headache / Migraine,Pharmacology,Mechanism of Action,Receptor Pharmacology,Consciousness,Drug Interactions", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:41", "last_checked": "2026-07-04 07:00:34", "bibtex": null, "source_record_id": "DOI:10.46793/iccbikg25.477k", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.46793/iccbikg25.477k", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.46793/iccbikg25.477k", "source_url": "https://doi.org/10.46793/iccbikg25.477k", "doi": "10.46793/iccbikg25.477k", "pmid": "", "publication_date": "2024-12-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4482, "title": "Attitudes Towards Psilocybin: A General Population’s Opinions on Psilocybin and Psilocybin-Assisted Therapies", "authors": "Madison M. H. Simounet, Joy Drinnon", "journal": "Psi Chi Journal of Psychological Research", "publication_date": "2024-12-31", "publication_year": 2024, "doi": "10.24839/2325-7342.jn30.4.345", "pubmed_id": null, "openalex_id": "https://openalex.org/W4414907947", "source_url": "https://doi.org/10.24839/2325-7342.jn30.4.345", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,OCD,Observational Study", "study_type": "Observational Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:41", "last_checked": "2026-07-04 07:00:34", "bibtex": null, "source_record_id": "DOI:10.24839/2325-7342.jn30.4.345", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.24839/2325-7342.jn30.4.345", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.24839/2325-7342.jn30.4.345", "source_url": "https://doi.org/10.24839/2325-7342.jn30.4.345", "doi": "10.24839/2325-7342.jn30.4.345", "pmid": "", "publication_date": "2024-12-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4475, "title": "Effects of escitalopram and psilocybin therapy on mesolimbic resting-state functional connectivity in depression", "authors": "Rebecca Harding, Natalie Ertl, Rabia Zafar, Magnus Wall, Rajkanya Das, David Erritzøe, David Nutt, Robin Carhart-Harris", "journal": "Neuroscience Applied", "publication_date": "2024-12-31", "publication_year": 2024, "doi": "10.1016/j.nsa.2025.105421", "pubmed_id": null, "openalex_id": "https://openalex.org/W4408526135", "source_url": "https://doi.org/10.1016/j.nsa.2025.105421", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:41", "last_checked": "2026-07-04 07:00:34", "bibtex": null, "source_record_id": "DOI:10.1016/j.nsa.2025.105421", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.nsa.2025.105421", "source_url": "https://doi.org/10.1016/j.nsa.2025.105421", "doi": "10.1016/j.nsa.2025.105421", "pmid": "", "publication_date": "2024-12-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4471, "title": "Therapieresistente Depression: Studie zur Psilocybin-augmentierten Psychotherapie nicht erfolgreich", "authors": "Friederike Klein", "journal": "InFo Neurologie + Psychiatrie", "publication_date": "2024-12-31", "publication_year": 2024, "doi": "10.1007/s15005-024-4209-z", "pubmed_id": null, "openalex_id": "https://openalex.org/W4406591022", "source_url": "https://doi.org/10.1007/s15005-024-4209-z", "substance_tags": "psilocybin", "topic_tags": "Depression", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:41", "last_checked": "2026-07-04 07:00:34", "bibtex": null, "source_record_id": "DOI:10.1007/s15005-024-4209-z", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1007/s15005-024-4209-z", "source_url": "https://doi.org/10.1007/s15005-024-4209-z", "doi": "10.1007/s15005-024-4209-z", "pmid": "", "publication_date": "2024-12-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4468, "title": "The effects of psychedelics on neuroplasticity: A review of current research and the possibility of therapeutic application in psychiatry", "authors": "Mile Jevtić", "journal": "Engrami", "publication_date": "2024-12-31", "publication_year": 2024, "doi": "10.5937/engrami47-57385", "pubmed_id": null, "openalex_id": "https://openalex.org/W4413629699", "source_url": "https://doi.org/10.5937/engrami47-57385", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Consciousness,Review Article", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:41", "last_checked": "2026-07-04 07:00:34", "bibtex": null, "source_record_id": "DOI:10.5937/engrami47-57385", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.5937/engrami47-57385", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.5937/engrami47-57385", "source_url": "https://doi.org/10.5937/engrami47-57385", "doi": "10.5937/engrami47-57385", "pmid": "", "publication_date": "2024-12-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3687, "title": "Psilocybin Therapy for Depression and Anxiety in Parkinson's Disease: a Pilot Study", "authors": "Joshua Woolley, MD, PhD", "journal": "ClinicalTrials.gov", "publication_date": "2024-12-31", "publication_year": 2024, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT04932434", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Safety,Adverse Events", "study_type": "Other", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:34", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT04932434", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT04932434", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT04932434", "source_url": "https://clinicaltrials.gov/study/NCT04932434", "doi": "", "pmid": "", "publication_date": "2024-12-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 906, "title": "Compass Psychological Support Model for COMP360 Psilocybin Treatment of Serious Mental Health Conditions", "authors": "Namik Kirlić, Molly Lennard-Jones, Merve Atli, Ekaterina Malievskaia, Nadav Liam Modlin, Stéphanie Knatz Peck, Alice Gaillard, Guy M. Goodwin, Don Koelpin", "journal": "American Journal of Psychiatry", "publication_date": "2024-12-31", "publication_year": 2024, "doi": "10.1176/appi.ajp.20230884", "pubmed_id": "39741434", "openalex_id": "https://openalex.org/W4405978092", "source_url": "https://doi.org/10.1176/appi.ajp.20230884", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Treatment-Resistant Depression", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:34", "bibtex": null, "source_record_id": "PMID:39741434", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1176/appi.ajp.20230884", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:39741434", "source_url": "https://doi.org/10.1176/appi.ajp.20230884", "doi": "10.1176/appi.ajp.20230884", "pmid": "39741434", "publication_date": "2024-12-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 904, "title": "Psilocybin: From Psychiatric Pariah to Perceived Panacea.", "authors": "Fonzo GA, Wolfgang AS, Barksdale BR, Krystal JH, Carpenter LL, Kraguljac NV, Grzenda A, McDonald WM, Widge AS, Rodriguez CI, Nemeroff CB.", "journal": null, "publication_date": "2024-12-31", "publication_year": 2024, "doi": "10.1176/appi.ajp.20230682", "pubmed_id": "39741437", "openalex_id": null, "source_url": "https://doi.org/10.1176/appi.ajp.20230682", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,OCD,Eating Disorders,Mechanism of Action,Clinical Trial,Randomized Controlled Trial", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:00", "bibtex": null, "source_record_id": "PMID:39741437", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1176/appi.ajp.20230682", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:39741437", "source_url": "https://doi.org/10.1176/appi.ajp.20230682", "doi": "10.1176/appi.ajp.20230682", "pmid": "39741437", "publication_date": "2024-12-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 903, "title": "Benefits and Challenges of Ultra-Fast, Short-Acting Psychedelics in the Treatment of Depression.", "authors": "Ramaekers JG, Reckweg JT, Mason NL.", "journal": null, "publication_date": "2024-12-31", "publication_year": 2024, "doi": "10.1176/appi.ajp.20230890", "pubmed_id": "39741439", "openalex_id": null, "source_url": "https://doi.org/10.1176/appi.ajp.20230890", "substance_tags": "psilocybin", "topic_tags": "Depression,Pharmacology,Receptor Pharmacology,Clinical Trial,Review Article", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:04", "bibtex": null, "source_record_id": "PMID:39741439", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1176/appi.ajp.20230890", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:39741439", "source_url": "https://doi.org/10.1176/appi.ajp.20230890", "doi": "10.1176/appi.ajp.20230890", "pmid": "39741439", "publication_date": "2024-12-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 902, "title": "Single-Dose Psilocybin for Depression With Severe Treatment Resistance: An Open-Label Trial", "authors": "Scott T. Aaronson, Andrew van der Vaart, Tammy Miller, Jeffrey LaPratt, Kimberly Swartz, Audrey Shoultz, Margo Lauterbach, Trisha Suppes, Harold A. Sackeïm", "journal": "American Journal of Psychiatry", "publication_date": "2024-12-31", "publication_year": 2024, "doi": "10.1176/appi.ajp.20231063", "pubmed_id": "39741440", "openalex_id": "https://openalex.org/W4405955624", "source_url": "https://doi.org/10.1176/appi.ajp.20231063", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Chronic Pain,Clinical Trial,Treatment-Resistant Depression,Safety,Toxicity,Drug Interactions", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:34", "bibtex": null, "source_record_id": "PMID:39741440", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1176/appi.ajp.20231063", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:39741440", "source_url": "https://doi.org/10.1176/appi.ajp.20231063", "doi": "10.1176/appi.ajp.20231063", "pmid": "39741440", "publication_date": "2024-12-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 901, "title": "Research and Implementation of Psychedelic-Assisted Therapy in the Veterans Health Administration.", "authors": "Wolfgang AS, McClair VL, Schnurr PP, Holtzheimer PE, Woolley JD, Stauffer CS, Wolf RC, States LJ, Benedek DM, Capaldi VF, Bradley J, Fuller MA, Smyth MJ, Hermes EDA, Tenhula W, Wiechers IR", "journal": "The American journal of psychiatry", "publication_date": "2024-12-31", "publication_year": 2024, "doi": "10.1176/appi.ajp.20240751", "pubmed_id": "39741441", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/39741441/", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Veterans", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:20:36", "bibtex": null, "source_record_id": "PMID:39741441", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39741441", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39741441/", "doi": "10.1176/appi.ajp.20240751", "pmid": "39741441", "publication_date": "2024-12-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 900, "title": "Multidimensional Personality Changes Following Psilocybin-Assisted Therapy in Patients With Alcohol Use Disorder: Results From a Double-Blind, Placebo-Controlled Clinical Trial", "authors": "Broc A. Pagni, Richard J. Zeifman, Sarah E. Mennenga, Brennan M. Carrithers, Noam Goldway, Snehal Bhatt, Kelley C. O’Donnell, Stephen Ross, Michael P. Bogenschutz", "journal": "American Journal of Psychiatry", "publication_date": "2024-12-31", "publication_year": 2024, "doi": "10.1176/appi.ajp.20230887", "pubmed_id": "39741446", "openalex_id": "https://openalex.org/W4405955644", "source_url": "https://doi.org/10.1176/appi.ajp.20230887", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Chronic Pain,Personality Change,Clinical Trial,Randomized Controlled Trial,Safety,Toxicity", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:34", "bibtex": null, "source_record_id": "PMID:39741446", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1176/appi.ajp.20230887", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:39741446", "source_url": "https://doi.org/10.1176/appi.ajp.20230887", "doi": "10.1176/appi.ajp.20230887", "pmid": "39741446", "publication_date": "2024-12-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 899, "title": "Exploring Psychedelics Pharmacology: A Scoping Review Charting the Course of Psilocybin Pharmacokinetics.", "authors": "Manzano-Nunez R, Gomez DA, Toledo-Mendoza C, Perez-Otero M, Matilla IL, Prats C, Perez-Lopez E, Pardo H, Díaz-Pellicer P, De La Torre-Fornell R, Aldea AM.", "journal": null, "publication_date": "2024-12-31", "publication_year": 2024, "doi": "10.1097/wnf.0000000000000617", "pubmed_id": "39787428", "openalex_id": null, "source_url": "https://doi.org/10.1097/wnf.0000000000000617", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,End-of-Life Distress,Pharmacology,Clinical Trial,Review Article,Healthy Volunteers,Cancer Patients,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:00", "bibtex": null, "source_record_id": "PMID:39787428", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1097/wnf.0000000000000617", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:39787428", "source_url": "https://doi.org/10.1097/wnf.0000000000000617", "doi": "10.1097/wnf.0000000000000617", "pmid": "39787428", "publication_date": "2024-12-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 898, "title": "Psilocybin-Assisted Group Psychotherapy + Mindfulness Based Stress Reduction (MBSR) for Frontline Healthcare Provider COVID-19 Related Depression and Burnout: A Randomized Clinical Trial", "authors": "Lewis BR, Hendrick J, Byrne K, Odette M, Wu C, Garland EL.", "journal": "medRxiv", "publication_date": "2024-12-31", "publication_year": 2024, "doi": "10.1101/2024.12.31.24319806", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.1101/2024.12.31.24319806", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Randomized Controlled Trial,Observational Study,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "medRxiv", "publication_status": "preprint", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:01", "bibtex": null, "source_record_id": "DOI:10.1101/2024.12.31.24319806", "abstract_available": true, "abstract_source": "medRxiv", "abstract_source_url": "https://doi.org/10.1101/2024.12.31.24319806", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "medRxiv", "source_record_id": "DOI:10.1101/2024.12.31.24319806", "source_url": "https://doi.org/10.1101/2024.12.31.24319806", "doi": "10.1101/2024.12.31.24319806", "pmid": "", "publication_date": "2024-12-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 882, "title": "Psychedelics for the treatment of end-of-life distress in patients with a life-threatening disease.", "authors": "Tap S, Bostoen T, Breeksema J, Schoevers R", "journal": "International review of neurobiology", "publication_date": "2024-12-31", "publication_year": 2024, "doi": "10.1016/bs.irn.2025.03.001", "pubmed_id": "40541316", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/40541316/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Wellbeing,Emotional Processing,Spirituality", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:20:36", "bibtex": null, "source_record_id": "PMID:40541316", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40541316/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40541316", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40541316/", "doi": "10.1016/bs.irn.2025.03.001", "pmid": "40541316", "publication_date": "2024-12-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 864, "title": "Early psilocybin intervention alleviates behavioral despair and cognitive impairment in stressed Wistar rats", "authors": "Zitong Wang, Brett Robbins, Ryan Zhuang, Thaísa Meira Sandini, Rebekah van Bruggen, Xin-Min Li, Yanbo Zhang", "journal": "Progress in Neuro-Psychopharmacology and Biological Psychiatry", "publication_date": "2024-12-31", "publication_year": 2024, "doi": "10.1016/j.pnpbp.2024.111243", "pubmed_id": "39756636", "openalex_id": "https://openalex.org/W4406062303", "source_url": "https://doi.org/10.1016/j.pnpbp.2024.111243", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Mechanism of Action,Receptor Pharmacology,Biomarkers", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:34", "bibtex": null, "source_record_id": "PMID:39756636", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1016/j.pnpbp.2024.111243", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:39756636", "source_url": "https://doi.org/10.1016/j.pnpbp.2024.111243", "doi": "10.1016/j.pnpbp.2024.111243", "pmid": "39756636", "publication_date": "2024-12-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 861, "title": "Use of psychedelic treatments in psychiatric clinical practice: an EPA policy paper", "authors": "Marianne Destoop, Pavel Mohr, Florence Butlen-Ducuing, Péter Kéri, Jerzy Samochowiec, Livia De Picker, Andrea Fiorillo, Kim P. C. Kuypers, Geert Dom", "journal": "European Psychiatry", "publication_date": "2024-12-31", "publication_year": 2024, "doi": "10.1192/j.eurpsy.2024.1806", "pubmed_id": "39791347", "openalex_id": "https://openalex.org/W4406246123", "source_url": "https://doi.org/10.1192/j.eurpsy.2024.1806", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Mechanism of Action,Toxicity", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:34", "bibtex": null, "source_record_id": "PMID:39791347", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1192/j.eurpsy.2024.1806", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:39791347", "source_url": "https://doi.org/10.1192/j.eurpsy.2024.1806", "doi": "10.1192/j.eurpsy.2024.1806", "pmid": "39791347", "publication_date": "2024-12-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 786, "title": "Characteristics and mental health of psychedelic mushroom and multi-psychedelic users relative to non-psychedelic users in American adults, 2020-2021.", "authors": "Abramsky-Sze S, Marseille E, Matzopoulos R, Morlock R, Lerer L", "journal": "Frontiers in psychiatry", "publication_date": "2024-12-31", "publication_year": 2024, "doi": "10.3389/fpsyt.2025.1508811", "pubmed_id": "40109441", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/40109441/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Observational Study,Veterans", "study_type": "Observational Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:20:36", "bibtex": null, "source_record_id": "PMID:40109441", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40109441/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40109441", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40109441/", "doi": "10.3389/fpsyt.2025.1508811", "pmid": "40109441", "publication_date": "2024-12-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 646, "title": "PolDrugs 2025: results of the third edition of the nationwide study on psychoactive substance use in the context of psychiatry and harm reduction.", "authors": "Marek J, Domek-Gumprecht M, Macionga A, Szafoni S, Więckiewicz G", "journal": "Frontiers in psychiatry", "publication_date": "2024-12-31", "publication_year": 2024, "doi": "10.3389/fpsyt.2025.1591658", "pubmed_id": "40656049", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/40656049/", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Observational Study", "study_type": "Observational Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:20:35", "bibtex": null, "source_record_id": "PMID:40656049", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40656049/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40656049", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40656049/", "doi": "10.3389/fpsyt.2025.1591658", "pmid": "40656049", "publication_date": "2024-12-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 597, "title": "Psychedelic Treatment with Psilocybin: Addressing Medical Malpractice Risk and Physicians’ Concerns", "authors": "Katherine Cheung, Maxwell Brodie, Sue-Ling Chang, P. Deschamps, Jean-Sébastien Fallu, Houman Farzin, Johanne Hébert, Jean-François Stephan, Michel Dorval, Yann Joly, for the P3A Study Group", "journal": "The Journal of Law Medicine & Ethics", "publication_date": "2024-12-31", "publication_year": 2024, "doi": "10.1017/jme.2025.10109", "pubmed_id": "40739983", "openalex_id": "https://openalex.org/W4412810429", "source_url": "https://doi.org/10.1017/jme.2025.10109", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:34", "bibtex": null, "source_record_id": "PMID:40739983", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1017/jme.2025.10109", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:40739983", "source_url": "https://doi.org/10.1017/jme.2025.10109", "doi": "10.1017/jme.2025.10109", "pmid": "40739983", "publication_date": "2024-12-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 471, "title": "Home-based psilocybin-assisted therapy for a patient with advanced cancer: A case report", "authors": "Houman Farzin, Benjamin Koren, Helen Ferrier, Justin J. Sanders, Nicolas Garel", "journal": "Palliative & Supportive Care", "publication_date": "2024-12-31", "publication_year": 2024, "doi": "10.1017/s1478951525100941", "pubmed_id": "41127918", "openalex_id": "https://openalex.org/W4415464487", "source_url": "https://doi.org/10.1017/s1478951525100941", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Chronic Pain,Wellbeing,Emotional Processing,Spirituality,Case Report,Cancer Patients,Toxicity", "study_type": "Case Report", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:34", "bibtex": null, "source_record_id": "PMID:41127918", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1017/s1478951525100941", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41127918", "source_url": "https://doi.org/10.1017/s1478951525100941", "doi": "10.1017/s1478951525100941", "pmid": "41127918", "publication_date": "2024-12-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 393, "title": "Which Psychotherapy Model Should be Used in Psilocybin Treatment for Depression?", "authors": "Elena Koning, Pedro Starzynski Bacchi, Cristiano Chaves, Fabiano A. Gomes, Elisa Brietzke", "journal": "Trends in Psychiatry and Psychotherapy", "publication_date": "2024-12-31", "publication_year": 2024, "doi": "10.47626/2237-6089-2025-1197", "pubmed_id": "41405984", "openalex_id": "https://openalex.org/W4417437388", "source_url": "https://doi.org/10.47626/2237-6089-2025-1197", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Psychological Flexibility,Review Article,Toxicity", "study_type": "Review Article", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:34", "bibtex": null, "source_record_id": "PMID:41405984", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.47626/2237-6089-2025-1197", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41405984", "source_url": "https://doi.org/10.47626/2237-6089-2025-1197", "doi": "10.47626/2237-6089-2025-1197", "pmid": "41405984", "publication_date": "2024-12-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4505, "title": "Psychedelic-Assisted Therapy: The Emerging Role of the Psychiatric-Mental Health Nurse", "authors": "Khalaud Naseeb Alhajry, Zahra Mohammed Sukairi, Hamidah Abdullah Lajami, Safiah Anber Bin Ali Ibrahim, Nawal Obaid Alanazi, Eman Ali Alsafwani, Ashwag Saad Hnif Albishi, Nada Naser Alomi, Zahrh Ahmed Ali Al-Hamadah, Anwar Mehdaf Akash Alrowaly", "journal": "Saudi Journal of Medicine and Public Health", "publication_date": "2024-12-30", "publication_year": 2024, "doi": "10.64483/20251153", "pubmed_id": null, "openalex_id": "https://openalex.org/W7104738164", "source_url": "https://doi.org/10.64483/20251153", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Addiction,End-of-Life Distress,Chronic Pain,Mechanism of Action,Clinical Trial,Systematic Review,Review Article,Safety,Toxicity", "study_type": "Systematic Review", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:41", "last_checked": "2026-07-04 07:00:34", "bibtex": null, "source_record_id": "DOI:10.64483/20251153", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.64483/20251153", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.64483/20251153", "source_url": "https://doi.org/10.64483/20251153", "doi": "10.64483/20251153", "pmid": "", "publication_date": "2024-12-30", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4504, "title": "Treatment-Resistant Depression: A Comprehensive Insight of Ketamine Infusion Therapy, Transcranial Magnetic Stimulation (TMS), and Psychedelic-Assisted Psychotherapy", "authors": "Mohammad Ali, Urbah Viqar", "journal": "Annals of Punjab Medical College", "publication_date": "2024-12-30", "publication_year": 2024, "doi": "10.29054/apmc/2024.1658", "pubmed_id": null, "openalex_id": "https://openalex.org/W4408418352", "source_url": "https://doi.org/10.29054/apmc/2024.1658", "substance_tags": "psilocybin", "topic_tags": "Depression,Receptor Pharmacology,Clinical Trial,Systematic Review,Review Article,Case Report,Observational Study,Treatment-Resistant Depression", "study_type": "Systematic Review", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:41", "last_checked": "2026-07-04 07:00:34", "bibtex": null, "source_record_id": "DOI:10.29054/apmc/2024.1658", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.29054/apmc/2024.1658", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.29054/apmc/2024.1658", "source_url": "https://doi.org/10.29054/apmc/2024.1658", "doi": "10.29054/apmc/2024.1658", "pmid": "", "publication_date": "2024-12-30", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 780, "title": "Concurrent stress modulates the acute and post-acute effects of psilocybin in a sex-dependent manner", "authors": "Miguel Farinha-Ferreira, Catarina Miranda-Lourenço, Chloé Galipeau, Zsolt Lenkei, Ana M. Sebastião", "journal": "Neuropharmacology", "publication_date": "2024-12-23", "publication_year": 2024, "doi": "10.1016/j.neuropharm.2024.110280", "pubmed_id": "39725123", "openalex_id": "https://openalex.org/W4405738640", "source_url": "https://doi.org/10.1016/j.neuropharm.2024.110280", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Chronic Pain,Pharmacology,Observational Study,Animal Study,Drug Interactions", "study_type": "Observational Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:34", "bibtex": null, "source_record_id": "PMID:39725123", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1016/j.neuropharm.2024.110280", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:39725123", "source_url": "https://doi.org/10.1016/j.neuropharm.2024.110280", "doi": "10.1016/j.neuropharm.2024.110280", "pmid": "39725123", "publication_date": "2024-12-23", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 833, "title": "Efficacy and safety of psilocybin in the treatment of Major Depressive Disorder (MDD): A dose-response network meta-analysis of randomized placebo-controlled clinical trials.", "authors": "Swieczkowski D, Kwaśny A, Pruc M, Gaca Z, Szarpak L, Cubała WJ.", "journal": null, "publication_date": "2024-12-22", "publication_year": 2024, "doi": "10.1016/j.psychres.2024.116337", "pubmed_id": "39754904", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.psychres.2024.116337", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Treatment-Resistant Depression,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:01", "bibtex": null, "source_record_id": "PMID:39754904", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.psychres.2024.116337", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:39754904", "source_url": "https://doi.org/10.1016/j.psychres.2024.116337", "doi": "10.1016/j.psychres.2024.116337", "pmid": "39754904", "publication_date": "2024-12-22", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3114, "title": "Characterizing psilocybin as an antidepressant for adolescence in male and female rats", "authors": "García-Cabrerizo R, Beruete-Fresnillo I, García-Fuster MJ.", "journal": "bioRxiv", "publication_date": "2024-12-21", "publication_year": 2024, "doi": "10.1101/2024.12.20.629571", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.1101/2024.12.20.629571", "substance_tags": "psilocybin", "topic_tags": "Depression,Adolescents", "study_type": "Other", "source_name": "bioRxiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:46", "last_checked": "2026-07-01 11:22:01", "bibtex": null, "source_record_id": "DOI:10.1101/2024.12.20.629571", "abstract_available": true, "abstract_source": "bioRxiv", "abstract_source_url": "https://doi.org/10.1101/2024.12.20.629571", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "bioRxiv", "source_record_id": "DOI:10.1101/2024.12.20.629571", "source_url": "https://doi.org/10.1101/2024.12.20.629571", "doi": "10.1101/2024.12.20.629571", "pmid": "", "publication_date": "2024-12-21", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 835, "title": "Therapeutic Potential of MDMA- and Psychedelic-Assisted Psychotherapy for Adolescent Depression and Trauma.", "authors": "Geller J, Whitney E.", "journal": null, "publication_date": "2024-12-18", "publication_year": 2024, "doi": "10.1007/s11920-024-01577-2", "pubmed_id": "39699759", "openalex_id": null, "source_url": "https://doi.org/10.1007/s11920-024-01577-2", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Aging,Clinical Trial,Review Article,Adolescents,Safety", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:03", "bibtex": null, "source_record_id": "PMID:39699759", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1007/s11920-024-01577-2", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:39699759", "source_url": "https://doi.org/10.1007/s11920-024-01577-2", "doi": "10.1007/s11920-024-01577-2", "pmid": "39699759", "publication_date": "2024-12-18", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 808, "title": "The role of the psychedelic experience in psilocybin treatment for treatment-resistant depression", "authors": "Guy M. Goodwin, Scott T. Aaronson, Oscar Alvarez, Robin Carhart-Harris, J. Chai-Rees, Megan Croal, Charles DeBattista, Boadie W. Dunlop, David Feifel, David J. Hellerstein, Muhammad Ishrat Husain, John R. Kelly, Namik Kirlić, Rasmus Wentzer Licht, Lindsey Marwood, Thomas D. Meyer, Sunil Mistry, Ania Nowakowska, Tomáš Páleníček, Dimitris Repantis, Robert A. Schoevers, Hollie Simmons, Metten Somers, Emma Teoh, Joyce Tsai, Mourad Wahba, Sam Williams, Allan H. Young, Matthew B. Young, Sidney Zisook, Ekaterina Malievskaia", "journal": "Journal of Affective Disorders", "publication_date": "2024-12-17", "publication_year": 2024, "doi": "10.1016/j.jad.2024.12.061", "pubmed_id": "39706482", "openalex_id": "https://openalex.org/W4405528804", "source_url": "https://doi.org/10.1016/j.jad.2024.12.061", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Treatment-Resistant Depression,Toxicity", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:34", "bibtex": null, "source_record_id": "PMID:39706482", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:39706482", "source_url": "https://doi.org/10.1016/j.jad.2024.12.061", "doi": "10.1016/j.jad.2024.12.061", "pmid": "39706482", "publication_date": "2024-12-17", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 684, "title": "Psilocybin increases emotional empathy in patients with major depression", "authors": "Johannes Jungwirth, Robin von Rotz, Isabel Dziobek, Franz X. Vollenweider, Katrin H. Preller", "journal": "Molecular Psychiatry", "publication_date": "2024-12-17", "publication_year": 2024, "doi": "10.1038/s41380-024-02875-0", "pubmed_id": "39695323", "openalex_id": "https://openalex.org/W4405510726", "source_url": "https://doi.org/10.1038/s41380-024-02875-0", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Receptor Pharmacology,Emotional Processing,Healthy Volunteers,Drug Interactions", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:34", "bibtex": null, "source_record_id": "PMID:39695323", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1038/s41380-024-02875-0", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:39695323", "source_url": "https://doi.org/10.1038/s41380-024-02875-0", "doi": "10.1038/s41380-024-02875-0", "pmid": "39695323", "publication_date": "2024-12-17", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3101, "title": "Psilocybin causes sex, time, and dose dependent alterations in brain signaling pathways", "authors": "Barnett JH, Todd KT, Benetatos J, Rabichow BE, Gibson KA, Olney KC, Fryer JD.", "journal": "bioRxiv", "publication_date": "2024-12-16", "publication_year": 2024, "doi": "10.1101/2024.12.16.628764", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.1101/2024.12.16.628764", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Neurogenesis,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Animal Study,Healthcare Workers,Transcriptomics", "study_type": "Clinical Trial", "source_name": "bioRxiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:46", "last_checked": "2026-07-01 11:22:00", "bibtex": null, "source_record_id": "DOI:10.1101/2024.12.16.628764", "abstract_available": true, "abstract_source": "bioRxiv", "abstract_source_url": "https://doi.org/10.1101/2024.12.16.628764", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "bioRxiv", "source_record_id": "DOI:10.1101/2024.12.16.628764", "source_url": "https://doi.org/10.1101/2024.12.16.628764", "doi": "10.1101/2024.12.16.628764", "pmid": "", "publication_date": "2024-12-16", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 837, "title": "The safety of psilocybin-assisted psychotherapy: A systematic review.", "authors": "Freitas RR, Gotsis ES, Gallo AT, Fitzgibbon BM, Bailey NW, Fitzgerald PB.", "journal": null, "publication_date": "2024-12-12", "publication_year": 2024, "doi": "10.1177/00048674241289024", "pubmed_id": "39670342", "openalex_id": null, "source_url": "https://doi.org/10.1177/00048674241289024", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Headache / Migraine,Clinical Trial,Systematic Review,Review Article,Treatment-Resistant Depression,Safety,Adverse Events", "study_type": "Systematic Review", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:00", "bibtex": null, "source_record_id": "PMID:39670342", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1177/00048674241289024", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:39670342", "source_url": "https://doi.org/10.1177/00048674241289024", "doi": "10.1177/00048674241289024", "pmid": "39670342", "publication_date": "2024-12-12", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 781, "title": "Psychedelic use and bipolar disorder - An investigation of recreational use and its impact on mental health.", "authors": "Meyer TD, Ibrahim M, Vale LN, Soares JC.", "journal": null, "publication_date": "2024-12-12", "publication_year": 2024, "doi": "10.1016/j.jad.2024.12.044", "pubmed_id": "39675677", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.jad.2024.12.044", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Clinical Trial,Randomized Controlled Trial", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:04", "bibtex": null, "source_record_id": "PMID:39675677", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.jad.2024.12.044", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:39675677", "source_url": "https://doi.org/10.1016/j.jad.2024.12.044", "doi": "10.1016/j.jad.2024.12.044", "pmid": "39675677", "publication_date": "2024-12-12", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4510, "title": "Chronic pain education: past, present, and future of psychedelics for the management of chronic pain", "authors": "Christopher L. Robinson, Pawan Solanki, S Snyder, Adam Amir, Antje M. Barreveld, Rory Vu Mather, Ivo H. Cerda, Michael Motoc, Harman Chopra, R. Jason Yong, Joel Castellanos, Timothy Furnish, Alan D. Kaye, Vwaire Orhurhu, Trent Emerick", "journal": "Pain Medicine", "publication_date": "2024-12-09", "publication_year": 2024, "doi": "10.1093/pm/pnae124", "pubmed_id": "39658247", "openalex_id": "https://openalex.org/W4405231848", "source_url": "https://doi.org/10.1093/pm/pnae124", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,End-of-Life Distress,Chronic Pain,Neuroplasticity,Brain Imaging,Pharmacology,Mechanism of Action,Receptor Pharmacology,Default Mode Network,Consciousness,Aging,Microdosing,Spirituality,Review Article,Animal Study,Healthcare Workers,Safety,Adverse Events,Drug Interactions,Inflammation", "study_type": "Review Article", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:41", "last_checked": "2026-07-04 07:00:34", "bibtex": null, "source_record_id": "PMID:39658247", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1093/pm/pnae124", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:39658247", "source_url": "https://doi.org/10.1093/pm/pnae124", "doi": "10.1093/pm/pnae124", "pmid": "39658247", "publication_date": "2024-12-09", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 942, "title": "The revival of psilocybin between scientific excitement, evidence of efficacy, and real-world challenges.", "authors": "Scala M, Fabbri C, Fusar-Poli P, Di Lorenzo G, Ferrara M, Amerio A, Fusar-Poli L, Pichiecchio A, Asteggiano C, Menchetti M, De Ronchi D, MNESYS - Mood and Psychosis Sub-Project (Spoke 5), Fanelli G, Serretti A.", "journal": null, "publication_date": "2024-12-09", "publication_year": 2024, "doi": "10.1017/s1092852924002268", "pubmed_id": "39655426", "openalex_id": null, "source_url": "https://doi.org/10.1017/s1092852924002268", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,OCD,Review Article,Safety", "study_type": "Review Article", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:01", "bibtex": null, "source_record_id": "PMID:39655426", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1017/s1092852924002268", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:39655426", "source_url": "https://doi.org/10.1017/s1092852924002268", "doi": "10.1017/s1092852924002268", "pmid": "39655426", "publication_date": "2024-12-09", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 809, "title": "Treatment Expectancies and Psilocybin vs Escitalopram for Depression", "authors": "Ethan G. Dutcher, Andrew D. Krystal", "journal": "JAMA Psychiatry", "publication_date": "2024-12-09", "publication_year": 2024, "doi": "10.1001/jamapsychiatry.2024.4387", "pubmed_id": "39653344", "openalex_id": "https://openalex.org/W4405172984", "source_url": "https://doi.org/10.1001/jamapsychiatry.2024.4387", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Receptor Pharmacology,Clinical Trial", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:34", "bibtex": null, "source_record_id": "PMID:39653344", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1001/jamapsychiatry.2024.4387", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:39653344", "source_url": "https://doi.org/10.1001/jamapsychiatry.2024.4387", "doi": "10.1001/jamapsychiatry.2024.4387", "pmid": "39653344", "publication_date": "2024-12-09", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 368, "title": "Psychedelics as an intervention for psychological, existential distress in terminally ill patients: A systematic review and network meta-analysis.", "authors": "Marchi M, Farina R, Rachedi K, Laonigro F, Žuljević MF, Pingani L, Ferrari S, Somers M, Boks MPM, Galeazzi GM.", "journal": null, "publication_date": "2024-12-09", "publication_year": 2024, "doi": "10.1177/02698811241303594", "pubmed_id": "39655749", "openalex_id": null, "source_url": "https://doi.org/10.1177/02698811241303594", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Mechanism of Action,Spirituality,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:03", "bibtex": null, "source_record_id": "PMID:39655749", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1177/02698811241303594", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:39655749", "source_url": "https://doi.org/10.1177/02698811241303594", "doi": "10.1177/02698811241303594", "pmid": "39655749", "publication_date": "2024-12-09", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 936, "title": "Psilocybin Therapy for Clinicians With Symptoms of Depression From Frontline Care During the COVID-19 Pandemic", "authors": "Anthony L. Back, Timara K. Freeman-Young, Ladybird Morgan, Tanmeet Sethi, Kelsey K. Baker, Susanna Myers, Bonnie A. McGregor, Kalin Harvey, Marlene Tai, Austin Kollefrath, Brandon J. Thomas, Dennis Sorta, Mendel Kaelen, Benjamin Kelmendi, Ted Gooley", "journal": "JAMA Network Open", "publication_date": "2024-12-04", "publication_year": 2024, "doi": "10.1001/jamanetworkopen.2024.49026", "pubmed_id": "39636638", "openalex_id": "https://openalex.org/W4405031949", "source_url": "https://doi.org/10.1001/jamanetworkopen.2024.49026", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Chronic Pain,Clinical Trial,Randomized Controlled Trial,Healthcare Workers", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:34", "bibtex": null, "source_record_id": "PMID:39636638", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1001/jamanetworkopen.2024.49026", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:39636638", "source_url": "https://doi.org/10.1001/jamanetworkopen.2024.49026", "doi": "10.1001/jamanetworkopen.2024.49026", "pmid": "39636638", "publication_date": "2024-12-04", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 932, "title": "Synergistic, multi-level understanding of psychedelics: three systematic reviews and meta-analyses of their pharmacology, neuroimaging and phenomenology.", "authors": "Shinozuka K, Jerotic K, Mediano P, Zhao AT, Preller KH, Carhart-Harris R, Kringelbach ML.", "journal": null, "publication_date": "2024-12-03", "publication_year": 2024, "doi": "10.1038/s41398-024-03187-1", "pubmed_id": "39632810", "openalex_id": null, "source_url": "https://doi.org/10.1038/s41398-024-03187-1", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Addiction,Brain Imaging,Pharmacology,Receptor Pharmacology,Consciousness,Aging,Systematic Review,Review Article,Safety", "study_type": "Systematic Review", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:01", "bibtex": null, "source_record_id": "PMID:39632810", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1038/s41398-024-03187-1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:39632810", "source_url": "https://doi.org/10.1038/s41398-024-03187-1", "doi": "10.1038/s41398-024-03187-1", "pmid": "39632810", "publication_date": "2024-12-03", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 931, "title": "Comparative antidepressant effects and safety of intravenous racemic ketamine, psilocybin and theta burst stimulation for major depressive disorder: A systematic review and network meta-analyses of randomized controlled trials.", "authors": "Terao I, Kodama W.", "journal": null, "publication_date": "2024-12-03", "publication_year": 2024, "doi": "10.1002/pcn5.70042", "pubmed_id": "39641126", "openalex_id": null, "source_url": "https://doi.org/10.1002/pcn5.70042", "substance_tags": "psilocybin", "topic_tags": "Depression,Randomized Controlled Trial,Systematic Review,Review Article,Safety", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:01", "bibtex": null, "source_record_id": "PMID:39641126", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1002/pcn5.70042", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:39641126", "source_url": "https://doi.org/10.1002/pcn5.70042", "doi": "10.1002/pcn5.70042", "pmid": "39641126", "publication_date": "2024-12-03", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 915, "title": "Therapeutic Potential of Psychedelic Drugs: Navigating High Hopes, Strong Claims, Weak Evidence, and Big Money.", "authors": "Humphreys K, Todd Korthuis P, Stjepanović D, Hall W.", "journal": null, "publication_date": "2024-12-02", "publication_year": 2024, "doi": "10.1146/annurev-psych-020124-023532", "pubmed_id": "39094057", "openalex_id": null, "source_url": "https://doi.org/10.1146/annurev-psych-020124-023532", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Addiction,Mechanism of Action,Treatment-Resistant Depression,Safety,Adverse Events", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:04", "bibtex": null, "source_record_id": "PMID:39094057", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1146/annurev-psych-020124-023532", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:39094057", "source_url": "https://doi.org/10.1146/annurev-psych-020124-023532", "doi": "10.1146/annurev-psych-020124-023532", "pmid": "39094057", "publication_date": "2024-12-02", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 724, "title": "Randomized Controlled Trials of Psilocybin-Assisted Therapy in the Treatment of Major Depressive Disorder: Systematic Review and Meta-Analysis.", "authors": "Menon V, Ramamurthy P, Venu S, Andrade C.", "journal": null, "publication_date": "2024-12-02", "publication_year": 2024, "doi": "10.1111/acps.13778", "pubmed_id": "39627679", "openalex_id": null, "source_url": "https://doi.org/10.1111/acps.13778", "substance_tags": "psilocybin", "topic_tags": "Depression,Headache / Migraine,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Treatment-Resistant Depression,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:01", "bibtex": null, "source_record_id": "PMID:39627679", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1111/acps.13778", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:39627679", "source_url": "https://doi.org/10.1111/acps.13778", "doi": "10.1111/acps.13778", "pmid": "39627679", "publication_date": "2024-12-02", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 935, "title": "Correction to: A Bayesian Reanalysis of a Trial of Psilocybin Versus Escitalopram for Depression by Nayak, et al. Psychedelic Med 2023;1(1):18-26; doi: 10.1089/psymed.2022.0002.", "authors": "", "journal": null, "publication_date": "2024-12-01", "publication_year": 2024, "doi": "10.1089/psymed.2022.0002.correx", "pubmed_id": "40045987", "openalex_id": null, "source_url": "https://doi.org/10.1089/psymed.2022.0002.correx", "substance_tags": "psilocybin", "topic_tags": "Depression", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:05", "bibtex": null, "source_record_id": "PMID:40045987", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1089/psymed.2022.0002.correx", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:40045987", "source_url": "https://doi.org/10.1089/psymed.2022.0002.correx", "doi": "10.1089/psymed.2022.0002.correx", "pmid": "40045987", "publication_date": "2024-12-01", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 951, "title": "Adverse Events in Studies of Classic Psychedelics: A Systematic Review and Meta-Analysis.", "authors": "Hinkle JT, Graziosi M, Nayak SM, Yaden DB.", "journal": null, "publication_date": "2024-11-30", "publication_year": 2024, "doi": "10.1001/jamapsychiatry.2024.2546", "pubmed_id": "39230883", "openalex_id": null, "source_url": "https://doi.org/10.1001/jamapsychiatry.2024.2546", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Headache / Migraine,Meta-Analysis,Systematic Review,Review Article,Healthy Volunteers,Safety,Adverse Events", "study_type": "Meta-Analysis", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:04", "bibtex": null, "source_record_id": "PMID:39230883", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1001/jamapsychiatry.2024.2546", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:39230883", "source_url": "https://doi.org/10.1001/jamapsychiatry.2024.2546", "doi": "10.1001/jamapsychiatry.2024.2546", "pmid": "39230883", "publication_date": "2024-11-30", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 944, "title": "Psychedelics for the Treatment of Obsessive-Compulsive Disorder: Efficacy and Proposed Mechanisms.", "authors": "Collins HM.", "journal": null, "publication_date": "2024-11-30", "publication_year": 2024, "doi": "10.1093/ijnp/pyae057", "pubmed_id": "39611453", "openalex_id": null, "source_url": "https://doi.org/10.1093/ijnp/pyae057", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,OCD,Neuroplasticity,Mechanism of Action,Review Article,Treatment-Resistant Depression", "study_type": "Review Article", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:02", "bibtex": null, "source_record_id": "PMID:39611453", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1093/ijnp/pyae057", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:39611453", "source_url": "https://doi.org/10.1093/ijnp/pyae057", "doi": "10.1093/ijnp/pyae057", "pmid": "39611453", "publication_date": "2024-11-30", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 941, "title": "Psilocybin and hallucinogenic mushrooms.", "authors": "Fradet M, Kelly CM, Donnelly AJ, Suppes T.", "journal": null, "publication_date": "2024-11-30", "publication_year": 2024, "doi": "10.1017/s1092852924002487", "pubmed_id": "39789676", "openalex_id": null, "source_url": "https://doi.org/10.1017/s1092852924002487", "substance_tags": "psilocybin", "topic_tags": "Depression,Pharmacology,Aging,Safety", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:00", "bibtex": null, "source_record_id": "PMID:39789676", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1017/s1092852924002487", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:39789676", "source_url": "https://doi.org/10.1017/s1092852924002487", "doi": "10.1017/s1092852924002487", "pmid": "39789676", "publication_date": "2024-11-30", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 922, "title": "Psilocybin as a Disease-Modifying Drug-A Salutogenic Approach in Psychiatry.", "authors": "Spangemacher M, Mertens LJ, Färber LV, Jungaberle A, Jungaberle H, Gründer G.", "journal": null, "publication_date": "2024-11-30", "publication_year": 2024, "doi": "10.3238/arztebl.m2024.0224", "pubmed_id": "39628414", "openalex_id": null, "source_url": "https://doi.org/10.3238/arztebl.m2024.0224", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,End-of-Life Distress,Mechanism of Action,Clinical Trial,Randomized Controlled Trial,Review Article", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:00", "bibtex": null, "source_record_id": "PMID:39628414", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.3238/arztebl.m2024.0224", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:39628414", "source_url": "https://doi.org/10.3238/arztebl.m2024.0224", "doi": "10.3238/arztebl.m2024.0224", "pmid": "39628414", "publication_date": "2024-11-30", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4517, "title": "Exploring Psychotherapeutic Benefits of Psilocybin and Psychedelics In Controlled Medical Settings", "authors": "Arman Fard, Allison Cohen", "journal": "Journal of Student Research", "publication_date": "2024-11-29", "publication_year": 2024, "doi": "10.47611/jsrhs.v13i4.7602", "pubmed_id": null, "openalex_id": "https://openalex.org/W4413513275", "source_url": "https://doi.org/10.47611/jsrhs.v13i4.7602", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Receptor Pharmacology,Consciousness", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:42", "last_checked": "2026-07-04 07:00:34", "bibtex": null, "source_record_id": "DOI:10.47611/jsrhs.v13i4.7602", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.47611/jsrhs.v13i4.7602", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.47611/jsrhs.v13i4.7602", "source_url": "https://doi.org/10.47611/jsrhs.v13i4.7602", "doi": "10.47611/jsrhs.v13i4.7602", "pmid": "", "publication_date": "2024-11-29", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 943, "title": "Psychedelic Research for Alcohol Use Disorder with Comorbid Major Depressive Disorder: An Unmet Need.", "authors": "de Jonge D, van der Meer PB, Kramers C, Schellekens A.", "journal": null, "publication_date": "2024-11-28", "publication_year": 2024, "doi": "10.1007/s11920-024-01567-4", "pubmed_id": "39612154", "openalex_id": null, "source_url": "https://doi.org/10.1007/s11920-024-01567-4", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Meta-Analysis,Review Article", "study_type": "Meta-Analysis", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:02", "bibtex": null, "source_record_id": "PMID:39612154", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1007/s11920-024-01567-4", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:39612154", "source_url": "https://doi.org/10.1007/s11920-024-01567-4", "doi": "10.1007/s11920-024-01567-4", "pmid": "39612154", "publication_date": "2024-11-28", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3157, "title": "Synergistic Behavioral and Neuroplastic Effects of Psilocybin-NMDAR Modulator Administration", "authors": "Ben-Tal T, Pogodin I, Botvinnik A, Lifschytz T, Heresco-Levy U, Lerer B.", "journal": "bioRxiv", "publication_date": "2024-11-27", "publication_year": 2024, "doi": "10.1101/2024.11.28.625811", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.1101/2024.11.28.625811", "substance_tags": "psilocybin", "topic_tags": "Depression,Neuroplasticity,Receptor Pharmacology,Animal Study,Safety", "study_type": "Animal Study", "source_name": "bioRxiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:47", "last_checked": "2026-07-01 11:22:01", "bibtex": null, "source_record_id": "DOI:10.1101/2024.11.28.625811", "abstract_available": true, "abstract_source": "bioRxiv", "abstract_source_url": "https://doi.org/10.1101/2024.11.28.625811", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "bioRxiv", "source_record_id": "DOI:10.1101/2024.11.28.625811", "source_url": "https://doi.org/10.1101/2024.11.28.625811", "doi": "10.1101/2024.11.28.625811", "pmid": "", "publication_date": "2024-11-27", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 811, "title": "Reconsidering evidence for psychedelic-induced psychosis: an overview of reviews, a systematic review, and meta-analysis of human studies.", "authors": "Sabé M, Sulstarova A, Glangetas A, De Pieri M, Mallet L, Curtis L, Richard-Lepouriel H, Penzenstadler L, Seragnoli F, Thorens G, Zullino D, Preller K, Böge K, Leucht S, Correll CU, Solmi M, Kaiser S, Kirschner M.", "journal": null, "publication_date": "2024-11-26", "publication_year": 2024, "doi": "10.1038/s41380-024-02800-5", "pubmed_id": "39592825", "openalex_id": null, "source_url": "https://doi.org/10.1038/s41380-024-02800-5", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Observational Study,Treatment-Resistant Depression,Safety", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:04", "bibtex": null, "source_record_id": "PMID:39592825", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1038/s41380-024-02800-5", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:39592825", "source_url": "https://doi.org/10.1038/s41380-024-02800-5", "doi": "10.1038/s41380-024-02800-5", "pmid": "39592825", "publication_date": "2024-11-26", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3512, "title": "A Phase 2a Safety and Feasibility Study Evaluating Psilocybin (TRP-8802) Administration in Concert With Psychotherapy in the Treatment of Binge Eating Disorder", "authors": "TRYP Therapeutics", "journal": "ClinicalTrials.gov", "publication_date": "2024-11-18", "publication_year": 2024, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05035927", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Eating Disorders,Pharmacology,Clinical Trial,Cancer Patients,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05035927", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05035927", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05035927", "source_url": "https://clinicaltrials.gov/study/NCT05035927", "doi": "", "pmid": "", "publication_date": "2024-11-18", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 794, "title": "Psilocybin-Assisted Psychotherapy for Treatment-Resistant Depression in Bipolar II Disorder", "authors": "Shakila Meshkat, Erica Kaczmarek, Zoe Doyle, Ryan M. Brudner, Fabiano A. Gomes, Marc G. Blainey, Geneva Weiglein, Roger S McIntyre, Rodrigo B. Mansur, Joshua D. Rosenblat", "journal": "Psychedelic Medicine", "publication_date": "2024-11-17", "publication_year": 2024, "doi": "10.1089/psymed.2024.0032", "pubmed_id": "40337756", "openalex_id": "https://openalex.org/W4404460385", "source_url": "https://doi.org/10.1089/psymed.2024.0032", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Treatment-Resistant Depression,Safety", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:34", "bibtex": null, "source_record_id": "PMID:40337756", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1089/psymed.2024.0032", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:40337756", "source_url": "https://doi.org/10.1089/psymed.2024.0032", "doi": "10.1089/psymed.2024.0032", "pmid": "40337756", "publication_date": "2024-11-17", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4521, "title": "Psilocybin Fungi Unveiled: Morphological Characteristics and Pharmacological Potentials", "authors": "Raj Nashikkar, Kavita Mane, Rajendra Patil", "journal": "International Journal for Research in Applied Science and Engineering Technology", "publication_date": "2024-11-16", "publication_year": 2024, "doi": "10.22214/ijraset.2024.65160", "pubmed_id": null, "openalex_id": "https://openalex.org/W4404448166", "source_url": "https://doi.org/10.22214/ijraset.2024.65160", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Pharmacology,Mechanism of Action,Aging,Review Article", "study_type": "Review Article", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:42", "last_checked": "2026-07-04 07:00:34", "bibtex": null, "source_record_id": "DOI:10.22214/ijraset.2024.65160", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.22214/ijraset.2024.65160", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.22214/ijraset.2024.65160", "source_url": "https://doi.org/10.22214/ijraset.2024.65160", "doi": "10.22214/ijraset.2024.65160", "pmid": "", "publication_date": "2024-11-16", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 958, "title": "Knowledge, attitudes, and concerns about psilocybin and MDMA as novel therapies among U.S. healthcare professionals", "authors": "Erin Y. Wang, David S. Mathai, Natalie Gukasyan, Sandeep M. Nayak, Albert Garcia-Romeu", "journal": "Scientific Reports", "publication_date": "2024-11-13", "publication_year": 2024, "doi": "10.1038/s41598-024-78736-1", "pubmed_id": "39543323", "openalex_id": "https://openalex.org/W4404374254", "source_url": "https://doi.org/10.1038/s41598-024-78736-1", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Pharmacology,Observational Study,Safety,Contraindications", "study_type": "Observational Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:34", "bibtex": null, "source_record_id": "PMID:39543323", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1038/s41598-024-78736-1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:39543323", "source_url": "https://doi.org/10.1038/s41598-024-78736-1", "doi": "10.1038/s41598-024-78736-1", "pmid": "39543323", "publication_date": "2024-11-13", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 970, "title": "Preliminary Evidence of Sleep Improvements Following Psilocybin Administration, and their Involvement in Antidepressant Therapeutic Action.", "authors": "Reid MJ, Kettner H, Blanken TF, Weiss B, Carhart-Harris R.", "journal": null, "publication_date": "2024-11-12", "publication_year": 2024, "doi": "10.1007/s11920-024-01539-8", "pubmed_id": "39532819", "openalex_id": null, "source_url": "https://doi.org/10.1007/s11920-024-01539-8", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Clinical Trial,Drug Interactions", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:00", "bibtex": null, "source_record_id": "PMID:39532819", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1007/s11920-024-01539-8", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:39532819", "source_url": "https://doi.org/10.1007/s11920-024-01539-8", "doi": "10.1007/s11920-024-01539-8", "pmid": "39532819", "publication_date": "2024-11-12", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3430, "title": "PAPR: Psilocybin-assisted Psychotherapy + Mindfulness-Based Stress Reduction (MBSR) for Front-line Healthcare Provider COVID-19 Related Burnout", "authors": "University of Utah", "journal": "ClinicalTrials.gov", "publication_date": "2024-11-11", "publication_year": 2024, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05557643", "substance_tags": "psilocybin", "topic_tags": "Depression", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05557643", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05557643", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05557643", "source_url": "https://clinicaltrials.gov/study/NCT05557643", "doi": "", "pmid": "", "publication_date": "2024-11-11", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 871, "title": "Structural insights into tryptamine psychedelics: The role of hydroxyl indole ring site in 5-HT2A receptor activation and psychedelic-like activity.", "authors": "Zhang M, Yang Y, Yang Z, Wen X, Zhang C, Xiao P, Wang Y, Sun J, Wang H, Wang X.", "journal": null, "publication_date": "2024-11-11", "publication_year": 2024, "doi": "10.1016/j.ejmech.2024.117049", "pubmed_id": "39541872", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.ejmech.2024.117049", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Receptor Pharmacology,Drug Interactions", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:01", "bibtex": null, "source_record_id": "PMID:39541872", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.ejmech.2024.117049", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:39541872", "source_url": "https://doi.org/10.1016/j.ejmech.2024.117049", "doi": "10.1016/j.ejmech.2024.117049", "pmid": "39541872", "publication_date": "2024-11-11", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 925, "title": "Advances in Psychedelic Therapeutics: Novel Prodrugs and Derivatives for Enhanced Mental Health Treatment.", "authors": "Kargbo RB.", "journal": null, "publication_date": "2024-11-10", "publication_year": 2024, "doi": "10.1021/acsmedchemlett.4c00519", "pubmed_id": "39691516", "openalex_id": null, "source_url": "https://doi.org/10.1021/acsmedchemlett.4c00519", "substance_tags": "psilocin", "topic_tags": "Depression,Anxiety,Addiction,Review Article,Animal Study", "study_type": "Review Article", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:03", "bibtex": null, "source_record_id": "PMID:39691516", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1021/acsmedchemlett.4c00519", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:39691516", "source_url": "https://doi.org/10.1021/acsmedchemlett.4c00519", "doi": "10.1021/acsmedchemlett.4c00519", "pmid": "39691516", "publication_date": "2024-11-10", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 924, "title": "Advanced Delivery Systems and Novel Psilocin Derivatives for Enhanced Therapeutic Applications.", "authors": "Kargbo RB.", "journal": null, "publication_date": "2024-11-10", "publication_year": 2024, "doi": "10.1021/acsmedchemlett.4c00521", "pubmed_id": "39691529", "openalex_id": null, "source_url": "https://doi.org/10.1021/acsmedchemlett.4c00521", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Chronic Pain,Pharmacology,Review Article", "study_type": "Review Article", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:00", "bibtex": null, "source_record_id": "PMID:39691529", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1021/acsmedchemlett.4c00521", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:39691529", "source_url": "https://doi.org/10.1021/acsmedchemlett.4c00521", "doi": "10.1021/acsmedchemlett.4c00521", "pmid": "39691529", "publication_date": "2024-11-10", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3108, "title": "Long-term effects of psilocybin on dynamic and effectivity connectivity of fronto-striatal-thalamic circuits", "authors": "Pasquini L, Vohryzek J, Escrichs A, Sanz Perl Y, Ponce-Alvarez A, Idesis S, Girn M, Roseman L, Mitchell JM, Gazzaley A, Kringelbach M, Nutt DJ, Lyons T, Carhart-Harris RL, Deco G.", "journal": "bioRxiv", "publication_date": "2024-11-06", "publication_year": 2024, "doi": "10.1101/2024.11.06.622302", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.1101/2024.11.06.622302", "substance_tags": "psilocybin", "topic_tags": "Depression,Eating Disorders,Brain Imaging,Mechanism of Action,Receptor Pharmacology,Wellbeing,Healthy Volunteers", "study_type": "Other", "source_name": "bioRxiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:46", "last_checked": "2026-07-01 11:22:01", "bibtex": null, "source_record_id": "DOI:10.1101/2024.11.06.622302", "abstract_available": true, "abstract_source": "bioRxiv", "abstract_source_url": "https://doi.org/10.1101/2024.11.06.622302", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "bioRxiv", "source_record_id": "DOI:10.1101/2024.11.06.622302", "source_url": "https://doi.org/10.1101/2024.11.06.622302", "doi": "10.1101/2024.11.06.622302", "pmid": "", "publication_date": "2024-11-06", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 962, "title": "Amid magic and menace: psychiatrists’ attitudes to psilocybin therapy", "authors": "Andrew Gribben, T. R. JUN. BURKE, Colm Harrington, Amanda Husein, Kevin S. Murnane, Peter S. Hendricks, Katy Tobin, Jo-Hanna Ivers, Guillaume Thuery, Andrew Harkin, John R. Kelly", "journal": "Irish Journal of Psychological Medicine", "publication_date": "2024-11-06", "publication_year": 2024, "doi": "10.1017/ipm.2024.49", "pubmed_id": "39506378", "openalex_id": "https://openalex.org/W4404152712", "source_url": "https://doi.org/10.1017/ipm.2024.49", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Personality Change,Emotional Processing,Toxicity", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:34", "bibtex": null, "source_record_id": "PMID:39506378", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1017/ipm.2024.49", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:39506378", "source_url": "https://doi.org/10.1017/ipm.2024.49", "doi": "10.1017/ipm.2024.49", "pmid": "39506378", "publication_date": "2024-11-06", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4524, "title": "Why N,N-dimethyltryptamine matters: unique features and therapeutic potential beyond classical psychedelics", "authors": "Cristiano Chaves, Rafael G. dos Santos, Serdar Dursun, Massimo Tusconi, Mauro Giovanni Carta, Elisa Brietzke, Jaime E. C. Hallak", "journal": "Frontiers in Psychiatry", "publication_date": "2024-11-05", "publication_year": 2024, "doi": "10.3389/fpsyt.2024.1485337", "pubmed_id": "39568756", "openalex_id": "https://openalex.org/W4404119543", "source_url": "https://doi.org/10.3389/fpsyt.2024.1485337", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Neuroplasticity,Neurogenesis,Brain Imaging,Pharmacology,Mechanism of Action,Receptor Pharmacology,Consciousness,Mitochondrial Function,Oxidative Stress,Emotional Processing,Mystical Experience,Review Article,Observational Study,Animal Study,Healthy Volunteers,Treatment-Resistant Depression,Safety,Toxicity,Drug Interactions,Inflammation,Immune Function", "study_type": "Review Article", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:42", "last_checked": "2026-07-04 07:00:34", "bibtex": null, "source_record_id": "PMID:39568756", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.3389/fpsyt.2024.1485337", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:39568756", "source_url": "https://doi.org/10.3389/fpsyt.2024.1485337", "doi": "10.3389/fpsyt.2024.1485337", "pmid": "39568756", "publication_date": "2024-11-05", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 370, "title": "Masking Influences: A Systematic Review of Placebo Control and Masking in Psychedelic Studies.", "authors": "Barstowe A, Kajonius PJ.", "journal": null, "publication_date": "2024-11-05", "publication_year": 2024, "doi": "10.1080/02791072.2024.2424272", "pubmed_id": "39503404", "openalex_id": null, "source_url": "https://doi.org/10.1080/02791072.2024.2424272", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,End-of-Life Distress,Systematic Review,Review Article,Treatment-Resistant Depression", "study_type": "Systematic Review", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:04", "bibtex": null, "source_record_id": "PMID:39503404", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1080/02791072.2024.2424272", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:39503404", "source_url": "https://doi.org/10.1080/02791072.2024.2424272", "doi": "10.1080/02791072.2024.2424272", "pmid": "39503404", "publication_date": "2024-11-05", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 965, "title": "Enhanced visual contrast suppression during peak psilocybin effects: Psychophysical results from a pilot randomized controlled trial", "authors": "Link Swanson, Sophia Jungers, Ranji Varghese, Kathryn R. Cullen, Michael D. Evans, Jessica L. Nielson, Michael-Paul Schallmo", "journal": "Journal of Vision", "publication_date": "2024-11-04", "publication_year": 2024, "doi": "10.1167/jov.24.12.5", "pubmed_id": "39499526", "openalex_id": "https://openalex.org/W4404059935", "source_url": "https://doi.org/10.1167/jov.24.12.5", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Randomized Controlled Trial,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:34", "bibtex": null, "source_record_id": "PMID:39499526", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1167/jov.24.12.5", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:39499526", "source_url": "https://doi.org/10.1167/jov.24.12.5", "doi": "10.1167/jov.24.12.5", "pmid": "39499526", "publication_date": "2024-11-04", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 912, "title": "Australian psychologists' attitudes towards psychedelic-assisted therapy and training following a world-first drug down-scheduling", "authors": "Jordan J. Negrine, Cheneal Puljević, Jason Ferris, Paul Liknaitzky, Christopher M. Perlman, Timothy Piatkowski", "journal": "Drug and Alcohol Review", "publication_date": "2024-11-04", "publication_year": 2024, "doi": "10.1111/dar.13973", "pubmed_id": "39499579", "openalex_id": "https://openalex.org/W4404059132", "source_url": "https://doi.org/10.1111/dar.13973", "substance_tags": "psilocybin", "topic_tags": "Depression,Observational Study,Safety,Toxicity", "study_type": "Observational Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:34", "bibtex": null, "source_record_id": "PMID:39499579", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1111/dar.13973", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:39499579", "source_url": "https://doi.org/10.1111/dar.13973", "doi": "10.1111/dar.13973", "pmid": "39499579", "publication_date": "2024-11-04", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 5670, "title": "Worsening suicidal ideation and prolonged adverse event following psilocybin administration in a clinical setting: case report and thematic analysis of one participant's experience", "authors": "Mourad Wahba, Caroline Hayes, Maartje Kletter, R. Hamish McAllister-Williams", "journal": "BJPsych Open", "publication_date": "2024-10-31", "publication_year": 2024, "doi": "10.1192/bjo.2024.768", "pubmed_id": "39654264", "openalex_id": "https://openalex.org/W4405215942", "source_url": "https://doi.org/10.1192/bjo.2024.768", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Pharmacology,Clinical Trial,Case Report,Treatment-Resistant Depression,Adverse Events,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 07:00:34", "last_checked": "2026-07-04 07:00:34", "bibtex": null, "source_record_id": "PMID:39654264", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1192/bjo.2024.768", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:39654264", "source_url": "https://doi.org/10.1192/bjo.2024.768", "doi": "10.1192/bjo.2024.768", "pmid": "39654264", "publication_date": "2024-10-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4529, "title": "Psilocybin-unterstützte Psychotherapie reduziert Ängste und Depressionen", "authors": "Lamia Özgör", "journal": "InFo Hämatologie + Onkologie", "publication_date": "2024-10-31", "publication_year": 2024, "doi": "10.1007/s15004-024-0785-9", "pubmed_id": null, "openalex_id": "https://openalex.org/W4404556355", "source_url": "https://doi.org/10.1007/s15004-024-0785-9", "substance_tags": "psilocybin", "topic_tags": "Depression,Pharmacology", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:42", "last_checked": "2026-07-04 07:00:34", "bibtex": null, "source_record_id": "DOI:10.1007/s15004-024-0785-9", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1007/s15004-024-0785-9", "source_url": "https://doi.org/10.1007/s15004-024-0785-9", "doi": "10.1007/s15004-024-0785-9", "pmid": "", "publication_date": "2024-10-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 971, "title": "Optimized psilocybin production in tryptophan catabolism-repressed fungi", "authors": "Slavica Janevska, Sophie Weiser, Ying Huang, Jun Lin, Sandra Hoefgen, Katarina Jojić, Amelia E. Barber, Tim Schäfer, Janis Fricke, Dirk Hoffmeister, Lars Regestein, Vito Valiante, Johann E. Kufs", "journal": "Microbial Biotechnology", "publication_date": "2024-10-31", "publication_year": 2024, "doi": "10.1111/1751-7915.70039", "pubmed_id": "39487767", "openalex_id": "https://openalex.org/W4404004370", "source_url": "https://doi.org/10.1111/1751-7915.70039", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Addiction,Eating Disorders,Pharmacology,Genomics", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:34", "bibtex": null, "source_record_id": "PMID:39487767", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1111/1751-7915.70039", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:39487767", "source_url": "https://doi.org/10.1111/1751-7915.70039", "doi": "10.1111/1751-7915.70039", "pmid": "39487767", "publication_date": "2024-10-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 927, "title": "Worsening suicidal ideation and prolonged adverse event following psilocybin administration in a clinical setting: case report and thematic analysis of one participant's experience", "authors": "Mourad Wahba, Caroline Hayes, Maartje Kletter, R. Hamish McAllister-Williams", "journal": "BJPsych Open", "publication_date": "2024-10-31", "publication_year": 2024, "doi": null, "pubmed_id": null, "openalex_id": "https://openalex.org/W7139416359", "source_url": "https://doi.org/10.1192/bjo.2024.768", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Pharmacology,Clinical Trial,Case Report,Treatment-Resistant Depression,Adverse Events,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 06:34:42", "bibtex": null, "source_record_id": "https://doi.org/10.1192/bjo.2024.768", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1192/bjo.2024.768", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "https://doi.org/10.1192/bjo.2024.768", "source_url": "https://doi.org/10.1192/bjo.2024.768", "doi": "", "pmid": "", "publication_date": "2024-10-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 371, "title": "Psilocybin for major depressive disorder: An updated systematic review and meta-analysis of randomized clinical trials", "authors": "Sepehr Aghajanian, Arman Shafiee, Samira Parvizi Omran, Aida Rezaei Nejad, Kyana Jafarabady, Omid Kohandel Gargari, Shahryar Rajai Firouzabadi, Ida Mohammadi, Touran Bahrami Babaheidari, Mahmood Bakhtiyari", "journal": "Journal of Psychopharmacology", "publication_date": "2024-10-30", "publication_year": 2024, "doi": "10.1177/02698811241287542", "pubmed_id": "39480198", "openalex_id": "https://openalex.org/W4403943147", "source_url": "https://doi.org/10.1177/02698811241287542", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Receptor Pharmacology,Clinical Trial,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Toxicity", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:34", "bibtex": null, "source_record_id": "PMID:39480198", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1177/02698811241287542", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:39480198", "source_url": "https://doi.org/10.1177/02698811241287542", "doi": "10.1177/02698811241287542", "pmid": "39480198", "publication_date": "2024-10-30", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3644, "title": "Psilocybin vs Escitalopram for Major Depressive Disorder: Comparative Mechanisms", "authors": "Imperial College London", "journal": "ClinicalTrials.gov", "publication_date": "2024-10-23", "publication_year": 2024, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT03429075", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Receptor Pharmacology,Clinical Trial", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:34", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT03429075", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT03429075", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT03429075", "source_url": "https://clinicaltrials.gov/study/NCT03429075", "doi": "", "pmid": "", "publication_date": "2024-10-23", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 988, "title": "Critical appraisal of evidence supporting prescription of psychedelics from clinic websites in Ontario, Canada", "authors": "K S Kim, Abban Yusuf, Abhimanyu Sud, Nav Persaud, Abirami Kirubarajan, Monique Moller, Taryn Lloyd, Braden O’Neill", "journal": "PLoS ONE", "publication_date": "2024-10-23", "publication_year": 2024, "doi": "10.1371/journal.pone.0309911", "pubmed_id": "39446753", "openalex_id": "https://openalex.org/W4403721028", "source_url": "https://doi.org/10.1371/journal.pone.0309911", "substance_tags": "psilocybin", "topic_tags": "Depression,Receptor Pharmacology,Healthcare Workers,Safety,Toxicity", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:34", "bibtex": null, "source_record_id": "PMID:39446753", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1371/journal.pone.0309911", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:39446753", "source_url": "https://doi.org/10.1371/journal.pone.0309911", "doi": "10.1371/journal.pone.0309911", "pmid": "39446753", "publication_date": "2024-10-23", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 839, "title": "Substrate recognition by the 4-hydroxytryptamine kinase PsiK in psilocybin biosynthesis", "authors": "Kai Rogge, Tobias Wagner, Dirk Hoffmeister, Bernhard Rupp, Sebastiaan Werten", "journal": "FEBS Letters", "publication_date": "2024-10-23", "publication_year": 2024, "doi": "10.1002/1873-3468.15042", "pubmed_id": "39449146", "openalex_id": "https://openalex.org/W4403779143", "source_url": "https://doi.org/10.1002/1873-3468.15042", "substance_tags": "psilocybin", "topic_tags": "Depression,Pharmacology", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:34", "bibtex": null, "source_record_id": "PMID:39449146", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1002/1873-3468.15042", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:39449146", "source_url": "https://doi.org/10.1002/1873-3468.15042", "doi": "10.1002/1873-3468.15042", "pmid": "39449146", "publication_date": "2024-10-23", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3098, "title": "The serotonin 1B receptor is required for some of the behavioral effects of psilocybin in mice", "authors": "Fleury S, Nautiyal KM.", "journal": "bioRxiv", "publication_date": "2024-10-20", "publication_year": 2024, "doi": "10.1101/2024.10.18.618582", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.1101/2024.10.18.618582", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Neuroplasticity,Receptor Pharmacology,Emotional Processing,Animal Study", "study_type": "Animal Study", "source_name": "bioRxiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:46", "last_checked": "2026-07-01 11:22:00", "bibtex": null, "source_record_id": "DOI:10.1101/2024.10.18.618582", "abstract_available": true, "abstract_source": "bioRxiv", "abstract_source_url": "https://doi.org/10.1101/2024.10.18.618582", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "bioRxiv", "source_record_id": "DOI:10.1101/2024.10.18.618582", "source_url": "https://doi.org/10.1101/2024.10.18.618582", "doi": "10.1101/2024.10.18.618582", "pmid": "", "publication_date": "2024-10-20", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 937, "title": "Psilocybin-assisted neurofeedback for the improvement of executive functions: a randomized semi-naturalistic-lab feasibility study", "authors": "Stefanie Enriquez-Geppert, Jaroslav Krc, Fiachra O'Higgins, Morten Peter Lietz", "journal": "Philosophical Transactions of the Royal Society B Biological Sciences", "publication_date": "2024-10-20", "publication_year": 2024, "doi": "10.1098/rstb.2023.0095", "pubmed_id": "39428872", "openalex_id": "https://openalex.org/W4403615858", "source_url": "https://doi.org/10.1098/rstb.2023.0095", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Aging,Microdosing", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:34", "bibtex": null, "source_record_id": "PMID:39428872", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1098/rstb.2023.0095", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:39428872", "source_url": "https://doi.org/10.1098/rstb.2023.0095", "doi": "10.1098/rstb.2023.0095", "pmid": "39428872", "publication_date": "2024-10-20", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3784, "title": "Aesthetic quality of psychedelic experience is linked to greater insight and improved psychological outcomes.", "authors": "Hooper J, Gyongyosi E, Hutchison K, Mueller R.", "journal": "PsyArXiv", "publication_date": "2024-10-17", "publication_year": 2024, "doi": "10.31234/osf.io/u9yeg_v1", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.31234/osf.io/u9yeg_v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Emotional Processing,Mystical Experience,Observational Study", "study_type": "Observational Study", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:10:22", "last_checked": "2026-07-01 11:22:04", "bibtex": null, "source_record_id": "DOI:10.31234/osf.io/u9yeg_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://doi.org/10.31234/osf.io/u9yeg_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "DOI:10.31234/osf.io/u9yeg_v1", "source_url": "https://doi.org/10.31234/osf.io/u9yeg_v1", "doi": "10.31234/osf.io/u9yeg_v1", "pmid": "", "publication_date": "2024-10-17", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3453, "title": "Neurobiological Effects of Psilocybin in Treatment Resistant Bipolar Depression: An Emotional-Processing fMRI Pilot Study", "authors": "University Health Network, Toronto", "journal": "ClinicalTrials.gov", "publication_date": "2024-10-17", "publication_year": 2024, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06506019", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Brain Imaging,Mechanism of Action,Receptor Pharmacology,Consciousness,Aging,Emotional Processing,Clinical Trial,Randomized Controlled Trial,Healthy Volunteers,Treatment-Resistant Depression", "study_type": "Randomized Controlled Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06506019", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06506019", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06506019", "source_url": "https://clinicaltrials.gov/study/NCT06506019", "doi": "", "pmid": "", "publication_date": "2024-10-17", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3320, "title": "Aesthetic quality of psychedelic experience is linked to greater insight and improved psychological outcomes.", "authors": "Hooper J, Gyongyosi E, Hutchison K, Mueller R.", "journal": "PsyArXiv", "publication_date": "2024-10-17", "publication_year": 2024, "doi": "10.31234/osf.io/u9yeg", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.31234/osf.io/u9yeg", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Emotional Processing,Mystical Experience,Observational Study", "study_type": "Observational Study", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:50", "last_checked": "2026-07-01 11:22:04", "bibtex": null, "source_record_id": "DOI:10.31234/osf.io/u9yeg", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://doi.org/10.31234/osf.io/u9yeg", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "DOI:10.31234/osf.io/u9yeg", "source_url": "https://doi.org/10.31234/osf.io/u9yeg", "doi": "10.31234/osf.io/u9yeg", "pmid": "", "publication_date": "2024-10-17", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3319, "title": "Aesthetic quality of psychedelic experience is linked to greater insight and improved psychological outcomes.", "authors": "", "journal": "PsyArXiv", "publication_date": "2024-10-17", "publication_year": 2024, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://osf.io/preprints/psyarxiv/u9yeg_v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Pharmacology,Emotional Processing,Mystical Experience,Observational Study", "study_type": "Observational Study", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:50", "last_checked": "2026-07-01 11:22:30", "bibtex": null, "source_record_id": "https://osf.io/preprints/psyarxiv/u9yeg_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/u9yeg_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "https://osf.io/preprints/psyarxiv/u9yeg_v1", "source_url": "https://osf.io/preprints/psyarxiv/u9yeg_v1", "doi": "", "pmid": "", "publication_date": "2024-10-17", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 954, "title": "Moving psychedelic-assisted therapies from promising research into routine clinical practice: Lessons from the field of implementation science", "authors": "Danielle R. Adams, Heidi Allen, Ginger E. Nicol, Leopoldo J. Cabassa", "journal": "Translational Behavioral Medicine", "publication_date": "2024-10-16", "publication_year": 2024, "doi": "10.1093/tbm/ibae053", "pubmed_id": "39419768", "openalex_id": "https://openalex.org/W4403502370", "source_url": "https://doi.org/10.1093/tbm/ibae053", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Addiction,Mechanism of Action,Clinical Trial,Veterans,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:34", "bibtex": null, "source_record_id": "PMID:39419768", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1093/tbm/ibae053", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:39419768", "source_url": "https://doi.org/10.1093/tbm/ibae053", "doi": "10.1093/tbm/ibae053", "pmid": "39419768", "publication_date": "2024-10-16", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 946, "title": "Psilocybin and the glutamatergic pathway: implications for the treatment of neuropsychiatric diseases.", "authors": "Szpręgiel I, Bysiek A.", "journal": null, "publication_date": "2024-10-15", "publication_year": 2024, "doi": "10.1007/s43440-024-00660-y", "pubmed_id": "39412581", "openalex_id": null, "source_url": "https://doi.org/10.1007/s43440-024-00660-y", "substance_tags": "psilocybin", "topic_tags": "Depression,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Review Article,Animal Study", "study_type": "Review Article", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:00", "bibtex": null, "source_record_id": "PMID:39412581", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1007/s43440-024-00660-y", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:39412581", "source_url": "https://doi.org/10.1007/s43440-024-00660-y", "doi": "10.1007/s43440-024-00660-y", "pmid": "39412581", "publication_date": "2024-10-15", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 957, "title": "Expanding the Therapeutic Horizons of Psilocybin in Mental Health.", "authors": "Kargbo RB.", "journal": null, "publication_date": "2024-10-14", "publication_year": 2024, "doi": "10.1021/acsmedchemlett.4c00488", "pubmed_id": "39563826", "openalex_id": null, "source_url": "https://doi.org/10.1021/acsmedchemlett.4c00488", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Wellbeing,Clinical Trial", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:00", "bibtex": null, "source_record_id": "PMID:39563826", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1021/acsmedchemlett.4c00488", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:39563826", "source_url": "https://doi.org/10.1021/acsmedchemlett.4c00488", "doi": "10.1021/acsmedchemlett.4c00488", "pmid": "39563826", "publication_date": "2024-10-14", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 669, "title": "Characterization and Identification of an Antimicrobial Compound Psilocybin from Psychedelic Mushroom.", "authors": "Karthiyayini B, Kalyani NN, Gowdhami B, Muthuselvam M, Dharumadurai D.", "journal": null, "publication_date": "2024-10-12", "publication_year": 2024, "doi": "10.1007/s12088-024-01396-2", "pubmed_id": "40655360", "openalex_id": null, "source_url": "https://doi.org/10.1007/s12088-024-01396-2", "substance_tags": "psilocybin", "topic_tags": "Depression,Toxicity", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:00", "bibtex": null, "source_record_id": "PMID:40655360", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1007/s12088-024-01396-2", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:40655360", "source_url": "https://doi.org/10.1007/s12088-024-01396-2", "doi": "10.1007/s12088-024-01396-2", "pmid": "40655360", "publication_date": "2024-10-12", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 945, "title": "The impact of antidepressant discontinuation prior to treatment with psilocybin for treatment-resistant depression", "authors": "Lindsey Marwood, Megan Croal, Sunil Mistry, Hollie Simmons, Joyce Tsai, Matthew B. Young, Guy M. Goodwin", "journal": "Journal of Psychiatric Research", "publication_date": "2024-10-10", "publication_year": 2024, "doi": "10.1016/j.jpsychires.2024.10.009", "pubmed_id": "39427449", "openalex_id": "https://openalex.org/W4403332337", "source_url": "https://doi.org/10.1016/j.jpsychires.2024.10.009", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Treatment-Resistant Depression", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:34", "bibtex": null, "source_record_id": "PMID:39427449", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:39427449", "source_url": "https://doi.org/10.1016/j.jpsychires.2024.10.009", "doi": "10.1016/j.jpsychires.2024.10.009", "pmid": "39427449", "publication_date": "2024-10-10", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4537, "title": "The therapeutic potential and mechanisms of action of psilocybin-assisted therapy in anorexia nervosa treatment", "authors": "Hannah Douglass", "journal": "Open MIND", "publication_date": "2024-10-09", "publication_year": 2024, "doi": "10.25560/118978", "pubmed_id": null, "openalex_id": "https://openalex.org/W7166080670", "source_url": "https://hdl.handle.net/10044/1/118978", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Eating Disorders,Chronic Pain,Neuroplasticity,Brain Imaging,Mechanism of Action,Consciousness,Aging,Resilience,Observational Study,Safety", "study_type": "Observational Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:42", "last_checked": "2026-07-04 07:00:34", "bibtex": null, "source_record_id": "DOI:10.25560/118978", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://hdl.handle.net/10044/1/118978", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.25560/118978", "source_url": "https://hdl.handle.net/10044/1/118978", "doi": "10.25560/118978", "pmid": "", "publication_date": "2024-10-09", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4541, "title": "Does psilocybin reduce symptoms of depression in adults with major depressive disorder or life-threatening cancer?", "authors": "Morgan Justin, Kerry Watrin", "journal": "Evidence-Based Practice", "publication_date": "2024-10-08", "publication_year": 2024, "doi": "10.1097/ebp.0000000000002281", "pubmed_id": null, "openalex_id": "https://openalex.org/W4403272071", "source_url": "https://doi.org/10.1097/ebp.0000000000002281", "substance_tags": "psilocybin", "topic_tags": "Depression,End-of-Life Distress", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:42", "last_checked": "2026-07-04 07:00:34", "bibtex": null, "source_record_id": "DOI:10.1097/ebp.0000000000002281", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1097/ebp.0000000000002281", "source_url": "https://doi.org/10.1097/ebp.0000000000002281", "doi": "10.1097/ebp.0000000000002281", "pmid": "", "publication_date": "2024-10-08", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 858, "title": "The association between study design and antidepressant effects in psychedelic-assisted therapy: A meta-analysis.", "authors": "Li JR, Chiang KT, Kao YC, Yu CL, Yang FC, Liang CS, Hsu TW.", "journal": null, "publication_date": "2024-10-08", "publication_year": 2024, "doi": "10.1016/j.jad.2024.10.016", "pubmed_id": "39389119", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.jad.2024.10.016", "substance_tags": "psilocybin", "topic_tags": "Depression,Meta-Analysis", "study_type": "Meta-Analysis", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:03", "bibtex": null, "source_record_id": "PMID:39389119", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.jad.2024.10.016", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:39389119", "source_url": "https://doi.org/10.1016/j.jad.2024.10.016", "doi": "10.1016/j.jad.2024.10.016", "pmid": "39389119", "publication_date": "2024-10-08", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3750, "title": "Qualitative Research on Psilocybin-Assisted Psychotherapy for the Treatment of Mental Health Disorders: A Scoping Review Protocol", "authors": "Pincombe J, Williams M, Carruthers S, Rossell S.", "journal": "PsyArXiv", "publication_date": "2024-10-06", "publication_year": 2024, "doi": "10.31234/osf.io/ga9p2", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.31234/osf.io/ga9p2", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Microdosing,Review Article", "study_type": "Review Article", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:10:18", "last_checked": "2026-07-01 11:22:01", "bibtex": null, "source_record_id": "DOI:10.31234/osf.io/ga9p2", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://doi.org/10.31234/osf.io/ga9p2", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "DOI:10.31234/osf.io/ga9p2", "source_url": "https://doi.org/10.31234/osf.io/ga9p2", "doi": "10.31234/osf.io/ga9p2", "pmid": "", "publication_date": "2024-10-06", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3121, "title": "Qualitative Research on Psilocybin-Assisted Psychotherapy for the Treatment of Mental Health Disorders: A Scoping Review Protocol", "authors": "", "journal": "PsyArXiv", "publication_date": "2024-10-06", "publication_year": 2024, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://osf.io/preprints/psyarxiv/ga9p2_v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Microdosing,Review Article", "study_type": "Review Article", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:47", "last_checked": "2026-07-01 11:22:30", "bibtex": null, "source_record_id": "https://osf.io/preprints/psyarxiv/ga9p2_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/ga9p2_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "https://osf.io/preprints/psyarxiv/ga9p2_v1", "source_url": "https://osf.io/preprints/psyarxiv/ga9p2_v1", "doi": "", "pmid": "", "publication_date": "2024-10-06", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 995, "title": "Meta-correlation of the effect of ketamine and psilocybin induced subjective effects on therapeutic outcome", "authors": "Jack D. C. Dahan, David Dadiomov, Tijmen Bostoen, Albert Dahan", "journal": "npj Mental Health Research", "publication_date": "2024-10-05", "publication_year": 2024, "doi": "10.1038/s44184-024-00091-w", "pubmed_id": "39369173", "openalex_id": "https://openalex.org/W4403151209", "source_url": "https://doi.org/10.1038/s44184-024-00091-w", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Pharmacology,Meta-Analysis,Systematic Review,Review Article", "study_type": "Meta-Analysis", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:34", "bibtex": null, "source_record_id": "PMID:39369173", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1038/s44184-024-00091-w", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:39369173", "source_url": "https://doi.org/10.1038/s44184-024-00091-w", "doi": "10.1038/s44184-024-00091-w", "pmid": "39369173", "publication_date": "2024-10-05", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4542, "title": "Rapid and Prolonged Antidepressant and Antianxiety Effects of Psychedelics and 3,4-Methylenedioxy-methamphetamine-A Systematic Review and Meta-Analysis", "authors": "Dimy Fluyau, Vasanth Kattalai Kailasam, Neelambika Revadigar", "journal": "Psychoactives", "publication_date": "2024-10-03", "publication_year": 2024, "doi": "10.3390/psychoactives3040029", "pubmed_id": null, "openalex_id": "https://openalex.org/W4403113128", "source_url": "https://doi.org/10.3390/psychoactives3040029", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,End-of-Life Distress,Headache / Migraine,Pharmacology,Aging,Personality Change,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Safety,Toxicity", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:42", "last_checked": "2026-07-04 07:00:34", "bibtex": null, "source_record_id": "DOI:10.3390/psychoactives3040029", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.3390/psychoactives3040029", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.3390/psychoactives3040029", "source_url": "https://doi.org/10.3390/psychoactives3040029", "doi": "10.3390/psychoactives3040029", "pmid": "", "publication_date": "2024-10-03", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 813, "title": "Exploring the biocatalysis of psilocybin and other tryptamines: Enzymatic pathways, synthetic strategies, and industrial implications.", "authors": "Junges LH, Müller-Santos M.", "journal": null, "publication_date": "2024-10-03", "publication_year": 2024, "doi": "10.1002/btpr.3513", "pubmed_id": "39366919", "openalex_id": null, "source_url": "https://doi.org/10.1002/btpr.3513", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Mechanism of Action,Aging,Review Article", "study_type": "Review Article", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:01", "bibtex": null, "source_record_id": "PMID:39366919", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1002/btpr.3513", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:39366919", "source_url": "https://doi.org/10.1002/btpr.3513", "doi": "10.1002/btpr.3513", "pmid": "39366919", "publication_date": "2024-10-03", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4543, "title": "Does psilocybin really provide long-term relief from depression, as new study suggests?", "authors": "Johan Lundberg, Guusje Haver", "journal": null, "publication_date": "2024-10-01", "publication_year": 2024, "doi": "10.64628/ab.ywdthqf9c", "pubmed_id": null, "openalex_id": "https://openalex.org/W4413541602", "source_url": "https://doi.org/10.64628/ab.ywdthqf9c", "substance_tags": "psilocybin", "topic_tags": "Depression", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:42", "last_checked": "2026-07-04 07:00:34", "bibtex": null, "source_record_id": "DOI:10.64628/ab.ywdthqf9c", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.64628/ab.ywdthqf9c", "source_url": "https://doi.org/10.64628/ab.ywdthqf9c", "doi": "10.64628/ab.ywdthqf9c", "pmid": "", "publication_date": "2024-10-01", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3332, "title": "From efficacy to effectiveness: evaluating psychedelic randomised controlled trials for trustworthy evidence-based policy and practice.", "authors": "Schenberg EE.", "journal": "PsyArXiv", "publication_date": "2024-09-30", "publication_year": 2024, "doi": "10.31234/osf.io/uxhv7", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.31234/osf.io/uxhv7", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Randomized Controlled Trial,Review Article", "study_type": "Randomized Controlled Trial", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:50", "last_checked": "2026-07-01 11:22:04", "bibtex": null, "source_record_id": "DOI:10.31234/osf.io/uxhv7", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://doi.org/10.31234/osf.io/uxhv7", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "DOI:10.31234/osf.io/uxhv7", "source_url": "https://doi.org/10.31234/osf.io/uxhv7", "doi": "10.31234/osf.io/uxhv7", "pmid": "", "publication_date": "2024-09-30", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3330, "title": "From efficacy to effectiveness: evaluating psychedelic randomised controlled trials for trustworthy evidence-based policy and practice.", "authors": "Schenberg EE.", "journal": "PsyArXiv", "publication_date": "2024-09-30", "publication_year": 2024, "doi": "10.31234/osf.io/uxhv7_v1", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.31234/osf.io/uxhv7_v1", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Randomized Controlled Trial,Review Article", "study_type": "Randomized Controlled Trial", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:50", "last_checked": "2026-07-01 11:22:04", "bibtex": null, "source_record_id": "DOI:10.31234/osf.io/uxhv7_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://doi.org/10.31234/osf.io/uxhv7_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "DOI:10.31234/osf.io/uxhv7_v1", "source_url": "https://doi.org/10.31234/osf.io/uxhv7_v1", "doi": "10.31234/osf.io/uxhv7_v1", "pmid": "", "publication_date": "2024-09-30", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 947, "title": "Impact of psilocybin on cognitive function: A systematic review.", "authors": "Meshkat S, Tello-Gerez TJ, Gholaminezhad F, Dunkley BT, Reichelt AC, Erritzoe D, Vermetten E, Zhang Y, Greenshaw A, Burback L, Winkler O, Jetly R, Mayo LM, Bhat V.", "journal": null, "publication_date": "2024-09-30", "publication_year": 2024, "doi": "10.1111/pcn.13741", "pubmed_id": "39354706", "openalex_id": null, "source_url": "https://doi.org/10.1111/pcn.13741", "substance_tags": "psilocybin", "topic_tags": "Depression,Emotional Processing,Creativity,Systematic Review,Review Article,Healthy Volunteers,Treatment-Resistant Depression,Safety", "study_type": "Systematic Review", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:01", "bibtex": null, "source_record_id": "PMID:39354706", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1111/pcn.13741", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:39354706", "source_url": "https://doi.org/10.1111/pcn.13741", "doi": "10.1111/pcn.13741", "pmid": "39354706", "publication_date": "2024-09-30", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 751, "title": "From efficacy to effectiveness: evaluating psychedelic randomised controlled trials for trustworthy evidence-based policy and practice.", "authors": "", "journal": "PsyArXiv", "publication_date": "2024-09-30", "publication_year": 2024, "doi": "10.1002/prp2.70097", "pubmed_id": null, "openalex_id": null, "source_url": "https://osf.io/preprints/psyarxiv/uxhv7_v1", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Randomized Controlled Trial,Review Article", "study_type": "Randomized Controlled Trial", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:30", "bibtex": null, "source_record_id": "DOI:10.1002/prp2.70097", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/uxhv7_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "DOI:10.1002/prp2.70097", "source_url": "https://osf.io/preprints/psyarxiv/uxhv7_v1", "doi": "10.1002/prp2.70097", "pmid": "", "publication_date": "2024-09-30", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1016, "title": "Psilocybin increases optimistic engagement over time: computational modelling of behaviour in rats", "authors": "Elizabeth L. Fisher, Ryan Smith, Kyna-Anne Conn, Andrew W. Corcoran, Laura K Milton, Jakob Hohwy, Claire J. Foldi", "journal": "Translational Psychiatry", "publication_date": "2024-09-29", "publication_year": 2024, "doi": "10.1038/s41398-024-03103-7", "pubmed_id": "39349428", "openalex_id": "https://openalex.org/W4402975017", "source_url": "https://doi.org/10.1038/s41398-024-03103-7", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Receptor Pharmacology,Clinical Trial", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:34", "bibtex": null, "source_record_id": "PMID:39349428", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1038/s41398-024-03103-7", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:39349428", "source_url": "https://doi.org/10.1038/s41398-024-03103-7", "doi": "10.1038/s41398-024-03103-7", "pmid": "39349428", "publication_date": "2024-09-29", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4546, "title": "The Action on Psilocybin in Neural Plasticity, Brain Reorganization and Cognitive Enhancement", "authors": "Carlos Henrique Marchiori, Marco Vinícios de Oliveira Santana, Klebert de Paula Malheiros", "journal": "Middle East Research Journal of Biological Sciences", "publication_date": "2024-09-27", "publication_year": 2024, "doi": "10.36348/merjbs.2024.v04i05.001", "pubmed_id": null, "openalex_id": "https://openalex.org/W4403659615", "source_url": "https://doi.org/10.36348/merjbs.2024.v04i05.001", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Anxiety,Addiction,Neuroplasticity,Receptor Pharmacology,Review Article", "study_type": "Review Article", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:42", "last_checked": "2026-07-04 07:00:34", "bibtex": null, "source_record_id": "DOI:10.36348/merjbs.2024.v04i05.001", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.36348/merjbs.2024.v04i05.001", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.36348/merjbs.2024.v04i05.001", "source_url": "https://doi.org/10.36348/merjbs.2024.v04i05.001", "doi": "10.36348/merjbs.2024.v04i05.001", "pmid": "", "publication_date": "2024-09-27", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 859, "title": "Single-dose psilocybin for U.S. military Veterans with severe treatment-resistant depression - A first-in-kind open-label pilot study", "authors": "Sara Ellis, Catherine Bostian, Wendy Feng, E. Grace Fischer, Garrett Schwartz, Katherine Eisen, Melanie Lean, Elizabeth Conlan, Michael J. Ostacher, Scott T. Aaronson, Trisha Suppes", "journal": "Journal of Affective Disorders", "publication_date": "2024-09-26", "publication_year": 2024, "doi": "10.1016/j.jad.2024.09.133", "pubmed_id": "39343309", "openalex_id": "https://openalex.org/W4402912774", "source_url": "https://doi.org/10.1016/j.jad.2024.09.133", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Clinical Trial,Treatment-Resistant Depression,Veterans,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:34", "bibtex": null, "source_record_id": "PMID:39343309", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:39343309", "source_url": "https://doi.org/10.1016/j.jad.2024.09.133", "doi": "10.1016/j.jad.2024.09.133", "pmid": "39343309", "publication_date": "2024-09-26", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3099, "title": "Ketamine and Psilocybin Differentially Impact Sensory Learning During the Mismatch Negativity", "authors": "Allohverdi S, Soltanzadeh M, Schmidt A, Charlton C, Hauke D, Karvelis P, Vollenweider F, Diaconescu A.", "journal": "Research Square", "publication_date": "2024-09-25", "publication_year": 2024, "doi": "10.21203/rs.3.rs-4492873/v1", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.21203/rs.3.rs-4492873/v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging,Mechanism of Action", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "preprint", "date_added": "2026-07-01 11:03:46", "last_checked": "2026-07-01 11:22:00", "bibtex": null, "source_record_id": "DOI:10.21203/rs.3.rs-4492873/v1", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.21203/rs.3.rs-4492873/v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "DOI:10.21203/rs.3.rs-4492873/v1", "source_url": "https://doi.org/10.21203/rs.3.rs-4492873/v1", "doi": "10.21203/rs.3.rs-4492873/v1", "pmid": "", "publication_date": "2024-09-25", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3592, "title": "An Open-Label Pilot Study Examining the Feasibility, Safety, and Effectiveness of Psilocybin Therapy for Depression in Bipolar II Disorder", "authors": "University of California, San Francisco", "journal": "ClinicalTrials.gov", "publication_date": "2024-09-24", "publication_year": 2024, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05065294", "substance_tags": "psilocybin", "topic_tags": "Depression,Healthcare Workers,Safety", "study_type": "Other", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05065294", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05065294", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05065294", "source_url": "https://clinicaltrials.gov/study/NCT05065294", "doi": "", "pmid": "", "publication_date": "2024-09-24", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3151, "title": "Distinct classes of antidepressants commonly act to shape pallidal structure and function in mice", "authors": "Abe Y, Sugiura Y, Maeda R, Taira S, Yoshida K, Ibi D, Moritoh S, Hashimoto K, Yagishita S, Tanaka KF.", "journal": "bioRxiv", "publication_date": "2024-09-23", "publication_year": 2024, "doi": "10.1101/2024.09.23.614626", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.1101/2024.09.23.614626", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Brain Imaging,Mechanism of Action,Receptor Pharmacology,Aging,Animal Study", "study_type": "Animal Study", "source_name": "bioRxiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:47", "last_checked": "2026-07-01 11:22:01", "bibtex": null, "source_record_id": "DOI:10.1101/2024.09.23.614626", "abstract_available": true, "abstract_source": "bioRxiv", "abstract_source_url": "https://doi.org/10.1101/2024.09.23.614626", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "bioRxiv", "source_record_id": "DOI:10.1101/2024.09.23.614626", "source_url": "https://doi.org/10.1101/2024.09.23.614626", "doi": "10.1101/2024.09.23.614626", "pmid": "", "publication_date": "2024-09-23", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 891, "title": "Single-dose psilocybin alters resting state functional networks in patients with body dysmorphic disorder", "authors": "Xi Zhu, Chen Zhang, David J. Hellerstein, Jamie D. Feusner, Michael G. Wheaton, Gloria J. Gomez, Franklin R. Schneier", "journal": "Psychedelics.", "publication_date": "2024-09-23", "publication_year": 2024, "doi": "10.61373/pp024r.0028", "pubmed_id": "40458078", "openalex_id": "https://openalex.org/W4404286681", "source_url": "https://doi.org/10.61373/pp024r.0028", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging,Receptor Pharmacology,Default Mode Network,Aging", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:34", "bibtex": null, "source_record_id": "PMID:40458078", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.61373/pp024r.0028", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:40458078", "source_url": "https://doi.org/10.61373/pp024r.0028", "doi": "10.61373/pp024r.0028", "pmid": "40458078", "publication_date": "2024-09-23", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1017, "title": "Psilocybin for major depressive disorder: a systematic review of randomized controlled studies.", "authors": "Li LJ, Mo Y, Shi ZM, Huang XB, Ning YP, Wu HW, Yang XH, Zheng W.", "journal": null, "publication_date": "2024-09-22", "publication_year": 2024, "doi": "10.3389/fpsyt.2024.1416420", "pubmed_id": "39376971", "openalex_id": null, "source_url": "https://doi.org/10.3389/fpsyt.2024.1416420", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Headache / Migraine,Randomized Controlled Trial,Systematic Review,Review Article,Safety", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:00", "bibtex": null, "source_record_id": "PMID:39376971", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.3389/fpsyt.2024.1416420", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:39376971", "source_url": "https://doi.org/10.3389/fpsyt.2024.1416420", "doi": "10.3389/fpsyt.2024.1416420", "pmid": "39376971", "publication_date": "2024-09-22", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 997, "title": "Effect of psilocybin versus escitalopram on depression symptom severity in patients with moderate-to-severe major depressive disorder: observational 6-month follow-up of a phase 2, double-blind, randomised, controlled trial", "authors": "David Erritzøe, Tommaso Barba, Kyle T. Greenway, Roberta Murphy, Jonny Martell, Bruna Giribaldi, Christopher Timmermann, Ashleigh Murphy-Beiner, Michelle Baker Jones, David Nutt, Brandon Weiss, Robin Carhart-Harris", "journal": "EClinicalMedicine", "publication_date": "2024-09-22", "publication_year": 2024, "doi": "10.1016/j.eclinm.2024.102799", "pubmed_id": "39764567", "openalex_id": "https://openalex.org/W4402747955", "source_url": "https://doi.org/10.1016/j.eclinm.2024.102799", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Chronic Pain,Receptor Pharmacology,Clinical Trial,Randomized Controlled Trial,Observational Study,Safety,Contraindications", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:34", "bibtex": null, "source_record_id": "PMID:39764567", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1016/j.eclinm.2024.102799", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:39764567", "source_url": "https://doi.org/10.1016/j.eclinm.2024.102799", "doi": "10.1016/j.eclinm.2024.102799", "pmid": "39764567", "publication_date": "2024-09-22", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3034, "title": "Acute psilocybin and ketanserin effects on cerebral blood flow: 5-HT2AR neuromodulation in healthy humans", "authors": "Larsen K, Lindberg U, Ozenne B, McCulloch DE, Armand S, Madsen MK, Johansen A, Stenbæk DS, Knudsen GM, Fisher PM.", "journal": "medRxiv", "publication_date": "2024-09-21", "publication_year": 2024, "doi": "10.1101/2024.09.19.24313958", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.1101/2024.09.19.24313958", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Brain Imaging,Receptor Pharmacology,Aging,Healthy Volunteers", "study_type": "Other", "source_name": "medRxiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:46", "last_checked": "2026-07-01 11:22:00", "bibtex": null, "source_record_id": "DOI:10.1101/2024.09.19.24313958", "abstract_available": true, "abstract_source": "medRxiv", "abstract_source_url": "https://doi.org/10.1101/2024.09.19.24313958", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "medRxiv", "source_record_id": "DOI:10.1101/2024.09.19.24313958", "source_url": "https://doi.org/10.1101/2024.09.19.24313958", "doi": "10.1101/2024.09.19.24313958", "pmid": "", "publication_date": "2024-09-21", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1001, "title": "Naturalistic psychedelic therapy: The role of relaxation and subjective drug effects in antidepressant response", "authors": "Abigail E. Calder, Benjamin Rausch, Matthias E. Liechti, Friederike Holze, Gregor Hasler", "journal": "Journal of Psychopharmacology", "publication_date": "2024-09-19", "publication_year": 2024, "doi": "10.1177/02698811241278873", "pubmed_id": "39302087", "openalex_id": "https://openalex.org/W4402680012", "source_url": "https://doi.org/10.1177/02698811241278873", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Chronic Pain,Mystical Experience,Healthy Volunteers,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:34", "bibtex": null, "source_record_id": "PMID:39302087", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1177/02698811241278873", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:39302087", "source_url": "https://doi.org/10.1177/02698811241278873", "doi": "10.1177/02698811241278873", "pmid": "39302087", "publication_date": "2024-09-19", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3528, "title": "Psilocybin-assisted Psychotherapy in the Treatment of Patients Hospitalized for Treatment-resistant Depression: an Open-label Feasibility Study with an Experiential and Systemic Focus", "authors": "University Hospital, Ghent", "journal": "ClinicalTrials.gov", "publication_date": "2024-09-18", "publication_year": 2024, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06378229", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Brain Imaging,Observational Study,Treatment-Resistant Depression,Safety,Toxicity", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06378229", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06378229", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06378229", "source_url": "https://clinicaltrials.gov/study/NCT06378229", "doi": "", "pmid": "", "publication_date": "2024-09-18", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1018, "title": "Psychedelic research at a crossroads.", "authors": "Armstrong SB, Davis AK.", "journal": null, "publication_date": "2024-09-18", "publication_year": 2024, "doi": "10.1126/science.adt1024", "pubmed_id": "39298596", "openalex_id": null, "source_url": "https://doi.org/10.1126/science.adt1024", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Consciousness,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:04", "bibtex": null, "source_record_id": "PMID:39298596", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1126/science.adt1024", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:39298596", "source_url": "https://doi.org/10.1126/science.adt1024", "doi": "10.1126/science.adt1024", "pmid": "39298596", "publication_date": "2024-09-18", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4551, "title": "Use of Psilocybin in the Treatment of Mental Disorders: Systematic Review of Clinal Trials", "authors": "Danielle B Rodrigues", "journal": "Journal of Complementary Medicine & Alternative Healthcare", "publication_date": "2024-09-16", "publication_year": 2024, "doi": "10.19080/jcmah.2024.13.555852", "pubmed_id": null, "openalex_id": "https://openalex.org/W4408545862", "source_url": "https://doi.org/10.19080/jcmah.2024.13.555852", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,OCD,Clinical Trial,Systematic Review,Review Article,Safety", "study_type": "Systematic Review", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:42", "last_checked": "2026-07-04 07:00:34", "bibtex": null, "source_record_id": "DOI:10.19080/jcmah.2024.13.555852", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.19080/jcmah.2024.13.555852", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.19080/jcmah.2024.13.555852", "source_url": "https://doi.org/10.19080/jcmah.2024.13.555852", "doi": "10.19080/jcmah.2024.13.555852", "pmid": "", "publication_date": "2024-09-16", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 949, "title": "Exploring the regulatory framework of psychedelics in the US & Europe.", "authors": "Behera HK, Joga R, Yerram S, Karnati P, Mergu T, Gandhi K, M S, Nathiya D, Singh RP, Srivastava S, Kumar S.", "journal": null, "publication_date": "2024-09-16", "publication_year": 2024, "doi": "10.1016/j.ajp.2024.104242", "pubmed_id": null, "openalex_id": "https://openalex.org/W39305768", "source_url": "https://doi.org/10.1016/j.ajp.2024.104242", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Mechanism of Action,Safety", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:04", "bibtex": null, "source_record_id": "DOI:10.1016/j.ajp.2024.104242", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.ajp.2024.104242", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "DOI:10.1016/j.ajp.2024.104242", "source_url": "https://doi.org/10.1016/j.ajp.2024.104242", "doi": "10.1016/j.ajp.2024.104242", "pmid": "", "publication_date": "2024-09-16", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 950, "title": "New frontiers in the biosynthesis of psychoactive specialized metabolites.", "authors": "Li G, Facchini PJ.", "journal": null, "publication_date": "2024-09-15", "publication_year": 2024, "doi": "10.1016/j.pbi.2024.102626", "pubmed_id": "39288539", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.pbi.2024.102626", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Mechanism of Action,Clinical Trial,Review Article", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:03", "bibtex": null, "source_record_id": "PMID:39288539", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.pbi.2024.102626", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:39288539", "source_url": "https://doi.org/10.1016/j.pbi.2024.102626", "doi": "10.1016/j.pbi.2024.102626", "pmid": "39288539", "publication_date": "2024-09-15", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4553, "title": "An estimate of the number of people with clinical depression eligible for psilocybin-assisted therapy in the United States", "authors": "Syed F. Rab, Charles L. Raison, Elliot Marseille", "journal": "Psychedelics.", "publication_date": "2024-09-12", "publication_year": 2024, "doi": "10.61373/pp024r.0025", "pubmed_id": null, "openalex_id": "https://openalex.org/W4404378875", "source_url": "https://doi.org/10.61373/pp024r.0025", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Treatment-Resistant Depression", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:42", "last_checked": "2026-07-04 07:00:34", "bibtex": null, "source_record_id": "DOI:10.61373/pp024r.0025", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.61373/pp024r.0025", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.61373/pp024r.0025", "source_url": "https://doi.org/10.61373/pp024r.0025", "doi": "10.61373/pp024r.0025", "pmid": "", "publication_date": "2024-09-12", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1025, "title": "Psychedelic-assisted therapy for treating anxiety, depression, and existential distress in people with life-threatening diseases.", "authors": "Schipper S, Nigam K, Schmid Y, Piechotta V, Ljuslin M, Beaussant Y, Schwarzer G, Boehlke C.", "journal": null, "publication_date": "2024-09-11", "publication_year": 2024, "doi": "10.1002/14651858.cd015383.pub2", "pubmed_id": "39260823", "openalex_id": null, "source_url": "https://doi.org/10.1002/14651858.cd015383.pub2", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Headache / Migraine,Emotional Processing,Spirituality,Randomized Controlled Trial,Review Article,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:04", "bibtex": null, "source_record_id": "PMID:39260823", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1002/14651858.cd015383.pub2", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:39260823", "source_url": "https://doi.org/10.1002/14651858.cd015383.pub2", "doi": "10.1002/14651858.cd015383.pub2", "pmid": "39260823", "publication_date": "2024-09-11", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 553, "title": "Pharmacokinetics of Psilocybin, a Tryptamine Alkaloid in Magic Mushroom (Psilocybe cubensis): A Systematic Review.", "authors": "Thaoboonruang N, Lohitnavy M, Lohitnavy O.", "journal": null, "publication_date": "2024-09-09", "publication_year": 2024, "doi": "10.1080/02791072.2024.2399128", "pubmed_id": "39257234", "openalex_id": null, "source_url": "https://doi.org/10.1080/02791072.2024.2399128", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Pharmacology,Clinical Trial,Systematic Review,Review Article,In Vitro Study", "study_type": "Systematic Review", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:00", "bibtex": null, "source_record_id": "PMID:39257234", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1080/02791072.2024.2399128", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:39257234", "source_url": "https://doi.org/10.1080/02791072.2024.2399128", "doi": "10.1080/02791072.2024.2399128", "pmid": "39257234", "publication_date": "2024-09-09", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 977, "title": "Psychoactive substances for the treatment of neuropsychiatric disorders.", "authors": "Zhen Z, Sun X, Yuan S, Zhang J.", "journal": null, "publication_date": "2024-09-02", "publication_year": 2024, "doi": "10.1016/j.ajp.2024.104193", "pubmed_id": "39243659", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.ajp.2024.104193", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Mechanism of Action,Receptor Pharmacology,Resilience,Emotional Processing,Review Article,Treatment-Resistant Depression,Safety", "study_type": "Review Article", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:04", "bibtex": null, "source_record_id": "PMID:39243659", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.ajp.2024.104193", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:39243659", "source_url": "https://doi.org/10.1016/j.ajp.2024.104193", "doi": "10.1016/j.ajp.2024.104193", "pmid": "39243659", "publication_date": "2024-09-02", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4560, "title": "G33 Psychedelic drugs for the treatment of chronic pain: is ketamine included?", "authors": "Amany E. Ayad", "journal": null, "publication_date": "2024-08-31", "publication_year": 2024, "doi": "10.1136/rapm-2024-esra.582", "pubmed_id": null, "openalex_id": "https://openalex.org/W4402766768", "source_url": "https://doi.org/10.1136/rapm-2024-esra.582", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Addiction,Chronic Pain,Headache / Migraine,Mechanism of Action,Receptor Pharmacology,Consciousness,Emotional Processing,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Observational Study,Safety", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:42", "last_checked": "2026-07-04 07:00:35", "bibtex": null, "source_record_id": "DOI:10.1136/rapm-2024-esra.582", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1136/rapm-2024-esra.582", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1136/rapm-2024-esra.582", "source_url": "https://doi.org/10.1136/rapm-2024-esra.582", "doi": "10.1136/rapm-2024-esra.582", "pmid": "", "publication_date": "2024-08-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4559, "title": "Einmalig Psilocybin: antidepressive Effekte", "authors": "Arnim Quante", "journal": "PSYCH up2date", "publication_date": "2024-08-31", "publication_year": 2024, "doi": "10.1055/a-2185-5208", "pubmed_id": null, "openalex_id": "https://openalex.org/W4402347011", "source_url": "http://dx.doi.org/10.1055/a-2185-5208", "substance_tags": "psilocybin", "topic_tags": "Depression", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:42", "last_checked": "2026-07-04 07:00:35", "bibtex": null, "source_record_id": "DOI:10.1055/a-2185-5208", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.1055/a-2185-5208", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1055/a-2185-5208", "source_url": "http://dx.doi.org/10.1055/a-2185-5208", "doi": "10.1055/a-2185-5208", "pmid": "", "publication_date": "2024-08-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1028, "title": "Rapidly Trading Down Depression's 3 Pillars to 5HT3-Receptors Through ECT or Psilocybin?", "authors": "Treviranus GRS.", "journal": null, "publication_date": "2024-08-31", "publication_year": 2024, "doi": null, "pubmed_id": "39378462", "openalex_id": null, "source_url": "https://europepmc.org/article/MED/39378462", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Neuroplasticity,Receptor Pharmacology,Mitochondrial Function", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:00", "bibtex": null, "source_record_id": "PMID:39378462", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://europepmc.org/article/MED/39378462", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:39378462", "source_url": "https://europepmc.org/article/MED/39378462", "doi": "", "pmid": "39378462", "publication_date": "2024-08-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1029, "title": "Psychedelic-assisted therapy for palliative care within a home treatment setting: A case report", "authors": "Federico Seragnoli, Martignoni Geo, Martignoni Entela, Silke Bachmann, Elisa Rabitti, Silvio Cavuto, Dubus Zoë, Penzenstadler Louise, Gabriel Thorens, Joël Billieux, Zullino Daniele", "journal": "Clinical Case Reports", "publication_date": "2024-08-29", "publication_year": 2024, "doi": "10.1002/ccr3.9305", "pubmed_id": "39219779", "openalex_id": "https://openalex.org/W4402098372", "source_url": "https://doi.org/10.1002/ccr3.9305", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Pharmacology,Case Report,Safety", "study_type": "Case Report", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:35", "bibtex": null, "source_record_id": "PMID:39219779", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1002/ccr3.9305", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:39219779", "source_url": "https://doi.org/10.1002/ccr3.9305", "doi": "10.1002/ccr3.9305", "pmid": "39219779", "publication_date": "2024-08-29", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1030, "title": "[Psychedelic and dissociative agents in psychiatry: challenges in the treatment].", "authors": "Jungwirth J, Bavato F, Quednow BB.", "journal": null, "publication_date": "2024-08-27", "publication_year": 2024, "doi": "10.1007/s00115-024-01727-0", "pubmed_id": "39196383", "openalex_id": null, "source_url": "https://doi.org/10.1007/s00115-024-01727-0", "substance_tags": "psilocybin", "topic_tags": "Depression,Review Article,Treatment-Resistant Depression,Healthcare Workers,Safety", "study_type": "Review Article", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:03", "bibtex": null, "source_record_id": "PMID:39196383", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1007/s00115-024-01727-0", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:39196383", "source_url": "https://doi.org/10.1007/s00115-024-01727-0", "doi": "10.1007/s00115-024-01727-0", "pmid": "39196383", "publication_date": "2024-08-27", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1003, "title": "The role of psilocybin in depressive disorders.", "authors": "Najib J.", "journal": null, "publication_date": "2024-08-27", "publication_year": 2024, "doi": "10.1080/03007995.2024.2396536", "pubmed_id": "39177339", "openalex_id": null, "source_url": "https://doi.org/10.1080/03007995.2024.2396536", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Clinical Trial,Review Article,Treatment-Resistant Depression,Safety,Drug Interactions", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:00", "bibtex": null, "source_record_id": "PMID:39177339", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1080/03007995.2024.2396536", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:39177339", "source_url": "https://doi.org/10.1080/03007995.2024.2396536", "doi": "10.1080/03007995.2024.2396536", "pmid": "39177339", "publication_date": "2024-08-27", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1049, "title": "Comparative oral monotherapy of psilocybin, lysergic acid diethylamide, 3,4-methylenedioxymethamphetamine, ayahuasca, and escitalopram for depressive symptoms: systematic review and Bayesian network meta-analysis.", "authors": "Hsu TW, Tsai CK, Kao YC, Thompson T, Carvalho AF, Yang FC, Tseng PT, Hsu CW, Yu CL, Tu YK, Liang CS.", "journal": null, "publication_date": "2024-08-20", "publication_year": 2024, "doi": "10.1136/bmj-2023-078607", "pubmed_id": "39168500", "openalex_id": null, "source_url": "https://doi.org/10.1136/bmj-2023-078607", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:01", "bibtex": null, "source_record_id": "PMID:39168500", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1136/bmj-2023-078607", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:39168500", "source_url": "https://doi.org/10.1136/bmj-2023-078607", "doi": "10.1136/bmj-2023-078607", "pmid": "39168500", "publication_date": "2024-08-20", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4566, "title": "Psilocybin in the Treatment of Mental Disorders", "authors": "Doğancan Sönmez, Aslı Enzel Koç", "journal": "DergiPark (Istanbul University)", "publication_date": "2024-08-18", "publication_year": 2024, "doi": "10.30708/mantar.1535344", "pubmed_id": null, "openalex_id": "https://openalex.org/W4414850748", "source_url": "https://dergipark.org.tr/tr/pub/mantar/issue/91439/1535344", "substance_tags": "psilocybin", "topic_tags": "Depression", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:42", "last_checked": "2026-07-04 07:00:35", "bibtex": null, "source_record_id": "DOI:10.30708/mantar.1535344", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://dergipark.org.tr/tr/pub/mantar/issue/91439/1535344", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.30708/mantar.1535344", "source_url": "https://dergipark.org.tr/tr/pub/mantar/issue/91439/1535344", "doi": "10.30708/mantar.1535344", "pmid": "", "publication_date": "2024-08-18", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4565, "title": "Tripping on Utopia: Margaret Mead, the Cold War, and the troubled birth of psychedelic science By BenjaminBreen. New York: Grand Central Publishing, 2024. 384 pp.", "authors": "Jim Weil", "journal": "American Anthropologist", "publication_date": "2024-08-18", "publication_year": 2024, "doi": "10.1111/aman.28009", "pubmed_id": null, "openalex_id": "https://openalex.org/W4401690921", "source_url": "http://dx.doi.org/10.1111/aman.28009", "substance_tags": "psilocybin", "topic_tags": "Depression,Consciousness,Personality Change,Mystical Experience,Observational Study,Veterans,Safety", "study_type": "Observational Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:42", "last_checked": "2026-07-04 07:00:35", "bibtex": null, "source_record_id": "DOI:10.1111/aman.28009", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.1111/aman.28009", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1111/aman.28009", "source_url": "http://dx.doi.org/10.1111/aman.28009", "doi": "10.1111/aman.28009", "pmid": "", "publication_date": "2024-08-18", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1051, "title": "Comparison between Single-Dose and Two-Dose Psilocybin Administration in the Treatment of Major Depression: A Systematic Review and Meta-Analysis of Current Clinical Trials.", "authors": "Salvetti G, Saccenti D, Moro AS, Lamanna J, Ferro M.", "journal": null, "publication_date": "2024-08-17", "publication_year": 2024, "doi": "10.3390/brainsci14080829", "pubmed_id": "39199520", "openalex_id": null, "source_url": "https://doi.org/10.3390/brainsci14080829", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Meta-Analysis,Systematic Review,Review Article,Treatment-Resistant Depression", "study_type": "Meta-Analysis", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:01", "bibtex": null, "source_record_id": "PMID:39199520", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.3390/brainsci14080829", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:39199520", "source_url": "https://doi.org/10.3390/brainsci14080829", "doi": "10.3390/brainsci14080829", "pmid": "39199520", "publication_date": "2024-08-17", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 980, "title": "Psilocybin-assisted psychotherapy for existential distress: practical considerations for therapeutic application-a review.", "authors": "Kim A, Halton B, Shah A, Seecof OM, Ross S.", "journal": null, "publication_date": "2024-08-15", "publication_year": 2024, "doi": "10.21037/apm-24-35", "pubmed_id": "39168642", "openalex_id": null, "source_url": "https://doi.org/10.21037/apm-24-35", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Pharmacology,Clinical Trial,Review Article", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:01", "bibtex": null, "source_record_id": "PMID:39168642", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.21037/apm-24-35", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:39168642", "source_url": "https://doi.org/10.21037/apm-24-35", "doi": "10.21037/apm-24-35", "pmid": "39168642", "publication_date": "2024-08-15", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1053, "title": "The association between diverse psychological protocols and the efficacy of psilocybin-assisted therapy for clinical depressive symptoms: a Bayesian meta-analysis.", "authors": "Chen MH, Cheng SL, Kao YC, Tseng PT, Hsu CW, Yu CL, Yang FC, Thompson T, Hsu TW, Liang CS.", "journal": null, "publication_date": "2024-08-12", "publication_year": 2024, "doi": "10.3389/fpsyt.2024.1439347", "pubmed_id": "39193583", "openalex_id": null, "source_url": "https://doi.org/10.3389/fpsyt.2024.1439347", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Meta-Analysis,Review Article", "study_type": "Meta-Analysis", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:01", "bibtex": null, "source_record_id": "PMID:39193583", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.3389/fpsyt.2024.1439347", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:39193583", "source_url": "https://doi.org/10.3389/fpsyt.2024.1439347", "doi": "10.3389/fpsyt.2024.1439347", "pmid": "39193583", "publication_date": "2024-08-12", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1006, "title": "Psilocybin for clinical indications: A scoping review.", "authors": "Madden K, Flood B, Young Shing D, Ade-Conde M, Kashir I, Mark M, MacKillop J, Bhandari M, Adili A.", "journal": null, "publication_date": "2024-08-12", "publication_year": 2024, "doi": "10.1177/02698811241269751", "pubmed_id": "39135496", "openalex_id": null, "source_url": "https://doi.org/10.1177/02698811241269751", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,OCD,End-of-Life Distress,Chronic Pain,Headache / Migraine,Randomized Controlled Trial,Systematic Review,Review Article", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:01", "bibtex": null, "source_record_id": "PMID:39135496", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1177/02698811241269751", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:39135496", "source_url": "https://doi.org/10.1177/02698811241269751", "doi": "10.1177/02698811241269751", "pmid": "39135496", "publication_date": "2024-08-12", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4569, "title": "Psilocybin-assisted psychotherapy: Advancements, challenges, and future directions for treating resistant depression", "authors": "Rodolfo Myronn de Melo Rodrigues", "journal": "Psychedelics.", "publication_date": "2024-08-11", "publication_year": 2024, "doi": "10.61373/pp024c.0022", "pubmed_id": null, "openalex_id": "https://openalex.org/W4404285144", "source_url": "https://doi.org/10.61373/pp024c.0022", "substance_tags": "psilocybin", "topic_tags": "Depression,Receptor Pharmacology", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:42", "last_checked": "2026-07-04 07:00:35", "bibtex": null, "source_record_id": "DOI:10.61373/pp024c.0022", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.61373/pp024c.0022", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.61373/pp024c.0022", "source_url": "https://doi.org/10.61373/pp024c.0022", "doi": "10.61373/pp024c.0022", "pmid": "", "publication_date": "2024-08-11", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 842, "title": "A clinical research perspective on the regulation of medical and non-medical use of psychedelic drugs", "authors": "Michael P. Bogenschutz", "journal": "Addiction", "publication_date": "2024-08-11", "publication_year": 2024, "doi": "10.1111/add.16647", "pubmed_id": "39129581", "openalex_id": "https://openalex.org/W4401521492", "source_url": "https://doi.org/10.1111/add.16647", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Chronic Pain,Receptor Pharmacology,Consciousness,Clinical Trial,Review Article,Treatment-Resistant Depression,Healthcare Workers,Safety,Adverse Events,Toxicity,Drug Interactions", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:35", "bibtex": null, "source_record_id": "PMID:39129581", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1111/add.16647", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:39129581", "source_url": "https://doi.org/10.1111/add.16647", "doi": "10.1111/add.16647", "pmid": "39129581", "publication_date": "2024-08-11", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3609, "title": "An Open Label Study of the Safety and Efficacy of Psilocybin in Participants With Treatment-Resistant Depression (P-TRD)", "authors": "Sheppard Pratt Health System", "journal": "ClinicalTrials.gov", "publication_date": "2024-08-08", "publication_year": 2024, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT04433858", "substance_tags": "psilocybin", "topic_tags": "Depression,Treatment-Resistant Depression,Safety", "study_type": "Other", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT04433858", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT04433858", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT04433858", "source_url": "https://clinicaltrials.gov/study/NCT04433858", "doi": "", "pmid": "", "publication_date": "2024-08-08", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1004, "title": "Letter to editor regarding \"Psilocybin-assisted therapy for depression: A systematic review and meta-analysis\".", "authors": "Yang X, Kuang W.", "journal": null, "publication_date": "2024-08-07", "publication_year": 2024, "doi": "10.1016/j.psychres.2024.116136", "pubmed_id": "39141970", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.psychres.2024.116136", "substance_tags": "psilocybin", "topic_tags": "Depression,Meta-Analysis,Systematic Review,Review Article", "study_type": "Meta-Analysis", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:04", "bibtex": null, "source_record_id": "PMID:39141970", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:39141970", "source_url": "https://doi.org/10.1016/j.psychres.2024.116136", "doi": "10.1016/j.psychres.2024.116136", "pmid": "39141970", "publication_date": "2024-08-07", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3438, "title": "Psilocybin-Assisted Therapy for Severe Alcohol Use Disorder: Feasibility, Clinical Efficacy & (Neuro)Cognitive Mechanisms", "authors": "Brugmann University Hospital", "journal": "ClinicalTrials.gov", "publication_date": "2024-08-06", "publication_year": 2024, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06160232", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Neuroplasticity,Mechanism of Action,Biomarkers,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06160232", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06160232", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06160232", "source_url": "https://clinicaltrials.gov/study/NCT06160232", "doi": "", "pmid": "", "publication_date": "2024-08-06", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4572, "title": "Different hierarchical reconfigurations in the brain by psilocybin and escitalopram for depression", "authors": "Gustavo Deco, Yonatan Sanz Perl, Samuel Johnson, Niamh Bourke, Robin Carhart-Harris, Morten L. Kringelbach", "journal": "Nature Mental Health", "publication_date": "2024-08-04", "publication_year": 2024, "doi": "10.1038/s44220-024-00298-y", "pubmed_id": null, "openalex_id": "https://openalex.org/W4401339608", "source_url": "https://doi.org/10.1038/s44220-024-00298-y", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Brain Imaging,Mechanism of Action,Aging,Clinical Trial,Randomized Controlled Trial", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:42", "last_checked": "2026-07-04 07:00:35", "bibtex": null, "source_record_id": "DOI:10.1038/s44220-024-00298-y", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1038/s44220-024-00298-y", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1038/s44220-024-00298-y", "source_url": "https://doi.org/10.1038/s44220-024-00298-y", "doi": "10.1038/s44220-024-00298-y", "pmid": "", "publication_date": "2024-08-04", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4574, "title": "Insights into the efficacy of psilocybin in treating depression and other disorders", "authors": "Sarah Jane Palmer", "journal": "British Journal of Neuroscience Nursing", "publication_date": "2024-08-01", "publication_year": 2024, "doi": "10.12968/bjnn.2024.0046", "pubmed_id": null, "openalex_id": "https://openalex.org/W4401907376", "source_url": "http://dx.doi.org/10.12968/bjnn.2024.0046", "substance_tags": "psilocybin", "topic_tags": "Depression", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:42", "last_checked": "2026-07-04 07:00:35", "bibtex": null, "source_record_id": "DOI:10.12968/bjnn.2024.0046", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.12968/bjnn.2024.0046", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.12968/bjnn.2024.0046", "source_url": "http://dx.doi.org/10.12968/bjnn.2024.0046", "doi": "10.12968/bjnn.2024.0046", "pmid": "", "publication_date": "2024-08-01", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1065, "title": "Psychedelic-assisted psychotherapy: where is the psychotherapy research?", "authors": "Aday JS, Horton D, Fernandes-Osterhold G, O'Donovan A, Bradley ER, Rosen RC, Woolley JD", "journal": "Psychopharmacology", "publication_date": "2024-07-31", "publication_year": 2024, "doi": "10.1007/s00213-024-06620-x", "pubmed_id": "38782821", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/38782821/", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Mechanism of Action,Clinical Trial,Review Article,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:20:36", "bibtex": null, "source_record_id": "PMID:38782821", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38782821/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38782821", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38782821/", "doi": "10.1007/s00213-024-06620-x", "pmid": "38782821", "publication_date": "2024-07-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1056, "title": "CURRENT STATE OF PSILOCYBIN-ASSISTED THERAPY IN MOOD DISORDERS.", "authors": "Kaiserman A, Vanderjist L, Kornreich C.", "journal": null, "publication_date": "2024-07-31", "publication_year": 2024, "doi": "10.24869/psyd.2024.174", "pubmed_id": "39546645", "openalex_id": null, "source_url": "https://doi.org/10.24869/psyd.2024.174", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Neuroplasticity,Receptor Pharmacology,Review Article", "study_type": "Review Article", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:01", "bibtex": null, "source_record_id": "PMID:39546645", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.24869/psyd.2024.174", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:39546645", "source_url": "https://doi.org/10.24869/psyd.2024.174", "doi": "10.24869/psyd.2024.174", "pmid": "39546645", "publication_date": "2024-07-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4578, "title": "Psilocybin - A Drug to be Considered for the Treatment of Anxiety and Depression in Cancer Patients", "authors": "V Suresh, Jitendra Lakhani, R Balaraman", "journal": "Journal of Natural Remedies", "publication_date": "2024-07-30", "publication_year": 2024, "doi": "10.18311/jnr/2024/35676", "pubmed_id": null, "openalex_id": "https://openalex.org/W4401276469", "source_url": "http://dx.doi.org/10.18311/jnr/2024/35676", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Pharmacology,Review Article,Cancer Patients", "study_type": "Review Article", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:42", "last_checked": "2026-07-04 07:00:35", "bibtex": null, "source_record_id": "DOI:10.18311/jnr/2024/35676", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.18311/jnr/2024/35676", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.18311/jnr/2024/35676", "source_url": "http://dx.doi.org/10.18311/jnr/2024/35676", "doi": "10.18311/jnr/2024/35676", "pmid": "", "publication_date": "2024-07-30", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4580, "title": "From chaos to kaleidoscope: Exploring factors in psychedelic self-treatment for mental health conditions", "authors": "Claire Walker, Timothy Piatkowski, Jason Ferris, Emma Davies, Monica J. Barratt, Adam Winstock, Cheneal Puljević", "journal": "Journal of Psychopharmacology", "publication_date": "2024-07-28", "publication_year": 2024, "doi": "10.1177/02698811241265762", "pubmed_id": "39075756", "openalex_id": "https://openalex.org/W4401152982", "source_url": "https://doi.org/10.1177/02698811241265762", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Chronic Pain,Observational Study,Toxicity", "study_type": "Observational Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:42", "last_checked": "2026-07-04 06:34:42", "bibtex": null, "source_record_id": "PMID:39075756", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1177/02698811241265762", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:39075756", "source_url": "https://doi.org/10.1177/02698811241265762", "doi": "10.1177/02698811241265762", "pmid": "39075756", "publication_date": "2024-07-28", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3450, "title": "Psilocybin for the Treatment of Major Depressive Disorder", "authors": "Washington University School of Medicine", "journal": "ClinicalTrials.gov", "publication_date": "2024-07-24", "publication_year": 2024, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05675800", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action", "study_type": "Other", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05675800", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05675800", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05675800", "source_url": "https://clinicaltrials.gov/study/NCT05675800", "doi": "", "pmid": "", "publication_date": "2024-07-24", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1008, "title": "Current Perspectives on the Clinical Research and Medicalization of Psychedelic Drugs for Addiction Treatments: Safety, Efficacy, Limitations and Challenges.", "authors": "Gomez-Escolar A, Folch-Sanchez D, Stefaniuk J, Swithenbank Z, Nisa A, Braddick F, Idrees Chaudhary N, van der Meer PB, Batalla A.", "journal": null, "publication_date": "2024-07-19", "publication_year": 2024, "doi": "10.1007/s40263-024-01101-3", "pubmed_id": "39033264", "openalex_id": null, "source_url": "https://doi.org/10.1007/s40263-024-01101-3", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Addiction,Review Article,Safety", "study_type": "Review Article", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:04", "bibtex": null, "source_record_id": "PMID:39033264", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1007/s40263-024-01101-3", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:39033264", "source_url": "https://doi.org/10.1007/s40263-024-01101-3", "doi": "10.1007/s40263-024-01101-3", "pmid": "39033264", "publication_date": "2024-07-19", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1074, "title": "Longitudinal experiences of Canadians receiving compassionate access to psilocybin-assisted psychotherapy", "authors": "Sara de la Salle, Hannes Kettner, Julien Thibault Lévesque, Nicolas Garel, Shannon Dames, Ryan Patchett-Marble, Soham Rej, Sara G. Gloeckler, David Erritzøe, Robin Carhart-Harris, Kyle T. Greenway", "journal": "Scientific Reports", "publication_date": "2024-07-16", "publication_year": 2024, "doi": "10.1038/s41598-024-66817-0", "pubmed_id": "39019922", "openalex_id": "https://openalex.org/W4400737202", "source_url": "https://doi.org/10.1038/s41598-024-66817-0", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Chronic Pain,Mechanism of Action,Wellbeing,Spirituality,Clinical Trial,Observational Study", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:35", "bibtex": null, "source_record_id": "PMID:39019922", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1038/s41598-024-66817-0", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:39019922", "source_url": "https://doi.org/10.1038/s41598-024-66817-0", "doi": "10.1038/s41598-024-66817-0", "pmid": "39019922", "publication_date": "2024-07-16", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1076, "title": "Serotoninergic antidepressants combination in psilocybin-assisted psychotherapy: a case report", "authors": "André Do, Vanessa Michaud, Jean-François Stephan, Miltiadis Moreau, Élise Benoît, Felix-Antoine Berubé, Antoine Bibaud-De Serres, Alain Taillefer, Philippe Vincent", "journal": "Frontiers in Psychiatry", "publication_date": "2024-07-15", "publication_year": 2024, "doi": "10.3389/fpsyt.2024.1394962", "pubmed_id": "39086732", "openalex_id": "https://openalex.org/W4400695899", "source_url": "https://doi.org/10.3389/fpsyt.2024.1394962", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Headache / Migraine,Pharmacology,Receptor Pharmacology,Clinical Trial,Case Report,Safety,Adverse Events,Drug Interactions", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:35", "bibtex": null, "source_record_id": "PMID:39086732", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.3389/fpsyt.2024.1394962", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:39086732", "source_url": "https://doi.org/10.3389/fpsyt.2024.1394962", "doi": "10.3389/fpsyt.2024.1394962", "pmid": "39086732", "publication_date": "2024-07-15", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1077, "title": "Psilocybin for the treatment of Alzheimer's disease.", "authors": "Zheng S, Ma R, Yang Y, Li G.", "journal": null, "publication_date": "2024-07-09", "publication_year": 2024, "doi": "10.3389/fnins.2024.1420601", "pubmed_id": "39050672", "openalex_id": null, "source_url": "https://doi.org/10.3389/fnins.2024.1420601", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Anxiety,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Emotional Processing,Creativity,Review Article,Safety,Inflammation", "study_type": "Review Article", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:00", "bibtex": null, "source_record_id": "PMID:39050672", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.3389/fnins.2024.1420601", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:39050672", "source_url": "https://doi.org/10.3389/fnins.2024.1420601", "doi": "10.3389/fnins.2024.1420601", "pmid": "39050672", "publication_date": "2024-07-09", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4590, "title": "Psilocybin in the Management of Substance Use Disorders: A Summary ofCurrent Evidence", "authors": "Hussein El Bourji, Aziz Farhat, Zahi Hamdan, Ritvij Satodiya, Rashmi Shukla, Samer El Hayek", "journal": "Current Psychopharmacologye", "publication_date": "2024-07-03", "publication_year": 2024, "doi": "10.2174/0122115560288779240628043307", "pubmed_id": null, "openalex_id": "https://openalex.org/W4400323479", "source_url": "https://doi.org/10.2174/0122115560288779240628043307", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Chronic Pain,Clinical Trial,Randomized Controlled Trial,Review Article", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:42", "last_checked": "2026-07-04 07:00:35", "bibtex": null, "source_record_id": "DOI:10.2174/0122115560288779240628043307", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.2174/0122115560288779240628043307", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.2174/0122115560288779240628043307", "source_url": "https://doi.org/10.2174/0122115560288779240628043307", "doi": "10.2174/0122115560288779240628043307", "pmid": "", "publication_date": "2024-07-03", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1052, "title": "Addressing a major interference in the quantification of psilocin in mouse plasma: Development of a validated liquid chromatography tandem mass spectrometry method", "authors": "Amir Khajavinia, Déborah Michel, Udoka C. Ezeaka, Randy W. Purves, Robert B. Laprairie, Anas El-Aneed", "journal": "Journal of Chromatography A", "publication_date": "2024-07-03", "publication_year": 2024, "doi": "10.1016/j.chroma.2024.465123", "pubmed_id": "38981146", "openalex_id": "https://openalex.org/W4400333801", "source_url": "https://doi.org/10.1016/j.chroma.2024.465123", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Anxiety,PTSD,Pharmacology,Receptor Pharmacology,Animal Study,Safety,Toxicity,Drug Interactions", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:35", "bibtex": null, "source_record_id": "PMID:38981146", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1016/j.chroma.2024.465123", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:38981146", "source_url": "https://doi.org/10.1016/j.chroma.2024.465123", "doi": "10.1016/j.chroma.2024.465123", "pmid": "38981146", "publication_date": "2024-07-03", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 638, "title": "Unraveling psilocybin’s therapeutic potential: behavioral and neuroplasticity insights in Wistar-Kyoto and Wistar male rat models of treatment-resistant depression", "authors": "Magdalena Kolasa, Agnieszka Nikiforuk, Agata Korlatowicz, Joanna Solich, Agnieszka Potasiewicz, Marta Dziedzicka-Wasylewska, Ryszard Bugno, Adam S. Hogendorf, Andrzej J. Bojarski, Agata Faron-Górecka", "journal": "Psychopharmacology", "publication_date": "2024-07-03", "publication_year": 2024, "doi": "10.1007/s00213-024-06644-3", "pubmed_id": "38963553", "openalex_id": "https://openalex.org/W4400335852", "source_url": "https://doi.org/10.1007/s00213-024-06644-3", "substance_tags": "psilocybin", "topic_tags": "Depression,Neuroplasticity,Pharmacology,Mechanism of Action,Receptor Pharmacology,Animal Study,Treatment-Resistant Depression,Drug Interactions", "study_type": "Animal Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:35", "bibtex": null, "source_record_id": "PMID:38963553", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1007/s00213-024-06644-3", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:38963553", "source_url": "https://doi.org/10.1007/s00213-024-06644-3", "doi": "10.1007/s00213-024-06644-3", "pmid": "38963553", "publication_date": "2024-07-03", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1080, "title": "Engaging Mood Brain Circuits with Psilocybin (EMBRACE): a study protocol for a randomized, placebo-controlled and delayed-start, neuroimaging trial in depression", "authors": "Joshua M. Poulin, Gregory E. Bigford, Krista L. Lanctôt, Peter Giacobbe, Ayal Schaffer, Mark Sinyor, Jennifer S. Rabin, Mario Masellis, Amit Singnurkar, Christopher B. Pople, Nir Lipsman, Muhammad Ishrat Husain, Joshua D. Rosenblat, Xingshan Cao, Bradley J. MacIntosh, Sean M. Nestor", "journal": "Trials", "publication_date": "2024-07-02", "publication_year": 2024, "doi": "10.1186/s13063-024-08268-6", "pubmed_id": "38956594", "openalex_id": "https://openalex.org/W4400306738", "source_url": "https://doi.org/10.1186/s13063-024-08268-6", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Chronic Pain,Neuroplasticity,Brain Imaging,Mechanism of Action,Biomarkers,Aging,Randomized Controlled Trial,Inflammation", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:35", "bibtex": null, "source_record_id": "PMID:38956594", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1186/s13063-024-08268-6", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:38956594", "source_url": "https://doi.org/10.1186/s13063-024-08268-6", "doi": "10.1186/s13063-024-08268-6", "pmid": "38956594", "publication_date": "2024-07-02", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4594, "title": "Lifetime Depression and Psilocybin Mushroom Use in U.S. Adults, 2008-2019", "authors": "Lauren Gorfinkel, Julia M. Bujno, Claire Walsh, Dvora Shmulewitz, Deborah S. Hasin", "journal": "Drug and Alcohol Dependence", "publication_date": "2024-06-30", "publication_year": 2024, "doi": "10.1016/j.drugalcdep.2023.110267", "pubmed_id": null, "openalex_id": "https://openalex.org/W4400574683", "source_url": "https://doi.org/10.1016/j.drugalcdep.2023.110267", "substance_tags": "psilocybin", "topic_tags": "Depression", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:43", "last_checked": "2026-07-04 07:00:35", "bibtex": null, "source_record_id": "DOI:10.1016/j.drugalcdep.2023.110267", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.drugalcdep.2023.110267", "source_url": "https://doi.org/10.1016/j.drugalcdep.2023.110267", "doi": "10.1016/j.drugalcdep.2023.110267", "pmid": "", "publication_date": "2024-06-30", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1081, "title": "Treating Anxiety and Depression With Psilocybin Therapy.", "authors": "Amanda Paige Hanstein, Chance Felchlin", "journal": "PubMed", "publication_date": "2024-06-30", "publication_year": 2024, "doi": null, "pubmed_id": "39079732", "openalex_id": "https://openalex.org/W4401200580", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39079732", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:35", "bibtex": null, "source_record_id": "PMID:39079732", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:39079732", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39079732", "doi": "", "pmid": "39079732", "publication_date": "2024-06-30", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1079, "title": "The Black Book of Psychotropic Dosing and Monitoring.", "authors": "DeBattista C, Schatzberg AF.", "journal": null, "publication_date": "2024-06-30", "publication_year": 2024, "doi": "10.64719/pb.4493", "pubmed_id": "38993656", "openalex_id": null, "source_url": "https://doi.org/10.64719/pb.4493", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Headache / Migraine,Brain Imaging,Pharmacology,Receptor Pharmacology,Aging,Clinical Trial,Review Article,Healthcare Workers,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:07", "bibtex": null, "source_record_id": "PMID:38993656", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.64719/pb.4493", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:38993656", "source_url": "https://doi.org/10.64719/pb.4493", "doi": "10.64719/pb.4493", "pmid": "38993656", "publication_date": "2024-06-30", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1071, "title": "Investigating the therapeutic efficacy of psilocybin in advanced cancer patients: A comprehensive review and meta-analysis.", "authors": "Bader H, Farraj H, Maghnam J, Abu Omar Y.", "journal": null, "publication_date": "2024-06-30", "publication_year": 2024, "doi": "10.5306/wjco.v15.i7.908", "pubmed_id": "39071471", "openalex_id": null, "source_url": "https://doi.org/10.5306/wjco.v15.i7.908", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Chronic Pain,Wellbeing,Meta-Analysis,Systematic Review,Review Article,Cancer Patients", "study_type": "Meta-Analysis", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:01", "bibtex": null, "source_record_id": "PMID:39071471", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.5306/wjco.v15.i7.908", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:39071471", "source_url": "https://doi.org/10.5306/wjco.v15.i7.908", "doi": "10.5306/wjco.v15.i7.908", "pmid": "39071471", "publication_date": "2024-06-30", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4601, "title": "IS PSYCHEDELIC TREATMENT OF MENTAL HEALTH DISORDERS READY FOR PRIME TIME?", "authors": "Nauman Ashraf", "journal": "Journal of Pakistan Psychiatric Society", "publication_date": "2024-06-29", "publication_year": 2024, "doi": "10.63050/jpps.21.02.935", "pubmed_id": null, "openalex_id": "https://openalex.org/W4400219530", "source_url": "http://dx.doi.org/10.63050/jpps.21.02.935", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Default Mode Network,Consciousness,Emotional Processing,Spirituality,Safety,Toxicity", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:43", "last_checked": "2026-07-04 07:00:35", "bibtex": null, "source_record_id": "DOI:10.63050/jpps.21.02.935", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.63050/jpps.21.02.935", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.63050/jpps.21.02.935", "source_url": "http://dx.doi.org/10.63050/jpps.21.02.935", "doi": "10.63050/jpps.21.02.935", "pmid": "", "publication_date": "2024-06-29", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4604, "title": "Review identifies factors associated with response to psilocybin", "authors": "", "journal": "The Brown University Psychopharmacology Update", "publication_date": "2024-06-26", "publication_year": 2024, "doi": "10.1002/pu.31193", "pubmed_id": null, "openalex_id": "https://openalex.org/W4400083626", "source_url": "https://doi.org/10.1002/pu.31193", "substance_tags": "psilocybin", "topic_tags": "Depression,Pharmacology,Aging,Systematic Review,Review Article,Healthcare Workers", "study_type": "Systematic Review", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:43", "last_checked": "2026-07-04 07:00:35", "bibtex": null, "source_record_id": "DOI:10.1002/pu.31193", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1002/pu.31193", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1002/pu.31193", "source_url": "https://doi.org/10.1002/pu.31193", "doi": "10.1002/pu.31193", "pmid": "", "publication_date": "2024-06-26", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 639, "title": "Hypertensive Emergency Secondary to Combining Psilocybin Mushrooms, Extended Release Dextroamphetamine-Amphetamine, and Tranylcypromine", "authors": "Brian S. Barnett, Curtis J. Koons, Vincent Van den Eynde, Peter Kenneth Gillman, J. Alexander Bodkin", "journal": "Journal of Psychoactive Drugs", "publication_date": "2024-06-20", "publication_year": 2024, "doi": "10.1080/02791072.2024.2368617", "pubmed_id": "38903003", "openalex_id": "https://openalex.org/W4399897612", "source_url": "https://doi.org/10.1080/02791072.2024.2368617", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Headache / Migraine,Pharmacology,Receptor Pharmacology,Randomized Controlled Trial,Drug Interactions", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:35", "bibtex": null, "source_record_id": "PMID:38903003", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1080/02791072.2024.2368617", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:38903003", "source_url": "https://doi.org/10.1080/02791072.2024.2368617", "doi": "10.1080/02791072.2024.2368617", "pmid": "38903003", "publication_date": "2024-06-20", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3184, "title": "Rapid and prolonged antidepressant and antianxiety effects of psilocybin, lysergic acid diethylamide, ayahuasca, and 3, 4-methylenedioxy-methamphetamine. A systematic review and meta-analysis of randomized controlled trials", "authors": "Fluyau D, Kailasam VK, Revadigar N.", "journal": "medRxiv", "publication_date": "2024-06-19", "publication_year": 2024, "doi": "10.1101/2024.06.17.24308787", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.1101/2024.06.17.24308787", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,End-of-Life Distress,Headache / Migraine,Aging,Personality Change,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Safety", "study_type": "Randomized Controlled Trial", "source_name": "medRxiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:47", "last_checked": "2026-07-01 11:22:02", "bibtex": null, "source_record_id": "DOI:10.1101/2024.06.17.24308787", "abstract_available": true, "abstract_source": "medRxiv", "abstract_source_url": "https://doi.org/10.1101/2024.06.17.24308787", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "medRxiv", "source_record_id": "DOI:10.1101/2024.06.17.24308787", "source_url": "https://doi.org/10.1101/2024.06.17.24308787", "doi": "10.1101/2024.06.17.24308787", "pmid": "", "publication_date": "2024-06-19", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1062, "title": "The cyclical revival of psychedelics in psychiatric treatment.", "authors": "Appiani FJ, Caroff SN.", "journal": null, "publication_date": "2024-06-19", "publication_year": 2024, "doi": "10.1080/03007995.2024.2368725", "pubmed_id": "38880945", "openalex_id": null, "source_url": "https://doi.org/10.1080/03007995.2024.2368725", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:03", "bibtex": null, "source_record_id": "PMID:38880945", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1080/03007995.2024.2368725", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:38880945", "source_url": "https://doi.org/10.1080/03007995.2024.2368725", "doi": "10.1080/03007995.2024.2368725", "pmid": "38880945", "publication_date": "2024-06-19", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1034, "title": "Efficacy and safety of eight enhanced therapies for treatment-resistant depression: A systematic review and network meta-analysis of RCTs.", "authors": "Guo Q, Guo L, Wang Y, Shang S.", "journal": null, "publication_date": "2024-06-19", "publication_year": 2024, "doi": "10.1016/j.psychres.2024.116018", "pubmed_id": "38924903", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.psychres.2024.116018", "substance_tags": "psilocybin", "topic_tags": "Depression,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Treatment-Resistant Depression,Safety", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:03", "bibtex": null, "source_record_id": "PMID:38924903", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.psychres.2024.116018", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:38924903", "source_url": "https://doi.org/10.1016/j.psychres.2024.116018", "doi": "10.1016/j.psychres.2024.116018", "pmid": "38924903", "publication_date": "2024-06-19", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1061, "title": "Developing the Open Psychedelic Evaluation Nexus consensus measures for assessment of supervised psilocybin services: An e-Delphi study", "authors": "P. Todd Korthuis, Kim Hoffman, Adrianne R. Wilson-Poe, Jason B. Luoma, Alissa Bazinet, Kellie Pertl, David L. Morgan, Ryan Cook, Sarann Bielavitz, Renae Myers, R. Cameron Wolf, Dennis McCarty, Christopher S. Stauffer", "journal": "Journal of Psychopharmacology", "publication_date": "2024-06-17", "publication_year": 2024, "doi": "10.1177/02698811241257839", "pubmed_id": "38888164", "openalex_id": "https://openalex.org/W4399780176", "source_url": "https://doi.org/10.1177/02698811241257839", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Wellbeing,Clinical Trial,Observational Study,Safety,Adverse Events,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:35", "bibtex": null, "source_record_id": "PMID:38888164", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1177/02698811241257839", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:38888164", "source_url": "https://doi.org/10.1177/02698811241257839", "doi": "10.1177/02698811241257839", "pmid": "38888164", "publication_date": "2024-06-17", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1107, "title": "Licit use of illicit drugs for treating depression: the pill and the process.", "authors": "Torrado Pacheco A, Moghaddam B.", "journal": null, "publication_date": "2024-06-16", "publication_year": 2024, "doi": "10.1172/jci180217", "pubmed_id": "40047885", "openalex_id": null, "source_url": "https://doi.org/10.1172/jci180217", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Clinical Trial,Review Article,Animal Study,Healthcare Workers", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:03", "bibtex": null, "source_record_id": "PMID:40047885", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1172/jci180217", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:40047885", "source_url": "https://doi.org/10.1172/jci180217", "doi": "10.1172/jci180217", "pmid": "40047885", "publication_date": "2024-06-16", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4605, "title": "Psychedelics’ Use as Medicine Hits Significant Roadblock", "authors": "Linda M. Richmond", "journal": "Psychiatric News", "publication_date": "2024-06-11", "publication_year": 2024, "doi": "10.1176/appi.pn.2024.07.7.54", "pubmed_id": null, "openalex_id": "https://openalex.org/W4399577191", "source_url": "https://doi.org/10.1176/appi.pn.2024.07.7.54", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Pharmacology,Mechanism of Action,Aging,Clinical Trial,Review Article,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:43", "last_checked": "2026-07-04 07:00:35", "bibtex": null, "source_record_id": "DOI:10.1176/appi.pn.2024.07.7.54", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1176/appi.pn.2024.07.7.54", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1176/appi.pn.2024.07.7.54", "source_url": "https://doi.org/10.1176/appi.pn.2024.07.7.54", "doi": "10.1176/appi.pn.2024.07.7.54", "pmid": "", "publication_date": "2024-06-11", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1088, "title": "Effects of psilocin and psilocybin on human 5-HT4 serotonin receptors in atrial preparations of transgenic mice and humans", "authors": "Joachim Neumann, Kiril Dimov, Karyna Azatsian, Britt Hofmann, Ulrich Gergs", "journal": "Toxicology Letters", "publication_date": "2024-06-11", "publication_year": 2024, "doi": "10.1016/j.toxlet.2024.06.006", "pubmed_id": "38876450", "openalex_id": "https://openalex.org/W4399577263", "source_url": "https://doi.org/10.1016/j.toxlet.2024.06.006", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Pharmacology,Receptor Pharmacology,Animal Study,In Vitro Study", "study_type": "Animal Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:35", "bibtex": null, "source_record_id": "PMID:38876450", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1016/j.toxlet.2024.06.006", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:38876450", "source_url": "https://doi.org/10.1016/j.toxlet.2024.06.006", "doi": "10.1016/j.toxlet.2024.06.006", "pmid": "38876450", "publication_date": "2024-06-11", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1110, "title": "Unlocking the healing power of psilocybin: an overview of the role of psilocybin therapy in major depressive disorder, obsessive-compulsive disorder and substance use disorder", "authors": "Sandra Szafoni, Piotr Gręblowski, Klaudia Grabowska, Gniewko Więckiewicz", "journal": "Frontiers in Psychiatry", "publication_date": "2024-06-10", "publication_year": 2024, "doi": "10.3389/fpsyt.2024.1406888", "pubmed_id": "38919636", "openalex_id": "https://openalex.org/W4399572299", "source_url": "https://doi.org/10.3389/fpsyt.2024.1406888", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,OCD,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:35", "bibtex": null, "source_record_id": "PMID:38919636", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.3389/fpsyt.2024.1406888", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:38919636", "source_url": "https://doi.org/10.3389/fpsyt.2024.1406888", "doi": "10.3389/fpsyt.2024.1406888", "pmid": "38919636", "publication_date": "2024-06-10", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3445, "title": "A Multi-centre, Double-blinded, Placebo-controlled, Randomised, Phase II Clinical Trial for Psilocybin-assisted Therapy for Alcohol Use Disorder", "authors": "University of Sydney", "journal": "ClinicalTrials.gov", "publication_date": "2024-06-09", "publication_year": 2024, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06444243", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Wellbeing,Clinical Trial,Randomized Controlled Trial,Safety", "study_type": "Randomized Controlled Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06444243", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06444243", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06444243", "source_url": "https://clinicaltrials.gov/study/NCT06444243", "doi": "", "pmid": "", "publication_date": "2024-06-09", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3355, "title": "Who believes psychedelic-assisted therapies work? Risky cannabis use and other factors are associated with positive treatment-outcome expectancies", "authors": "", "journal": "PsyArXiv", "publication_date": "2024-06-09", "publication_year": 2024, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://osf.io/preprints/psyarxiv/adnpg_v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Pharmacology,Clinical Trial,Healthcare Workers,Safety", "study_type": "Clinical Trial", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:51", "last_checked": "2026-07-01 11:22:30", "bibtex": null, "source_record_id": "https://osf.io/preprints/psyarxiv/adnpg_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/adnpg_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "https://osf.io/preprints/psyarxiv/adnpg_v1", "source_url": "https://osf.io/preprints/psyarxiv/adnpg_v1", "doi": "", "pmid": "", "publication_date": "2024-06-09", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4611, "title": "Structure of a Hallucinogen-Activated Gq-Coupled 5-HT2A Serotonin Receptor", "authors": "Ouliana Panova, Nichols D.E, Shoichet B.K, Lyu J, Georgios Skiniotis, Che T, Roth B.L, DiBerto J.F, Daniel Wacker, Robertson M.J, Kami Kim, Krumm B.E, Seven A.B", "journal": "UNC Libraries", "publication_date": "2024-06-06", "publication_year": 2024, "doi": "10.17615/yb2v-ca64", "pubmed_id": null, "openalex_id": "https://openalex.org/W4400050300", "source_url": "https://doi.org/10.17615/yb2v-ca64", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Anxiety,Pharmacology,Receptor Pharmacology,Drug Interactions", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:43", "last_checked": "2026-07-04 07:00:35", "bibtex": null, "source_record_id": "DOI:10.17615/yb2v-ca64", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.17615/yb2v-ca64", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.17615/yb2v-ca64", "source_url": "https://doi.org/10.17615/yb2v-ca64", "doi": "10.17615/yb2v-ca64", "pmid": "", "publication_date": "2024-06-06", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1089, "title": "The effects of psilocybin on cognition and emotional processing in healthy adults and adults with depression: a systematic literature review.", "authors": "Ramos L, Vicente SG.", "journal": null, "publication_date": "2024-06-05", "publication_year": 2024, "doi": "10.1080/13803395.2024.2363343", "pubmed_id": "38842300", "openalex_id": null, "source_url": "https://doi.org/10.1080/13803395.2024.2363343", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Emotional Processing,Creativity,Review Article", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:01", "bibtex": null, "source_record_id": "PMID:38842300", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1080/13803395.2024.2363343", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:38842300", "source_url": "https://doi.org/10.1080/13803395.2024.2363343", "doi": "10.1080/13803395.2024.2363343", "pmid": "38842300", "publication_date": "2024-06-05", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1113, "title": "Effect of oral tryptamines on the gut microbiome of rats-a preliminary study", "authors": "Mengyang Xu, Andor J. Kiss, J. Andrew Jones, Matthew S. McMurray, Haifei Shi", "journal": "PeerJ", "publication_date": "2024-06-02", "publication_year": 2024, "doi": "10.7717/peerj.17517", "pubmed_id": "38846751", "openalex_id": "https://openalex.org/W4399293931", "source_url": "https://doi.org/10.7717/peerj.17517", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Pharmacology,Mechanism of Action,Microbiome", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:35", "bibtex": null, "source_record_id": "PMID:38846751", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.7717/peerj.17517", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:38846751", "source_url": "https://doi.org/10.7717/peerj.17517", "doi": "10.7717/peerj.17517", "pmid": "38846751", "publication_date": "2024-06-02", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1112, "title": "A scoping review of the effects of mushroom and fungus extracts in rodent models of depression and tests of antidepressant activity.", "authors": "Wang CK, Kim G, Aleksandrova LR, Panenka WJ, Barr AM.", "journal": null, "publication_date": "2024-06-02", "publication_year": 2024, "doi": "10.3389/fphar.2024.1387158", "pubmed_id": "38887548", "openalex_id": null, "source_url": "https://doi.org/10.3389/fphar.2024.1387158", "substance_tags": "psilocybin", "topic_tags": "Depression,Pharmacology,Systematic Review,Review Article,Animal Study,Treatment-Resistant Depression", "study_type": "Systematic Review", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:03", "bibtex": null, "source_record_id": "PMID:38887548", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.3389/fphar.2024.1387158", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:38887548", "source_url": "https://doi.org/10.3389/fphar.2024.1387158", "doi": "10.3389/fphar.2024.1387158", "pmid": "38887548", "publication_date": "2024-06-02", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1123, "title": "Single-Dose Synthetic Psilocybin With Psychotherapy for Treatment-Resistant Bipolar Type II Major Depressive Episodes: A Nonrandomized Open-Label Trial.", "authors": "Aaronson ST, van der Vaart A, Miller T, LaPratt J, Swartz K, Shoultz A, Lauterbach M, Sackeim HA, Suppes T.", "journal": null, "publication_date": "2024-05-31", "publication_year": 2024, "doi": "10.1001/jamapsychiatry.2023.4685", "pubmed_id": "38055270", "openalex_id": null, "source_url": "https://doi.org/10.1001/jamapsychiatry.2023.4685", "substance_tags": "psilocybin", "topic_tags": "Depression,Safety", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:01", "bibtex": null, "source_record_id": "PMID:38055270", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1001/jamapsychiatry.2023.4685", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:38055270", "source_url": "https://doi.org/10.1001/jamapsychiatry.2023.4685", "doi": "10.1001/jamapsychiatry.2023.4685", "pmid": "38055270", "publication_date": "2024-05-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1121, "title": "Psilocybin for dementia prevention? The potential role of psilocybin to alter mechanisms associated with major depression and neurodegenerative diseases", "authors": "Haniff Z, Bocharova M, Mantingh T, Rucker J, Velayudhan L, Taylor D, Young A, Aarsland D, Vernon A, Thuret S.", "journal": null, "publication_date": "2024-05-31", "publication_year": 2024, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://europepmc.org/article/PMC/PMC11847495", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:03", "bibtex": null, "source_record_id": "https://europepmc.org/article/PMC/PMC11847495", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "https://europepmc.org/article/PMC/PMC11847495", "source_url": "https://europepmc.org/article/PMC/PMC11847495", "doi": "", "pmid": "", "publication_date": "2024-05-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1119, "title": "Treating Bipolar Depression Using Psilocybin-Validity Threats Regarding Efficacy and Safety-Reply.", "authors": "Aaronson ST, van der Vaart A, Sackeim HA.", "journal": null, "publication_date": "2024-05-31", "publication_year": 2024, "doi": "10.1001/jamapsychiatry.2024.0423", "pubmed_id": "38598225", "openalex_id": null, "source_url": "https://doi.org/10.1001/jamapsychiatry.2024.0423", "substance_tags": "psilocybin", "topic_tags": "Depression,Safety", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:04", "bibtex": null, "source_record_id": "PMID:38598225", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:38598225", "source_url": "https://doi.org/10.1001/jamapsychiatry.2024.0423", "doi": "10.1001/jamapsychiatry.2024.0423", "pmid": "38598225", "publication_date": "2024-05-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1064, "title": "Protocols and practices in psilocybin assisted psychotherapy for depression: A systematic review.", "authors": "Chisamore N, Johnson D, Chen MJQ, Offman H, Chen-Li D, Kaczmarek ES, Doyle Z, McIntyre RS, Rosenblat JD.", "journal": null, "publication_date": "2024-05-30", "publication_year": 2024, "doi": "10.1016/j.jpsychires.2024.05.051", "pubmed_id": "38850581", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.jpsychires.2024.05.051", "substance_tags": "psilocybin", "topic_tags": "Depression,End-of-Life Distress,Clinical Trial,Randomized Controlled Trial,Systematic Review,Review Article,Safety", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:02", "bibtex": null, "source_record_id": "PMID:38850581", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.jpsychires.2024.05.051", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:38850581", "source_url": "https://doi.org/10.1016/j.jpsychires.2024.05.051", "doi": "10.1016/j.jpsychires.2024.05.051", "pmid": "38850581", "publication_date": "2024-05-30", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3277, "title": "On serotonin, psychedelics, entactogens and psychoplastogens in depression, anxiety, post-traumatic stress, and related disorders.", "authors": "Hoyer D.", "journal": "Authorea Preprints", "publication_date": "2024-05-22", "publication_year": 2024, "doi": "10.22541/au.171648613.31141136/v1", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.22541/au.171648613.31141136/v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Neuroplasticity,Receptor Pharmacology,Clinical Trial,Treatment-Resistant Depression,Inflammation,Immune Function", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "preprint", "date_added": "2026-07-01 11:03:49", "last_checked": "2026-07-01 11:22:03", "bibtex": null, "source_record_id": "DOI:10.22541/au.171648613.31141136/v1", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.22541/au.171648613.31141136/v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "DOI:10.22541/au.171648613.31141136/v1", "source_url": "https://doi.org/10.22541/au.171648613.31141136/v1", "doi": "10.22541/au.171648613.31141136/v1", "pmid": "", "publication_date": "2024-05-22", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 939, "title": "Narrative review of the potential for psychedelics to treat Prolonged Grief Disorder.", "authors": "Ehrenkranz R, Agrawal M, Penberthy JK, Yaden DB.", "journal": null, "publication_date": "2024-05-22", "publication_year": 2024, "doi": "10.1080/09540261.2024.2357668", "pubmed_id": "39980217", "openalex_id": null, "source_url": "https://doi.org/10.1080/09540261.2024.2357668", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Addiction,Mystical Experience,Clinical Trial,Review Article,Observational Study,Safety", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:03", "bibtex": null, "source_record_id": "PMID:39980217", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1080/09540261.2024.2357668", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:39980217", "source_url": "https://doi.org/10.1080/09540261.2024.2357668", "doi": "10.1080/09540261.2024.2357668", "pmid": "39980217", "publication_date": "2024-05-22", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1091, "title": "Efficacy and safety of psilocybin on treatment-resistant depression: A systematic review and meta-analysis.", "authors": "Fang Q, Chan VKY, Chan SSM, Jiao Y, Wang J, Li X.", "journal": null, "publication_date": "2024-05-21", "publication_year": 2024, "doi": "10.1016/j.psychres.2024.115960", "pubmed_id": "38781672", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.psychres.2024.115960", "substance_tags": "psilocybin", "topic_tags": "Depression,Meta-Analysis,Systematic Review,Review Article,Treatment-Resistant Depression,Safety", "study_type": "Meta-Analysis", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:04", "bibtex": null, "source_record_id": "PMID:38781672", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:38781672", "source_url": "https://doi.org/10.1016/j.psychres.2024.115960", "doi": "10.1016/j.psychres.2024.115960", "pmid": "38781672", "publication_date": "2024-05-21", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1092, "title": "Psychedelic therapy in depression and substance use disorders.", "authors": "Korkmaz ND, Cikrikcili U, Akan M, Yucesan E.", "journal": null, "publication_date": "2024-05-20", "publication_year": 2024, "doi": "10.1111/ejn.16421", "pubmed_id": "38773750", "openalex_id": null, "source_url": "https://doi.org/10.1111/ejn.16421", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,End-of-Life Distress,Receptor Pharmacology,Emotional Processing,Cancer Patients,Treatment-Resistant Depression", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:03", "bibtex": null, "source_record_id": "PMID:38773750", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1111/ejn.16421", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:38773750", "source_url": "https://doi.org/10.1111/ejn.16421", "doi": "10.1111/ejn.16421", "pmid": "38773750", "publication_date": "2024-05-20", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 953, "title": "A Case Report of Psilocybin-induced Psychosis in a Predisposed Patient", "authors": "S Morris", "journal": "Clinical Psychopharmacology and Neuroscience", "publication_date": "2024-05-20", "publication_year": 2024, "doi": "10.9758/cpn.24.1180", "pubmed_id": "39420616", "openalex_id": "https://openalex.org/W4398182074", "source_url": "http://dx.doi.org/10.9758/cpn.24.1180", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Personality Change,Review Article,Case Report,Safety", "study_type": "Review Article", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:35", "bibtex": null, "source_record_id": "PMID:39420616", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.9758/cpn.24.1180", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:39420616", "source_url": "http://dx.doi.org/10.9758/cpn.24.1180", "doi": "10.9758/cpn.24.1180", "pmid": "39420616", "publication_date": "2024-05-20", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1066, "title": "Is it now time to prepare psychiatry for a psychedelic future?", "authors": "David Nutt, Ilana Crome, Allan H. Young", "journal": "The British Journal of Psychiatry", "publication_date": "2024-05-19", "publication_year": 2024, "doi": "10.1192/bjp.2024.76", "pubmed_id": "38764044", "openalex_id": "https://openalex.org/W4398137313", "source_url": "https://doi.org/10.1192/bjp.2024.76", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Treatment-Resistant Depression", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:35", "bibtex": null, "source_record_id": "PMID:38764044", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1192/bjp.2024.76", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:38764044", "source_url": "https://doi.org/10.1192/bjp.2024.76", "doi": "10.1192/bjp.2024.76", "pmid": "38764044", "publication_date": "2024-05-19", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3118, "title": "Psilocybin increases optimistic engagement over time: computational modelling of behavior in rats", "authors": "Fisher EL, Smith R, Corcoran AW, Milton LK, Conn K, Hohwy J, Foldi CJ.", "journal": "bioRxiv", "publication_date": "2024-05-16", "publication_year": 2024, "doi": "10.1101/2024.05.16.594614", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.1101/2024.05.16.594614", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Clinical Trial", "study_type": "Clinical Trial", "source_name": "bioRxiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:47", "last_checked": "2026-07-01 11:22:01", "bibtex": null, "source_record_id": "DOI:10.1101/2024.05.16.594614", "abstract_available": true, "abstract_source": "bioRxiv", "abstract_source_url": "https://doi.org/10.1101/2024.05.16.594614", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "bioRxiv", "source_record_id": "DOI:10.1101/2024.05.16.594614", "source_url": "https://doi.org/10.1101/2024.05.16.594614", "doi": "10.1101/2024.05.16.594614", "pmid": "", "publication_date": "2024-05-16", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1104, "title": "RE104: Synthesis and Activity of a Novel Serotonergic Psychedelic Prodrug of 4-Hydroxy-N,N-diisopropyltryptamine", "authors": "Nathan Bryson, Robert Alexander, Aviva Asnis-Alibozek, Michael Ehlers", "journal": "ACS Chemical Neuroscience", "publication_date": "2024-05-16", "publication_year": 2024, "doi": "10.1021/acschemneuro.4c00058", "pubmed_id": "38758589", "openalex_id": "https://openalex.org/W4396988535", "source_url": "https://doi.org/10.1021/acschemneuro.4c00058", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Pharmacology,Receptor Pharmacology,Clinical Trial,Animal Study", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:35", "bibtex": null, "source_record_id": "PMID:38758589", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1021/acschemneuro.4c00058", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:38758589", "source_url": "https://doi.org/10.1021/acschemneuro.4c00058", "doi": "10.1021/acschemneuro.4c00058", "pmid": "38758589", "publication_date": "2024-05-16", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4623, "title": "Psychedelic renaissance: A renewed focus on the clinical utility of hallucinogens", "authors": "Shunichiro Ikeda, Toshihiko Kinoshita", "journal": "Psychiatry and Clinical Neurosciences Reports", "publication_date": "2024-05-15", "publication_year": 2024, "doi": "10.1002/pcn5.196", "pubmed_id": null, "openalex_id": "https://openalex.org/W4397013596", "source_url": "https://doi.org/10.1002/pcn5.196", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Receptor Pharmacology,Clinical Trial,Review Article,Treatment-Resistant Depression,Safety,Inflammation", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:43", "last_checked": "2026-07-04 07:00:35", "bibtex": null, "source_record_id": "DOI:10.1002/pcn5.196", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1002/pcn5.196", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1002/pcn5.196", "source_url": "https://doi.org/10.1002/pcn5.196", "doi": "10.1002/pcn5.196", "pmid": "", "publication_date": "2024-05-15", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4624, "title": "Psilocybin as a new way for depression treatment", "authors": "Mateusz Pawlicki, Aleksandra Kłos, Karol Stachyrak, Dawid Mika, Bartosz Mazur, Kamila Turek, Maciej Lambach, Anna Gregułą, Aleksandra Mazurek, Wiktoria Wilanowska", "journal": "Journal of Education Health and Sport", "publication_date": "2024-05-14", "publication_year": 2024, "doi": "10.12775/jehs.2024.68.50168", "pubmed_id": null, "openalex_id": "https://openalex.org/W4396937684", "source_url": "http://dx.doi.org/10.12775/jehs.2024.68.50168", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Safety,Adverse Events", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:43", "last_checked": "2026-07-04 07:00:35", "bibtex": null, "source_record_id": "DOI:10.12775/jehs.2024.68.50168", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.12775/jehs.2024.68.50168", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.12775/jehs.2024.68.50168", "source_url": "http://dx.doi.org/10.12775/jehs.2024.68.50168", "doi": "10.12775/jehs.2024.68.50168", "pmid": "", "publication_date": "2024-05-14", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4628, "title": "Calls to Poison Centers Involving Psilocybin Rising in Youth", "authors": "Terri D’Arrigo", "journal": "Psychiatric News", "publication_date": "2024-05-09", "publication_year": 2024, "doi": "10.1176/appi.pn.2024.06.6.2", "pubmed_id": null, "openalex_id": "https://openalex.org/W4396797833", "source_url": "http://dx.doi.org/10.1176/appi.pn.2024.06.6.2", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Adolescents,Healthcare Workers,Safety,Adverse Events,Toxicity", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:43", "last_checked": "2026-07-04 07:00:35", "bibtex": null, "source_record_id": "DOI:10.1176/appi.pn.2024.06.6.2", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.1176/appi.pn.2024.06.6.2", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1176/appi.pn.2024.06.6.2", "source_url": "http://dx.doi.org/10.1176/appi.pn.2024.06.6.2", "doi": "10.1176/appi.pn.2024.06.6.2", "pmid": "", "publication_date": "2024-05-09", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 952, "title": "Clinical Research Trials of Psychedelic-Assisted Therapy in Adolescents Aged 16 to 17 Years: Rationale Balanced With Caution.", "authors": "Jeffrey JK, Weintraub MJ, Grob CS.", "journal": null, "publication_date": "2024-05-08", "publication_year": 2024, "doi": "10.1016/j.jaac.2024.03.021", "pubmed_id": "38734406", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.jaac.2024.03.021", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Addiction,Clinical Trial,Adolescents,Safety", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:03", "bibtex": null, "source_record_id": "PMID:38734406", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.jaac.2024.03.021", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:38734406", "source_url": "https://doi.org/10.1016/j.jaac.2024.03.021", "doi": "10.1016/j.jaac.2024.03.021", "pmid": "38734406", "publication_date": "2024-05-08", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3534, "title": "An Open-Label Investigation of the Effects of Sub-Perceptual Repeat Dosing of Psilocybin on the Behavioural and Cognitive Symptoms of Fragile X Syndrome in Adult Patients", "authors": "Nova Mentis Life Science Corp", "journal": "ClinicalTrials.gov", "publication_date": "2024-05-07", "publication_year": 2024, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05832255", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Neuroplasticity,Receptor Pharmacology,Biomarkers,Microdosing,Review Article,Healthcare Workers,Toxicity,Inflammation", "study_type": "Review Article", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05832255", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05832255", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05832255", "source_url": "https://clinicaltrials.gov/study/NCT05832255", "doi": "", "pmid": "", "publication_date": "2024-05-07", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1115, "title": "Structural pharmacology and therapeutic potential of 5-methoxytryptamines.", "authors": "Warren AL, Lankri D, Cunningham MJ, Serrano IC, Parise LF, Kruegel AC, Duggan P, Zilberg G, Capper MJ, Havel V, Russo SJ, Sames D, Wacker D.", "journal": null, "publication_date": "2024-05-07", "publication_year": 2024, "doi": "10.1038/s41586-024-07403-2", "pubmed_id": "38720072", "openalex_id": null, "source_url": "https://doi.org/10.1038/s41586-024-07403-2", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Pharmacology,Receptor Pharmacology,Animal Study,In Vitro Study,Drug Interactions", "study_type": "Animal Study", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:05", "bibtex": null, "source_record_id": "PMID:38720072", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1038/s41586-024-07403-2", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:38720072", "source_url": "https://doi.org/10.1038/s41586-024-07403-2", "doi": "10.1038/s41586-024-07403-2", "pmid": "38720072", "publication_date": "2024-05-07", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1139, "title": "EXPRESSION OF CONCERN: Efficacy of psilocybin for treating symptoms of depression: systematic review and meta-analysis", "authors": "British Medical Journal Publishing Group", "journal": "BMJ", "publication_date": "2024-05-03", "publication_year": 2024, "doi": "10.1136/bmj.q1025", "pubmed_id": "38704154", "openalex_id": "https://openalex.org/W4396634501", "source_url": "https://doi.org/10.1136/bmj.q1025", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Meta-Analysis,Systematic Review,Review Article", "study_type": "Meta-Analysis", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:35", "bibtex": null, "source_record_id": "PMID:38704154", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1136/bmj.q1025", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:38704154", "source_url": "https://doi.org/10.1136/bmj.q1025", "doi": "10.1136/bmj.q1025", "pmid": "38704154", "publication_date": "2024-05-03", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4631, "title": "Efficacy of Psilocybin in the Treatment of Substance and Alcohol Use Disorders", "authors": "Hanna Brancaccio", "journal": null, "publication_date": "2024-05-01", "publication_year": 2024, "doi": "10.31986/issn.2689-0690_rdw.stratford_research_day.149_2024", "pubmed_id": null, "openalex_id": "https://openalex.org/W4401380403", "source_url": "http://dx.doi.org/10.31986/issn.2689-0690_rdw.stratford_research_day.149_2024", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Microdosing,Clinical Trial,Review Article,Animal Study", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:43", "last_checked": "2026-07-04 07:00:35", "bibtex": null, "source_record_id": "DOI:10.31986/issn.2689-0690_rdw.stratford_research_day.149_2024", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.31986/issn.2689-0690_rdw.stratford_research_day.149_2024", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.31986/issn.2689-0690_rdw.stratford_research_day.149_2024", "source_url": "http://dx.doi.org/10.31986/issn.2689-0690_rdw.stratford_research_day.149_2024", "doi": "10.31986/issn.2689-0690_rdw.stratford_research_day.149_2024", "pmid": "", "publication_date": "2024-05-01", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1103, "title": "At the Forefront: Social Workers’ Role in Psilocybin Treatment for Depression and Substance Misuse", "authors": "Claire Parker, Bethany Wood", "journal": "Social Work", "publication_date": "2024-05-01", "publication_year": 2024, "doi": "10.1093/sw/swae019", "pubmed_id": "38697188", "openalex_id": "https://openalex.org/W4396599639", "source_url": "http://dx.doi.org/10.1093/sw/swae019", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Adverse Events", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:35", "bibtex": null, "source_record_id": "PMID:38697188", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.1093/sw/swae019", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:38697188", "source_url": "http://dx.doi.org/10.1093/sw/swae019", "doi": "10.1093/sw/swae019", "pmid": "38697188", "publication_date": "2024-05-01", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4633, "title": "From Venerable Cultural Practices to Modern Psychological Solutions: Enter Entheogens into Mainstream Medicine", "authors": "Nicholas A Kerna, Kevin D. Pruitt, N.D. Victor Carsrud, Kyle Kadivi, Dabeluchi C. Ngwu, Hilary M. Holets, John V. Flores, Ijeoma Nnake, Cornelius I. Azi, Joseph Anderson, Fatimah A. Olunlade, Uzoamaka Nwokorie", "journal": "European Journal of Arts Humanities and Social Sciences", "publication_date": "2024-04-30", "publication_year": 2024, "doi": "10.59324/ejahss.2024.1(3).10", "pubmed_id": null, "openalex_id": "https://openalex.org/W4399259513", "source_url": "https://doi.org/10.59324/ejahss.2024.1(3).10", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Chronic Pain,Headache / Migraine,Mechanism of Action,Receptor Pharmacology,Spirituality,Clinical Trial,Review Article,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:43", "last_checked": "2026-07-04 07:00:35", "bibtex": null, "source_record_id": "DOI:10.59324/ejahss.2024.1(3).10", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.59324/ejahss.2024.1(3).10", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.59324/ejahss.2024.1(3).10", "source_url": "https://doi.org/10.59324/ejahss.2024.1(3).10", "doi": "10.59324/ejahss.2024.1(3).10", "pmid": "", "publication_date": "2024-04-30", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 2992, "title": "PSYCHEDELIC PSILOCYBIN-ASSISTED THERAPY REDUCES DEPRESSIVE SYMPTOMS IN ADULTS WITH CANCER AND DEPRESSION.", "authors": "", "journal": null, "publication_date": "2024-04-30", "publication_year": 2024, "doi": null, "pubmed_id": "38740403", "openalex_id": null, "source_url": "https://europepmc.org/article/MED/38740403", "substance_tags": "psilocybin", "topic_tags": "Depression", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 07:01:03", "last_checked": "2026-07-01 11:22:04", "bibtex": null, "source_record_id": "PMID:38740403", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:38740403", "source_url": "https://europepmc.org/article/MED/38740403", "doi": "", "pmid": "38740403", "publication_date": "2024-04-30", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1143, "title": "Psilocybin for depression.", "authors": "De Giorgi R, Ede R.", "journal": null, "publication_date": "2024-04-30", "publication_year": 2024, "doi": "10.1136/bmj.q798", "pubmed_id": "38692675", "openalex_id": null, "source_url": "https://doi.org/10.1136/bmj.q798", "substance_tags": "psilocybin", "topic_tags": "Depression", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:03", "bibtex": null, "source_record_id": "PMID:38692675", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:38692675", "source_url": "https://doi.org/10.1136/bmj.q798", "doi": "10.1136/bmj.q798", "pmid": "38692675", "publication_date": "2024-04-30", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1142, "title": "Efficacy of psilocybin for treating symptoms of depression: systematic review and meta-analysis.", "authors": "Metaxa AM, Clarke M.", "journal": null, "publication_date": "2024-04-30", "publication_year": 2024, "doi": "10.1136/bmj-2023-078084", "pubmed_id": "38692686", "openalex_id": null, "source_url": "https://doi.org/10.1136/bmj-2023-078084", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Healthcare Workers,Safety", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:01", "bibtex": null, "source_record_id": "PMID:38692686", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1136/bmj-2023-078084", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:38692686", "source_url": "https://doi.org/10.1136/bmj-2023-078084", "doi": "10.1136/bmj-2023-078084", "pmid": "38692686", "publication_date": "2024-04-30", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1159, "title": "Review of Psilocybin Use for Depression among Cancer Patients after Approval in Oregon", "authors": "Val Bellman", "journal": "Cancers", "publication_date": "2024-04-26", "publication_year": 2024, "doi": "10.3390/cancers16091702", "pubmed_id": "38730654", "openalex_id": "https://openalex.org/W4396230194", "source_url": "https://doi.org/10.3390/cancers16091702", "substance_tags": "psilocybin", "topic_tags": "Depression,End-of-Life Distress,Review Article,Cancer Patients", "study_type": "Review Article", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:35", "bibtex": null, "source_record_id": "PMID:38730654", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.3390/cancers16091702", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:38730654", "source_url": "https://doi.org/10.3390/cancers16091702", "doi": "10.3390/cancers16091702", "pmid": "38730654", "publication_date": "2024-04-26", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1013, "title": "Psilocybin restrains activity-based anorexia in female rats by enhancing cognitive flexibility: contributions from 5-HT1A and 5-HT2A receptor mechanisms", "authors": "Kyna-Anne Conn, Laura K Milton, Kaixin Huang, Hermany Munguba, Janika Ruuska, M. B. Lemus, Erin Greaves, Jihane Homman-Ludiye, Brian J. Oldfield, Claire J. Foldi", "journal": "Molecular Psychiatry", "publication_date": "2024-04-26", "publication_year": 2024, "doi": "10.1038/s41380-024-02575-9", "pubmed_id": "38678087", "openalex_id": "https://openalex.org/W4395688958", "source_url": "https://doi.org/10.1038/s41380-024-02575-9", "substance_tags": "psilocybin", "topic_tags": "Depression,Eating Disorders,Pharmacology,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Animal Study", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:35", "bibtex": null, "source_record_id": "PMID:38678087", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1038/s41380-024-02575-9", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:38678087", "source_url": "https://doi.org/10.1038/s41380-024-02575-9", "doi": "10.1038/s41380-024-02575-9", "pmid": "38678087", "publication_date": "2024-04-26", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4638, "title": "MedCheck: Psilocybin for Depression, LSD for Anxiety, Donanemab, LSD, and More", "authors": "Terri D’Arrigo", "journal": "Psychiatric News", "publication_date": "2024-04-22", "publication_year": 2024, "doi": "10.1176/appi.pn.2024.05.5.1", "pubmed_id": null, "openalex_id": "https://openalex.org/W4395032120", "source_url": "http://dx.doi.org/10.1176/appi.pn.2024.05.5.1", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Review Article,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:43", "last_checked": "2026-07-04 07:00:35", "bibtex": null, "source_record_id": "DOI:10.1176/appi.pn.2024.05.5.1", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.1176/appi.pn.2024.05.5.1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1176/appi.pn.2024.05.5.1", "source_url": "http://dx.doi.org/10.1176/appi.pn.2024.05.5.1", "doi": "10.1176/appi.pn.2024.05.5.1", "pmid": "", "publication_date": "2024-04-22", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1138, "title": "Discovery and Structure-Activity Relationships of 2,5-Dimethoxyphenylpiperidines as Selective Serotonin 5-HT2A Receptor Agonists", "authors": "Emil Märcher-Rørsted, Anders A. Jensen, Gints Šmits, Karla Frydenvang, Jesper L. Kristensen", "journal": "Journal of Medicinal Chemistry", "publication_date": "2024-04-21", "publication_year": 2024, "doi": "10.1021/acs.jmedchem.4c00082", "pubmed_id": "38648420", "openalex_id": "https://openalex.org/W4394993604", "source_url": "https://doi.org/10.1021/acs.jmedchem.4c00082", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Pharmacology,Receptor Pharmacology,Clinical Trial,In Vitro Study", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:35", "bibtex": null, "source_record_id": "PMID:38648420", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1021/acs.jmedchem.4c00082", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:38648420", "source_url": "https://doi.org/10.1021/acs.jmedchem.4c00082", "doi": "10.1021/acs.jmedchem.4c00082", "pmid": "38648420", "publication_date": "2024-04-21", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3434, "title": "The Effect of Psilocybin on MDD Symptom Severity and Synaptic Density - A Single Dose Randomized, Double Blind, Placebo- Controlled Phase 2 Positron Emission Tomography Study", "authors": "Section for Affective Disorders; Northern Stockholm Psychiatry", "journal": "ClinicalTrials.gov", "publication_date": "2024-04-18", "publication_year": 2024, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT04630964", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Neuroplasticity,Brain Imaging,Aging,Clinical Trial,Healthy Volunteers,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT04630964", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT04630964", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT04630964", "source_url": "https://clinicaltrials.gov/study/NCT04630964", "doi": "", "pmid": "", "publication_date": "2024-04-18", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1166, "title": "Psychological flexibility as a mechanism of change in psilocybin-assisted therapy for major depression: results from an exploratory placebo-controlled trial", "authors": "Jordan Sloshower, Richard J. Zeifman, Jeffrey Guss, Robert Krause, Hamideh Safi-Aghdam, Surbhi Pathania, Brian Pittman, Deepak Cyril D’Souza", "journal": "Scientific Reports", "publication_date": "2024-04-16", "publication_year": 2024, "doi": "10.1038/s41598-024-58318-x", "pubmed_id": "38632313", "openalex_id": "https://openalex.org/W4394886406", "source_url": "https://doi.org/10.1038/s41598-024-58318-x", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Mechanism of Action,Receptor Pharmacology,Psychological Flexibility,Clinical Trial,Observational Study", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:35", "bibtex": null, "source_record_id": "PMID:38632313", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1038/s41598-024-58318-x", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:38632313", "source_url": "https://doi.org/10.1038/s41598-024-58318-x", "doi": "10.1038/s41598-024-58318-x", "pmid": "38632313", "publication_date": "2024-04-16", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4639, "title": "Mind the Psychedelic Hype: Characterizing the Risks and Benefits of Psychedelics for Depression", "authors": "Daniel Meling, Rebecca Ehrenkranz, Sandeep M. Nayak, Helena Aicher, Xaver Funk, Michiel van Elk, Marianna Graziosi, Prisca R. Bauer, Milan Scheidegger, David B. Yaden", "journal": "Psychoactives", "publication_date": "2024-04-15", "publication_year": 2024, "doi": "10.3390/psychoactives3020014", "pubmed_id": null, "openalex_id": "https://openalex.org/W4394855468", "source_url": "https://doi.org/10.3390/psychoactives3020014", "substance_tags": "psilocybin", "topic_tags": "Depression,Receptor Pharmacology,Review Article,Safety", "study_type": "Review Article", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:43", "last_checked": "2026-07-04 06:34:43", "bibtex": null, "source_record_id": "DOI:10.3390/psychoactives3020014", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.3390/psychoactives3020014", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.3390/psychoactives3020014", "source_url": "https://doi.org/10.3390/psychoactives3020014", "doi": "10.3390/psychoactives3020014", "pmid": "", "publication_date": "2024-04-15", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1145, "title": "Psychedelics and the ‘inner healer’: Myth or mechanism?", "authors": "Joseph Peill, M. Marguilho, David Erritzøe, Tommaso Barba, Kyle T. Greenway, Fernando E. Rosas, Christopher Timmermann, Robin Carhart-Harris", "journal": "Journal of Psychopharmacology", "publication_date": "2024-04-11", "publication_year": 2024, "doi": "10.1177/02698811241239206", "pubmed_id": "38605658", "openalex_id": "https://openalex.org/W4394755797", "source_url": "https://doi.org/10.1177/02698811241239206", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Mechanism of Action,Randomized Controlled Trial,Toxicity", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:35", "bibtex": null, "source_record_id": "PMID:38605658", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1177/02698811241239206", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:38605658", "source_url": "https://doi.org/10.1177/02698811241239206", "doi": "10.1177/02698811241239206", "pmid": "38605658", "publication_date": "2024-04-11", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1120, "title": "Treating Bipolar Depression Using Psilocybin-Validity Threats Regarding Efficacy and Safety", "authors": "Eiko I. Fried, Ioana A. Cristea, Florian Naudet", "journal": "JAMA Psychiatry", "publication_date": "2024-04-09", "publication_year": 2024, "doi": "10.1001/jamapsychiatry.2024.0420", "pubmed_id": "38598200", "openalex_id": "https://openalex.org/W4394676727", "source_url": "https://doi.org/10.1001/jamapsychiatry.2024.0420", "substance_tags": "psilocybin", "topic_tags": "Depression,Safety", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:35", "bibtex": null, "source_record_id": "PMID:38598200", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1001/jamapsychiatry.2024.0420", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:38598200", "source_url": "https://doi.org/10.1001/jamapsychiatry.2024.0420", "doi": "10.1001/jamapsychiatry.2024.0420", "pmid": "38598200", "publication_date": "2024-04-09", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4642, "title": "Who will staff the psychedelic resurgence?", "authors": "Erika Dyck", "journal": "Open Access Government", "publication_date": "2024-04-08", "publication_year": 2024, "doi": "10.56367/oag-042-10690", "pubmed_id": null, "openalex_id": "https://openalex.org/W4394904988", "source_url": "http://dx.doi.org/10.56367/oag-042-10690", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Clinical Trial", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:43", "last_checked": "2026-07-04 07:00:35", "bibtex": null, "source_record_id": "DOI:10.56367/oag-042-10690", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.56367/oag-042-10690", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.56367/oag-042-10690", "source_url": "http://dx.doi.org/10.56367/oag-042-10690", "doi": "10.56367/oag-042-10690", "pmid": "", "publication_date": "2024-04-08", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1133, "title": "Psilocybin induces acute anxiety and changes in amygdalar phosphopeptides independently from the 5-HT2A receptor", "authors": "Ram Harari, Ipsita Chatterjee, Dmitriy Getselter, Evan Elliott", "journal": "iScience", "publication_date": "2024-04-08", "publication_year": 2024, "doi": "10.1016/j.isci.2024.109686", "pubmed_id": "38660396", "openalex_id": "https://openalex.org/W4394602238", "source_url": "https://doi.org/10.1016/j.isci.2024.109686", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Anxiety,Neuroplasticity,Pharmacology,Mechanism of Action,Receptor Pharmacology,Animal Study", "study_type": "Animal Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:35", "bibtex": null, "source_record_id": "PMID:38660396", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1016/j.isci.2024.109686", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:38660396", "source_url": "https://doi.org/10.1016/j.isci.2024.109686", "doi": "10.1016/j.isci.2024.109686", "pmid": "38660396", "publication_date": "2024-04-08", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3724, "title": "Psilocybin for dementia prevention? The potential role of psilocybin to alter mechanisms associated with major depression and neurodegenerative diseases.", "authors": "Haniff ZR, Bocharova M, Mantingh T, Rucker JJ, Velayudhan L, Taylor DM, Young AH, Aarsland D, Vernon AC, Thuret S.", "journal": null, "publication_date": "2024-04-05", "publication_year": 2024, "doi": "10.1016/j.pharmthera.2024.108641", "pubmed_id": "38583670", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.pharmthera.2024.108641", "substance_tags": "psilocybin", "topic_tags": "Depression,Neuroplasticity,Neurogenesis,Mechanism of Action,Biomarkers,Review Article,Animal Study,Safety,Immune Function", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 11:08:41", "last_checked": "2026-07-01 11:22:01", "bibtex": null, "source_record_id": "PMID:38583670", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.pharmthera.2024.108641", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:38583670", "source_url": "https://doi.org/10.1016/j.pharmthera.2024.108641", "doi": "10.1016/j.pharmthera.2024.108641", "pmid": "38583670", "publication_date": "2024-04-05", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3726, "title": "[Psychedelic psychiatry].", "authors": "López E, Yngwe H, Beckman M, Tiger M, Hieronymus F, Lundberg J.", "journal": null, "publication_date": "2024-04-03", "publication_year": 2024, "doi": null, "pubmed_id": "38572715", "openalex_id": null, "source_url": "https://europepmc.org/article/MED/38572715", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Receptor Pharmacology,Clinical Trial,Review Article,Adverse Events", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 11:08:41", "last_checked": "2026-07-01 11:22:03", "bibtex": null, "source_record_id": "PMID:38572715", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://europepmc.org/article/MED/38572715", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:38572715", "source_url": "https://europepmc.org/article/MED/38572715", "doi": "", "pmid": "38572715", "publication_date": "2024-04-03", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4658, "title": "Current situation regarding psychedelics and magic mushroom in Korea", "authors": "J. S. Seo", "journal": "European Psychiatry", "publication_date": "2024-03-31", "publication_year": 2024, "doi": "10.1192/j.eurpsy.2024.1695", "pubmed_id": null, "openalex_id": "https://openalex.org/W4401921810", "source_url": "http://dx.doi.org/10.1192/j.eurpsy.2024.1695", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Clinical Trial,Review Article,Cancer Patients,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:43", "last_checked": "2026-07-04 07:00:35", "bibtex": null, "source_record_id": "DOI:10.1192/j.eurpsy.2024.1695", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.1192/j.eurpsy.2024.1695", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1192/j.eurpsy.2024.1695", "source_url": "http://dx.doi.org/10.1192/j.eurpsy.2024.1695", "doi": "10.1192/j.eurpsy.2024.1695", "pmid": "", "publication_date": "2024-03-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4655, "title": "Fallbeispiele zur Therapie der rezidivierenden Depression mit Psilocybin", "authors": "Eva Maria Schindowski, Franz X. Vollenweider", "journal": "Nervenheilkunde", "publication_date": "2024-03-31", "publication_year": 2024, "doi": "10.1055/a-2283-0221", "pubmed_id": null, "openalex_id": "https://openalex.org/W4396883294", "source_url": "http://dx.doi.org/10.1055/a-2283-0221", "substance_tags": "psilocybin", "topic_tags": "Depression", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:43", "last_checked": "2026-07-04 07:00:35", "bibtex": null, "source_record_id": "DOI:10.1055/a-2283-0221", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.1055/a-2283-0221", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1055/a-2283-0221", "source_url": "http://dx.doi.org/10.1055/a-2283-0221", "doi": "10.1055/a-2283-0221", "pmid": "", "publication_date": "2024-03-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4652, "title": "Depressionen: Remission durch Psilocybin bei laufender SSRI-Therapie", "authors": "", "journal": "Fortschritte der Neurologie · Psychiatrie", "publication_date": "2024-03-31", "publication_year": 2024, "doi": "10.1055/a-2254-0360", "pubmed_id": null, "openalex_id": "https://openalex.org/W4394936295", "source_url": "http://dx.doi.org/10.1055/a-2254-0360", "substance_tags": "psilocybin", "topic_tags": "Depression,Treatment-Resistant Depression", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:43", "last_checked": "2026-07-04 07:00:35", "bibtex": null, "source_record_id": "DOI:10.1055/a-2254-0360", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.1055/a-2254-0360", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1055/a-2254-0360", "source_url": "http://dx.doi.org/10.1055/a-2254-0360", "doi": "10.1055/a-2254-0360", "pmid": "", "publication_date": "2024-03-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4646, "title": "Microdosing psychedelics in the treatment of ADHD and comorbid disorders", "authors": "Kim P. C. Kuypers", "journal": "European Psychiatry", "publication_date": "2024-03-31", "publication_year": 2024, "doi": "10.1192/j.eurpsy.2024.44", "pubmed_id": null, "openalex_id": "https://openalex.org/W4401920710", "source_url": "https://doi.org/10.1192/j.eurpsy.2024.44", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Neuroplasticity,Default Mode Network,Microdosing,Personality Change,Emotional Processing,Clinical Trial,Observational Study", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:43", "last_checked": "2026-07-04 07:00:35", "bibtex": null, "source_record_id": "DOI:10.1192/j.eurpsy.2024.44", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1192/j.eurpsy.2024.44", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1192/j.eurpsy.2024.44", "source_url": "https://doi.org/10.1192/j.eurpsy.2024.44", "doi": "10.1192/j.eurpsy.2024.44", "pmid": "", "publication_date": "2024-03-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1172, "title": "Acute Adverse Effects of Therapeutic Doses of Psilocybin: A Systematic Review and Meta-Analysis.", "authors": "Yerubandi A, Thomas JE, Bhuiya NMMA, Harrington C, Villa Zapata L, Caballero J.", "journal": null, "publication_date": "2024-03-31", "publication_year": 2024, "doi": "10.1001/jamanetworkopen.2024.5960", "pubmed_id": "38598236", "openalex_id": null, "source_url": "https://doi.org/10.1001/jamanetworkopen.2024.5960", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Headache / Migraine,Clinical Trial,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:01", "bibtex": null, "source_record_id": "PMID:38598236", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1001/jamanetworkopen.2024.5960", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:38598236", "source_url": "https://doi.org/10.1001/jamanetworkopen.2024.5960", "doi": "10.1001/jamanetworkopen.2024.5960", "pmid": "38598236", "publication_date": "2024-03-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1108, "title": "Spectral signatures of psilocybin, lysergic acid diethylamide (LSD) and ketamine in healthy volunteers and persons with major depressive disorder and treatment-resistant depression: A systematic review.", "authors": "Le GH, Wong S, Badulescu S, Au H, Di Vincenzo JD, Gill H, Phan L, Rhee TG, Ho R, Teopiz KM, Kwan ATH, Rosenblat JD, Mansur RB, McIntyre RS.", "journal": null, "publication_date": "2024-03-31", "publication_year": 2024, "doi": "10.1016/j.jad.2024.03.165", "pubmed_id": "38570038", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.jad.2024.03.165", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging,Mechanism of Action,Biomarkers,Systematic Review,Review Article,Healthy Volunteers,Treatment-Resistant Depression", "study_type": "Systematic Review", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:02", "bibtex": null, "source_record_id": "PMID:38570038", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.jad.2024.03.165", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:38570038", "source_url": "https://doi.org/10.1016/j.jad.2024.03.165", "doi": "10.1016/j.jad.2024.03.165", "pmid": "38570038", "publication_date": "2024-03-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1190, "title": "Methyl transfer in psilocybin biosynthesis", "authors": "Jesse Hudspeth, Kai Rogge, Sebastian Dörner, Maximilian Müll, Dirk Hoffmeister, Bernhard Rupp, Sebastiaan Werten", "journal": "Nature Communications", "publication_date": "2024-03-27", "publication_year": 2024, "doi": "10.1038/s41467-024-46997-z", "pubmed_id": "38548735", "openalex_id": "https://openalex.org/W4393270574", "source_url": "https://doi.org/10.1038/s41467-024-46997-z", "substance_tags": "psilocybin", "topic_tags": "Depression,Pharmacology,Mechanism of Action,Epigenetics,Transcriptomics,Microbiome", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:35", "bibtex": null, "source_record_id": "PMID:38548735", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1038/s41467-024-46997-z", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:38548735", "source_url": "https://doi.org/10.1038/s41467-024-46997-z", "doi": "10.1038/s41467-024-46997-z", "pmid": "38548735", "publication_date": "2024-03-27", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1147, "title": "Efficacy and safety of psychedelics for the treatment of mental disorders: A systematic review and meta-analysis.", "authors": "Yao Y, Guo D, Lu TS, Liu FL, Huang SH, Diao MQ, Li SX, Zhang XJ, Kosten TR, Shi J, Bao YP, Lu L, Han Y.", "journal": null, "publication_date": "2024-03-27", "publication_year": 2024, "doi": "10.1016/j.psychres.2024.115886", "pubmed_id": "38574699", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.psychres.2024.115886", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,OCD,Eating Disorders,Headache / Migraine,Personality Change,Meta-Analysis,Systematic Review,Review Article,Safety,Adverse Events", "study_type": "Meta-Analysis", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:03", "bibtex": null, "source_record_id": "PMID:38574699", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.psychres.2024.115886", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:38574699", "source_url": "https://doi.org/10.1016/j.psychres.2024.115886", "doi": "10.1016/j.psychres.2024.115886", "pmid": "38574699", "publication_date": "2024-03-27", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 5659, "title": "Psychedelics: reconnecting the brain to heal the mind", "authors": "David Nutt", "journal": "The Biochemist", "publication_date": "2024-03-24", "publication_year": 2024, "doi": "10.1042/bio_2023_156", "pubmed_id": null, "openalex_id": "https://openalex.org/W4393157656", "source_url": "https://doi.org/10.1042/bio_2023_156", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Receptor Pharmacology,Healthy Volunteers,Treatment-Resistant Depression", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:52:11", "last_checked": "2026-07-04 06:52:11", "bibtex": null, "source_record_id": "DOI:10.1042/bio_2023_156", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1042/bio_2023_156", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1042/bio_2023_156", "source_url": "https://doi.org/10.1042/bio_2023_156", "doi": "10.1042/bio_2023_156", "pmid": "", "publication_date": "2024-03-24", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4661, "title": "Psychedelic Drugs: A Mind-expanding Hallucinogens", "authors": "Shreyasee Das, Rahul Shil", "journal": "Indian Journal of Behavioural Sciences", "publication_date": "2024-03-21", "publication_year": 2024, "doi": "10.55229/ijbs.v27i1.13", "pubmed_id": null, "openalex_id": "https://openalex.org/W4396671169", "source_url": "http://dx.doi.org/10.55229/ijbs.v27i1.13", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Addiction,Emotional Processing,Treatment-Resistant Depression", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:43", "last_checked": "2026-07-04 07:00:35", "bibtex": null, "source_record_id": "DOI:10.55229/ijbs.v27i1.13", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.55229/ijbs.v27i1.13", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.55229/ijbs.v27i1.13", "source_url": "http://dx.doi.org/10.55229/ijbs.v27i1.13", "doi": "10.55229/ijbs.v27i1.13", "pmid": "", "publication_date": "2024-03-21", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1148, "title": "Effects of discontinuation of serotonergic antidepressants prior to psilocybin therapy versus escitalopram for major depression", "authors": "David Erritzøe, Tommaso Barba, Meg J. Spriggs, Fernando E. Rosas, David Nutt, Robin Carhart-Harris", "journal": "Journal of Psychopharmacology", "publication_date": "2024-03-21", "publication_year": 2024, "doi": "10.1177/02698811241237870", "pubmed_id": "38520045", "openalex_id": "https://openalex.org/W4393118291", "source_url": "https://doi.org/10.1177/02698811241237870", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Chronic Pain,Receptor Pharmacology,Wellbeing,Clinical Trial,Safety,Toxicity,Drug Interactions", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:35", "bibtex": null, "source_record_id": "PMID:38520045", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1177/02698811241237870", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:38520045", "source_url": "https://doi.org/10.1177/02698811241237870", "doi": "10.1177/02698811241237870", "pmid": "38520045", "publication_date": "2024-03-21", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4663, "title": "Psychedelic Renaissance: Evidence and Culture", "authors": "Adrian Preda", "journal": "Psychiatric News", "publication_date": "2024-03-20", "publication_year": 2024, "doi": "10.1176/appi.pn.2024.04.4.39", "pubmed_id": null, "openalex_id": "https://openalex.org/W4393030764", "source_url": "http://dx.doi.org/10.1176/appi.pn.2024.04.4.39", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Neuroplasticity,Emotional Processing,Spirituality,Clinical Trial,Animal Study,Healthcare Workers,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:43", "last_checked": "2026-07-04 07:00:35", "bibtex": null, "source_record_id": "DOI:10.1176/appi.pn.2024.04.4.39", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.1176/appi.pn.2024.04.4.39", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1176/appi.pn.2024.04.4.39", "source_url": "http://dx.doi.org/10.1176/appi.pn.2024.04.4.39", "doi": "10.1176/appi.pn.2024.04.4.39", "pmid": "", "publication_date": "2024-03-20", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4665, "title": "Scanning the new frontier of mental health: psychedelic brain imaging", "authors": "Natalie Ertl, Matthew B. Wall", "journal": "The Biochemist", "publication_date": "2024-03-13", "publication_year": 2024, "doi": "10.1042/bio_2023_171", "pubmed_id": null, "openalex_id": "https://openalex.org/W4392799517", "source_url": "http://dx.doi.org/10.1042/bio_2023_171", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Brain Imaging,Mechanism of Action,Receptor Pharmacology,Consciousness,Aging,Emotional Processing,Spirituality", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:43", "last_checked": "2026-07-04 07:00:35", "bibtex": null, "source_record_id": "DOI:10.1042/bio_2023_171", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.1042/bio_2023_171", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1042/bio_2023_171", "source_url": "http://dx.doi.org/10.1042/bio_2023_171", "doi": "10.1042/bio_2023_171", "pmid": "", "publication_date": "2024-03-13", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4664, "title": "Psychedelic drugs and the law: What’s next?", "authors": "Ben Seal", "journal": "Knowable Magazine", "publication_date": "2024-03-13", "publication_year": 2024, "doi": "10.1146/knowable-031424-2", "pubmed_id": null, "openalex_id": "https://openalex.org/W4392794286", "source_url": "http://dx.doi.org/10.1146/knowable-031424-2", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,End-of-Life Distress,Chronic Pain,Mechanism of Action,Receptor Pharmacology,Spirituality,Clinical Trial,Systematic Review,Review Article,Cancer Patients,Safety", "study_type": "Systematic Review", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:43", "last_checked": "2026-07-04 07:00:35", "bibtex": null, "source_record_id": "DOI:10.1146/knowable-031424-2", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.1146/knowable-031424-2", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1146/knowable-031424-2", "source_url": "http://dx.doi.org/10.1146/knowable-031424-2", "doi": "10.1146/knowable-031424-2", "pmid": "", "publication_date": "2024-03-13", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1199, "title": "The therapeutic alliance between study participants and intervention facilitators is associated with acute effects and clinical outcomes in a psilocybin-assisted therapy trial for major depressive disorder", "authors": "Adam W. Levin, Rafael Lancelotta, Nathan D. Sepeda, Natalie Gukasyan, Sandeep M. Nayak, Theodore L. Wagener, Frederick S. Barrett, Roland R. Griffiths, Alan K. Davis", "journal": "PLoS ONE", "publication_date": "2024-03-13", "publication_year": 2024, "doi": "10.1371/journal.pone.0300501", "pubmed_id": "38483940", "openalex_id": "https://openalex.org/W4392797453", "source_url": "https://doi.org/10.1371/journal.pone.0300501", "substance_tags": "psilocybin", "topic_tags": "Depression,Mystical Experience,Clinical Trial,Randomized Controlled Trial", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:35", "bibtex": null, "source_record_id": "PMID:38483940", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1371/journal.pone.0300501", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:38483940", "source_url": "https://doi.org/10.1371/journal.pone.0300501", "doi": "10.1371/journal.pone.0300501", "pmid": "38483940", "publication_date": "2024-03-13", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4667, "title": "Unique Psychological Mechanisms Underlying Psilocybin Therapy Versus Escitalopram Treatment in the Treatment of Major Depressive Disorder", "authors": "Brandon Weiss, Leor Roseman, Bruna Giribaldi, David Nutt, Robin Carhart-Harris, David Erritzøe", "journal": "International Journal of Mental Health and Addiction", "publication_date": "2024-03-06", "publication_year": 2024, "doi": "10.1007/s11469-024-01253-9", "pubmed_id": null, "openalex_id": "https://openalex.org/W4392550813", "source_url": "https://doi.org/10.1007/s11469-024-01253-9", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Mechanism of Action,Receptor Pharmacology,Emotional Processing,Mystical Experience,Clinical Trial,Treatment-Resistant Depression", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:43", "last_checked": "2026-07-04 07:00:35", "bibtex": null, "source_record_id": "DOI:10.1007/s11469-024-01253-9", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1007/s11469-024-01253-9", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1007/s11469-024-01253-9", "source_url": "https://doi.org/10.1007/s11469-024-01253-9", "doi": "10.1007/s11469-024-01253-9", "pmid": "", "publication_date": "2024-03-06", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4668, "title": "Patients with bipolar II disorder benefit from single dose of psilocybin", "authors": "", "journal": "The Brown University Psychopharmacology Update", "publication_date": "2024-03-03", "publication_year": 2024, "doi": "10.1002/pu.31143", "pubmed_id": null, "openalex_id": "https://openalex.org/W4392379407", "source_url": "https://doi.org/10.1002/pu.31143", "substance_tags": "psilocybin", "topic_tags": "Depression,Pharmacology", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:43", "last_checked": "2026-07-04 07:00:35", "bibtex": null, "source_record_id": "DOI:10.1002/pu.31143", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1002/pu.31143", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1002/pu.31143", "source_url": "https://doi.org/10.1002/pu.31143", "doi": "10.1002/pu.31143", "pmid": "", "publication_date": "2024-03-03", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1208, "title": "A Systematic Review of the Neurocognitive Effects of Psychedelics in Healthy Populations: Implications for Depressive Disorders and Post-Traumatic Stress Disorder.", "authors": "Velit-Salazar MR, Shiroma PR, Cherian E.", "journal": null, "publication_date": "2024-03-02", "publication_year": 2024, "doi": "10.3390/brainsci14030248", "pubmed_id": "38539636", "openalex_id": null, "source_url": "https://doi.org/10.3390/brainsci14030248", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Emotional Processing,Systematic Review,Review Article", "study_type": "Systematic Review", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:04", "bibtex": null, "source_record_id": "PMID:38539636", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.3390/brainsci14030248", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:38539636", "source_url": "https://doi.org/10.3390/brainsci14030248", "doi": "10.3390/brainsci14030248", "pmid": "38539636", "publication_date": "2024-03-02", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4671, "title": "Psilocybin zur Behandlung depressiver Erkrankungen", "authors": "Henning Hintzsche", "journal": "BIOspektrum", "publication_date": "2024-02-29", "publication_year": 2024, "doi": "10.1007/s12268-024-2157-2", "pubmed_id": null, "openalex_id": "https://openalex.org/W4393593704", "source_url": "http://dx.doi.org/10.1007/s12268-024-2157-2", "substance_tags": "psilocybin", "topic_tags": "Depression", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:44", "last_checked": "2026-07-04 07:00:35", "bibtex": null, "source_record_id": "DOI:10.1007/s12268-024-2157-2", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1007/s12268-024-2157-2", "source_url": "http://dx.doi.org/10.1007/s12268-024-2157-2", "doi": "10.1007/s12268-024-2157-2", "pmid": "", "publication_date": "2024-02-29", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1210, "title": "Psychedelic Therapy: A Primer for Primary Care Clinicians-Historical Perspective and Overview", "authors": "Burton J. Tabaac, Kenneth Shinozuka, Alejandro Arenas, Bryce D. Beutler, Kirsten Cherian, Viviana D. Evans, Chelsey Fasano, Owen S. Muir", "journal": "American Journal of Therapeutics", "publication_date": "2024-02-29", "publication_year": 2024, "doi": "10.1097/mjt.0000000000001727", "pubmed_id": "38518266", "openalex_id": "https://openalex.org/W4393098943", "source_url": "https://doi.org/10.1097/mjt.0000000000001727", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Chronic Pain,Pharmacology,Receptor Pharmacology,Clinical Trial,Randomized Controlled Trial,Healthcare Workers,Adverse Events,Toxicity", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:35", "bibtex": null, "source_record_id": "PMID:38518266", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1097/mjt.0000000000001727", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:38518266", "source_url": "https://doi.org/10.1097/mjt.0000000000001727", "doi": "10.1097/mjt.0000000000001727", "pmid": "38518266", "publication_date": "2024-02-29", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1209, "title": "Psychedelic Therapy: A Primer for Primary Care Clinicians-Psilocybin", "authors": "Burton J. Tabaac, Kenneth Shinozuka, Alejandro Arenas, Bryce D. Beutler, Kirsten Cherian, Viviana D. Evans, Chelsey Fasano, Owen S. Muir", "journal": "American Journal of Therapeutics", "publication_date": "2024-02-29", "publication_year": 2024, "doi": "10.1097/mjt.0000000000001724", "pubmed_id": "38518269", "openalex_id": "https://openalex.org/W4393098899", "source_url": "https://doi.org/10.1097/mjt.0000000000001724", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,End-of-Life Distress,Chronic Pain,Headache / Migraine,Pharmacology,Receptor Pharmacology,Consciousness,Clinical Trial,Review Article,Treatment-Resistant Depression,Healthcare Workers,Safety,Adverse Events,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:35", "bibtex": null, "source_record_id": "PMID:38518269", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1097/mjt.0000000000001724", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:38518269", "source_url": "https://doi.org/10.1097/mjt.0000000000001724", "doi": "10.1097/mjt.0000000000001724", "pmid": "38518269", "publication_date": "2024-02-29", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1105, "title": "Impact of Psilocybin on Peripheral Cytokine Production", "authors": "Dana DiRenzo, Frederick S. Barrett, Jamie Perin, Erika Darrah, Lisa Christopher-Stine, Roland R. Griffiths", "journal": "Psychedelic Medicine", "publication_date": "2024-02-27", "publication_year": 2024, "doi": "10.1089/psymed.2023.0039", "pubmed_id": "40051582", "openalex_id": "https://openalex.org/W4392242985", "source_url": "https://doi.org/10.1089/psymed.2023.0039", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Pharmacology,Clinical Trial,Randomized Controlled Trial,Toxicity,Inflammation,Immune Function", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:35", "bibtex": null, "source_record_id": "PMID:40051582", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1089/psymed.2023.0039", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:40051582", "source_url": "https://doi.org/10.1089/psymed.2023.0039", "doi": "10.1089/psymed.2023.0039", "pmid": "40051582", "publication_date": "2024-02-27", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1135, "title": "Predicting the outcome of psilocybin treatment for depression from baseline fMRI functional connectivity", "authors": "Débora Copa, David Erritzøe, Bruna Giribaldi, David Nutt, Robin Carhart-Harris, Enzo Tagliazucchi", "journal": "Journal of Affective Disorders", "publication_date": "2024-02-26", "publication_year": 2024, "doi": "10.1016/j.jad.2024.02.089", "pubmed_id": "38423367", "openalex_id": "https://openalex.org/W4392203910", "source_url": "https://doi.org/10.1016/j.jad.2024.02.089", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging,Default Mode Network,Toxicity", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:35", "bibtex": null, "source_record_id": "PMID:38423367", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:38423367", "source_url": "https://doi.org/10.1016/j.jad.2024.02.089", "doi": "10.1016/j.jad.2024.02.089", "pmid": "38423367", "publication_date": "2024-02-26", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 594, "title": "Are \"mystical experiences\" essential for antidepressant actions of ketamine and the classic psychedelics?", "authors": "Hashimoto K.", "journal": null, "publication_date": "2024-02-26", "publication_year": 2024, "doi": "10.1007/s00406-024-01770-7", "pubmed_id": "38411629", "openalex_id": null, "source_url": "https://doi.org/10.1007/s00406-024-01770-7", "substance_tags": "psilocybin", "topic_tags": "Depression,Receptor Pharmacology,Mystical Experience,Clinical Trial,Adverse Events", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:04", "bibtex": null, "source_record_id": "PMID:38411629", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1007/s00406-024-01770-7", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:38411629", "source_url": "https://doi.org/10.1007/s00406-024-01770-7", "doi": "10.1007/s00406-024-01770-7", "pmid": "38411629", "publication_date": "2024-02-26", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1227, "title": "Multimodal Neuroimaging of the Effect of Serotonergic Psychedelics on the Brain.", "authors": "Frautschi PC, Singh AP, Stowe NA, Yu JJ.", "journal": null, "publication_date": "2024-02-14", "publication_year": 2024, "doi": "10.3174/ajnr.a8118", "pubmed_id": "38360790", "openalex_id": null, "source_url": "https://doi.org/10.3174/ajnr.a8118", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Addiction,Brain Imaging,Mechanism of Action,Aging,Review Article", "study_type": "Review Article", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:03", "bibtex": null, "source_record_id": "PMID:38360790", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.3174/ajnr.a8118", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:38360790", "source_url": "https://doi.org/10.3174/ajnr.a8118", "doi": "10.3174/ajnr.a8118", "pmid": "38360790", "publication_date": "2024-02-14", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1225, "title": "Efficacy and acceptability of psilocybin for primary or secondary depression: A systematic review and meta-analysis of randomized controlled trials.", "authors": "Fang S, Yang X, Zhang W.", "journal": null, "publication_date": "2024-02-14", "publication_year": 2024, "doi": "10.3389/fpsyt.2024.1359088", "pubmed_id": "38426002", "openalex_id": null, "source_url": "https://doi.org/10.3389/fpsyt.2024.1359088", "substance_tags": "psilocybin", "topic_tags": "Depression,End-of-Life Distress,Clinical Trial,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:01", "bibtex": null, "source_record_id": "PMID:38426002", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.3389/fpsyt.2024.1359088", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:38426002", "source_url": "https://doi.org/10.3389/fpsyt.2024.1359088", "doi": "10.3389/fpsyt.2024.1359088", "pmid": "38426002", "publication_date": "2024-02-14", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1205, "title": "New evidence for flexible psilocybin dosing in patients with treatment-resistant depression", "authors": "Scott T. Aaronson, Zofia Kozak", "journal": "Med", "publication_date": "2024-02-13", "publication_year": 2024, "doi": "10.1016/j.medj.2024.01.014", "pubmed_id": "38359837", "openalex_id": "https://openalex.org/W4391810224", "source_url": "https://doi.org/10.1016/j.medj.2024.01.014", "substance_tags": "psilocybin", "topic_tags": "Depression,Pharmacology,Treatment-Resistant Depression", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:35", "bibtex": null, "source_record_id": "PMID:38359837", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:38359837", "source_url": "https://doi.org/10.1016/j.medj.2024.01.014", "doi": "10.1016/j.medj.2024.01.014", "pmid": "38359837", "publication_date": "2024-02-13", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1204, "title": "Psilocybin-assisted psychotherapy for treatment resistant depression: A randomized clinical trial evaluating repeated doses of psilocybin", "authors": "Joshua D. Rosenblat, Shakila Meshkat, Zoe Doyle, Erica Kaczmarek, Ryan M. Brudner, Kevin Kratiuk, Rodrigo B. Mansur, Christian Schulz, Rickinder Sethi, Amanda Abate, Shaun Ali, Jordan Bawks, Marc G. Blainey, Elisa Brietzke, Victoria Cronin, Jessica Danilewitz, Shalini Dhawan, Anthony Di Fonzo, M. Di Fonzo, Pawel Drzadzewski, William Dunlop, Hajnalka Fiszter, Fabiano A. Gomes, Smrita Grewal, Marisa Leon-Carlyle, Marilyn McCallum, Niki Mofidi, Hilary Offman, Jeremy Riva-Cambrin, Joel E. Schmidt, Mark E. Smolkin, Joan M. Quinn, Andrea Zumrova, Michelle Marlborough, Roger S. McIntyre", "journal": "Med", "publication_date": "2024-02-13", "publication_year": 2024, "doi": "10.1016/j.medj.2024.01.005", "pubmed_id": "38359838", "openalex_id": "https://openalex.org/W4391810199", "source_url": "https://doi.org/10.1016/j.medj.2024.01.005", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Clinical Trial,Randomized Controlled Trial,Treatment-Resistant Depression,Toxicity", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:35", "bibtex": null, "source_record_id": "PMID:38359838", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:38359838", "source_url": "https://doi.org/10.1016/j.medj.2024.01.005", "doi": "10.1016/j.medj.2024.01.005", "pmid": "38359838", "publication_date": "2024-02-13", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1231, "title": "Psychedelics and sexual functioning: a mixed-methods study", "authors": "Tommaso Barba, Hannes Kettner, Caterina Radu, Joseph Peill, Leor Roseman, David Nutt, David Erritzøe, Robin Carhart-Harris, Bruna Giribaldi", "journal": "Scientific Reports", "publication_date": "2024-02-06", "publication_year": 2024, "doi": "10.1038/s41598-023-49817-4", "pubmed_id": "38326446", "openalex_id": "https://openalex.org/W4391630740", "source_url": "https://doi.org/10.1038/s41598-023-49817-4", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Receptor Pharmacology,Wellbeing,Clinical Trial,Adverse Events", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:35", "bibtex": null, "source_record_id": "PMID:38326446", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1038/s41598-023-49817-4", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:38326446", "source_url": "https://doi.org/10.1038/s41598-023-49817-4", "doi": "10.1038/s41598-023-49817-4", "pmid": "38326446", "publication_date": "2024-02-06", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1235, "title": "Patient perspectives and experiences with psilocybin treatment for treatment-resistant depression: a qualitative study", "authors": "Joost J. Breeksema, Alistair Niemeijer, Erwin Krediet, T.L. Karsten, Jeanine Kamphuis, Eric Vermetten, Wim van den Brink, Robert A. Schoevers", "journal": "Scientific Reports", "publication_date": "2024-02-04", "publication_year": 2024, "doi": "10.1038/s41598-024-53188-9", "pubmed_id": "38316896", "openalex_id": "https://openalex.org/W4391540455", "source_url": "https://doi.org/10.1038/s41598-024-53188-9", "substance_tags": "psilocybin", "topic_tags": "Depression,Receptor Pharmacology,Aging,Clinical Trial,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:35", "bibtex": null, "source_record_id": "PMID:38316896", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1038/s41598-024-53188-9", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:38316896", "source_url": "https://doi.org/10.1038/s41598-024-53188-9", "doi": "10.1038/s41598-024-53188-9", "pmid": "38316896", "publication_date": "2024-02-04", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4680, "title": "Psilocybin gegen Depressionen", "authors": "Thomas Müller", "journal": "CME", "publication_date": "2024-01-31", "publication_year": 2024, "doi": "10.1007/s11298-023-3754-y", "pubmed_id": null, "openalex_id": "https://openalex.org/W4392731896", "source_url": "https://doi.org/10.1007/s11298-023-3754-y", "substance_tags": "psilocybin", "topic_tags": "Depression,Pharmacology", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:44", "last_checked": "2026-07-04 07:00:35", "bibtex": null, "source_record_id": "DOI:10.1007/s11298-023-3754-y", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1007/s11298-023-3754-y", "source_url": "https://doi.org/10.1007/s11298-023-3754-y", "doi": "10.1007/s11298-023-3754-y", "pmid": "", "publication_date": "2024-01-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4677, "title": "Ketamine-assisted psychotherapy, psychedelic methodologies, and the impregnable value of the subjective-a new and evolving approach", "authors": "Phil Wolfson, Gita Vaid", "journal": "Frontiers in Psychiatry", "publication_date": "2024-01-31", "publication_year": 2024, "doi": "10.3389/fpsyt.2024.1209419", "pubmed_id": "38362026", "openalex_id": "https://openalex.org/W4391444130", "source_url": "https://doi.org/10.3389/fpsyt.2024.1209419", "substance_tags": "psilocybin", "topic_tags": "Depression,Consciousness,Clinical Trial,Adverse Events", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:44", "last_checked": "2026-07-04 06:34:44", "bibtex": null, "source_record_id": "PMID:38362026", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.3389/fpsyt.2024.1209419", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:38362026", "source_url": "https://doi.org/10.3389/fpsyt.2024.1209419", "doi": "10.3389/fpsyt.2024.1209419", "pmid": "38362026", "publication_date": "2024-01-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1247, "title": "The development of psilocybin therapy for treatment-resistant depression: an update.", "authors": "Borissova A, Rucker JJ.", "journal": null, "publication_date": "2024-01-31", "publication_year": 2024, "doi": "10.1192/bjb.2023.25", "pubmed_id": "37357767", "openalex_id": null, "source_url": "https://doi.org/10.1192/bjb.2023.25", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Aging,Clinical Trial,Randomized Controlled Trial,Healthy Volunteers,Treatment-Resistant Depression,Safety", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:01", "bibtex": null, "source_record_id": "PMID:37357767", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1192/bjb.2023.25", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:37357767", "source_url": "https://doi.org/10.1192/bjb.2023.25", "doi": "10.1192/bjb.2023.25", "pmid": "37357767", "publication_date": "2024-01-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1154, "title": "Serotonergic Psychedelics: A Comparative Review of Efficacy, Safety, Pharmacokinetics, and Binding Profile.", "authors": "Holze F, Singh N, Liechti ME, D'Souza DC.", "journal": null, "publication_date": "2024-01-31", "publication_year": 2024, "doi": "10.1016/j.bpsc.2024.01.007", "pubmed_id": "38301886", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.bpsc.2024.01.007", "substance_tags": "psilocybin", "topic_tags": "Depression,Pharmacology,Receptor Pharmacology,Review Article,Safety", "study_type": "Review Article", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:03", "bibtex": null, "source_record_id": "PMID:38301886", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.bpsc.2024.01.007", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:38301886", "source_url": "https://doi.org/10.1016/j.bpsc.2024.01.007", "doi": "10.1016/j.bpsc.2024.01.007", "pmid": "38301886", "publication_date": "2024-01-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3492, "title": "The Effects of Psilocybin on Self-Focus and Self-Related Processing in Treatment Resistant MDD", "authors": "Massachusetts General Hospital", "journal": "ClinicalTrials.gov", "publication_date": "2024-01-23", "publication_year": 2024, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05381974", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging", "study_type": "Other", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05381974", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05381974", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05381974", "source_url": "https://clinicaltrials.gov/study/NCT05381974", "doi": "", "pmid": "", "publication_date": "2024-01-23", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1122, "title": "Assessing expectancy and suggestibility in a trial of escitalopram v. psilocybin for depression", "authors": "Balázs Szigeti, Brandon Weiss, Fernando E. Rosas, David Erritzøe, David Nutt, Robin Carhart-Harris", "journal": "Psychological Medicine", "publication_date": "2024-01-21", "publication_year": 2024, "doi": "10.1017/s0033291723003653", "pubmed_id": "38247730", "openalex_id": "https://openalex.org/W4391109410", "source_url": "https://doi.org/10.1017/s0033291723003653", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Chronic Pain,Randomized Controlled Trial,Toxicity", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "PMID:38247730", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1017/s0033291723003653", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:38247730", "source_url": "https://doi.org/10.1017/s0033291723003653", "doi": "10.1017/s0033291723003653", "pmid": "38247730", "publication_date": "2024-01-21", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4685, "title": "Pharmacotherapy of Psychological Disorders Using Psychedelic Drugs: A Treatise for Psychiatrists", "authors": "Payal Ghosh, Debjeet Sur", "journal": "Current Psychiatry Research and Reviews", "publication_date": "2024-01-20", "publication_year": 2024, "doi": "10.2174/0126660822258502231120074036", "pubmed_id": null, "openalex_id": "https://openalex.org/W4391067287", "source_url": "https://doi.org/10.2174/0126660822258502231120074036", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,End-of-Life Distress,Receptor Pharmacology,Review Article,Treatment-Resistant Depression,Safety", "study_type": "Review Article", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:44", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "DOI:10.2174/0126660822258502231120074036", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.2174/0126660822258502231120074036", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.2174/0126660822258502231120074036", "source_url": "https://doi.org/10.2174/0126660822258502231120074036", "doi": "10.2174/0126660822258502231120074036", "pmid": "", "publication_date": "2024-01-20", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1252, "title": "Trauma-Informed Care in Psychedelic Therapy Research: A Qualitative Literature Review of Evidence-Based Psychotherapy Interventions in PTSD and Psychedelic Therapy Across Conditions.", "authors": "Modlin NL, Creed M, Sarang M, Maggio C, Rucker JJ, Williamson V.", "journal": null, "publication_date": "2024-01-19", "publication_year": 2024, "doi": "10.2147/ndt.s432537", "pubmed_id": "38268571", "openalex_id": null, "source_url": "https://doi.org/10.2147/ndt.s432537", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Mechanism of Action,Review Article,Safety", "study_type": "Review Article", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:05", "bibtex": null, "source_record_id": "PMID:38268571", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.2147/ndt.s432537", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:38268571", "source_url": "https://doi.org/10.2147/ndt.s432537", "doi": "10.2147/ndt.s432537", "pmid": "38268571", "publication_date": "2024-01-19", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4686, "title": "Psychedelics for mental health: a biochemical perspective", "authors": "Javier González-Maeso", "journal": "The Biochemist", "publication_date": "2024-01-18", "publication_year": 2024, "doi": "10.1042/bio_2023_161", "pubmed_id": null, "openalex_id": "https://openalex.org/W4391026101", "source_url": "http://dx.doi.org/10.1042/bio_2023_161", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Neuroplasticity,Receptor Pharmacology,Animal Study", "study_type": "Animal Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:44", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "DOI:10.1042/bio_2023_161", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.1042/bio_2023_161", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1042/bio_2023_161", "source_url": "http://dx.doi.org/10.1042/bio_2023_161", "doi": "10.1042/bio_2023_161", "pmid": "", "publication_date": "2024-01-18", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1272, "title": "Older adults in psychedelic-assisted therapy trials: A systematic review.", "authors": "Bouchet L, Sager Z, Yrondi A, Nigam KB, Anderson BT, Ross S, Petridis PD, Beaussant Y.", "journal": null, "publication_date": "2024-01-18", "publication_year": 2024, "doi": "10.1177/02698811231215420", "pubmed_id": "38240068", "openalex_id": null, "source_url": "https://doi.org/10.1177/02698811231215420", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Aging,Clinical Trial,Systematic Review,Review Article,Older Adults,Safety,Adverse Events", "study_type": "Systematic Review", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:05", "bibtex": null, "source_record_id": "PMID:38240068", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1177/02698811231215420", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:38240068", "source_url": "https://doi.org/10.1177/02698811231215420", "doi": "10.1177/02698811231215420", "pmid": "38240068", "publication_date": "2024-01-18", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1177, "title": "A comparison between psilocybin and esketamine in treatment-resistant depression using number needed to treat (NNT): A systematic review.", "authors": "Wong S, Kwan ATH, Teopiz KM, Le GH, Meshkat S, Ho R, d'Andrea G, Cao B, Di Vincenzo JD, Rosenblat JD, McIntyre RS.", "journal": null, "publication_date": "2024-01-17", "publication_year": 2024, "doi": "10.1016/j.jad.2024.01.142", "pubmed_id": "38244804", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.jad.2024.01.142", "substance_tags": "psilocybin", "topic_tags": "Depression,Headache / Migraine,Randomized Controlled Trial,Systematic Review,Review Article,Treatment-Resistant Depression", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:01", "bibtex": null, "source_record_id": "PMID:38244804", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.jad.2024.01.142", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:38244804", "source_url": "https://doi.org/10.1016/j.jad.2024.01.142", "doi": "10.1016/j.jad.2024.01.142", "pmid": "38244804", "publication_date": "2024-01-17", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4687, "title": "Abstract C001: A pilot study of palliadelic treatment with psilocybin to reduce psychological distress and improve quality of life in patients with advanced pancreatic adenocarcinoma", "authors": "Kelsey Klute, Lou Lukas, Soonjo Hwang, Yeongjin Gwon, Mridula Krishnan, Jean L. Grem, Sunil R. Hingorani, Jody Koenig Kellas", "journal": "Cancer Research", "publication_date": "2024-01-15", "publication_year": 2024, "doi": "10.1158/1538-7445.panca2023-c001", "pubmed_id": null, "openalex_id": "https://openalex.org/W4390915346", "source_url": "https://doi.org/10.1158/1538-7445.panca2023-c001", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Brain Imaging,Cancer Patients,Safety", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:44", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "DOI:10.1158/1538-7445.panca2023-c001", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1158/1538-7445.panca2023-c001", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1158/1538-7445.panca2023-c001", "source_url": "https://doi.org/10.1158/1538-7445.panca2023-c001", "doi": "10.1158/1538-7445.panca2023-c001", "pmid": "", "publication_date": "2024-01-15", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3145, "title": "MicroRNAs underlying the antidepressant effect of psilocybin - Establishing an nCounter pipeline for microRNA-quantification in the pig brain", "authors": "Kaadt E, Søkilde R, Hansen H, Raval N, Lundgaard L, Just J, Knudsen G, Elfving B.", "journal": "Research Square", "publication_date": "2024-01-11", "publication_year": 2024, "doi": "10.21203/rs.3.rs-3787179/v1", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.21203/rs.3.rs-3787179/v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Personality Change,Inflammation", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "preprint", "date_added": "2026-07-01 11:03:47", "last_checked": "2026-07-01 11:22:01", "bibtex": null, "source_record_id": "DOI:10.21203/rs.3.rs-3787179/v1", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.21203/rs.3.rs-3787179/v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "DOI:10.21203/rs.3.rs-3787179/v1", "source_url": "https://doi.org/10.21203/rs.3.rs-3787179/v1", "doi": "10.21203/rs.3.rs-3787179/v1", "pmid": "", "publication_date": "2024-01-11", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3752, "title": "Enhanced visual contrast suppression during peak psilocybin effects: A psychophysical study", "authors": "Swanson L, Jungers S, Varghese R, Cullen KR, Evans MD, Nielson J, Schallmo M.", "journal": "PsyArXiv", "publication_date": "2024-01-10", "publication_year": 2024, "doi": "10.31234/osf.io/5rm62", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.31234/osf.io/5rm62", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action", "study_type": "Other", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:10:19", "last_checked": "2026-07-01 11:22:01", "bibtex": null, "source_record_id": "DOI:10.31234/osf.io/5rm62", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://doi.org/10.31234/osf.io/5rm62", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "DOI:10.31234/osf.io/5rm62", "source_url": "https://doi.org/10.31234/osf.io/5rm62", "doi": "10.31234/osf.io/5rm62", "pmid": "", "publication_date": "2024-01-10", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3139, "title": "Enhanced visual contrast suppression during peak psilocybin effects: A psychophysical study", "authors": "", "journal": "PsyArXiv", "publication_date": "2024-01-10", "publication_year": 2024, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://osf.io/preprints/psyarxiv/5rm62_v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action", "study_type": "Other", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:47", "last_checked": "2026-07-01 11:22:30", "bibtex": null, "source_record_id": "https://osf.io/preprints/psyarxiv/5rm62_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/5rm62_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "https://osf.io/preprints/psyarxiv/5rm62_v1", "source_url": "https://osf.io/preprints/psyarxiv/5rm62_v1", "doi": "", "pmid": "", "publication_date": "2024-01-10", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1257, "title": "Knowledge gaps in psychedelic medicalisation: Clinical studies and regulatory aspects.", "authors": "E-Wen McCulloch D, Liechti ME, Kuypers KP, Nutt D, Lundberg J, Stenbæk DS, Goodwin GM, Gründer G, Butlen-Ducuing F, Haberkamp M, Thirstrup S, Knudsen GM.", "journal": null, "publication_date": "2024-01-10", "publication_year": 2024, "doi": "10.1016/j.nsa.2024.103938", "pubmed_id": "40656112", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.nsa.2024.103938", "substance_tags": "psilocybin", "topic_tags": "Depression,Pharmacology,Clinical Trial", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:04", "bibtex": null, "source_record_id": "PMID:40656112", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.nsa.2024.103938", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:40656112", "source_url": "https://doi.org/10.1016/j.nsa.2024.103938", "doi": "10.1016/j.nsa.2024.103938", "pmid": "40656112", "publication_date": "2024-01-10", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1213, "title": "Antidepressant-like effects of psychedelics in a chronic despair mouse model: is the 5-HT2A receptor the unique player?", "authors": "Mehdi Sekssaoui, Joël Bockaert, Philippe Marin, Carine Bécamel", "journal": "Neuropsychopharmacology", "publication_date": "2024-01-10", "publication_year": 2024, "doi": "10.1038/s41386-024-01794-6", "pubmed_id": "38212441", "openalex_id": "https://openalex.org/W4390755783", "source_url": "https://doi.org/10.1038/s41386-024-01794-6", "substance_tags": "psilocybin", "topic_tags": "Depression,Pharmacology,Mechanism of Action,Receptor Pharmacology,Animal Study", "study_type": "Animal Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "PMID:38212441", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1038/s41386-024-01794-6", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:38212441", "source_url": "https://doi.org/10.1038/s41386-024-01794-6", "doi": "10.1038/s41386-024-01794-6", "pmid": "38212441", "publication_date": "2024-01-10", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3076, "title": "Psilocybin Promotes Cell-Type-Specific Changes in the Orbitofrontal Cortex Revealed by Single-Nucleus RNA-seq", "authors": "Huang Z, Wei X, Wang Y, Tian J, Dong J, Liang B, Lu L, Zhang W.", "journal": "bioRxiv", "publication_date": "2024-01-06", "publication_year": 2024, "doi": "10.1101/2024.01.07.573163", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.1101/2024.01.07.573163", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Addiction,OCD,Mechanism of Action,Receptor Pharmacology", "study_type": "Other", "source_name": "bioRxiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:46", "last_checked": "2026-07-01 11:22:00", "bibtex": null, "source_record_id": "DOI:10.1101/2024.01.07.573163", "abstract_available": true, "abstract_source": "bioRxiv", "abstract_source_url": "https://doi.org/10.1101/2024.01.07.573163", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "bioRxiv", "source_record_id": "DOI:10.1101/2024.01.07.573163", "source_url": "https://doi.org/10.1101/2024.01.07.573163", "doi": "10.1101/2024.01.07.573163", "pmid": "", "publication_date": "2024-01-06", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3174, "title": "Psilocybin-Assisted Therapy for Severe Alcohol Use Disorder: Protocol for a Double-Blind, Randomized, Placebo-Controlled, 7-month Parallel-Group Phase II Superiority Trial", "authors": "Vanderijst L, Hever F, Buot A, Dauré C, Benoit J, Hanak C, Veeser J, Morgiève M, Campanella S, Kornreich C, Mallet L, Leys C, Noël X.", "journal": "Research Square", "publication_date": "2024-01-03", "publication_year": 2024, "doi": "10.21203/rs.3.rs-3829237/v1", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.21203/rs.3.rs-3829237/v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Neuroplasticity,Mechanism of Action,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "preprint", "date_added": "2026-07-01 11:03:47", "last_checked": "2026-07-01 11:22:02", "bibtex": null, "source_record_id": "DOI:10.21203/rs.3.rs-3829237/v1", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.21203/rs.3.rs-3829237/v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "DOI:10.21203/rs.3.rs-3829237/v1", "source_url": "https://doi.org/10.21203/rs.3.rs-3829237/v1", "doi": "10.21203/rs.3.rs-3829237/v1", "pmid": "", "publication_date": "2024-01-03", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4722, "title": "Psilocybin’s Role in Major Depressive Disorder: A Scoping Review", "authors": "Barajas, Carlos", "journal": "Digital Commons - George Fox University (George Fox University)", "publication_date": "2023-12-31", "publication_year": 2023, "doi": null, "pubmed_id": null, "openalex_id": "https://openalex.org/W7110533292", "source_url": "https://digitalcommons.georgefox.edu/dmsc/31", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Chronic Pain,Receptor Pharmacology,Consciousness,Review Article,Treatment-Resistant Depression,Safety,Toxicity", "study_type": "Review Article", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:44", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "https://digitalcommons.georgefox.edu/dmsc/31", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://digitalcommons.georgefox.edu/dmsc/31", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "https://digitalcommons.georgefox.edu/dmsc/31", "source_url": "https://digitalcommons.georgefox.edu/dmsc/31", "doi": "", "pmid": "", "publication_date": "2023-12-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4721, "title": "RAPIDLY TRADING DOWN DEPRESSION'S3 PILLARS TO 5HT3-RECEPTORS THROUGH ECT OR PSILOCYBIN?", "authors": "R.S. Treviranus, Gottfried", "journal": "University of Zagreb University Computing Centre (SRCE)", "publication_date": "2023-12-31", "publication_year": 2023, "doi": "10.24869/psyd.2024.134", "pubmed_id": null, "openalex_id": "https://openalex.org/W7110263788", "source_url": "https://hrcak.srce.hr/327222", "substance_tags": "psilocybin", "topic_tags": "Depression,OCD,Receptor Pharmacology", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:44", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "DOI:10.24869/psyd.2024.134", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.24869/psyd.2024.134", "source_url": "https://hrcak.srce.hr/327222", "doi": "10.24869/psyd.2024.134", "pmid": "", "publication_date": "2023-12-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4714, "title": "Panini and Psilocybin", "authors": "Bridget Verhaaren", "journal": "Dialogue A Journal of Mormon Thought", "publication_date": "2023-12-31", "publication_year": 2023, "doi": "10.5406/15549399.57.4.08", "pubmed_id": null, "openalex_id": "https://openalex.org/W4408422024", "source_url": "https://doi.org/10.5406/15549399.57.4.08", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Addiction,End-of-Life Distress,Chronic Pain,Consciousness,Aging,Emotional Processing,Spirituality,Observational Study,Cancer Patients", "study_type": "Observational Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:44", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "DOI:10.5406/15549399.57.4.08", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.5406/15549399.57.4.08", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.5406/15549399.57.4.08", "source_url": "https://doi.org/10.5406/15549399.57.4.08", "doi": "10.5406/15549399.57.4.08", "pmid": "", "publication_date": "2023-12-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4713, "title": "Changes in positive and negative affect in participants with treatment-resistant depression following COMP360 psilocybin treatment", "authors": "Matthew B. Young, J. Chai-Rees, Anna Nowakowska, Jeng-Yu Tsai, Guy M. Goodwin", "journal": "Neuroscience Applied", "publication_date": "2023-12-31", "publication_year": 2023, "doi": "10.1016/j.nsa.2024.104163", "pubmed_id": null, "openalex_id": "https://openalex.org/W4405637298", "source_url": "https://doi.org/10.1016/j.nsa.2024.104163", "substance_tags": "psilocybin", "topic_tags": "Depression,Treatment-Resistant Depression", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:44", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "DOI:10.1016/j.nsa.2024.104163", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.nsa.2024.104163", "source_url": "https://doi.org/10.1016/j.nsa.2024.104163", "doi": "10.1016/j.nsa.2024.104163", "pmid": "", "publication_date": "2023-12-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4712, "title": "Psilocybin vs Escitalopram for depression: 6-month follow-up", "authors": "Thomas Barba, David Erritzøe, Kyle T. Greenway, Rinki Murphy, John Martell, Christopher Timmermann, Ashleigh Murphy-Beiner, Bruna Giribaldi, Michelle Baker Jones, Brandon Weiss, Robin Carhart-Harris", "journal": "Neuroscience Applied", "publication_date": "2023-12-31", "publication_year": 2023, "doi": "10.1016/j.nsa.2024.104377", "pubmed_id": null, "openalex_id": "https://openalex.org/W4405637013", "source_url": "https://doi.org/10.1016/j.nsa.2024.104377", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:44", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "DOI:10.1016/j.nsa.2024.104377", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.nsa.2024.104377", "source_url": "https://doi.org/10.1016/j.nsa.2024.104377", "doi": "10.1016/j.nsa.2024.104377", "pmid": "", "publication_date": "2023-12-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4710, "title": "Neural effects of psilocybin-treatment in patients with treatment-resistant depression", "authors": "C. Schmitz, Hana Adolphi, Michael Frank, E. Seeger, Maciej Musiał, Moritz Spangemacher, Michael Koslowski, Lea J. Mertens, Florian Schlagenhauf, Gerhard Gründer", "journal": "Neuroscience Applied", "publication_date": "2023-12-31", "publication_year": 2023, "doi": "10.1016/j.nsa.2024.105028", "pubmed_id": null, "openalex_id": "https://openalex.org/W4405635994", "source_url": "https://doi.org/10.1016/j.nsa.2024.105028", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Treatment-Resistant Depression", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:44", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "DOI:10.1016/j.nsa.2024.105028", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.nsa.2024.105028", "source_url": "https://doi.org/10.1016/j.nsa.2024.105028", "doi": "10.1016/j.nsa.2024.105028", "pmid": "", "publication_date": "2023-12-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4704, "title": "The Therapeutic Potential of Psilocybin for Depression", "authors": "Tessa Watford", "journal": null, "publication_date": "2023-12-31", "publication_year": 2023, "doi": "10.33548/scientia1082", "pubmed_id": null, "openalex_id": "https://openalex.org/W4402233221", "source_url": "http://dx.doi.org/10.33548/scientia1082", "substance_tags": "psilocybin", "topic_tags": "Depression,Systematic Review,Review Article,Adverse Events", "study_type": "Systematic Review", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:44", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "DOI:10.33548/scientia1082", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.33548/scientia1082", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.33548/scientia1082", "source_url": "http://dx.doi.org/10.33548/scientia1082", "doi": "10.33548/scientia1082", "pmid": "", "publication_date": "2023-12-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4703, "title": "Psilocybin may be as effective as escitalopram in treating depression, study suggests", "authors": "", "journal": "Pharmaceutical journal/˜The œpharmaceutical journal", "publication_date": "2023-12-31", "publication_year": 2023, "doi": "10.1211/pj.2024.1.327949", "pubmed_id": null, "openalex_id": "https://openalex.org/W4401813485", "source_url": "http://dx.doi.org/10.1211/pj.2024.1.327949", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Receptor Pharmacology,Meta-Analysis,Systematic Review,Review Article", "study_type": "Meta-Analysis", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:44", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "DOI:10.1211/pj.2024.1.327949", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.1211/pj.2024.1.327949", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1211/pj.2024.1.327949", "source_url": "http://dx.doi.org/10.1211/pj.2024.1.327949", "doi": "10.1211/pj.2024.1.327949", "pmid": "", "publication_date": "2023-12-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4700, "title": "Psychedelics: The New Kid on the Block", "authors": "Prosenjit Ghosh, Avinash Desousa", "journal": "Annals of Indian Psychiatry", "publication_date": "2023-12-31", "publication_year": 2023, "doi": "10.4103/aip.aip_195_23", "pubmed_id": null, "openalex_id": "https://openalex.org/W4392949566", "source_url": "https://doi.org/10.4103/aip.aip_195_23", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Eating Disorders,End-of-Life Distress,Chronic Pain,Brain Imaging,Pharmacology,Mechanism of Action,Receptor Pharmacology,Consciousness,Aging,Clinical Trial,Randomized Controlled Trial,Healthy Volunteers,Adolescents,Cancer Patients,Treatment-Resistant Depression,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:44", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "DOI:10.4103/aip.aip_195_23", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.4103/aip.aip_195_23", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.4103/aip.aip_195_23", "source_url": "https://doi.org/10.4103/aip.aip_195_23", "doi": "10.4103/aip.aip_195_23", "pmid": "", "publication_date": "2023-12-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4699, "title": "Exploring the molecular basis of treatment-resistant depression: Discoveries from a rat model and psilocybin therapy", "authors": "Agata Korlatowicz, Katarzyna Latocha, Paulina Pabian, Ryszard Bugno, Adam S. Hogendorf, Tamás Kovács, Andrzej J. Bojarski, Zoltán V. Varga, Agata Faron-Górecka", "journal": "Neuroscience Applied", "publication_date": "2023-12-31", "publication_year": 2023, "doi": "10.1016/j.nsa.2024.104020", "pubmed_id": null, "openalex_id": "https://openalex.org/W4392405867", "source_url": "http://dx.doi.org/10.1016/j.nsa.2024.104020", "substance_tags": "psilocybin", "topic_tags": "Depression,Receptor Pharmacology,Animal Study,Treatment-Resistant Depression", "study_type": "Animal Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:44", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "DOI:10.1016/j.nsa.2024.104020", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.nsa.2024.104020", "source_url": "http://dx.doi.org/10.1016/j.nsa.2024.104020", "doi": "10.1016/j.nsa.2024.104020", "pmid": "", "publication_date": "2023-12-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4698, "title": "Introduction to the Special Section on Psychedelics Research and Treatment", "authors": "Dominic Sisti", "journal": "Perspectives in biology and medicine", "publication_date": "2023-12-31", "publication_year": 2023, "doi": "10.1353/pbm.2024.a919714", "pubmed_id": "38662067", "openalex_id": "https://openalex.org/W4391959887", "source_url": "http://dx.doi.org/10.1353/pbm.2024.a919714", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Emotional Processing,Spirituality,Mystical Experience,Healthcare Workers,Safety", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:44", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "PMID:38662067", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.1353/pbm.2024.a919714", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:38662067", "source_url": "http://dx.doi.org/10.1353/pbm.2024.a919714", "doi": "10.1353/pbm.2024.a919714", "pmid": "38662067", "publication_date": "2023-12-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4696, "title": "Investigational COMP360 psilocybin treatment for treatment-resistant depression: assessing altered states of consciousness", "authors": "N. Hewitt, J. Chai-Rees, Megan Croal, S. Mistry, Jeng-Yu Tsai, Matthew B. Young, Guy M. Goodwin", "journal": "Neuroscience Applied", "publication_date": "2023-12-31", "publication_year": 2023, "doi": "10.1016/j.nsa.2024.104391", "pubmed_id": null, "openalex_id": "https://openalex.org/W4405660466", "source_url": "https://doi.org/10.1016/j.nsa.2024.104391", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Consciousness,Treatment-Resistant Depression", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:44", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "DOI:10.1016/j.nsa.2024.104391", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.nsa.2024.104391", "source_url": "https://doi.org/10.1016/j.nsa.2024.104391", "doi": "10.1016/j.nsa.2024.104391", "pmid": "", "publication_date": "2023-12-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1286, "title": "Psilocybin and Other Classic Psychedelics in Depression.", "authors": "Nutt DJ, Peill JM, Weiss B, Godfrey K, Carhart-Harris RL, Erritzoe D.", "journal": null, "publication_date": "2023-12-31", "publication_year": 2023, "doi": "10.1007/7854_2023_451", "pubmed_id": "37955822", "openalex_id": null, "source_url": "https://doi.org/10.1007/7854_2023_451", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging,Mechanism of Action,Receptor Pharmacology,Aging,Emotional Processing,Mystical Experience", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:01", "bibtex": null, "source_record_id": "PMID:37955822", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1007/7854_2023_451", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:37955822", "source_url": "https://doi.org/10.1007/7854_2023_451", "doi": "10.1007/7854_2023_451", "pmid": "37955822", "publication_date": "2023-12-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1268, "title": "Efficacy, Safety, and Tolerability of Psychedelics in Treatment-Resistant Depression (TRD).", "authors": "Olivier B, Olivier JDA.", "journal": null, "publication_date": "2023-12-31", "publication_year": 2023, "doi": "10.1007/978-981-97-4402-2_3", "pubmed_id": "39261423", "openalex_id": null, "source_url": "https://doi.org/10.1007/978-981-97-4402-2_3", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Treatment-Resistant Depression,Safety", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:03", "bibtex": null, "source_record_id": "PMID:39261423", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1007/978-981-97-4402-2_3", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:39261423", "source_url": "https://doi.org/10.1007/978-981-97-4402-2_3", "doi": "10.1007/978-981-97-4402-2_3", "pmid": "39261423", "publication_date": "2023-12-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1196, "title": "Safety pharmacology of acute psilocybin administration in healthy participants", "authors": "Isabelle Straumann, Friederike Holze, A. Becker, Laura Ley, Nepomuk Halter, Matthias E. Liechti", "journal": "Neuroscience Applied", "publication_date": "2023-12-31", "publication_year": 2023, "doi": "10.1016/j.nsa.2024.104060", "pubmed_id": "40656108", "openalex_id": "https://openalex.org/W4392888270", "source_url": "https://doi.org/10.1016/j.nsa.2024.104060", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Pharmacology,Receptor Pharmacology,Healthy Volunteers,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "PMID:40656108", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1016/j.nsa.2024.104060", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:40656108", "source_url": "https://doi.org/10.1016/j.nsa.2024.104060", "doi": "10.1016/j.nsa.2024.104060", "pmid": "40656108", "publication_date": "2023-12-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1054, "title": "Exploring psychedelic use in athletes and their attitudes toward psilocybin-assisted therapy in concussion recovery", "authors": "Baeleigh VanderZwaag, Albert Garcia-Romeu, Mauricio A. García-Barrera", "journal": "Therapeutic Advances in Psychopharmacology", "publication_date": "2023-12-31", "publication_year": 2023, "doi": "10.1177/20451253241264812", "pubmed_id": "39132012", "openalex_id": "https://openalex.org/W4401432739", "source_url": "https://doi.org/10.1177/20451253241264812", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Chronic Pain,Aging,Observational Study,Safety,Toxicity", "study_type": "Observational Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "PMID:39132012", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1177/20451253241264812", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:39132012", "source_url": "https://doi.org/10.1177/20451253241264812", "doi": "10.1177/20451253241264812", "pmid": "39132012", "publication_date": "2023-12-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4723, "title": "Psilocybin - new remedy for patients with psychiatric disorders? Critical analysis of the current state of knowledge", "authors": "Karolina Wąsik, Sebastian Tomaszuk, Magda Wojtuś", "journal": "Journal of Education Health and Sport", "publication_date": "2023-12-29", "publication_year": 2023, "doi": "10.12775/jehs.2023.50.01.005", "pubmed_id": null, "openalex_id": "https://openalex.org/W4390439845", "source_url": "http://dx.doi.org/10.12775/jehs.2023.50.01.005", "substance_tags": "psilocybin", "topic_tags": "Depression,OCD,Pharmacology,Review Article,Safety,Adverse Events", "study_type": "Review Article", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:44", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "DOI:10.12775/jehs.2023.50.01.005", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.12775/jehs.2023.50.01.005", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.12775/jehs.2023.50.01.005", "source_url": "http://dx.doi.org/10.12775/jehs.2023.50.01.005", "doi": "10.12775/jehs.2023.50.01.005", "pmid": "", "publication_date": "2023-12-29", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1264, "title": "Amygdala response to emotional faces following acute administration of psilocybin in healthy individuals", "authors": "Sophia Armand, Kristian Larsen, M. Madsen, Brice Ozenne, Katrin H. Preller, Gitte M. Knudsen, Dea Siggaard Stenbæk, Patrick M. Fisher", "journal": "Neuroscience Applied", "publication_date": "2023-12-29", "publication_year": 2023, "doi": "10.1016/j.nsa.2023.103934", "pubmed_id": "40656071", "openalex_id": "https://openalex.org/W4390452945", "source_url": "https://doi.org/10.1016/j.nsa.2023.103934", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Brain Imaging,Receptor Pharmacology,Aging,Emotional Processing,Toxicity", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "PMID:40656071", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1016/j.nsa.2023.103934", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:40656071", "source_url": "https://doi.org/10.1016/j.nsa.2023.103934", "doi": "10.1016/j.nsa.2023.103934", "pmid": "40656071", "publication_date": "2023-12-29", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4724, "title": "The Therapeutic Effect and Potential Application of Psilocybin", "authors": "Tianran Liu", "journal": "Highlights in Science Engineering and Technology", "publication_date": "2023-12-28", "publication_year": 2023, "doi": "10.54097/3cfwjn09", "pubmed_id": null, "openalex_id": "https://openalex.org/W4391277213", "source_url": "http://dx.doi.org/10.54097/3cfwjn09", "substance_tags": "psilocybin", "topic_tags": "Depression,Eating Disorders,Pharmacology,Cancer Patients,Adverse Events", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:44", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "DOI:10.54097/3cfwjn09", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.54097/3cfwjn09", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.54097/3cfwjn09", "source_url": "http://dx.doi.org/10.54097/3cfwjn09", "doi": "10.54097/3cfwjn09", "pmid": "", "publication_date": "2023-12-28", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3164, "title": "Engaging Mood Brain Circuits with Psilocybin (EMBRACE): a study protocol for a randomized, proof-of-principle, placebo-controlled and crossover, neuroimaging trial in depression", "authors": "Poulin JM, Bigford GE, Lanctot KL, Giacobbe P, Schaffer A, Sinyor M, Rabin JS, Masellis M, Singnurkar A, Pople CB, Lipsman N, MacIntosh BJ, Nestor SM.", "journal": "Research Square", "publication_date": "2023-12-27", "publication_year": 2023, "doi": "10.21203/rs.3.rs-3474764/v1", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.21203/rs.3.rs-3474764/v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Neuroplasticity,Brain Imaging,Mechanism of Action,Biomarkers,Aging,Inflammation", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "preprint", "date_added": "2026-07-01 11:03:47", "last_checked": "2026-07-01 11:22:01", "bibtex": null, "source_record_id": "DOI:10.21203/rs.3.rs-3474764/v1", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.21203/rs.3.rs-3474764/v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "DOI:10.21203/rs.3.rs-3474764/v1", "source_url": "https://doi.org/10.21203/rs.3.rs-3474764/v1", "doi": "10.21203/rs.3.rs-3474764/v1", "pmid": "", "publication_date": "2023-12-27", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3780, "title": "Psychedelic Therapy: A Primer for Primary Care Clinicians - Part I. Historical Perspective and Overview", "authors": "Tabaac BJ, Shinozuka K, Arenas A, Beutler BD, Cherian K, Evans VD, Fasano C, Muir OS.", "journal": "PsyArXiv", "publication_date": "2023-12-25", "publication_year": 2023, "doi": "10.31234/osf.io/byms6", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.31234/osf.io/byms6", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Receptor Pharmacology,Clinical Trial,Healthcare Workers", "study_type": "Clinical Trial", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:10:21", "last_checked": "2026-07-01 11:22:04", "bibtex": null, "source_record_id": "DOI:10.31234/osf.io/byms6", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://doi.org/10.31234/osf.io/byms6", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "DOI:10.31234/osf.io/byms6", "source_url": "https://doi.org/10.31234/osf.io/byms6", "doi": "10.31234/osf.io/byms6", "pmid": "", "publication_date": "2023-12-25", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3751, "title": "Psychedelic Therapy: A Primer for Primary Care Clinicians - Part IV. Psilocybin", "authors": "Tabaac BJ, Shinozuka K, Arenas A, Beutler BD, Cherian K, Evans VD, Fasano C, Muir OS.", "journal": "PsyArXiv", "publication_date": "2023-12-25", "publication_year": 2023, "doi": "10.31234/osf.io/a8xwk", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.31234/osf.io/a8xwk", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,End-of-Life Distress,Pharmacology,Receptor Pharmacology,Consciousness,Clinical Trial,Review Article,Treatment-Resistant Depression,Healthcare Workers,Safety", "study_type": "Clinical Trial", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:10:18", "last_checked": "2026-07-01 11:22:01", "bibtex": null, "source_record_id": "DOI:10.31234/osf.io/a8xwk", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://doi.org/10.31234/osf.io/a8xwk", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "DOI:10.31234/osf.io/a8xwk", "source_url": "https://doi.org/10.31234/osf.io/a8xwk", "doi": "10.31234/osf.io/a8xwk", "pmid": "", "publication_date": "2023-12-25", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3572, "title": "Psilocybin-assisted Psychotherapy in the Management of Anxiety Associated With Stage IV Melanoma.", "authors": "Multidisciplinary Association for Psychedelic Studies", "journal": "ClinicalTrials.gov", "publication_date": "2023-12-25", "publication_year": 2023, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT00979693", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Aging,Spirituality,Mystical Experience,Safety,Immune Function", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT00979693", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT00979693", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT00979693", "source_url": "https://clinicaltrials.gov/study/NCT00979693", "doi": "", "pmid": "", "publication_date": "2023-12-25", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3293, "title": "Psychedelic Therapy: A Primer for Primary Care Clinicians - Part I. Historical Perspective and Overview", "authors": "", "journal": "PsyArXiv", "publication_date": "2023-12-25", "publication_year": 2023, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://osf.io/preprints/psyarxiv/byms6_v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Receptor Pharmacology,Clinical Trial,Healthcare Workers", "study_type": "Clinical Trial", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:50", "last_checked": "2026-07-01 11:22:30", "bibtex": null, "source_record_id": "https://osf.io/preprints/psyarxiv/byms6_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/byms6_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "https://osf.io/preprints/psyarxiv/byms6_v1", "source_url": "https://osf.io/preprints/psyarxiv/byms6_v1", "doi": "", "pmid": "", "publication_date": "2023-12-25", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3133, "title": "Psychedelic Therapy: A Primer for Primary Care Clinicians - Part IV. Psilocybin", "authors": "", "journal": "PsyArXiv", "publication_date": "2023-12-25", "publication_year": 2023, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://osf.io/preprints/psyarxiv/a8xwk_v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,End-of-Life Distress,Pharmacology,Receptor Pharmacology,Consciousness,Clinical Trial,Review Article,Treatment-Resistant Depression,Healthcare Workers,Safety", "study_type": "Clinical Trial", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:47", "last_checked": "2026-07-01 11:22:30", "bibtex": null, "source_record_id": "https://osf.io/preprints/psyarxiv/a8xwk_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/a8xwk_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "https://osf.io/preprints/psyarxiv/a8xwk_v1", "source_url": "https://osf.io/preprints/psyarxiv/a8xwk_v1", "doi": "", "pmid": "", "publication_date": "2023-12-25", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1324, "title": "Potential use of psilocybin drugs in the treatment of depression.", "authors": "Śladowska K, Kawalec P, Brzostek T, Pilc A.", "journal": null, "publication_date": "2023-12-25", "publication_year": 2023, "doi": "10.1080/14728214.2023.2264180", "pubmed_id": "37817501", "openalex_id": null, "source_url": "https://doi.org/10.1080/14728214.2023.2264180", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Randomized Controlled Trial,Observational Study,Treatment-Resistant Depression,Safety", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:01", "bibtex": null, "source_record_id": "PMID:37817501", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1080/14728214.2023.2264180", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:37817501", "source_url": "https://doi.org/10.1080/14728214.2023.2264180", "doi": "10.1080/14728214.2023.2264180", "pmid": "37817501", "publication_date": "2023-12-25", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1301, "title": "Molecular and Medical Aspects of Psychedelics.", "authors": "Wojtas A, Gołembiowska K.", "journal": null, "publication_date": "2023-12-22", "publication_year": 2023, "doi": "10.3390/ijms25010241", "pubmed_id": "38203411", "openalex_id": null, "source_url": "https://doi.org/10.3390/ijms25010241", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,OCD,End-of-Life Distress,Mechanism of Action,Receptor Pharmacology,Review Article,Animal Study,Toxicity", "study_type": "Review Article", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:03", "bibtex": null, "source_record_id": "PMID:38203411", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.3390/ijms25010241", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:38203411", "source_url": "https://doi.org/10.3390/ijms25010241", "doi": "10.3390/ijms25010241", "pmid": "38203411", "publication_date": "2023-12-22", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4725, "title": "Application of psilocybin in mental health disorders", "authors": "Jingxuan Chen", "journal": "Theoretical and Natural Science", "publication_date": "2023-12-19", "publication_year": 2023, "doi": "10.54254/2753-8818/21/20230859", "pubmed_id": null, "openalex_id": "https://openalex.org/W4390006951", "source_url": "https://doi.org/10.54254/2753-8818/21/20230859", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Anxiety,Addiction,OCD,Pharmacology,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Adverse Events", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:44", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "DOI:10.54254/2753-8818/21/20230859", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.54254/2753-8818/21/20230859", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.54254/2753-8818/21/20230859", "source_url": "https://doi.org/10.54254/2753-8818/21/20230859", "doi": "10.54254/2753-8818/21/20230859", "pmid": "", "publication_date": "2023-12-19", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1280, "title": "Is there credible evidence to assert psilocybin-assisted therapy for depression?", "authors": "Nogueira GN, Vasconcelos MMA, Souza FGM, Bisol LW.", "journal": null, "publication_date": "2023-12-19", "publication_year": 2023, "doi": "10.1016/j.euroneuro.2023.11.003", "pubmed_id": "38128153", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.euroneuro.2023.11.003", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:04", "bibtex": null, "source_record_id": "PMID:38128153", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:38128153", "source_url": "https://doi.org/10.1016/j.euroneuro.2023.11.003", "doi": "10.1016/j.euroneuro.2023.11.003", "pmid": "38128153", "publication_date": "2023-12-19", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 917, "title": "Unveiling the Psychedelic Journey: An Appraisal of Psilocybin as a Profound Antidepressant Therapy.", "authors": "Shah FI, Shehzadi S, Akram F, Haq IU, Javed B, Sabir S, Kazim Y, Ashfaq S.", "journal": null, "publication_date": "2023-12-19", "publication_year": 2023, "doi": "10.1007/s12033-023-00994-7", "pubmed_id": "38117395", "openalex_id": null, "source_url": "https://doi.org/10.1007/s12033-023-00994-7", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Receptor Pharmacology,Consciousness,Review Article", "study_type": "Review Article", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:01", "bibtex": null, "source_record_id": "PMID:38117395", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1007/s12033-023-00994-7", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:38117395", "source_url": "https://doi.org/10.1007/s12033-023-00994-7", "doi": "10.1007/s12033-023-00994-7", "pmid": "38117395", "publication_date": "2023-12-19", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1183, "title": "Acceptability of psilocybin-assisted group therapy in patients with cancer and major depressive disorder: Qualitative analysis", "authors": "Yvan Beaussant, Elise C. Tarbi, Kabir Nigam, Skye A. Miner, Zachary Sager, Justin J. Sanders, Michael Ljuslin, Benjamin Guérin, Paul Thambi, James A. Tulsky, Manish Agrawal", "journal": "Cancer", "publication_date": "2023-12-17", "publication_year": 2023, "doi": "10.1002/cncr.35024", "pubmed_id": "38105653", "openalex_id": "https://openalex.org/W4389895437", "source_url": "https://doi.org/10.1002/cncr.35024", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Aging,Clinical Trial,Cancer Patients,Safety,Toxicity,Drug Interactions", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "PMID:38105653", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1002/cncr.35024", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:38105653", "source_url": "https://doi.org/10.1002/cncr.35024", "doi": "10.1002/cncr.35024", "pmid": "38105653", "publication_date": "2023-12-17", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1182, "title": "Innovations in group-based psilocybin-assisted therapy of major depression in patients with cancer.", "authors": "Thrul J, Kozak Z, Carducci MA, Garcia-Romeu A, Yaden DB.", "journal": null, "publication_date": "2023-12-17", "publication_year": 2023, "doi": "10.1002/cncr.35127", "pubmed_id": "38105654", "openalex_id": null, "source_url": "https://doi.org/10.1002/cncr.35127", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:04", "bibtex": null, "source_record_id": "PMID:38105654", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:38105654", "source_url": "https://doi.org/10.1002/cncr.35127", "doi": "10.1002/cncr.35127", "pmid": "38105654", "publication_date": "2023-12-17", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1181, "title": "Psilocybin-assisted group therapy in patients with cancer diagnosed with a major depressive disorder", "authors": "Manish Agrawal, William A. Richards, Yvan Beaussant, Sarah Shnayder, Rezvan Ameli, Kimberly Roddy, Norma Stevens, Brian D. Richards, Nick Schor, Heather Honstein, Betsy Jenkins, Mark Bates, Paul Thambi", "journal": "Cancer", "publication_date": "2023-12-17", "publication_year": 2023, "doi": "10.1002/cncr.35010", "pubmed_id": "38105655", "openalex_id": "https://openalex.org/W4389900078", "source_url": "https://doi.org/10.1002/cncr.35010", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Chronic Pain,Headache / Migraine,Clinical Trial,Observational Study,Cancer Patients,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "PMID:38105655", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1002/cncr.35010", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:38105655", "source_url": "https://doi.org/10.1002/cncr.35010", "doi": "10.1002/cncr.35010", "pmid": "38105655", "publication_date": "2023-12-17", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3152, "title": "Psilocybin prevents activity-based anorexia in female rats by enhancing cognitive flexibility: contributions from 5-HT1A and 5-HT2A receptor mechanisms", "authors": "Conn K, Milton L, Huang K, Munguba H, Ruuska J, Lemus M, Greaves E, Homman-Ludiye J, Oldfield B, Foldi C.", "journal": "bioRxiv", "publication_date": "2023-12-12", "publication_year": 2023, "doi": "10.1101/2023.12.12.571374", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.1101/2023.12.12.571374", "substance_tags": "psilocybin", "topic_tags": "Depression,Eating Disorders,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Animal Study", "study_type": "Clinical Trial", "source_name": "bioRxiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:47", "last_checked": "2026-07-01 11:22:01", "bibtex": null, "source_record_id": "DOI:10.1101/2023.12.12.571374", "abstract_available": true, "abstract_source": "bioRxiv", "abstract_source_url": "https://doi.org/10.1101/2023.12.12.571374", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "bioRxiv", "source_record_id": "DOI:10.1101/2023.12.12.571374", "source_url": "https://doi.org/10.1101/2023.12.12.571374", "doi": "10.1101/2023.12.12.571374", "pmid": "", "publication_date": "2023-12-12", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4726, "title": "Psychotropics: A scientific, regulatory, and public view on the medicinal uses of cannabinoids and psilocybin", "authors": "Ivana Turek", "journal": "Medical Writing", "publication_date": "2023-12-10", "publication_year": 2023, "doi": "10.56012/tsen2260", "pubmed_id": null, "openalex_id": "https://openalex.org/W4389763815", "source_url": "http://dx.doi.org/10.56012/tsen2260", "substance_tags": "psilocybin", "topic_tags": "Depression,Pharmacology,Receptor Pharmacology,Clinical Trial,Animal Study", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:44", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "DOI:10.56012/tsen2260", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.56012/tsen2260", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.56012/tsen2260", "source_url": "http://dx.doi.org/10.56012/tsen2260", "doi": "10.56012/tsen2260", "pmid": "", "publication_date": "2023-12-10", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1311, "title": "Drugs for depressionr.", "authors": "", "journal": "The Medical letter on drugs and therapeutics", "publication_date": "2023-12-10", "publication_year": 2023, "doi": "10.58347/tml.2023.1691a", "pubmed_id": "38133585", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/38133585/", "substance_tags": "psilocybin", "topic_tags": "Depression,Safety,Drug Interactions", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:20:37", "bibtex": null, "source_record_id": "PMID:38133585", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38133585", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38133585/", "doi": "10.58347/tml.2023.1691a", "pmid": "38133585", "publication_date": "2023-12-10", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1312, "title": "Group psychedelic therapy: empirical estimates of cost-savings and improved access", "authors": "Elliot Marseille, Christopher S. Stauffer, Manish Agrawal, Paul Thambi, Kimberly Roddy, Michael C. Mithoefer, Stefano Bertozzi, James G. Kahn", "journal": "Frontiers in Psychiatry", "publication_date": "2023-12-05", "publication_year": 2023, "doi": "10.3389/fpsyt.2023.1293243", "pubmed_id": "38125286", "openalex_id": "https://openalex.org/W4389392873", "source_url": "https://doi.org/10.3389/fpsyt.2023.1293243", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Chronic Pain,Healthcare Workers,Toxicity", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "PMID:38125286", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.3389/fpsyt.2023.1293243", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:38125286", "source_url": "https://doi.org/10.3389/fpsyt.2023.1293243", "doi": "10.3389/fpsyt.2023.1293243", "pmid": "38125286", "publication_date": "2023-12-05", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1322, "title": "Preclinical models of treatment-resistant depression: challenges and perspectives.", "authors": "Kolasa M, Faron-Górecka A", "journal": "Pharmacological reports: PR", "publication_date": "2023-11-30", "publication_year": 2023, "doi": "10.1007/s43440-023-00542-9", "pubmed_id": "37882914", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/37882914/", "substance_tags": "psilocybin", "topic_tags": "Depression,Pharmacology,Review Article,Animal Study,Treatment-Resistant Depression", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:20:37", "bibtex": null, "source_record_id": "PMID:37882914", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37882914/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37882914", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37882914/", "doi": "10.1007/s43440-023-00542-9", "pmid": "37882914", "publication_date": "2023-11-30", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1320, "title": "Mindfulness meditation and psychedelics: potential synergies and commonalities.", "authors": "Holas P, Kamińska J", "journal": "Pharmacological reports: PR", "publication_date": "2023-11-30", "publication_year": 2023, "doi": "10.1007/s43440-023-00551-8", "pubmed_id": "37926796", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/37926796/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Mechanism of Action,Consciousness,Wellbeing,Mystical Experience,Review Article,Healthy Volunteers", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:20:37", "bibtex": null, "source_record_id": "PMID:37926796", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37926796/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37926796", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37926796/", "doi": "10.1007/s43440-023-00551-8", "pmid": "37926796", "publication_date": "2023-11-30", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1304, "title": "Intravenous psilocybin attenuates mechanical hypersensitivity in a rat model of chronic pain", "authors": "Nicholas Kolbman, Tiecheng Liu, Peter R. Guzzo, Jim Gilligan, George A. Mashour, Giancarlo Vanini, Dinesh Pal", "journal": "Current Biology", "publication_date": "2023-11-30", "publication_year": 2023, "doi": "10.1016/j.cub.2023.10.016", "pubmed_id": "38113836", "openalex_id": "https://openalex.org/W4389891609", "source_url": "https://doi.org/10.1016/j.cub.2023.10.016", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Chronic Pain,Pharmacology,Receptor Pharmacology,Animal Study", "study_type": "Animal Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "PMID:38113836", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1016/j.cub.2023.10.016", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:38113836", "source_url": "https://doi.org/10.1016/j.cub.2023.10.016", "doi": "10.1016/j.cub.2023.10.016", "pmid": "38113836", "publication_date": "2023-11-30", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1260, "title": "Serotonin 2A Receptor (5-HT2AR) Agonists: Psychedelics and Non-Hallucinogenic Analogues as Emerging Antidepressants.", "authors": "Duan W, Cao D, Wang S, Cheng J.", "journal": null, "publication_date": "2023-11-29", "publication_year": 2023, "doi": "10.1021/acs.chemrev.3c00375", "pubmed_id": "38033123", "openalex_id": null, "source_url": "https://doi.org/10.1021/acs.chemrev.3c00375", "substance_tags": "psilocybin", "topic_tags": "Depression,Pharmacology,Mechanism of Action,Receptor Pharmacology,Aging,Clinical Trial", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:05", "bibtex": null, "source_record_id": "PMID:38033123", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1021/acs.chemrev.3c00375", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:38033123", "source_url": "https://doi.org/10.1021/acs.chemrev.3c00375", "doi": "10.1021/acs.chemrev.3c00375", "pmid": "38033123", "publication_date": "2023-11-29", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1127, "title": "Current Understanding on Psilocybin for Major Depressive Disorder: A Review Focusing on Clinical Trials.", "authors": "Wang SM, Kim S, Choi WS, Lim HK, Woo YS, Pae CU, Bahk WM.", "journal": null, "publication_date": "2023-11-29", "publication_year": 2023, "doi": "10.9758/cpn.23.1134", "pubmed_id": "38627070", "openalex_id": null, "source_url": "https://doi.org/10.9758/cpn.23.1134", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Receptor Pharmacology,Default Mode Network,Clinical Trial,Randomized Controlled Trial,Review Article,Cancer Patients,Treatment-Resistant Depression,Safety,Inflammation", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:01", "bibtex": null, "source_record_id": "PMID:38627070", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.9758/cpn.23.1134", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:38627070", "source_url": "https://doi.org/10.9758/cpn.23.1134", "doi": "10.9758/cpn.23.1134", "pmid": "38627070", "publication_date": "2023-11-29", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3629, "title": "A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability and Efficacy of Psilocybin-Assisted Psychotherapy in Treating Severe Depression Among Adults With Post-Traumatic Stress Disorder (PTSD).", "authors": "Apex Labs Ltd.", "journal": "ClinicalTrials.gov", "publication_date": "2023-11-28", "publication_year": 2023, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06141876", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,OCD,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:34", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06141876", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06141876", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06141876", "source_url": "https://clinicaltrials.gov/study/NCT06141876", "doi": "", "pmid": "", "publication_date": "2023-11-28", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1041, "title": "Psilocybin as a lead candidate molecule in preclinical therapeutic studies of psychiatric disorders: A systematic review.", "authors": "Gattuso JJ, Wilson C, Hannan AJ, Renoir T.", "journal": null, "publication_date": "2023-11-28", "publication_year": 2023, "doi": "10.1111/jnc.16017", "pubmed_id": "38019032", "openalex_id": null, "source_url": "https://doi.org/10.1111/jnc.16017", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Mechanism of Action,Receptor Pharmacology,Systematic Review,Review Article,Animal Study,Treatment-Resistant Depression", "study_type": "Systematic Review", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:01", "bibtex": null, "source_record_id": "PMID:38019032", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1111/jnc.16017", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:38019032", "source_url": "https://doi.org/10.1111/jnc.16017", "doi": "10.1111/jnc.16017", "pmid": "38019032", "publication_date": "2023-11-28", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1300, "title": "Public Interest in Psilocybin and Psychedelic Therapy in the Context of the COVID-19 Pandemic: Google Trends Analysis", "authors": "George Danias, Jacob M. Appel", "journal": "JMIR Formative Research", "publication_date": "2023-11-27", "publication_year": 2023, "doi": "10.2196/43850", "pubmed_id": "38064635", "openalex_id": "https://openalex.org/W4389086750", "source_url": "https://doi.org/10.2196/43850", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "PMID:38064635", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.2196/43850", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:38064635", "source_url": "https://doi.org/10.2196/43850", "doi": "10.2196/43850", "pmid": "38064635", "publication_date": "2023-11-27", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1317, "title": "Psilocybin therapy to reduce depression following a terminal diagnosis", "authors": "Elizabeth Boudreau, Krissa Orlowski", "journal": "JAAPA", "publication_date": "2023-11-20", "publication_year": 2023, "doi": "10.1097/01.jaa.0000994952.07847.2d", "pubmed_id": "37989175", "openalex_id": "https://openalex.org/W4388850907", "source_url": "https://doi.org/10.1097/01.jaa.0000994952.07847.2d", "substance_tags": "psilocybin", "topic_tags": "Depression,End-of-Life Distress", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "PMID:37989175", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1097/01.jaa.0000994952.07847.2d", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:37989175", "source_url": "https://doi.org/10.1097/01.jaa.0000994952.07847.2d", "doi": "10.1097/01.jaa.0000994952.07847.2d", "pmid": "37989175", "publication_date": "2023-11-20", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4733, "title": "Altered stakes: Identifying gaps in the informed consent process for psychedelic-assisted therapy trials", "authors": "Tahlia R. Harrison", "journal": "Journal of Psychedelic Studies", "publication_date": "2023-11-19", "publication_year": 2023, "doi": "10.1556/2054.2023.00267", "pubmed_id": null, "openalex_id": "https://openalex.org/W4388822593", "source_url": "https://doi.org/10.1556/2054.2023.00267", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Clinical Trial,Review Article,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:44", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "DOI:10.1556/2054.2023.00267", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1556/2054.2023.00267", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1556/2054.2023.00267", "source_url": "https://doi.org/10.1556/2054.2023.00267", "doi": "10.1556/2054.2023.00267", "pmid": "", "publication_date": "2023-11-19", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4735, "title": "Psychedelic Integration: Psychotherapy for non-ordinary states of consciousness", "authors": "Danelle Jones", "journal": "Journal of Psychedelic Studies", "publication_date": "2023-11-15", "publication_year": 2023, "doi": "10.1556/2054.2023.00306", "pubmed_id": null, "openalex_id": "https://openalex.org/W4388730617", "source_url": "http://dx.doi.org/10.1556/2054.2023.00306", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Chronic Pain,Consciousness,Clinical Trial,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:44", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "DOI:10.1556/2054.2023.00306", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.1556/2054.2023.00306", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1556/2054.2023.00306", "source_url": "http://dx.doi.org/10.1556/2054.2023.00306", "doi": "10.1556/2054.2023.00306", "pmid": "", "publication_date": "2023-11-15", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1229, "title": "Antidepressant- and anxiolytic-like activities and acute toxicity evaluation of the Psilocybe cubensis mushroom in experimental models in mice.", "authors": "Hernandez-Leon A, Escamilla-Orozco RI, Tabal-Robles AR, Martínez-Vargas D, Romero-Bautista L, Escamilla-Soto G, González-Romero OS, Torres-Valencia M, González-Trujano ME.", "journal": null, "publication_date": "2023-11-14", "publication_year": 2023, "doi": "10.1016/j.jep.2023.117415", "pubmed_id": "37977425", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.jep.2023.117415", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Anxiety,Brain Imaging,Pharmacology,Animal Study,Toxicity", "study_type": "Animal Study", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:01", "bibtex": null, "source_record_id": "PMID:37977425", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.jep.2023.117415", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:37977425", "source_url": "https://doi.org/10.1016/j.jep.2023.117415", "doi": "10.1016/j.jep.2023.117415", "pmid": "37977425", "publication_date": "2023-11-14", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 919, "title": "Efficacy and Safety of Four Psychedelic-Assisted Therapies for Adults with Symptoms of Depression, Anxiety, and Posttraumatic Stress Disorder: A Systematic Review and Meta-Analysis.", "authors": "Bahji A, Lunsky I, Gutierrez G, Vazquez G.", "journal": null, "publication_date": "2023-11-14", "publication_year": 2023, "doi": "10.1080/02791072.2023.2278586", "pubmed_id": "37968944", "openalex_id": null, "source_url": "https://doi.org/10.1080/02791072.2023.2278586", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Aging,Meta-Analysis,Systematic Review,Review Article,Safety,Adverse Events", "study_type": "Meta-Analysis", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:04", "bibtex": null, "source_record_id": "PMID:37968944", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1080/02791072.2023.2278586", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:37968944", "source_url": "https://doi.org/10.1080/02791072.2023.2278586", "doi": "10.1080/02791072.2023.2278586", "pmid": "37968944", "publication_date": "2023-11-14", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3364, "title": "Aesthetic Chills Mitigate Maladaptive Cognition In Depression", "authors": "Schoeller F, Jain A, Adrien V, Maes P, Reggente N.", "journal": "Research Square", "publication_date": "2023-11-13", "publication_year": 2023, "doi": "10.21203/rs.3.rs-3582420/v1", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.21203/rs.3.rs-3582420/v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Consciousness,Emotional Processing,Safety", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "preprint", "date_added": "2026-07-01 11:03:51", "last_checked": "2026-07-01 11:22:05", "bibtex": null, "source_record_id": "DOI:10.21203/rs.3.rs-3582420/v1", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.21203/rs.3.rs-3582420/v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "DOI:10.21203/rs.3.rs-3582420/v1", "source_url": "https://doi.org/10.21203/rs.3.rs-3582420/v1", "doi": "10.21203/rs.3.rs-3582420/v1", "pmid": "", "publication_date": "2023-11-13", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1334, "title": "Psychedelic Drugs or Hallucinogens: Exploring Their Medicinal Potential.", "authors": "Raj P, Rauniyar S, Sapkale B.", "journal": null, "publication_date": "2023-11-12", "publication_year": 2023, "doi": "10.7759/cureus.48719", "pubmed_id": "38094517", "openalex_id": null, "source_url": "https://doi.org/10.7759/cureus.48719", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Neuroplasticity,Receptor Pharmacology,Consciousness,Aging", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:04", "bibtex": null, "source_record_id": "PMID:38094517", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.7759/cureus.48719", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:38094517", "source_url": "https://doi.org/10.7759/cureus.48719", "doi": "10.7759/cureus.48719", "pmid": "38094517", "publication_date": "2023-11-12", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3680, "title": "The Safety and Efficacy Of Psilocybin as an Adjunctive Therapy in Participants With Treatment Resistant Depression", "authors": "COMPASS Pathways", "journal": "ClinicalTrials.gov", "publication_date": "2023-11-08", "publication_year": 2023, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT04739865", "substance_tags": "psilocybin", "topic_tags": "Depression,Treatment-Resistant Depression,Safety", "study_type": "Other", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:34", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT04739865", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT04739865", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT04739865", "source_url": "https://clinicaltrials.gov/study/NCT04739865", "doi": "", "pmid": "", "publication_date": "2023-11-08", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1288, "title": "Synergistic psychedelic - NMDAR modulator treatment for neuropsychiatric disorders.", "authors": "Heresco-Levy U, Lerer B.", "journal": null, "publication_date": "2023-11-08", "publication_year": 2023, "doi": "10.1038/s41380-023-02312-8", "pubmed_id": "37945694", "openalex_id": null, "source_url": "https://doi.org/10.1038/s41380-023-02312-8", "substance_tags": "psilocybin", "topic_tags": "Depression,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Safety,Drug Interactions", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:05", "bibtex": null, "source_record_id": "PMID:37945694", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1038/s41380-023-02312-8", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:37945694", "source_url": "https://doi.org/10.1038/s41380-023-02312-8", "doi": "10.1038/s41380-023-02312-8", "pmid": "37945694", "publication_date": "2023-11-08", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4737, "title": "Pharmacists’ perspectives on psilocybin in Canada", "authors": "Elizabeth Sugiarto, Rebecca Leung, Jamie Yuen", "journal": "JAPhA Practice Innovations", "publication_date": "2023-11-07", "publication_year": 2023, "doi": "10.1016/j.japhpi.2023.100003", "pubmed_id": null, "openalex_id": "https://openalex.org/W4388498988", "source_url": "https://doi.org/10.1016/j.japhpi.2023.100003", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Observational Study,Treatment-Resistant Depression", "study_type": "Observational Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:44", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "DOI:10.1016/j.japhpi.2023.100003", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1016/j.japhpi.2023.100003", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.japhpi.2023.100003", "source_url": "https://doi.org/10.1016/j.japhpi.2023.100003", "doi": "10.1016/j.japhpi.2023.100003", "pmid": "", "publication_date": "2023-11-07", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1319, "title": "Interaction of hallucinogenic rapid-acting antidepressants with mGlu2/3 receptor ligands as a window for more effective therapies.", "authors": "Chruścicka-Smaga B, Machaczka A, Szewczyk B, Pilc A.", "journal": null, "publication_date": "2023-11-06", "publication_year": 2023, "doi": "10.1007/s43440-023-00547-4", "pubmed_id": "37932583", "openalex_id": null, "source_url": "https://doi.org/10.1007/s43440-023-00547-4", "substance_tags": "psilocybin", "topic_tags": "Depression,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Review Article,Drug Interactions", "study_type": "Review Article", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:04", "bibtex": null, "source_record_id": "PMID:37932583", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1007/s43440-023-00547-4", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:37932583", "source_url": "https://doi.org/10.1007/s43440-023-00547-4", "doi": "10.1007/s43440-023-00547-4", "pmid": "37932583", "publication_date": "2023-11-06", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1318, "title": "The possible place for psychedelics in pharmacotherapy of mental disorders.", "authors": "Wojtas A.", "journal": null, "publication_date": "2023-11-06", "publication_year": 2023, "doi": "10.1007/s43440-023-00550-9", "pubmed_id": "37934320", "openalex_id": null, "source_url": "https://doi.org/10.1007/s43440-023-00550-9", "substance_tags": "psilocybin", "topic_tags": "Depression,Receptor Pharmacology,Review Article,Adverse Events", "study_type": "Review Article", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:05", "bibtex": null, "source_record_id": "PMID:37934320", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1007/s43440-023-00550-9", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:37934320", "source_url": "https://doi.org/10.1007/s43440-023-00550-9", "doi": "10.1007/s43440-023-00550-9", "pmid": "37934320", "publication_date": "2023-11-06", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1337, "title": "LSD and psilocybin for chronic nociplastic pain: A narrative review of the literature supporting the use of classic psychedelic agents in chronic pain.", "authors": "Van Der Walt J, Parker R.", "journal": null, "publication_date": "2023-11-05", "publication_year": 2023, "doi": "10.7196/samj.2023.v113i11.814", "pubmed_id": "38525640", "openalex_id": null, "source_url": "https://doi.org/10.7196/samj.2023.v113i11.814", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Mechanism of Action,Aging,Review Article,Healthcare Workers", "study_type": "Review Article", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:02", "bibtex": null, "source_record_id": "PMID:38525640", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.7196/samj.2023.v113i11.814", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:38525640", "source_url": "https://doi.org/10.7196/samj.2023.v113i11.814", "doi": "10.7196/samj.2023.v113i11.814", "pmid": "38525640", "publication_date": "2023-11-05", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1336, "title": "Beyond the 5-HT2A Receptor: Classic and Nonclassic Targets in Psychedelic Drug Action.", "authors": "Cameron LP, Benetatos J, Lewis V, Bonniwell EM, Jaster AM, Moliner R, Castrén E, McCorvy JD, Palner M, Aguilar-Valles A.", "journal": null, "publication_date": "2023-10-31", "publication_year": 2023, "doi": "10.1523/jneurosci.1384-23.2023", "pubmed_id": "37940583", "openalex_id": null, "source_url": "https://doi.org/10.1523/jneurosci.1384-23.2023", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Emotional Processing,Review Article,Safety,Drug Interactions", "study_type": "Review Article", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:05", "bibtex": null, "source_record_id": "PMID:37940583", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1523/jneurosci.1384-23.2023", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:37940583", "source_url": "https://doi.org/10.1523/jneurosci.1384-23.2023", "doi": "10.1523/jneurosci.1384-23.2023", "pmid": "37940583", "publication_date": "2023-10-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4744, "title": "Single dose of psilocybin improves depressive symptoms in Phase 2 study", "authors": "", "journal": "The Brown University Psychopharmacology Update", "publication_date": "2023-10-29", "publication_year": 2023, "doi": "10.1002/pu.31093", "pubmed_id": null, "openalex_id": "https://openalex.org/W4388023533", "source_url": "http://dx.doi.org/10.1002/pu.31093", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Pharmacology,Clinical Trial,Adverse Events", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:45", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "DOI:10.1002/pu.31093", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.1002/pu.31093", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1002/pu.31093", "source_url": "http://dx.doi.org/10.1002/pu.31093", "doi": "10.1002/pu.31093", "pmid": "", "publication_date": "2023-10-29", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3798, "title": "A protocol for a scoping review of psychedelic interventions to alleviate psychological suffering in populations coping with end-of-life issues", "authors": "Kratina S, Lo C, Schwartz R, Strike C, Jopling S, Nayfeh A, Rush B.", "journal": "PsyArXiv", "publication_date": "2023-10-26", "publication_year": 2023, "doi": "10.31234/osf.io/4gfyd", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.31234/osf.io/4gfyd", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Mechanism of Action,Systematic Review,Review Article,Safety", "study_type": "Systematic Review", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:10:22", "last_checked": "2026-07-01 11:22:05", "bibtex": null, "source_record_id": "DOI:10.31234/osf.io/4gfyd", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://doi.org/10.31234/osf.io/4gfyd", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "DOI:10.31234/osf.io/4gfyd", "source_url": "https://doi.org/10.31234/osf.io/4gfyd", "doi": "10.31234/osf.io/4gfyd", "pmid": "", "publication_date": "2023-10-26", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3369, "title": "A protocol for a scoping review of psychedelic interventions to alleviate psychological suffering in populations coping with end-of-life issues", "authors": "", "journal": "PsyArXiv", "publication_date": "2023-10-26", "publication_year": 2023, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://osf.io/preprints/psyarxiv/4gfyd_v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Mechanism of Action,Systematic Review,Review Article,Safety", "study_type": "Systematic Review", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:51", "last_checked": "2026-07-01 11:22:30", "bibtex": null, "source_record_id": "https://osf.io/preprints/psyarxiv/4gfyd_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/4gfyd_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "https://osf.io/preprints/psyarxiv/4gfyd_v1", "source_url": "https://osf.io/preprints/psyarxiv/4gfyd_v1", "doi": "", "pmid": "", "publication_date": "2023-10-26", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4746, "title": "Psilocybin-assisted psychotherapy for the treatment of PTSD in UK armed forces veterans: A feasibility study protocol", "authors": "Natasha Biscoe, Amanda Bonson, Max Slavin, Walter Busuttil, Deirdre MacManus, Andrew T. Cox, Dominic Murphy", "journal": "European Journal of Trauma & Dissociation", "publication_date": "2023-10-24", "publication_year": 2023, "doi": "10.1016/j.ejtd.2023.100359", "pubmed_id": null, "openalex_id": "https://openalex.org/W4387941143", "source_url": "https://doi.org/10.1016/j.ejtd.2023.100359", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Veterans", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:45", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "DOI:10.1016/j.ejtd.2023.100359", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.ejtd.2023.100359", "source_url": "https://doi.org/10.1016/j.ejtd.2023.100359", "doi": "10.1016/j.ejtd.2023.100359", "pmid": "", "publication_date": "2023-10-24", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 2991, "title": "Ethopharmacological evaluation of antidepressant-like effect of serotonergic psychedelics in C57BL/6J male mice.", "authors": "Takaba R, Ibi D, Yoshida K, Hosomi E, Kawase R, Kitagawa H, Goto H, Achiwa M, Mizutani K, Maeda K, González-Maeso J, Kitagaki S, Hiramatsu M.", "journal": null, "publication_date": "2023-10-23", "publication_year": 2023, "doi": "10.1007/s00210-023-02778-x", "pubmed_id": "37874338", "openalex_id": null, "source_url": "https://doi.org/10.1007/s00210-023-02778-x", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Anxiety,Receptor Pharmacology,Animal Study", "study_type": "Animal Study", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 07:01:03", "last_checked": "2026-07-01 11:22:01", "bibtex": null, "source_record_id": "PMID:37874338", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1007/s00210-023-02778-x", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:37874338", "source_url": "https://doi.org/10.1007/s00210-023-02778-x", "doi": "10.1007/s00210-023-02778-x", "pmid": "37874338", "publication_date": "2023-10-23", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1323, "title": "Cardiovascular safety of psychedelic medicine: current status and future directions.", "authors": "Wsół A.", "journal": null, "publication_date": "2023-10-23", "publication_year": 2023, "doi": "10.1007/s43440-023-00539-4", "pubmed_id": "37874530", "openalex_id": null, "source_url": "https://doi.org/10.1007/s43440-023-00539-4", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Receptor Pharmacology,Microdosing,Clinical Trial,Review Article,Safety,Toxicity", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:05", "bibtex": null, "source_record_id": "PMID:37874530", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1007/s43440-023-00539-4", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:37874530", "source_url": "https://doi.org/10.1007/s43440-023-00539-4", "doi": "10.1007/s43440-023-00539-4", "pmid": "37874530", "publication_date": "2023-10-23", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4749, "title": "Is psilocybin effective for treatment of depression?", "authors": "Lucia Carbajal, Tessa E. Moore, R. H. Barry Sample, Joseph Nelson", "journal": "Evidence-Based Practice", "publication_date": "2023-10-18", "publication_year": 2023, "doi": "10.1097/ebp.0000000000002021", "pubmed_id": null, "openalex_id": "https://openalex.org/W4387880074", "source_url": "https://doi.org/10.1097/ebp.0000000000002021", "substance_tags": "psilocybin", "topic_tags": "Depression", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:45", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "DOI:10.1097/ebp.0000000000002021", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1097/ebp.0000000000002021", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1097/ebp.0000000000002021", "source_url": "https://doi.org/10.1097/ebp.0000000000002021", "doi": "10.1097/ebp.0000000000002021", "pmid": "", "publication_date": "2023-10-18", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1218, "title": "Psilocybin, an Effective Treatment for Major Depressive Disorder in Adults - A Systematic Review.", "authors": "Watford T, Masood N.", "journal": null, "publication_date": "2023-10-15", "publication_year": 2023, "doi": "10.9758/cpn.23.1120", "pubmed_id": "38247407", "openalex_id": null, "source_url": "https://doi.org/10.9758/cpn.23.1120", "substance_tags": "psilocybin", "topic_tags": "Depression,Receptor Pharmacology,Randomized Controlled Trial,Systematic Review,Review Article,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:01", "bibtex": null, "source_record_id": "PMID:38247407", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.9758/cpn.23.1120", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:38247407", "source_url": "https://doi.org/10.9758/cpn.23.1120", "doi": "10.9758/cpn.23.1120", "pmid": "38247407", "publication_date": "2023-10-15", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4751, "title": "Repurposing of recreational drugs: will these new ‘medicines’ (e.g., psychedelics, psilocybin, cannabinoids, LSD, MDMA, ketamine) deliver short- or longer-term benefits for those with depressive or other mood disorders?", "authors": "Ian B. Hickie, Allan H. Young, F. Markus Leweke", "journal": "Research Directions Depression", "publication_date": "2023-10-12", "publication_year": 2023, "doi": "10.1017/dep.2023.21", "pubmed_id": null, "openalex_id": "https://openalex.org/W4387617056", "source_url": "https://doi.org/10.1017/dep.2023.21", "substance_tags": "psilocybin", "topic_tags": "Depression,Pharmacology,Treatment-Resistant Depression", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:45", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "DOI:10.1017/dep.2023.21", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1017/dep.2023.21", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1017/dep.2023.21", "source_url": "https://doi.org/10.1017/dep.2023.21", "doi": "10.1017/dep.2023.21", "pmid": "", "publication_date": "2023-10-12", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4752, "title": "Assessing Metro Vancouver Residents’ Knowledge and Opinions of Psilocybin", "authors": "Payman Baharmand, Amardeep Kambo", "journal": "BCIT Environmental Public Health Journal", "publication_date": "2023-10-11", "publication_year": 2023, "doi": "10.47339/ephj.2023.229", "pubmed_id": null, "openalex_id": "https://openalex.org/W4387616208", "source_url": "http://dx.doi.org/10.47339/ephj.2023.229", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,OCD", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:45", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "DOI:10.47339/ephj.2023.229", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.47339/ephj.2023.229", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.47339/ephj.2023.229", "source_url": "http://dx.doi.org/10.47339/ephj.2023.229", "doi": "10.47339/ephj.2023.229", "pmid": "", "publication_date": "2023-10-11", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1342, "title": "Psilocybin-assisted therapy for depression: A systematic review and meta-analysis.", "authors": "Haikazian S, Chen-Li DCJ, Johnson DE, Fancy F, Levinta A, Husain MI, Mansur RB, McIntyre RS, Rosenblat JD.", "journal": null, "publication_date": "2023-10-10", "publication_year": 2023, "doi": "10.1016/j.psychres.2023.115531", "pubmed_id": "37844352", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.psychres.2023.115531", "substance_tags": "psilocybin", "topic_tags": "Depression,End-of-Life Distress,Clinical Trial,Meta-Analysis,Systematic Review,Review Article", "study_type": "Meta-Analysis", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:01", "bibtex": null, "source_record_id": "PMID:37844352", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.psychres.2023.115531", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:37844352", "source_url": "https://doi.org/10.1016/j.psychres.2023.115531", "doi": "10.1016/j.psychres.2023.115531", "pmid": "37844352", "publication_date": "2023-10-10", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4753, "title": "Psilocybin, Depression, and Synaptogenesis: Insights into the Field’s Past, Present, and Future", "authors": "Anna Douglas, Daniel Staas, Anna Hampton, Kylie Burns, F. Suter", "journal": "Georgetown Scientific Research Journal", "publication_date": "2023-10-09", "publication_year": 2023, "doi": "10.48091/gsr.v3i2.62", "pubmed_id": null, "openalex_id": "https://openalex.org/W4387521317", "source_url": "https://doi.org/10.48091/gsr.v3i2.62", "substance_tags": "psilocybin", "topic_tags": "Depression,Neuroplasticity,Pharmacology,Mechanism of Action,Receptor Pharmacology", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:45", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "DOI:10.48091/gsr.v3i2.62", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.48091/gsr.v3i2.62", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.48091/gsr.v3i2.62", "source_url": "https://doi.org/10.48091/gsr.v3i2.62", "doi": "10.48091/gsr.v3i2.62", "pmid": "", "publication_date": "2023-10-09", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3188, "title": "Synergistic, Multi-level Understanding of Psychedelics: Three Systematic Reviews and Meta-analyses of Their Pharmacology, Neuroimaging and Phenomenology", "authors": "Shinozuka K, Jerotic K, Mediano P, Zhao AT, Preller KH, Carhart-Harris R, Kringelbach ML.", "journal": "bioRxiv", "publication_date": "2023-10-06", "publication_year": 2023, "doi": "10.1101/2023.10.06.561183", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.1101/2023.10.06.561183", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Addiction,Brain Imaging,Pharmacology,Receptor Pharmacology,Consciousness,Aging,Systematic Review,Review Article,Safety", "study_type": "Systematic Review", "source_name": "bioRxiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:48", "last_checked": "2026-07-01 11:22:02", "bibtex": null, "source_record_id": "DOI:10.1101/2023.10.06.561183", "abstract_available": true, "abstract_source": "bioRxiv", "abstract_source_url": "https://doi.org/10.1101/2023.10.06.561183", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "bioRxiv", "source_record_id": "DOI:10.1101/2023.10.06.561183", "source_url": "https://doi.org/10.1101/2023.10.06.561183", "doi": "10.1101/2023.10.06.561183", "pmid": "", "publication_date": "2023-10-06", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4754, "title": "Psychedelics and Psychotherapy: Is the Whole Greater than the Sum of its Parts?", "authors": "Robert H. Dworkin, Michael McDermott, Sandeep M. Nayak, Eric C. Strain", "journal": "Clinical Pharmacology & Therapeutics", "publication_date": "2023-10-04", "publication_year": 2023, "doi": "10.1002/cpt.3050", "pubmed_id": "37795632", "openalex_id": "https://openalex.org/W4387357883", "source_url": "https://doi.org/10.1002/cpt.3050", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Chronic Pain,Headache / Migraine,Neuroplasticity,Pharmacology,Mechanism of Action,Receptor Pharmacology,Consciousness,Microdosing,Wellbeing,Clinical Trial,Healthcare Workers,Safety,Adverse Events,Drug Interactions", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:45", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "PMID:37795632", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1002/cpt.3050", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:37795632", "source_url": "https://doi.org/10.1002/cpt.3050", "doi": "10.1002/cpt.3050", "pmid": "37795632", "publication_date": "2023-10-04", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1360, "title": "An open-label pilot trial assessing tolerability and feasibility of LSD microdosing in patients with major depressive disorder (LSDDEP1)", "authors": "C Donegan, Dimitri Daldegan-Bueno, Rachael L. Sumner, David B Menkes, William J. Evans, Nicholas Hoeh, Frederick Sundram, Lisa Reynolds, Rhys Ponton, Alana Cavadino, Todd Smith, Partha S. Roop, Nathan Allen, Binu Abeysinghe, Darren Svirskis, Anna Forsyth, Mahima Bansal, Suresh Muthukumaraswamy", "journal": "Pilot and Feasibility Studies", "publication_date": "2023-10-04", "publication_year": 2023, "doi": "10.1186/s40814-023-01399-8", "pubmed_id": "37798662", "openalex_id": "https://openalex.org/W4387372869", "source_url": "https://doi.org/10.1186/s40814-023-01399-8", "substance_tags": "psilocybin", "topic_tags": "Depression,Pharmacology,Receptor Pharmacology,Microdosing,Clinical Trial,Randomized Controlled Trial,Observational Study,Healthy Volunteers,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "PMID:37798662", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1186/s40814-023-01399-8", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:37798662", "source_url": "https://doi.org/10.1186/s40814-023-01399-8", "doi": "10.1186/s40814-023-01399-8", "pmid": "37798662", "publication_date": "2023-10-04", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4755, "title": "Psilocybin shows promising results in subjects continuing to use an antidepressant", "authors": "", "journal": "The Brown University Psychopharmacology Update", "publication_date": "2023-10-03", "publication_year": 2023, "doi": "10.1002/pu.31089", "pubmed_id": null, "openalex_id": "https://openalex.org/W4387361294", "source_url": "http://dx.doi.org/10.1002/pu.31089", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Pharmacology,Receptor Pharmacology,Clinical Trial,Treatment-Resistant Depression,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:45", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "DOI:10.1002/pu.31089", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.1002/pu.31089", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1002/pu.31089", "source_url": "http://dx.doi.org/10.1002/pu.31089", "doi": "10.1002/pu.31089", "pmid": "", "publication_date": "2023-10-03", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4762, "title": "MODULATION OF SYNAPTIC FUNCTION AND NEURONAL NETWORK ACTIVITY BY SEROTONERGIC PSYCHEDELICS", "authors": "Aneta Petrušková, Eva-Maria Weiss, Debarpan Guhathakurta, Enes Yağız Akdaş, Bartomeu Perelló, Renato Frischknecht, Tomáš Páleníček, Anna Fejtová", "journal": "IBRO Neuroscience Reports", "publication_date": "2023-09-30", "publication_year": 2023, "doi": "10.1016/j.ibneur.2023.08.608", "pubmed_id": null, "openalex_id": "https://openalex.org/W4388365459", "source_url": "https://doi.org/10.1016/j.ibneur.2023.08.608", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Addiction,Neuroplasticity,Brain Imaging,Mechanism of Action,Receptor Pharmacology,Aging", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:45", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "DOI:10.1016/j.ibneur.2023.08.608", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1016/j.ibneur.2023.08.608", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.ibneur.2023.08.608", "source_url": "https://doi.org/10.1016/j.ibneur.2023.08.608", "doi": "10.1016/j.ibneur.2023.08.608", "pmid": "", "publication_date": "2023-09-30", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4760, "title": "DOES THE PHENOMENOLOGY OF THE PSILOCYBIN EXPERIENCE PREDICT LONG-TERM EFFECTS ON MOOD AND WELL-BEING IN HEALTHY VOLUNTEERS?", "authors": "Tomáš Páleníček, Tereza Klučková, M. Nikolič, Čestmír Vejmola, Filip Tylš, Vojtěch Viktorin, Jiřı́ Horáček, Martin Brunovský", "journal": "IBRO Neuroscience Reports", "publication_date": "2023-09-30", "publication_year": 2023, "doi": "10.1016/j.ibneur.2023.08.1240", "pubmed_id": null, "openalex_id": "https://openalex.org/W4388363682", "source_url": "https://doi.org/10.1016/j.ibneur.2023.08.1240", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Wellbeing,Spirituality,Healthy Volunteers", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:45", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "DOI:10.1016/j.ibneur.2023.08.1240", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1016/j.ibneur.2023.08.1240", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.ibneur.2023.08.1240", "source_url": "https://doi.org/10.1016/j.ibneur.2023.08.1240", "doi": "10.1016/j.ibneur.2023.08.1240", "pmid": "", "publication_date": "2023-09-30", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1359, "title": "Predicting the Intensity of Psychedelic-Induced Mystical and Challenging Experience in a Healthy Population: An Exploratory Post-Hoc Analysis", "authors": "Kwonmok Ko, Ben Carter, Anthony J. Cleare, James Rucker", "journal": "Neuropsychiatric Disease and Treatment", "publication_date": "2023-09-30", "publication_year": 2023, "doi": "10.2147/ndt.s426193", "pubmed_id": "37818448", "openalex_id": "https://openalex.org/W4387389328", "source_url": "https://doi.org/10.2147/ndt.s426193", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Personality Change,Mystical Experience,Clinical Trial,Healthy Volunteers,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "PMID:37818448", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.2147/ndt.s426193", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:37818448", "source_url": "https://doi.org/10.2147/ndt.s426193", "doi": "10.2147/ndt.s426193", "pmid": "37818448", "publication_date": "2023-09-30", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3728, "title": "Neuroimaging in psychedelic drug development: past, present, and future.", "authors": "Wall MB, Harding R, Zafar R, Rabiner EA, Nutt DJ, Erritzoe D.", "journal": null, "publication_date": "2023-09-26", "publication_year": 2023, "doi": "10.1038/s41380-023-02271-0", "pubmed_id": "37759038", "openalex_id": null, "source_url": "https://doi.org/10.1038/s41380-023-02271-0", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Addiction,Neuroplasticity,Brain Imaging,Pharmacology,Receptor Pharmacology,Aging", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 11:08:42", "last_checked": "2026-07-01 11:22:05", "bibtex": null, "source_record_id": "PMID:37759038", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1038/s41380-023-02271-0", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:37759038", "source_url": "https://doi.org/10.1038/s41380-023-02271-0", "doi": "10.1038/s41380-023-02271-0", "pmid": "37759038", "publication_date": "2023-09-26", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3300, "title": "Psilocybin kann offenbar Depressionen lindern", "authors": "Thomas Müller", "journal": "MMW - Fortschritte der Medizin", "publication_date": "2023-09-26", "publication_year": 2023, "doi": "10.1007/s15006-023-3025-6", "pubmed_id": "37758991", "openalex_id": "https://openalex.org/W4387081757", "source_url": "http://dx.doi.org/10.1007/s15006-023-3025-6", "substance_tags": "psilocybin", "topic_tags": "Depression,Pharmacology", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 11:03:50", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "PMID:37758991", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:37758991", "source_url": "http://dx.doi.org/10.1007/s15006-023-3025-6", "doi": "10.1007/s15006-023-3025-6", "pmid": "37758991", "publication_date": "2023-09-26", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3667, "title": "Effects and Therapeutic Potential of Psilocybin in Alcohol Dependence", "authors": "University of New Mexico", "journal": "ClinicalTrials.gov", "publication_date": "2023-09-25", "publication_year": 2023, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT01534494", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Spirituality,Safety", "study_type": "Other", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:34", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT01534494", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT01534494", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT01534494", "source_url": "https://clinicaltrials.gov/study/NCT01534494", "doi": "", "pmid": "", "publication_date": "2023-09-25", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1369, "title": "A suite of engineered mice for interrogating psychedelic drug actions", "authors": "Chiu Y, Deutch AY, Wang W, Schmitz GP, Huang KL, Kocak DD, Llorach P, Bowyer K, Liu B, Sciaky N, Hua K, Chen C, Mott SE, Niehaus J, DiBerto JF, English J, Walsh JJ, Scherrer G, Herman MA, Wu Z, Wetsel WC, Roth BL.", "journal": "bioRxiv", "publication_date": "2023-09-25", "publication_year": 2023, "doi": "10.1101/2023.09.25.559347", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.1101/2023.09.25.559347", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Headache / Migraine,Receptor Pharmacology,Animal Study", "study_type": "Animal Study", "source_name": "bioRxiv", "publication_status": "preprint", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:04", "bibtex": null, "source_record_id": "DOI:10.1101/2023.09.25.559347", "abstract_available": true, "abstract_source": "bioRxiv", "abstract_source_url": "https://doi.org/10.1101/2023.09.25.559347", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "bioRxiv", "source_record_id": "DOI:10.1101/2023.09.25.559347", "source_url": "https://doi.org/10.1101/2023.09.25.559347", "doi": "10.1101/2023.09.25.559347", "pmid": "", "publication_date": "2023-09-25", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1314, "title": "Perceptions of psychedelic-assisted therapy among Black Americans", "authors": "Sierra Carter, Grace Packard, Callan Coghlan, Jamilah R. George, Ashanti J. Brown, Terence H. W. Ching, Jacob Julian, Jessica L. Maples-Keller", "journal": "Journal of Mood and Anxiety Disorders", "publication_date": "2023-09-25", "publication_year": 2023, "doi": "10.1016/j.xjmad.2023.100023", "pubmed_id": "40656968", "openalex_id": "https://openalex.org/W4387063622", "source_url": "https://doi.org/10.1016/j.xjmad.2023.100023", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Receptor Pharmacology,Clinical Trial,Observational Study,Drug Interactions", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "PMID:40656968", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1016/j.xjmad.2023.100023", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:40656968", "source_url": "https://doi.org/10.1016/j.xjmad.2023.100023", "doi": "10.1016/j.xjmad.2023.100023", "pmid": "40656968", "publication_date": "2023-09-25", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3150, "title": "Limbic System Response to Psilocybin and Ketamine Administration in Rats: A Neurochemical and Behavioral Study", "authors": "Wojtas A, Bysiek A, Wawrzczak-Bargiela A, Maćkowiak M, Gołembiowska K.", "journal": "Preprints.org", "publication_date": "2023-09-24", "publication_year": 2023, "doi": "10.20944/preprints202309.1649.v1", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.20944/preprints202309.1649.v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Receptor Pharmacology", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "preprint", "date_added": "2026-07-01 11:03:47", "last_checked": "2026-07-01 11:22:01", "bibtex": null, "source_record_id": "DOI:10.20944/preprints202309.1649.v1", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.20944/preprints202309.1649.v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "DOI:10.20944/preprints202309.1649.v1", "source_url": "https://doi.org/10.20944/preprints202309.1649.v1", "doi": "10.20944/preprints202309.1649.v1", "pmid": "", "publication_date": "2023-09-24", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4764, "title": "Expectancies for Subjective and Antidepressant Effects in Psilocybin Users", "authors": "Mitch Earleywine, Maha N. Mian, Joseph A. De Leo", "journal": "Journal of Humanistic Psychology", "publication_date": "2023-09-21", "publication_year": 2023, "doi": "10.1177/00221678231194798", "pubmed_id": null, "openalex_id": "https://openalex.org/W4386958768", "source_url": "https://doi.org/10.1177/00221678231194798", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Receptor Pharmacology,Wellbeing,Emotional Processing,Mystical Experience,Clinical Trial", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:45", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "DOI:10.1177/00221678231194798", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1177/00221678231194798", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1177/00221678231194798", "source_url": "https://doi.org/10.1177/00221678231194798", "doi": "10.1177/00221678231194798", "pmid": "", "publication_date": "2023-09-21", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1370, "title": "Manic episode following psilocybin use in a man with bipolar II disorder: a case report", "authors": "Haniya J. Halim, Bradley G. Burk, Rachel E. Fargason, Badari Birur", "journal": "Frontiers in Psychiatry", "publication_date": "2023-09-21", "publication_year": 2023, "doi": "10.3389/fpsyt.2023.1221131", "pubmed_id": "37810598", "openalex_id": "https://openalex.org/W4386961159", "source_url": "https://doi.org/10.3389/fpsyt.2023.1221131", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,OCD,End-of-Life Distress,Receptor Pharmacology,Case Report,Treatment-Resistant Depression,Safety", "study_type": "Case Report", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "PMID:37810598", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.3389/fpsyt.2023.1221131", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:37810598", "source_url": "https://doi.org/10.3389/fpsyt.2023.1221131", "doi": "10.3389/fpsyt.2023.1221131", "pmid": "37810598", "publication_date": "2023-09-21", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1372, "title": "Naturalistic psilocybin use is associated with persisting improvements in mental health and wellbeing: results from a prospective, longitudinal survey", "authors": "Sandeep M. Nayak, Hillary Jackson, Nathan D. Sepeda, David S. Mathai, Sara So, Abigail Yaffe, Hadi Zaki, Trey Brasher, Matthew X. Lowe, Del R. P. Jolly, Frederick S. Barrett, Roland R. Griffiths, Justin C. Strickland, Matthew W. Johnson, Heather Jackson, Albert Garcia-Romeu", "journal": "Frontiers in Psychiatry", "publication_date": "2023-09-18", "publication_year": 2023, "doi": "10.3389/fpsyt.2023.1199642", "pubmed_id": "37795509", "openalex_id": "https://openalex.org/W4386861633", "source_url": "https://doi.org/10.3389/fpsyt.2023.1199642", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Chronic Pain,Wellbeing,Emotional Processing,Spirituality,Observational Study,Toxicity", "study_type": "Observational Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "PMID:37795509", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.3389/fpsyt.2023.1199642", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:37795509", "source_url": "https://doi.org/10.3389/fpsyt.2023.1199642", "doi": "10.3389/fpsyt.2023.1199642", "pmid": "37795509", "publication_date": "2023-09-18", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1201, "title": "American Psychiatrists' Opinions About Classic Hallucinogens and Their Potential Therapeutic Applications: A7-Year Follow-Up Survey", "authors": "Brian S. Barnett, Miranda Arakelian, David S. Beebe, Jared Ontko, Connor Riegal, Willie O. Siu, Jeremy Weleff, Harrison G. Pope", "journal": "Psychedelic Medicine", "publication_date": "2023-09-17", "publication_year": 2023, "doi": "10.1089/psymed.2023.0036", "pubmed_id": "40051760", "openalex_id": "https://openalex.org/W4386824127", "source_url": "https://doi.org/10.1089/psymed.2023.0036", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Chronic Pain,Clinical Trial,Observational Study,Treatment-Resistant Depression,Safety,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "PMID:40051760", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1089/psymed.2023.0036", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:40051760", "source_url": "https://doi.org/10.1089/psymed.2023.0036", "doi": "10.1089/psymed.2023.0036", "pmid": "40051760", "publication_date": "2023-09-17", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4769, "title": "The psychedelic experience and treatment-resistant depression", "authors": "Guy M. Goodwin", "journal": "World Psychiatry", "publication_date": "2023-09-14", "publication_year": 2023, "doi": "10.1002/wps.21140", "pubmed_id": "37713542", "openalex_id": "https://openalex.org/W4386765441", "source_url": "http://dx.doi.org/10.1002/wps.21140", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Anxiety,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Consciousness,Personality Change,Emotional Processing,Clinical Trial,Randomized Controlled Trial,Review Article,Healthy Volunteers,Treatment-Resistant Depression,Safety,Adverse Events,Drug Interactions", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:45", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "PMID:37713542", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.1002/wps.21140", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:37713542", "source_url": "http://dx.doi.org/10.1002/wps.21140", "doi": "10.1002/wps.21140", "pmid": "37713542", "publication_date": "2023-09-14", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1358, "title": "Tryptamines and Mental Health: Activating the 5-HT Receptor for Therapeutic Potential.", "authors": "Kargbo RB.", "journal": null, "publication_date": "2023-09-14", "publication_year": 2023, "doi": "10.1021/acsmedchemlett.3c00390", "pubmed_id": "37849550", "openalex_id": null, "source_url": "https://doi.org/10.1021/acsmedchemlett.3c00390", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Receptor Pharmacology,Clinical Trial,Treatment-Resistant Depression", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:03", "bibtex": null, "source_record_id": "PMID:37849550", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1021/acsmedchemlett.3c00390", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:37849550", "source_url": "https://doi.org/10.1021/acsmedchemlett.3c00390", "doi": "10.1021/acsmedchemlett.3c00390", "pmid": "37849550", "publication_date": "2023-09-14", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1377, "title": "Predictors of Pharmacy Students' Attitudes About the Therapeutic Use of Psilocybin", "authors": "NM Mahmudul Alam Bhuiya, Robin J. Jacobs, Karina Wang, Yiqun Sun, Brenda Nava, Luke Sampiere, Akhila Yerubandi, Joshua Caballero", "journal": "Cureus", "publication_date": "2023-09-12", "publication_year": 2023, "doi": "10.7759/cureus.45169", "pubmed_id": "37842360", "openalex_id": "https://openalex.org/W4386702998", "source_url": "http://dx.doi.org/10.7759/cureus.45169", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,OCD,Pharmacology,Review Article,Observational Study,Safety", "study_type": "Review Article", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "PMID:37842360", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.7759/cureus.45169", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:37842360", "source_url": "http://dx.doi.org/10.7759/cureus.45169", "doi": "10.7759/cureus.45169", "pmid": "37842360", "publication_date": "2023-09-12", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4775, "title": "Classic Psychedelics for the Treatment of Depressive Disorders: An Update for Psychiatrists in Training", "authors": "Lawrence Canale, Dhvanit Raval, Preet Chatha, Katie Penn, Claudia Weber, Catherine Stout, Jeremy Weleff", "journal": "American Journal of Psychiatry Residents Journal", "publication_date": "2023-09-07", "publication_year": 2023, "doi": "10.1176/appi.ajp-rj.2023.190103", "pubmed_id": null, "openalex_id": "https://openalex.org/W4386544759", "source_url": "http://dx.doi.org/10.1176/appi.ajp-rj.2023.190103", "substance_tags": "psilocybin", "topic_tags": "Depression,Pharmacology,Receptor Pharmacology,Clinical Trial,Treatment-Resistant Depression,Healthcare Workers", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:45", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "DOI:10.1176/appi.ajp-rj.2023.190103", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.1176/appi.ajp-rj.2023.190103", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1176/appi.ajp-rj.2023.190103", "source_url": "http://dx.doi.org/10.1176/appi.ajp-rj.2023.190103", "doi": "10.1176/appi.ajp-rj.2023.190103", "pmid": "", "publication_date": "2023-09-07", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1364, "title": "Psychedelic-Assisted Therapy in Military and Veterans Healthcare Systems: Clinical, Legal, and Implementation Considerations.", "authors": "Wolfgang AS, Hoge CW.", "journal": null, "publication_date": "2023-09-07", "publication_year": 2023, "doi": "10.1007/s11920-023-01446-4", "pubmed_id": "37682446", "openalex_id": null, "source_url": "https://doi.org/10.1007/s11920-023-01446-4", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Mechanism of Action,Clinical Trial,Review Article,Veterans,Safety", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:04", "bibtex": null, "source_record_id": "PMID:37682446", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1007/s11920-023-01446-4", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:37682446", "source_url": "https://doi.org/10.1007/s11920-023-01446-4", "doi": "10.1007/s11920-023-01446-4", "pmid": "37682446", "publication_date": "2023-09-07", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1345, "title": "Psilocybin induces acute and persisting alterations in immune status in healthy volunteers: An experimental, placebo-controlled study", "authors": "Natasha L. Mason, Attila Szabó, Kim P. C. Kuypers, Pablo Mallaroni, R. de la Torre Fornell, Johannes T. Reckweg, Desmond H. Y. Tse, Nadia R. P. W. Hutten, Amanda Feilding, Johannes G. Ramaekers", "journal": "Brain Behavior and Immunity", "publication_date": "2023-09-06", "publication_year": 2023, "doi": "10.1016/j.bbi.2023.09.004", "pubmed_id": "37689275", "openalex_id": "https://openalex.org/W4386504040", "source_url": "https://doi.org/10.1016/j.bbi.2023.09.004", "substance_tags": "psilocybin", "topic_tags": "Depression,Pharmacology,Mechanism of Action,Receptor Pharmacology,Biomarkers,Healthy Volunteers,Inflammation,Immune Function", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "PMID:37689275", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1016/j.bbi.2023.09.004", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:37689275", "source_url": "https://doi.org/10.1016/j.bbi.2023.09.004", "doi": "10.1016/j.bbi.2023.09.004", "pmid": "37689275", "publication_date": "2023-09-06", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1309, "title": "Psilocybin-Assisted Cognitive Behavioral Therapy for Adults with Major Depressive Disorder: Rationale and Treatment Development", "authors": "Marc J. Weintraub, Jessica Jeffrey, Charles S. Grob, Megan Ichinose, R. Lindsey Bergman, Ziva D. Cooper, David J. Miklowitz", "journal": "Psychedelic Medicine", "publication_date": "2023-09-05", "publication_year": 2023, "doi": "10.1089/psymed.2023.0018", "pubmed_id": "40046861", "openalex_id": "https://openalex.org/W4386469528", "source_url": "https://doi.org/10.1089/psymed.2023.0018", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Mechanism of Action,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "PMID:40046861", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1089/psymed.2023.0018", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:40046861", "source_url": "https://doi.org/10.1089/psymed.2023.0018", "doi": "10.1089/psymed.2023.0018", "pmid": "40046861", "publication_date": "2023-09-05", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4779, "title": "Psilocybin, escitalopram have comparable effects on personality in patients with depression", "authors": "", "journal": "The Brown University Psychopharmacology Update", "publication_date": "2023-09-02", "publication_year": 2023, "doi": "10.1002/pu.31080", "pubmed_id": null, "openalex_id": "https://openalex.org/W4386410207", "source_url": "http://dx.doi.org/10.1002/pu.31080", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Personality Change", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:45", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "DOI:10.1002/pu.31080", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1002/pu.31080", "source_url": "http://dx.doi.org/10.1002/pu.31080", "doi": "10.1002/pu.31080", "pmid": "", "publication_date": "2023-09-02", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1392, "title": "Bayesian analysis of real-world data as evidence for drug approval: Remembering Sir Michael Rawlins.", "authors": "Szigeti B, Phillips LD, Nutt D", "journal": "British journal of clinical pharmacology", "publication_date": "2023-08-31", "publication_year": 2023, "doi": "10.1111/bcp.15841", "pubmed_id": "37455605", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/37455605/", "substance_tags": "psilocybin", "topic_tags": "Depression,Randomized Controlled Trial", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:20:38", "bibtex": null, "source_record_id": "PMID:37455605", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37455605", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37455605/", "doi": "10.1111/bcp.15841", "pmid": "37455605", "publication_date": "2023-08-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1386, "title": "Psychedelics, With a Focus on Psilocybin: Issues for the Clinician.", "authors": "Garakani A, Alexander JL, Sumner CR, Pine JH, Gross LS, Raison CL, Aaronson ST, Baron DA.", "journal": null, "publication_date": "2023-08-31", "publication_year": 2023, "doi": "10.1097/pra.0000000000000729", "pubmed_id": "37678363", "openalex_id": null, "source_url": "https://doi.org/10.1097/pra.0000000000000729", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Review Article,Cancer Patients,Treatment-Resistant Depression,Healthcare Workers", "study_type": "Review Article", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:01", "bibtex": null, "source_record_id": "PMID:37678363", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1097/pra.0000000000000729", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:37678363", "source_url": "https://doi.org/10.1097/pra.0000000000000729", "doi": "10.1097/pra.0000000000000729", "pmid": "37678363", "publication_date": "2023-08-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1380, "title": "Psychedelics for treatment resistant depression: are they game changers?", "authors": "Kalfas M, Taylor RH, Tsapekos D, Young AH.", "journal": null, "publication_date": "2023-08-31", "publication_year": 2023, "doi": "10.1080/14656566.2023.2281582", "pubmed_id": "37947195", "openalex_id": null, "source_url": "https://doi.org/10.1080/14656566.2023.2281582", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Mechanism of Action,Receptor Pharmacology,Randomized Controlled Trial,Review Article,Treatment-Resistant Depression,Safety", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:03", "bibtex": null, "source_record_id": "PMID:37947195", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1080/14656566.2023.2281582", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:37947195", "source_url": "https://doi.org/10.1080/14656566.2023.2281582", "doi": "10.1080/14656566.2023.2281582", "pmid": "37947195", "publication_date": "2023-08-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1375, "title": "Psychedelic Use Among Psychiatric Medication Prescribers: Effects on Well-Being, Depression, Anxiety, and Associations with Patterns of Use, Reported Harms, and Transformative Mental States.", "authors": "Herrmann Z, Levin AW, Cole SP, Slabaugh S, Barnett B, Penn A, Jain R, Raison C, Rajanna B, Jain S", "journal": "Psychedelic medicine (New Rochelle, N.Y.)", "publication_date": "2023-08-31", "publication_year": 2023, "doi": "10.1089/psymed.2023.0030", "pubmed_id": "40046570", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/40046570/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Wellbeing,Resilience,Mystical Experience,Clinical Trial,Observational Study", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:20:38", "bibtex": null, "source_record_id": "PMID:40046570", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40046570/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40046570", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40046570/", "doi": "10.1089/psymed.2023.0030", "pmid": "40046570", "publication_date": "2023-08-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1435, "title": "Adapting psychedelic medicine for headache and chronic pain disorders", "authors": "Emmanuelle A. D. Schindler, Peter S. Hendricks", "journal": "Expert Review of Neurotherapeutics", "publication_date": "2023-08-30", "publication_year": 2023, "doi": "10.1080/14737175.2023.2246655", "pubmed_id": "37652000", "openalex_id": "https://openalex.org/W4386317658", "source_url": "https://doi.org/10.1080/14737175.2023.2246655", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Chronic Pain,Headache / Migraine,Mechanism of Action,Clinical Trial,Review Article,Case Report,Safety,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "PMID:37652000", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1080/14737175.2023.2246655", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:37652000", "source_url": "https://doi.org/10.1080/14737175.2023.2246655", "doi": "10.1080/14737175.2023.2246655", "pmid": "37652000", "publication_date": "2023-08-30", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1387, "title": "Psilocybin history, action and reaction: A narrative clinical review.", "authors": "Sharma P, Nguyen QA, Matthews SJ, Carpenter E, Mathews DB, Patten CA, Hammond CJ.", "journal": null, "publication_date": "2023-08-30", "publication_year": 2023, "doi": "10.1177/02698811231190858", "pubmed_id": "37650489", "openalex_id": null, "source_url": "https://doi.org/10.1177/02698811231190858", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Mechanism of Action,Clinical Trial,Review Article,Healthcare Workers,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:01", "bibtex": null, "source_record_id": "PMID:37650489", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1177/02698811231190858", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:37650489", "source_url": "https://doi.org/10.1177/02698811231190858", "doi": "10.1177/02698811231190858", "pmid": "37650489", "publication_date": "2023-08-30", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1379, "title": "Single-Dose Psilocybin Treatment for Major Depressive Disorder", "authors": "Charles L. Raison, Gerard Sanacora, Joshua Woolley, Keith G. Heinzerling, Boadie W. Dunlop, Randall Brown, Rishi Kakar, Michael Hassman, Rupal Trivedi, Reid Robison, Natalie Gukasyan, Sandeep M. Nayak, Xiaojue Hu, Kelley C. O’Donnell, Benjamin Kelmendi, Jordan Sloshower, Andrew Penn, Ellen Bradley, Daniel F. Kelly, Tanja Mletzko, Christopher R. Nicholas, Paul R. Hutson, Gary Tarpley, Malynn Utzinger, Kelsey Lenoch, Kasia Warchol, Theraysa Gapasin, Mike C. Davis, Courtney Nelson-Douthit, Steffanie H Wilson, Carrie Brown, William Linton, Matthew W. Johnson, Stephen Ross, Roland R. Griffiths", "journal": "JAMA", "publication_date": "2023-08-30", "publication_year": 2023, "doi": "10.1001/jama.2023.14530", "pubmed_id": "37651119", "openalex_id": "https://openalex.org/W4386305655", "source_url": "https://doi.org/10.1001/jama.2023.14530", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Chronic Pain,Clinical Trial,Safety,Adverse Events,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "PMID:37651119", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1001/jama.2023.14530", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:37651119", "source_url": "https://doi.org/10.1001/jama.2023.14530", "doi": "10.1001/jama.2023.14530", "pmid": "37651119", "publication_date": "2023-08-30", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1246, "title": "The changing outlook of psychedelic drugs: The importance of risk assessment and occupational exposure limits", "authors": "Natália Bernardi Videira, Vijayalekshmi Nair, Valérie Paquet, Dean Calhoun", "journal": "Journal of Applied Toxicology", "publication_date": "2023-08-29", "publication_year": 2023, "doi": "10.1002/jat.4533", "pubmed_id": "37646119", "openalex_id": "https://openalex.org/W4386272089", "source_url": "https://doi.org/10.1002/jat.4533", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Pharmacology,Mechanism of Action,Receptor Pharmacology,Emotional Processing,Clinical Trial,Safety,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "PMID:37646119", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1002/jat.4533", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:37646119", "source_url": "https://doi.org/10.1002/jat.4533", "doi": "10.1002/jat.4533", "pmid": "37646119", "publication_date": "2023-08-29", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4784, "title": "Pharmacology and Therapeutic Effects of Psilocybin", "authors": "Xuehan Du", "journal": "Highlights in Science Engineering and Technology", "publication_date": "2023-08-28", "publication_year": 2023, "doi": "10.54097/hset.v65i.11331", "pubmed_id": null, "openalex_id": "https://openalex.org/W4386519663", "source_url": "http://dx.doi.org/10.54097/hset.v65i.11331", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,OCD,Pharmacology,Mechanism of Action,Receptor Pharmacology,Adverse Events,Toxicity", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:45", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "DOI:10.54097/hset.v65i.11331", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.54097/hset.v65i.11331", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.54097/hset.v65i.11331", "source_url": "http://dx.doi.org/10.54097/hset.v65i.11331", "doi": "10.54097/hset.v65i.11331", "pmid": "", "publication_date": "2023-08-28", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1376, "title": "Medical Students' Attitudes and Beliefs Toward Psilocybin: Does Terminology and Personal Experience with Psychedelics Matter?", "authors": "Antonio F. Pagán, Claudia Lex, Jair C. Soares, Thomas D. Meyer", "journal": "Psychedelic Medicine", "publication_date": "2023-08-17", "publication_year": 2023, "doi": "10.1089/psymed.2023.0022", "pubmed_id": "40046569", "openalex_id": "https://openalex.org/W4385987387", "source_url": "https://doi.org/10.1089/psymed.2023.0022", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Observational Study,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "PMID:40046569", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1089/psymed.2023.0022", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:40046569", "source_url": "https://doi.org/10.1089/psymed.2023.0022", "doi": "10.1089/psymed.2023.0022", "pmid": "40046569", "publication_date": "2023-08-17", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1347, "title": "A Proposal to Study the Safety and Efficacy of Psilocybe cubensis in Preclinical and Clinical Studies as a Therapeutic Alternative for Major Depressive Disorder", "authors": "Raúl Escamilla, María Eva González-Trujano, Jesús M. González Mariscal, J. Martı́n Torres-Valencia, Héctor Guzmán-González, José Luis Vega, Anja Loizaga-Velder", "journal": "Journal of Psychoactive Drugs", "publication_date": "2023-08-17", "publication_year": 2023, "doi": "10.1080/02791072.2023.2246459", "pubmed_id": "37594163", "openalex_id": "https://openalex.org/W4385969211", "source_url": "https://doi.org/10.1080/02791072.2023.2246459", "substance_tags": "psilocybin", "topic_tags": "Depression,Pharmacology,Animal Study,Safety,Toxicity", "study_type": "Animal Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "PMID:37594163", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1080/02791072.2023.2246459", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:37594163", "source_url": "https://doi.org/10.1080/02791072.2023.2246459", "doi": "10.1080/02791072.2023.2246459", "pmid": "37594163", "publication_date": "2023-08-17", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1328, "title": "Psilocybin-assisted psychotherapy for treatment-resistant depression: Which psychotherapy?", "authors": "Marie Crowe, Jenni Manuel, Dave Carlyle, Cameron Lacey", "journal": "International Journal of Mental Health Nursing", "publication_date": "2023-08-16", "publication_year": 2023, "doi": "10.1111/inm.13214", "pubmed_id": "37589380", "openalex_id": "https://openalex.org/W4385898071", "source_url": "https://doi.org/10.1111/inm.13214", "substance_tags": "psilocybin", "topic_tags": "Depression,Emotional Processing,Randomized Controlled Trial,Review Article,Treatment-Resistant Depression", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "PMID:37589380", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1111/inm.13214", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:37589380", "source_url": "https://doi.org/10.1111/inm.13214", "doi": "10.1111/inm.13214", "pmid": "37589380", "publication_date": "2023-08-16", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4787, "title": "use of psilocybin in the treatment of psychiatric disorders - review", "authors": "Justyna Woźniak, Rafał BOGACZ, Magdalena Gaik, Ewa URAM, Inga MAGDA, Karol Womperski, Magdalena OSUCH", "journal": "Journal of Education Health and Sport", "publication_date": "2023-08-14", "publication_year": 2023, "doi": "10.12775/jehs.2023.43.01.009", "pubmed_id": null, "openalex_id": "https://openalex.org/W4385645939", "source_url": "https://doi.org/10.12775/jehs.2023.43.01.009", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,OCD,Headache / Migraine,Review Article,Cancer Patients,Treatment-Resistant Depression", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:45", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "DOI:10.12775/jehs.2023.43.01.009", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.12775/jehs.2023.43.01.009", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.12775/jehs.2023.43.01.009", "source_url": "https://doi.org/10.12775/jehs.2023.43.01.009", "doi": "10.12775/jehs.2023.43.01.009", "pmid": "", "publication_date": "2023-08-14", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4786, "title": "Australia Legalizes Psychedelics for Use in Depression, PTSD Therapy", "authors": "Nick Zagorski", "journal": "Psychiatric News", "publication_date": "2023-08-14", "publication_year": 2023, "doi": "10.1176/appi.pn.2023.09.9.20", "pubmed_id": null, "openalex_id": "https://openalex.org/W4385829163", "source_url": "https://doi.org/10.1176/appi.pn.2023.09.9.20", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Mechanism of Action,Consciousness,Clinical Trial,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:45", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "DOI:10.1176/appi.pn.2023.09.9.20", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1176/appi.pn.2023.09.9.20", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1176/appi.pn.2023.09.9.20", "source_url": "https://doi.org/10.1176/appi.pn.2023.09.9.20", "doi": "10.1176/appi.pn.2023.09.9.20", "pmid": "", "publication_date": "2023-08-14", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4788, "title": "Psilocybin's Emerging Role in Combating Depressive Disorder", "authors": "Anna Jaremek, Joanna Kępa, Norbert Kandefer, Michał Wyszkowski, Aleksandra Grabarczyk, Anna Pawlak, Sylwia Grad, Małgorzata Gregorek, Paweł Gregorek", "journal": "Journal of Education Health and Sport", "publication_date": "2023-08-07", "publication_year": 2023, "doi": "10.12775/jehs.2023.40.01.011", "pubmed_id": null, "openalex_id": "https://openalex.org/W4385658334", "source_url": "https://doi.org/10.12775/jehs.2023.40.01.011", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Neuroplasticity,Neurogenesis,Mechanism of Action,Default Mode Network,Aging,Emotional Processing,Clinical Trial,Review Article,Animal Study,Cancer Patients,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:45", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "DOI:10.12775/jehs.2023.40.01.011", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.12775/jehs.2023.40.01.011", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.12775/jehs.2023.40.01.011", "source_url": "https://doi.org/10.12775/jehs.2023.40.01.011", "doi": "10.12775/jehs.2023.40.01.011", "pmid": "", "publication_date": "2023-08-07", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1414, "title": "A Brief Review on the Potential of Psychedelics for Treating Alzheimer's Disease and Related Depression.", "authors": "Pilozzi A, Foster S, Mischoulon D, Fava M, Huang X", "journal": "International journal of molecular sciences", "publication_date": "2023-08-06", "publication_year": 2023, "doi": "10.3390/ijms241512513", "pubmed_id": "37569888", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/37569888/", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Receptor Pharmacology,Microdosing,Review Article,Animal Study", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:20:38", "bibtex": null, "source_record_id": "PMID:37569888", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37569888/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37569888", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37569888/", "doi": "10.3390/ijms241512513", "pmid": "37569888", "publication_date": "2023-08-06", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1348, "title": "Psilocybin-assisted therapy for depression: A systematic review and dose-response meta-analysis of human studies.", "authors": "Perez N, Langlest F, Mallet L, De Pieri M, Sentissi O, Thorens G, Seragnoli F, Zullino D, Kirschner M, Kaiser S, Solmi M, Sabé M.", "journal": null, "publication_date": "2023-08-06", "publication_year": 2023, "doi": "10.1016/j.euroneuro.2023.07.011", "pubmed_id": "37557019", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.euroneuro.2023.07.011", "substance_tags": "psilocybin", "topic_tags": "Depression,Headache / Migraine,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Treatment-Resistant Depression,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:02", "bibtex": null, "source_record_id": "PMID:37557019", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.euroneuro.2023.07.011", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:37557019", "source_url": "https://doi.org/10.1016/j.euroneuro.2023.07.011", "doi": "10.1016/j.euroneuro.2023.07.011", "pmid": "37557019", "publication_date": "2023-08-06", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4789, "title": "Psilocybin und Funktionalität bei Depression", "authors": "Moritz Spangemacher", "journal": "InFo Neurologie + Psychiatrie", "publication_date": "2023-07-31", "publication_year": 2023, "doi": "10.1007/s15005-023-3336-2", "pubmed_id": null, "openalex_id": "https://openalex.org/W4386013106", "source_url": "http://dx.doi.org/10.1007/s15005-023-3336-2", "substance_tags": "psilocybin", "topic_tags": "Depression", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:45", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "DOI:10.1007/s15005-023-3336-2", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1007/s15005-023-3336-2", "source_url": "http://dx.doi.org/10.1007/s15005-023-3336-2", "doi": "10.1007/s15005-023-3336-2", "pmid": "", "publication_date": "2023-07-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1420, "title": "Psychedelic medicines for end-of-life care: Pipeline clinical trial review 2022.", "authors": "Jing X, Hoeh NR, Menkes DB.", "journal": null, "publication_date": "2023-07-31", "publication_year": 2023, "doi": "10.1017/s147895152300069x", "pubmed_id": "37334486", "openalex_id": null, "source_url": "https://doi.org/10.1017/s147895152300069x", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Microdosing,Clinical Trial,Randomized Controlled Trial,Review Article,Safety", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:05", "bibtex": null, "source_record_id": "PMID:37334486", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1017/s147895152300069x", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:37334486", "source_url": "https://doi.org/10.1017/s147895152300069x", "doi": "10.1017/s147895152300069x", "pmid": "37334486", "publication_date": "2023-07-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1413, "title": "Psychedelic drugs in the treatment of psychiatric disorders.", "authors": "Ibrahim IB, Videbech P, Straszek SPV.", "journal": null, "publication_date": "2023-07-31", "publication_year": 2023, "doi": null, "pubmed_id": "37615227", "openalex_id": null, "source_url": "https://europepmc.org/article/MED/37615227", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Clinical Trial,Randomized Controlled Trial,Review Article,Cancer Patients,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:03", "bibtex": null, "source_record_id": "PMID:37615227", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://europepmc.org/article/MED/37615227", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:37615227", "source_url": "https://europepmc.org/article/MED/37615227", "doi": "", "pmid": "37615227", "publication_date": "2023-07-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3519, "title": "The Efficacy and Tolerability of Psilocybin in Participants With Treatment-Resistant Depression: a Phase 2, Randomized Feasibility Study", "authors": "Brain and Cognition Discovery Foundation", "journal": "ClinicalTrials.gov", "publication_date": "2023-07-26", "publication_year": 2023, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05029466", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Treatment-Resistant Depression,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05029466", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05029466", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05029466", "source_url": "https://clinicaltrials.gov/study/NCT05029466", "doi": "", "pmid": "", "publication_date": "2023-07-26", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1391, "title": "Natural psychedelics in the treatment of depression; a review focusing on neurotransmitters.", "authors": "Jahanabadi S, Amiri S, Karkeh-Abadi M, Razmi A.", "journal": null, "publication_date": "2023-07-22", "publication_year": 2023, "doi": "10.1016/j.fitote.2023.105620", "pubmed_id": "37490982", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.fitote.2023.105620", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Mechanism of Action,Review Article", "study_type": "Review Article", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:01", "bibtex": null, "source_record_id": "PMID:37490982", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.fitote.2023.105620", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:37490982", "source_url": "https://doi.org/10.1016/j.fitote.2023.105620", "doi": "10.1016/j.fitote.2023.105620", "pmid": "37490982", "publication_date": "2023-07-22", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1390, "title": "Assessing the risk of symptom worsening in psilocybin-assisted therapy for depression: A systematic review and individual participant data meta-analysis.", "authors": "Simonsson O, Carlbring P, Carhart-Harris R, Davis AK, Nutt DJ, Griffiths RR, Erritzoe D, Goldberg SB.", "journal": null, "publication_date": "2023-07-22", "publication_year": 2023, "doi": "10.1016/j.psychres.2023.115349", "pubmed_id": "37523886", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.psychres.2023.115349", "substance_tags": "psilocybin", "topic_tags": "Depression,Meta-Analysis,Systematic Review,Review Article,Safety", "study_type": "Meta-Analysis", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:01", "bibtex": null, "source_record_id": "PMID:37523886", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.psychres.2023.115349", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:37523886", "source_url": "https://doi.org/10.1016/j.psychres.2023.115349", "doi": "10.1016/j.psychres.2023.115349", "pmid": "37523886", "publication_date": "2023-07-22", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3382, "title": "Improvement in Depression Symptoms Measured by Montgomery-Åsberg Depression Rating Scale and Quick Inventory of Depressive Symptomatology-Self Rated Items after Randomised Double-blind COMP360 Psilocybin Therapy for Treatment-resistant Depression", "authors": "Goodwin G, Marwood L, Mistry S, Nowakowska A, Simmons H, Tsai J, Williams S, Young M, Malievskaia E.", "journal": null, "publication_date": "2023-07-18", "publication_year": 2023, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://europepmc.org/article/PMC/PMC10595939", "substance_tags": "psilocybin", "topic_tags": "Depression,Treatment-Resistant Depression", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 11:03:52", "last_checked": "2026-07-01 11:22:06", "bibtex": null, "source_record_id": "https://europepmc.org/article/PMC/PMC10595939", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "https://europepmc.org/article/PMC/PMC10595939", "source_url": "https://europepmc.org/article/PMC/PMC10595939", "doi": "", "pmid": "", "publication_date": "2023-07-18", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3349, "title": "Psychedelics for depression: from neurobiology to treatment", "authors": "Kuypers K.", "journal": null, "publication_date": "2023-07-18", "publication_year": 2023, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://europepmc.org/article/PMC/PMC10417770", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 11:03:51", "last_checked": "2026-07-01 11:22:05", "bibtex": null, "source_record_id": "https://europepmc.org/article/PMC/PMC10417770", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://europepmc.org/article/PMC/PMC10417770", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "https://europepmc.org/article/PMC/PMC10417770", "source_url": "https://europepmc.org/article/PMC/PMC10417770", "doi": "", "pmid": "", "publication_date": "2023-07-18", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3310, "title": "The therapeutic potential of psilocybin in depression resistant to psychotropic drugs", "authors": "Ramírez González J, Fernández Márquez I, Ferreiro González S, Ruíz E.", "journal": null, "publication_date": "2023-07-18", "publication_year": 2023, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://europepmc.org/article/PMC/PMC10479004", "substance_tags": "psilocybin", "topic_tags": "Depression", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 11:03:50", "last_checked": "2026-07-01 11:22:04", "bibtex": null, "source_record_id": "https://europepmc.org/article/PMC/PMC10479004", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "https://europepmc.org/article/PMC/PMC10479004", "source_url": "https://europepmc.org/article/PMC/PMC10479004", "doi": "", "pmid": "", "publication_date": "2023-07-18", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3146, "title": "Systematic Review on the Mechanisms of Action of Psilocybin in the Treatment of Depression", "authors": "Lin M, Lee H, Tsang V, Chai B, Howard A, Uy C, Elefante J.", "journal": null, "publication_date": "2023-07-18", "publication_year": 2023, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://europepmc.org/article/PMC/PMC10434693", "substance_tags": "psilocybin", "topic_tags": "Depression,Neuroplasticity,Neurogenesis,Mechanism of Action,Receptor Pharmacology,Systematic Review,Review Article,Animal Study", "study_type": "Systematic Review", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 11:03:47", "last_checked": "2026-07-01 11:22:01", "bibtex": null, "source_record_id": "https://europepmc.org/article/PMC/PMC10434693", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://europepmc.org/article/PMC/PMC10434693", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "https://europepmc.org/article/PMC/PMC10434693", "source_url": "https://europepmc.org/article/PMC/PMC10434693", "doi": "", "pmid": "", "publication_date": "2023-07-18", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1293, "title": "Personality Change in a Trial of Psilocybin Therapy vs Escitalopram Treatment for Depression - CORRIGENDUM.", "authors": "Weiss B, Ginige I, Shannon L, Giribaldi B, Murphy-Beiner A, Murphy R, Baker-Jones M, Martell J, Nutt DJ, Carhart-Harris RL, Erritzoe D.", "journal": null, "publication_date": "2023-07-18", "publication_year": 2023, "doi": "10.1017/s0033291723002039", "pubmed_id": "37466289", "openalex_id": null, "source_url": "https://doi.org/10.1017/s0033291723002039", "substance_tags": "psilocybin", "topic_tags": "Depression,Personality Change", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:05", "bibtex": null, "source_record_id": "PMID:37466289", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:37466289", "source_url": "https://doi.org/10.1017/s0033291723002039", "doi": "10.1017/s0033291723002039", "pmid": "37466289", "publication_date": "2023-07-18", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4792, "title": "Imprinting: expanding the extra-pharmacological model of psychedelic drug action to incorporate delayed influences of sets and settings", "authors": "Nicolas Garel, Julien Thibault Lévesque, Dasha A. Sandra, Justin Lessard-Wajcer, Elizaveta Solomonova, Michael Lifshitz, Stéphane Richard-Devantoy, Kyle T. Greenway", "journal": "Frontiers in Human Neuroscience", "publication_date": "2023-07-17", "publication_year": 2023, "doi": "10.3389/fnhum.2023.1200393", "pubmed_id": "37533588", "openalex_id": "https://openalex.org/W4384695430", "source_url": "https://doi.org/10.3389/fnhum.2023.1200393", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Receptor Pharmacology,Emotional Processing,Mystical Experience,Clinical Trial,Review Article,Treatment-Resistant Depression,Healthcare Workers,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:45", "last_checked": "2026-07-04 06:34:45", "bibtex": null, "source_record_id": "PMID:37533588", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.3389/fnhum.2023.1200393", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:37533588", "source_url": "https://doi.org/10.3389/fnhum.2023.1200393", "doi": "10.3389/fnhum.2023.1200393", "pmid": "37533588", "publication_date": "2023-07-17", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1415, "title": "Psilocybin-assisted psychotherapy for cancer-related anxiety and depression", "authors": "Dan Yaniv, Lois M. Ramondetta, Lorenzo Cohen, Moran Amit", "journal": "International Journal of Gynecological Cancer", "publication_date": "2023-07-17", "publication_year": 2023, "doi": "10.1136/ijgc-2023-004659", "pubmed_id": "37463745", "openalex_id": "https://openalex.org/W4384661659", "source_url": "https://doi.org/10.1136/ijgc-2023-004659", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Cancer Patients", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "PMID:37463745", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:37463745", "source_url": "https://doi.org/10.1136/ijgc-2023-004659", "doi": "10.1136/ijgc-2023-004659", "pmid": "37463745", "publication_date": "2023-07-17", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1393, "title": "Psilocybin for treatment resistant depression in patients taking a concomitant SSRI medication", "authors": "Guy M. Goodwin, Megan Croal, David Feifel, John R. Kelly, Lindsey Marwood, Sunil Mistry, Veronica O’Keane, Stéphanie Knatz Peck, Hollie Simmons, Claudia Sisa, S. C. Stansfield, Joyce Tsai, Sam Williams, Ekaterina Malievskaia", "journal": "Neuropsychopharmacology", "publication_date": "2023-07-12", "publication_year": 2023, "doi": "10.1038/s41386-023-01648-7", "pubmed_id": "37443386", "openalex_id": "https://openalex.org/W4384130479", "source_url": "https://doi.org/10.1038/s41386-023-01648-7", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Receptor Pharmacology,Clinical Trial,Treatment-Resistant Depression,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "PMID:37443386", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1038/s41386-023-01648-7", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:37443386", "source_url": "https://doi.org/10.1038/s41386-023-01648-7", "doi": "10.1038/s41386-023-01648-7", "pmid": "37443386", "publication_date": "2023-07-12", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1431, "title": "Australia’s approval of MDMA and psilocybin for PTSD and depression is premature, say critics", "authors": "Bianca Nogrady", "journal": "BMJ", "publication_date": "2023-07-10", "publication_year": 2023, "doi": "10.1136/bmj.p1599", "pubmed_id": "37433614", "openalex_id": "https://openalex.org/W4383874233", "source_url": "https://doi.org/10.1136/bmj.p1599", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "PMID:37433614", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:37433614", "source_url": "https://doi.org/10.1136/bmj.p1599", "doi": "10.1136/bmj.p1599", "pmid": "37433614", "publication_date": "2023-07-10", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1156, "title": "Ethopharmacological evaluation of antidepressant-like effect of serotonergic psychedelics in C57BL/6J male mice", "authors": "Takaba R, Ibi D, Yoshida K, Hosomi E, Kawase R, Kitagawa H, Goto H, Achiwa M, Mizutani K, Maede K, González-Maeso J, Kitagaki S, Hiramatsu M.", "journal": "Research Square", "publication_date": "2023-07-06", "publication_year": 2023, "doi": "10.21203/rs.3.rs-3138705/v1", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.21203/rs.3.rs-3138705/v1", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Anxiety,Receptor Pharmacology,Animal Study", "study_type": "Animal Study", "source_name": "Europe PMC", "publication_status": "preprint", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:01", "bibtex": null, "source_record_id": "DOI:10.21203/rs.3.rs-3138705/v1", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.21203/rs.3.rs-3138705/v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "DOI:10.21203/rs.3.rs-3138705/v1", "source_url": "https://doi.org/10.21203/rs.3.rs-3138705/v1", "doi": "10.21203/rs.3.rs-3138705/v1", "pmid": "", "publication_date": "2023-07-06", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3755, "title": "Psychoactive substances in psychotherapy - A vision for the future? - A systematic review on Psilocybin", "authors": "Tetem J, Fischmann T, Möller TJ.", "journal": "PsyArXiv", "publication_date": "2023-07-05", "publication_year": 2023, "doi": "10.31234/osf.io/ztyxh", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.31234/osf.io/ztyxh", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,End-of-Life Distress,Systematic Review,Review Article,Treatment-Resistant Depression,Safety,Adverse Events", "study_type": "Systematic Review", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:10:19", "last_checked": "2026-07-01 11:22:01", "bibtex": null, "source_record_id": "DOI:10.31234/osf.io/ztyxh", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://doi.org/10.31234/osf.io/ztyxh", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "DOI:10.31234/osf.io/ztyxh", "source_url": "https://doi.org/10.31234/osf.io/ztyxh", "doi": "10.31234/osf.io/ztyxh", "pmid": "", "publication_date": "2023-07-05", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3449, "title": "Evaluating the Effect of Length of Time on Selective Serotonin Reuptake Inhibitors (SSRIs) on the Response to Psilocybin-assisted Therapy in Individuals With Mild-moderate Major Depressive Disorder (MDD)", "authors": "Cybin Therapeutics Inc.", "journal": "ClinicalTrials.gov", "publication_date": "2023-07-05", "publication_year": 2023, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05594667", "substance_tags": "psilocybin", "topic_tags": "Depression,Receptor Pharmacology", "study_type": "Other", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05594667", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05594667", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05594667", "source_url": "https://clinicaltrials.gov/study/NCT05594667", "doi": "", "pmid": "", "publication_date": "2023-07-05", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3161, "title": "Psychoactive substances in psychotherapy - A vision for the future? - A systematic review on Psilocybin", "authors": "", "journal": "PsyArXiv", "publication_date": "2023-07-05", "publication_year": 2023, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://osf.io/preprints/psyarxiv/ztyxh_v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,End-of-Life Distress,Systematic Review,Review Article,Treatment-Resistant Depression,Safety,Adverse Events", "study_type": "Systematic Review", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:47", "last_checked": "2026-07-01 11:22:30", "bibtex": null, "source_record_id": "https://osf.io/preprints/psyarxiv/ztyxh_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/ztyxh_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "https://osf.io/preprints/psyarxiv/ztyxh_v1", "source_url": "https://osf.io/preprints/psyarxiv/ztyxh_v1", "doi": "", "pmid": "", "publication_date": "2023-07-05", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1438, "title": "Risk of bias in randomized clinical trials on psychedelic medicine: A systematic review.", "authors": "Hovmand OR, Poulsen ED, Arnfred S, Storebø OJ.", "journal": null, "publication_date": "2023-07-03", "publication_year": 2023, "doi": "10.1177/02698811231180276", "pubmed_id": "37403379", "openalex_id": null, "source_url": "https://doi.org/10.1177/02698811231180276", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,OCD,Clinical Trial,Randomized Controlled Trial,Systematic Review,Review Article,Healthcare Workers,Safety", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:05", "bibtex": null, "source_record_id": "PMID:37403379", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1177/02698811231180276", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:37403379", "source_url": "https://doi.org/10.1177/02698811231180276", "doi": "10.1177/02698811231180276", "pmid": "37403379", "publication_date": "2023-07-03", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1434, "title": "Assessing potential of psilocybin for depressive disorders.", "authors": "Kozak Z, Johnson MW, Aaronson ST.", "journal": null, "publication_date": "2023-06-30", "publication_year": 2023, "doi": "10.1080/13543784.2023.2273493", "pubmed_id": "37869790", "openalex_id": null, "source_url": "https://doi.org/10.1080/13543784.2023.2273493", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Clinical Trial,Review Article,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:01", "bibtex": null, "source_record_id": "PMID:37869790", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1080/13543784.2023.2273493", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:37869790", "source_url": "https://doi.org/10.1080/13543784.2023.2273493", "doi": "10.1080/13543784.2023.2273493", "pmid": "37869790", "publication_date": "2023-06-30", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1427, "title": "Psilocybin for treatment-resistant depression without psychedelic effects: study protocol for a 4-week, double-blind, proof-of-concept randomised controlled trial", "authors": "Muhammad Ishrat Husain, Daniel M. Blumberger, David Castle, Nicole Ledwos, Elise Fellows, Brett D. M. Jones, Abigail Ortiz, Stefan Kloiber, Wei Wang, Joshua D. Rosenblat, Benoit H. Mulsant", "journal": "BJPsych Open", "publication_date": "2023-06-30", "publication_year": 2023, "doi": "10.1192/bjo.2023.535", "pubmed_id": "37489299", "openalex_id": "https://openalex.org/W4385230722", "source_url": "https://doi.org/10.1192/bjo.2023.535", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Chronic Pain,Pharmacology,Receptor Pharmacology,Consciousness,Randomized Controlled Trial,Animal Study,Treatment-Resistant Depression,Safety,Adverse Events,Toxicity", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "PMID:37489299", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1192/bjo.2023.535", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:37489299", "source_url": "https://doi.org/10.1192/bjo.2023.535", "doi": "10.1192/bjo.2023.535", "pmid": "37489299", "publication_date": "2023-06-30", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1441, "title": "Australia to prescribe MDMA and psilocybin for PTSD and depression in world first", "authors": "Rich Haridy", "journal": "Nature", "publication_date": "2023-06-29", "publication_year": 2023, "doi": "10.1038/d41586-023-02093-8", "pubmed_id": "37386185", "openalex_id": "https://openalex.org/W4382515410", "source_url": "https://doi.org/10.1038/d41586-023-02093-8", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Toxicity", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "PMID:37386185", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:37386185", "source_url": "https://doi.org/10.1038/d41586-023-02093-8", "doi": "10.1038/d41586-023-02093-8", "pmid": "37386185", "publication_date": "2023-06-29", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1440, "title": "Sub-acute effects of psilocybin on EEG correlates of neural plasticity in major depression: Relationship to symptoms", "authors": "Patrick D. Skosnik, Jordan Sloshower, Hamideh Safi-Aghdam, Surbhi Pathania, Shariful A. Syed, Brian Pittman, Deepak Cyril D’Souza", "journal": "Journal of Psychopharmacology", "publication_date": "2023-06-29", "publication_year": 2023, "doi": "10.1177/02698811231179800", "pubmed_id": "37392016", "openalex_id": "https://openalex.org/W4382776629", "source_url": "https://doi.org/10.1177/02698811231179800", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Neuroplasticity,Brain Imaging,Mechanism of Action,Biomarkers,Toxicity", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "PMID:37392016", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1177/02698811231179800", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:37392016", "source_url": "https://doi.org/10.1177/02698811231179800", "doi": "10.1177/02698811231179800", "pmid": "37392016", "publication_date": "2023-06-29", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1394, "title": "Clinical specificity profile for novel rapid acting antidepressant drugs.", "authors": "Scala M, Fanelli G, De Ronchi D, Serretti A, Fabbri C.", "journal": null, "publication_date": "2023-06-29", "publication_year": 2023, "doi": "10.1097/yic.0000000000000488", "pubmed_id": "37381161", "openalex_id": null, "source_url": "https://doi.org/10.1097/yic.0000000000000488", "substance_tags": "psilocybin", "topic_tags": "Depression,Pharmacology,Mechanism of Action,Receptor Pharmacology,Review Article,Healthcare Workers,Safety,Adverse Events", "study_type": "Review Article", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:05", "bibtex": null, "source_record_id": "PMID:37381161", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1097/yic.0000000000000488", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:37381161", "source_url": "https://doi.org/10.1097/yic.0000000000000488", "doi": "10.1097/yic.0000000000000488", "pmid": "37381161", "publication_date": "2023-06-29", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3538, "title": "Investigating the Therapeutic Effects of Psilocybin in Treatment-Resistant Post-Traumatic Stress Disorder", "authors": "Halucenex Life Sciences Inc.", "journal": "ClinicalTrials.gov", "publication_date": "2023-06-28", "publication_year": 2023, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05243329", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Neuroplasticity,Neurogenesis,Receptor Pharmacology,Clinical Trial,Animal Study,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05243329", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05243329", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05243329", "source_url": "https://clinicaltrials.gov/study/NCT05243329", "doi": "", "pmid": "", "publication_date": "2023-06-28", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1098, "title": "Psilocybin's Potential Mechanisms in the Treatment of Depression: A Systematic Review.", "authors": "Lee HJ, Tsang VW, Chai BS, Lin MC, Howard A, Uy C, Elefante JO.", "journal": null, "publication_date": "2023-06-28", "publication_year": 2023, "doi": "10.1080/02791072.2023.2223195", "pubmed_id": "37385217", "openalex_id": null, "source_url": "https://doi.org/10.1080/02791072.2023.2223195", "substance_tags": "psilocybin", "topic_tags": "Depression,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Systematic Review,Review Article", "study_type": "Systematic Review", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:04", "bibtex": null, "source_record_id": "PMID:37385217", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1080/02791072.2023.2223195", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:37385217", "source_url": "https://doi.org/10.1080/02791072.2023.2223195", "doi": "10.1080/02791072.2023.2223195", "pmid": "37385217", "publication_date": "2023-06-28", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4803, "title": "Experts Offer Tips on Talking With Patients About Psychedelics", "authors": "Terri D’Arrigo", "journal": "Psychiatric News", "publication_date": "2023-06-27", "publication_year": 2023, "doi": "10.1176/appi.pn.2023.07.7.51", "pubmed_id": null, "openalex_id": "https://openalex.org/W4382360061", "source_url": "https://doi.org/10.1176/appi.pn.2023.07.7.51", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Mechanism of Action,Receptor Pharmacology,Emotional Processing,Clinical Trial,Veterans,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:45", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "DOI:10.1176/appi.pn.2023.07.7.51", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1176/appi.pn.2023.07.7.51", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1176/appi.pn.2023.07.7.51", "source_url": "https://doi.org/10.1176/appi.pn.2023.07.7.51", "doi": "10.1176/appi.pn.2023.07.7.51", "pmid": "", "publication_date": "2023-06-27", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1459, "title": "Psychedelics, Meaningfulness, and the “Proper Scope” of Medicine: Continuing the Conversation", "authors": "Katherine Cheung, Kyle Patch, Brian D. Earp, David B. Yaden", "journal": "Cambridge Quarterly of Healthcare Ethics", "publication_date": "2023-06-26", "publication_year": 2023, "doi": "10.1017/s0963180123000270", "pubmed_id": "37366110", "openalex_id": "https://openalex.org/W4382182909", "source_url": "https://doi.org/10.1017/s0963180123000270", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Consciousness", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "PMID:37366110", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1017/s0963180123000270", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:37366110", "source_url": "https://doi.org/10.1017/s0963180123000270", "doi": "10.1017/s0963180123000270", "pmid": "37366110", "publication_date": "2023-06-26", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1460, "title": "Changes in synaptic markers after administration of ketamine or psychedelics: a systematic scoping review", "authors": "Simon Zhornitsky, Henrique Nunes Pereira Oliva, Laura A. Jayne, AZA Stephen Allsop, Alfred P. Kaye, Marc N. Potenza, Gustavo A. Angarita", "journal": "Frontiers in Psychiatry", "publication_date": "2023-06-25", "publication_year": 2023, "doi": "10.3389/fpsyt.2023.1197890", "pubmed_id": "37435405", "openalex_id": "https://openalex.org/W4382141215", "source_url": "https://doi.org/10.3389/fpsyt.2023.1197890", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Addiction,Neuroplasticity,Receptor Pharmacology,Biomarkers,Review Article,Animal Study,Toxicity,Abuse Liability", "study_type": "Review Article", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "PMID:37435405", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.3389/fpsyt.2023.1197890", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:37435405", "source_url": "https://doi.org/10.3389/fpsyt.2023.1197890", "doi": "10.3389/fpsyt.2023.1197890", "pmid": "37435405", "publication_date": "2023-06-25", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1418, "title": "Molecular mechanisms of rapid-acting antidepressants: New perspectives for developing antidepressants.", "authors": "Chen T, Cheng L, Ma J, Yuan J, Pi C, Xiong L, Chen J, Liu H, Tang J, Zhong Y, Zhang X, Liu Z, Zuo Y, Shen H, Wei Y, Zhao L.", "journal": null, "publication_date": "2023-06-25", "publication_year": 2023, "doi": "10.1016/j.phrs.2023.106837", "pubmed_id": "37379962", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.phrs.2023.106837", "substance_tags": "psilocybin", "topic_tags": "Depression,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Review Article,Animal Study", "study_type": "Review Article", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:04", "bibtex": null, "source_record_id": "PMID:37379962", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.phrs.2023.106837", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:37379962", "source_url": "https://doi.org/10.1016/j.phrs.2023.106837", "doi": "10.1016/j.phrs.2023.106837", "pmid": "37379962", "publication_date": "2023-06-25", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4805, "title": "Psychedelics reopen the social reward learning critical period", "authors": "Romain Nardou, Edward J. Sawyer, Young Jun Song, M. F. Wilkinson, Yasmin Padovan-Hernandez, Júnia L. de Deus, Noelle Wright, Carine Lama, Sehr Faltin, Loyal A. Goff, Genevieve Stein-O’Brien, Gül Dölen", "journal": "Nature", "publication_date": "2023-06-13", "publication_year": 2023, "doi": "10.1038/s41586-023-06204-3", "pubmed_id": "37316665", "openalex_id": "https://openalex.org/W4380684709", "source_url": "https://doi.org/10.1038/s41586-023-06204-3", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Receptor Pharmacology,Consciousness,Spirituality,Animal Study", "study_type": "Animal Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:45", "last_checked": "2026-07-04 06:34:45", "bibtex": null, "source_record_id": "PMID:37316665", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1038/s41586-023-06204-3", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:37316665", "source_url": "https://doi.org/10.1038/s41586-023-06204-3", "doi": "10.1038/s41586-023-06204-3", "pmid": "37316665", "publication_date": "2023-06-13", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4806, "title": "A regulatory framework review of Schedule I psychedelics in the United States", "authors": "Kevin Herkenham", "journal": "JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY", "publication_date": "2023-06-11", "publication_year": 2023, "doi": "10.1002/jac5.1841", "pubmed_id": null, "openalex_id": "https://openalex.org/W4380357539", "source_url": "https://doi.org/10.1002/jac5.1841", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Review Article,Healthcare Workers,Safety,Toxicity", "study_type": "Review Article", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:45", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "DOI:10.1002/jac5.1841", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1002/jac5.1841", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1002/jac5.1841", "source_url": "https://doi.org/10.1002/jac5.1841", "doi": "10.1002/jac5.1841", "pmid": "", "publication_date": "2023-06-11", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3771, "title": "Self-treatment of parental neglect-induced mixed anxiety and depressive disorder with psilocybin - A retrospective case study", "authors": "Turkia M.", "journal": "PsyArXiv", "publication_date": "2023-06-08", "publication_year": 2023, "doi": "10.31234/osf.io/qyce5", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.31234/osf.io/qyce5", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Emotional Processing", "study_type": "Other", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:10:20", "last_checked": "2026-07-01 11:22:02", "bibtex": null, "source_record_id": "DOI:10.31234/osf.io/qyce5", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://doi.org/10.31234/osf.io/qyce5", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "DOI:10.31234/osf.io/qyce5", "source_url": "https://doi.org/10.31234/osf.io/qyce5", "doi": "10.31234/osf.io/qyce5", "pmid": "", "publication_date": "2023-06-08", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3387, "title": "The treatment of abandonment anxiety with MDMA and LSD", "authors": "", "journal": "PsyArXiv", "publication_date": "2023-06-08", "publication_year": 2023, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://osf.io/preprints/psyarxiv/pw2tf_v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Emotional Processing", "study_type": "Other", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:52", "last_checked": "2026-07-01 11:22:30", "bibtex": null, "source_record_id": "https://osf.io/preprints/psyarxiv/pw2tf_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/pw2tf_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "https://osf.io/preprints/psyarxiv/pw2tf_v1", "source_url": "https://osf.io/preprints/psyarxiv/pw2tf_v1", "doi": "", "pmid": "", "publication_date": "2023-06-08", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3229, "title": "Self-treatment of parental neglect-induced mixed anxiety and depressive disorder with psilocybin - A retrospective case study", "authors": "", "journal": "PsyArXiv", "publication_date": "2023-06-08", "publication_year": 2023, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://osf.io/preprints/psyarxiv/qyce5_v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Emotional Processing", "study_type": "Other", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:48", "last_checked": "2026-07-01 11:22:30", "bibtex": null, "source_record_id": "https://osf.io/preprints/psyarxiv/qyce5_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/qyce5_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "https://osf.io/preprints/psyarxiv/qyce5_v1", "source_url": "https://osf.io/preprints/psyarxiv/qyce5_v1", "doi": "", "pmid": "", "publication_date": "2023-06-08", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1468, "title": "No trip needed for psychedelics to lift mood?", "authors": "O'Grady C.", "journal": null, "publication_date": "2023-06-07", "publication_year": 2023, "doi": "10.1126/science.adj1031", "pubmed_id": "37289868", "openalex_id": "https://openalex.org/W4379792537", "source_url": "https://doi.org/10.1126/science.adj1031", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Receptor Pharmacology,Animal Study", "study_type": "Animal Study", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:03", "bibtex": null, "source_record_id": "PMID:37289868", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1126/science.adj1031", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:37289868", "source_url": "https://doi.org/10.1126/science.adj1031", "doi": "10.1126/science.adj1031", "pmid": "37289868", "publication_date": "2023-06-07", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1443, "title": "Attenuation of psilocybin mushroom effects during and after SSRI/SNRI antidepressant use", "authors": "Natalie Gukasyan, Roland R. Griffiths, David B. Yaden, Denis Antoine, Sandeep M. Nayak", "journal": "Journal of Psychopharmacology", "publication_date": "2023-06-07", "publication_year": 2023, "doi": "10.1177/02698811231179910", "pubmed_id": "37291890", "openalex_id": "https://openalex.org/W4379967727", "source_url": "https://doi.org/10.1177/02698811231179910", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Chronic Pain,Pharmacology,Receptor Pharmacology,Observational Study,Toxicity", "study_type": "Observational Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "PMID:37291890", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1177/02698811231179910", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:37291890", "source_url": "https://doi.org/10.1177/02698811231179910", "doi": "10.1177/02698811231179910", "pmid": "37291890", "publication_date": "2023-06-07", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3153, "title": "Reduced brain responsiveness to emotional stimuli with escitalopram but not psilocybin therapy for depression", "authors": "Wall MB, Demetriou L, Giribaldi B, Roseman L, Ertl N, Erritzoe D, Nutt DJ, Carhart-Harris RL.", "journal": "medRxiv", "publication_date": "2023-06-02", "publication_year": 2023, "doi": "10.1101/2023.05.29.23290667", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.1101/2023.05.29.23290667", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging,Receptor Pharmacology,Biomarkers,Aging,Emotional Processing,Drug Interactions", "study_type": "Other", "source_name": "medRxiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:47", "last_checked": "2026-07-01 11:22:01", "bibtex": null, "source_record_id": "DOI:10.1101/2023.05.29.23290667", "abstract_available": true, "abstract_source": "medRxiv", "abstract_source_url": "https://doi.org/10.1101/2023.05.29.23290667", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "medRxiv", "source_record_id": "DOI:10.1101/2023.05.29.23290667", "source_url": "https://doi.org/10.1101/2023.05.29.23290667", "doi": "10.1101/2023.05.29.23290667", "pmid": "", "publication_date": "2023-06-02", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4808, "title": "Psilocybin therapy: A novel approach to treating depression", "authors": "Tooba Noor, Areej Shakil, Aimen Waqar Khan, Syeda Mahrukh Fatima Zaidi, Hussain Sohail Rangwala, Burhanuddin Sohail Rangwala", "journal": "International Journal of Surgery Global Health", "publication_date": "2023-06-01", "publication_year": 2023, "doi": "10.1097/gh9.0000000000000175", "pubmed_id": null, "openalex_id": "https://openalex.org/W4379142909", "source_url": "http://dx.doi.org/10.1097/gh9.0000000000000175", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Anxiety,Addiction,Headache / Migraine,Brain Imaging,Pharmacology,Receptor Pharmacology,Default Mode Network,Consciousness,Aging,Wellbeing,Emotional Processing,Clinical Trial,Review Article,Adolescents,Treatment-Resistant Depression,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:46", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "DOI:10.1097/gh9.0000000000000175", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.1097/gh9.0000000000000175", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1097/gh9.0000000000000175", "source_url": "http://dx.doi.org/10.1097/gh9.0000000000000175", "doi": "10.1097/gh9.0000000000000175", "pmid": "", "publication_date": "2023-06-01", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1330, "title": "Cost-effectiveness of psilocybin-assisted therapy for severe depression: exploratory findings from a decision analytic model", "authors": "Paul McCrone, Henry Fisher, Clare Knight, Rebecca Harding, Anne Katrin Schlag, David Nutt, Joanna C. Neill", "journal": "Psychological Medicine", "publication_date": "2023-06-01", "publication_year": 2023, "doi": "10.1017/s0033291723001411", "pubmed_id": "37264950", "openalex_id": "https://openalex.org/W4379095570", "source_url": "https://doi.org/10.1017/s0033291723001411", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Toxicity", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "PMID:37264950", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1017/s0033291723001411", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:37264950", "source_url": "https://doi.org/10.1017/s0033291723001411", "doi": "10.1017/s0033291723001411", "pmid": "37264950", "publication_date": "2023-06-01", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1295, "title": "Personality change in a trial of psilocybin therapy v. escitalopram treatment for depression", "authors": "Brandon Weiss, Induni Ginige, Lu Shannon, Bruna Giribaldi, Ashleigh Murphy-Beiner, Roberta Murphy, Michelle Baker-Jones, Jonny Martell, David Nutt, Robin Carhart-Harris, David Erritzøe", "journal": "Psychological Medicine", "publication_date": "2023-06-01", "publication_year": 2023, "doi": "10.1017/s0033291723001514", "pubmed_id": "37264814", "openalex_id": "https://openalex.org/W4379093876", "source_url": "https://doi.org/10.1017/s0033291723001514", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Receptor Pharmacology,Personality Change,Clinical Trial", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "PMID:37264814", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1017/s0033291723001514", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:37264814", "source_url": "https://doi.org/10.1017/s0033291723001514", "doi": "10.1017/s0033291723001514", "pmid": "37264814", "publication_date": "2023-06-01", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4810, "title": "Long term efficacy of psilocybin in patients with cancer and major depressive disorder (MDD).", "authors": "Manish Agrawal, Sarah Shnayder, Heather Honstein, Ezekiel Emanuel, Paul Thambi", "journal": "Journal of Clinical Oncology", "publication_date": "2023-05-31", "publication_year": 2023, "doi": "10.1200/jco.2023.41.16_suppl.12021", "pubmed_id": null, "openalex_id": "https://openalex.org/W4379281082", "source_url": "http://dx.doi.org/10.1200/jco.2023.41.16_suppl.12021", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Observational Study,Cancer Patients", "study_type": "Observational Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:46", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "DOI:10.1200/jco.2023.41.16_suppl.12021", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.1200/jco.2023.41.16_suppl.12021", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1200/jco.2023.41.16_suppl.12021", "source_url": "http://dx.doi.org/10.1200/jco.2023.41.16_suppl.12021", "doi": "10.1200/jco.2023.41.16_suppl.12021", "pmid": "", "publication_date": "2023-05-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1466, "title": "Examining the Rationale for Studying Psychedelic-Assisted Psychotherapy for the Treatment of Caregiver Distress.", "authors": "Gold ND, Podrebarac SK, White LA, Marini C, Simon NM, Mittelman MS, Ross S, Bogenschutz MP, Petridis PD", "journal": "Psychedelic medicine (New Rochelle, N.Y.)", "publication_date": "2023-05-31", "publication_year": 2023, "doi": "10.1089/psymed.2022.0011", "pubmed_id": "40046728", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/40046728/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Spirituality,Clinical Trial,Review Article,Cancer Patients,Safety,Inflammation", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:20:38", "bibtex": null, "source_record_id": "PMID:40046728", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40046728/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40046728", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40046728/", "doi": "10.1089/psymed.2022.0011", "pmid": "40046728", "publication_date": "2023-05-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1194, "title": "Ethical considerations for psychedelic-assisted therapy in military clinical settings", "authors": "Scott Hoener, Aaron Wolfgang, David A. Nissan, Edmund G. Howe", "journal": "Journal of Medical Ethics", "publication_date": "2023-05-29", "publication_year": 2023, "doi": "10.1136/jme-2023-108943", "pubmed_id": "37253556", "openalex_id": "https://openalex.org/W4378782490", "source_url": "http://dx.doi.org/10.1136/jme-2023-108943", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "PMID:37253556", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.1136/jme-2023-108943", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:37253556", "source_url": "http://dx.doi.org/10.1136/jme-2023-108943", "doi": "10.1136/jme-2023-108943", "pmid": "37253556", "publication_date": "2023-05-29", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1366, "title": "Letter to the editor on \"Increased low-frequency brain responses to music after psilocybin therapy for depression\".", "authors": "Brown O.", "journal": null, "publication_date": "2023-05-28", "publication_year": 2023, "doi": "10.1016/j.jad.2023.05.088", "pubmed_id": "37257781", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.jad.2023.05.088", "substance_tags": "psilocybin", "topic_tags": "Depression", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:02", "bibtex": null, "source_record_id": "PMID:37257781", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.jad.2023.05.088", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:37257781", "source_url": "https://doi.org/10.1016/j.jad.2023.05.088", "doi": "10.1016/j.jad.2023.05.088", "pmid": "37257781", "publication_date": "2023-05-28", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1186, "title": "Evidence versus expectancy: the development of psilocybin therapy", "authors": "James Rucker", "journal": "BJPsych Bulletin", "publication_date": "2023-05-28", "publication_year": 2023, "doi": "10.1192/bjb.2023.28", "pubmed_id": "37246405", "openalex_id": "https://openalex.org/W4378640469", "source_url": "https://doi.org/10.1192/bjb.2023.28", "substance_tags": "psilocybin", "topic_tags": "Depression,Receptor Pharmacology,Clinical Trial,Treatment-Resistant Depression", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "PMID:37246405", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1192/bjb.2023.28", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:37246405", "source_url": "https://doi.org/10.1192/bjb.2023.28", "doi": "10.1192/bjb.2023.28", "pmid": "37246405", "publication_date": "2023-05-28", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1374, "title": "Psychedelics: Threshold of a Therapeutic Revolution.", "authors": "Heal DJ, Smith SL, Belouin SJ, Henningfield JE.", "journal": null, "publication_date": "2023-05-26", "publication_year": 2023, "doi": "10.1016/j.neuropharm.2023.109610", "pubmed_id": "37247807", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.neuropharm.2023.109610", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Eating Disorders,Chronic Pain,Pharmacology,Clinical Trial,Review Article,Cancer Patients,Treatment-Resistant Depression", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:03", "bibtex": null, "source_record_id": "PMID:37247807", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.neuropharm.2023.109610", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:37247807", "source_url": "https://doi.org/10.1016/j.neuropharm.2023.109610", "doi": "10.1016/j.neuropharm.2023.109610", "pmid": "37247807", "publication_date": "2023-05-26", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3475, "title": "Evaluation of the Acceptability, Safety, Feasibility, and Efficacy of Psilocybin-assisted Psychotherapy (PaP) for the Treatment of Post-traumatic Stress Disorder (PTSD) in Military Veterans", "authors": "Combat Stress", "journal": "ClinicalTrials.gov", "publication_date": "2023-05-24", "publication_year": 2023, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05876481", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Treatment-Resistant Depression,Veterans,Safety", "study_type": "Other", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05876481", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05876481", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05876481", "source_url": "https://clinicaltrials.gov/study/NCT05876481", "doi": "", "pmid": "", "publication_date": "2023-05-24", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1445, "title": "New Pharmacologic Approaches to the Treatment of Bipolar Depression.", "authors": "Keramatian K, Chakrabarty T, DuBow A, Saraf G, Yatham LN.", "journal": null, "publication_date": "2023-05-24", "publication_year": 2023, "doi": "10.1007/s40265-023-01872-x", "pubmed_id": "37227597", "openalex_id": null, "source_url": "https://doi.org/10.1007/s40265-023-01872-x", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Mitochondrial Function,Randomized Controlled Trial,Review Article,Inflammation", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:04", "bibtex": null, "source_record_id": "PMID:37227597", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1007/s40265-023-01872-x", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:37227597", "source_url": "https://doi.org/10.1007/s40265-023-01872-x", "doi": "10.1007/s40265-023-01872-x", "pmid": "37227597", "publication_date": "2023-05-24", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1481, "title": "Neurobiological Correlates of Psilocybin Response in Depression.", "authors": "Qasim S, Zaheer Z, Jawad MY, Shad MU.", "journal": null, "publication_date": "2023-05-22", "publication_year": 2023, "doi": "10.4088/pcc.22r03419", "pubmed_id": "37230065", "openalex_id": null, "source_url": "https://doi.org/10.4088/pcc.22r03419", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging,Aging,Randomized Controlled Trial,Safety", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:01", "bibtex": null, "source_record_id": "PMID:37230065", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.4088/pcc.22r03419", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:37230065", "source_url": "https://doi.org/10.4088/pcc.22r03419", "doi": "10.4088/pcc.22r03419", "pmid": "37230065", "publication_date": "2023-05-22", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1480, "title": "Acute psilocybin increased cortical activities in rats", "authors": "Junhong Liu, Yuanyuan Wang, Ke Xia, Jinfeng Wu, Danhao Zheng, Aoling Cai, Haitao Yan, Ruibin Su", "journal": "Frontiers in Neuroscience", "publication_date": "2023-05-22", "publication_year": 2023, "doi": "10.3389/fnins.2023.1168911", "pubmed_id": "37287797", "openalex_id": "https://openalex.org/W4378084778", "source_url": "https://doi.org/10.3389/fnins.2023.1168911", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging,Mechanism of Action,Receptor Pharmacology,Aging,Clinical Trial,Animal Study", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "PMID:37287797", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.3389/fnins.2023.1168911", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:37287797", "source_url": "https://doi.org/10.3389/fnins.2023.1168911", "doi": "10.3389/fnins.2023.1168911", "pmid": "37287797", "publication_date": "2023-05-22", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3683, "title": "Recall of Experience and Conscious Awareness in Psilocybin Treatment of Depression (The RECAP Study): Pilot Phase in Healthy Adult Volunteers", "authors": "University of Wisconsin, Madison", "journal": "ClinicalTrials.gov", "publication_date": "2023-05-18", "publication_year": 2023, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT04842045", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Clinical Trial,Healthy Volunteers,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:34", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT04842045", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT04842045", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT04842045", "source_url": "https://clinicaltrials.gov/study/NCT04842045", "doi": "", "pmid": "", "publication_date": "2023-05-18", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1482, "title": "Therapeutic role of psilocybin and 3,4-methylenedioxymethamphetamine in trauma: A literature review.", "authors": "Fonseka LN, Woo BK.", "journal": null, "publication_date": "2023-05-18", "publication_year": 2023, "doi": "10.5498/wjp.v13.i5.182", "pubmed_id": "37303932", "openalex_id": null, "source_url": "https://doi.org/10.5498/wjp.v13.i5.182", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Review Article,Treatment-Resistant Depression,Healthcare Workers", "study_type": "Review Article", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:01", "bibtex": null, "source_record_id": "PMID:37303932", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.5498/wjp.v13.i5.182", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:37303932", "source_url": "https://doi.org/10.5498/wjp.v13.i5.182", "doi": "10.5498/wjp.v13.i5.182", "pmid": "37303932", "publication_date": "2023-05-18", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1126, "title": "[Psilocybin-Assisted Treatment of Depression, Anxiety and Substance use Disorders: Neurobiological Basis and Clinical Application].", "authors": "Lasch A, Schweikert T, Dora E, Kolb T, Schurig HL, Walther A.", "journal": null, "publication_date": "2023-05-18", "publication_year": 2023, "doi": "10.1055/a-2046-5202", "pubmed_id": "37207669", "openalex_id": null, "source_url": "https://doi.org/10.1055/a-2046-5202", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Mechanism of Action,Clinical Trial,Review Article", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:01", "bibtex": null, "source_record_id": "PMID:37207669", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1055/a-2046-5202", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:37207669", "source_url": "https://doi.org/10.1055/a-2046-5202", "doi": "10.1055/a-2046-5202", "pmid": "37207669", "publication_date": "2023-05-18", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3063, "title": "Novel psilocin prodrugs with altered pharmacological properties as candidate therapies for treatment-resistant anxiety disorders", "authors": "Raithatha SA, Hagel JM, Matinkhoo K, Yu L, Press D, Cook SG, Sharma G, D D, Jensen G, Lee JB, Cai C, Gallant J, Bains JS, Tucker JE, Facchini PJ.", "journal": "bioRxiv", "publication_date": "2023-05-17", "publication_year": 2023, "doi": "10.1101/2023.05.16.540994", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.1101/2023.05.16.540994", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Anxiety,Pharmacology,Receptor Pharmacology,Biomarkers,Clinical Trial,Animal Study,In Vitro Study,Cancer Patients,Treatment-Resistant Depression", "study_type": "Clinical Trial", "source_name": "bioRxiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:46", "last_checked": "2026-07-01 11:22:00", "bibtex": null, "source_record_id": "DOI:10.1101/2023.05.16.540994", "abstract_available": true, "abstract_source": "bioRxiv", "abstract_source_url": "https://doi.org/10.1101/2023.05.16.540994", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "bioRxiv", "source_record_id": "DOI:10.1101/2023.05.16.540994", "source_url": "https://doi.org/10.1101/2023.05.16.540994", "doi": "10.1101/2023.05.16.540994", "pmid": "", "publication_date": "2023-05-17", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3634, "title": "A Phase 1 Study Comparing the Pharmacokinetics and Safety of Intravenous and Oral Psilocybin", "authors": "University of Wisconsin, Madison", "journal": "ClinicalTrials.gov", "publication_date": "2023-05-14", "publication_year": 2023, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05467761", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Anxiety,Addiction,Pharmacology,Clinical Trial,Cancer Patients,Treatment-Resistant Depression,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:34", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05467761", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05467761", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05467761", "source_url": "https://clinicaltrials.gov/study/NCT05467761", "doi": "", "pmid": "", "publication_date": "2023-05-14", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3167, "title": "Exposure therapy under psilocybin for general anxiety disorder and claustrophobia", "authors": "THORENS G, PENZENSTADLER l, FURTADO LCDC, SERAGNOLI F, ROTHEN S, MABILAIS C, ZULLINO D.", "journal": "Research Square", "publication_date": "2023-05-11", "publication_year": 2023, "doi": "10.21203/rs.3.rs-2859973/v1", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.21203/rs.3.rs-2859973/v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Case Report", "study_type": "Case Report", "source_name": "Europe PMC", "publication_status": "preprint", "date_added": "2026-07-01 11:03:47", "last_checked": "2026-07-01 11:22:01", "bibtex": null, "source_record_id": "DOI:10.21203/rs.3.rs-2859973/v1", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.21203/rs.3.rs-2859973/v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "DOI:10.21203/rs.3.rs-2859973/v1", "source_url": "https://doi.org/10.21203/rs.3.rs-2859973/v1", "doi": "10.21203/rs.3.rs-2859973/v1", "pmid": "", "publication_date": "2023-05-11", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3463, "title": "Effects of Psilocybin in Anorexia Nervosa", "authors": "Johns Hopkins University", "journal": "ClinicalTrials.gov", "publication_date": "2023-05-05", "publication_year": 2023, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT04052568", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Eating Disorders,Safety", "study_type": "Other", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT04052568", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT04052568", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT04052568", "source_url": "https://clinicaltrials.gov/study/NCT04052568", "doi": "", "pmid": "", "publication_date": "2023-05-05", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1448, "title": "Why didn't the TGA consult with Australian researchers and clinicians with experience in psilocybin-assisted psychotherapy for treatment-resistant major depressive disorder?", "authors": "Rossell SL, Meikle SE, Williams ML, Castle DJ.", "journal": null, "publication_date": "2023-05-02", "publication_year": 2023, "doi": "10.1177/00048674231172691", "pubmed_id": "37139585", "openalex_id": null, "source_url": "https://doi.org/10.1177/00048674231172691", "substance_tags": "psilocybin", "topic_tags": "Depression,Healthcare Workers", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:05", "bibtex": null, "source_record_id": "PMID:37139585", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:37139585", "source_url": "https://doi.org/10.1177/00048674231172691", "doi": "10.1177/00048674231172691", "pmid": "37139585", "publication_date": "2023-05-02", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1497, "title": "Unblinding and demand characteristics in the treatment of depression.", "authors": "Goodwin GM, Croal M, Marwood L, Malievskaia E", "journal": "Journal of affective disorders", "publication_date": "2023-04-30", "publication_year": 2023, "doi": "10.1016/j.jad.2023.02.030", "pubmed_id": "36781142", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/36781142/", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Randomized Controlled Trial", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:20:38", "bibtex": null, "source_record_id": "PMID:36781142", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/36781142/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:36781142", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36781142/", "doi": "10.1016/j.jad.2023.02.030", "pmid": "36781142", "publication_date": "2023-04-30", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4819, "title": "A suicide attempt following psilocybin ingestion in a patient with no prior psychiatric history", "authors": "Eric N. Kramer, Kalyn Reddy, Bryan Shapiro", "journal": "Psychiatry Research Case Reports", "publication_date": "2023-04-25", "publication_year": 2023, "doi": "10.1016/j.psycr.2023.100118", "pubmed_id": null, "openalex_id": "https://openalex.org/W4367043450", "source_url": "https://doi.org/10.1016/j.psycr.2023.100118", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Pharmacology,Safety,Adverse Events,Toxicity", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:46", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "DOI:10.1016/j.psycr.2023.100118", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1016/j.psycr.2023.100118", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.psycr.2023.100118", "source_url": "https://doi.org/10.1016/j.psycr.2023.100118", "doi": "10.1016/j.psycr.2023.100118", "pmid": "", "publication_date": "2023-04-25", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1449, "title": "A critical evaluation of QIDS-SR-16 using data from a trial of psilocybin therapy versus escitalopram treatment for depression", "authors": "Brandon Weiss, David Erritzøe, Bruna Giribaldi, David Nutt, Robin Carhart-Harris", "journal": "Journal of Psychopharmacology", "publication_date": "2023-04-24", "publication_year": 2023, "doi": "10.1177/02698811231167848", "pubmed_id": "37122239", "openalex_id": "https://openalex.org/W4367053025", "source_url": "https://doi.org/10.1177/02698811231167848", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Chronic Pain,Clinical Trial,Healthcare Workers", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "PMID:37122239", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1177/02698811231167848", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:37122239", "source_url": "https://doi.org/10.1177/02698811231167848", "doi": "10.1177/02698811231167848", "pmid": "37122239", "publication_date": "2023-04-24", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3563, "title": "The Safety and Efficacy of Psilocybin in Participants With Treatment Resistant Depression", "authors": "COMPASS Pathways", "journal": "ClinicalTrials.gov", "publication_date": "2023-04-23", "publication_year": 2023, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT03775200", "substance_tags": "psilocybin", "topic_tags": "Depression,Safety", "study_type": "Other", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT03775200", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT03775200", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT03775200", "source_url": "https://clinicaltrials.gov/study/NCT03775200", "doi": "", "pmid": "", "publication_date": "2023-04-23", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1475, "title": "Assessment of Psilocybin Therapy for Patients With Cancer and Major Depression Disorder", "authors": "Manish Agrawal, Ezekiel Emanuel, Brian D. Richards, William A. Richards, Kim Roddy, Paul Thambi", "journal": "JAMA Oncology", "publication_date": "2023-04-12", "publication_year": 2023, "doi": "10.1001/jamaoncol.2023.0351", "pubmed_id": "37052904", "openalex_id": "https://openalex.org/W4365444032", "source_url": "https://doi.org/10.1001/jamaoncol.2023.0351", "substance_tags": "psilocybin", "topic_tags": "Depression,Randomized Controlled Trial", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "PMID:37052904", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1001/jamaoncol.2023.0351", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:37052904", "source_url": "https://doi.org/10.1001/jamaoncol.2023.0351", "doi": "10.1001/jamaoncol.2023.0351", "pmid": "37052904", "publication_date": "2023-04-12", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4823, "title": "347. Changes in Resting State Functional Connectivity After Psilocybin for Body Dysmorphic Disorder", "authors": "Xi Zhu, David J. Hellerstein, Jamie D. Feusner, Michael G. Wheaton, Gloria Gómez, Franklin R. Schneier", "journal": "Biological Psychiatry", "publication_date": "2023-04-09", "publication_year": 2023, "doi": "10.1016/j.biopsych.2023.02.587", "pubmed_id": null, "openalex_id": "https://openalex.org/W4362733849", "source_url": "https://doi.org/10.1016/j.biopsych.2023.02.587", "substance_tags": "psilocybin", "topic_tags": "Depression,Receptor Pharmacology", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:46", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "DOI:10.1016/j.biopsych.2023.02.587", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.biopsych.2023.02.587", "source_url": "https://doi.org/10.1016/j.biopsych.2023.02.587", "doi": "10.1016/j.biopsych.2023.02.587", "pmid": "", "publication_date": "2023-04-09", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4822, "title": "96. An Open Label Study of Synthetic Psilocybin in Bipolar Type II Depression", "authors": "Scott Aaronson, Tammy Miller, Samuel Rudow, MacKenzie Forbes, Audrey Shoultz, Trisha Suppes", "journal": "Biological Psychiatry", "publication_date": "2023-04-09", "publication_year": 2023, "doi": "10.1016/j.biopsych.2023.02.336", "pubmed_id": null, "openalex_id": "https://openalex.org/W4363675215", "source_url": "https://doi.org/10.1016/j.biopsych.2023.02.336", "substance_tags": "psilocybin", "topic_tags": "Depression", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:46", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "DOI:10.1016/j.biopsych.2023.02.336", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.biopsych.2023.02.336", "source_url": "https://doi.org/10.1016/j.biopsych.2023.02.336", "doi": "10.1016/j.biopsych.2023.02.336", "pmid": "", "publication_date": "2023-04-09", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1424, "title": "Are psychedelic medicines the reset for chronic pain? Preliminary findings and research needs.", "authors": "Zia FZ, Baumann MH, Belouin SJ, Dworkin RH, Ghauri MH, Hendricks PS, Henningfield JE, Lanier RK, Ross S, Berger A.", "journal": null, "publication_date": "2023-04-01", "publication_year": 2023, "doi": "10.1016/j.neuropharm.2023.109528", "pubmed_id": "37015315", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.neuropharm.2023.109528", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Chronic Pain,Pharmacology,Mechanism of Action,Spirituality,Clinical Trial,Safety,Adverse Events,Inflammation", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:05", "bibtex": null, "source_record_id": "PMID:37015315", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.neuropharm.2023.109528", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:37015315", "source_url": "https://doi.org/10.1016/j.neuropharm.2023.109528", "doi": "10.1016/j.neuropharm.2023.109528", "pmid": "37015315", "publication_date": "2023-04-01", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3318, "title": "Psilocybin zeigt Wirkung bei Depression.", "authors": "Julia Mertens L.", "journal": null, "publication_date": "2023-03-31", "publication_year": 2023, "doi": "10.1007/s15006-023-2540-9", "pubmed_id": "37016226", "openalex_id": null, "source_url": "https://doi.org/10.1007/s15006-023-2540-9", "substance_tags": "psilocybin", "topic_tags": "Depression", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 11:03:50", "last_checked": "2026-07-01 11:22:04", "bibtex": null, "source_record_id": "PMID:37016226", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:37016226", "source_url": "https://doi.org/10.1007/s15006-023-2540-9", "doi": "10.1007/s15006-023-2540-9", "pmid": "37016226", "publication_date": "2023-03-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1524, "title": "Psychotherapy with Psilocybin for Depression: Systematic Review.", "authors": "Dawood Hristova JJ, Pérez-Jover V.", "journal": null, "publication_date": "2023-03-30", "publication_year": 2023, "doi": "10.3390/bs13040297", "pubmed_id": "37102811", "openalex_id": null, "source_url": "https://doi.org/10.3390/bs13040297", "substance_tags": "psilocybin", "topic_tags": "Depression,End-of-Life Distress,Wellbeing,Systematic Review,Review Article,Treatment-Resistant Depression", "study_type": "Systematic Review", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:01", "bibtex": null, "source_record_id": "PMID:37102811", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.3390/bs13040297", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:37102811", "source_url": "https://doi.org/10.3390/bs13040297", "doi": "10.3390/bs13040297", "pmid": "37102811", "publication_date": "2023-03-30", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1451, "title": "The need for establishing best practices and gold standards in psychedelic medicine.", "authors": "Feduccia A, Agin-Liebes G, Price CM, Grinsell N, Paradise S, Rabin DM.", "journal": null, "publication_date": "2023-03-29", "publication_year": 2023, "doi": "10.1016/j.jad.2023.03.083", "pubmed_id": "37003433", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.jad.2023.03.083", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Clinical Trial,Review Article,Safety", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:05", "bibtex": null, "source_record_id": "PMID:37003433", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.jad.2023.03.083", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:37003433", "source_url": "https://doi.org/10.1016/j.jad.2023.03.083", "doi": "10.1016/j.jad.2023.03.083", "pmid": "37003433", "publication_date": "2023-03-29", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1303, "title": "Psilocybin facilitates fear extinction in mice by promoting hippocampal neuroplasticity", "authors": "Yingjie Du, Yunfeng Li, Xiangting Zhao, Yishan Yao, Bin Wang, Liming Zhang, Guyan Wang", "journal": "Chinese Medical Journal", "publication_date": "2023-03-29", "publication_year": 2023, "doi": "10.1097/cm9.0000000000002647", "pubmed_id": "37000971", "openalex_id": "https://openalex.org/W4362457938", "source_url": "https://doi.org/10.1097/cm9.0000000000002647", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Neuroplasticity,Neurogenesis,Mechanism of Action,Receptor Pharmacology,Animal Study", "study_type": "Animal Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "PMID:37000971", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1097/cm9.0000000000002647", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:37000971", "source_url": "https://doi.org/10.1097/cm9.0000000000002647", "doi": "10.1097/cm9.0000000000002647", "pmid": "37000971", "publication_date": "2023-03-29", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1494, "title": "[Contribution of serotonin 5-HT2A receptor to antidepressant effect of serotonergic psychedelics].", "authors": "Ibi D.", "journal": null, "publication_date": "2023-03-28", "publication_year": 2023, "doi": "10.1254/fpj.22141", "pubmed_id": "36990794", "openalex_id": null, "source_url": "https://doi.org/10.1254/fpj.22141", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Mechanism of Action,Receptor Pharmacology,Mystical Experience,Review Article,Treatment-Resistant Depression,Adverse Events", "study_type": "Review Article", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:04", "bibtex": null, "source_record_id": "PMID:36990794", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1254/fpj.22141", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:36990794", "source_url": "https://doi.org/10.1254/fpj.22141", "doi": "10.1254/fpj.22141", "pmid": "36990794", "publication_date": "2023-03-28", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1474, "title": "Role of Psychedelics in Treatment-Resistant Depression.", "authors": "Kamal S, Jha MK, Radhakrishnan R.", "journal": null, "publication_date": "2023-03-24", "publication_year": 2023, "doi": "10.1016/j.psc.2023.02.004", "pubmed_id": "37149346", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.psc.2023.02.004", "substance_tags": "psilocybin", "topic_tags": "Depression,Treatment-Resistant Depression", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:04", "bibtex": null, "source_record_id": "PMID:37149346", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.psc.2023.02.004", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:37149346", "source_url": "https://doi.org/10.1016/j.psc.2023.02.004", "doi": "10.1016/j.psc.2023.02.004", "pmid": "37149346", "publication_date": "2023-03-24", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1495, "title": "Antidepressant Effects of Psilocybin in the Absence of Psychedelic Effects.", "authors": "Rosenblat JD, Leon-Carlyle M, Ali S, Husain MI, McIntyre RS.", "journal": null, "publication_date": "2023-03-21", "publication_year": 2023, "doi": "10.1176/appi.ajp.20220835", "pubmed_id": "36945824", "openalex_id": null, "source_url": "https://doi.org/10.1176/appi.ajp.20220835", "substance_tags": "psilocybin", "topic_tags": "Depression", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:04", "bibtex": null, "source_record_id": "PMID:36945824", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:36945824", "source_url": "https://doi.org/10.1176/appi.ajp.20220835", "doi": "10.1176/appi.ajp.20220835", "pmid": "36945824", "publication_date": "2023-03-21", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3433, "title": "Mood and Cognitive Effects of Low Doses of Psilocybin Observed in Healthy Subjects (\"MELO\"): A Blinded, Placebo-Controlled, Dose-Finding Study", "authors": "Optimi Health Corporation", "journal": "ClinicalTrials.gov", "publication_date": "2023-03-19", "publication_year": 2023, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05252598", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Anxiety,Microdosing,Wellbeing,Safety,Toxicity", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05252598", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05252598", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05252598", "source_url": "https://clinicaltrials.gov/study/NCT05252598", "doi": "", "pmid": "", "publication_date": "2023-03-19", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1452, "title": "Psilocybin-assisted therapy for major depressive disorder: An exploratory placebo-controlled, fixed-order trial", "authors": "Jordan Sloshower, Patrick D. Skosnik, Hamideh Safi-Aghdam, Surbhi Pathania, Shariful A. Syed, Brian Pittman, Deepak Cyril D’Souza", "journal": "Journal of Psychopharmacology", "publication_date": "2023-03-19", "publication_year": 2023, "doi": "10.1177/02698811231154852", "pubmed_id": "36938991", "openalex_id": "https://openalex.org/W4327895864", "source_url": "https://doi.org/10.1177/02698811231154852", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Chronic Pain,Pharmacology,Mystical Experience,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "PMID:36938991", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1177/02698811231154852", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:36938991", "source_url": "https://doi.org/10.1177/02698811231154852", "doi": "10.1177/02698811231154852", "pmid": "36938991", "publication_date": "2023-03-19", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1531, "title": "The Effect of Combined Treatment of Psilocybin and Eugenol on Lipopolysaccharide-Induced Brain Inflammation in Mice", "authors": "Timur Zanikov, Marta Gerasymchuk, Esmaeel Ghasemi Gojani, Gregory Ian Robinson, Shima Asghari, Alyssa Groves, Lucie Haselhorst, Sanjana Nandakumar, Cora Stahl, Mackenzie Cameron, Dongping Li, Rocio Rodriguez-Juarez, Alexandra Snelling, Darryl Hudson, Anna Fiselier, Olga Kovalchuk, Igor Kovalchuk", "journal": "Molecules", "publication_date": "2023-03-13", "publication_year": 2023, "doi": "10.3390/molecules28062624", "pubmed_id": "36985596", "openalex_id": "https://openalex.org/W4324147331", "source_url": "https://doi.org/10.3390/molecules28062624", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Pharmacology,Mechanism of Action,Biomarkers,Animal Study,Inflammation", "study_type": "Animal Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "PMID:36985596", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.3390/molecules28062624", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:36985596", "source_url": "https://doi.org/10.3390/molecules28062624", "doi": "10.3390/molecules28062624", "pmid": "36985596", "publication_date": "2023-03-13", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3524, "title": "Safety and Efficacy of Psilocybin for Body Dysmorphic Disorder", "authors": "New York State Psychiatric Institute", "journal": "ClinicalTrials.gov", "publication_date": "2023-03-12", "publication_year": 2023, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT04656301", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging,Receptor Pharmacology,Aging,Safety", "study_type": "Other", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT04656301", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT04656301", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT04656301", "source_url": "https://clinicaltrials.gov/study/NCT04656301", "doi": "", "pmid": "", "publication_date": "2023-03-12", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1465, "title": "Preclinical perspectives on the mechanisms underlying the therapeutic actions of psilocybin in psychiatric disorders.", "authors": "Wulff AB, Nichols CD, Thompson SM.", "journal": null, "publication_date": "2023-03-12", "publication_year": 2023, "doi": "10.1016/j.neuropharm.2023.109504", "pubmed_id": "36921889", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.neuropharm.2023.109504", "substance_tags": "psilocybin", "topic_tags": "Depression,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Review Article,Animal Study,Treatment-Resistant Depression,Inflammation", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:02", "bibtex": null, "source_record_id": "PMID:36921889", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.neuropharm.2023.109504", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:36921889", "source_url": "https://doi.org/10.1016/j.neuropharm.2023.109504", "doi": "10.1016/j.neuropharm.2023.109504", "pmid": "36921889", "publication_date": "2023-03-12", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3772, "title": "Self-treatment of depression and complex post-traumatic stress disorder with psilocybin and LSD-A retrospective case study", "authors": "Turkia M.", "journal": "PsyArXiv", "publication_date": "2023-03-09", "publication_year": 2023, "doi": "10.31234/osf.io/wupvy", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.31234/osf.io/wupvy", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Treatment-Resistant Depression,Healthcare Workers,Safety,Drug Interactions", "study_type": "Other", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:10:20", "last_checked": "2026-07-01 11:22:02", "bibtex": null, "source_record_id": "DOI:10.31234/osf.io/wupvy", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://doi.org/10.31234/osf.io/wupvy", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "DOI:10.31234/osf.io/wupvy", "source_url": "https://doi.org/10.31234/osf.io/wupvy", "doi": "10.31234/osf.io/wupvy", "pmid": "", "publication_date": "2023-03-09", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3767, "title": "Underground small-group therapy of treatment-resistant depression and complex post-traumatic stress disorder (C-PTSD) with psilocybin-A retrospective case study", "authors": "Turkia M.", "journal": "PsyArXiv", "publication_date": "2023-03-09", "publication_year": 2023, "doi": "10.31234/osf.io/t6k9b", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.31234/osf.io/t6k9b", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Clinical Trial,Treatment-Resistant Depression", "study_type": "Clinical Trial", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:10:19", "last_checked": "2026-07-01 11:22:02", "bibtex": null, "source_record_id": "DOI:10.31234/osf.io/t6k9b", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://doi.org/10.31234/osf.io/t6k9b", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "DOI:10.31234/osf.io/t6k9b", "source_url": "https://doi.org/10.31234/osf.io/t6k9b", "doi": "10.31234/osf.io/t6k9b", "pmid": "", "publication_date": "2023-03-09", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3233, "title": "Self-treatment of depression and complex post-traumatic stress disorder with psilocybin and LSD-A retrospective case study", "authors": "", "journal": "PsyArXiv", "publication_date": "2023-03-09", "publication_year": 2023, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://osf.io/preprints/psyarxiv/wupvy_v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Treatment-Resistant Depression,Healthcare Workers,Safety,Drug Interactions", "study_type": "Other", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:48", "last_checked": "2026-07-01 11:22:30", "bibtex": null, "source_record_id": "https://osf.io/preprints/psyarxiv/wupvy_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/wupvy_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "https://osf.io/preprints/psyarxiv/wupvy_v1", "source_url": "https://osf.io/preprints/psyarxiv/wupvy_v1", "doi": "", "pmid": "", "publication_date": "2023-03-09", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3207, "title": "Underground small-group therapy of treatment-resistant depression and complex post-traumatic stress disorder (C-PTSD) with psilocybin-A retrospective case study", "authors": "", "journal": "PsyArXiv", "publication_date": "2023-03-09", "publication_year": 2023, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://osf.io/preprints/psyarxiv/t6k9b_v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Clinical Trial,Treatment-Resistant Depression", "study_type": "Clinical Trial", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:48", "last_checked": "2026-07-01 11:22:30", "bibtex": null, "source_record_id": "https://osf.io/preprints/psyarxiv/t6k9b_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/t6k9b_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "https://osf.io/preprints/psyarxiv/t6k9b_v1", "source_url": "https://osf.io/preprints/psyarxiv/t6k9b_v1", "doi": "", "pmid": "", "publication_date": "2023-03-09", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4833, "title": "Psychedelics for Medicinal Use: How Will This Alter the Collective Laboratory Consciousness?", "authors": "Steven W. Cotten, Frederick G. Strathmann, Frederick S. Barrett, Laura Labay, James Mullally, Alexander M. Sherwood, Frank Wiegand", "journal": "Clinical Chemistry", "publication_date": "2023-03-06", "publication_year": 2023, "doi": "10.1093/clinchem/hvad016", "pubmed_id": "36881769", "openalex_id": "https://openalex.org/W4323351497", "source_url": "http://dx.doi.org/10.1093/clinchem/hvad016", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Anxiety,Addiction,Chronic Pain,Pharmacology,Mechanism of Action,Receptor Pharmacology,Consciousness,Clinical Trial,Review Article,Treatment-Resistant Depression,Safety,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:46", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "PMID:36881769", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.1093/clinchem/hvad016", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:36881769", "source_url": "http://dx.doi.org/10.1093/clinchem/hvad016", "doi": "10.1093/clinchem/hvad016", "pmid": "36881769", "publication_date": "2023-03-06", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1536, "title": "Inhibition of Microglial GSK3β Activity Is Common to Different Kinds of Antidepressants: A Proposal for an In Vitro Screen to Detect Novel Antidepressant Principles.", "authors": "Kalkman HO", "journal": "Biomedicines", "publication_date": "2023-03-06", "publication_year": 2023, "doi": "10.3390/biomedicines11030806", "pubmed_id": "36979785", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/36979785/", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Pharmacology,Mechanism of Action,Receptor Pharmacology,Review Article,In Vitro Study,Safety,Inflammation", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:20:38", "bibtex": null, "source_record_id": "PMID:36979785", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/36979785/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:36979785", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36979785/", "doi": "10.3390/biomedicines11030806", "pmid": "36979785", "publication_date": "2023-03-06", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4834, "title": "How psychedelics spark neuronal growth", "authors": "Shi En Kim", "journal": "C&EN Global Enterprise", "publication_date": "2023-03-05", "publication_year": 2023, "doi": "10.1021/cen-10108-scicon1", "pubmed_id": null, "openalex_id": "https://openalex.org/W4323321700", "source_url": "http://dx.doi.org/10.1021/cen-10108-scicon1", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Neuroplasticity,Mechanism of Action,Receptor Pharmacology", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:46", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "DOI:10.1021/cen-10108-scicon1", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.1021/cen-10108-scicon1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1021/cen-10108-scicon1", "source_url": "http://dx.doi.org/10.1021/cen-10108-scicon1", "doi": "10.1021/cen-10108-scicon1", "pmid": "", "publication_date": "2023-03-05", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1539, "title": "Is the Requirement for First-Person Experience of Psychedelic Drugs a Justified Component of a Psychedelic Therapist’s Training?", "authors": "Nathan Emmerich, Bryce Humphries", "journal": "Cambridge Quarterly of Healthcare Ethics", "publication_date": "2023-03-01", "publication_year": 2023, "doi": "10.1017/s0963180123000099", "pubmed_id": "36861394", "openalex_id": "https://openalex.org/W4322757924", "source_url": "https://doi.org/10.1017/s0963180123000099", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Addiction", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "PMID:36861394", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1017/s0963180123000099", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:36861394", "source_url": "https://doi.org/10.1017/s0963180123000099", "doi": "10.1017/s0963180123000099", "pmid": "36861394", "publication_date": "2023-03-01", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1538, "title": "Discovering the Potential Mechanisms of Medicinal Mushrooms Antidepressant Activity: A Review.", "authors": "Lazur J, Hnatyk K, Kała K, Sułkowska-Ziaja K, Muszyńska B.", "journal": null, "publication_date": "2023-03-01", "publication_year": 2023, "doi": "10.3390/antiox12030623", "pubmed_id": "36978872", "openalex_id": null, "source_url": "https://doi.org/10.3390/antiox12030623", "substance_tags": "psilocybin", "topic_tags": "Depression,Neurogenesis,Mechanism of Action,Receptor Pharmacology,Review Article,Treatment-Resistant Depression,Inflammation", "study_type": "Review Article", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:05", "bibtex": null, "source_record_id": "PMID:36978872", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.3390/antiox12030623", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:36978872", "source_url": "https://doi.org/10.3390/antiox12030623", "doi": "10.3390/antiox12030623", "pmid": "36978872", "publication_date": "2023-03-01", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1546, "title": "Interaction of psychedelic tryptamine derivatives with a lipid bilayer.", "authors": "Zohairi F, Khandelia H, Hakami Zanjani AA", "journal": "Chemistry and physics of lipids", "publication_date": "2023-02-28", "publication_year": 2023, "doi": "10.1016/j.chemphyslip.2023.105279", "pubmed_id": "36627076", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/36627076/", "substance_tags": "psilocin", "topic_tags": "Depression,Anxiety,Addiction,Headache / Migraine,Mechanism of Action,Receptor Pharmacology,Drug Interactions", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:20:38", "bibtex": null, "source_record_id": "PMID:36627076", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/36627076/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:36627076", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36627076/", "doi": "10.1016/j.chemphyslip.2023.105279", "pmid": "36627076", "publication_date": "2023-02-28", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1542, "title": "Pharmacotherapies for Treatment-Resistant Depression: How Antipsychotics Fit in the Rapidly Evolving Therapeutic Landscape.", "authors": "Jha MK, Mathew SJ.", "journal": null, "publication_date": "2023-02-28", "publication_year": 2023, "doi": "10.1176/appi.ajp.20230025", "pubmed_id": "36855876", "openalex_id": null, "source_url": "https://doi.org/10.1176/appi.ajp.20230025", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Treatment-Resistant Depression,Healthcare Workers,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:05", "bibtex": null, "source_record_id": "PMID:36855876", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1176/appi.ajp.20230025", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:36855876", "source_url": "https://doi.org/10.1176/appi.ajp.20230025", "doi": "10.1176/appi.ajp.20230025", "pmid": "36855876", "publication_date": "2023-02-28", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1541, "title": "Psychedelische Therapie mit Psilocybin und Psychotherapie - Wo stehen wir?", "authors": "Anne Karow", "journal": "PPmP - Psychotherapie · Psychosomatik · Medizinische Psychologie", "publication_date": "2023-02-28", "publication_year": 2023, "doi": "10.1055/a-2010-7640", "pubmed_id": "36944348", "openalex_id": "https://openalex.org/W4328054033", "source_url": "http://dx.doi.org/10.1055/a-2010-7640", "substance_tags": "psilocybin", "topic_tags": "Depression,End-of-Life Distress,Receptor Pharmacology", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "PMID:36944348", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.1055/a-2010-7640", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:36944348", "source_url": "http://dx.doi.org/10.1055/a-2010-7640", "doi": "10.1055/a-2010-7640", "pmid": "36944348", "publication_date": "2023-02-28", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1534, "title": "A Single Administration of Psilocybin Persistently Rescues Cognitive Deficits Caused by Adolescent Chronic Restraint Stress Without Long-Term Changes in Synaptic Protein Gene Expression in a Rat Experimental System with Translational Relevance to Depression", "authors": "Meghan Hibicke, Hannah M. Kramer, Charles D. Nichols", "journal": "Psychedelic Medicine", "publication_date": "2023-02-28", "publication_year": 2023, "doi": "10.1089/psymed.2022.0012", "pubmed_id": "40047006", "openalex_id": "https://openalex.org/W4323041020", "source_url": "https://doi.org/10.1089/psymed.2022.0012", "substance_tags": "psilocybin", "topic_tags": "Depression,Neuroplasticity,Pharmacology,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Animal Study,Adolescents,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "PMID:40047006", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1089/psymed.2022.0012", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:40047006", "source_url": "https://doi.org/10.1089/psymed.2022.0012", "doi": "10.1089/psymed.2022.0012", "pmid": "40047006", "publication_date": "2023-02-28", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1527, "title": "Default Mode Network Modulation by Psychedelics: A Systematic Review.", "authors": "Gattuso JJ, Perkins D, Ruffell S, Lawrence AJ, Hoyer D, Jacobson LH, Timmermann C, Castle D, Rossell SL, Downey LA, Pagni BA, Galvão-Coelho NL, Nutt D, Sarris J.", "journal": null, "publication_date": "2023-02-28", "publication_year": 2023, "doi": "10.1093/ijnp/pyac074", "pubmed_id": "36272145", "openalex_id": null, "source_url": "https://doi.org/10.1093/ijnp/pyac074", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,OCD,Brain Imaging,Mechanism of Action,Default Mode Network,Aging,Mystical Experience,Systematic Review,Review Article", "study_type": "Systematic Review", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:05", "bibtex": null, "source_record_id": "PMID:36272145", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1093/ijnp/pyac074", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:36272145", "source_url": "https://doi.org/10.1093/ijnp/pyac074", "doi": "10.1093/ijnp/pyac074", "pmid": "36272145", "publication_date": "2023-02-28", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4846, "title": "Psychedelic Renaissance: Clinical Health Justice, Patient Safety, and Equity Need to Be Put First", "authors": "Jacques Ambrose, J.S. Zabinski", "journal": "Psychiatric News", "publication_date": "2023-02-15", "publication_year": 2023, "doi": "10.1176/appi.pn.2023.03.3.43", "pubmed_id": null, "openalex_id": "https://openalex.org/W4321033113", "source_url": "https://doi.org/10.1176/appi.pn.2023.03.3.43", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Pharmacology,Mechanism of Action,Receptor Pharmacology,Review Article,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:46", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "DOI:10.1176/appi.pn.2023.03.3.43", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1176/appi.pn.2023.03.3.43", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1176/appi.pn.2023.03.3.43", "source_url": "https://doi.org/10.1176/appi.pn.2023.03.3.43", "doi": "10.1176/appi.pn.2023.03.3.43", "pmid": "", "publication_date": "2023-02-15", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4844, "title": "Psychedelics for the Neuropsychiatric Symptoms of Alzheimer's disease", "authors": "Ashish Sarangi, Omotola Akinkunmi", "journal": "American Journal of Geriatric Psychiatry", "publication_date": "2023-02-15", "publication_year": 2023, "doi": "10.1016/j.jagp.2022.12.201", "pubmed_id": null, "openalex_id": "https://openalex.org/W4321014012", "source_url": "https://doi.org/10.1016/j.jagp.2022.12.201", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Receptor Pharmacology,Clinical Trial", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:46", "last_checked": "2026-07-04 06:34:46", "bibtex": null, "source_record_id": "DOI:10.1016/j.jagp.2022.12.201", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.jagp.2022.12.201", "source_url": "https://doi.org/10.1016/j.jagp.2022.12.201", "doi": "10.1016/j.jagp.2022.12.201", "pmid": "", "publication_date": "2023-02-15", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1533, "title": "Personal Psychedelic Use Is Common Among a Sample of Psychedelic Therapists: Implications for Research and Practice", "authors": "Jacob S. Aday, Zachary Skiles, Noa Eaton, Lisa Fredenburg, Mollie Pleet, Jessica Mantia, Ellen Bradley, Gisele Fernandes-Osterhold, Joshua Woolley", "journal": "Psychedelic Medicine", "publication_date": "2023-02-15", "publication_year": 2023, "doi": "10.1089/psymed.2022.0004", "pubmed_id": "40047007", "openalex_id": "https://openalex.org/W4321016287", "source_url": "https://doi.org/10.1089/psymed.2022.0004", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Spirituality,Clinical Trial,Review Article,Observational Study", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "PMID:40047007", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1089/psymed.2022.0004", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:40047007", "source_url": "https://doi.org/10.1089/psymed.2022.0004", "doi": "10.1089/psymed.2022.0004", "pmid": "40047007", "publication_date": "2023-02-15", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1425, "title": "Experiences of psilocybin treatment for clinical conditions: A qualitative meta-synthesis.", "authors": "Crowe M, Manuel J, Carlyle D, Lacey C.", "journal": null, "publication_date": "2023-02-12", "publication_year": 2023, "doi": "10.1111/inm.13127", "pubmed_id": "36779424", "openalex_id": null, "source_url": "https://doi.org/10.1111/inm.13127", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Review Article", "study_type": "Review Article", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:01", "bibtex": null, "source_record_id": "PMID:36779424", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1111/inm.13127", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:36779424", "source_url": "https://doi.org/10.1111/inm.13127", "doi": "10.1111/inm.13127", "pmid": "36779424", "publication_date": "2023-02-12", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4848, "title": "The History, Legalization and Potentials of Psilocybin-Assisted Psychotherapy", "authors": "Jeffery Heilman", "journal": "Journal of Scientific Exploration", "publication_date": "2023-02-10", "publication_year": 2023, "doi": "10.31275/20222633", "pubmed_id": null, "openalex_id": "https://openalex.org/W4320035163", "source_url": "http://dx.doi.org/10.31275/20222633", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,End-of-Life Distress,Clinical Trial,Review Article", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:46", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "DOI:10.31275/20222633", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.31275/20222633", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.31275/20222633", "source_url": "http://dx.doi.org/10.31275/20222633", "doi": "10.31275/20222633", "pmid": "", "publication_date": "2023-02-10", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1502, "title": "Single-dose psilocybin for a treatment-resistant episode of major depression: Impact on patient-reported depression severity, anxiety, function, and quality of life", "authors": "Guy M. Goodwin, Scott T. Aaronson, Oscar Alvarez, Merve Atli, James Bennett, Megan Croal, Charles DeBattista, Boadie W. Dunlop, David Feifel, David J. Hellerstein, Muhammad Ishrat Husain, John R. Kelly, Molly Lennard-Jones, Rasmus Wentzer Licht, Lindsey Marwood, Sunil Mistry, Tomáš Páleníček, Ozlem Redjep, Dimitris Repantis, Robert A. Schoevers, Batya Septimus, Hollie Simmons, Jair C. Soares, Metten Somers, S. C. Stansfield, Jessica R. Stuart, Hannah H. Tadley, Nisha K. Thiara, Joyce Tsai, Mourad Wahba, Sam Williams, Rachel I. Winzer, Allan H. Young, Matthew B. Young, Sid Zisook, Ekaterina Malievskaia", "journal": "Journal of Affective Disorders", "publication_date": "2023-02-02", "publication_year": 2023, "doi": "10.1016/j.jad.2023.01.108", "pubmed_id": "36740140", "openalex_id": "https://openalex.org/W4319067008", "source_url": "https://doi.org/10.1016/j.jad.2023.01.108", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Chronic Pain,Clinical Trial,Randomized Controlled Trial,Treatment-Resistant Depression,Toxicity", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "PMID:36740140", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1016/j.jad.2023.01.108", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:36740140", "source_url": "https://doi.org/10.1016/j.jad.2023.01.108", "doi": "10.1016/j.jad.2023.01.108", "pmid": "36740140", "publication_date": "2023-02-02", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1565, "title": "Psilocybin therapy for depression. A good trip?", "authors": "Rucker JJ.", "journal": null, "publication_date": "2023-01-31", "publication_year": 2023, "doi": "10.1080/09638237.2023.2183492", "pubmed_id": "36913702", "openalex_id": null, "source_url": "https://doi.org/10.1080/09638237.2023.2183492", "substance_tags": "psilocybin", "topic_tags": "Depression", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:04", "bibtex": null, "source_record_id": "PMID:36913702", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:36913702", "source_url": "https://doi.org/10.1080/09638237.2023.2183492", "doi": "10.1080/09638237.2023.2183492", "pmid": "36913702", "publication_date": "2023-01-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1555, "title": "Psilocybin for Treatment-Resistant Depression.", "authors": "Østergaard SD, Hieronymus F.", "journal": null, "publication_date": "2023-01-31", "publication_year": 2023, "doi": "10.1056/nejmc2215459", "pubmed_id": "36812443", "openalex_id": null, "source_url": "https://doi.org/10.1056/nejmc2215459", "substance_tags": "psilocybin", "topic_tags": "Depression,Treatment-Resistant Depression", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:04", "bibtex": null, "source_record_id": "PMID:36812443", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:36812443", "source_url": "https://doi.org/10.1056/nejmc2215459", "doi": "10.1056/nejmc2215459", "pmid": "36812443", "publication_date": "2023-01-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4852, "title": "Plant Medicine Healing! Discovering the Roots of Psychedelic-Assisted Therapy in Mental Health", "authors": "Jennings Hernandez", "journal": "Advances in Research", "publication_date": "2023-01-29", "publication_year": 2023, "doi": "10.9734/air/2023/v24i1931", "pubmed_id": null, "openalex_id": "https://openalex.org/W4318591507", "source_url": "http://dx.doi.org/10.9734/air/2023/v24i1931", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Pharmacology,Receptor Pharmacology,Observational Study,Adverse Events", "study_type": "Observational Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:46", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "DOI:10.9734/air/2023/v24i1931", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.9734/air/2023/v24i1931", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.9734/air/2023/v24i1931", "source_url": "http://dx.doi.org/10.9734/air/2023/v24i1931", "doi": "10.9734/air/2023/v24i1931", "pmid": "", "publication_date": "2023-01-29", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3695, "title": "SV2A Marker of Synaptogenesis in a Clinical Trial of Psilocybin for Depression", "authors": "Washington University School of Medicine", "journal": "ClinicalTrials.gov", "publication_date": "2023-01-29", "publication_year": 2023, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05601648", "substance_tags": "psilocybin", "topic_tags": "Depression,Neuroplasticity,Brain Imaging,Receptor Pharmacology,Biomarkers,Aging,Clinical Trial,Animal Study", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:34", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05601648", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05601648", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05601648", "source_url": "https://clinicaltrials.gov/study/NCT05601648", "doi": "", "pmid": "", "publication_date": "2023-01-29", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1566, "title": "Corrigendum to 'Single-dose psilocybin-assisted therapy in major depressive disorder: a placebo-controlled, double-blind, randomised clinical trial'.", "authors": "von Rotz R, Schindowski EM, Jungwirth J, Schuldt A, Rieser NM, Zahoranszky K, Seifritz E, Nowak A, Nowak P, Jäncke L, Preller KH, Vollenweider FX.", "journal": null, "publication_date": "2023-01-29", "publication_year": 2023, "doi": "10.1016/j.eclinm.2023.101841", "pubmed_id": "36747965", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.eclinm.2023.101841", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:05", "bibtex": null, "source_record_id": "PMID:36747965", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.eclinm.2023.101841", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:36747965", "source_url": "https://doi.org/10.1016/j.eclinm.2023.101841", "doi": "10.1016/j.eclinm.2023.101841", "pmid": "36747965", "publication_date": "2023-01-29", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4855, "title": "Group format psychedelic-assisted therapy interventions: Observations and impressions from the HOPE trial", "authors": "Benjamin R. Lewis, Kevin Byrne, John Hendrick, Eric L. Garland, Paul Thielking, Anna C. Beck", "journal": "Journal of Psychedelic Studies", "publication_date": "2023-01-17", "publication_year": 2023, "doi": "10.1556/2054.2022.00222", "pubmed_id": null, "openalex_id": "https://openalex.org/W4317355030", "source_url": "https://doi.org/10.1556/2054.2022.00222", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Pharmacology,Clinical Trial,Observational Study,Cancer Patients,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:46", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "DOI:10.1556/2054.2022.00222", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1556/2054.2022.00222", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1556/2054.2022.00222", "source_url": "https://doi.org/10.1556/2054.2022.00222", "doi": "10.1556/2054.2022.00222", "pmid": "", "publication_date": "2023-01-17", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4856, "title": "Therapeutic potential of psilocybin: a promising agent in treating major depressive disorder", "authors": "Dragana Marković, Eleonora Čapelja", "journal": "AIDASCO Reviews", "publication_date": "2023-01-16", "publication_year": 2023, "doi": "10.59783/aire.2023.15", "pubmed_id": null, "openalex_id": "https://openalex.org/W4406142619", "source_url": "https://doi.org/10.59783/aire.2023.15", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Anxiety,PTSD,Receptor Pharmacology,Safety", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:46", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "DOI:10.59783/aire.2023.15", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.59783/aire.2023.15", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.59783/aire.2023.15", "source_url": "https://doi.org/10.59783/aire.2023.15", "doi": "10.59783/aire.2023.15", "pmid": "", "publication_date": "2023-01-16", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1398, "title": "Psychedelics for Patients With Cancer: A Comprehensive Literature Review.", "authors": "White CM, Weisman N, Dalo J.", "journal": null, "publication_date": "2023-01-11", "publication_year": 2023, "doi": "10.1177/10600280221144055", "pubmed_id": "36635883", "openalex_id": null, "source_url": "https://doi.org/10.1177/10600280221144055", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Mechanism of Action,Randomized Controlled Trial,Review Article", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:06", "bibtex": null, "source_record_id": "PMID:36635883", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1177/10600280221144055", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:36635883", "source_url": "https://doi.org/10.1177/10600280221144055", "doi": "10.1177/10600280221144055", "pmid": "36635883", "publication_date": "2023-01-11", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1580, "title": "The Bright Side of Psychedelics: Latest Advances and Challenges in Neuropharmacology.", "authors": "Mastinu A, Anyanwu M, Carone M, Abate G, Bonini SA, Peron G, Tirelli E, Pucci M, Ribaudo G, Oselladore E, Premoli M, Gianoncelli A, Uberti DL, Memo M.", "journal": null, "publication_date": "2023-01-09", "publication_year": 2023, "doi": "10.3390/ijms24021329", "pubmed_id": "36674849", "openalex_id": null, "source_url": "https://doi.org/10.3390/ijms24021329", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,PTSD,OCD,Pharmacology,Mechanism of Action,Receptor Pharmacology,Review Article", "study_type": "Review Article", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:02", "bibtex": null, "source_record_id": "PMID:36674849", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.3390/ijms24021329", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:36674849", "source_url": "https://doi.org/10.3390/ijms24021329", "doi": "10.3390/ijms24021329", "pmid": "36674849", "publication_date": "2023-01-09", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1478, "title": "Acute psilocybin enhances cognitive flexibility in rats", "authors": "Pacheco AT, Olson RJ, Garza G, Moghaddam B.", "journal": "bioRxiv", "publication_date": "2023-01-08", "publication_year": 2023, "doi": "10.1101/2023.01.09.523291", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.1101/2023.01.09.523291", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Pharmacology,Receptor Pharmacology,Healthcare Workers", "study_type": "Other", "source_name": "bioRxiv", "publication_status": "preprint", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:01", "bibtex": null, "source_record_id": "DOI:10.1101/2023.01.09.523291", "abstract_available": true, "abstract_source": "bioRxiv", "abstract_source_url": "https://doi.org/10.1101/2023.01.09.523291", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "bioRxiv", "source_record_id": "DOI:10.1101/2023.01.09.523291", "source_url": "https://doi.org/10.1101/2023.01.09.523291", "doi": "10.1101/2023.01.09.523291", "pmid": "", "publication_date": "2023-01-08", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3354, "title": "Et psykoanalytisk og et postmoderne perspektiv på selv/egoopløsning i en psykedelisk kontekst", "authors": "", "journal": "PsyArXiv", "publication_date": "2023-01-03", "publication_year": 2023, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://osf.io/preprints/psyarxiv/f26ce_v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Pharmacology,Personality Change,Systematic Review,Review Article", "study_type": "Systematic Review", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:51", "last_checked": "2026-07-01 11:22:30", "bibtex": null, "source_record_id": "https://osf.io/preprints/psyarxiv/f26ce_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/f26ce_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "https://osf.io/preprints/psyarxiv/f26ce_v1", "source_url": "https://osf.io/preprints/psyarxiv/f26ce_v1", "doi": "", "pmid": "", "publication_date": "2023-01-03", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4888, "title": "Psilocybin rescues depressive phenotype and modulates serotonin-2A and glucocorticoid receptor mRNA expression in brain cortex of a stress animal model", "authors": "Ines Erkizia-Santamaría, Guadalupe Rivero, Igor Horrillo, J. Javier Meana, Jorge E. Ortega", "journal": "Neuroscience Applied", "publication_date": "2022-12-31", "publication_year": 2022, "doi": "10.1016/j.nsa.2023.102452", "pubmed_id": null, "openalex_id": "https://openalex.org/W4390223807", "source_url": "http://dx.doi.org/10.1016/j.nsa.2023.102452", "substance_tags": "psilocybin", "topic_tags": "Depression,Pharmacology,Receptor Pharmacology,Animal Study", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:47", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "DOI:10.1016/j.nsa.2023.102452", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.nsa.2023.102452", "source_url": "http://dx.doi.org/10.1016/j.nsa.2023.102452", "doi": "10.1016/j.nsa.2023.102452", "pmid": "", "publication_date": "2022-12-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4887, "title": "The safety and efficacy of COMP360 psilocybin therapy in treatment-resistant depression: results from a long-term observational follow-up study", "authors": "Guy M. Goodwin, Lindsey Marwood, S. Mistry, Anna Nowakowska, Zainib Shabir, H. Clifton Simmons, E.K. Teoh, Jeng-Yu Tsai, E. Malievskaia", "journal": "Neuroscience Applied", "publication_date": "2022-12-31", "publication_year": 2022, "doi": "10.1016/j.nsa.2023.102906", "pubmed_id": null, "openalex_id": "https://openalex.org/W4390223380", "source_url": "http://dx.doi.org/10.1016/j.nsa.2023.102906", "substance_tags": "psilocybin", "topic_tags": "Depression,Observational Study,Treatment-Resistant Depression,Safety", "study_type": "Observational Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:47", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "DOI:10.1016/j.nsa.2023.102906", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.nsa.2023.102906", "source_url": "http://dx.doi.org/10.1016/j.nsa.2023.102906", "doi": "10.1016/j.nsa.2023.102906", "pmid": "", "publication_date": "2022-12-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4886, "title": "Effect of co-administration of low doses of psilocybin and mGluR2/3 antagonist LY341495 in chronic restraint stress model of depression", "authors": "Agata Machaczka, Jane Turek, Dorota Bederska-Łojewska, Bartłomiej Pochwat, Łukasz Gąsior, Bernadeta Szewczyk, Andrzej Pilc", "journal": "Neuroscience Applied", "publication_date": "2022-12-31", "publication_year": 2022, "doi": "10.1016/j.nsa.2023.102939", "pubmed_id": null, "openalex_id": "https://openalex.org/W4390223307", "source_url": "https://doi.org/10.1016/j.nsa.2023.102939", "substance_tags": "psilocybin", "topic_tags": "Depression,Receptor Pharmacology", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:47", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "DOI:10.1016/j.nsa.2023.102939", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.nsa.2023.102939", "source_url": "https://doi.org/10.1016/j.nsa.2023.102939", "doi": "10.1016/j.nsa.2023.102939", "pmid": "", "publication_date": "2022-12-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4883, "title": "Change in whole blood BDNF after escitalopram or psilocybin intervention in patients with depression and healthy controls", "authors": "Miriam L. Navarro, Alberte Wollesen Breum, Annette Johansen, Brice Ozenne, Vibe G. Frøkjær, Gitte M. Knudsen", "journal": "Neuroscience Applied", "publication_date": "2022-12-31", "publication_year": 2022, "doi": "10.1016/j.nsa.2023.103646", "pubmed_id": null, "openalex_id": "https://openalex.org/W4390222237", "source_url": "http://dx.doi.org/10.1016/j.nsa.2023.103646", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Personality Change", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:47", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "DOI:10.1016/j.nsa.2023.103646", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.nsa.2023.103646", "source_url": "http://dx.doi.org/10.1016/j.nsa.2023.103646", "doi": "10.1016/j.nsa.2023.103646", "pmid": "", "publication_date": "2022-12-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4879, "title": "Italian psychedelic therapies of the past century: An historical overview", "authors": "Adriana D’Arienzo, Giorgio Samorini", "journal": "Drug Science Policy and Law", "publication_date": "2022-12-31", "publication_year": 2022, "doi": "10.1177/20503245231179687", "pubmed_id": null, "openalex_id": "https://openalex.org/W4379659828", "source_url": "https://doi.org/10.1177/20503245231179687", "substance_tags": "psilocybin", "topic_tags": "Depression,Receptor Pharmacology", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:46", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "DOI:10.1177/20503245231179687", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1177/20503245231179687", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1177/20503245231179687", "source_url": "https://doi.org/10.1177/20503245231179687", "doi": "10.1177/20503245231179687", "pmid": "", "publication_date": "2022-12-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4876, "title": "Therapeutic mechanism of psilocybin in the treatment of depression and other psychiatric disorders.", "authors": "O. Shahar, A. Botvinik, T. Lifschytz, B. Lerer", "journal": "Neuroscience Applied", "publication_date": "2022-12-31", "publication_year": 2022, "doi": "10.1016/j.nsa.2023.101067", "pubmed_id": null, "openalex_id": "https://openalex.org/W4327497830", "source_url": "http://dx.doi.org/10.1016/j.nsa.2023.101067", "substance_tags": "psilocybin", "topic_tags": "Depression", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:46", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "DOI:10.1016/j.nsa.2023.101067", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.nsa.2023.101067", "source_url": "http://dx.doi.org/10.1016/j.nsa.2023.101067", "doi": "10.1016/j.nsa.2023.101067", "pmid": "", "publication_date": "2022-12-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4870, "title": "Psychedelic-Assisted Therapy and Meditative Experience as Factors of Personal Change", "authors": "Nadiia Omelchenko, Anton Kurapov", "journal": "Bulletin of Taras Shevchenko National University of Kyiv Psychology", "publication_date": "2022-12-31", "publication_year": 2022, "doi": "10.17721/bpsy.2023.1(17).8", "pubmed_id": null, "openalex_id": "https://openalex.org/W4386903146", "source_url": "https://doi.org/10.17721/bpsy.2023.1(17).8", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Wellbeing,Emotional Processing", "study_type": "Qualitative Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:46", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "DOI:10.17721/bpsy.2023.1(17).8", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.17721/bpsy.2023.1(17).8", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.17721/bpsy.2023.1(17).8", "source_url": "https://doi.org/10.17721/bpsy.2023.1(17).8", "doi": "10.17721/bpsy.2023.1(17).8", "pmid": "", "publication_date": "2022-12-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4869, "title": "Psychedelic Drug Therapy for Mental Disorders?", "authors": "John R. Rossiter", "journal": "Open Journal of Medical Psychology", "publication_date": "2022-12-31", "publication_year": 2022, "doi": "10.4236/ojmp.2023.123010", "pubmed_id": null, "openalex_id": "https://openalex.org/W4386593692", "source_url": "http://dx.doi.org/10.4236/ojmp.2023.123010", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Addiction,Receptor Pharmacology,Clinical Trial,Review Article", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:46", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "DOI:10.4236/ojmp.2023.123010", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.4236/ojmp.2023.123010", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.4236/ojmp.2023.123010", "source_url": "http://dx.doi.org/10.4236/ojmp.2023.123010", "doi": "10.4236/ojmp.2023.123010", "pmid": "", "publication_date": "2022-12-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1592, "title": "Addressing the Current Knowledge and Gaps in Research Surrounding Lysergic Acid Diethylamide (LSD), Psilocybin, and Psilocin in Rodent Models.", "authors": "Ezeaka UC, Kim HJJ, Laprairie RB.", "journal": null, "publication_date": "2022-12-31", "publication_year": 2022, "doi": "10.2174/1568026623666230705151922", "pubmed_id": "37409550", "openalex_id": null, "source_url": "https://doi.org/10.2174/1568026623666230705151922", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Anxiety,Addiction,Pharmacology,Review Article", "study_type": "Review Article", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:00", "bibtex": null, "source_record_id": "PMID:37409550", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.2174/1568026623666230705151922", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:37409550", "source_url": "https://doi.org/10.2174/1568026623666230705151922", "doi": "10.2174/1568026623666230705151922", "pmid": "37409550", "publication_date": "2022-12-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1591, "title": "Functional MRI markers for treatment-resistant depression: Insights and challenges.", "authors": "Kotoula V, Evans JW, Punturieri C, Johnson SC, Zarate CA", "journal": "Progress in brain research", "publication_date": "2022-12-31", "publication_year": 2022, "doi": "10.1016/bs.pbr.2023.04.001", "pubmed_id": "37414490", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/37414490/", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging,Biomarkers,Aging,Treatment-Resistant Depression", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:20:38", "bibtex": null, "source_record_id": "PMID:37414490", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37414490/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37414490", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37414490/", "doi": "10.1016/bs.pbr.2023.04.001", "pmid": "37414490", "publication_date": "2022-12-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1586, "title": "UNCOVERING THE UNTAPPED POTENTIAL OF PSILOCYBIN THERAPY IN ALLEVIATING CANCER-RELATED DEPRESSION: AN URGENT CALL TO RE-EVALUATE TREATMENT STRATEGIES.", "authors": "Ahmed H, Mushahid H, Arshad T.", "journal": null, "publication_date": "2022-12-31", "publication_year": 2022, "doi": null, "pubmed_id": "37992112", "openalex_id": null, "source_url": "https://europepmc.org/article/MED/37992112", "substance_tags": "psilocybin", "topic_tags": "Depression,Cancer Patients", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:05", "bibtex": null, "source_record_id": "PMID:37992112", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:37992112", "source_url": "https://europepmc.org/article/MED/37992112", "doi": "", "pmid": "37992112", "publication_date": "2022-12-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1584, "title": "Past Is Prologue: Ethical Issues in Pediatric Psychedelics Research and Treatment", "authors": "Gail A. Edelsohn, Dominic Sisti", "journal": "Perspectives in biology and medicine", "publication_date": "2022-12-31", "publication_year": 2022, "doi": "10.1353/pbm.2023.0007", "pubmed_id": "38662012", "openalex_id": "https://openalex.org/W4324007078", "source_url": "https://doi.org/10.1353/pbm.2023.0007", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Addiction,Personality Change,Clinical Trial,Adolescents,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "PMID:38662012", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1353/pbm.2023.0007", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:38662012", "source_url": "https://doi.org/10.1353/pbm.2023.0007", "doi": "10.1353/pbm.2023.0007", "pmid": "38662012", "publication_date": "2022-12-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1577, "title": "On blinding and suicide risk in a recent trial of psilocybin-assisted therapy for treatment-resistant depression", "authors": "Natalie Gukasyan", "journal": "Med", "publication_date": "2022-12-31", "publication_year": 2022, "doi": "10.1016/j.medj.2022.12.003", "pubmed_id": "36640755", "openalex_id": "https://openalex.org/W4315874306", "source_url": "https://doi.org/10.1016/j.medj.2022.12.003", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "PMID:36640755", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:36640755", "source_url": "https://doi.org/10.1016/j.medj.2022.12.003", "doi": "10.1016/j.medj.2022.12.003", "pmid": "36640755", "publication_date": "2022-12-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1576, "title": "Is psilocybin an effective antidepressant and what is its Mechanism of action?", "authors": "Mann JJ.", "journal": null, "publication_date": "2022-12-31", "publication_year": 2022, "doi": "10.1016/j.xcrm.2022.100906", "pubmed_id": "36652915", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.xcrm.2022.100906", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Safety", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:01", "bibtex": null, "source_record_id": "PMID:36652915", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.xcrm.2022.100906", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:36652915", "source_url": "https://doi.org/10.1016/j.xcrm.2022.100906", "doi": "10.1016/j.xcrm.2022.100906", "pmid": "36652915", "publication_date": "2022-12-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1509, "title": "The Impact of Psilocybin on Patients Experiencing Psychiatric Symptoms: A Systematic Review of Randomized Clinical Trials.", "authors": "IsHak WW, Garcia P, Pearl R, Dang J, William C, Totlani J, Danovitch I.", "journal": null, "publication_date": "2022-12-31", "publication_year": 2022, "doi": null, "pubmed_id": "37387703", "openalex_id": null, "source_url": "https://europepmc.org/article/MED/37387703", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Wellbeing,Clinical Trial,Randomized Controlled Trial,Systematic Review,Review Article,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:02", "bibtex": null, "source_record_id": "PMID:37387703", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://europepmc.org/article/MED/37387703", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:37387703", "source_url": "https://europepmc.org/article/MED/37387703", "doi": "", "pmid": "37387703", "publication_date": "2022-12-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1402, "title": "Scoping Review of Experiential Measures from Psychedelic Research and Clinical Trials.", "authors": "Herrmann Z, Earleywine M, De Leo J, Slabaugh S, Kenny T, Rush AJ", "journal": "Journal of psychoactive drugs", "publication_date": "2022-12-31", "publication_year": 2022, "doi": "10.1080/02791072.2022.2125467", "pubmed_id": "36127639", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/36127639/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Consciousness,Wellbeing,Emotional Processing,Mystical Experience,Clinical Trial,Review Article", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:20:38", "bibtex": null, "source_record_id": "PMID:36127639", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/36127639/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:36127639", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36127639/", "doi": "10.1080/02791072.2022.2125467", "pmid": "36127639", "publication_date": "2022-12-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1361, "title": "Bedside to bench: the outlook for psychedelic research.", "authors": "Acero VP, Cribas ES, Browne KD, Rivellini O, Burrell JC, O'Donnell JC, Das S, Cullen DK", "journal": "Frontiers in pharmacology", "publication_date": "2022-12-31", "publication_year": 2022, "doi": "10.3389/fphar.2023.1240295", "pubmed_id": "37869749", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/37869749/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Neuroplasticity,Mechanism of Action,Epigenetics,Clinical Trial,Review Article,Treatment-Resistant Depression", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:20:38", "bibtex": null, "source_record_id": "PMID:37869749", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37869749/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37869749", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37869749/", "doi": "10.3389/fphar.2023.1240295", "pmid": "37869749", "publication_date": "2022-12-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1615, "title": "Psilocybin for Depression: From Credibility to Feasibility, What’s Missing?", "authors": "Antonio Munafò, Davide Arillotta, Guido Mannaioni, Fabrizio Schifano, Renato Bernardini, Giuseppina Cantarella", "journal": "Pharmaceuticals", "publication_date": "2022-12-30", "publication_year": 2022, "doi": "10.3390/ph16010068", "pubmed_id": "36678564", "openalex_id": "https://openalex.org/W4313471532", "source_url": "https://doi.org/10.3390/ph16010068", "substance_tags": "psilocybin", "topic_tags": "Depression", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "PMID:36678564", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.3390/ph16010068", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:36678564", "source_url": "https://doi.org/10.3390/ph16010068", "doi": "10.3390/ph16010068", "pmid": "36678564", "publication_date": "2022-12-30", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1547, "title": "Genome sequencing progenies of magic mushrooms (Psilocybe subaeruginosa) identifies tetrapolar mating and gene duplications in the psilocybin pathway", "authors": "Alistair R. McTaggart, Timothy Y. James, Jason C. Slot, Caine Barlow, Nigel Fechner, Louise S. Shuey, A. Drenth", "journal": "Fungal Genetics and Biology", "publication_date": "2022-12-28", "publication_year": 2022, "doi": "10.1016/j.fgb.2022.103769", "pubmed_id": "36587787", "openalex_id": "https://openalex.org/W4313334084", "source_url": "https://doi.org/10.1016/j.fgb.2022.103769", "substance_tags": "psilocybin", "topic_tags": "Depression,Pharmacology,Mechanism of Action,Genomics", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "PMID:36587787", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:36587787", "source_url": "https://doi.org/10.1016/j.fgb.2022.103769", "doi": "10.1016/j.fgb.2022.103769", "pmid": "36587787", "publication_date": "2022-12-28", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4892, "title": "The Potential of Psilocybe Genus Fungi to Treat Depression and Some Addictions", "authors": "Vanessa Eveline VLAIC, Andreea ONA", "journal": "Hop and Medicinal Plants", "publication_date": "2022-12-27", "publication_year": 2022, "doi": "10.15835/hpm.v30i1-2.14453", "pubmed_id": null, "openalex_id": "https://openalex.org/W4405141401", "source_url": "https://doi.org/10.15835/hpm.v30i1-2.14453", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Addiction", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:47", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "DOI:10.15835/hpm.v30i1-2.14453", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.15835/hpm.v30i1-2.14453", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.15835/hpm.v30i1-2.14453", "source_url": "https://doi.org/10.15835/hpm.v30i1-2.14453", "doi": "10.15835/hpm.v30i1-2.14453", "pmid": "", "publication_date": "2022-12-27", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1567, "title": "Single-dose psilocybin-assisted therapy in major depressive disorder: a placebo-controlled, double-blind, randomised clinical trial", "authors": "Robin von Rotz, Eva Maria Schindowski, Johannes Jungwirth, Anna Schuldt, Nathalie M. Rieser, Katharina Zahoranszky, Erich Seifritz, Albina Nowak, Peter J.C.M. Nowak, Lutz Jäncke, Katrin H. Preller, Franz X. Vollenweider", "journal": "EClinicalMedicine", "publication_date": "2022-12-27", "publication_year": 2022, "doi": "10.1016/j.eclinm.2022.101809", "pubmed_id": "36636296", "openalex_id": "https://openalex.org/W4313530670", "source_url": "https://doi.org/10.1016/j.eclinm.2022.101809", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Clinical Trial,Randomized Controlled Trial,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "PMID:36636296", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1016/j.eclinm.2022.101809", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:36636296", "source_url": "https://doi.org/10.1016/j.eclinm.2022.101809", "doi": "10.1016/j.eclinm.2022.101809", "pmid": "36636296", "publication_date": "2022-12-27", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4893, "title": "High dose of psilocybin effective for treatment-resistant depression", "authors": "", "journal": "The Brown University Psychopharmacology Update", "publication_date": "2022-12-26", "publication_year": 2022, "doi": "10.1002/pu.30970", "pubmed_id": null, "openalex_id": "https://openalex.org/W4312206785", "source_url": "https://doi.org/10.1002/pu.30970", "substance_tags": "psilocybin", "topic_tags": "Depression,Pharmacology,Clinical Trial,Treatment-Resistant Depression,Adverse Events", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:47", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "DOI:10.1002/pu.30970", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1002/pu.30970", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1002/pu.30970", "source_url": "https://doi.org/10.1002/pu.30970", "doi": "10.1002/pu.30970", "pmid": "", "publication_date": "2022-12-26", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1528, "title": "Canalization and plasticity in psychopathology.", "authors": "Carhart-Harris RL, Chandaria S, Erritzoe DE, Gazzaley A, Girn M, Kettner H, Mediano PAM, Nutt DJ, Rosas FE, Roseman L, Timmermann C, Weiss B, Zeifman RJ, Friston KJ.", "journal": null, "publication_date": "2022-12-26", "publication_year": 2022, "doi": "10.1016/j.neuropharm.2022.109398", "pubmed_id": "36584883", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.neuropharm.2022.109398", "substance_tags": "psilocybin", "topic_tags": "Depression,Neuroplasticity,Mechanism of Action", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:05", "bibtex": null, "source_record_id": "PMID:36584883", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.neuropharm.2022.109398", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:36584883", "source_url": "https://doi.org/10.1016/j.neuropharm.2022.109398", "doi": "10.1016/j.neuropharm.2022.109398", "pmid": "36584883", "publication_date": "2022-12-26", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4894, "title": "Depression Improves Following Single Dose of Psilocybin", "authors": "Nick Zagorski", "journal": "Psychiatric News", "publication_date": "2022-12-25", "publication_year": 2022, "doi": "10.1176/appi.pn.2023.01.1.50", "pubmed_id": null, "openalex_id": "https://openalex.org/W4312194249", "source_url": "https://doi.org/10.1176/appi.pn.2023.01.1.50", "substance_tags": "psilocybin", "topic_tags": "Depression,Randomized Controlled Trial,Treatment-Resistant Depression,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:47", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "DOI:10.1176/appi.pn.2023.01.1.50", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1176/appi.pn.2023.01.1.50", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1176/appi.pn.2023.01.1.50", "source_url": "https://doi.org/10.1176/appi.pn.2023.01.1.50", "doi": "10.1176/appi.pn.2023.01.1.50", "pmid": "", "publication_date": "2022-12-25", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1596, "title": "Probing the antidepressant potential of psilocybin: integrating insight from human research and animal models towards an understanding of neural circuit mechanisms.", "authors": "Meccia J, Lopez J, Bagot RC.", "journal": null, "publication_date": "2022-12-23", "publication_year": 2022, "doi": "10.1007/s00213-022-06297-0", "pubmed_id": "36564671", "openalex_id": null, "source_url": "https://doi.org/10.1007/s00213-022-06297-0", "substance_tags": "psilocybin", "topic_tags": "Depression,Neuroplasticity,Brain Imaging,Mechanism of Action,Aging,Review Article,Animal Study", "study_type": "Review Article", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:02", "bibtex": null, "source_record_id": "PMID:36564671", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1007/s00213-022-06297-0", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:36564671", "source_url": "https://doi.org/10.1007/s00213-022-06297-0", "doi": "10.1007/s00213-022-06297-0", "pmid": "36564671", "publication_date": "2022-12-23", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1338, "title": "Beliefs and Perceived Barriers Regarding Psychedelic-assisted Therapy in a Pilot Study of Service Members and Veterans With a History of Traumatic Brain Injury", "authors": "Joshua C. Gray, Mikela A. Murphy, Sierra Carter, Matthew W. Johnson, Aaron Wolfgang, Michael J. Roy, Jessica L. Maples-Keller", "journal": "Military Medicine", "publication_date": "2022-12-23", "publication_year": 2022, "doi": "10.1093/milmed/usac400", "pubmed_id": "36564939", "openalex_id": "https://openalex.org/W4312129485", "source_url": "https://doi.org/10.1093/milmed/usac400", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Chronic Pain,Receptor Pharmacology,Aging,Personality Change,Veterans", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "PMID:36564939", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1093/milmed/usac400", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:36564939", "source_url": "https://doi.org/10.1093/milmed/usac400", "doi": "10.1093/milmed/usac400", "pmid": "36564939", "publication_date": "2022-12-23", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1620, "title": "“A sense of the bigger picture:” A qualitative analysis of follow-up interviews with people with bipolar disorder who self-reported psilocybin use", "authors": "Meghan DellaCrosse, Mollie Pleet, Emma Morton, Amir Ashtari, Kimberly Sakai, Josh Woolley, Erin E. Michalak", "journal": "PLoS ONE", "publication_date": "2022-12-13", "publication_year": 2022, "doi": "10.1371/journal.pone.0279073", "pubmed_id": "36516137", "openalex_id": "https://openalex.org/W4311439362", "source_url": "https://doi.org/10.1371/journal.pone.0279073", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Emotional Processing,Clinical Trial,Observational Study,Safety,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "PMID:36516137", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1371/journal.pone.0279073", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:36516137", "source_url": "https://doi.org/10.1371/journal.pone.0279073", "doi": "10.1371/journal.pone.0279073", "pmid": "36516137", "publication_date": "2022-12-13", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1597, "title": "Risks and benefits of psilocybin use in people with bipolar disorder: An international web-based survey on experiences of ‘magic mushroom’ consumption", "authors": "Emma Morton, Kimberly Sakai, Amir Ashtari, Mollie Pleet, Erin E. Michalak, Josh Woolley", "journal": "Journal of Psychopharmacology", "publication_date": "2022-12-13", "publication_year": 2022, "doi": "10.1177/02698811221131997", "pubmed_id": "36515370", "openalex_id": "https://openalex.org/W4311477082", "source_url": "https://doi.org/10.1177/02698811221131997", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Chronic Pain,Clinical Trial,Observational Study,Safety,Adverse Events,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "PMID:36515370", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1177/02698811221131997", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:36515370", "source_url": "https://doi.org/10.1177/02698811221131997", "doi": "10.1177/02698811221131997", "pmid": "36515370", "publication_date": "2022-12-13", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4897, "title": "History of epilepsy increases risk of psychedelic-induced seizures", "authors": "", "journal": "The Brown University Psychopharmacology Update", "publication_date": "2022-12-09", "publication_year": 2022, "doi": "10.1002/pu.30967", "pubmed_id": null, "openalex_id": "https://openalex.org/W4312063948", "source_url": "https://doi.org/10.1002/pu.30967", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Pharmacology,Receptor Pharmacology,Observational Study,Safety,Adverse Events", "study_type": "Observational Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:47", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "DOI:10.1002/pu.30967", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1002/pu.30967", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1002/pu.30967", "source_url": "https://doi.org/10.1002/pu.30967", "doi": "10.1002/pu.30967", "pmid": "", "publication_date": "2022-12-09", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1517, "title": "Psychedelic-Assisted Therapy and Psychedelic Science: A Review and Perspective on Opportunities in Neurosurgery and Neuro-Oncology.", "authors": "Kelly DF, Kelly DF, Heinzerling K, Sharma A, Gowrinathan S, Sergi K, Mallari RJ.", "journal": null, "publication_date": "2022-12-07", "publication_year": 2022, "doi": "10.1227/neu.0000000000002275", "pubmed_id": "36512813", "openalex_id": null, "source_url": "https://doi.org/10.1227/neu.0000000000002275", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Eating Disorders,Chronic Pain,Brain Imaging,Mechanism of Action,Aging,Clinical Trial,Review Article,Cancer Patients,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:06", "bibtex": null, "source_record_id": "PMID:36512813", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1227/neu.0000000000002275", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:36512813", "source_url": "https://doi.org/10.1227/neu.0000000000002275", "doi": "10.1227/neu.0000000000002275", "pmid": "36512813", "publication_date": "2022-12-07", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1570, "title": "Subacute effects of a single dose of psilocybin on biomarkers of inflammation in healthy humans: An open-label preliminary investigation", "authors": "Daniel Burmester, M. Madsen, Attila Szabó, Sanjay S. Aripaka, Dea Siggaard Stenbæk, Vibe G. Frøkjær, Betina Elfving, Jens D. Mikkelsen, Gitte M. Knudsen, Patrick M. Fisher", "journal": "Comprehensive Psychoneuroendocrinology", "publication_date": "2022-12-05", "publication_year": 2022, "doi": "10.1016/j.cpnec.2022.100163", "pubmed_id": "36545240", "openalex_id": "https://openalex.org/W4312056223", "source_url": "https://doi.org/10.1016/j.cpnec.2022.100163", "substance_tags": "psilocybin", "topic_tags": "Depression,Pharmacology,Receptor Pharmacology,Biomarkers,Observational Study,Healthy Volunteers,Toxicity,Inflammation", "study_type": "Observational Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "PMID:36545240", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1016/j.cpnec.2022.100163", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:36545240", "source_url": "https://doi.org/10.1016/j.cpnec.2022.100163", "doi": "10.1016/j.cpnec.2022.100163", "pmid": "36545240", "publication_date": "2022-12-05", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1623, "title": "Psychedelic-Induced Serotonin 2A Receptor Downregulation Does Not Predict Swim Stress Coping in Mice", "authors": "Błażej D. Pędzich, Mireia Medrano, An Buckinx, Ilse Smolders, Dimitri De Bundel", "journal": "International Journal of Molecular Sciences", "publication_date": "2022-12-03", "publication_year": 2022, "doi": "10.3390/ijms232315284", "pubmed_id": "36499610", "openalex_id": "https://openalex.org/W4310675742", "source_url": "https://doi.org/10.3390/ijms232315284", "substance_tags": "psilocybin", "topic_tags": "Depression,Receptor Pharmacology,Animal Study", "study_type": "Animal Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "PMID:36499610", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.3390/ijms232315284", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:36499610", "source_url": "https://doi.org/10.3390/ijms232315284", "doi": "10.3390/ijms232315284", "pmid": "36499610", "publication_date": "2022-12-03", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 2015, "title": "Direct Quantitation of Psilocybin and Psilocin by One-Dimensional 1H and 31P qNMR in a revived Greek specimen of Psilocybe cyanescens", "authors": "Prokopios Magiatis, Evangelos Dadiotis, Romanos Konstantinos Antonopoulos, K Ioannidis, V Mitsis, E Melliou, Zacharoula Gonou-Zagou", "journal": "Planta Medica", "publication_date": "2022-11-30", "publication_year": 2022, "doi": "10.1055/s-0042-1759062", "pubmed_id": null, "openalex_id": "https://openalex.org/W4317241495", "source_url": "https://doi.org/10.1055/s-0042-1759062", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Addiction,End-of-Life Distress,Pharmacology,Clinical Trial", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:52:05", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "DOI:10.1055/s-0042-1759062", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1055/s-0042-1759062", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1055/s-0042-1759062", "source_url": "https://doi.org/10.1055/s-0042-1759062", "doi": "10.1055/s-0042-1759062", "pmid": "", "publication_date": "2022-11-30", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1626, "title": "A Case of Prolonged Mania, Psychosis, and Severe Depression After Psilocybin Use: Implications of Increased Psychedelic Drug Availability", "authors": "Gregory Barber, Charles B. Nemeroff, Steven Siegel", "journal": "American Journal of Psychiatry", "publication_date": "2022-11-30", "publication_year": 2022, "doi": "10.1176/appi.ajp.22010073", "pubmed_id": "36453037", "openalex_id": "https://openalex.org/W4310598708", "source_url": "https://doi.org/10.1176/appi.ajp.22010073", "substance_tags": "psilocybin", "topic_tags": "Depression,Receptor Pharmacology", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "PMID:36453037", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:36453037", "source_url": "https://doi.org/10.1176/appi.ajp.22010073", "doi": "10.1176/appi.ajp.22010073", "pmid": "36453037", "publication_date": "2022-11-30", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1617, "title": "DNA Authentication and Chemical Analysis of Psilocybe Mushrooms Reveal Widespread Misdeterminations in Fungaria and Inconsistencies in Metabolites", "authors": "Alexander J. Bradshaw, Talia Backman, Virginia Ramírez-Cruz, Dale L. Forrister, Jaclyn M. Winter, Laura Guzmán-Dávalos, Giuliana Furci, Paul Stamets, Bryn T. M. Dentinger", "journal": "Applied and Environmental Microbiology", "publication_date": "2022-11-28", "publication_year": 2022, "doi": "10.1128/aem.01498-22", "pubmed_id": "36445079", "openalex_id": "https://openalex.org/W4310466310", "source_url": "https://doi.org/10.1128/aem.01498-22", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,End-of-Life Distress,Pharmacology", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "PMID:36445079", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1128/aem.01498-22", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:36445079", "source_url": "https://doi.org/10.1128/aem.01498-22", "doi": "10.1128/aem.01498-22", "pmid": "36445079", "publication_date": "2022-11-28", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4901, "title": "Fast and sustained effect of 2 administrations of psilocybin on depression", "authors": "Marten Dooper", "journal": null, "publication_date": "2022-11-27", "publication_year": 2022, "doi": "10.55788/0629715f", "pubmed_id": null, "openalex_id": "https://openalex.org/W4310033391", "source_url": "https://doi.org/10.55788/0629715f", "substance_tags": "psilocybin", "topic_tags": "Depression", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:56", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "DOI:10.55788/0629715f", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.55788/0629715f", "source_url": "https://doi.org/10.55788/0629715f", "doi": "10.55788/0629715f", "pmid": "", "publication_date": "2022-11-27", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1600, "title": "Changes in music-evoked emotion and ventral striatal functional connectivity after psilocybin therapy for depression.", "authors": "Shukuroglou M, Roseman L, Wall M, Nutt D, Kaelen M, Carhart-Harris R.", "journal": "Journal of Psychopharmacology", "publication_date": "2022-11-25", "publication_year": 2022, "doi": "10.1177/02698811221125354", "pubmed_id": "36433778", "openalex_id": "https://openalex.org/W4310295919", "source_url": "https://doi.org/10.1177/02698811221125354", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging,Mechanism of Action,Default Mode Network,Aging,Emotional Processing,Treatment-Resistant Depression", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "PMID:36433778", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1177/02698811221125354", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:36433778", "source_url": "https://doi.org/10.1177/02698811221125354", "doi": "10.1177/02698811221125354", "pmid": "36433778", "publication_date": "2022-11-25", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1635, "title": "Psilocybin as a Treatment for Psychiatric Illness: A Meta-Analysis.", "authors": "Irizarry R, Winczura A, Dimassi O, Dhillon N, Minhas A, Larice J.", "journal": null, "publication_date": "2022-11-21", "publication_year": 2022, "doi": "10.7759/cureus.31796", "pubmed_id": "36569662", "openalex_id": null, "source_url": "https://doi.org/10.7759/cureus.31796", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,OCD,Microdosing,Clinical Trial,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Safety", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:01", "bibtex": null, "source_record_id": "PMID:36569662", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.7759/cureus.31796", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:36569662", "source_url": "https://doi.org/10.7759/cureus.31796", "doi": "10.7759/cureus.31796", "pmid": "36569662", "publication_date": "2022-11-21", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1619, "title": "Characterization of the Gateway Decarboxylase for Psilocybin Biosynthesis.", "authors": "Schäfer T, Kramer K, Werten S, Rupp B, Hoffmeister D.", "journal": "ChemBioChem", "publication_date": "2022-11-21", "publication_year": 2022, "doi": "10.1002/cbic.202200551", "pubmed_id": "36327140", "openalex_id": "https://openalex.org/W4308053113", "source_url": "https://doi.org/10.1002/cbic.202200551", "substance_tags": "psilocybin", "topic_tags": "Depression,In Vitro Study", "study_type": "In Vitro Study", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "PMID:36327140", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1002/cbic.202200551", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:36327140", "source_url": "https://doi.org/10.1002/cbic.202200551", "doi": "10.1002/cbic.202200551", "pmid": "36327140", "publication_date": "2022-11-21", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3639, "title": "NW Trauma Therapies, Chronic Illness of Chronic Depression, PTSD, MS, HIV, and SARS-CoV-2, Long Haulers Syndrome. Treatment of Unregulaaible Trauma by the Treatment of Enhanced Micro Dosing the Levels of 0.15, Thru 0.33, With a Maintenance Dose of 1 Gram Per Month for Neural Pathway Increase of Non Synthesized Psilocybin, Using the Actual Plant to Regulate the Highjacked Nervous System.", "authors": "NWTraumatherapies", "journal": "ClinicalTrials.gov", "publication_date": "2022-11-15", "publication_year": 2022, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05042466", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,End-of-Life Distress,Mechanism of Action,Receptor Pharmacology,Microdosing,Immune Function", "study_type": "Other", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:34", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05042466", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05042466", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05042466", "source_url": "https://clinicaltrials.gov/study/NCT05042466", "doi": "", "pmid": "", "publication_date": "2022-11-15", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3794, "title": "Manuel de Yale pour la Thérapie de la Dépression Assistée par la Psilocybine", "authors": "Guss J, Krause R, Sloshower J.", "journal": "PsyArXiv", "publication_date": "2022-11-14", "publication_year": 2022, "doi": "10.31234/osf.io/r96tc", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.31234/osf.io/r96tc", "substance_tags": "psilocybin", "topic_tags": "Depression", "study_type": "Other", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:10:22", "last_checked": "2026-07-01 11:22:05", "bibtex": null, "source_record_id": "DOI:10.31234/osf.io/r96tc", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://doi.org/10.31234/osf.io/r96tc", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "DOI:10.31234/osf.io/r96tc", "source_url": "https://doi.org/10.31234/osf.io/r96tc", "doi": "10.31234/osf.io/r96tc", "pmid": "", "publication_date": "2022-11-14", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3360, "title": "Manuel de Yale pour la Thérapie de la Dépression Assistée par la Psilocybine", "authors": "", "journal": "PsyArXiv", "publication_date": "2022-11-14", "publication_year": 2022, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://osf.io/preprints/psyarxiv/r96tc_v1", "substance_tags": "psilocybin", "topic_tags": "Depression", "study_type": "Other", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:51", "last_checked": "2026-07-01 11:22:30", "bibtex": null, "source_record_id": "https://osf.io/preprints/psyarxiv/r96tc_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/r96tc_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "https://osf.io/preprints/psyarxiv/r96tc_v1", "source_url": "https://osf.io/preprints/psyarxiv/r96tc_v1", "doi": "", "pmid": "", "publication_date": "2022-11-14", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3442, "title": "A Double-Blind Trial of Psilocybin-Assisted Treatment of Alcohol Dependence", "authors": "NYU Langone Health", "journal": "ClinicalTrials.gov", "publication_date": "2022-11-07", "publication_year": 2022, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT02061293", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Spirituality,Safety", "study_type": "Other", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT02061293", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT02061293", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT02061293", "source_url": "https://clinicaltrials.gov/study/NCT02061293", "doi": "", "pmid": "", "publication_date": "2022-11-07", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3314, "title": "5-MeO-DMT modifies innate behaviors and promotes structural neural plasticity in mice", "authors": "Jefferson SJ, Gregg I, Dibbs M, Liao C, Wu H, Davoudian PA, Sprouse JS, Sherwood AM, Kaye AP, Pittenger C, Kwan AC.", "journal": "bioRxiv", "publication_date": "2022-11-02", "publication_year": 2022, "doi": "10.1101/2022.11.03.515044", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.1101/2022.11.03.515044", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Neuroplasticity,Mechanism of Action,Animal Study", "study_type": "Animal Study", "source_name": "bioRxiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:50", "last_checked": "2026-07-01 11:22:04", "bibtex": null, "source_record_id": "DOI:10.1101/2022.11.03.515044", "abstract_available": true, "abstract_source": "bioRxiv", "abstract_source_url": "https://doi.org/10.1101/2022.11.03.515044", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "bioRxiv", "source_record_id": "DOI:10.1101/2022.11.03.515044", "source_url": "https://doi.org/10.1101/2022.11.03.515044", "doi": "10.1101/2022.11.03.515044", "pmid": "", "publication_date": "2022-11-02", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1643, "title": "Psilocybin reduces symptoms in treatment resistant depression, trial results show.", "authors": "Iacobucci G.", "journal": "BMJ", "publication_date": "2022-11-01", "publication_year": 2022, "doi": "10.1136/bmj.o2623", "pubmed_id": "36411539", "openalex_id": "https://openalex.org/W4308444860", "source_url": "https://doi.org/10.1136/bmj.o2623", "substance_tags": "psilocybin", "topic_tags": "Depression", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "PMID:36411539", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:36411539", "source_url": "https://doi.org/10.1136/bmj.o2623", "doi": "10.1136/bmj.o2623", "pmid": "36411539", "publication_date": "2022-11-01", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4910, "title": "The psychedelic renaissance: can psilocybin possibly combat depression?", "authors": "Hamna Raheel, Unaiza Naeem, Asim Shaikh, Omer Ahmed Shaikh", "journal": "International Journal of Surgery Global Health", "publication_date": "2022-10-31", "publication_year": 2022, "doi": "10.1097/gh9.0000000000000089", "pubmed_id": null, "openalex_id": "https://openalex.org/W4318965036", "source_url": "http://dx.doi.org/10.1097/gh9.0000000000000089", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Headache / Migraine,Mechanism of Action,Wellbeing,Personality Change,Emotional Processing,Clinical Trial,Systematic Review,Review Article,Observational Study,Cancer Patients,Treatment-Resistant Depression,Safety,Adverse Events,Toxicity", "study_type": "Systematic Review", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:56", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "DOI:10.1097/gh9.0000000000000089", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.1097/gh9.0000000000000089", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1097/gh9.0000000000000089", "source_url": "http://dx.doi.org/10.1097/gh9.0000000000000089", "doi": "10.1097/gh9.0000000000000089", "pmid": "", "publication_date": "2022-10-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3191, "title": "Psilocybin induces acute and persisting alterations in immune status and the stress response in healthy volunteers", "authors": "Mason N, Szabo A, Kuypers K, Mallaroni P, de la Torre Fornell R, Reckweg J, Tse D, Hutten N, Feilding A, Ramaekers J.", "journal": "medRxiv", "publication_date": "2022-10-31", "publication_year": 2022, "doi": "10.1101/2022.10.31.22281688", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.1101/2022.10.31.22281688", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Biomarkers,Healthy Volunteers,Inflammation,Immune Function", "study_type": "Other", "source_name": "medRxiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:48", "last_checked": "2026-07-01 11:22:02", "bibtex": null, "source_record_id": "DOI:10.1101/2022.10.31.22281688", "abstract_available": true, "abstract_source": "medRxiv", "abstract_source_url": "https://doi.org/10.1101/2022.10.31.22281688", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "medRxiv", "source_record_id": "DOI:10.1101/2022.10.31.22281688", "source_url": "https://doi.org/10.1101/2022.10.31.22281688", "doi": "10.1101/2022.10.31.22281688", "pmid": "", "publication_date": "2022-10-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1644, "title": "[Treatment-resistant depression. From classification to new therapies.]", "authors": "Paganin W, Signorini S, Signorini S, Leccese V, Sciarretta A.", "journal": "Rivista di psichiatria", "publication_date": "2022-10-31", "publication_year": 2022, "doi": "10.1708/3922.39072", "pubmed_id": "36503940", "openalex_id": "https://openalex.org/W4311667760", "source_url": "https://doi.org/10.1708/3922.39072", "substance_tags": "psilocybin", "topic_tags": "Depression,Aging,Treatment-Resistant Depression,Healthcare Workers,Safety", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "PMID:36503940", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1708/3922.39072", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:36503940", "source_url": "https://doi.org/10.1708/3922.39072", "doi": "10.1708/3922.39072", "pmid": "36503940", "publication_date": "2022-10-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1642, "title": "Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression.", "authors": "Goodwin GM, Aaronson ST, Alvarez O, Arden PC, Baker A, Bennett JC, Bird C, Blom RE, Brennan C, Brusch D, Burke L, Campbell-Coker K, Carhart-Harris R, Cattell J, Daniel A, DeBattista C, Dunlop BW, Eisen K, Feifel D, Forbes M, Haumann HM, Hellerstein DJ, Hoppe AI, Husain MI, Jelen LA, Kamphuis J, Kawasaki J, Kelly JR, Key RE, Kishon R, Knatz Peck S, Knight G, Koolen MHB, Lean M, Licht RW, Maples-Keller JL, Mars J, Marwood L, McElhiney MC, Miller TL, Mirow A, Mistry S, Mletzko-Crowe T, Modlin LN, Nielsen RE, Nielson EM, Offerhaus SR, O'Keane V, Páleníček T, Printz D, Rademaker MC, van Reemst A, Reinholdt F, Repantis D, Rucker J, Rudow S, Ruffell S, Rush AJ, Schoevers RA, Seynaeve M, Shao S, Soares JC, Somers M, Stansfield SC, Sterling D, Strockis A, Tsai J, Visser L, Wahba M, Williams S, Young AH, Ywema P, Zisook S, Malievskaia E.", "journal": "New England Journal of Medicine", "publication_date": "2022-10-31", "publication_year": 2022, "doi": "10.1056/nejmoa2206443", "pubmed_id": "36322843", "openalex_id": "https://openalex.org/W4308146982", "source_url": "https://doi.org/10.1056/nejmoa2206443", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Treatment-Resistant Depression", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "PMID:36322843", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1056/nejmoa2206443", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:36322843", "source_url": "https://doi.org/10.1056/nejmoa2206443", "doi": "10.1056/nejmoa2206443", "pmid": "36322843", "publication_date": "2022-10-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1641, "title": "Psilocybin in Treatment-Resistant Depression.", "authors": "Madras BK.", "journal": null, "publication_date": "2022-10-31", "publication_year": 2022, "doi": "10.1056/nejme2210975", "pubmed_id": "36322849", "openalex_id": null, "source_url": "https://doi.org/10.1056/nejme2210975", "substance_tags": "psilocybin", "topic_tags": "Depression,Treatment-Resistant Depression", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:04", "bibtex": null, "source_record_id": "PMID:36322849", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:36322849", "source_url": "https://doi.org/10.1056/nejme2210975", "doi": "10.1056/nejme2210975", "pmid": "36322849", "publication_date": "2022-10-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1604, "title": "Race and ethnicity moderate the associations between lifetime psychedelic use (MDMA/ecstasy and psilocybin) and major depressive episodes.", "authors": "Jones GM.", "journal": "Journal of Psychopharmacology", "publication_date": "2022-10-30", "publication_year": 2022, "doi": "10.1177/02698811221127304", "pubmed_id": "36314881", "openalex_id": "https://openalex.org/W4307773202", "source_url": "https://doi.org/10.1177/02698811221127304", "substance_tags": "psilocybin", "topic_tags": "Depression,Observational Study,Drug Interactions", "study_type": "Observational Study", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "PMID:36314881", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1177/02698811221127304", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:36314881", "source_url": "https://doi.org/10.1177/02698811221127304", "doi": "10.1177/02698811221127304", "pmid": "36314881", "publication_date": "2022-10-30", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3756, "title": "Serotonergic antidepressant use is associated with weaker psilocybin effects", "authors": "Gukasyan N, Griffiths RR, Yaden DB, Antoine D, Nayak SM.", "journal": "PsyArXiv", "publication_date": "2022-10-27", "publication_year": 2022, "doi": "10.31234/osf.io/2zys9", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.31234/osf.io/2zys9", "substance_tags": "psilocybin", "topic_tags": "Depression,Observational Study", "study_type": "Observational Study", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:10:19", "last_checked": "2026-07-01 11:22:01", "bibtex": null, "source_record_id": "DOI:10.31234/osf.io/2zys9", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://doi.org/10.31234/osf.io/2zys9", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "DOI:10.31234/osf.io/2zys9", "source_url": "https://doi.org/10.31234/osf.io/2zys9", "doi": "10.31234/osf.io/2zys9", "pmid": "", "publication_date": "2022-10-27", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3730, "title": "A Bayesian Reanalysis of a Trial of Psilocybin versus Escitalopram for Depression.", "authors": "Nayak SM, Bari BA, Yaden DB, Spriggs MJ, Rosas FE, Peill JM, Giribaldi B, Erritzoe D, Nutt DJ, Carhart-Harris R.", "journal": "Psychedelic Medicine", "publication_date": "2022-10-27", "publication_year": 2022, "doi": "10.1089/psymed.2022.0002", "pubmed_id": "37337526", "openalex_id": "https://openalex.org/W4307481727", "source_url": "https://doi.org/10.1089/psymed.2022.0002", "substance_tags": "psilocybin", "topic_tags": "Depression", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 11:08:42", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "PMID:37337526", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1089/psymed.2022.0002", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:37337526", "source_url": "https://doi.org/10.1089/psymed.2022.0002", "doi": "10.1089/psymed.2022.0002", "pmid": "37337526", "publication_date": "2022-10-27", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3170, "title": "Serotonergic antidepressant use is associated with weaker psilocybin effects", "authors": "", "journal": "PsyArXiv", "publication_date": "2022-10-27", "publication_year": 2022, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://osf.io/preprints/psyarxiv/2zys9_v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Receptor Pharmacology,Observational Study,Drug Interactions", "study_type": "Observational Study", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:47", "last_checked": "2026-07-01 11:22:30", "bibtex": null, "source_record_id": "https://osf.io/preprints/psyarxiv/2zys9_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/2zys9_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "https://osf.io/preprints/psyarxiv/2zys9_v1", "source_url": "https://osf.io/preprints/psyarxiv/2zys9_v1", "doi": "", "pmid": "", "publication_date": "2022-10-27", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3461, "title": "The Safety and Efficacy of Psilocybin in Participants With Type 2 Bipolar Disorder (BP-II) Depression.", "authors": "Sheppard Pratt Health System", "journal": "ClinicalTrials.gov", "publication_date": "2022-10-24", "publication_year": 2022, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT04433845", "substance_tags": "psilocybin", "topic_tags": "Depression,Safety", "study_type": "Other", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT04433845", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT04433845", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT04433845", "source_url": "https://clinicaltrials.gov/study/NCT04433845", "doi": "", "pmid": "", "publication_date": "2022-10-24", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1672, "title": "Culture, context, and ethics in the therapeutic use of hallucinogens: Psychedelics as active super-placebos?", "authors": "Dupuis D, Veissière S.", "journal": null, "publication_date": "2022-10-18", "publication_year": 2022, "doi": "10.1177/13634615221131465", "pubmed_id": "36263513", "openalex_id": null, "source_url": "https://doi.org/10.1177/13634615221131465", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Mechanism of Action,Review Article", "study_type": "Review Article", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:05", "bibtex": null, "source_record_id": "PMID:36263513", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1177/13634615221131465", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:36263513", "source_url": "https://doi.org/10.1177/13634615221131465", "doi": "10.1177/13634615221131465", "pmid": "36263513", "publication_date": "2022-10-18", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1648, "title": "Are Magic Mushrooms Really Magic?: Psilocybin in the Treatment of Depression.", "authors": "Balon R.", "journal": null, "publication_date": "2022-10-15", "publication_year": 2022, "doi": "10.1097/jcp.0000000000001610", "pubmed_id": "36251379", "openalex_id": null, "source_url": "https://doi.org/10.1097/jcp.0000000000001610", "substance_tags": "psilocybin", "topic_tags": "Depression", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:05", "bibtex": null, "source_record_id": "PMID:36251379", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:36251379", "source_url": "https://doi.org/10.1097/jcp.0000000000001610", "doi": "10.1097/jcp.0000000000001610", "pmid": "36251379", "publication_date": "2022-10-15", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1660, "title": "Potential Therapeutic Effects of Psilocybin: A Systematic Review.", "authors": "Goel DB, Zilate S.", "journal": null, "publication_date": "2022-10-11", "publication_year": 2022, "doi": "10.7759/cureus.30214", "pubmed_id": "36381758", "openalex_id": null, "source_url": "https://doi.org/10.7759/cureus.30214", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Pharmacology,Mechanism of Action,Receptor Pharmacology,Aging,Spirituality,Systematic Review,Review Article,Cancer Patients,Treatment-Resistant Depression,Contraindications", "study_type": "Systematic Review", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:02", "bibtex": null, "source_record_id": "PMID:36381758", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.7759/cureus.30214", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:36381758", "source_url": "https://doi.org/10.7759/cureus.30214", "doi": "10.7759/cureus.30214", "pmid": "36381758", "publication_date": "2022-10-11", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1572, "title": "Psychedelic therapy for depressive symptoms: A systematic review and meta-analysis.", "authors": "Ko K, Kopra EI, Cleare AJ, Rucker JJ.", "journal": null, "publication_date": "2022-10-06", "publication_year": 2022, "doi": "10.1016/j.jad.2022.09.168", "pubmed_id": "36209780", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.jad.2022.09.168", "substance_tags": "psilocybin", "topic_tags": "Depression,End-of-Life Distress,Clinical Trial,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:05", "bibtex": null, "source_record_id": "PMID:36209780", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.jad.2022.09.168", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:36209780", "source_url": "https://doi.org/10.1016/j.jad.2022.09.168", "doi": "10.1016/j.jad.2022.09.168", "pmid": "36209780", "publication_date": "2022-10-06", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1667, "title": "3,4-Methylenedioxy methamphetamine, synthetic cathinones and psychedelics: From recreational to novel psychotherapeutic drugs.", "authors": "López-Arnau R, Camarasa J, Carbó ML, Nadal-Gratacós N, Puigseslloses P, Espinosa-Velasco M, Urquizu E, Escubedo E, Pubill D.", "journal": null, "publication_date": "2022-10-02", "publication_year": 2022, "doi": "10.3389/fpsyt.2022.990405", "pubmed_id": "36262632", "openalex_id": null, "source_url": "https://doi.org/10.3389/fpsyt.2022.990405", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Mechanism of Action,Consciousness,Review Article,Treatment-Resistant Depression,Adverse Events", "study_type": "Review Article", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:06", "bibtex": null, "source_record_id": "PMID:36262632", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.3389/fpsyt.2022.990405", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:36262632", "source_url": "https://doi.org/10.3389/fpsyt.2022.990405", "doi": "10.3389/fpsyt.2022.990405", "pmid": "36262632", "publication_date": "2022-10-02", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1649, "title": "A Critical Appraisal of Evidence on the Efficacy and Safety of Serotonergic Psychedelic Drugs as Emerging Antidepressants: Mind the Evidence Gap.", "authors": "Ledwos N, Rosenblat JD, Blumberger DM, Castle DJ, McIntyre RS, Mulsant BH, Husain MI.", "journal": null, "publication_date": "2022-10-02", "publication_year": 2022, "doi": "10.1097/jcp.0000000000001608", "pubmed_id": "36193898", "openalex_id": null, "source_url": "https://doi.org/10.1097/jcp.0000000000001608", "substance_tags": "psilocybin", "topic_tags": "Depression,End-of-Life Distress,Receptor Pharmacology,Clinical Trial,Randomized Controlled Trial,Review Article,Treatment-Resistant Depression,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:05", "bibtex": null, "source_record_id": "PMID:36193898", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1097/jcp.0000000000001608", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:36193898", "source_url": "https://doi.org/10.1097/jcp.0000000000001608", "doi": "10.1097/jcp.0000000000001608", "pmid": "36193898", "publication_date": "2022-10-02", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4920, "title": "19.3 Psilocybin-Assisted Therapy for MDD: Current Evidence and Clinical Considerations", "authors": "Natalie Gukasyan", "journal": "Journal of the American Academy of Child & Adolescent Psychiatry", "publication_date": "2022-09-30", "publication_year": 2022, "doi": "10.1016/j.jaac.2022.07.664", "pubmed_id": null, "openalex_id": "https://openalex.org/W4304633208", "source_url": "https://doi.org/10.1016/j.jaac.2022.07.664", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Receptor Pharmacology,Randomized Controlled Trial", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:56", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "DOI:10.1016/j.jaac.2022.07.664", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.jaac.2022.07.664", "source_url": "https://doi.org/10.1016/j.jaac.2022.07.664", "doi": "10.1016/j.jaac.2022.07.664", "pmid": "", "publication_date": "2022-09-30", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1683, "title": "New investigational agents for the treatment of major depressive disorder.", "authors": "Pochwat B, Krupa AJ, Siwek M, Szewczyk B", "journal": "Expert opinion on investigational drugs", "publication_date": "2022-09-30", "publication_year": 2022, "doi": "10.1080/13543784.2022.2113376", "pubmed_id": "35975761", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/35975761/", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Receptor Pharmacology,Review Article", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:20:38", "bibtex": null, "source_record_id": "PMID:35975761", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/35975761/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:35975761", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35975761/", "doi": "10.1080/13543784.2022.2113376", "pmid": "35975761", "publication_date": "2022-09-30", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1673, "title": "Animal Behavior in Psychedelic Research.", "authors": "Odland AU, Kristensen JL, Andreasen JT.", "journal": null, "publication_date": "2022-09-30", "publication_year": 2022, "doi": "10.1124/pharmrev.122.000590", "pubmed_id": "36180111", "openalex_id": null, "source_url": "https://doi.org/10.1124/pharmrev.122.000590", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Receptor Pharmacology,Consciousness,Emotional Processing,Review Article,Drug Interactions", "study_type": "Review Article", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:06", "bibtex": null, "source_record_id": "PMID:36180111", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1124/pharmrev.122.000590", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:36180111", "source_url": "https://doi.org/10.1124/pharmrev.122.000590", "doi": "10.1124/pharmrev.122.000590", "pmid": "36180111", "publication_date": "2022-09-30", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3244, "title": "Psilocybin Therapy for Treatment Resistant Depression: Prediction of Clinical Outcome by Natural Language Processing", "authors": "Dougherty RF, Clarke P, Alti M, Kuc J, Schlosser D, Dunlop BW, Hellerstein DJ, Aaronson ST, Zisook S, Young AH, Carhart-Harris R, Goodwin G, Ryslik GA.", "journal": "PsyArXiv", "publication_date": "2022-09-29", "publication_year": 2022, "doi": "10.31234/osf.io/kh3cx", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.31234/osf.io/kh3cx", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Emotional Processing,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:49", "last_checked": "2026-07-01 11:22:03", "bibtex": null, "source_record_id": "DOI:10.31234/osf.io/kh3cx", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://doi.org/10.31234/osf.io/kh3cx", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "DOI:10.31234/osf.io/kh3cx", "source_url": "https://doi.org/10.31234/osf.io/kh3cx", "doi": "10.31234/osf.io/kh3cx", "pmid": "", "publication_date": "2022-09-29", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 643, "title": "Psilocybin Therapy for Treatment Resistant Depression: Prediction of Clinical Outcome by Natural Language Processing", "authors": "", "journal": "PsyArXiv", "publication_date": "2022-09-29", "publication_year": 2022, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://osf.io/preprints/psyarxiv/kh3cx_v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Emotional Processing,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:30", "bibtex": null, "source_record_id": "https://osf.io/preprints/psyarxiv/kh3cx_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/kh3cx_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "https://osf.io/preprints/psyarxiv/kh3cx_v1", "source_url": "https://osf.io/preprints/psyarxiv/kh3cx_v1", "doi": "", "pmid": "", "publication_date": "2022-09-29", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4923, "title": "The psychedelic escape from depression", "authors": "Michael Eisenstein", "journal": "Nature", "publication_date": "2022-09-27", "publication_year": 2022, "doi": "10.1038/d41586-022-02872-9", "pubmed_id": "36171370", "openalex_id": "https://openalex.org/W4297493645", "source_url": "https://doi.org/10.1038/d41586-022-02872-9", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:56", "last_checked": "2026-07-04 06:51:56", "bibtex": null, "source_record_id": "PMID:36171370", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:36171370", "source_url": "https://doi.org/10.1038/d41586-022-02872-9", "doi": "10.1038/d41586-022-02872-9", "pmid": "36171370", "publication_date": "2022-09-27", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1691, "title": "Esketamine and Psilocybin-The Comparison of Two Mind-Altering Agents in Depression Treatment: Systematic Review.", "authors": "Psiuk D, Nowak EM, Dycha N, Łopuszańska U, Kurzepa J, Samardakiewicz M.", "journal": null, "publication_date": "2022-09-27", "publication_year": 2022, "doi": "10.3390/ijms231911450", "pubmed_id": "36232748", "openalex_id": null, "source_url": "https://doi.org/10.3390/ijms231911450", "substance_tags": "psilocybin", "topic_tags": "Depression,Systematic Review,Review Article", "study_type": "Systematic Review", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:02", "bibtex": null, "source_record_id": "PMID:36232748", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.3390/ijms231911450", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:36232748", "source_url": "https://doi.org/10.3390/ijms231911450", "doi": "10.3390/ijms231911450", "pmid": "36232748", "publication_date": "2022-09-27", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3477, "title": "Multicentre Study To Assess Safety And Efficacy Of Psilocybin In Patients With Treatment-Resistant Depression Following Completion Of COMP001 And COMP003 Trials (P-TRD LTFU)", "authors": "COMPASS Pathways", "journal": "ClinicalTrials.gov", "publication_date": "2022-09-21", "publication_year": 2022, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT04519957", "substance_tags": "psilocybin", "topic_tags": "Depression,Treatment-Resistant Depression,Safety", "study_type": "Other", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT04519957", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT04519957", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT04519957", "source_url": "https://clinicaltrials.gov/study/NCT04519957", "doi": "", "pmid": "", "publication_date": "2022-09-21", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1674, "title": "The Emerging Field of Psychedelic Psychotherapy.", "authors": "Barber GS, Aaronson ST.", "journal": null, "publication_date": "2022-09-20", "publication_year": 2022, "doi": "10.1007/s11920-022-01363-y", "pubmed_id": "36129571", "openalex_id": null, "source_url": "https://doi.org/10.1007/s11920-022-01363-y", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Review Article", "study_type": "Review Article", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:05", "bibtex": null, "source_record_id": "PMID:36129571", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1007/s11920-022-01363-y", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:36129571", "source_url": "https://doi.org/10.1007/s11920-022-01363-y", "doi": "10.1007/s11920-022-01363-y", "pmid": "36129571", "publication_date": "2022-09-20", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3126, "title": "Brain dynamics predictive of response to psilocybin for treatment-resistant depression", "authors": "Vohryzek J, Cabral J, Lord L, Fernandes H, Roseman L, Nutt D, Carhart-Harris R, Deco G, Kringelbach M.", "journal": "Research Square", "publication_date": "2022-09-19", "publication_year": 2022, "doi": "10.21203/rs.3.rs-2060381/v1", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.21203/rs.3.rs-2060381/v1", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Mechanism of Action,Receptor Pharmacology,Treatment-Resistant Depression", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "preprint", "date_added": "2026-07-01 11:03:47", "last_checked": "2026-07-01 11:22:01", "bibtex": null, "source_record_id": "DOI:10.21203/rs.3.rs-2060381/v1", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.21203/rs.3.rs-2060381/v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "DOI:10.21203/rs.3.rs-2060381/v1", "source_url": "https://doi.org/10.21203/rs.3.rs-2060381/v1", "doi": "10.21203/rs.3.rs-2060381/v1", "pmid": "", "publication_date": "2022-09-19", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1607, "title": "Towards an understanding of psychedelic-induced neuroplasticity.", "authors": "Calder AE, Hasler G.", "journal": null, "publication_date": "2022-09-18", "publication_year": 2022, "doi": "10.1038/s41386-022-01389-z", "pubmed_id": "36123427", "openalex_id": null, "source_url": "https://doi.org/10.1038/s41386-022-01389-z", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Neuroplasticity,Neurogenesis,Mechanism of Action,Microdosing,Review Article", "study_type": "Review Article", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:05", "bibtex": null, "source_record_id": "PMID:36123427", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1038/s41386-022-01389-z", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:36123427", "source_url": "https://doi.org/10.1038/s41386-022-01389-z", "doi": "10.1038/s41386-022-01389-z", "pmid": "36123427", "publication_date": "2022-09-18", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4929, "title": "Psilocybin as a healer", "authors": "Kavita Golia", "journal": "Consciousness Spirituality & Transpersonal Psychology", "publication_date": "2022-09-11", "publication_year": 2022, "doi": "10.53074/cstp.2022.37", "pubmed_id": null, "openalex_id": "https://openalex.org/W4297872378", "source_url": "https://doi.org/10.53074/cstp.2022.37", "substance_tags": "psilocybin", "topic_tags": "Depression,Microdosing,Wellbeing,Creativity", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:56", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "DOI:10.53074/cstp.2022.37", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.53074/cstp.2022.37", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.53074/cstp.2022.37", "source_url": "https://doi.org/10.53074/cstp.2022.37", "doi": "10.53074/cstp.2022.37", "pmid": "", "publication_date": "2022-09-11", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3178, "title": "Effective connectivity of emotion and cognition under psilocybin", "authors": "Stoliker D, Novelli L, Vollenweider FX, Egan GF, Preller KH, Razi A.", "journal": "medRxiv", "publication_date": "2022-09-08", "publication_year": 2022, "doi": "10.1101/2022.09.06.22279626", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.1101/2022.09.06.22279626", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Default Mode Network,Biomarkers,Emotional Processing,Clinical Trial", "study_type": "Clinical Trial", "source_name": "medRxiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:47", "last_checked": "2026-07-01 11:22:02", "bibtex": null, "source_record_id": "DOI:10.1101/2022.09.06.22279626", "abstract_available": true, "abstract_source": "medRxiv", "abstract_source_url": "https://doi.org/10.1101/2022.09.06.22279626", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "medRxiv", "source_record_id": "DOI:10.1101/2022.09.06.22279626", "source_url": "https://doi.org/10.1101/2022.09.06.22279626", "doi": "10.1101/2022.09.06.22279626", "pmid": "", "publication_date": "2022-09-08", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1698, "title": "Effects of psilocybin versus escitalopram on rumination and thought suppression in depression.", "authors": "Barba T, Buehler S, Kettner H, Radu C, Cunha BG, Nutt DJ, Erritzoe D, Roseman L, Carhart-Harris R.", "journal": "BJPsych Open", "publication_date": "2022-09-05", "publication_year": 2022, "doi": "10.1192/bjo.2022.565", "pubmed_id": "36065128", "openalex_id": "https://openalex.org/W4294808278", "source_url": "https://doi.org/10.1192/bjo.2022.565", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Drug Interactions", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "PMID:36065128", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1192/bjo.2022.565", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:36065128", "source_url": "https://doi.org/10.1192/bjo.2022.565", "doi": "10.1192/bjo.2022.565", "pmid": "36065128", "publication_date": "2022-09-05", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1520, "title": "Microdosing psilocybin for chronic pain: a case series.", "authors": "Lyes M, Yang KH, Castellanos J, Furnish T.", "journal": "Pain", "publication_date": "2022-09-04", "publication_year": 2022, "doi": "10.1097/j.pain.0000000000002778", "pubmed_id": "36066961", "openalex_id": "https://openalex.org/W4294804950", "source_url": "https://doi.org/10.1097/j.pain.0000000000002778", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Chronic Pain,Neuroplasticity,Microdosing,Clinical Trial,Case Report", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "PMID:36066961", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1097/j.pain.0000000000002778", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:36066961", "source_url": "https://doi.org/10.1097/j.pain.0000000000002778", "doi": "10.1097/j.pain.0000000000002778", "pmid": "36066961", "publication_date": "2022-09-04", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 5632, "title": "Psychedelics’ binding depends on receptor mutations", "authors": "special to C EN Attabey Rodríguez Benítez", "journal": "C&EN Global Enterprise", "publication_date": "2022-09-01", "publication_year": 2022, "doi": "10.1021/cen-10031-scicon6", "pubmed_id": null, "openalex_id": "https://openalex.org/W4294310361", "source_url": "https://doi.org/10.1021/cen-10031-scicon6", "substance_tags": "psilocin", "topic_tags": "Depression,PTSD,Pharmacology,Receptor Pharmacology,Emotional Processing,Clinical Trial", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:52:10", "last_checked": "2026-07-04 06:52:10", "bibtex": null, "source_record_id": "DOI:10.1021/cen-10031-scicon6", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1021/cen-10031-scicon6", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1021/cen-10031-scicon6", "source_url": "https://doi.org/10.1021/cen-10031-scicon6", "doi": "10.1021/cen-10031-scicon6", "pmid": "", "publication_date": "2022-09-01", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4933, "title": "Psychedelics for Psychiatric Disorders: Promise, Not Panacea", "authors": "Mitch Earleywine, Zachary Herrmann", "journal": "Psychiatric Annals", "publication_date": "2022-08-31", "publication_year": 2022, "doi": "10.3928/00485713-20220810-01", "pubmed_id": null, "openalex_id": "https://openalex.org/W4294911993", "source_url": "https://doi.org/10.3928/00485713-20220810-01", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,End-of-Life Distress,Mechanism of Action,Cancer Patients,Treatment-Resistant Depression,Toxicity", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:56", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "DOI:10.3928/00485713-20220810-01", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.3928/00485713-20220810-01", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.3928/00485713-20220810-01", "source_url": "https://doi.org/10.3928/00485713-20220810-01", "doi": "10.3928/00485713-20220810-01", "pmid": "", "publication_date": "2022-08-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3377, "title": "Psychopathological descriptive model of hallucinogenic/psychedelic drugs effect in the treatment of depression and addictions", "authors": "Girala N.", "journal": null, "publication_date": "2022-08-31", "publication_year": 2022, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://europepmc.org/article/PMC/PMC9567945", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Emotional Processing,Mystical Experience,Review Article", "study_type": "Review Article", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 11:03:52", "last_checked": "2026-07-01 11:22:05", "bibtex": null, "source_record_id": "https://europepmc.org/article/PMC/PMC9567945", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://europepmc.org/article/PMC/PMC9567945", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "https://europepmc.org/article/PMC/PMC9567945", "source_url": "https://europepmc.org/article/PMC/PMC9567945", "doi": "", "pmid": "", "publication_date": "2022-08-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3376, "title": "Exploring Psychedelics and Entactogens as Treatments for Psychiatric Disorders: Proceedings of a Workshop", "authors": "National Academies of Sciences, Engineering, and Medicine; Health and Medicine Division; Board on Health Sciences Policy; Forum on Neuroscience and Nervous System Disorders.", "journal": "National Academies Press (US), Washington (DC)", "publication_date": "2022-08-31", "publication_year": 2022, "doi": null, "pubmed_id": "36049038", "openalex_id": null, "source_url": "https://europepmc.org/article/MED/36049038", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Mechanism of Action,Healthcare Workers,Safety", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 11:03:52", "last_checked": "2026-07-01 11:22:05", "bibtex": null, "source_record_id": "PMID:36049038", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://europepmc.org/article/MED/36049038", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:36049038", "source_url": "https://europepmc.org/article/MED/36049038", "doi": "", "pmid": "36049038", "publication_date": "2022-08-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3169, "title": "Association of Psilocybin Use in Adolescents with Major Depressive Episode", "authors": "Shah K, Trivedi C, Kamrai D, Akbar M, Tankersley W.", "journal": null, "publication_date": "2022-08-31", "publication_year": 2022, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://europepmc.org/article/PMC/PMC9563652", "substance_tags": "psilocybin", "topic_tags": "Depression,Observational Study,Adolescents", "study_type": "Observational Study", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 11:03:47", "last_checked": "2026-07-01 11:22:01", "bibtex": null, "source_record_id": "https://europepmc.org/article/PMC/PMC9563652", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://europepmc.org/article/PMC/PMC9563652", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "https://europepmc.org/article/PMC/PMC9563652", "source_url": "https://europepmc.org/article/PMC/PMC9563652", "doi": "", "pmid": "", "publication_date": "2022-08-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1702, "title": "[The use of psilocybin for treatment-resistant depression].", "authors": "Johannesdottir A, Sigurdsson E.", "journal": null, "publication_date": "2022-08-31", "publication_year": 2022, "doi": "10.17992/lbl.2022.09.706", "pubmed_id": "36040772", "openalex_id": null, "source_url": "https://doi.org/10.17992/lbl.2022.09.706", "substance_tags": "psilocybin", "topic_tags": "Depression,Headache / Migraine,Mechanism of Action,Clinical Trial,Randomized Controlled Trial,Systematic Review,Review Article,Treatment-Resistant Depression", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:01", "bibtex": null, "source_record_id": "PMID:36040772", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.17992/lbl.2022.09.706", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:36040772", "source_url": "https://doi.org/10.17992/lbl.2022.09.706", "doi": "10.17992/lbl.2022.09.706", "pmid": "36040772", "publication_date": "2022-08-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1694, "title": "The Use of Psychedelics in the Treatment of Medical Conditions: An Analysis of Currently Registered Psychedelics Studies in the American Drug Trial Registry.", "authors": "Kurtz JS, Patel NA, Gendreau JL, Yang C, Brown N, Bui N, Picton B, Harris M, Hatter M, Beyer R, Sahyouni R, Diaz-Aguilar LD, Castellanos J, Schuster N, Abraham ME", "journal": "Cureus", "publication_date": "2022-08-31", "publication_year": 2022, "doi": "10.7759/cureus.29167", "pubmed_id": "36259015", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/36259015/", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Addiction,Receptor Pharmacology,Clinical Trial", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:20:38", "bibtex": null, "source_record_id": "PMID:36259015", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/36259015/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:36259015", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36259015/", "doi": "10.7759/cureus.29167", "pmid": "36259015", "publication_date": "2022-08-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1168, "title": "Psychedelic Psychiatry", "authors": "Nutt D.", "journal": null, "publication_date": "2022-08-31", "publication_year": 2022, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://europepmc.org/article/PMC/PMC9565852", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,OCD,Eating Disorders,Neuroplasticity,Brain Imaging,Mechanism of Action,Receptor Pharmacology,Default Mode Network,Aging", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:05", "bibtex": null, "source_record_id": "https://europepmc.org/article/PMC/PMC9565852", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://europepmc.org/article/PMC/PMC9565852", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "https://europepmc.org/article/PMC/PMC9565852", "source_url": "https://europepmc.org/article/PMC/PMC9565852", "doi": "", "pmid": "", "publication_date": "2022-08-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1697, "title": "Skepticism about Recent Evidence That Psilocybin \"Liberates\" Depressed Minds.", "authors": "Doss MK, Barrett FS, Corlett PR.", "journal": "ACS Chemical Neuroscience", "publication_date": "2022-08-23", "publication_year": 2022, "doi": "10.1021/acschemneuro.2c00461", "pubmed_id": "36001741", "openalex_id": "https://openalex.org/W4293101872", "source_url": "https://doi.org/10.1021/acschemneuro.2c00461", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging,Receptor Pharmacology,Aging,Drug Interactions", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "PMID:36001741", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1021/acschemneuro.2c00461", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:36001741", "source_url": "https://doi.org/10.1021/acschemneuro.2c00461", "doi": "10.1021/acschemneuro.2c00461", "pmid": "36001741", "publication_date": "2022-08-23", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4938, "title": "Dark Side of the Shroom: Erasing Indigenous and Counterculture Wisdoms with Psychedelic Capitalism, and the Open Source Alternative", "authors": "Neşe Devenot, Trey Conner, Richard Doyle", "journal": "Anthropology of Consciousness", "publication_date": "2022-08-21", "publication_year": 2022, "doi": "10.1111/anoc.12154", "pubmed_id": null, "openalex_id": "https://openalex.org/W4292574083", "source_url": "https://doi.org/10.1111/anoc.12154", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Headache / Migraine,Clinical Trial,Review Article", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:56", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "DOI:10.1111/anoc.12154", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1111/anoc.12154", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1111/anoc.12154", "source_url": "https://doi.org/10.1111/anoc.12154", "doi": "10.1111/anoc.12154", "pmid": "", "publication_date": "2022-08-21", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1687, "title": "Where do we go next in antidepressant drug discovery? A new generation of antidepressants: a pivotal role of AMPA receptor potentiation and mGlu2/3 receptor antagonism.", "authors": "Pilc A, Machaczka A, Kawalec P, Smith JL, Witkin JM.", "journal": "Expert Opinion on Drug Discovery", "publication_date": "2022-08-21", "publication_year": 2022, "doi": "10.1080/17460441.2022.2111415", "pubmed_id": "35934973", "openalex_id": "https://openalex.org/W4290613434", "source_url": "https://doi.org/10.1080/17460441.2022.2111415", "substance_tags": "psilocybin", "topic_tags": "Depression,Pharmacology,Mechanism of Action,Receptor Pharmacology,Animal Study", "study_type": "Animal Study", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "PMID:35934973", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1080/17460441.2022.2111415", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:35934973", "source_url": "https://doi.org/10.1080/17460441.2022.2111415", "doi": "10.1080/17460441.2022.2111415", "pmid": "35934973", "publication_date": "2022-08-21", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1711, "title": "Cystathionine Gamma-Lyase Regulate Psilocybin Biosynthesis in Gymnopilus dilepis Mushroom via Amino Acid Metabolism Pathways.", "authors": "Yao S, Wei C, Lin H, Zhang P, Liu Y, Deng Y, Huang Q, Xie B.", "journal": "Journal of Fungi", "publication_date": "2022-08-17", "publication_year": 2022, "doi": "10.3390/jof8080870", "pubmed_id": "36012858", "openalex_id": "https://openalex.org/W4292248697", "source_url": "https://doi.org/10.3390/jof8080870", "substance_tags": "psilocybin", "topic_tags": "Depression,Pharmacology,Mechanism of Action,Transcriptomics", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "PMID:36012858", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.3390/jof8080870", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:36012858", "source_url": "https://doi.org/10.3390/jof8080870", "doi": "10.3390/jof8080870", "pmid": "36012858", "publication_date": "2022-08-17", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4941, "title": "A-118 Psychedelic Interventions for Neuropsychological Conditions", "authors": "Brian Peacock", "journal": "Archives of Clinical Neuropsychology", "publication_date": "2022-08-16", "publication_year": 2022, "doi": "10.1093/arclin/acac060.118", "pubmed_id": null, "openalex_id": "https://openalex.org/W4292089187", "source_url": "https://doi.org/10.1093/arclin/acac060.118", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Pharmacology,Receptor Pharmacology,Clinical Trial,Safety,Contraindications", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:57", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "DOI:10.1093/arclin/acac060.118", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1093/arclin/acac060.118", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1093/arclin/acac060.118", "source_url": "https://doi.org/10.1093/arclin/acac060.118", "doi": "10.1093/arclin/acac060.118", "pmid": "", "publication_date": "2022-08-16", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1608, "title": "The Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Report: Serotonergic Psychedelic Treatments for Major Depressive Disorder.", "authors": "Rosenblat JD, Husain MI, Lee Y, McIntyre RS, Mansur RB, Castle D, Offman H, Parikh SV, Frey BN, Schaffer A, Greenway KT, Garel N, Beaulieu S, Kennedy SH, Lam RW, Milev R, Ravindran AV, Tourjman V, Ameringen MV, Yatham LN, Taylor V.", "journal": null, "publication_date": "2022-08-16", "publication_year": 2022, "doi": "10.1177/07067437221111371", "pubmed_id": "35975555", "openalex_id": null, "source_url": "https://doi.org/10.1177/07067437221111371", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Headache / Migraine,Clinical Trial,Randomized Controlled Trial,Systematic Review,Review Article,Cancer Patients,Treatment-Resistant Depression,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:04", "bibtex": null, "source_record_id": "PMID:35975555", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1177/07067437221111371", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:35975555", "source_url": "https://doi.org/10.1177/07067437221111371", "doi": "10.1177/07067437221111371", "pmid": "35975555", "publication_date": "2022-08-16", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1686, "title": "Psilocybin Efficacy and Mechanisms of Action in Major Depressive Disorder: a Review.", "authors": "Prouzeau D, Conejero I, Voyvodic PL, Becamel C, Abbar M, Lopez-Castroman J.", "journal": null, "publication_date": "2022-08-11", "publication_year": 2022, "doi": "10.1007/s11920-022-01361-0", "pubmed_id": "35953638", "openalex_id": null, "source_url": "https://doi.org/10.1007/s11920-022-01361-0", "substance_tags": "psilocybin", "topic_tags": "Depression,End-of-Life Distress,Mechanism of Action,Clinical Trial,Review Article,Adverse Events", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:02", "bibtex": null, "source_record_id": "PMID:35953638", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1007/s11920-022-01361-0", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:35953638", "source_url": "https://doi.org/10.1007/s11920-022-01361-0", "doi": "10.1007/s11920-022-01361-0", "pmid": "35953638", "publication_date": "2022-08-11", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1692, "title": "Differences across sexes on head-twitch behavior and 5-HT2A receptor signaling in C57BL/6J mice.", "authors": "Jaster AM, Younkin J, Cuddy T, de la Fuente Revenga M, Poklis JL, Dozmorov MG, González-Maeso J.", "journal": null, "publication_date": "2022-08-09", "publication_year": 2022, "doi": "10.1016/j.neulet.2022.136836", "pubmed_id": "35963476", "openalex_id": "https://openalex.org/W4291398459", "source_url": "https://doi.org/10.1016/j.neulet.2022.136836", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Pharmacology,Mechanism of Action,Receptor Pharmacology,Animal Study", "study_type": "Animal Study", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:06", "bibtex": null, "source_record_id": "PMID:35963476", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.neulet.2022.136836", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:35963476", "source_url": "https://doi.org/10.1016/j.neulet.2022.136836", "doi": "10.1016/j.neulet.2022.136836", "pmid": "35963476", "publication_date": "2022-08-09", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1651, "title": "The Watts Connectedness Scale: a new scale for measuring a sense of connectedness to self, others, and world.", "authors": "Watts R, Kettner H, Geerts D, Gandy S, Kartner L, Mertens L, Timmermann C, Nour MM, Kaelen M, Nutt D, Carhart-Harris R, Roseman L.", "journal": "Psychopharmacology", "publication_date": "2022-08-07", "publication_year": 2022, "doi": "10.1007/s00213-022-06187-5", "pubmed_id": "35939083", "openalex_id": "https://openalex.org/W4290631853", "source_url": "https://doi.org/10.1007/s00213-022-06187-5", "substance_tags": "psilocybin", "topic_tags": "Depression,Emotional Processing,Clinical Trial,Randomized Controlled Trial,Observational Study", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "PMID:35939083", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1007/s00213-022-06187-5", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:35939083", "source_url": "https://doi.org/10.1007/s00213-022-06187-5", "doi": "10.1007/s00213-022-06187-5", "pmid": "35939083", "publication_date": "2022-08-07", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4947, "title": "Depression: Psilocybin etwas besser als Escitalopram", "authors": "", "journal": "Zeitschrift für Phytotherapie", "publication_date": "2022-07-31", "publication_year": 2022, "doi": "10.1055/a-1857-9047", "pubmed_id": null, "openalex_id": "https://openalex.org/W4297691226", "source_url": "https://doi.org/10.1055/a-1857-9047", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:57", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "DOI:10.1055/a-1857-9047", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1055/a-1857-9047", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1055/a-1857-9047", "source_url": "https://doi.org/10.1055/a-1857-9047", "doi": "10.1055/a-1857-9047", "pmid": "", "publication_date": "2022-07-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4946, "title": "Med Check: Psilocybin for OCD, Nuplazid Vote, and More", "authors": "Terri D’Arrigo", "journal": "Psychiatric News", "publication_date": "2022-07-31", "publication_year": 2022, "doi": "10.1176/appi.pn.2022.08.8.2", "pubmed_id": null, "openalex_id": "https://openalex.org/W4289781881", "source_url": "https://doi.org/10.1176/appi.pn.2022.08.8.2", "substance_tags": "psilocybin", "topic_tags": "Depression,OCD,Headache / Migraine,Pharmacology,Mechanism of Action,Clinical Trial,Review Article,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:57", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "DOI:10.1176/appi.pn.2022.08.8.2", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1176/appi.pn.2022.08.8.2", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1176/appi.pn.2022.08.8.2", "source_url": "https://doi.org/10.1176/appi.pn.2022.08.8.2", "doi": "10.1176/appi.pn.2022.08.8.2", "pmid": "", "publication_date": "2022-07-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1729, "title": "Top Ten Tips Palliative Care Clinicians Should Know About Psychedelic-Assisted Therapy in the Context of Serious Illness.", "authors": "Rosa WE, Sager Z, Miller M, Bernstein I, Doerner Rinaldi A, Addicott K, Ljuslin M, Adrian C, Back AL, Beachy J, Bossis AP, Breitbart WS, Cosimano MP, Fischer SM, Guss J, Knighton E, Phelps J, Richards BD, Richards WA, Tulsky JA, Williams MT, Beaussant Y", "journal": "Journal of palliative medicine", "publication_date": "2022-07-31", "publication_year": 2022, "doi": "10.1089/jpm.2022.0036", "pubmed_id": "35285721", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/35285721/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,End-of-Life Distress,Treatment-Resistant Depression,Healthcare Workers,Safety", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:20:39", "bibtex": null, "source_record_id": "PMID:35285721", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/35285721/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:35285721", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35285721/", "doi": "10.1089/jpm.2022.0036", "pmid": "35285721", "publication_date": "2022-07-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1719, "title": "Antidepressant effects of a psychedelic experience in a large prospective naturalistic sample.", "authors": "Nygart VA, Pommerencke LM, Haijen E, Kettner H, Kaelen M, Mortensen EL, Nutt DJ, Carhart-Harris RL, Erritzoe D", "journal": "Journal of psychopharmacology (Oxford, England)", "publication_date": "2022-07-31", "publication_year": 2022, "doi": "10.1177/02698811221101061", "pubmed_id": "35924888", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/35924888/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Emotional Processing,Mystical Experience,Observational Study", "study_type": "Observational Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:20:38", "bibtex": null, "source_record_id": "PMID:35924888", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/35924888/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:35924888", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35924888/", "doi": "10.1177/02698811221101061", "pmid": "35924888", "publication_date": "2022-07-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1731, "title": "Psilocybin reduces low frequency oscillatory power and neuronal phase-locking in the anterior cingulate cortex of awake rodents.", "authors": "Golden CT, Chadderton P.", "journal": "Scientific Reports", "publication_date": "2022-07-25", "publication_year": 2022, "doi": "10.1038/s41598-022-16325-w", "pubmed_id": "35882885", "openalex_id": "https://openalex.org/W4287981303", "source_url": "https://doi.org/10.1038/s41598-022-16325-w", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Mechanism of Action,Default Mode Network,Animal Study", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "PMID:35882885", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1038/s41598-022-16325-w", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:35882885", "source_url": "https://doi.org/10.1038/s41598-022-16325-w", "doi": "10.1038/s41598-022-16325-w", "pmid": "35882885", "publication_date": "2022-07-25", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3594, "title": "Evaluation of Psilocybin in Anorexia Nervosa: Safety and Efficacy", "authors": "University of California, San Diego", "journal": "ClinicalTrials.gov", "publication_date": "2022-07-24", "publication_year": 2022, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT04661514", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Eating Disorders,Clinical Trial,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT04661514", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT04661514", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT04661514", "source_url": "https://clinicaltrials.gov/study/NCT04661514", "doi": "", "pmid": "", "publication_date": "2022-07-24", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1688, "title": "Magic Mushrooms - an exploratory look at how mental health professionals feel and think about Psilocybin.", "authors": "Meyer TD, Meir P, Lex C, Soares JC.", "journal": "Psychiatry Research", "publication_date": "2022-07-15", "publication_year": 2022, "doi": "10.1016/j.psychres.2022.114727", "pubmed_id": "35878481", "openalex_id": "https://openalex.org/W4285605468", "source_url": "https://doi.org/10.1016/j.psychres.2022.114727", "substance_tags": "psilocybin", "topic_tags": "Depression,Emotional Processing,Observational Study", "study_type": "Observational Study", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "PMID:35878481", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.psychres.2022.114727", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:35878481", "source_url": "https://doi.org/10.1016/j.psychres.2022.114727", "doi": "10.1016/j.psychres.2022.114727", "pmid": "35878481", "publication_date": "2022-07-15", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1736, "title": "Psychedelics, Mystical Experience, and Therapeutic Efficacy: A Systematic Review.", "authors": "Ko K, Knight G, Rucker JJ, Cleare AJ.", "journal": null, "publication_date": "2022-07-11", "publication_year": 2022, "doi": "10.3389/fpsyt.2022.917199", "pubmed_id": "35923458", "openalex_id": null, "source_url": "https://doi.org/10.3389/fpsyt.2022.917199", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Mystical Experience,Systematic Review,Review Article,Cancer Patients", "study_type": "Systematic Review", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:05", "bibtex": null, "source_record_id": "PMID:35923458", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.3389/fpsyt.2022.917199", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:35923458", "source_url": "https://doi.org/10.3389/fpsyt.2022.917199", "doi": "10.3389/fpsyt.2022.917199", "pmid": "35923458", "publication_date": "2022-07-11", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1652, "title": "Rapid-Response Treatments for Depression and Requests for Physician-Assisted Death: An Ethical Analysis.", "authors": "Berens N, Kim SY.", "journal": null, "publication_date": "2022-07-10", "publication_year": 2022, "doi": "10.1016/j.jagp.2022.07.003", "pubmed_id": "35927119", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.jagp.2022.07.003", "substance_tags": "psilocybin", "topic_tags": "Depression,End-of-Life Distress,Case Report,Healthcare Workers", "study_type": "Case Report", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:05", "bibtex": null, "source_record_id": "PMID:35927119", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.jagp.2022.07.003", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:35927119", "source_url": "https://doi.org/10.1016/j.jagp.2022.07.003", "doi": "10.1016/j.jagp.2022.07.003", "pmid": "35927119", "publication_date": "2022-07-10", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1426, "title": "Psilocybin in neuropsychiatry: a review of its pharmacology, safety, and efficacy.", "authors": "Dodd S, Norman TR, Eyre HA, Stahl SM, Phillips A, Carvalho AF, Berk M.", "journal": null, "publication_date": "2022-07-10", "publication_year": 2022, "doi": "10.1017/s1092852922000888", "pubmed_id": "35811423", "openalex_id": null, "source_url": "https://doi.org/10.1017/s1092852922000888", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Anxiety,Pharmacology,Mechanism of Action,Receptor Pharmacology,Review Article,Safety", "study_type": "Review Article", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:00", "bibtex": null, "source_record_id": "PMID:35811423", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1017/s1092852922000888", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:35811423", "source_url": "https://doi.org/10.1017/s1092852922000888", "doi": "10.1017/s1092852922000888", "pmid": "35811423", "publication_date": "2022-07-10", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1738, "title": "Psychedelics in the treatment of unipolar and bipolar depression.", "authors": "Bosch OG, Halm S, Seifritz E.", "journal": null, "publication_date": "2022-07-04", "publication_year": 2022, "doi": "10.1186/s40345-022-00265-5", "pubmed_id": "35788817", "openalex_id": null, "source_url": "https://doi.org/10.1186/s40345-022-00265-5", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Receptor Pharmacology,Emotional Processing,Clinical Trial,Review Article,Safety", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:05", "bibtex": null, "source_record_id": "PMID:35788817", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1186/s40345-022-00265-5", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:35788817", "source_url": "https://doi.org/10.1186/s40345-022-00265-5", "doi": "10.1186/s40345-022-00265-5", "pmid": "35788817", "publication_date": "2022-07-04", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1693, "title": "Psychedelic drugs for psychiatric disorders.", "authors": "da Costa SC, Oesterle T, Rummans TA, Richelson E, Gold M.", "journal": null, "publication_date": "2022-07-04", "publication_year": 2022, "doi": "10.1016/j.jns.2022.120332", "pubmed_id": "35841696", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.jns.2022.120332", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,End-of-Life Distress,Consciousness,Aging,Spirituality,Clinical Trial,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:06", "bibtex": null, "source_record_id": "PMID:35841696", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.jns.2022.120332", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:35841696", "source_url": "https://doi.org/10.1016/j.jns.2022.120332", "doi": "10.1016/j.jns.2022.120332", "pmid": "35841696", "publication_date": "2022-07-04", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3131, "title": "Brain dynamics predictive of response to psilocybin for treatment-resistant depression", "authors": "Vohryzek J, Cabral J, Lord L, Fernandes HM, Roseman L, Nutt DJ, Carhart-Harris RL, Deco G, Kringelbach ML.", "journal": "bioRxiv", "publication_date": "2022-07-03", "publication_year": 2022, "doi": "10.1101/2022.06.30.497950", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.1101/2022.06.30.497950", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Mechanism of Action,Receptor Pharmacology,Treatment-Resistant Depression", "study_type": "Other", "source_name": "bioRxiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:47", "last_checked": "2026-07-01 11:22:01", "bibtex": null, "source_record_id": "DOI:10.1101/2022.06.30.497950", "abstract_available": true, "abstract_source": "bioRxiv", "abstract_source_url": "https://doi.org/10.1101/2022.06.30.497950", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "bioRxiv", "source_record_id": "DOI:10.1101/2022.06.30.497950", "source_url": "https://doi.org/10.1101/2022.06.30.497950", "doi": "10.1101/2022.06.30.497950", "pmid": "", "publication_date": "2022-07-03", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3384, "title": "Synapses, predictions, and prediction errors: a neocortical computational study of MDD using the temporal memory algorithm of HTM", "authors": "Sherif MA, Khalil MZ, Shukla R, Brown JC, Carpenter LL.", "journal": "bioRxiv", "publication_date": "2022-07-02", "publication_year": 2022, "doi": "10.1101/2022.06.29.498015", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.1101/2022.06.29.498015", "substance_tags": "psilocybin", "topic_tags": "Depression,Neuroplasticity,Mechanism of Action", "study_type": "Other", "source_name": "bioRxiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:52", "last_checked": "2026-07-01 11:22:06", "bibtex": null, "source_record_id": "DOI:10.1101/2022.06.29.498015", "abstract_available": true, "abstract_source": "bioRxiv", "abstract_source_url": "https://doi.org/10.1101/2022.06.29.498015", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "bioRxiv", "source_record_id": "DOI:10.1101/2022.06.29.498015", "source_url": "https://doi.org/10.1101/2022.06.29.498015", "doi": "10.1101/2022.06.29.498015", "pmid": "", "publication_date": "2022-07-02", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4951, "title": "Psychedelic use in India, its pattern and personal significance - findings from an online survey", "authors": "Gokul Raj", "journal": "Indian Journal of Psychiatry", "publication_date": "2022-06-30", "publication_year": 2022, "doi": "10.4103/indianjpsychiatry.indianjpsychiatry_447_21", "pubmed_id": "36060724", "openalex_id": "https://openalex.org/W4285412529", "source_url": "https://doi.org/10.4103/indianjpsychiatry.indianjpsychiatry_447_21", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,End-of-Life Distress,Personality Change,Spirituality,Mystical Experience,Observational Study,Treatment-Resistant Depression", "study_type": "Observational Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:57", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "PMID:36060724", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.4103/indianjpsychiatry.indianjpsychiatry_447_21", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:36060724", "source_url": "https://doi.org/10.4103/indianjpsychiatry.indianjpsychiatry_447_21", "doi": "10.4103/indianjpsychiatry.indianjpsychiatry_447_21", "pmid": "36060724", "publication_date": "2022-06-30", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3187, "title": "A Bayesian Reanalysis of a Trial of Psilocybin versus Escitalopram for Depression", "authors": "Nayak SM, Bari BA, Yaden DB, Spriggs MJ, Rosas F, Peill JM, Giribaldi B, Erritzoe D, Nutt D, Carhart-Harris R.", "journal": "PsyArXiv", "publication_date": "2022-06-30", "publication_year": 2022, "doi": "10.31234/osf.io/sb5ur", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.31234/osf.io/sb5ur", "substance_tags": "psilocybin", "topic_tags": "Depression", "study_type": "Other", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:48", "last_checked": "2026-07-01 11:22:02", "bibtex": null, "source_record_id": "DOI:10.31234/osf.io/sb5ur", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://doi.org/10.31234/osf.io/sb5ur", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "DOI:10.31234/osf.io/sb5ur", "source_url": "https://doi.org/10.31234/osf.io/sb5ur", "doi": "10.31234/osf.io/sb5ur", "pmid": "", "publication_date": "2022-06-30", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1748, "title": "Psychedelic-inspired approaches for treating neurodegenerative disorders.", "authors": "Saeger HN, Olson DE", "journal": "Journal of neurochemistry", "publication_date": "2022-06-30", "publication_year": 2022, "doi": "10.1111/jnc.15544", "pubmed_id": "34816433", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/34816433/", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Addiction,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Inflammation,Immune Function", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:20:39", "bibtex": null, "source_record_id": "PMID:34816433", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/34816433/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:34816433", "source_url": "https://pubmed.ncbi.nlm.nih.gov/34816433/", "doi": "10.1111/jnc.15544", "pmid": "34816433", "publication_date": "2022-06-30", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1740, "title": "Self-administration of Psilocybin in the Setting of Treatment-resistant Depression.", "authors": "Lyons A.", "journal": "PubMed", "publication_date": "2022-06-30", "publication_year": 2022, "doi": null, "pubmed_id": "36204170", "openalex_id": "https://openalex.org/W4303509980", "source_url": "https://europepmc.org/article/MED/36204170", "substance_tags": "psilocybin", "topic_tags": "Depression,Microdosing,Randomized Controlled Trial,Treatment-Resistant Depression,Adverse Events", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:38", "bibtex": null, "source_record_id": "PMID:36204170", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://europepmc.org/article/MED/36204170", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:36204170", "source_url": "https://europepmc.org/article/MED/36204170", "doi": "", "pmid": "36204170", "publication_date": "2022-06-30", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1540, "title": "A Bayesian Reanalysis of a Trial of Psilocybin versus Escitalopram for Depression", "authors": "", "journal": "PsyArXiv", "publication_date": "2022-06-30", "publication_year": 2022, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://osf.io/preprints/psyarxiv/sb5ur_v1", "substance_tags": "psilocybin", "topic_tags": "Depression", "study_type": "Other", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:30", "bibtex": null, "source_record_id": "https://osf.io/preprints/psyarxiv/sb5ur_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/sb5ur_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "https://osf.io/preprints/psyarxiv/sb5ur_v1", "source_url": "https://osf.io/preprints/psyarxiv/sb5ur_v1", "doi": "", "pmid": "", "publication_date": "2022-06-30", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4952, "title": "Psilocybin microdosers demonstrate greater observed improvements in mood and mental health at one month relative to non-microdosing controls", "authors": "Joseph M. Rootman, Maggie Kiraga, Pamela Kryskow, Kalin Harvey, Paul Stamets, Eesmyal Santos-Brault, Kim P.C. Kuypers, Zach Walsh", "journal": "VIUspace", "publication_date": "2022-06-29", "publication_year": 2022, "doi": "10.25316/ir-20556", "pubmed_id": null, "openalex_id": "https://openalex.org/W7125943988", "source_url": "https://doi.org/10.25316/ir-20556", "substance_tags": "psilocybin", "topic_tags": "Depression,Microdosing,Observational Study,Toxicity", "study_type": "Observational Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:57", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "DOI:10.25316/ir-20556", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.25316/ir-20556", "source_url": "https://doi.org/10.25316/ir-20556", "doi": "10.25316/ir-20556", "pmid": "", "publication_date": "2022-06-29", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3653, "title": "Randomized Double Blind Placebo Controlled Assessing the Efficacy of Micro-dosed Psilocybin in Reducing Anxiety and or Depression Levels in Adults", "authors": "Wake Network, Inc.", "journal": "ClinicalTrials.gov", "publication_date": "2022-06-29", "publication_year": 2022, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT04989972", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Wellbeing,Clinical Trial,Review Article,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:34", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT04989972", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT04989972", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT04989972", "source_url": "https://clinicaltrials.gov/study/NCT04989972", "doi": "", "pmid": "", "publication_date": "2022-06-29", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3381, "title": "Neuroimaging in psychedelic drug development: Past, present, and future", "authors": "Wall M, Harding R, Zafar R, Rabiner EA, Nutt D, Erritzoe D.", "journal": "PsyArXiv", "publication_date": "2022-06-29", "publication_year": 2022, "doi": "10.31234/osf.io/xwu4j", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.31234/osf.io/xwu4j", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Addiction,Eating Disorders,Brain Imaging,Pharmacology,Aging", "study_type": "Other", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:52", "last_checked": "2026-07-01 11:22:06", "bibtex": null, "source_record_id": "DOI:10.31234/osf.io/xwu4j", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://doi.org/10.31234/osf.io/xwu4j", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "DOI:10.31234/osf.io/xwu4j", "source_url": "https://doi.org/10.31234/osf.io/xwu4j", "doi": "10.31234/osf.io/xwu4j", "pmid": "", "publication_date": "2022-06-29", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1383, "title": "Neuroimaging in psychedelic drug development: Past, present, and future", "authors": "", "journal": "PsyArXiv", "publication_date": "2022-06-29", "publication_year": 2022, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://osf.io/preprints/psyarxiv/xwu4j_v1", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Addiction,Eating Disorders,Brain Imaging,Pharmacology,Aging", "study_type": "Other", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:30", "bibtex": null, "source_record_id": "https://osf.io/preprints/psyarxiv/xwu4j_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/xwu4j_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "https://osf.io/preprints/psyarxiv/xwu4j_v1", "source_url": "https://osf.io/preprints/psyarxiv/xwu4j_v1", "doi": "", "pmid": "", "publication_date": "2022-06-29", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1754, "title": "Three Naturally-Occurring Psychedelics and Their Significance in the Treatment of Mental Health Disorders.", "authors": "Vorobyeva N, Kozlova AA.", "journal": null, "publication_date": "2022-06-27", "publication_year": 2022, "doi": "10.3389/fphar.2022.927984", "pubmed_id": "35837277", "openalex_id": null, "source_url": "https://doi.org/10.3389/fphar.2022.927984", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Receptor Pharmacology,Review Article", "study_type": "Review Article", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:05", "bibtex": null, "source_record_id": "PMID:35837277", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.3389/fphar.2022.927984", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:35837277", "source_url": "https://doi.org/10.3389/fphar.2022.927984", "doi": "10.3389/fphar.2022.927984", "pmid": "35837277", "publication_date": "2022-06-27", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1753, "title": "3,4-Methylenedioxymethamphetamine (MDMA)-Assisted Therapy in Hawaii: A Brief Review.", "authors": "Inouye A, Wolfgang A.", "journal": null, "publication_date": "2022-06-27", "publication_year": 2022, "doi": "10.7759/cureus.26402", "pubmed_id": "35915689", "openalex_id": null, "source_url": "https://doi.org/10.7759/cureus.26402", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Clinical Trial,Review Article,Safety", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:05", "bibtex": null, "source_record_id": "PMID:35915689", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.7759/cureus.26402", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:35915689", "source_url": "https://doi.org/10.7759/cureus.26402", "doi": "10.7759/cureus.26402", "pmid": "35915689", "publication_date": "2022-06-27", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4954, "title": "MSR20 Challenges in the Development of Economic Evaluations for Psychedelics in Treatment of Depression", "authors": "J Schneider, JP Cooper, S Davies, K Beltran", "journal": "Value in Health", "publication_date": "2022-06-24", "publication_year": 2022, "doi": "10.1016/j.jval.2022.04.1227", "pubmed_id": null, "openalex_id": "https://openalex.org/W4283528627", "source_url": "https://doi.org/10.1016/j.jval.2022.04.1227", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:57", "last_checked": "2026-07-04 06:51:57", "bibtex": null, "source_record_id": "DOI:10.1016/j.jval.2022.04.1227", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.jval.2022.04.1227", "source_url": "https://doi.org/10.1016/j.jval.2022.04.1227", "doi": "10.1016/j.jval.2022.04.1227", "pmid": "", "publication_date": "2022-06-24", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1609, "title": "Sustained effects of single doses of classical psychedelics in humans.", "authors": "Knudsen GM.", "journal": null, "publication_date": "2022-06-20", "publication_year": 2022, "doi": "10.1038/s41386-022-01361-x", "pubmed_id": "35729252", "openalex_id": null, "source_url": "https://doi.org/10.1038/s41386-022-01361-x", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Neuroplasticity,Brain Imaging,Receptor Pharmacology,Aging,Personality Change,Emotional Processing,Review Article", "study_type": "Review Article", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:04", "bibtex": null, "source_record_id": "PMID:35729252", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1038/s41386-022-01361-x", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:35729252", "source_url": "https://doi.org/10.1038/s41386-022-01361-x", "doi": "10.1038/s41386-022-01361-x", "pmid": "35729252", "publication_date": "2022-06-20", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1551, "title": "[Attitudes of Mental Health Experts Towards Psilocybin].", "authors": "Schmidt C, Wolff M, Gründer G, Jungaberle H.", "journal": "Fortschritte der Neurologie · Psychiatrie", "publication_date": "2022-06-19", "publication_year": 2022, "doi": "10.1055/a-1846-1161", "pubmed_id": "35724682", "openalex_id": "https://openalex.org/W4283204986", "source_url": "https://doi.org/10.1055/a-1846-1161", "substance_tags": "psilocybin", "topic_tags": "Depression,Observational Study", "study_type": "Observational Study", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "PMID:35724682", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1055/a-1846-1161", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:35724682", "source_url": "https://doi.org/10.1055/a-1846-1161", "doi": "10.1055/a-1846-1161", "pmid": "35724682", "publication_date": "2022-06-19", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1758, "title": "Effect of Psilocybin and Ketamine on Brain Neurotransmitters, Glutamate Receptors, DNA and Rat Behavior.", "authors": "Wojtas A, Bysiek A, Wawrzczak-Bargiela A, Szych Z, Majcher-Maślanka I, Herian M, Maćkowiak M, Gołembiowska K.", "journal": "International Journal of Molecular Sciences", "publication_date": "2022-06-15", "publication_year": 2022, "doi": "10.3390/ijms23126713", "pubmed_id": "35743159", "openalex_id": "https://openalex.org/W4283011889", "source_url": "https://doi.org/10.3390/ijms23126713", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Receptor Pharmacology,Animal Study,Toxicity", "study_type": "Animal Study", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "PMID:35743159", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.3390/ijms23126713", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:35743159", "source_url": "https://doi.org/10.3390/ijms23126713", "doi": "10.3390/ijms23126713", "pmid": "35743159", "publication_date": "2022-06-15", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1759, "title": "Validation of the forced swim test in Drosophila, and its use to demonstrate psilocybin has long-lasting antidepressant-like effects in flies.", "authors": "Hibicke M, Nichols CD.", "journal": "Scientific Reports", "publication_date": "2022-06-14", "publication_year": 2022, "doi": "10.1038/s41598-022-14165-2", "pubmed_id": "35705666", "openalex_id": "https://openalex.org/W4282963889", "source_url": "https://doi.org/10.1038/s41598-022-14165-2", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "PMID:35705666", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1038/s41598-022-14165-2", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:35705666", "source_url": "https://doi.org/10.1038/s41598-022-14165-2", "doi": "10.1038/s41598-022-14165-2", "pmid": "35705666", "publication_date": "2022-06-14", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4956, "title": "Psychedelic assisted therapy for major depressive disorder: Recent work and clinical directions", "authors": "Annie M. McCartney, H. T. McGovern, Alexander De Foe", "journal": "Journal of Psychedelic Studies", "publication_date": "2022-06-08", "publication_year": 2022, "doi": "10.1556/2054.2022.00211", "pubmed_id": null, "openalex_id": "https://openalex.org/W4282040347", "source_url": "https://doi.org/10.1556/2054.2022.00211", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Receptor Pharmacology,Clinical Trial,Review Article,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:57", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "DOI:10.1556/2054.2022.00211", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1556/2054.2022.00211", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1556/2054.2022.00211", "source_url": "https://doi.org/10.1556/2054.2022.00211", "doi": "10.1556/2054.2022.00211", "pmid": "", "publication_date": "2022-06-08", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4961, "title": "Neuropharmacological analysis of the anti-addictive and therapeutic effects of psilocybin", "authors": "Anthony Principe", "journal": "SURG Journal", "publication_date": "2022-05-31", "publication_year": 2022, "doi": "10.21083/surg.v14i1.6870", "pubmed_id": null, "openalex_id": "https://openalex.org/W4281736251", "source_url": "https://doi.org/10.21083/surg.v14i1.6870", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,OCD,Pharmacology,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Review Article", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:57", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "DOI:10.21083/surg.v14i1.6870", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.21083/surg.v14i1.6870", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.21083/surg.v14i1.6870", "source_url": "https://doi.org/10.21083/surg.v14i1.6870", "doi": "10.21083/surg.v14i1.6870", "pmid": "", "publication_date": "2022-05-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4959, "title": "The safety and efficacy of psilocybin therapy in patients with cancer and major depressive disorder.", "authors": "Manish Agrawal, Paul Thambi, Sarah Shnayder", "journal": "Journal of Clinical Oncology", "publication_date": "2022-05-31", "publication_year": 2022, "doi": "10.1200/jco.2022.40.16_suppl.12097", "pubmed_id": null, "openalex_id": "https://openalex.org/W4281784879", "source_url": "https://doi.org/10.1200/jco.2022.40.16_suppl.12097", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Clinical Trial,Observational Study,Cancer Patients,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:57", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "DOI:10.1200/jco.2022.40.16_suppl.12097", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1200/jco.2022.40.16_suppl.12097", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1200/jco.2022.40.16_suppl.12097", "source_url": "https://doi.org/10.1200/jco.2022.40.16_suppl.12097", "doi": "10.1200/jco.2022.40.16_suppl.12097", "pmid": "", "publication_date": "2022-05-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4958, "title": "Association of Psilocybin Use in Adolescents with Major Depressive Episode", "authors": "Kaushal Shah, C. Trivedi, D. Kamrai, M. Akbar, W. Tankersley", "journal": "European Psychiatry", "publication_date": "2022-05-31", "publication_year": 2022, "doi": "10.1192/j.eurpsy.2022.837", "pubmed_id": null, "openalex_id": "https://openalex.org/W4294189301", "source_url": "https://doi.org/10.1192/j.eurpsy.2022.837", "substance_tags": "psilocybin", "topic_tags": "Depression,Observational Study,Adolescents", "study_type": "Observational Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:57", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "DOI:10.1192/j.eurpsy.2022.837", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1192/j.eurpsy.2022.837", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1192/j.eurpsy.2022.837", "source_url": "https://doi.org/10.1192/j.eurpsy.2022.837", "doi": "10.1192/j.eurpsy.2022.837", "pmid": "", "publication_date": "2022-05-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1763, "title": "How to account for hallucinations in the interpretation of the antidepressant effects of psychedelics: a translational framework.", "authors": "van den Berg M, Magaraggia I, Schreiber R, Hillhouse TM, Porter JH", "journal": "Psychopharmacology", "publication_date": "2022-05-31", "publication_year": 2022, "doi": "10.1007/s00213-022-06106-8", "pubmed_id": "35348806", "openalex_id": "https://openalex.org/W4220677776", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35348806/", "substance_tags": "psilocybin", "topic_tags": "Depression,Pharmacology,Mystical Experience,Treatment-Resistant Depression", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:20:39", "bibtex": null, "source_record_id": "PMID:35348806", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/35348806/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:35348806", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35348806/", "doi": "10.1007/s00213-022-06106-8", "pmid": "35348806", "publication_date": "2022-05-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1762, "title": "Can the revival of serotonergic psychedelic drugs as treatments for mental disorders help to characterize their risks and benefits?", "authors": "Husain MI, Umer M, Mulsant BH", "journal": "Expert opinion on drug safety", "publication_date": "2022-05-31", "publication_year": 2022, "doi": "10.1080/14740338.2022.2063274", "pubmed_id": "35387542", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/35387542/", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Addiction,Safety", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:20:39", "bibtex": null, "source_record_id": "PMID:35387542", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:35387542", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35387542/", "doi": "10.1080/14740338.2022.2063274", "pmid": "35387542", "publication_date": "2022-05-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1742, "title": "Neural mechanisms underlying psilocybin's therapeutic potential - the need for preclinical in vivo electrophysiology.", "authors": "Smausz R, Neill J, Gigg J.", "journal": null, "publication_date": "2022-05-29", "publication_year": 2022, "doi": "10.1177/02698811221092508", "pubmed_id": "35638159", "openalex_id": null, "source_url": "https://doi.org/10.1177/02698811221092508", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging,Mechanism of Action,Receptor Pharmacology,Default Mode Network,Consciousness,Aging,Emotional Processing,Review Article,Animal Study", "study_type": "Review Article", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:06", "bibtex": null, "source_record_id": "PMID:35638159", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1177/02698811221092508", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:35638159", "source_url": "https://doi.org/10.1177/02698811221092508", "doi": "10.1177/02698811221092508", "pmid": "35638159", "publication_date": "2022-05-29", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1724, "title": "Postpartum depression: A role for psychedelics?", "authors": "Jairaj C, Rucker JJ.", "journal": null, "publication_date": "2022-05-29", "publication_year": 2022, "doi": "10.1177/02698811221093793", "pubmed_id": "35638179", "openalex_id": null, "source_url": "https://doi.org/10.1177/02698811221093793", "substance_tags": "psilocybin", "topic_tags": "Depression,Aging,Review Article,Safety", "study_type": "Review Article", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:05", "bibtex": null, "source_record_id": "PMID:35638179", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1177/02698811221093793", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:35638179", "source_url": "https://doi.org/10.1177/02698811221093793", "doi": "10.1177/02698811221093793", "pmid": "35638179", "publication_date": "2022-05-29", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1780, "title": "Unraveling the Mysteries of Mental Illness With Psilocybin.", "authors": "Sotille R, Singh H, Weisman A, Vida T.", "journal": null, "publication_date": "2022-05-26", "publication_year": 2022, "doi": "10.7759/cureus.25414", "pubmed_id": "35769681", "openalex_id": null, "source_url": "https://doi.org/10.7759/cureus.25414", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Neuroplasticity,Receptor Pharmacology,Clinical Trial,Review Article,Animal Study,Treatment-Resistant Depression", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:01", "bibtex": null, "source_record_id": "PMID:35769681", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.7759/cureus.25414", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:35769681", "source_url": "https://doi.org/10.7759/cureus.25414", "doi": "10.7759/cureus.25414", "pmid": "35769681", "publication_date": "2022-05-26", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4967, "title": "Psilocybin-Assisted Therapy Found to Improve Depression, Offer Other Benefits", "authors": "Richard Karel", "journal": "Psychiatric News", "publication_date": "2022-05-22", "publication_year": 2022, "doi": "10.1176/appi.pn.2022.06.6.30", "pubmed_id": null, "openalex_id": "https://openalex.org/W4281400661", "source_url": "https://doi.org/10.1176/appi.pn.2022.06.6.30", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Pharmacology,Consciousness,Wellbeing,Spirituality,Mystical Experience,Observational Study,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:57", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "DOI:10.1176/appi.pn.2022.06.6.30", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1176/appi.pn.2022.06.6.30", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1176/appi.pn.2022.06.6.30", "source_url": "https://doi.org/10.1176/appi.pn.2022.06.6.30", "doi": "10.1176/appi.pn.2022.06.6.30", "pmid": "", "publication_date": "2022-05-22", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1784, "title": "New Paradigms of Old Psychedelics in Schizophrenia.", "authors": "Mahmood D, Alenezi SK, Anwar MJ, Azam F, Qureshi KA, Jaremko M.", "journal": null, "publication_date": "2022-05-22", "publication_year": 2022, "doi": "10.3390/ph15050640", "pubmed_id": "35631466", "openalex_id": null, "source_url": "https://doi.org/10.3390/ph15050640", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Mechanism of Action,Receptor Pharmacology,Microdosing,Drug Interactions", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:06", "bibtex": null, "source_record_id": "PMID:35631466", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.3390/ph15050640", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:35631466", "source_url": "https://doi.org/10.3390/ph15050640", "doi": "10.3390/ph15050640", "pmid": "35631466", "publication_date": "2022-05-22", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3676, "title": "Psilocybin Versus Ketamine - Fast Acting Antidepressant Strategies in Treatment-resistant Depression", "authors": "National Institute of Mental Health, Czech Republic", "journal": "ClinicalTrials.gov", "publication_date": "2022-05-19", "publication_year": 2022, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05383313", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Neuroplasticity,Brain Imaging,Biomarkers,Aging,Emotional Processing,Clinical Trial,Healthy Volunteers,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:34", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05383313", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05383313", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05383313", "source_url": "https://clinicaltrials.gov/study/NCT05383313", "doi": "", "pmid": "", "publication_date": "2022-05-19", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1739, "title": "Assessment of Bioactivity-Modulating Pseudo-Ring Formation in Psilocin and Related Tryptamines.", "authors": "Lenz C, Dörner S, Trottmann F, Hertweck C, Sherwood A, Hoffmeister D.", "journal": "ChemBioChem", "publication_date": "2022-05-17", "publication_year": 2022, "doi": "10.1002/cbic.202200183", "pubmed_id": "35483009", "openalex_id": "https://openalex.org/W4225114051", "source_url": "https://doi.org/10.1002/cbic.202200183", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Pharmacology,Consciousness,Drug Interactions", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "PMID:35483009", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1002/cbic.202200183", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:35483009", "source_url": "https://doi.org/10.1002/cbic.202200183", "doi": "10.1002/cbic.202200183", "pmid": "35483009", "publication_date": "2022-05-17", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4968, "title": "The Efficacy of Psilocybin in the Treatment of Depression andAnxiety: A Meta-Analysis", "authors": "Andrew Hodge, Suporn Sukpraprut-Braaten, Robert Strayhan", "journal": "Current Psychiatry Research and Reviews", "publication_date": "2022-05-15", "publication_year": 2022, "doi": "10.2174/2666082218666220513142002", "pubmed_id": null, "openalex_id": "https://openalex.org/W4280584826", "source_url": "https://doi.org/10.2174/2666082218666220513142002", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Receptor Pharmacology,Clinical Trial,Randomized Controlled Trial,Meta-Analysis", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:57", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "DOI:10.2174/2666082218666220513142002", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.2174/2666082218666220513142002", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.2174/2666082218666220513142002", "source_url": "https://doi.org/10.2174/2666082218666220513142002", "doi": "10.2174/2666082218666220513142002", "pmid": "", "publication_date": "2022-05-15", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1705, "title": "Magic mushroom extracts in lipid membranes.", "authors": "Nguyen TQT, Lund FW, Zanjani AAH, Khandelia H.", "journal": "Biochimica et Biophysica Acta (BBA) - Biomembranes", "publication_date": "2022-05-09", "publication_year": 2022, "doi": "10.1016/j.bbamem.2022.183957", "pubmed_id": "35561790", "openalex_id": "https://openalex.org/W4280500709", "source_url": "https://doi.org/10.1016/j.bbamem.2022.183957", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Addiction,Receptor Pharmacology,Treatment-Resistant Depression", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "PMID:35561790", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.bbamem.2022.183957", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:35561790", "source_url": "https://doi.org/10.1016/j.bbamem.2022.183957", "doi": "10.1016/j.bbamem.2022.183957", "pmid": "35561790", "publication_date": "2022-05-09", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1789, "title": "The psychological processes of classic psychedelics in the treatment of depression: a systematic review protocol.", "authors": "Johansen L, Liknaitzky P, Nedeljkovic M, Mastin-Purcell L, Murray G", "journal": "Systematic reviews", "publication_date": "2022-05-04", "publication_year": 2022, "doi": "10.1186/s13643-022-01930-7", "pubmed_id": "35513876", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/35513876/", "substance_tags": "psilocybin", "topic_tags": "Depression,Systematic Review,Review Article", "study_type": "Systematic Review", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:20:39", "bibtex": null, "source_record_id": "PMID:35513876", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/35513876/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:35513876", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35513876/", "doi": "10.1186/s13643-022-01930-7", "pmid": "35513876", "publication_date": "2022-05-04", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1790, "title": "The Pharmacology and Clinical Applications of Psychedelic Medicines Within Midwifery Practice.", "authors": "Stein CA, Penn A, Van Hope S, Dorsen CG, Mangini M", "journal": "Journal of midwifery & women's health", "publication_date": "2022-04-30", "publication_year": 2022, "doi": "10.1111/jmwh.13371", "pubmed_id": "35522087", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/35522087/", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Pharmacology,Review Article", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:20:39", "bibtex": null, "source_record_id": "PMID:35522087", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/35522087/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:35522087", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35522087/", "doi": "10.1111/jmwh.13371", "pmid": "35522087", "publication_date": "2022-04-30", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4972, "title": "Socio-psychedelic imaginaries: envisioning and building legal psychedelic worlds in the United States", "authors": "Claudia Schwarz-Plaschg", "journal": "European Journal of Futures Research", "publication_date": "2022-04-29", "publication_year": 2022, "doi": "10.1186/s40309-022-00199-2", "pubmed_id": null, "openalex_id": "https://openalex.org/W4225266953", "source_url": "https://doi.org/10.1186/s40309-022-00199-2", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:57", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "DOI:10.1186/s40309-022-00199-2", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1186/s40309-022-00199-2", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1186/s40309-022-00199-2", "source_url": "https://doi.org/10.1186/s40309-022-00199-2", "doi": "10.1186/s40309-022-00199-2", "pmid": "", "publication_date": "2022-04-29", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3659, "title": "Phase II, Randomized, Double Blind, Placebo Controlled, Parallel Group, Single Center Study of Psilocybin Efficacy in Major Depression", "authors": "University of Zurich", "journal": "ClinicalTrials.gov", "publication_date": "2022-04-28", "publication_year": 2022, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT03715127", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Neuroplasticity,Brain Imaging,Mechanism of Action,Receptor Pharmacology,Consciousness,Biomarkers,Aging,Resilience,Emotional Processing,Clinical Trial,Randomized Controlled Trial,Review Article,Cancer Patients", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:34", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT03715127", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT03715127", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT03715127", "source_url": "https://clinicaltrials.gov/study/NCT03715127", "doi": "", "pmid": "", "publication_date": "2022-04-28", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4974, "title": "P388. Open Label Psilocybin Administration in Severely Treatment Resistant Depression", "authors": "Scott Aaronson, Tammy Miller, Samuel Rudow, MacKenzie Forbes, Trisha Suppes", "journal": "Biological Psychiatry", "publication_date": "2022-04-27", "publication_year": 2022, "doi": "10.1016/j.biopsych.2022.02.624", "pubmed_id": null, "openalex_id": "https://openalex.org/W4225010514", "source_url": "https://doi.org/10.1016/j.biopsych.2022.02.624", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Clinical Trial,Randomized Controlled Trial,Treatment-Resistant Depression", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:57", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "DOI:10.1016/j.biopsych.2022.02.624", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.biopsych.2022.02.624", "source_url": "https://doi.org/10.1016/j.biopsych.2022.02.624", "doi": "10.1016/j.biopsych.2022.02.624", "pmid": "", "publication_date": "2022-04-27", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3365, "title": "Skepticism About Recent Evidence that Psilocybin Opens Depressed Minds", "authors": "", "journal": "PsyArXiv", "publication_date": "2022-04-27", "publication_year": 2022, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://osf.io/preprints/psyarxiv/a25wb_v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging", "study_type": "Other", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:51", "last_checked": "2026-07-01 11:22:30", "bibtex": null, "source_record_id": "https://osf.io/preprints/psyarxiv/a25wb_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/a25wb_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "https://osf.io/preprints/psyarxiv/a25wb_v1", "source_url": "https://osf.io/preprints/psyarxiv/a25wb_v1", "doi": "", "pmid": "", "publication_date": "2022-04-27", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1761, "title": "Safety issues of psilocybin and LSD as potential rapid acting antidepressants and potential challenges.", "authors": "Rossi GN, Hallak JEC, Bouso Saiz JC, Dos Santos RG.", "journal": "Expert Opinion on Drug Safety", "publication_date": "2022-04-26", "publication_year": 2022, "doi": "10.1080/14740338.2022.2066650", "pubmed_id": "35426754", "openalex_id": "https://openalex.org/W4223893856", "source_url": "https://doi.org/10.1080/14740338.2022.2066650", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Clinical Trial,Randomized Controlled Trial,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "PMID:35426754", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1080/14740338.2022.2066650", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:35426754", "source_url": "https://doi.org/10.1080/14740338.2022.2066650", "doi": "10.1080/14740338.2022.2066650", "pmid": "35426754", "publication_date": "2022-04-26", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1653, "title": "Diverse therapeutic developments for post-traumatic stress disorder (PTSD) indicate common mechanisms of memory modulation.", "authors": "Raut SB, Marathe PA, van Eijk L, Eri R, Ravindran M, Benedek DM, Ursano RJ, Canales JJ, Johnson LR.", "journal": null, "publication_date": "2022-04-26", "publication_year": 2022, "doi": "10.1016/j.pharmthera.2022.108195", "pubmed_id": "35489438", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.pharmthera.2022.108195", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Mechanism of Action,Clinical Trial,Animal Study", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:05", "bibtex": null, "source_record_id": "PMID:35489438", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.pharmthera.2022.108195", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:35489438", "source_url": "https://doi.org/10.1016/j.pharmthera.2022.108195", "doi": "10.1016/j.pharmthera.2022.108195", "pmid": "35489438", "publication_date": "2022-04-26", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1744, "title": "The Effects of Psilocybin in Adults with Major Depressive Disorder and the General Population: Findings from Neuroimaging Studies.", "authors": "Gill H, Puramat P, Patel P, Gill B, Marks CA, Rodrigues NB, Castle D, Cha DS, Mansur RB, Rosenblat JD, McIntyre RS.", "journal": null, "publication_date": "2022-04-25", "publication_year": 2022, "doi": "10.1016/j.psychres.2022.114577", "pubmed_id": "35580433", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.psychres.2022.114577", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging,Aging,Review Article,Safety", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:02", "bibtex": null, "source_record_id": "PMID:35580433", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.psychres.2022.114577", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:35580433", "source_url": "https://doi.org/10.1016/j.psychres.2022.114577", "doi": "10.1016/j.psychres.2022.114577", "pmid": "35580433", "publication_date": "2022-04-25", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1792, "title": "Will psilocybin lose its magic in the clinical setting?", "authors": "Hayes C, Wahba M, Watson S.", "journal": null, "publication_date": "2022-04-21", "publication_year": 2022, "doi": "10.1177/20451253221090822", "pubmed_id": "35480296", "openalex_id": null, "source_url": "https://doi.org/10.1177/20451253221090822", "substance_tags": "psilocybin", "topic_tags": "Depression,Review Article,Healthcare Workers", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:02", "bibtex": null, "source_record_id": "PMID:35480296", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1177/20451253221090822", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:35480296", "source_url": "https://doi.org/10.1177/20451253221090822", "doi": "10.1177/20451253221090822", "pmid": "35480296", "publication_date": "2022-04-21", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1795, "title": "Psychedelics: Alternative and Potential Therapeutic Options for Treating Mood and Anxiety Disorders.", "authors": "Lowe H, Toyang N, Steele B, Grant J, Ali A, Gordon L, Ngwa W.", "journal": null, "publication_date": "2022-04-13", "publication_year": 2022, "doi": "10.3390/molecules27082520", "pubmed_id": "35458717", "openalex_id": null, "source_url": "https://doi.org/10.3390/molecules27082520", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Spirituality,Review Article,Cancer Patients,Adverse Events,Toxicity", "study_type": "Review Article", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:06", "bibtex": null, "source_record_id": "PMID:35458717", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.3390/molecules27082520", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:35458717", "source_url": "https://doi.org/10.3390/molecules27082520", "doi": "10.3390/molecules27082520", "pmid": "35458717", "publication_date": "2022-04-13", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1798, "title": "Increased global integration in the brain after psilocybin therapy for depression.", "authors": "Daws RE, Timmermann C, Giribaldi B, Sexton JD, Wall MB, Erritzoe D, Roseman L, Nutt D, Carhart-Harris R.", "journal": "Nature Medicine", "publication_date": "2022-04-10", "publication_year": 2022, "doi": "10.1038/s41591-022-01744-z", "pubmed_id": "35411074", "openalex_id": "https://openalex.org/W4223491164", "source_url": "https://doi.org/10.1038/s41591-022-01744-z", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging,Receptor Pharmacology,Aging,Clinical Trial,Randomized Controlled Trial,Treatment-Resistant Depression", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "PMID:35411074", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1038/s41591-022-01744-z", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:35411074", "source_url": "https://doi.org/10.1038/s41591-022-01744-z", "doi": "10.1038/s41591-022-01744-z", "pmid": "35411074", "publication_date": "2022-04-10", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 2016, "title": "Psylocybin and Psilocin as new tools to fight depression: an overview of the Pharmacodynamic and pharmacokinetic mechanisms", "authors": "Lemos Martins Sofia, Machado Brito-da-Costa Andreia, Madureira-Carvalho Áurea, Dinis-Oliveira Ricardo Jorge, Dias da Silva Diana", "journal": "RevSALUS - Revista Científica da Rede Académica das Ciências da Saúde da Lusofonia", "publication_date": "2022-04-05", "publication_year": 2022, "doi": "10.51126/revsalus.v4isup.271", "pubmed_id": null, "openalex_id": "https://openalex.org/W4223588025", "source_url": "https://doi.org/10.51126/revsalus.v4isup.271", "substance_tags": "psilocin", "topic_tags": "Depression,Pharmacology,Mechanism of Action", "study_type": "Other", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-07-01 06:52:05", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "DOI:10.51126/revsalus.v4isup.271", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "DOI:10.51126/revsalus.v4isup.271", "source_url": "https://doi.org/10.51126/revsalus.v4isup.271", "doi": "10.51126/revsalus.v4isup.271", "pmid": "", "publication_date": "2022-04-05", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4978, "title": "Psilocybe mexicana R. Heim - Mexikanischer Kahlkopf", "authors": "Antonia Kuhn, Matthias F. Melzig", "journal": "Zeitschrift für Phytotherapie", "publication_date": "2022-03-31", "publication_year": 2022, "doi": "10.1055/a-1540-9907", "pubmed_id": null, "openalex_id": "https://openalex.org/W4224935312", "source_url": "https://doi.org/10.1055/a-1540-9907", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Pharmacology", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:57", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "DOI:10.1055/a-1540-9907", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1055/a-1540-9907", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1055/a-1540-9907", "source_url": "https://doi.org/10.1055/a-1540-9907", "doi": "10.1055/a-1540-9907", "pmid": "", "publication_date": "2022-03-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1797, "title": "Psilocybin increases brain network integration in patients with depression.", "authors": "", "journal": "Nature Medicine", "publication_date": "2022-03-31", "publication_year": 2022, "doi": "10.1038/s41591-022-01769-4", "pubmed_id": "35411079", "openalex_id": "https://openalex.org/W4223461155", "source_url": "https://doi.org/10.1038/s41591-022-01769-4", "substance_tags": "psilocybin", "topic_tags": "Depression", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "PMID:35411079", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:35411079", "source_url": "https://doi.org/10.1038/s41591-022-01769-4", "doi": "10.1038/s41591-022-01769-4", "pmid": "35411079", "publication_date": "2022-03-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1802, "title": "Therapeutic Alliance and Rapport Modulate Responses to Psilocybin Assisted Therapy for Depression.", "authors": "Murphy R, Kettner H, Zeifman R, Giribaldi B, Kartner L, Martell J, Read T, Murphy-Beiner A, Baker-Jones M, Nutt D, Erritzoe D, Watts R, Carhart-Harris R.", "journal": "Frontiers in Pharmacology", "publication_date": "2022-03-30", "publication_year": 2022, "doi": "10.3389/fphar.2021.788155", "pubmed_id": "35431912", "openalex_id": "https://openalex.org/W4221001769", "source_url": "https://doi.org/10.3389/fphar.2021.788155", "substance_tags": "psilocybin", "topic_tags": "Depression,Emotional Processing,Mystical Experience,Clinical Trial,Randomized Controlled Trial", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "PMID:35431912", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.3389/fphar.2021.788155", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:35431912", "source_url": "https://doi.org/10.3389/fphar.2021.788155", "doi": "10.3389/fphar.2021.788155", "pmid": "35431912", "publication_date": "2022-03-30", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1803, "title": "Psilocybin-Assisted Compassion Focused Therapy for Depression.", "authors": "Pots W, Chakhssi F.", "journal": "Frontiers in Psychology", "publication_date": "2022-03-24", "publication_year": 2022, "doi": "10.3389/fpsyg.2022.812930", "pubmed_id": "35401294", "openalex_id": "https://openalex.org/W4221031753", "source_url": "https://doi.org/10.3389/fpsyg.2022.812930", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "PMID:35401294", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.3389/fpsyg.2022.812930", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:35401294", "source_url": "https://doi.org/10.3389/fpsyg.2022.812930", "doi": "10.3389/fpsyg.2022.812930", "pmid": "35401294", "publication_date": "2022-03-24", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4980, "title": "Demystifying Psychedelic Treatments in Psychiatry: Is Ego Dissolution the Solution?", "authors": "Michael Avissar, Adrian Jacques H. Ambrose", "journal": "Psychiatric News", "publication_date": "2022-03-23", "publication_year": 2022, "doi": "10.1176/appi.pn.2022.04.4.35", "pubmed_id": null, "openalex_id": "https://openalex.org/W4220982704", "source_url": "https://doi.org/10.1176/appi.pn.2022.04.4.35", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,OCD,Eating Disorders,End-of-Life Distress,Headache / Migraine,Mechanism of Action,Receptor Pharmacology,Default Mode Network,Biomarkers,Personality Change,Emotional Processing,Mystical Experience,Clinical Trial,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:57", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "DOI:10.1176/appi.pn.2022.04.4.35", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1176/appi.pn.2022.04.4.35", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1176/appi.pn.2022.04.4.35", "source_url": "https://doi.org/10.1176/appi.pn.2022.04.4.35", "doi": "10.1176/appi.pn.2022.04.4.35", "pmid": "", "publication_date": "2022-03-23", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1610, "title": "How Important Is a Guide Who Has Taken Psilocybin in Psilocybin-Assisted Therapy for Depression?", "authors": "Earleywine M, Low F, Altman BR, De Leo J.", "journal": "Journal of Psychoactive Drugs", "publication_date": "2022-03-22", "publication_year": 2022, "doi": "10.1080/02791072.2022.2047842", "pubmed_id": "35318904", "openalex_id": "https://openalex.org/W4220813054", "source_url": "https://doi.org/10.1080/02791072.2022.2047842", "substance_tags": "psilocybin", "topic_tags": "Depression", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "PMID:35318904", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1080/02791072.2022.2047842", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:35318904", "source_url": "https://doi.org/10.1080/02791072.2022.2047842", "doi": "10.1080/02791072.2022.2047842", "pmid": "35318904", "publication_date": "2022-03-22", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1765, "title": "The promises and perils of psychedelic pharmacology for psychiatry.", "authors": "McClure-Begley TD, Roth BL.", "journal": null, "publication_date": "2022-03-16", "publication_year": 2022, "doi": "10.1038/s41573-022-00421-7", "pubmed_id": "35301459", "openalex_id": null, "source_url": "https://doi.org/10.1038/s41573-022-00421-7", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Pharmacology,Mechanism of Action,Receptor Pharmacology,Clinical Trial", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:05", "bibtex": null, "source_record_id": "PMID:35301459", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1038/s41573-022-00421-7", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:35301459", "source_url": "https://doi.org/10.1038/s41573-022-00421-7", "doi": "10.1038/s41573-022-00421-7", "pmid": "35301459", "publication_date": "2022-03-16", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1552, "title": "A systematic literature review and meta-analysis of the effect of psilocybin and methylenedioxymethamphetamine on mental, behavioural or developmental disorders.", "authors": "Kisely S, Connor M, Somogyi AA, Siskind D.", "journal": null, "publication_date": "2022-03-11", "publication_year": 2022, "doi": "10.1177/00048674221083868", "pubmed_id": "35285280", "openalex_id": null, "source_url": "https://doi.org/10.1177/00048674221083868", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,OCD,End-of-Life Distress,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Treatment-Resistant Depression,Safety", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:02", "bibtex": null, "source_record_id": "PMID:35285280", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1177/00048674221083868", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:35285280", "source_url": "https://doi.org/10.1177/00048674221083868", "doi": "10.1177/00048674221083868", "pmid": "35285280", "publication_date": "2022-03-11", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1809, "title": "Mycotherapy: Potential of Fungal Bioactives for the Treatment of Mental Health Disorders and Morbidities of Chronic Pain.", "authors": "Meade E, Hehir S, Rowan N, Garvey M.", "journal": null, "publication_date": "2022-03-10", "publication_year": 2022, "doi": "10.3390/jof8030290", "pubmed_id": "35330292", "openalex_id": null, "source_url": "https://doi.org/10.3390/jof8030290", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Chronic Pain,Review Article,Safety,Inflammation,Immune Function", "study_type": "Review Article", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:05", "bibtex": null, "source_record_id": "PMID:35330292", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.3390/jof8030290", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:35330292", "source_url": "https://doi.org/10.3390/jof8030290", "doi": "10.3390/jof8030290", "pmid": "35330292", "publication_date": "2022-03-10", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3198, "title": "Psilocybin Combines Rapid Synaptogenic And Anti-Inflammatory Effects In Vitro", "authors": "Smedfors G, Glotfelty E, Kalani N, Hjelle CP, Horntvedt O, Wellfelt K, Brodin A, von Kieseritzky F, Olson L, Karlsson T.", "journal": "Research Square", "publication_date": "2022-03-07", "publication_year": 2022, "doi": "10.21203/rs.3.rs-1321542/v1", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.21203/rs.3.rs-1321542/v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Headache / Migraine,Neuroplasticity,Mechanism of Action,Animal Study,In Vitro Study,Inflammation", "study_type": "Animal Study", "source_name": "Europe PMC", "publication_status": "preprint", "date_added": "2026-07-01 11:03:48", "last_checked": "2026-07-01 11:22:02", "bibtex": null, "source_record_id": "DOI:10.21203/rs.3.rs-1321542/v1", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.21203/rs.3.rs-1321542/v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "DOI:10.21203/rs.3.rs-1321542/v1", "source_url": "https://doi.org/10.21203/rs.3.rs-1321542/v1", "doi": "10.21203/rs.3.rs-1321542/v1", "pmid": "", "publication_date": "2022-03-07", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4985, "title": "Rediscovering psychedelics", "authors": "Bethany Halford", "journal": "C&EN Global Enterprise", "publication_date": "2022-03-06", "publication_year": 2022, "doi": "10.1021/cen-10009-cover", "pubmed_id": null, "openalex_id": "https://openalex.org/W4220835321", "source_url": "https://doi.org/10.1021/cen-10009-cover", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Consciousness,Spirituality", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:57", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "DOI:10.1021/cen-10009-cover", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1021/cen-10009-cover", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1021/cen-10009-cover", "source_url": "https://doi.org/10.1021/cen-10009-cover", "doi": "10.1021/cen-10009-cover", "pmid": "", "publication_date": "2022-03-06", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1813, "title": "Depression and Long-Term Prescription Opioid Use and Opioid Use Disorder: Implications for Pain Management in Cancer.", "authors": "Bates N, Bello JK, Osazuwa-Peters N, Sullivan MD, Scherrer JF.", "journal": null, "publication_date": "2022-03-06", "publication_year": 2022, "doi": "10.1007/s11864-022-00954-4", "pubmed_id": "35254595", "openalex_id": null, "source_url": "https://doi.org/10.1007/s11864-022-00954-4", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,End-of-Life Distress,Chronic Pain,Receptor Pharmacology,Aging,Cancer Patients,Healthcare Workers,Safety", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:06", "bibtex": null, "source_record_id": "PMID:35254595", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1007/s11864-022-00954-4", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:35254595", "source_url": "https://doi.org/10.1007/s11864-022-00954-4", "doi": "10.1007/s11864-022-00954-4", "pmid": "35254595", "publication_date": "2022-03-06", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1811, "title": "Methodological challenges in psychedelic drug trials: Efficacy and safety of psilocybin in treatment-resistant major depression (EPIsoDE) - Rationale and study design.", "authors": "Mertens LJ, Koslowski M, Betzler F, Evens R, Gilles M, Jungaberle A, Jungaberle H, Majić T, Ströhle A, Wolff M, Wellek S, Gründer G.", "journal": "Neuroscience Applied", "publication_date": "2022-03-06", "publication_year": 2022, "doi": "10.1016/j.nsa.2022.100104", "pubmed_id": "40656230", "openalex_id": "https://openalex.org/W4220708535", "source_url": "https://doi.org/10.1016/j.nsa.2022.100104", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:38", "bibtex": null, "source_record_id": "PMID:40656230", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.nsa.2022.100104", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:40656230", "source_url": "https://doi.org/10.1016/j.nsa.2022.100104", "doi": "10.1016/j.nsa.2022.100104", "pmid": "40656230", "publication_date": "2022-03-06", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1766, "title": "Drug-drug interactions between psychiatric medications and MDMA or psilocybin: a systematic review.", "authors": "Sarparast A, Thomas K, Malcolm B, Stauffer CS.", "journal": null, "publication_date": "2022-03-06", "publication_year": 2022, "doi": "10.1007/s00213-022-06083-y", "pubmed_id": "35253070", "openalex_id": null, "source_url": "https://doi.org/10.1007/s00213-022-06083-y", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Pharmacology,Receptor Pharmacology,Randomized Controlled Trial,Systematic Review,Review Article,Case Report,Drug Interactions", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:02", "bibtex": null, "source_record_id": "PMID:35253070", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1007/s00213-022-06083-y", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:35253070", "source_url": "https://doi.org/10.1007/s00213-022-06083-y", "doi": "10.1007/s00213-022-06083-y", "pmid": "35253070", "publication_date": "2022-03-06", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1812, "title": "Virtual Reality as a Moderator of Psychedelic-Assisted Psychotherapy.", "authors": "Sekula AD, Downey L, Puspanathan P.", "journal": null, "publication_date": "2022-03-03", "publication_year": 2022, "doi": "10.3389/fpsyg.2022.813746", "pubmed_id": "35310225", "openalex_id": null, "source_url": "https://doi.org/10.3389/fpsyg.2022.813746", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Consciousness,Spirituality,Mystical Experience,Treatment-Resistant Depression,Adverse Events", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:06", "bibtex": null, "source_record_id": "PMID:35310225", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.3389/fpsyg.2022.813746", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:35310225", "source_url": "https://doi.org/10.3389/fpsyg.2022.813746", "doi": "10.3389/fpsyg.2022.813746", "pmid": "35310225", "publication_date": "2022-03-03", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1768, "title": "Effects of the 5-HT2A receptor antagonist volinanserin on head-twitch response and intracranial self-stimulation depression induced by different structural classes of psychedelics in rodents.", "authors": "Jaster AM, Elder H, Marsh SA, de la Fuente Revenga M, Negus SS, González-Maeso J.", "journal": null, "publication_date": "2022-03-01", "publication_year": 2022, "doi": "10.1007/s00213-022-06092-x", "pubmed_id": "35233648", "openalex_id": null, "source_url": "https://doi.org/10.1007/s00213-022-06092-x", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Pharmacology,Receptor Pharmacology,Animal Study,Safety", "study_type": "Animal Study", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:05", "bibtex": null, "source_record_id": "PMID:35233648", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1007/s00213-022-06092-x", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:35233648", "source_url": "https://doi.org/10.1007/s00213-022-06092-x", "doi": "10.1007/s00213-022-06092-x", "pmid": "35233648", "publication_date": "2022-03-01", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1767, "title": "Effects of ketamine optical isomers, psilocybin, psilocin and norpsilocin on time estimation and cognition in rats.", "authors": "Popik P, Hogendorf A, Bugno R, Khoo SY, Zajdel P, Malikowska-Racia N, Nikiforuk A, Golebiowska J.", "journal": "Psychopharmacology", "publication_date": "2022-03-01", "publication_year": 2022, "doi": "10.1007/s00213-021-06020-5", "pubmed_id": "35234983", "openalex_id": "https://openalex.org/W4214937728", "source_url": "https://doi.org/10.1007/s00213-021-06020-5", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Receptor Pharmacology", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "PMID:35234983", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1007/s00213-021-06020-5", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:35234983", "source_url": "https://doi.org/10.1007/s00213-021-06020-5", "doi": "10.1007/s00213-021-06020-5", "pmid": "35234983", "publication_date": "2022-03-01", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1611, "title": "The Use of Psilocybin in the Treatment of Psychiatric Disorders with Attention to Relative Safety Profile: A Systematic Review.", "authors": "Hodge AT, Sukpraprut-Braaten S, Narlesky M, Strayhan RC.", "journal": null, "publication_date": "2022-02-27", "publication_year": 2022, "doi": "10.1080/02791072.2022.2044096", "pubmed_id": "35225726", "openalex_id": null, "source_url": "https://doi.org/10.1080/02791072.2022.2044096", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Clinical Trial,Systematic Review,Review Article,Safety", "study_type": "Systematic Review", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:02", "bibtex": null, "source_record_id": "PMID:35225726", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1080/02791072.2022.2044096", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:35225726", "source_url": "https://doi.org/10.1080/02791072.2022.2044096", "doi": "10.1080/02791072.2022.2044096", "pmid": "35225726", "publication_date": "2022-02-27", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1819, "title": "Psilocin acutely alters sleep-wake architecture and cortical brain activity in laboratory mice.", "authors": "Thomas CW, Blanco-Duque C, Bréant BJ, Goodwin GM, Sharp T, Bannerman DM, Vyazovskiy VV.", "journal": "Translational Psychiatry", "publication_date": "2022-02-22", "publication_year": 2022, "doi": "10.1038/s41398-022-01846-9", "pubmed_id": "35197453", "openalex_id": "https://openalex.org/W4214570845", "source_url": "https://doi.org/10.1038/s41398-022-01846-9", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Neuroplasticity,Brain Imaging,Mechanism of Action,Consciousness,Wellbeing,Animal Study", "study_type": "Animal Study", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:38", "bibtex": null, "source_record_id": "PMID:35197453", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1038/s41398-022-01846-9", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:35197453", "source_url": "https://doi.org/10.1038/s41398-022-01846-9", "doi": "10.1038/s41398-022-01846-9", "pmid": "35197453", "publication_date": "2022-02-22", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3227, "title": "Increased low-frequency brain responses to music after psilocybin therapy for depression", "authors": "Wall MB, Lam C, Ertl N, Kaelen M, Roseman L, Nutt DJ, Carhart-Harris RL.", "journal": "bioRxiv", "publication_date": "2022-02-14", "publication_year": 2022, "doi": "10.1101/2022.02.13.480302", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.1101/2022.02.13.480302", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging,Aging,Emotional Processing,Treatment-Resistant Depression", "study_type": "Other", "source_name": "bioRxiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:48", "last_checked": "2026-07-01 11:22:02", "bibtex": null, "source_record_id": "DOI:10.1101/2022.02.13.480302", "abstract_available": true, "abstract_source": "bioRxiv", "abstract_source_url": "https://doi.org/10.1101/2022.02.13.480302", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "bioRxiv", "source_record_id": "DOI:10.1101/2022.02.13.480302", "source_url": "https://doi.org/10.1101/2022.02.13.480302", "doi": "10.1101/2022.02.13.480302", "pmid": "", "publication_date": "2022-02-14", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1822, "title": "Trajectory of Antidepressant Effects after Single- or Two-Dose Administration of Psilocybin: A Systematic Review and Multivariate Meta-Analysis.", "authors": "Yu CL, Liang CS, Yang FC, Tu YK, Hsu CW, Carvalho AF, Stubbs B, Thompson T, Tsai CK, Yeh TC, Yang SN, Shin JI, Chu CS, Tseng PT, Su KP.", "journal": null, "publication_date": "2022-02-10", "publication_year": 2022, "doi": "10.3390/jcm11040938", "pubmed_id": "35207210", "openalex_id": null, "source_url": "https://doi.org/10.3390/jcm11040938", "substance_tags": "psilocybin", "topic_tags": "Depression,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Safety", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:02", "bibtex": null, "source_record_id": "PMID:35207210", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.3390/jcm11040938", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:35207210", "source_url": "https://doi.org/10.3390/jcm11040938", "doi": "10.3390/jcm11040938", "pmid": "35207210", "publication_date": "2022-02-10", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4989, "title": "Hallucinogen chemistry guides antidepressant drug discovery", "authors": "Bethany Halford", "journal": "C&EN Global Enterprise", "publication_date": "2022-02-06", "publication_year": 2022, "doi": "10.1021/cen-10005-leadcon", "pubmed_id": null, "openalex_id": "https://openalex.org/W4210908417", "source_url": "https://doi.org/10.1021/cen-10005-leadcon", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Anxiety,Pharmacology,Receptor Pharmacology", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:57", "last_checked": "2026-07-04 07:00:38", "bibtex": null, "source_record_id": "DOI:10.1021/cen-10005-leadcon", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1021/cen-10005-leadcon", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1021/cen-10005-leadcon", "source_url": "https://doi.org/10.1021/cen-10005-leadcon", "doi": "10.1021/cen-10005-leadcon", "pmid": "", "publication_date": "2022-02-06", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1823, "title": "Psilocybin for Treating Psychiatric Disorders: A Psychonaut Legend or a Promising Therapeutic Perspective?", "authors": "Coppola M, Bevione F, Mondola R.", "journal": null, "publication_date": "2022-02-06", "publication_year": 2022, "doi": "10.3390/jox12010004", "pubmed_id": "35225956", "openalex_id": null, "source_url": "https://doi.org/10.3390/jox12010004", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Spirituality", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:02", "bibtex": null, "source_record_id": "PMID:35225956", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.3390/jox12010004", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:35225956", "source_url": "https://doi.org/10.3390/jox12010004", "doi": "10.3390/jox12010004", "pmid": "35225956", "publication_date": "2022-02-06", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1821, "title": "Psilocybin: Characterization of the Metastable Zone Width (MSZW), Control of Anhydrous Polymorphs, and Particle Size Distribution (PSD).", "authors": "Kargbo RB, Sherwood AM, Meisenheimer P, Lenoch K, Abebe S.", "journal": "ACS Omega", "publication_date": "2022-02-06", "publication_year": 2022, "doi": "10.1021/acsomega.1c06708", "pubmed_id": "35187358", "openalex_id": "https://openalex.org/W4210846812", "source_url": "https://doi.org/10.1021/acsomega.1c06708", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Clinical Trial,Treatment-Resistant Depression,Drug Interactions", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:38", "bibtex": null, "source_record_id": "PMID:35187358", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1021/acsomega.1c06708", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:35187358", "source_url": "https://doi.org/10.1021/acsomega.1c06708", "doi": "10.1021/acsomega.1c06708", "pmid": "35187358", "publication_date": "2022-02-06", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1825, "title": "Analysis of Psilocybin-Assisted Therapy in Medicine: A Narrative Review.", "authors": "Ziff S, Stern B, Lewis G, Majeed M, Gorantla VR.", "journal": null, "publication_date": "2022-02-04", "publication_year": 2022, "doi": "10.7759/cureus.21944", "pubmed_id": "35273885", "openalex_id": null, "source_url": "https://doi.org/10.7759/cureus.21944", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,End-of-Life Distress,Mechanism of Action,Receptor Pharmacology,Aging,Clinical Trial,Review Article,Safety,Toxicity", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:02", "bibtex": null, "source_record_id": "PMID:35273885", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.7759/cureus.21944", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:35273885", "source_url": "https://doi.org/10.7759/cureus.21944", "doi": "10.7759/cureus.21944", "pmid": "35273885", "publication_date": "2022-02-04", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1827, "title": "Efficacy and safety of psilocybin-assisted treatment for major depressive disorder: Prospective 12-month follow-up.", "authors": "Gukasyan N, Davis AK, Barrett FS, Cosimano MP, Sepeda ND, Johnson MW, Griffiths RR.", "journal": "Journal of Psychopharmacology", "publication_date": "2022-01-31", "publication_year": 2022, "doi": "10.1177/02698811211073759", "pubmed_id": "35166158", "openalex_id": "https://openalex.org/W4212903385", "source_url": "https://doi.org/10.1177/02698811211073759", "substance_tags": "psilocybin", "topic_tags": "Depression,Wellbeing,Spirituality,Mystical Experience,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:38", "bibtex": null, "source_record_id": "PMID:35166158", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1177/02698811211073759", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:35166158", "source_url": "https://doi.org/10.1177/02698811211073759", "doi": "10.1177/02698811211073759", "pmid": "35166158", "publication_date": "2022-01-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1816, "title": "[Are psychedelics fast acting antidepressant agents?]", "authors": "Gründer G, Brand M, Kärtner L, Scharf D, Schmitz C, Spangemacher M, Mertens LJ.", "journal": null, "publication_date": "2022-01-31", "publication_year": 2022, "doi": "10.1007/s00115-021-01255-1", "pubmed_id": "35103814", "openalex_id": null, "source_url": "https://doi.org/10.1007/s00115-021-01255-1", "substance_tags": "psilocybin", "topic_tags": "Depression", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:04", "bibtex": null, "source_record_id": "PMID:35103814", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1007/s00115-021-01255-1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:35103814", "source_url": "https://doi.org/10.1007/s00115-021-01255-1", "doi": "10.1007/s00115-021-01255-1", "pmid": "35103814", "publication_date": "2022-01-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1832, "title": "Evaluating the Potential Use of Serotonergic Psychedelics in Autism Spectrum Disorder.", "authors": "Markopoulos A, Inserra A, De Gregorio D, Gobbi G.", "journal": null, "publication_date": "2022-01-26", "publication_year": 2022, "doi": "10.3389/fphar.2021.749068", "pubmed_id": "35177979", "openalex_id": null, "source_url": "https://doi.org/10.3389/fphar.2021.749068", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Review Article,Animal Study,Safety", "study_type": "Review Article", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:06", "bibtex": null, "source_record_id": "PMID:35177979", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.3389/fphar.2021.749068", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:35177979", "source_url": "https://doi.org/10.3389/fphar.2021.749068", "doi": "10.3389/fphar.2021.749068", "pmid": "35177979", "publication_date": "2022-01-26", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1831, "title": "Structure-based discovery of nonhallucinogenic psychedelic analogs.", "authors": "Cao D, Yu J, Wang H, Luo Z, Liu X, He L, Qi J, Fan L, Tang L, Chen Z, Li J, Cheng J, Wang S.", "journal": "Science", "publication_date": "2022-01-26", "publication_year": 2022, "doi": "10.1126/science.abl8615", "pubmed_id": "35084960", "openalex_id": "https://openalex.org/W4210474529", "source_url": "https://doi.org/10.1126/science.abl8615", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Receptor Pharmacology,Animal Study", "study_type": "Animal Study", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:38", "bibtex": null, "source_record_id": "PMID:35084960", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1126/science.abl8615", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:35084960", "source_url": "https://doi.org/10.1126/science.abl8615", "doi": "10.1126/science.abl8615", "pmid": "35084960", "publication_date": "2022-01-26", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4992, "title": "Psychedelics hold promise for primary care research", "authors": "James Bailey Sanford", "journal": "Family Practice", "publication_date": "2022-01-23", "publication_year": 2022, "doi": "10.1093/fampra/cmac009", "pubmed_id": "35137025", "openalex_id": "https://openalex.org/W4207062049", "source_url": "https://doi.org/10.1093/fampra/cmac009", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,End-of-Life Distress,Receptor Pharmacology,Cancer Patients", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:58", "last_checked": "2026-07-04 07:00:38", "bibtex": null, "source_record_id": "PMID:35137025", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1093/fampra/cmac009", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:35137025", "source_url": "https://doi.org/10.1093/fampra/cmac009", "doi": "10.1093/fampra/cmac009", "pmid": "35137025", "publication_date": "2022-01-23", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1772, "title": "Psychedelic-assisted psychotherapy for the treatment of major depression: a synthesis of phenomenological explanations.", "authors": "Miceli McMillan R, Jordens C.", "journal": null, "publication_date": "2022-01-21", "publication_year": 2022, "doi": "10.1007/s11019-022-10070-7", "pubmed_id": "35064398", "openalex_id": null, "source_url": "https://doi.org/10.1007/s11019-022-10070-7", "substance_tags": "psilocybin", "topic_tags": "Depression", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:06", "bibtex": null, "source_record_id": "PMID:35064398", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1007/s11019-022-10070-7", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:35064398", "source_url": "https://doi.org/10.1007/s11019-022-10070-7", "doi": "10.1007/s11019-022-10070-7", "pmid": "35064398", "publication_date": "2022-01-21", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1746, "title": "Novel Antidepressants in the Pipeline (Phase II and III): A Systematic Review of the US Clinical Trials Registry.", "authors": "Sakurai H, Yonezawa K, Tani H, Mimura M, Bauer M, Uchida H.", "journal": null, "publication_date": "2022-01-18", "publication_year": 2022, "doi": "10.1055/a-1714-9097", "pubmed_id": "35045580", "openalex_id": null, "source_url": "https://doi.org/10.1055/a-1714-9097", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Clinical Trial,Systematic Review,Review Article,Treatment-Resistant Depression", "study_type": "Systematic Review", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:06", "bibtex": null, "source_record_id": "PMID:35045580", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1055/a-1714-9097", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:35045580", "source_url": "https://doi.org/10.1055/a-1714-9097", "doi": "10.1055/a-1714-9097", "pmid": "35045580", "publication_date": "2022-01-18", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 4993, "title": "Psilocybine vergeleken met escitalopram bij depressie", "authors": "Jurriaan F. M. Strous", "journal": "Pure Amsterdam UMC", "publication_date": "2022-01-16", "publication_year": 2022, "doi": null, "pubmed_id": null, "openalex_id": "https://openalex.org/W7132220122", "source_url": "https://pure.amsterdamumc.nl/en/publications/b99a8d48-a871-49d6-978c-969dd09a6dae", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Clinical Trial,Randomized Controlled Trial,Toxicity", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:58", "last_checked": "2026-07-04 07:00:38", "bibtex": null, "source_record_id": "https://pure.amsterdamumc.nl/en/publications/b99a8d48-a871-49d6-978c-969dd09a6dae", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://pure.amsterdamumc.nl/en/publications/b99a8d48-a871-49d6-978c-969dd09a6dae", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "https://pure.amsterdamumc.nl/en/publications/b99a8d48-a871-49d6-978c-969dd09a6dae", "source_url": "https://pure.amsterdamumc.nl/en/publications/b99a8d48-a871-49d6-978c-969dd09a6dae", "doi": "", "pmid": "", "publication_date": "2022-01-16", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1834, "title": "[Psilocybin compared with escitalopram for depression].", "authors": "Strous JFM.", "journal": "PubMed", "publication_date": "2022-01-16", "publication_year": 2022, "doi": null, "pubmed_id": "35138714", "openalex_id": "https://openalex.org/W4221159545", "source_url": "https://europepmc.org/article/MED/35138714", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Randomized Controlled Trial", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:38", "bibtex": null, "source_record_id": "PMID:35138714", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://europepmc.org/article/MED/35138714", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:35138714", "source_url": "https://europepmc.org/article/MED/35138714", "doi": "", "pmid": "35138714", "publication_date": "2022-01-16", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1848, "title": "Lifetime use of MDMA/ecstasy and psilocybin is associated with reduced odds of major depressive episodes.", "authors": "Jones GM, Nock MK.", "journal": "Journal of Psychopharmacology", "publication_date": "2022-01-04", "publication_year": 2022, "doi": "10.1177/02698811211066714", "pubmed_id": "34983261", "openalex_id": "https://openalex.org/W4205618858", "source_url": "https://doi.org/10.1177/02698811211066714", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Chronic Pain,Observational Study,Adolescents", "study_type": "Observational Study", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:38", "bibtex": null, "source_record_id": "PMID:34983261", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1177/02698811211066714", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:34983261", "source_url": "https://doi.org/10.1177/02698811211066714", "doi": "10.1177/02698811211066714", "pmid": "34983261", "publication_date": "2022-01-04", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1847, "title": "The effects of psilocybin on cognitive and emotional functions in healthy participants: Results from a phase 1, randomised, placebo-controlled trial involving simultaneous psilocybin administration and preparation.", "authors": "Rucker JJ, Marwood L, Ajantaival RJ, Bird C, Eriksson H, Harrison J, Lennard-Jones M, Mistry S, Saldarini F, Stansfield S, Tai SJ, Williams S, Weston N, Malievskaia E, Young AH.", "journal": "Journal of Psychopharmacology", "publication_date": "2022-01-03", "publication_year": 2022, "doi": "10.1177/02698811211064720", "pubmed_id": "35090363", "openalex_id": "https://openalex.org/W4205906672", "source_url": "https://doi.org/10.1177/02698811211064720", "substance_tags": "psilocybin", "topic_tags": "Depression,Receptor Pharmacology,Emotional Processing,Clinical Trial,Randomized Controlled Trial,Healthy Volunteers,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:38", "bibtex": null, "source_record_id": "PMID:35090363", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1177/02698811211064720", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:35090363", "source_url": "https://doi.org/10.1177/02698811211064720", "doi": "10.1177/02698811211064720", "pmid": "35090363", "publication_date": "2022-01-03", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1654, "title": "Exploring the Credibility of Psilocybin-assisted Therapy and Cognitive-behavioral Therapy for Depression.", "authors": "Altman BR, Earleywine M, De Leo J.", "journal": "Journal of Psychoactive Drugs", "publication_date": "2022-01-02", "publication_year": 2022, "doi": "10.1080/02791072.2021.2020382", "pubmed_id": "34979875", "openalex_id": "https://openalex.org/W4206767983", "source_url": "https://doi.org/10.1080/02791072.2021.2020382", "substance_tags": "psilocybin", "topic_tags": "Depression,Healthcare Workers,Adverse Events", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:38", "bibtex": null, "source_record_id": "PMID:34979875", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1080/02791072.2021.2020382", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:34979875", "source_url": "https://doi.org/10.1080/02791072.2021.2020382", "doi": "10.1080/02791072.2021.2020382", "pmid": "34979875", "publication_date": "2022-01-02", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 5023, "title": "Neurochemical properties of psilocybin in comparison to ketamine in vivo", "authors": "A. Wojtas, A. Bysiek, Z. Szych, M. Herian, K. Gołembiowska", "journal": "Neuroscience Applied", "publication_date": "2021-12-31", "publication_year": 2021, "doi": "10.1016/j.nsa.2022.100408", "pubmed_id": null, "openalex_id": "https://openalex.org/W4313201121", "source_url": "https://doi.org/10.1016/j.nsa.2022.100408", "substance_tags": "psilocybin", "topic_tags": "Depression,Pharmacology,Receptor Pharmacology", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:58", "last_checked": "2026-07-04 07:00:38", "bibtex": null, "source_record_id": "DOI:10.1016/j.nsa.2022.100408", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.nsa.2022.100408", "source_url": "https://doi.org/10.1016/j.nsa.2022.100408", "doi": "10.1016/j.nsa.2022.100408", "pmid": "", "publication_date": "2021-12-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 5016, "title": "Investigation of the neural network responsible for antidepressant effect of serotonergic psychedelics", "authors": "Daisuke Ibi", "journal": "Proceedings for Annual Meeting of The Japanese Pharmacological Society", "publication_date": "2021-12-31", "publication_year": 2021, "doi": "10.1254/jpssuppl.96.0_4-b-s43-2", "pubmed_id": null, "openalex_id": "https://openalex.org/W4313199284", "source_url": "https://doi.org/10.1254/jpssuppl.96.0_4-b-s43-2", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Pharmacology,Mechanism of Action,Receptor Pharmacology,Animal Study", "study_type": "Animal Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:58", "last_checked": "2026-07-04 07:00:38", "bibtex": null, "source_record_id": "DOI:10.1254/jpssuppl.96.0_4-b-s43-2", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1254/jpssuppl.96.0_4-b-s43-2", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1254/jpssuppl.96.0_4-b-s43-2", "source_url": "https://doi.org/10.1254/jpssuppl.96.0_4-b-s43-2", "doi": "10.1254/jpssuppl.96.0_4-b-s43-2", "pmid": "", "publication_date": "2021-12-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 5015, "title": "SPECIAL ISSUE: Do Biofeedback, Neurofeedback, and Neuromeditation Have a Role in Psychedelic-Assisted Therapies?", "authors": "Jeff Tarrant", "journal": "Biofeedback", "publication_date": "2021-12-31", "publication_year": 2021, "doi": "10.5298/1081-5937-50.03.03", "pubmed_id": null, "openalex_id": "https://openalex.org/W4313148936", "source_url": "https://doi.org/10.5298/1081-5937-50.03.03", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,OCD,End-of-Life Distress,Neuroplasticity,Brain Imaging,Receptor Pharmacology,Consciousness,Biomarkers,Aging,Wellbeing,Emotional Processing,Spirituality,Mystical Experience,Psychological Flexibility,Healthy Volunteers,Treatment-Resistant Depression", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:58", "last_checked": "2026-07-04 07:00:38", "bibtex": null, "source_record_id": "DOI:10.5298/1081-5937-50.03.03", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.5298/1081-5937-50.03.03", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.5298/1081-5937-50.03.03", "source_url": "https://doi.org/10.5298/1081-5937-50.03.03", "doi": "10.5298/1081-5937-50.03.03", "pmid": "", "publication_date": "2021-12-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 5014, "title": "Psilocybin may be effective for treatment-resistant depression", "authors": "", "journal": "Pharmaceutical journal/˜The œpharmaceutical journal", "publication_date": "2021-12-31", "publication_year": 2021, "doi": "10.1211/pj.2022.1.164911", "pubmed_id": null, "openalex_id": "https://openalex.org/W4313001717", "source_url": "https://doi.org/10.1211/pj.2022.1.164911", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Treatment-Resistant Depression", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:58", "last_checked": "2026-07-04 07:00:38", "bibtex": null, "source_record_id": "DOI:10.1211/pj.2022.1.164911", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1211/pj.2022.1.164911", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1211/pj.2022.1.164911", "source_url": "https://doi.org/10.1211/pj.2022.1.164911", "doi": "10.1211/pj.2022.1.164911", "pmid": "", "publication_date": "2021-12-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 5013, "title": "Psilocybin: a psychedelic alternative to antidepressants?", "authors": "", "journal": "Pharmaceutical journal/˜The œpharmaceutical journal", "publication_date": "2021-12-31", "publication_year": 2021, "doi": "10.1211/pj.2022.1.169269", "pubmed_id": null, "openalex_id": "https://openalex.org/W4312953170", "source_url": "https://doi.org/10.1211/pj.2022.1.169269", "substance_tags": "psilocybin", "topic_tags": "Depression,Pharmacology,Treatment-Resistant Depression", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:58", "last_checked": "2026-07-04 07:00:38", "bibtex": null, "source_record_id": "DOI:10.1211/pj.2022.1.169269", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1211/pj.2022.1.169269", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1211/pj.2022.1.169269", "source_url": "https://doi.org/10.1211/pj.2022.1.169269", "doi": "10.1211/pj.2022.1.169269", "pmid": "", "publication_date": "2021-12-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 5008, "title": "Investigation of neuronal basis underlying antidepressant effect of serotonergic psychedelics", "authors": "Daisuke Ibi", "journal": "Proceedings for Annual Meeting of The Japanese Pharmacological Society", "publication_date": "2021-12-31", "publication_year": 2021, "doi": "10.1254/jpssuppl.95.0_3-s35-1", "pubmed_id": null, "openalex_id": "https://openalex.org/W4225709710", "source_url": "https://doi.org/10.1254/jpssuppl.95.0_3-s35-1", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Neuroplasticity,Pharmacology,Mechanism of Action,Receptor Pharmacology,Emotional Processing,Animal Study", "study_type": "Animal Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:58", "last_checked": "2026-07-04 07:00:38", "bibtex": null, "source_record_id": "DOI:10.1254/jpssuppl.95.0_3-s35-1", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1254/jpssuppl.95.0_3-s35-1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1254/jpssuppl.95.0_3-s35-1", "source_url": "https://doi.org/10.1254/jpssuppl.95.0_3-s35-1", "doi": "10.1254/jpssuppl.95.0_3-s35-1", "pmid": "", "publication_date": "2021-12-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 5005, "title": "The efficacy of COMP360 psilocybin therapy in treatment-resistant depression: exploratory results from a phase IIb randomised controlled trial", "authors": "G. Goodwin, Scott T. Aaronson, Boadie W. Dunlop, D. Feifel, David J. Hellerstein, L. Marwood, S. Mistry, Metten Somers, S.C. Stansfield, J. Tsai, S. Williams, Allan H. Young, Sidney Zisook, E. Malievskaia", "journal": "Neuroscience Applied", "publication_date": "2021-12-31", "publication_year": 2021, "doi": "10.1016/j.nsa.2022.100213", "pubmed_id": null, "openalex_id": "https://openalex.org/W4313200620", "source_url": "https://doi.org/10.1016/j.nsa.2022.100213", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Randomized Controlled Trial,Treatment-Resistant Depression", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:58", "last_checked": "2026-07-04 07:00:38", "bibtex": null, "source_record_id": "DOI:10.1016/j.nsa.2022.100213", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.nsa.2022.100213", "source_url": "https://doi.org/10.1016/j.nsa.2022.100213", "doi": "10.1016/j.nsa.2022.100213", "pmid": "", "publication_date": "2021-12-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 5002, "title": "The safety and efficacy of COMP360 psilocybin therapy in treatment-resistant depression: results from a phase IIb randomised controlled trial", "authors": "G.M. Goodwin, Scott T. Aaronson, Boadie W. Dunlop, David Feifel, David J. Hellerstein, N. Hewitt, L. Marwood, S. Mistry, Metten Somers, S.C. Stansfield, J. Tsai, S. Williams, Antony Young, Sidney Zisook, E. Malievskaia", "journal": "Neuroscience Applied", "publication_date": "2021-12-31", "publication_year": 2021, "doi": "10.1016/j.nsa.2022.100511", "pubmed_id": null, "openalex_id": "https://openalex.org/W4313199626", "source_url": "https://doi.org/10.1016/j.nsa.2022.100511", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Randomized Controlled Trial,Treatment-Resistant Depression,Safety", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:58", "last_checked": "2026-07-04 07:00:38", "bibtex": null, "source_record_id": "DOI:10.1016/j.nsa.2022.100511", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.nsa.2022.100511", "source_url": "https://doi.org/10.1016/j.nsa.2022.100511", "doi": "10.1016/j.nsa.2022.100511", "pmid": "", "publication_date": "2021-12-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1860, "title": "Dosing Psychedelics and MDMA.", "authors": "Liechti ME, Holze F.", "journal": null, "publication_date": "2021-12-31", "publication_year": 2021, "doi": "10.1007/7854_2021_270", "pubmed_id": "34734392", "openalex_id": "https://openalex.org/W3210796807", "source_url": "https://doi.org/10.1007/7854_2021_270", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Headache / Migraine,Microdosing", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:05", "bibtex": null, "source_record_id": "PMID:34734392", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1007/7854_2021_270", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:34734392", "source_url": "https://doi.org/10.1007/7854_2021_270", "doi": "10.1007/7854_2021_270", "pmid": "34734392", "publication_date": "2021-12-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1857, "title": "Psilocybin for the Treatment of Depression: A Promising New Pharmacotherapy Approach.", "authors": "Agin-Liebes G, Davis AK.", "journal": "Current topics in behavioral neurosciences", "publication_date": "2021-12-31", "publication_year": 2021, "doi": "10.1007/7854_2021_282", "pubmed_id": "34811715", "openalex_id": "https://openalex.org/W3216485471", "source_url": "https://doi.org/10.1007/7854_2021_282", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging,Aging,Clinical Trial,Review Article,Treatment-Resistant Depression", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:38", "bibtex": null, "source_record_id": "PMID:34811715", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1007/7854_2021_282", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:34811715", "source_url": "https://doi.org/10.1007/7854_2021_282", "doi": "10.1007/7854_2021_282", "pmid": "34811715", "publication_date": "2021-12-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1855, "title": "Psychedelics and Hallucinogens in Psychiatry: Finding New Pharmacological Targets.", "authors": "Sousa TR, Rema J, Machado S, Novais F.", "journal": "Current Topics in Medicinal Chemistry", "publication_date": "2021-12-31", "publication_year": 2021, "doi": "10.2174/1568026621666211201145800", "pubmed_id": "34852736", "openalex_id": "https://openalex.org/W3215301772", "source_url": "https://doi.org/10.2174/1568026621666211201145800", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,OCD,Mechanism of Action,Default Mode Network,Randomized Controlled Trial,Review Article,Treatment-Resistant Depression,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:38", "bibtex": null, "source_record_id": "PMID:34852736", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.2174/1568026621666211201145800", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:34852736", "source_url": "https://doi.org/10.2174/1568026621666211201145800", "doi": "10.2174/1568026621666211201145800", "pmid": "34852736", "publication_date": "2021-12-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1854, "title": "Psychedelic medicines for mood disorders: current evidence and clinical considerations.", "authors": "Sarris J, Pinzon Rubiano D, Day K, Galvão-Coelho NL, Perkins D.", "journal": "PubMed", "publication_date": "2021-12-31", "publication_year": 2021, "doi": "10.1097/yco.0000000000000759", "pubmed_id": "34855694", "openalex_id": "https://openalex.org/W3214407741", "source_url": "https://doi.org/10.1097/yco.0000000000000759", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Neuroplasticity,Neurogenesis,Mechanism of Action,Aging,Microdosing,Clinical Trial,Review Article,Animal Study,Treatment-Resistant Depression,Genomics,Microbiome,Inflammation", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:38", "bibtex": null, "source_record_id": "PMID:34855694", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1097/yco.0000000000000759", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:34855694", "source_url": "https://doi.org/10.1097/yco.0000000000000759", "doi": "10.1097/yco.0000000000000759", "pmid": "34855694", "publication_date": "2021-12-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1851, "title": "The Potential of Psychedelics for End of Life and Palliative Care.", "authors": "Yaden DB, Nayak SM, Gukasyan N, Anderson BT, Griffiths RR", "journal": "Current topics in behavioral neurosciences", "publication_date": "2021-12-31", "publication_year": 2021, "doi": "10.1007/7854_2021_278", "pubmed_id": "34958455", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/34958455/", "substance_tags": "psilocybin", "topic_tags": "Depression,End-of-Life Distress,Wellbeing,Review Article,Healthcare Workers", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:20:39", "bibtex": null, "source_record_id": "PMID:34958455", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/34958455/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:34958455", "source_url": "https://pubmed.ncbi.nlm.nih.gov/34958455/", "doi": "10.1007/7854_2021_278", "pmid": "34958455", "publication_date": "2021-12-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1840, "title": "Psilocybin for Trauma-Related Disorders.", "authors": "Khan AJ, Bradley E, O'Donovan A, Woolley J.", "journal": null, "publication_date": "2021-12-31", "publication_year": 2021, "doi": "10.1007/7854_2022_366", "pubmed_id": "35711024", "openalex_id": null, "source_url": "https://doi.org/10.1007/7854_2022_366", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Mechanism of Action,Emotional Processing,Veterans,Safety", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:02", "bibtex": null, "source_record_id": "PMID:35711024", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1007/7854_2022_366", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:35711024", "source_url": "https://doi.org/10.1007/7854_2022_366", "doi": "10.1007/7854_2022_366", "pmid": "35711024", "publication_date": "2021-12-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1807, "title": "Effects of Naturalistic Psychedelic Use on Depression, Anxiety, and Well-Being: Associations With Patterns of Use, Reported Harms, and Transformative Mental States.", "authors": "Raison CL, Jain R, Penn AD, Cole SP, Jain S", "journal": "Frontiers in psychiatry", "publication_date": "2021-12-31", "publication_year": 2021, "doi": "10.3389/fpsyt.2022.831092", "pubmed_id": "35370864", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/35370864/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Wellbeing,Emotional Processing,Mystical Experience,Clinical Trial,Observational Study,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:20:39", "bibtex": null, "source_record_id": "PMID:35370864", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/35370864/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:35370864", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35370864/", "doi": "10.3389/fpsyt.2022.831092", "pmid": "35370864", "publication_date": "2021-12-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1805, "title": "Corrigendum: Psychedelic Mushrooms in the USA: Knowledge, Patterns of Use, and Association With Health Outcomes.", "authors": "Matzopoulos R, Morlock R, Morlock A, Lerer B, Lerer L", "journal": "Frontiers in psychiatry", "publication_date": "2021-12-31", "publication_year": 2021, "doi": "10.3389/fpsyt.2022.877390", "pubmed_id": "35401265", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/35401265/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Observational Study", "study_type": "Observational Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:20:39", "bibtex": null, "source_record_id": "PMID:35401265", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/35401265/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:35401265", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35401265/", "doi": "10.3389/fpsyt.2022.877390", "pmid": "35401265", "publication_date": "2021-12-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1716, "title": "Neuroimaging Correlates of Treatment Response with Psychedelics in Major Depressive Disorder: A Systematic Review.", "authors": "Kuburi S, Di Passa AM, Tassone VK, Mahmood R, Lalovic A, Ladha KS, Dunlop K, Rizvi S, Demchenko I, Bhat V.", "journal": null, "publication_date": "2021-12-31", "publication_year": 2021, "doi": "10.1177/24705470221115342", "pubmed_id": "35936944", "openalex_id": null, "source_url": "https://doi.org/10.1177/24705470221115342", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging,Mechanism of Action,Aging,Systematic Review,Review Article", "study_type": "Systematic Review", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:04", "bibtex": null, "source_record_id": "PMID:35936944", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1177/24705470221115342", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:35936944", "source_url": "https://doi.org/10.1177/24705470221115342", "doi": "10.1177/24705470221115342", "pmid": "35936944", "publication_date": "2021-12-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1622, "title": "The economics of psychedelic-assisted therapies: A research agenda.", "authors": "Marseille E, Bertozzi S, Kahn JG", "journal": "Frontiers in psychiatry", "publication_date": "2021-12-31", "publication_year": 2021, "doi": "10.3389/fpsyt.2022.1025726", "pubmed_id": "36545038", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/36545038/", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Addiction", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:20:38", "bibtex": null, "source_record_id": "PMID:36545038", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/36545038/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:36545038", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36545038/", "doi": "10.3389/fpsyt.2022.1025726", "pmid": "36545038", "publication_date": "2021-12-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1561, "title": "Serotonergic psychedelics for depression: What do we know about neurobiological mechanisms of action?", "authors": "Husain MI, Ledwos N, Fellows E, Baer J, Rosenblat JD, Blumberger DM, Mulsant BH, Castle DJ", "journal": "Frontiers in psychiatry", "publication_date": "2021-12-31", "publication_year": 2021, "doi": "10.3389/fpsyt.2022.1076459", "pubmed_id": "36844032", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/36844032/", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging,Mechanism of Action,Receptor Pharmacology,Default Mode Network,Aging,Review Article", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:20:38", "bibtex": null, "source_record_id": "PMID:36844032", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/36844032/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:36844032", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36844032/", "doi": "10.3389/fpsyt.2022.1076459", "pmid": "36844032", "publication_date": "2021-12-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1747, "title": "A systematic literature review of clinical trials and therapeutic applications of ibogaine.", "authors": "Köck P, Froelich K, Walter M, Lang U, Dürsteler KM.", "journal": null, "publication_date": "2021-12-29", "publication_year": 2021, "doi": "10.1016/j.jsat.2021.108717", "pubmed_id": "35012793", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.jsat.2021.108717", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Clinical Trial,Randomized Controlled Trial,Systematic Review,Review Article,Case Report,Observational Study", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:06", "bibtex": null, "source_record_id": "PMID:35012793", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.jsat.2021.108717", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:35012793", "source_url": "https://doi.org/10.1016/j.jsat.2021.108717", "doi": "10.1016/j.jsat.2021.108717", "pmid": "35012793", "publication_date": "2021-12-29", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3526, "title": "LSD Treatment in Persons Suffering From Anxiety Symptoms in Severe Somatic Diseases or in Psychiatric Anxiety Disorders: a Randomized, Double-blind, Placebo-controlled Phase II Study", "authors": "University Hospital, Basel, Switzerland", "journal": "ClinicalTrials.gov", "publication_date": "2021-12-21", "publication_year": 2021, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT03153579", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Clinical Trial", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT03153579", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT03153579", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT03153579", "source_url": "https://clinicaltrials.gov/study/NCT03153579", "doi": "", "pmid": "", "publication_date": "2021-12-21", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1852, "title": "Psilocybin microdosing does not affect emotion-related symptoms and processing: A preregistered field and lab-based study.", "authors": "Marschall J, Fejer G, Lempe P, Prochazkova L, Kuchar M, Hajkova K, van Elk M.", "journal": "Journal of Psychopharmacology", "publication_date": "2021-12-16", "publication_year": 2021, "doi": "10.1177/02698811211050556", "pubmed_id": "34915762", "openalex_id": "https://openalex.org/W4200583144", "source_url": "https://doi.org/10.1177/02698811211050556", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Mechanism of Action,Microdosing,Emotional Processing,Observational Study", "study_type": "Observational Study", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:38", "bibtex": null, "source_record_id": "PMID:34915762", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1177/02698811211050556", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:34915762", "source_url": "https://doi.org/10.1177/02698811211050556", "doi": "10.1177/02698811211050556", "pmid": "34915762", "publication_date": "2021-12-16", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1817, "title": "Beating pain with psychedelics: Matter over mind?", "authors": "Elman I, Pustilnik A, Borsook D.", "journal": null, "publication_date": "2021-12-15", "publication_year": 2021, "doi": "10.1016/j.neubiorev.2021.12.005", "pubmed_id": "34922987", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.neubiorev.2021.12.005", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Chronic Pain,Neuroplasticity,Brain Imaging,Mechanism of Action,Consciousness,Aging,Emotional Processing,Review Article,Safety,Inflammation", "study_type": "Review Article", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:06", "bibtex": null, "source_record_id": "PMID:34922987", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.neubiorev.2021.12.005", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:34922987", "source_url": "https://doi.org/10.1016/j.neubiorev.2021.12.005", "doi": "10.1016/j.neubiorev.2021.12.005", "pmid": "34922987", "publication_date": "2021-12-15", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1808, "title": "Psilocybin-assisted psychotherapy for depression: Emerging research on a psychedelic compound with a rich history.", "authors": "Pearson C, Siegel J, Gold JA.", "journal": null, "publication_date": "2021-12-15", "publication_year": 2021, "doi": "10.1016/j.jns.2021.120096", "pubmed_id": "34942586", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.jns.2021.120096", "substance_tags": "psilocybin", "topic_tags": "Depression,Pharmacology,Clinical Trial,Review Article,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:02", "bibtex": null, "source_record_id": "PMID:34942586", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.jns.2021.120096", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:34942586", "source_url": "https://doi.org/10.1016/j.jns.2021.120096", "doi": "10.1016/j.jns.2021.120096", "pmid": "34942586", "publication_date": "2021-12-15", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3500, "title": "Effects of Psilocybin in Major Depressive Disorder", "authors": "Johns Hopkins University", "journal": "ClinicalTrials.gov", "publication_date": "2021-12-14", "publication_year": 2021, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT03181529", "substance_tags": "psilocybin", "topic_tags": "Depression", "study_type": "Other", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT03181529", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT03181529", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT03181529", "source_url": "https://clinicaltrials.gov/study/NCT03181529", "doi": "", "pmid": "", "publication_date": "2021-12-14", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 5030, "title": "Announcement of two special issues: behavioural pharmacology of synaptopathies and psychedelic drugs", "authors": "Louk J. M. J. Vanderschuren, Paul Willner, Emily M. Jutkiewicz, Bart Ellenbroek", "journal": "Behavioural Pharmacology", "publication_date": "2021-12-12", "publication_year": 2021, "doi": "10.1097/fbp.0000000000000662", "pubmed_id": "35007231", "openalex_id": "https://openalex.org/W4200050959", "source_url": "https://doi.org/10.1097/fbp.0000000000000662", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Neuroplasticity,Pharmacology,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Review Article", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:58", "last_checked": "2026-07-04 07:00:38", "bibtex": null, "source_record_id": "PMID:35007231", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1097/fbp.0000000000000662", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:35007231", "source_url": "https://doi.org/10.1097/fbp.0000000000000662", "doi": "10.1097/fbp.0000000000000662", "pmid": "35007231", "publication_date": "2021-12-12", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1873, "title": "1H Nuclear Magnetic Resonance: A Future Approach to the Metabolic Profiling of Psychedelics in Human Biofluids?", "authors": "Vilca-Melendez S, Uthaug MV, Griffin JL.", "journal": null, "publication_date": "2021-12-12", "publication_year": 2021, "doi": "10.3389/fpsyt.2021.742856", "pubmed_id": "34966300", "openalex_id": null, "source_url": "https://doi.org/10.3389/fpsyt.2021.742856", "substance_tags": "psilocin", "topic_tags": "Depression,Mechanism of Action,Systematic Review,Review Article,Metabolomics,Microbiome", "study_type": "Systematic Review", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:06", "bibtex": null, "source_record_id": "PMID:34966300", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.3389/fpsyt.2021.742856", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:34966300", "source_url": "https://doi.org/10.3389/fpsyt.2021.742856", "doi": "10.3389/fpsyt.2021.742856", "pmid": "34966300", "publication_date": "2021-12-12", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1874, "title": "A Spectrum of Selves Reinforced in Multilevel Coherence: A Contextual Behavioural Response to the Challenges of Psychedelic-Assisted Therapy Development.", "authors": "Whitfield HJ.", "journal": "Frontiers in Psychiatry", "publication_date": "2021-12-06", "publication_year": 2021, "doi": "10.3389/fpsyt.2021.727572", "pubmed_id": "34950063", "openalex_id": "https://openalex.org/W4200524305", "source_url": "https://doi.org/10.3389/fpsyt.2021.727572", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Mechanism of Action,Psychological Flexibility,Review Article", "study_type": "Review Article", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:38", "bibtex": null, "source_record_id": "PMID:34950063", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.3389/fpsyt.2021.727572", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:34950063", "source_url": "https://doi.org/10.3389/fpsyt.2021.727572", "doi": "10.3389/fpsyt.2021.727572", "pmid": "34950063", "publication_date": "2021-12-06", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 5037, "title": "P.0421 Efficacy and safety of psilocybin in treatment-resistant major depression (EPIsoDE) - study design, rationale and current status", "authors": "Lea J. Mertens, Michael Koslowski, Felix Betzler, Ricarda Evens, Maria Gilles, Andrea Jungaberle, Henrik Jungaberle, Tomislav Majić, Max Wolff, Andreas Ströhle, Stefan Wellek, Gerhard Gründer", "journal": "European Neuropsychopharmacology", "publication_date": "2021-11-30", "publication_year": 2021, "doi": "10.1016/j.euroneuro.2021.10.394", "pubmed_id": null, "openalex_id": "https://openalex.org/W4200326768", "source_url": "https://doi.org/10.1016/j.euroneuro.2021.10.394", "substance_tags": "psilocybin", "topic_tags": "Depression,Consciousness,Safety", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:58", "last_checked": "2026-07-04 07:00:38", "bibtex": null, "source_record_id": "DOI:10.1016/j.euroneuro.2021.10.394", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.euroneuro.2021.10.394", "source_url": "https://doi.org/10.1016/j.euroneuro.2021.10.394", "doi": "10.1016/j.euroneuro.2021.10.394", "pmid": "", "publication_date": "2021-11-30", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 5033, "title": "P.0885 The effect of psilocybin therapy for depression on low-frequency brain activity in response to music", "authors": "Matthew B. Wall, Cynthia Lam, Natalie Ertl, Mendel Kaelen, Leor Roseman, David Nutt, Robin Carhart-Harris", "journal": "European Neuropsychopharmacology", "publication_date": "2021-11-30", "publication_year": 2021, "doi": "10.1016/j.euroneuro.2021.10.741", "pubmed_id": null, "openalex_id": "https://openalex.org/W4200025628", "source_url": "https://doi.org/10.1016/j.euroneuro.2021.10.741", "substance_tags": "psilocybin", "topic_tags": "Depression,Receptor Pharmacology", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:58", "last_checked": "2026-07-04 07:00:38", "bibtex": null, "source_record_id": "DOI:10.1016/j.euroneuro.2021.10.741", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.euroneuro.2021.10.741", "source_url": "https://doi.org/10.1016/j.euroneuro.2021.10.741", "doi": "10.1016/j.euroneuro.2021.10.741", "pmid": "", "publication_date": "2021-11-30", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 5032, "title": "P.0729 Highlights of psychedelic history and current research on psilocybin application for treatment of depression - a comprehensive literature review", "authors": "Sara Penedos, Caio Freitas Ramos, María José López Miguel, Márcio José Martins Alves, Luciana Campos Paulino, Adriano Valério S. Azevêdo, M. Magalhães, L. Moreno, N. Ribeiro, Inês Fonseca, Ana Margarida Romão Franco, Luís Madruga, A. Gamito", "journal": "European Neuropsychopharmacology", "publication_date": "2021-11-30", "publication_year": 2021, "doi": "10.1016/j.euroneuro.2021.10.797", "pubmed_id": null, "openalex_id": "https://openalex.org/W4200007802", "source_url": "https://doi.org/10.1016/j.euroneuro.2021.10.797", "substance_tags": "psilocybin", "topic_tags": "Depression,Eating Disorders,Review Article", "study_type": "Review Article", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:58", "last_checked": "2026-07-04 07:00:38", "bibtex": null, "source_record_id": "DOI:10.1016/j.euroneuro.2021.10.797", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.euroneuro.2021.10.797", "source_url": "https://doi.org/10.1016/j.euroneuro.2021.10.797", "doi": "10.1016/j.euroneuro.2021.10.797", "pmid": "", "publication_date": "2021-11-30", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1876, "title": "Homebrewed psilocybin: can new routes for pharmaceutical psilocybin production enable recreational use?", "authors": "Gibbons WJ, McKinney MG, O'Dell PJ, Bollinger BA, Jones JA.", "journal": "Bioengineered", "publication_date": "2021-11-30", "publication_year": 2021, "doi": "10.1080/21655979.2021.1987090", "pubmed_id": "34607532", "openalex_id": "https://openalex.org/W3203128580", "source_url": "https://doi.org/10.1080/21655979.2021.1987090", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:38", "bibtex": null, "source_record_id": "PMID:34607532", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1080/21655979.2021.1987090", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:34607532", "source_url": "https://doi.org/10.1080/21655979.2021.1987090", "doi": "10.1080/21655979.2021.1987090", "pmid": "34607532", "publication_date": "2021-11-30", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1875, "title": "Psilocybin-assisted therapy for the treatment of resistant major depressive disorder (PsiDeR): protocol for a randomised, placebo-controlled feasibility trial.", "authors": "Rucker J, Jafari H, Mantingh T, Bird C, Modlin NL, Knight G, Reinholdt F, Day C, Carter B, Young A.", "journal": "BMJ Open", "publication_date": "2021-11-30", "publication_year": 2021, "doi": "10.1136/bmjopen-2021-056091", "pubmed_id": "34853114", "openalex_id": "https://openalex.org/W3215511316", "source_url": "https://doi.org/10.1136/bmjopen-2021-056091", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging,Biomarkers,Aging,Randomized Controlled Trial,Review Article", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:38", "bibtex": null, "source_record_id": "PMID:34853114", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1136/bmjopen-2021-056091", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:34853114", "source_url": "https://doi.org/10.1136/bmjopen-2021-056091", "doi": "10.1136/bmjopen-2021-056091", "pmid": "34853114", "publication_date": "2021-11-30", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1749, "title": "Molecular insights into psychedelic drug action.", "authors": "Slocum ST, DiBerto JF, Roth BL.", "journal": null, "publication_date": "2021-11-30", "publication_year": 2021, "doi": "10.1111/jnc.15540", "pubmed_id": "34797943", "openalex_id": null, "source_url": "https://doi.org/10.1111/jnc.15540", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Review Article,Treatment-Resistant Depression", "study_type": "Review Article", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:05", "bibtex": null, "source_record_id": "PMID:34797943", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1111/jnc.15540", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:34797943", "source_url": "https://doi.org/10.1111/jnc.15540", "doi": "10.1111/jnc.15540", "pmid": "34797943", "publication_date": "2021-11-30", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 5041, "title": "Marijuana, Hallucinogen Use Reach Historic Levels Among Young Adults", "authors": "Linda M. Richmond", "journal": "Psychiatric News", "publication_date": "2021-11-29", "publication_year": 2021, "doi": "10.1176/appi.pn.2021.11.29", "pubmed_id": null, "openalex_id": "https://openalex.org/W3216860842", "source_url": "https://doi.org/10.1176/appi.pn.2021.11.29", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Spirituality,Mystical Experience,Observational Study,Safety", "study_type": "Observational Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:58", "last_checked": "2026-07-04 07:00:38", "bibtex": null, "source_record_id": "DOI:10.1176/appi.pn.2021.11.29", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1176/appi.pn.2021.11.29", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1176/appi.pn.2021.11.29", "source_url": "https://doi.org/10.1176/appi.pn.2021.11.29", "doi": "10.1176/appi.pn.2021.11.29", "pmid": "", "publication_date": "2021-11-29", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 5045, "title": "Psychedelic Drugs for Mental Disorders and Human Potential: Placebo or Panacea", "authors": "David J. Hellerstein, Kevin A. Sabet, Jeffrey A. Lieberman", "journal": "Psychiatric News", "publication_date": "2021-11-28", "publication_year": 2021, "doi": "10.1176/appi.pn.2021.12.14", "pubmed_id": null, "openalex_id": "https://openalex.org/W3216344082", "source_url": "https://doi.org/10.1176/appi.pn.2021.12.14", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Consciousness,Mystical Experience,Review Article,Adolescents,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:58", "last_checked": "2026-07-04 07:00:38", "bibtex": null, "source_record_id": "DOI:10.1176/appi.pn.2021.12.14", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1176/appi.pn.2021.12.14", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1176/appi.pn.2021.12.14", "source_url": "https://doi.org/10.1176/appi.pn.2021.12.14", "doi": "10.1176/appi.pn.2021.12.14", "pmid": "", "publication_date": "2021-11-28", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1856, "title": "Psychedelics for the treatment of depression, anxiety, and existential distress in patients with a terminal illness: a systematic review.", "authors": "Schimmers N, Breeksema JJ, Smith-Apeldoorn SY, Veraart J, van den Brink W, Schoevers RA.", "journal": null, "publication_date": "2021-11-22", "publication_year": 2021, "doi": "10.1007/s00213-021-06027-y", "pubmed_id": "34812901", "openalex_id": null, "source_url": "https://doi.org/10.1007/s00213-021-06027-y", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Wellbeing,Spirituality,Systematic Review,Review Article,Safety", "study_type": "Systematic Review", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:05", "bibtex": null, "source_record_id": "PMID:34812901", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1007/s00213-021-06027-y", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:34812901", "source_url": "https://doi.org/10.1007/s00213-021-06027-y", "doi": "10.1007/s00213-021-06027-y", "pmid": "34812901", "publication_date": "2021-11-22", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1800, "title": "Acute Effects of Psilocybin After Escitalopram or Placebo Pretreatment in a Randomized, Double-Blind, Placebo-Controlled, Crossover Study in Healthy Subjects.", "authors": "Becker AM, Holze F, Grandinetti T, Klaiber A, Toedtli VE, Kolaczynska KE, Duthaler U, Varghese N, Eckert A, Grünblatt E, Liechti ME.", "journal": "Clinical Pharmacology & Therapeutics", "publication_date": "2021-11-21", "publication_year": 2021, "doi": "10.1002/cpt.2487", "pubmed_id": "34743319", "openalex_id": "https://openalex.org/W3213378850", "source_url": "https://doi.org/10.1002/cpt.2487", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Anxiety,Pharmacology,Healthy Volunteers,Drug Interactions", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:38", "bibtex": null, "source_record_id": "PMID:34743319", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1002/cpt.2487", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:34743319", "source_url": "https://doi.org/10.1002/cpt.2487", "doi": "10.1002/cpt.2487", "pmid": "34743319", "publication_date": "2021-11-21", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1885, "title": "Adults who microdose psychedelics report health related motivations and lower levels of anxiety and depression compared to non-microdosers.", "authors": "Rootman JM, Kryskow P, Harvey K, Stamets P, Santos-Brault E, Kuypers KPC, Polito V, Bourzat F, Walsh Z.", "journal": "Scientific Reports", "publication_date": "2021-11-17", "publication_year": 2021, "doi": "10.1038/s41598-021-01811-4", "pubmed_id": "34795334", "openalex_id": "https://openalex.org/W3211842562", "source_url": "https://doi.org/10.1038/s41598-021-01811-4", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Microdosing,Wellbeing,Observational Study,Adolescents", "study_type": "Observational Study", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:06", "last_checked": "2026-07-04 07:00:38", "bibtex": null, "source_record_id": "PMID:34795334", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1038/s41598-021-01811-4", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:34795334", "source_url": "https://doi.org/10.1038/s41598-021-01811-4", "doi": "10.1038/s41598-021-01811-4", "pmid": "34795334", "publication_date": "2021-11-17", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1858, "title": "Molecular Mechanisms of Psilocybin and Implications for the Treatment of Depression.", "authors": "Ling S, Ceban F, Lui LMW, Lee Y, Teopiz KM, Rodrigues NB, Lipsitz O, Gill H, Subramaniapillai M, Mansur RB, Lin K, Ho R, Rosenblat JD, Castle D, McIntyre RS.", "journal": null, "publication_date": "2021-11-16", "publication_year": 2021, "doi": "10.1007/s40263-021-00877-y", "pubmed_id": "34791625", "openalex_id": null, "source_url": "https://doi.org/10.1007/s40263-021-00877-y", "substance_tags": "psilocybin", "topic_tags": "Depression,Pharmacology,Mechanism of Action,Receptor Pharmacology,Default Mode Network,Review Article,Treatment-Resistant Depression", "study_type": "Review Article", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:02", "bibtex": null, "source_record_id": "PMID:34791625", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1007/s40263-021-00877-y", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:34791625", "source_url": "https://doi.org/10.1007/s40263-021-00877-y", "doi": "10.1007/s40263-021-00877-y", "pmid": "34791625", "publication_date": "2021-11-16", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1845, "title": "Human behavioral pharmacology of psychedelics.", "authors": "Strickland JC, Johnson MW.", "journal": null, "publication_date": "2021-11-10", "publication_year": 2021, "doi": "10.1016/bs.apha.2021.10.003", "pubmed_id": "35341564", "openalex_id": null, "source_url": "https://doi.org/10.1016/bs.apha.2021.10.003", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Pharmacology,Mechanism of Action,Mystical Experience,Clinical Trial,Treatment-Resistant Depression,Abuse Liability", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:05", "bibtex": null, "source_record_id": "PMID:35341564", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/bs.apha.2021.10.003", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:35341564", "source_url": "https://doi.org/10.1016/bs.apha.2021.10.003", "doi": "10.1016/bs.apha.2021.10.003", "pmid": "35341564", "publication_date": "2021-11-10", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1818, "title": "[Rapid-acting antidepressants-neurobiological mechanisms of action].", "authors": "Gass P, Vasilescu AN, Inta D.", "journal": null, "publication_date": "2021-11-10", "publication_year": 2021, "doi": "10.1007/s00115-021-01225-7", "pubmed_id": "34766186", "openalex_id": null, "source_url": "https://doi.org/10.1007/s00115-021-01225-7", "substance_tags": "psilocybin", "topic_tags": "Depression,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Animal Study", "study_type": "Animal Study", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:06", "bibtex": null, "source_record_id": "PMID:34766186", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1007/s00115-021-01225-7", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:34766186", "source_url": "https://doi.org/10.1007/s00115-021-01225-7", "doi": "10.1007/s00115-021-01225-7", "pmid": "34766186", "publication_date": "2021-11-10", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1887, "title": "Daily briefing: Largest trial shows psilocybin is effective to treat depression.", "authors": "Graham F.", "journal": "Nature", "publication_date": "2021-11-09", "publication_year": 2021, "doi": "10.1038/d41586-021-03413-6", "pubmed_id": "34764467", "openalex_id": "https://openalex.org/W4200395175", "source_url": "https://doi.org/10.1038/d41586-021-03413-6", "substance_tags": "psilocybin", "topic_tags": "Depression", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:06", "last_checked": "2026-07-04 07:00:38", "bibtex": null, "source_record_id": "PMID:34764467", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:34764467", "source_url": "https://doi.org/10.1038/d41586-021-03413-6", "doi": "10.1038/d41586-021-03413-6", "pmid": "34764467", "publication_date": "2021-11-09", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1888, "title": "Psilocybin therapy increases cognitive and neural flexibility in patients with major depressive disorder.", "authors": "Doss MK, Považan M, Rosenberg MD, Sepeda ND, Davis AK, Finan PH, Smith GS, Pekar JJ, Barker PB, Griffiths RR, Barrett FS.", "journal": "Translational Psychiatry", "publication_date": "2021-11-07", "publication_year": 2021, "doi": "10.1038/s41398-021-01706-y", "pubmed_id": "34750350", "openalex_id": "https://openalex.org/W3213458191", "source_url": "https://doi.org/10.1038/s41398-021-01706-y", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging,Mechanism of Action,Aging", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:06", "last_checked": "2026-07-04 07:00:38", "bibtex": null, "source_record_id": "PMID:34750350", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1038/s41398-021-01706-y", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:34750350", "source_url": "https://doi.org/10.1038/s41398-021-01706-y", "doi": "10.1038/s41398-021-01706-y", "pmid": "34750350", "publication_date": "2021-11-07", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1750, "title": "From psychiatry to neurology: Psychedelics as prospective therapeutics for neurodegenerative disorders.", "authors": "Kozlowska U, Nichols C, Wiatr K, Figiel M.", "journal": null, "publication_date": "2021-10-21", "publication_year": 2021, "doi": "10.1111/jnc.15509", "pubmed_id": "34519052", "openalex_id": null, "source_url": "https://doi.org/10.1111/jnc.15509", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Neuroplasticity,Mechanism of Action,Biomarkers,Clinical Trial,Review Article,Animal Study,Drug Interactions,Inflammation", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:05", "bibtex": null, "source_record_id": "PMID:34519052", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1111/jnc.15509", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:34519052", "source_url": "https://doi.org/10.1111/jnc.15509", "doi": "10.1111/jnc.15509", "pmid": "34519052", "publication_date": "2021-10-21", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 5052, "title": "Finding the divine within: exploring the role of the sacred in psychedelic integration therapy for sexual trauma and dysfunction", "authors": "Dee Dee Goldpaugh", "journal": "Sexual & Relationship Therapy", "publication_date": "2021-10-19", "publication_year": 2021, "doi": "10.1080/14681994.2021.1994138", "pubmed_id": null, "openalex_id": "https://openalex.org/W3214272829", "source_url": "https://doi.org/10.1080/14681994.2021.1994138", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Pharmacology,Wellbeing", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:58", "last_checked": "2026-07-04 07:00:38", "bibtex": null, "source_record_id": "DOI:10.1080/14681994.2021.1994138", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1080/14681994.2021.1994138", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1080/14681994.2021.1994138", "source_url": "https://doi.org/10.1080/14681994.2021.1994138", "doi": "10.1080/14681994.2021.1994138", "pmid": "", "publication_date": "2021-10-19", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3459, "title": "The Safety and Efficacy of Psilocybin in Cancer Patients With Major Depressive Disorder", "authors": "Maryland Oncology Hematology, PA", "journal": "ClinicalTrials.gov", "publication_date": "2021-10-14", "publication_year": 2021, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT04593563", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Clinical Trial,Cancer Patients,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT04593563", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT04593563", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT04593563", "source_url": "https://clinicaltrials.gov/study/NCT04593563", "doi": "", "pmid": "", "publication_date": "2021-10-14", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 5054, "title": "Delix to synthesize psychedelic drugs", "authors": "Ryan Cross", "journal": "C&EN Global Enterprise", "publication_date": "2021-10-03", "publication_year": 2021, "doi": "10.1021/cen-09936-buscon3", "pubmed_id": null, "openalex_id": "https://openalex.org/W4367158646", "source_url": "http://dx.doi.org/10.1021/cen-09936-buscon3", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:58", "last_checked": "2026-07-04 07:00:38", "bibtex": null, "source_record_id": "DOI:10.1021/cen-09936-buscon3", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.1021/cen-09936-buscon3", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1021/cen-09936-buscon3", "source_url": "http://dx.doi.org/10.1021/cen-09936-buscon3", "doi": "10.1021/cen-09936-buscon3", "pmid": "", "publication_date": "2021-10-03", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1573, "title": "Novel antidepressant drugs: Beyond monoamine targets.", "authors": "Gonda X, Dome P, Neill JC, Tarazi FI.", "journal": null, "publication_date": "2021-09-29", "publication_year": 2021, "doi": "10.1017/s1092852921000791", "pubmed_id": "34588093", "openalex_id": null, "source_url": "https://doi.org/10.1017/s1092852921000791", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Treatment-Resistant Depression,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:06", "bibtex": null, "source_record_id": "PMID:34588093", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1017/s1092852921000791", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:34588093", "source_url": "https://doi.org/10.1017/s1092852921000791", "doi": "10.1017/s1092852921000791", "pmid": "34588093", "publication_date": "2021-09-29", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1904, "title": "Rediscovering Psilocybin as an Antidepressive Treatment Strategy.", "authors": "Zeiss R, Gahr M, Graf H.", "journal": null, "publication_date": "2021-09-27", "publication_year": 2021, "doi": "10.3390/ph14100985", "pubmed_id": "34681209", "openalex_id": null, "source_url": "https://doi.org/10.3390/ph14100985", "substance_tags": "psilocybin", "topic_tags": "Depression,Pharmacology,Mechanism of Action,Review Article,Safety,Adverse Events", "study_type": "Review Article", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:06", "last_checked": "2026-07-01 11:22:02", "bibtex": null, "source_record_id": "PMID:34681209", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.3390/ph14100985", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:34681209", "source_url": "https://doi.org/10.3390/ph14100985", "doi": "10.3390/ph14100985", "pmid": "34681209", "publication_date": "2021-09-27", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 5059, "title": "Psilocybin: Next to treat depression, OCD and nicotine addiction", "authors": "Alison Knopf", "journal": "Alcoholism & Drug Abuse Weekly", "publication_date": "2021-09-23", "publication_year": 2021, "doi": "10.1002/adaw.33204", "pubmed_id": null, "openalex_id": "https://openalex.org/W3202550363", "source_url": "https://doi.org/10.1002/adaw.33204", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,OCD", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:59", "last_checked": "2026-07-04 07:00:38", "bibtex": null, "source_record_id": "DOI:10.1002/adaw.33204", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1002/adaw.33204", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1002/adaw.33204", "source_url": "https://doi.org/10.1002/adaw.33204", "doi": "10.1002/adaw.33204", "pmid": "", "publication_date": "2021-09-23", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1890, "title": "Neuroplasticity as a convergent mechanism of ketamine and classical psychedelics.", "authors": "Aleksandrova LR, Phillips AG.", "journal": null, "publication_date": "2021-09-23", "publication_year": 2021, "doi": "10.1016/j.tips.2021.08.003", "pubmed_id": "34565579", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.tips.2021.08.003", "substance_tags": "psilocybin", "topic_tags": "Depression,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Review Article,Animal Study", "study_type": "Review Article", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:06", "last_checked": "2026-07-01 11:22:05", "bibtex": null, "source_record_id": "PMID:34565579", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.tips.2021.08.003", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:34565579", "source_url": "https://doi.org/10.1016/j.tips.2021.08.003", "doi": "10.1016/j.tips.2021.08.003", "pmid": "34565579", "publication_date": "2021-09-23", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 5061, "title": "New Insights Into the Clinical and Nonclinical Effects of Psychedelic Substances", "authors": "Matthias Forstmann, Christina Sagioglou", "journal": "European Psychologist", "publication_date": "2021-09-16", "publication_year": 2021, "doi": "10.1027/1016-9040/a000447", "pubmed_id": null, "openalex_id": "https://openalex.org/W3161737512", "source_url": "https://doi.org/10.1027/1016-9040/a000447", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Mechanism of Action,Receptor Pharmacology,Wellbeing,Personality Change,Creativity,Review Article", "study_type": "Review Article", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:59", "last_checked": "2026-07-04 07:00:38", "bibtex": null, "source_record_id": "DOI:10.1027/1016-9040/a000447", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1027/1016-9040/a000447", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1027/1016-9040/a000447", "source_url": "https://doi.org/10.1027/1016-9040/a000447", "doi": "10.1027/1016-9040/a000447", "pmid": "", "publication_date": "2021-09-16", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1863, "title": "Dose effect of psilocybin on primary and secondary depression: a preliminary systematic review and meta-analysis.", "authors": "Li NX, Hu YR, Chen WN, Zhang B.", "journal": null, "publication_date": "2021-09-16", "publication_year": 2021, "doi": "10.1016/j.jad.2021.09.041", "pubmed_id": "34587546", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.jad.2021.09.041", "substance_tags": "psilocybin", "topic_tags": "Depression,Meta-Analysis,Systematic Review,Review Article,Cancer Patients", "study_type": "Meta-Analysis", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:02", "bibtex": null, "source_record_id": "PMID:34587546", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.jad.2021.09.041", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:34587546", "source_url": "https://doi.org/10.1016/j.jad.2021.09.041", "doi": "10.1016/j.jad.2021.09.041", "pmid": "34587546", "publication_date": "2021-09-16", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 5064, "title": "The therapeutical role of psychedelic drugs in treatment of mental disorders", "authors": "Dan Cătălin Oprea, Loretta Epure, Vasile Chiriță, Adrian Cantemir", "journal": "Bulletin of Integrative Psychiatry", "publication_date": "2021-09-14", "publication_year": 2021, "doi": "10.36219/bpi.2021.3.09", "pubmed_id": null, "openalex_id": "https://openalex.org/W3202248738", "source_url": "https://doi.org/10.36219/bpi.2021.3.09", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,OCD,Receptor Pharmacology,Spirituality", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:59", "last_checked": "2026-07-04 07:00:38", "bibtex": null, "source_record_id": "DOI:10.36219/bpi.2021.3.09", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.36219/bpi.2021.3.09", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.36219/bpi.2021.3.09", "source_url": "https://doi.org/10.36219/bpi.2021.3.09", "doi": "10.36219/bpi.2021.3.09", "pmid": "", "publication_date": "2021-09-14", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 5063, "title": "Is MDD the right target for early-stage psychedelic-assisted therapy trials?", "authors": "Benjamin R. Lewis, Kevin Byrne", "journal": "Journal of Psychedelic Studies", "publication_date": "2021-09-14", "publication_year": 2021, "doi": "10.1556/2054.2021.00180", "pubmed_id": null, "openalex_id": "https://openalex.org/W3199274122", "source_url": "https://doi.org/10.1556/2054.2021.00180", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Receptor Pharmacology,Wellbeing,Clinical Trial,Randomized Controlled Trial", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:59", "last_checked": "2026-07-04 07:00:38", "bibtex": null, "source_record_id": "DOI:10.1556/2054.2021.00180", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1556/2054.2021.00180", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1556/2054.2021.00180", "source_url": "https://doi.org/10.1556/2054.2021.00180", "doi": "10.1556/2054.2021.00180", "pmid": "", "publication_date": "2021-09-14", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1864, "title": "Assessing the effects of methodological differences on outcomes in the use of psychedelics in the treatment of anxiety and depressive disorders: A systematic review and meta-analysis.", "authors": "Leger RF, Unterwald EM.", "journal": null, "publication_date": "2021-09-13", "publication_year": 2021, "doi": "10.1177/02698811211044688", "pubmed_id": "34519567", "openalex_id": null, "source_url": "https://doi.org/10.1177/02698811211044688", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Receptor Pharmacology,Clinical Trial,Meta-Analysis,Systematic Review,Review Article", "study_type": "Meta-Analysis", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:05", "bibtex": null, "source_record_id": "PMID:34519567", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1177/02698811211044688", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:34519567", "source_url": "https://doi.org/10.1177/02698811211044688", "doi": "10.1177/02698811211044688", "pmid": "34519567", "publication_date": "2021-09-13", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 5065, "title": "New Frontiers or a Bursting Bubble? Psychedelic Therapy Beyond the Dichotomy", "authors": "Tehseen Noorani, Jonny Martell", "journal": "Frontiers in Psychiatry", "publication_date": "2021-09-09", "publication_year": 2021, "doi": "10.3389/fpsyt.2021.727050", "pubmed_id": "34566724", "openalex_id": "https://openalex.org/W3201103091", "source_url": "https://doi.org/10.3389/fpsyt.2021.727050", "substance_tags": "psilocybin", "topic_tags": "Depression,Receptor Pharmacology,Wellbeing,Clinical Trial,Review Article", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:59", "last_checked": "2026-07-04 07:00:38", "bibtex": null, "source_record_id": "PMID:34566724", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.3389/fpsyt.2021.727050", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:34566724", "source_url": "https://doi.org/10.3389/fpsyt.2021.727050", "doi": "10.3389/fpsyt.2021.727050", "pmid": "34566724", "publication_date": "2021-09-09", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 5066, "title": "Treating Major Depression Disorder with Psychedelics: A Potential Therapeutic Application for Psilocybin?", "authors": "Gonçalo Cotovio, Ana Maia, Ana Velosa, Carolina Seybert, Albino J. Oliveira-Maia", "journal": "Revista Portuguesa de Psiquiatria e Saúde Mental", "publication_date": "2021-09-07", "publication_year": 2021, "doi": "10.51338/rppsm.2021.v7.i3.241", "pubmed_id": null, "openalex_id": "https://openalex.org/W3200752577", "source_url": "https://doi.org/10.51338/rppsm.2021.v7.i3.241", "substance_tags": "psilocybin", "topic_tags": "Depression,Receptor Pharmacology", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:59", "last_checked": "2026-07-04 07:00:38", "bibtex": null, "source_record_id": "DOI:10.51338/rppsm.2021.v7.i3.241", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.51338/rppsm.2021.v7.i3.241", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.51338/rppsm.2021.v7.i3.241", "source_url": "https://doi.org/10.51338/rppsm.2021.v7.i3.241", "doi": "10.51338/rppsm.2021.v7.i3.241", "pmid": "", "publication_date": "2021-09-07", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1910, "title": "Treatment-Resistant Depression: Approaches to Treatment.", "authors": "Kverno KS, Mangano E.", "journal": null, "publication_date": "2021-08-31", "publication_year": 2021, "doi": "10.3928/02793695-20210816-01", "pubmed_id": "34459676", "openalex_id": null, "source_url": "https://doi.org/10.3928/02793695-20210816-01", "substance_tags": "psilocybin", "topic_tags": "Depression,Review Article,Treatment-Resistant Depression,Healthcare Workers,Safety", "study_type": "Review Article", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:06", "last_checked": "2026-07-01 11:22:05", "bibtex": null, "source_record_id": "PMID:34459676", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.3928/02793695-20210816-01", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:34459676", "source_url": "https://doi.org/10.3928/02793695-20210816-01", "doi": "10.3928/02793695-20210816-01", "pmid": "34459676", "publication_date": "2021-08-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 5069, "title": "Beckley raises funds for psychedelic drugs", "authors": "Ryan Cross", "journal": "C&EN Global Enterprise", "publication_date": "2021-08-22", "publication_year": 2021, "doi": "10.1021/cen-09930-buscon17", "pubmed_id": null, "openalex_id": "https://openalex.org/W4367017439", "source_url": "http://dx.doi.org/10.1021/cen-09930-buscon17", "substance_tags": "psilocybin", "topic_tags": "Depression,Headache / Migraine,Clinical Trial,Treatment-Resistant Depression", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:59", "last_checked": "2026-07-04 07:00:38", "bibtex": null, "source_record_id": "DOI:10.1021/cen-09930-buscon17", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.1021/cen-09930-buscon17", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1021/cen-09930-buscon17", "source_url": "http://dx.doi.org/10.1021/cen-09930-buscon17", "doi": "10.1021/cen-09930-buscon17", "pmid": "", "publication_date": "2021-08-22", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 5070, "title": "Use of alternative therapy with Psilocybin in oncologic patients with depression and/or anxiety disorders - integrative review", "authors": "Frederico Marques Silveira, Amanda Pereira Mendes, Mayara Rodrigues dos Santos, Júlia Ramos Cerchi, IRIS TIYONO TAVARES UMEDA, Breno Basílio de Melo, Luiza Elena Casaburi, Mateus Nóbrega Oliveira, Douglas Reis Abdalla", "journal": "Research Society and Development", "publication_date": "2021-08-18", "publication_year": 2021, "doi": "10.33448/rsd-v10i10.19297", "pubmed_id": null, "openalex_id": "https://openalex.org/W3194848852", "source_url": "https://doi.org/10.33448/rsd-v10i10.19297", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Review Article,Observational Study,Cancer Patients", "study_type": "Review Article", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:59", "last_checked": "2026-07-04 07:00:38", "bibtex": null, "source_record_id": "DOI:10.33448/rsd-v10i10.19297", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.33448/rsd-v10i10.19297", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.33448/rsd-v10i10.19297", "source_url": "https://doi.org/10.33448/rsd-v10i10.19297", "doi": "10.33448/rsd-v10i10.19297", "pmid": "", "publication_date": "2021-08-18", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3371, "title": "Psychedelics and psychiatric disorders: A emerging role", "authors": "Peixoto C, Santos F, Rego D, Medeiros H.", "journal": null, "publication_date": "2021-08-12", "publication_year": 2021, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://europepmc.org/article/PMC/PMC9470409", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,End-of-Life Distress,Headache / Migraine,Receptor Pharmacology,Clinical Trial,Systematic Review,Review Article,Adverse Events", "study_type": "Systematic Review", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 11:03:51", "last_checked": "2026-07-01 11:22:05", "bibtex": null, "source_record_id": "https://europepmc.org/article/PMC/PMC9470409", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://europepmc.org/article/PMC/PMC9470409", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "https://europepmc.org/article/PMC/PMC9470409", "source_url": "https://europepmc.org/article/PMC/PMC9470409", "doi": "", "pmid": "", "publication_date": "2021-08-12", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3339, "title": "Psychedelics: A new era of treatment?", "authors": "Torres S.", "journal": null, "publication_date": "2021-08-12", "publication_year": 2021, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://europepmc.org/article/PMC/PMC9475866", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Neuroplasticity,Pharmacology,Receptor Pharmacology,Consciousness,Emotional Processing,Randomized Controlled Trial,Review Article,Cancer Patients,Treatment-Resistant Depression", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 11:03:51", "last_checked": "2026-07-01 11:22:05", "bibtex": null, "source_record_id": "https://europepmc.org/article/PMC/PMC9475866", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://europepmc.org/article/PMC/PMC9475866", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "https://europepmc.org/article/PMC/PMC9475866", "source_url": "https://europepmc.org/article/PMC/PMC9475866", "doi": "", "pmid": "", "publication_date": "2021-08-12", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3211, "title": "Effects of psilocybin-assisted therapy on treatment-resistant depression", "authors": "Fraga A, Esteves-Sousa D, Facucho-Oliveira J, Albuquerque M, Costa M, Dos Santos P, Moura N, Moutinho A.", "journal": null, "publication_date": "2021-08-12", "publication_year": 2021, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://europepmc.org/article/PMC/PMC9480034", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Clinical Trial,Review Article,Treatment-Resistant Depression", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 11:03:48", "last_checked": "2026-07-01 11:22:02", "bibtex": null, "source_record_id": "https://europepmc.org/article/PMC/PMC9480034", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://europepmc.org/article/PMC/PMC9480034", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "https://europepmc.org/article/PMC/PMC9480034", "source_url": "https://europepmc.org/article/PMC/PMC9480034", "doi": "", "pmid": "", "publication_date": "2021-08-12", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3156, "title": "Psilocybin in the treatment of obsessive-compulsive disorder: What do we know so far?", "authors": "Descalço N, Medeiros A, Santos C, Borges G.", "journal": null, "publication_date": "2021-08-12", "publication_year": 2021, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://europepmc.org/article/PMC/PMC9476072", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,OCD,Receptor Pharmacology,Aging,Clinical Trial,Systematic Review,Review Article,Case Report,Treatment-Resistant Depression", "study_type": "Systematic Review", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 11:03:47", "last_checked": "2026-07-01 11:22:01", "bibtex": null, "source_record_id": "https://europepmc.org/article/PMC/PMC9476072", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://europepmc.org/article/PMC/PMC9476072", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "https://europepmc.org/article/PMC/PMC9476072", "source_url": "https://europepmc.org/article/PMC/PMC9476072", "doi": "", "pmid": "", "publication_date": "2021-08-12", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 5071, "title": "What can we learn from the history of research on psychedelic drugs in the addictions?", "authors": "Wayne Hall, Michael Farrell", "journal": "Addiction", "publication_date": "2021-08-11", "publication_year": 2021, "doi": "10.1111/add.15560", "pubmed_id": "34382252", "openalex_id": "https://openalex.org/W3187445852", "source_url": "https://doi.org/10.1111/add.15560", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Addiction,Mechanism of Action,Receptor Pharmacology,Mystical Experience,Clinical Trial,Randomized Controlled Trial,Meta-Analysis,Healthcare Workers,Safety,Toxicity", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:59", "last_checked": "2026-07-04 07:00:38", "bibtex": null, "source_record_id": "PMID:34382252", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1111/add.15560", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:34382252", "source_url": "https://doi.org/10.1111/add.15560", "doi": "10.1111/add.15560", "pmid": "34382252", "publication_date": "2021-08-11", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 2132, "title": "Lysergic Acid Diethylamide, Psilocybin and Dimethyltryptamine in Depression Treatment: A Systematic Review.", "authors": "Więckiewicz G, Stokłosa I, Piegza M, Gorczyca P, Pudlo R.", "journal": null, "publication_date": "2021-08-11", "publication_year": 2021, "doi": "10.3390/ph14080793", "pubmed_id": "34451890", "openalex_id": null, "source_url": "https://doi.org/10.3390/ph14080793", "substance_tags": "psilocybin", "topic_tags": "Depression,Meta-Analysis,Systematic Review,Review Article", "study_type": "Meta-Analysis", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-01 11:22:02", "bibtex": null, "source_record_id": "PMID:34451890", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.3390/ph14080793", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:34451890", "source_url": "https://doi.org/10.3390/ph14080793", "doi": "10.3390/ph14080793", "pmid": "34451890", "publication_date": "2021-08-11", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1911, "title": "Classic Psychedelic Coadministration with Lithium, but Not Lamotrigine, is Associated with Seizures: An Analysis of Online Psychedelic Experience Reports.", "authors": "Nayak SM, Gukasyan N, Barrett FS, Erowid E, Erowid F, Griffiths RR.", "journal": "Pharmacopsychiatry", "publication_date": "2021-08-03", "publication_year": 2021, "doi": "10.1055/a-1524-2794", "pubmed_id": "34348413", "openalex_id": "https://openalex.org/W3160183306", "source_url": "https://doi.org/10.1055/a-1524-2794", "substance_tags": "psilocybin", "topic_tags": "Depression,Safety", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:06", "last_checked": "2026-07-04 07:00:38", "bibtex": null, "source_record_id": "PMID:34348413", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1055/a-1524-2794", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:34348413", "source_url": "https://doi.org/10.1055/a-1524-2794", "doi": "10.1055/a-1524-2794", "pmid": "34348413", "publication_date": "2021-08-03", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 5072, "title": "Mit Psilocybin gegen Depression", "authors": "Markus Weih", "journal": "InFo Neurologie + Psychiatrie", "publication_date": "2021-07-31", "publication_year": 2021, "doi": "10.1007/s15005-021-2012-7", "pubmed_id": null, "openalex_id": "https://openalex.org/W3194236679", "source_url": "https://doi.org/10.1007/s15005-021-2012-7", "substance_tags": "psilocybin", "topic_tags": "Depression", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:59", "last_checked": "2026-07-04 07:00:38", "bibtex": null, "source_record_id": "DOI:10.1007/s15005-021-2012-7", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1007/s15005-021-2012-7", "source_url": "https://doi.org/10.1007/s15005-021-2012-7", "doi": "10.1007/s15005-021-2012-7", "pmid": "", "publication_date": "2021-07-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1919, "title": "Psilocybin for Depression.", "authors": "Wiley JF, Bei B.", "journal": null, "publication_date": "2021-07-31", "publication_year": 2021, "doi": "10.1056/nejmc2108082", "pubmed_id": "34437794", "openalex_id": null, "source_url": "https://doi.org/10.1056/nejmc2108082", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:06", "last_checked": "2026-07-01 11:22:04", "bibtex": null, "source_record_id": "PMID:34437794", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:34437794", "source_url": "https://doi.org/10.1056/nejmc2108082", "doi": "10.1056/nejmc2108082", "pmid": "34437794", "publication_date": "2021-07-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 2139, "title": "The Potential Role of Serotonergic Hallucinogens in Depression Treatment.", "authors": "Psiuk D, Nowak E, Cholewa K, Łopuszańska U, Samardakiewicz M.", "journal": null, "publication_date": "2021-07-28", "publication_year": 2021, "doi": "10.3390/life11080765", "pubmed_id": "34440508", "openalex_id": null, "source_url": "https://doi.org/10.3390/life11080765", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Systematic Review,Review Article,Safety,Adverse Events", "study_type": "Systematic Review", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-01 11:22:05", "bibtex": null, "source_record_id": "PMID:34440508", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.3390/life11080765", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:34440508", "source_url": "https://doi.org/10.3390/life11080765", "doi": "10.3390/life11080765", "pmid": "34440508", "publication_date": "2021-07-28", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 2140, "title": "Serotonin Heteroreceptor Complexes and Their Integration of Signals in Neurons and Astroglia-Relevance for Mental Diseases.", "authors": "Borroto-Escuela DO, Ambrogini P, Narvaez M, Di Liberto V, Beggiato S, Ferraro L, Fores-Pons R, Alvarez-Contino JE, Lopez-Salas A, Mudò G, Díaz-Cabiale Z, Fuxe K.", "journal": null, "publication_date": "2021-07-26", "publication_year": 2021, "doi": "10.3390/cells10081902", "pubmed_id": "34440670", "openalex_id": null, "source_url": "https://doi.org/10.3390/cells10081902", "substance_tags": "psilocybin", "topic_tags": "Depression,End-of-Life Distress,Mechanism of Action,Receptor Pharmacology,Emotional Processing,Drug Interactions", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-01 11:22:06", "bibtex": null, "source_record_id": "PMID:34440670", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.3390/cells10081902", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:34440670", "source_url": "https://doi.org/10.3390/cells10081902", "doi": "10.3390/cells10081902", "pmid": "34440670", "publication_date": "2021-07-26", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 5075, "title": "Psychedelic Therapy Hits Another Milestone, But Caution Urged", "authors": "Nick Zagorski", "journal": "Psychiatric News", "publication_date": "2021-07-21", "publication_year": 2021, "doi": "10.1176/appi.pn.2021.7.14", "pubmed_id": null, "openalex_id": "https://openalex.org/W3193219878", "source_url": "https://doi.org/10.1176/appi.pn.2021.7.14", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Review Article,Cancer Patients,Healthcare Workers,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:59", "last_checked": "2026-07-04 07:00:38", "bibtex": null, "source_record_id": "DOI:10.1176/appi.pn.2021.7.14", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1176/appi.pn.2021.7.14", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1176/appi.pn.2021.7.14", "source_url": "https://doi.org/10.1176/appi.pn.2021.7.14", "doi": "10.1176/appi.pn.2021.7.14", "pmid": "", "publication_date": "2021-07-21", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3481, "title": "A Randomised, Placebo Controlled Trial of Psilocybin in Treatment Resistant Depression: A Feasibility Study", "authors": "King's College London", "journal": "ClinicalTrials.gov", "publication_date": "2021-07-21", "publication_year": 2021, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT04959253", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT04959253", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT04959253", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT04959253", "source_url": "https://clinicaltrials.gov/study/NCT04959253", "doi": "", "pmid": "", "publication_date": "2021-07-21", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 5076, "title": "Trial of psilocybin does not show major difference from antidepressant", "authors": "", "journal": "The Brown University Psychopharmacology Update", "publication_date": "2021-07-04", "publication_year": 2021, "doi": "10.1002/pu.30751", "pubmed_id": null, "openalex_id": "https://openalex.org/W4249533081", "source_url": "https://doi.org/10.1002/pu.30751", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Pharmacology", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:59", "last_checked": "2026-07-04 07:00:38", "bibtex": null, "source_record_id": "DOI:10.1002/pu.30751", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1002/pu.30751", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1002/pu.30751", "source_url": "https://doi.org/10.1002/pu.30751", "doi": "10.1002/pu.30751", "pmid": "", "publication_date": "2021-07-04", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3769, "title": "Psilocybin for Depression: The ACE Model Manual", "authors": "Watts R.", "journal": "PsyArXiv", "publication_date": "2021-07-04", "publication_year": 2021, "doi": "10.31234/osf.io/5x2bu", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.31234/osf.io/5x2bu", "substance_tags": "psilocybin", "topic_tags": "Depression", "study_type": "Other", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:10:20", "last_checked": "2026-07-01 11:22:02", "bibtex": null, "source_record_id": "DOI:10.31234/osf.io/5x2bu", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://doi.org/10.31234/osf.io/5x2bu", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "DOI:10.31234/osf.io/5x2bu", "source_url": "https://doi.org/10.31234/osf.io/5x2bu", "doi": "10.31234/osf.io/5x2bu", "pmid": "", "publication_date": "2021-07-04", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3214, "title": "Psilocybin for Depression: The ACE Model Manual", "authors": "", "journal": "PsyArXiv", "publication_date": "2021-07-04", "publication_year": 2021, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://osf.io/preprints/psyarxiv/5x2bu_v1", "substance_tags": "psilocybin", "topic_tags": "Depression", "study_type": "Other", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:48", "last_checked": "2026-07-01 11:22:30", "bibtex": null, "source_record_id": "https://osf.io/preprints/psyarxiv/5x2bu_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/5x2bu_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "https://osf.io/preprints/psyarxiv/5x2bu_v1", "source_url": "https://osf.io/preprints/psyarxiv/5x2bu_v1", "doi": "", "pmid": "", "publication_date": "2021-07-04", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3232, "title": "Psilocybin for Treating Psychiatric Disorders: Is it a Psychonaut Legend or a Promising Therapeutic Perspective?", "authors": "Coppola M, Bevione F, Mondola R.", "journal": "Preprints.org", "publication_date": "2021-06-27", "publication_year": 2021, "doi": "10.20944/preprints202106.0682.v1", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.20944/preprints202106.0682.v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Spirituality", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "preprint", "date_added": "2026-07-01 11:03:48", "last_checked": "2026-07-01 11:22:02", "bibtex": null, "source_record_id": "DOI:10.20944/preprints202106.0682.v1", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.20944/preprints202106.0682.v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "DOI:10.20944/preprints202106.0682.v1", "source_url": "https://doi.org/10.20944/preprints202106.0682.v1", "doi": "10.20944/preprints202106.0682.v1", "pmid": "", "publication_date": "2021-06-27", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3786, "title": "Psychedelic Assisted Therapy for Major Depressive Disorder: A Review", "authors": "McCartney A, McGovern H, De Foe A.", "journal": "PsyArXiv", "publication_date": "2021-06-26", "publication_year": 2021, "doi": "10.31234/osf.io/9kuhs", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.31234/osf.io/9kuhs", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Review Article,Safety", "study_type": "Clinical Trial", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:10:22", "last_checked": "2026-07-01 11:22:05", "bibtex": null, "source_record_id": "DOI:10.31234/osf.io/9kuhs", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://doi.org/10.31234/osf.io/9kuhs", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "DOI:10.31234/osf.io/9kuhs", "source_url": "https://doi.org/10.31234/osf.io/9kuhs", "doi": "10.31234/osf.io/9kuhs", "pmid": "", "publication_date": "2021-06-26", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3336, "title": "Psychedelic Assisted Therapy for Major Depressive Disorder: A Review", "authors": "", "journal": "PsyArXiv", "publication_date": "2021-06-26", "publication_year": 2021, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://osf.io/preprints/psyarxiv/9kuhs_v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Pharmacology,Clinical Trial,Review Article,Safety", "study_type": "Clinical Trial", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:51", "last_checked": "2026-07-01 11:22:30", "bibtex": null, "source_record_id": "https://osf.io/preprints/psyarxiv/9kuhs_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/9kuhs_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "https://osf.io/preprints/psyarxiv/9kuhs_v1", "source_url": "https://osf.io/preprints/psyarxiv/9kuhs_v1", "doi": "", "pmid": "", "publication_date": "2021-06-26", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 5080, "title": "Psilocybin as a Novel Pharmacotherapy for Treatment-Refractory Anorexia Nervosa", "authors": "Sarah-Catherine Rodan, Phillip Aouad, Iain S. McGregor, Sarah Maguire", "journal": "OBM Neurobiology", "publication_date": "2021-06-23", "publication_year": 2021, "doi": "10.21926/obm.neurobiol.2102102", "pubmed_id": null, "openalex_id": "https://openalex.org/W3174884462", "source_url": "https://doi.org/10.21926/obm.neurobiol.2102102", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Eating Disorders,Receptor Pharmacology,Treatment-Resistant Depression,Safety", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:59", "last_checked": "2026-07-04 07:00:38", "bibtex": null, "source_record_id": "DOI:10.21926/obm.neurobiol.2102102", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.21926/obm.neurobiol.2102102", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.21926/obm.neurobiol.2102102", "source_url": "https://doi.org/10.21926/obm.neurobiol.2102102", "doi": "10.21926/obm.neurobiol.2102102", "pmid": "", "publication_date": "2021-06-23", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3208, "title": "Psilocybin: the magic medicine for depression?", "authors": "Corrigan A, Burchill E, Pelton L, Marrocu A, Mazzoleni A, Shackshaft L.", "journal": null, "publication_date": "2021-06-17", "publication_year": 2021, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://europepmc.org/article/PMC/PMC8770735", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging,Mechanism of Action,Default Mode Network,Aging,Personality Change,Emotional Processing,Review Article,Treatment-Resistant Depression,Safety", "study_type": "Review Article", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 11:03:48", "last_checked": "2026-07-01 11:22:02", "bibtex": null, "source_record_id": "https://europepmc.org/article/PMC/PMC8770735", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://europepmc.org/article/PMC/PMC8770735", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "https://europepmc.org/article/PMC/PMC8770735", "source_url": "https://europepmc.org/article/PMC/PMC8770735", "doi": "", "pmid": "", "publication_date": "2021-06-17", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1777, "title": "Psychedelic perceptions: mental health service user attitudes to psilocybin therapy.", "authors": "Corrigan K, Haran M, McCandliss C, McManus R, Cleary S, Trant R, Kelly Y, Ledden K, Rush G, O'Keane V, Kelly JR.", "journal": "Irish Journal of Medical Science (1971 -)", "publication_date": "2021-06-14", "publication_year": 2021, "doi": "10.1007/s11845-021-02668-2", "pubmed_id": "34131812", "openalex_id": "https://openalex.org/W3171384877", "source_url": "https://doi.org/10.1007/s11845-021-02668-2", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Observational Study", "study_type": "Observational Study", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:38", "bibtex": null, "source_record_id": "PMID:34131812", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1007/s11845-021-02668-2", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:34131812", "source_url": "https://doi.org/10.1007/s11845-021-02668-2", "doi": "10.1007/s11845-021-02668-2", "pmid": "34131812", "publication_date": "2021-06-14", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1751, "title": "Psilocybin: A brief overview for psychiatric mental health nurse practitioners.", "authors": "Fradkin D.", "journal": "Perspectives In Psychiatric Care", "publication_date": "2021-06-07", "publication_year": 2021, "doi": "10.1111/ppc.12888", "pubmed_id": "34101846", "openalex_id": "https://openalex.org/W3169192423", "source_url": "https://doi.org/10.1111/ppc.12888", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Safety", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:38", "bibtex": null, "source_record_id": "PMID:34101846", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1111/ppc.12888", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:34101846", "source_url": "https://doi.org/10.1111/ppc.12888", "doi": "10.1111/ppc.12888", "pmid": "34101846", "publication_date": "2021-06-07", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1901, "title": "Ethnoracial health disparities and the ethnopsychopharmacology of psychedelic-assisted psychotherapies.", "authors": "Fogg C, Michaels TI, de la Salle S, Jahn ZW, Williams MT.", "journal": "Experimental and Clinical Psychopharmacology", "publication_date": "2021-06-06", "publication_year": 2021, "doi": "10.1037/pha0000490", "pubmed_id": "34096755", "openalex_id": "https://openalex.org/W3171546624", "source_url": "https://doi.org/10.1037/pha0000490", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Pharmacology,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:06", "last_checked": "2026-07-04 07:00:38", "bibtex": null, "source_record_id": "PMID:34096755", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1037/pha0000490", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:34096755", "source_url": "https://doi.org/10.1037/pha0000490", "doi": "10.1037/pha0000490", "pmid": "34096755", "publication_date": "2021-06-06", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 5087, "title": "Psilocybin: the magic medicine for depression?", "authors": "Amber Elyse Corrigan, Ella Burchill, Lucy Pelton, Alessia Marrocu, Adele Mazzoleni, Lydia Shackshaft", "journal": "BJPsych Open", "publication_date": "2021-05-31", "publication_year": 2021, "doi": "10.1192/bjo.2021.456", "pubmed_id": null, "openalex_id": "https://openalex.org/W3173209673", "source_url": "https://doi.org/10.1192/bjo.2021.456", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging,Mechanism of Action,Receptor Pharmacology,Default Mode Network,Aging,Personality Change,Emotional Processing,Review Article,Treatment-Resistant Depression,Safety", "study_type": "Review Article", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:59", "last_checked": "2026-07-04 07:00:38", "bibtex": null, "source_record_id": "DOI:10.1192/bjo.2021.456", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1192/bjo.2021.456", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1192/bjo.2021.456", "source_url": "https://doi.org/10.1192/bjo.2021.456", "doi": "10.1192/bjo.2021.456", "pmid": "", "publication_date": "2021-05-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3385, "title": "Psychedelic-Assisted Psychotherapy for Post-Traumatic Stress Disorder, Anxiety Disorders, Mood Disorders, or Substance Use Disorders", "authors": "Chao YS, Horton J.", "journal": "Canadian Agency for Drugs and Technologies in Health, Ottawa (ON)", "publication_date": "2021-05-31", "publication_year": 2021, "doi": null, "pubmed_id": "36170470", "openalex_id": null, "source_url": "https://europepmc.org/article/MED/36170470", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Receptor Pharmacology,Consciousness,Emotional Processing,Clinical Trial,Review Article,Healthcare Workers,Safety", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 11:03:52", "last_checked": "2026-07-01 11:22:06", "bibtex": null, "source_record_id": "PMID:36170470", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://europepmc.org/article/MED/36170470", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:36170470", "source_url": "https://europepmc.org/article/MED/36170470", "doi": "", "pmid": "36170470", "publication_date": "2021-05-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1867, "title": "Psychedelics and health behaviour change.", "authors": "Teixeira PJ, Johnson MW, Timmermann C, Watts R, Erritzoe D, Douglass H, Kettner H, Carhart-Harris RL.", "journal": null, "publication_date": "2021-05-28", "publication_year": 2021, "doi": "10.1177/02698811211008554", "pubmed_id": "34053342", "openalex_id": null, "source_url": "https://doi.org/10.1177/02698811211008554", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Eating Disorders,Mechanism of Action,Wellbeing,Safety,Toxicity", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:05", "bibtex": null, "source_record_id": "PMID:34053342", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1177/02698811211008554", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:34053342", "source_url": "https://doi.org/10.1177/02698811211008554", "doi": "10.1177/02698811211008554", "pmid": "34053342", "publication_date": "2021-05-28", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1914, "title": "Improving cognitive functioning in major depressive disorder with psychedelics: A dimensional approach.", "authors": "Magaraggia I, Kuiperes Z, Schreiber R.", "journal": null, "publication_date": "2021-05-25", "publication_year": 2021, "doi": "10.1016/j.nlm.2021.107467", "pubmed_id": "34048913", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.nlm.2021.107467", "substance_tags": "psilocybin", "topic_tags": "Depression,Neuroplasticity,Neurogenesis,Resilience,Emotional Processing", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:06", "last_checked": "2026-07-01 11:22:06", "bibtex": null, "source_record_id": "PMID:34048913", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.nlm.2021.107467", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:34048913", "source_url": "https://doi.org/10.1016/j.nlm.2021.107467", "doi": "10.1016/j.nlm.2021.107467", "pmid": "34048913", "publication_date": "2021-05-25", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3230, "title": "Decreased brain modularity after psilocybin therapy for depression.", "authors": "Daws R, Timmerman C, Giribaldi B, Sexton J, Wall M, Erritzoe D, Roseman L, Nutt D, Carhart-Harris R.", "journal": "Research Square", "publication_date": "2021-05-19", "publication_year": 2021, "doi": "10.21203/rs.3.rs-513323/v1", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.21203/rs.3.rs-513323/v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging,Clinical Trial,Randomized Controlled Trial,Observational Study,Treatment-Resistant Depression", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "preprint", "date_added": "2026-07-01 11:03:48", "last_checked": "2026-07-01 11:22:02", "bibtex": null, "source_record_id": "DOI:10.21203/rs.3.rs-513323/v1", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.21203/rs.3.rs-513323/v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "DOI:10.21203/rs.3.rs-513323/v1", "source_url": "https://doi.org/10.21203/rs.3.rs-513323/v1", "doi": "10.21203/rs.3.rs-513323/v1", "pmid": "", "publication_date": "2021-05-19", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3420, "title": "Future Directions for Clinical Psilocybin Research: The Relaxed Symptom Network", "authors": "", "journal": "PsyArXiv", "publication_date": "2021-05-18", "publication_year": 2021, "doi": "10.1037/pne0000290", "pubmed_id": null, "openalex_id": "https://openalex.org/W4281568156", "source_url": "https://osf.io/preprints/psyarxiv/q3ymd_v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Clinical Trial,Drug Interactions", "study_type": "Clinical Trial", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:04:24", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "DOI:10.1037/pne0000290", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/q3ymd_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "DOI:10.1037/pne0000290", "source_url": "https://osf.io/preprints/psyarxiv/q3ymd_v1", "doi": "10.1037/pne0000290", "pmid": "", "publication_date": "2021-05-18", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3247, "title": "Future Directions for Clinical Psilocybin Research: The Relaxed Symptom Network", "authors": "Lewis-Healey E, Laukkonen RE, van Elk M.", "journal": "PsyArXiv", "publication_date": "2021-05-18", "publication_year": 2021, "doi": "10.31234/osf.io/q3ymd", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.31234/osf.io/q3ymd", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Clinical Trial,Drug Interactions", "study_type": "Clinical Trial", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:49", "last_checked": "2026-07-01 11:22:03", "bibtex": null, "source_record_id": "DOI:10.31234/osf.io/q3ymd", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://doi.org/10.31234/osf.io/q3ymd", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "DOI:10.31234/osf.io/q3ymd", "source_url": "https://doi.org/10.31234/osf.io/q3ymd", "doi": "10.31234/osf.io/q3ymd", "pmid": "", "publication_date": "2021-05-18", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 5091, "title": "The need for publicly funded research on therapeutic use of psychedelic drugs", "authors": "Wayne Hall", "journal": "World Psychiatry", "publication_date": "2021-05-17", "publication_year": 2021, "doi": "10.1002/wps.20847", "pubmed_id": "34002493", "openalex_id": "https://openalex.org/W3162774823", "source_url": "https://doi.org/10.1002/wps.20847", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,End-of-Life Distress,Headache / Migraine,Pharmacology,Mechanism of Action,Receptor Pharmacology,Wellbeing,Emotional Processing,Spirituality,Clinical Trial,Randomized Controlled Trial,Observational Study,Treatment-Resistant Depression,Safety", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:59", "last_checked": "2026-07-04 07:00:38", "bibtex": null, "source_record_id": "PMID:34002493", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1002/wps.20847", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:34002493", "source_url": "https://doi.org/10.1002/wps.20847", "doi": "10.1002/wps.20847", "pmid": "34002493", "publication_date": "2021-05-17", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 2145, "title": "Registered clinical studies investigating psychedelic drugs for psychiatric disorders.", "authors": "Siegel AN, Meshkat S, Benitah K, Lipsitz O, Gill H, Lui LMW, Teopiz KM, McIntyre RS, Rosenblat JD.", "journal": null, "publication_date": "2021-05-17", "publication_year": 2021, "doi": "10.1016/j.jpsychires.2021.05.019", "pubmed_id": "34048997", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.jpsychires.2021.05.019", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Consciousness", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-01 11:22:05", "bibtex": null, "source_record_id": "PMID:34048997", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.jpsychires.2021.05.019", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:34048997", "source_url": "https://doi.org/10.1016/j.jpsychires.2021.05.019", "doi": "10.1016/j.jpsychires.2021.05.019", "pmid": "34048997", "publication_date": "2021-05-17", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3805, "title": "New insights into the clinical and nonclinical effects of psychedelic substances: an integrative review", "authors": "Forstmann M, Sagioglou C.", "journal": "PsyArXiv", "publication_date": "2021-05-04", "publication_year": 2021, "doi": "10.31234/osf.io/2489x", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.31234/osf.io/2489x", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Mechanism of Action,Wellbeing,Personality Change,Creativity,Review Article", "study_type": "Review Article", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:10:23", "last_checked": "2026-07-01 11:22:06", "bibtex": null, "source_record_id": "DOI:10.31234/osf.io/2489x", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://doi.org/10.31234/osf.io/2489x", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "DOI:10.31234/osf.io/2489x", "source_url": "https://doi.org/10.31234/osf.io/2489x", "doi": "10.31234/osf.io/2489x", "pmid": "", "publication_date": "2021-05-04", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3393, "title": "New insights into the clinical and nonclinical effects of psychedelic substances: an integrative review", "authors": "", "journal": "PsyArXiv", "publication_date": "2021-05-04", "publication_year": 2021, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://osf.io/preprints/psyarxiv/2489x_v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Pharmacology,Mechanism of Action,Wellbeing,Personality Change,Creativity,Review Article", "study_type": "Review Article", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:52", "last_checked": "2026-07-01 11:22:30", "bibtex": null, "source_record_id": "https://osf.io/preprints/psyarxiv/2489x_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/2489x_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "https://osf.io/preprints/psyarxiv/2489x_v1", "source_url": "https://osf.io/preprints/psyarxiv/2489x_v1", "doi": "", "pmid": "", "publication_date": "2021-05-04", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 5093, "title": "A utilização terapêutica da psilocibina como coadjuvante no tratamento do transtorno depressivo maior: uma revisão narrativa de literatura / The therapeutic use of psilocybin as an adjunct in the treatment of major depressive disorder: a narrative literature review", "authors": "Fabiana Venancio Santana Silva, Alexandre Libanio Silva Reis, Amanda Prazeres Costa, Maria Carolaine Souza da Silva, Rafaela da Conceição de Lemos, Elisângela Marcionilo Da Conceição, Joyce Kelly Soares da Silva, Carlos Alberto Tiburcio Valeriano, David Filipe de Santana", "journal": "Brazilian Journal of Health Review", "publication_date": "2021-05-02", "publication_year": 2021, "doi": "10.34119/bjhrv4n3-012", "pubmed_id": null, "openalex_id": "https://openalex.org/W3164004836", "source_url": "https://doi.org/10.34119/bjhrv4n3-012", "substance_tags": "psilocybin", "topic_tags": "Depression,Receptor Pharmacology,Review Article", "study_type": "Review Article", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:59", "last_checked": "2026-07-04 07:00:38", "bibtex": null, "source_record_id": "DOI:10.34119/bjhrv4n3-012", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.34119/bjhrv4n3-012", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.34119/bjhrv4n3-012", "source_url": "https://doi.org/10.34119/bjhrv4n3-012", "doi": "10.34119/bjhrv4n3-012", "pmid": "", "publication_date": "2021-05-02", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 2159, "title": "Psilocybin-Assisted Supportive Psychotherapy in the Treatment of Major Depression-Quo Vadis?", "authors": "Reynolds CF.", "journal": null, "publication_date": "2021-04-30", "publication_year": 2021, "doi": "10.1001/jamapsychiatry.2020.2901", "pubmed_id": "33146675", "openalex_id": null, "source_url": "https://doi.org/10.1001/jamapsychiatry.2020.2901", "substance_tags": "psilocybin", "topic_tags": "Depression", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-01 11:22:06", "bibtex": null, "source_record_id": "PMID:33146675", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:33146675", "source_url": "https://doi.org/10.1001/jamapsychiatry.2020.2901", "doi": "10.1001/jamapsychiatry.2020.2901", "pmid": "33146675", "publication_date": "2021-04-30", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 2158, "title": "Errors in a Response Rate and in Effect Sizes in Study of Psilocybin-Assisted Therapy for Major Depressive Disorder.", "authors": "Davis AK, Griffiths RR.", "journal": null, "publication_date": "2021-04-30", "publication_year": 2021, "doi": "10.1001/jamapsychiatry.2020.4638", "pubmed_id": "33566073", "openalex_id": null, "source_url": "https://doi.org/10.1001/jamapsychiatry.2020.4638", "substance_tags": "psilocybin", "topic_tags": "Depression", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-01 11:22:06", "bibtex": null, "source_record_id": "PMID:33566073", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:33566073", "source_url": "https://doi.org/10.1001/jamapsychiatry.2020.4638", "doi": "10.1001/jamapsychiatry.2020.4638", "pmid": "33566073", "publication_date": "2021-04-30", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 2157, "title": "Clinical and biological predictors of psychedelic response in the treatment of psychiatric and addictive disorders: A systematic review.", "authors": "Romeo B, Hermand M, Pétillion A, Karila L, Benyamina A", "journal": "Journal of psychiatric research", "publication_date": "2021-04-30", "publication_year": 2021, "doi": "10.1016/j.jpsychires.2021.03.002", "pubmed_id": "33730602", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/33730602/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,OCD,End-of-Life Distress,Receptor Pharmacology,Default Mode Network,Systematic Review,Review Article,Treatment-Resistant Depression,Inflammation", "study_type": "Systematic Review", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-01 11:20:39", "bibtex": null, "source_record_id": "PMID:33730602", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/33730602/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:33730602", "source_url": "https://pubmed.ncbi.nlm.nih.gov/33730602/", "doi": "10.1016/j.jpsychires.2021.03.002", "pmid": "33730602", "publication_date": "2021-04-30", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 2154, "title": "Psilocybin and MDMA for the treatment of trauma-related psychopathology.", "authors": "Bird CIV, Modlin NL, Rucker JJH.", "journal": null, "publication_date": "2021-04-30", "publication_year": 2021, "doi": "10.1080/09540261.2021.1919062", "pubmed_id": "34121583", "openalex_id": null, "source_url": "https://doi.org/10.1080/09540261.2021.1919062", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Review Article", "study_type": "Review Article", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-01 11:22:03", "bibtex": null, "source_record_id": "PMID:34121583", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1080/09540261.2021.1919062", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:34121583", "source_url": "https://doi.org/10.1080/09540261.2021.1919062", "doi": "10.1080/09540261.2021.1919062", "pmid": "34121583", "publication_date": "2021-04-30", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3487, "title": "Characterization of Altered Waking States of Consciousness in Healthy Humans", "authors": "University of Zurich", "journal": "ClinicalTrials.gov", "publication_date": "2021-04-28", "publication_year": 2021, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT03853577", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging,Consciousness,Emotional Processing,Spirituality,Mystical Experience,Clinical Trial,Toxicity,Drug Interactions", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT03853577", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT03853577", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT03853577", "source_url": "https://clinicaltrials.gov/study/NCT03853577", "doi": "", "pmid": "", "publication_date": "2021-04-28", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 5100, "title": "Altered Prediction-Error Processing May Underlie Psilocybin-Induced Changes in Self-Processing", "authors": "Katrin H. Preller", "journal": "Biological Psychiatry", "publication_date": "2021-04-26", "publication_year": 2021, "doi": "10.1016/j.biopsych.2021.02.036", "pubmed_id": null, "openalex_id": "https://openalex.org/W3159723459", "source_url": "https://doi.org/10.1016/j.biopsych.2021.02.036", "substance_tags": "psilocybin", "topic_tags": "Depression,Eating Disorders,Receptor Pharmacology", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:59", "last_checked": "2026-07-04 07:00:38", "bibtex": null, "source_record_id": "DOI:10.1016/j.biopsych.2021.02.036", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.biopsych.2021.02.036", "source_url": "https://doi.org/10.1016/j.biopsych.2021.02.036", "doi": "10.1016/j.biopsych.2021.02.036", "pmid": "", "publication_date": "2021-04-26", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 5098, "title": "Effectiveness of Psilocybin on Depression: A Qualitative Study", "authors": "Hisham Alshaikhli, Redhwan Ahmed Al-Naggar, Gwen Erlam", "journal": "Electronic Journal of General Medicine", "publication_date": "2021-04-26", "publication_year": 2021, "doi": "10.29333/ejgm/10862", "pubmed_id": null, "openalex_id": "https://openalex.org/W3157692430", "source_url": "https://doi.org/10.29333/ejgm/10862", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Mechanism of Action,Emotional Processing,Spirituality", "study_type": "Qualitative Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:59", "last_checked": "2026-07-04 07:00:38", "bibtex": null, "source_record_id": "DOI:10.29333/ejgm/10862", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.29333/ejgm/10862", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.29333/ejgm/10862", "source_url": "https://doi.org/10.29333/ejgm/10862", "doi": "10.29333/ejgm/10862", "pmid": "", "publication_date": "2021-04-26", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 5101, "title": "Psychedelic-Assisted Psychotherapy Practices and Human Caring Science: Toward a Care-Informed Model of Treatment", "authors": "Andrew Penn, Janis Phelps, William E. Rosa, Jean Watson", "journal": "Journal of Humanistic Psychology", "publication_date": "2021-04-22", "publication_year": 2021, "doi": "10.1177/00221678211011013", "pubmed_id": null, "openalex_id": "https://openalex.org/W3159796563", "source_url": "https://doi.org/10.1177/00221678211011013", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Spirituality", "study_type": "Qualitative Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:59", "last_checked": "2026-07-04 07:00:38", "bibtex": null, "source_record_id": "DOI:10.1177/00221678211011013", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1177/00221678211011013", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1177/00221678211011013", "source_url": "https://doi.org/10.1177/00221678211011013", "doi": "10.1177/00221678211011013", "pmid": "", "publication_date": "2021-04-22", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 2138, "title": "[Efficacy of psychedelics in psychiatry, a systematic review of the literature].", "authors": "Berkovitch L, Roméo B, Karila L, Gaillard R, Benyamina A.", "journal": null, "publication_date": "2021-04-19", "publication_year": 2021, "doi": "10.1016/j.encep.2020.12.002", "pubmed_id": "33888297", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.encep.2020.12.002", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,End-of-Life Distress,Personality Change,Emotional Processing,Randomized Controlled Trial,Systematic Review,Review Article,Observational Study,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-01 11:22:05", "bibtex": null, "source_record_id": "PMID:33888297", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.encep.2020.12.002", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:33888297", "source_url": "https://doi.org/10.1016/j.encep.2020.12.002", "doi": "10.1016/j.encep.2020.12.002", "pmid": "33888297", "publication_date": "2021-04-19", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 5104, "title": "O papel da Psilocibina no tratamento de depressão resistente / The role of Psilocybin in the treatment of resistant depression", "authors": "Giovanni Pereira Pio, Aline Moreira Vitorino, Naira Braga Aidar, Alissa Amoras Magalhães, Eduardo Cammerer Mombelli, Gabriela Marques Ferraz, Rodrigo Pereira Pio", "journal": "Brazilian Journal of Health Review", "publication_date": "2021-04-18", "publication_year": 2021, "doi": "10.34119/bjhrv4n2-395", "pubmed_id": null, "openalex_id": "https://openalex.org/W3164048627", "source_url": "https://doi.org/10.34119/bjhrv4n2-395", "substance_tags": "psilocybin", "topic_tags": "Depression,Pharmacology,Receptor Pharmacology", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:59", "last_checked": "2026-07-04 07:00:38", "bibtex": null, "source_record_id": "DOI:10.34119/bjhrv4n2-395", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.34119/bjhrv4n2-395", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.34119/bjhrv4n2-395", "source_url": "https://doi.org/10.34119/bjhrv4n2-395", "doi": "10.34119/bjhrv4n2-395", "pmid": "", "publication_date": "2021-04-18", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3255, "title": "Evaluating the Risk of Psilocybin for the Treatment of Bipolar Depression: A Review of the Research Literature and Published Case Studies", "authors": "Gard DE, Pleet MM, Bradley ER, Penn A, Gallenstein ML, Riley LS, DellaCrosse M, Garfinkle E, Michalak EE, Woolley JD.", "journal": "medRxiv", "publication_date": "2021-04-06", "publication_year": 2021, "doi": "10.1101/2021.04.02.21254838", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.1101/2021.04.02.21254838", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Review Article,Safety", "study_type": "Clinical Trial", "source_name": "medRxiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:49", "last_checked": "2026-07-01 11:22:03", "bibtex": null, "source_record_id": "DOI:10.1101/2021.04.02.21254838", "abstract_available": true, "abstract_source": "medRxiv", "abstract_source_url": "https://doi.org/10.1101/2021.04.02.21254838", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "medRxiv", "source_record_id": "DOI:10.1101/2021.04.02.21254838", "source_url": "https://doi.org/10.1101/2021.04.02.21254838", "doi": "10.1101/2021.04.02.21254838", "pmid": "", "publication_date": "2021-04-06", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3800, "title": "Phenomenological assessment of psychedelic induced experiences: Translation and validation of the German Challenging Experience Questionnaire (CEQ) and Ego-Dissolution Inventory (EDI)", "authors": "Dworatzyk K, Jansen T, Schmidt TT.", "journal": "PsyArXiv", "publication_date": "2021-04-01", "publication_year": 2021, "doi": "10.31234/osf.io/kxmgq", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.31234/osf.io/kxmgq", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Consciousness,Mystical Experience,Observational Study", "study_type": "Observational Study", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:10:23", "last_checked": "2026-07-01 11:22:05", "bibtex": null, "source_record_id": "DOI:10.31234/osf.io/kxmgq", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://doi.org/10.31234/osf.io/kxmgq", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "DOI:10.31234/osf.io/kxmgq", "source_url": "https://doi.org/10.31234/osf.io/kxmgq", "doi": "10.31234/osf.io/kxmgq", "pmid": "", "publication_date": "2021-04-01", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3378, "title": "Phenomenological assessment of psychedelic induced experiences: Translation and validation of the German Challenging Experience Questionnaire (CEQ) and Ego-Dissolution Inventory (EDI)", "authors": "", "journal": "PsyArXiv", "publication_date": "2021-04-01", "publication_year": 2021, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://osf.io/preprints/psyarxiv/kxmgq_v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Consciousness,Mystical Experience,Observational Study", "study_type": "Observational Study", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:52", "last_checked": "2026-07-01 11:22:30", "bibtex": null, "source_record_id": "https://osf.io/preprints/psyarxiv/kxmgq_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/kxmgq_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "https://osf.io/preprints/psyarxiv/kxmgq_v1", "source_url": "https://osf.io/preprints/psyarxiv/kxmgq_v1", "doi": "", "pmid": "", "publication_date": "2021-04-01", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 5113, "title": "Psilocybin in the treatment of obsessive-compulsive disorder: What do we know so far?", "authors": "Nelson Descalço, Ana Beatriz Medeiros, Cátia Fernandes Santos, Guilherme Borges", "journal": "European Psychiatry", "publication_date": "2021-03-31", "publication_year": 2021, "doi": "10.1192/j.eurpsy.2021.1114", "pubmed_id": null, "openalex_id": "https://openalex.org/W4212954018", "source_url": "https://doi.org/10.1192/j.eurpsy.2021.1114", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,OCD,Receptor Pharmacology,Aging,Clinical Trial,Systematic Review,Review Article,Case Report,Treatment-Resistant Depression", "study_type": "Systematic Review", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:59", "last_checked": "2026-07-04 07:00:38", "bibtex": null, "source_record_id": "DOI:10.1192/j.eurpsy.2021.1114", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1192/j.eurpsy.2021.1114", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1192/j.eurpsy.2021.1114", "source_url": "https://doi.org/10.1192/j.eurpsy.2021.1114", "doi": "10.1192/j.eurpsy.2021.1114", "pmid": "", "publication_date": "2021-03-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 5112, "title": "Effects of psilocybin-assisted therapy on treatment-resistant depression", "authors": "A. Fraga, Daniel Esteves-Sousa, João Facucho-Oliveira, Margarida Albuquerque, M. Costa, Paulo Santos, Nuno Moura, A. Moutinho", "journal": "European Psychiatry", "publication_date": "2021-03-31", "publication_year": 2021, "doi": "10.1192/j.eurpsy.2021.1836", "pubmed_id": null, "openalex_id": "https://openalex.org/W3212256162", "source_url": "https://doi.org/10.1192/j.eurpsy.2021.1836", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Review Article,Treatment-Resistant Depression", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:59", "last_checked": "2026-07-04 07:00:38", "bibtex": null, "source_record_id": "DOI:10.1192/j.eurpsy.2021.1836", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1192/j.eurpsy.2021.1836", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1192/j.eurpsy.2021.1836", "source_url": "https://doi.org/10.1192/j.eurpsy.2021.1836", "doi": "10.1192/j.eurpsy.2021.1836", "pmid": "", "publication_date": "2021-03-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 2165, "title": "Trial of Psilocybin versus Escitalopram for Depression.", "authors": "Carhart-Harris R, Giribaldi B, Watts R, Baker-Jones M, Murphy-Beiner A, Murphy R, Martell J, Blemings A, Erritzoe D, Nutt DJ.", "journal": "New England Journal of Medicine", "publication_date": "2021-03-31", "publication_year": 2021, "doi": "10.1056/nejmoa2032994", "pubmed_id": "33852780", "openalex_id": "https://openalex.org/W3156937150", "source_url": "https://doi.org/10.1056/nejmoa2032994", "substance_tags": "psilocybin", "topic_tags": "Depression,Receptor Pharmacology,Clinical Trial,Observational Study,Adverse Events", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-04 07:00:38", "bibtex": null, "source_record_id": "PMID:33852780", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1056/nejmoa2032994", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:33852780", "source_url": "https://doi.org/10.1056/nejmoa2032994", "doi": "10.1056/nejmoa2032994", "pmid": "33852780", "publication_date": "2021-03-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 2161, "title": "Harnessing psilocybin: antidepressant-like behavioral and synaptic actions of psilocybin are independent of 5-HT2R activation in mice.", "authors": "Hesselgrave N, Troppoli TA, Wulff AB, Cole AB, Thompson SM.", "journal": "Proceedings of the National Academy of Sciences", "publication_date": "2021-03-31", "publication_year": 2021, "doi": "10.1073/pnas.2022489118", "pubmed_id": "33850049", "openalex_id": "https://openalex.org/W3155245221", "source_url": "https://doi.org/10.1073/pnas.2022489118", "substance_tags": "psilocybin", "topic_tags": "Depression,Neuroplasticity,Receptor Pharmacology,Consciousness,Animal Study", "study_type": "Animal Study", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-04 07:00:38", "bibtex": null, "source_record_id": "PMID:33850049", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1073/pnas.2022489118", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:33850049", "source_url": "https://doi.org/10.1073/pnas.2022489118", "doi": "10.1073/pnas.2022489118", "pmid": "33850049", "publication_date": "2021-03-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 5115, "title": "The Return of Psychedelics: Still Time to Prevent Tragedy", "authors": "Stanley N. Caroff", "journal": "Psychiatric News", "publication_date": "2021-03-30", "publication_year": 2021, "doi": "10.1176/appi.pn.2021.4.8", "pubmed_id": null, "openalex_id": "https://openalex.org/W3147930394", "source_url": "https://doi.org/10.1176/appi.pn.2021.4.8", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Addiction,End-of-Life Distress,Chronic Pain,Headache / Migraine,Pharmacology,Consciousness,Emotional Processing,Clinical Trial,Review Article,Case Report,Observational Study,Adolescents,Safety,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:59", "last_checked": "2026-07-04 07:00:38", "bibtex": null, "source_record_id": "DOI:10.1176/appi.pn.2021.4.8", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1176/appi.pn.2021.4.8", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1176/appi.pn.2021.4.8", "source_url": "https://doi.org/10.1176/appi.pn.2021.4.8", "doi": "10.1176/appi.pn.2021.4.8", "pmid": "", "publication_date": "2021-03-30", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 2147, "title": "Cannabis-induced oceanic boundlessness.", "authors": "Earleywine M, Ueno LF, Mian MN, Altman BR.", "journal": "Journal of Psychopharmacology", "publication_date": "2021-03-27", "publication_year": 2021, "doi": "10.1177/0269881121997099", "pubmed_id": "33779383", "openalex_id": "https://openalex.org/W3151652679", "source_url": "https://doi.org/10.1177/0269881121997099", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Receptor Pharmacology,Mystical Experience,Clinical Trial,Adolescents,Cancer Patients,Treatment-Resistant Depression", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-04 07:00:38", "bibtex": null, "source_record_id": "PMID:33779383", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1177/0269881121997099", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:33779383", "source_url": "https://doi.org/10.1177/0269881121997099", "doi": "10.1177/0269881121997099", "pmid": "33779383", "publication_date": "2021-03-27", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3799, "title": "Psychedelics and Health Behavior Change - Journal of Psychopharmacology (in press)", "authors": "Teixeira PJ, Johnson M, Timmermann C, Watts R, Erritzoe D, Douglass H, Kettner H, Carhart-Harris R.", "journal": "PsyArXiv", "publication_date": "2021-03-23", "publication_year": 2021, "doi": "10.31234/osf.io/8vks6", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.31234/osf.io/8vks6", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Eating Disorders,Pharmacology,Mechanism of Action,Wellbeing,Safety,Toxicity", "study_type": "Other", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:10:23", "last_checked": "2026-07-01 11:22:05", "bibtex": null, "source_record_id": "DOI:10.31234/osf.io/8vks6", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://doi.org/10.31234/osf.io/8vks6", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "DOI:10.31234/osf.io/8vks6", "source_url": "https://doi.org/10.31234/osf.io/8vks6", "doi": "10.31234/osf.io/8vks6", "pmid": "", "publication_date": "2021-03-23", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3374, "title": "Psychedelics and Health Behavior Change - Journal of Psychopharmacology (in press)", "authors": "", "journal": "PsyArXiv", "publication_date": "2021-03-23", "publication_year": 2021, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://osf.io/preprints/psyarxiv/8vks6_v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Eating Disorders,Pharmacology,Mechanism of Action,Wellbeing,Safety,Toxicity", "study_type": "Other", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:51", "last_checked": "2026-07-01 11:22:30", "bibtex": null, "source_record_id": "https://osf.io/preprints/psyarxiv/8vks6_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/8vks6_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "https://osf.io/preprints/psyarxiv/8vks6_v1", "source_url": "https://osf.io/preprints/psyarxiv/8vks6_v1", "doi": "", "pmid": "", "publication_date": "2021-03-23", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 2175, "title": "Hallucinogenic/psychedelic 5HT2A receptor agonists as rapid antidepressant therapeutics: Evidence and mechanisms of action.", "authors": "Dos Santos RG, Hallak JE, Baker G, Dursun S.", "journal": "Journal of Psychopharmacology", "publication_date": "2021-03-18", "publication_year": 2021, "doi": "10.1177/0269881120986422", "pubmed_id": "33740877", "openalex_id": "https://openalex.org/W3137933781", "source_url": "https://doi.org/10.1177/0269881120986422", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Animal Study,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-04 07:00:38", "bibtex": null, "source_record_id": "PMID:33740877", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1177/0269881120986422", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:33740877", "source_url": "https://doi.org/10.1177/0269881120986422", "doi": "10.1177/0269881120986422", "pmid": "33740877", "publication_date": "2021-03-18", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 2168, "title": "Acute and Sustained Reductions in Loss of Meaning and Suicidal Ideation Following Psilocybin-Assisted Psychotherapy for Psychiatric and Existential Distress in Life-Threatening Cancer.", "authors": "Ross S, Agin-Liebes G, Lo S, Zeifman RJ, Ghazal L, Benville J, Franco Corso S, Bjerre Real C, Guss J, Bossis A, Mennenga SE.", "journal": "ACS Pharmacology & Translational Science", "publication_date": "2021-03-17", "publication_year": 2021, "doi": "10.1021/acsptsci.1c00020", "pubmed_id": "33860185", "openalex_id": "https://openalex.org/W3138429576", "source_url": "https://doi.org/10.1021/acsptsci.1c00020", "substance_tags": "psilocybin", "topic_tags": "Depression,End-of-Life Distress,Clinical Trial,Randomized Controlled Trial,Safety", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-04 07:00:38", "bibtex": null, "source_record_id": "PMID:33860185", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1021/acsptsci.1c00020", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:33860185", "source_url": "https://doi.org/10.1021/acsptsci.1c00020", "doi": "10.1021/acsptsci.1c00020", "pmid": "33860185", "publication_date": "2021-03-17", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3212, "title": "The DMT and Psilocin Treatment Changes CD11b+ Activated Microglia Immunological Phenotype", "authors": "Kozłowska U, Klimczak A, Wiatr K, Figiel M.", "journal": "bioRxiv", "publication_date": "2021-03-07", "publication_year": 2021, "doi": "10.1101/2021.03.07.434103", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.1101/2021.03.07.434103", "substance_tags": "psilocin", "topic_tags": "Depression,PTSD,Mechanism of Action,Receptor Pharmacology,Biomarkers,Treatment-Resistant Depression,Inflammation,Immune Function", "study_type": "Other", "source_name": "bioRxiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:48", "last_checked": "2026-07-01 11:22:02", "bibtex": null, "source_record_id": "DOI:10.1101/2021.03.07.434103", "abstract_available": true, "abstract_source": "bioRxiv", "abstract_source_url": "https://doi.org/10.1101/2021.03.07.434103", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "bioRxiv", "source_record_id": "DOI:10.1101/2021.03.07.434103", "source_url": "https://doi.org/10.1101/2021.03.07.434103", "doi": "10.1101/2021.03.07.434103", "pmid": "", "publication_date": "2021-03-07", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 5118, "title": "Stroke and Adverse Effects on The Immune and Cardiovascular Systems: The Danger of the Rise and Use of Psychedelic Drugs for Depression and PTSD", "authors": "", "journal": "Journal of Clinical & Experimental Immunology", "publication_date": "2021-03-02", "publication_year": 2021, "doi": "10.33140/jcei.06.02.01", "pubmed_id": null, "openalex_id": "https://openalex.org/W4254506988", "source_url": "http://doi.org/10.33140/jcei.06.02.01", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Receptor Pharmacology,Adolescents,Immune Function", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:52:00", "last_checked": "2026-07-04 07:00:38", "bibtex": null, "source_record_id": "DOI:10.33140/jcei.06.02.01", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://doi.org/10.33140/jcei.06.02.01", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.33140/jcei.06.02.01", "source_url": "http://doi.org/10.33140/jcei.06.02.01", "doi": "10.33140/jcei.06.02.01", "pmid": "", "publication_date": "2021-03-02", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 5119, "title": "Session on Psychedelics Sure to Be Enlightening", "authors": "Nick Zagorski", "journal": "Psychiatric News", "publication_date": "2021-02-28", "publication_year": 2021, "doi": "10.1176/appi.pn.2021.3.14", "pubmed_id": null, "openalex_id": "https://openalex.org/W3133604748", "source_url": "https://doi.org/10.1176/appi.pn.2021.3.14", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Consciousness,Wellbeing,Emotional Processing,Review Article,Cancer Patients,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:52:00", "last_checked": "2026-07-04 07:00:38", "bibtex": null, "source_record_id": "DOI:10.1176/appi.pn.2021.3.14", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1176/appi.pn.2021.3.14", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1176/appi.pn.2021.3.14", "source_url": "https://doi.org/10.1176/appi.pn.2021.3.14", "doi": "10.1176/appi.pn.2021.3.14", "pmid": "", "publication_date": "2021-02-28", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 2194, "title": "Low Doses of Psilocybin and Ketamine Enhance Motivation and Attention in Poor Performing Rats: Evidence for an Antidepressant Property.", "authors": "Higgins GA, Carroll NK, Brown M, MacMillan C, Silenieks LB, Thevarkunnel S, Izhakova J, Magomedova L, DeLannoy I, Sellers EM.", "journal": "Frontiers in Pharmacology", "publication_date": "2021-02-25", "publication_year": 2021, "doi": "10.3389/fphar.2021.640241", "pubmed_id": "33716753", "openalex_id": "https://openalex.org/W3134320342", "source_url": "https://doi.org/10.3389/fphar.2021.640241", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Animal Study", "study_type": "Animal Study", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-04 07:00:38", "bibtex": null, "source_record_id": "PMID:33716753", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.3389/fphar.2021.640241", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:33716753", "source_url": "https://doi.org/10.3389/fphar.2021.640241", "doi": "10.3389/fphar.2021.640241", "pmid": "33716753", "publication_date": "2021-02-25", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3370, "title": "Classic psychedelic coadministration with lithium, but not lamotrigine, is associated with seizures: an analysis of online psychedelic experience reports", "authors": "Nayak S, Gukasyan N, Barrett FS, Erowid E, Erowid F, Griffiths RR.", "journal": "PsyArXiv", "publication_date": "2021-02-23", "publication_year": 2021, "doi": "10.31234/osf.io/r726d", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.31234/osf.io/r726d", "substance_tags": "psilocybin", "topic_tags": "Depression,Safety", "study_type": "Other", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:51", "last_checked": "2026-07-01 11:22:05", "bibtex": null, "source_record_id": "DOI:10.31234/osf.io/r726d", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://doi.org/10.31234/osf.io/r726d", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "DOI:10.31234/osf.io/r726d", "source_url": "https://doi.org/10.31234/osf.io/r726d", "doi": "10.31234/osf.io/r726d", "pmid": "", "publication_date": "2021-02-23", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 2179, "title": "Optimal dosing for psilocybin pharmacotherapy: Considering weight-adjusted and fixed dosing approaches.", "authors": "Garcia-Romeu A, Barrett FS, Carbonaro TM, Johnson MW, Griffiths RR.", "journal": "Journal of Psychopharmacology", "publication_date": "2021-02-19", "publication_year": 2021, "doi": "10.1177/0269881121991822", "pubmed_id": "33611977", "openalex_id": "https://openalex.org/W3129221857", "source_url": "https://doi.org/10.1177/0269881121991822", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Receptor Pharmacology,Mystical Experience", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-04 07:00:38", "bibtex": null, "source_record_id": "PMID:33611977", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1177/0269881121991822", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:33611977", "source_url": "https://doi.org/10.1177/0269881121991822", "doi": "10.1177/0269881121991822", "pmid": "33611977", "publication_date": "2021-02-19", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 5123, "title": "How to Change Your Mind: What the New Science of Psychedelics Teaches Us About Consciousness, Dying, Addiction, Depression, and Transcendence", "authors": "Peter G. Brindley", "journal": "Anesthesia & Analgesia", "publication_date": "2021-02-16", "publication_year": 2021, "doi": "10.1213/ane.0000000000005349", "pubmed_id": null, "openalex_id": "https://openalex.org/W3129763680", "source_url": "https://doi.org/10.1213/ane.0000000000005349", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Addiction,Chronic Pain,Pharmacology,Mechanism of Action,Receptor Pharmacology,Default Mode Network,Consciousness,Aging,Emotional Processing,Spirituality,Mystical Experience,Review Article,Healthcare Workers", "study_type": "Review Article", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:52:00", "last_checked": "2026-07-04 07:00:38", "bibtex": null, "source_record_id": "DOI:10.1213/ane.0000000000005349", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1213/ane.0000000000005349", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1213/ane.0000000000005349", "source_url": "https://doi.org/10.1213/ane.0000000000005349", "doi": "10.1213/ane.0000000000005349", "pmid": "", "publication_date": "2021-02-16", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3203, "title": "Psilocin acutely disrupts sleep and affects local but not global sleep homeostasis in laboratory mice", "authors": "Thomas CW, Blanco-Duque C, Bréant B, Goodwin GM, Sharp T, Bannerman DM, Vyazovskiy VV.", "journal": "bioRxiv", "publication_date": "2021-02-16", "publication_year": 2021, "doi": "10.1101/2021.02.16.431276", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.1101/2021.02.16.431276", "substance_tags": "psilocin", "topic_tags": "Depression,Brain Imaging,Mechanism of Action,Consciousness,Wellbeing,Animal Study", "study_type": "Animal Study", "source_name": "bioRxiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:48", "last_checked": "2026-07-01 11:22:02", "bibtex": null, "source_record_id": "DOI:10.1101/2021.02.16.431276", "abstract_available": true, "abstract_source": "bioRxiv", "abstract_source_url": "https://doi.org/10.1101/2021.02.16.431276", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "bioRxiv", "source_record_id": "DOI:10.1101/2021.02.16.431276", "source_url": "https://doi.org/10.1101/2021.02.16.431276", "doi": "10.1101/2021.02.16.431276", "pmid": "", "publication_date": "2021-02-16", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 2198, "title": "Development and Evaluation of a Therapist Training Program for Psilocybin Therapy for Treatment-Resistant Depression in Clinical Research.", "authors": "Tai SJ, Nielson EM, Lennard-Jones M, Johanna Ajantaival RL, Winzer R, Richards WA, Reinholdt F, Richards BD, Gasser P, Malievskaia E.", "journal": "Frontiers in Psychiatry", "publication_date": "2021-02-02", "publication_year": 2021, "doi": "10.3389/fpsyt.2021.586682", "pubmed_id": "33643087", "openalex_id": "https://openalex.org/W3127909847", "source_url": "https://doi.org/10.3389/fpsyt.2021.586682", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Clinical Trial,Randomized Controlled Trial,Treatment-Resistant Depression,Safety", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-04 07:00:38", "bibtex": null, "source_record_id": "PMID:33643087", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.3389/fpsyt.2021.586682", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:33643087", "source_url": "https://doi.org/10.3389/fpsyt.2021.586682", "doi": "10.3389/fpsyt.2021.586682", "pmid": "33643087", "publication_date": "2021-02-02", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 5126, "title": "Behandeling met psilocybine", "authors": "Joost J. Breeksema, Martijn H B Koolen, Metten Somers, Robert A. Schoevers", "journal": "Data Archiving and Networked Services (DANS)", "publication_date": "2021-01-20", "publication_year": 2021, "doi": null, "pubmed_id": null, "openalex_id": "https://openalex.org/W3169076037", "source_url": "https://research.rug.nl/en/publications/5e83b45d-b208-402a-a435-f0380fad6429", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,OCD,End-of-Life Distress,Mechanism of Action,Aging,Clinical Trial", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:52:00", "last_checked": "2026-07-04 07:00:38", "bibtex": null, "source_record_id": "https://research.rug.nl/en/publications/5e83b45d-b208-402a-a435-f0380fad6429", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://research.rug.nl/en/publications/5e83b45d-b208-402a-a435-f0380fad6429", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "https://research.rug.nl/en/publications/5e83b45d-b208-402a-a435-f0380fad6429", "source_url": "https://research.rug.nl/en/publications/5e83b45d-b208-402a-a435-f0380fad6429", "doi": "", "pmid": "", "publication_date": "2021-01-20", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 2203, "title": "[Treatment with psilocybin: applications for patients with psychiatric disorders].", "authors": "Breeksema JJ, Koolen MHB, Somers M, Schoevers RA.", "journal": "PubMed", "publication_date": "2021-01-20", "publication_year": 2021, "doi": null, "pubmed_id": "33560605", "openalex_id": "https://openalex.org/W3127548368", "source_url": "https://europepmc.org/article/MED/33560605", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,OCD,End-of-Life Distress,Mechanism of Action,Aging,Clinical Trial", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-04 07:00:38", "bibtex": null, "source_record_id": "PMID:33560605", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://europepmc.org/article/MED/33560605", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:33560605", "source_url": "https://europepmc.org/article/MED/33560605", "doi": "", "pmid": "33560605", "publication_date": "2021-01-20", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 2144, "title": "Psychedelic Psychiatry and the Consult-Liaison Psychiatrist: A Primer.", "authors": "Barnett BS, Greer GR.", "journal": null, "publication_date": "2021-01-20", "publication_year": 2021, "doi": "10.1016/j.jaclp.2020.12.011", "pubmed_id": "34210406", "openalex_id": "https://openalex.org/W3123670341", "source_url": "https://doi.org/10.1016/j.jaclp.2020.12.011", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Addiction,Review Article,Safety,Adverse Events", "study_type": "Review Article", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-01 11:22:06", "bibtex": null, "source_record_id": "PMID:34210406", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.jaclp.2020.12.011", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:34210406", "source_url": "https://doi.org/10.1016/j.jaclp.2020.12.011", "doi": "10.1016/j.jaclp.2020.12.011", "pmid": "34210406", "publication_date": "2021-01-20", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 2148, "title": "Classical Psychedelics as Therapeutics in Psychiatry - Current Clinical Evidence and Potential Therapeutic Mechanisms in Substance Use and Mood Disorders.", "authors": "Mertens LJ, Preller KH.", "journal": null, "publication_date": "2021-01-19", "publication_year": 2021, "doi": "10.1055/a-1341-1907", "pubmed_id": "33472250", "openalex_id": null, "source_url": "https://doi.org/10.1055/a-1341-1907", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Mechanism of Action,Clinical Trial,Randomized Controlled Trial,Review Article,Animal Study,Safety", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-01 11:22:05", "bibtex": null, "source_record_id": "PMID:33472250", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1055/a-1341-1907", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:33472250", "source_url": "https://doi.org/10.1055/a-1341-1907", "doi": "10.1055/a-1341-1907", "pmid": "33472250", "publication_date": "2021-01-19", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 2204, "title": "A Single Dose of Psilocybin Increases Synaptic Density and Decreases 5-HT2A Receptor Density in the Pig Brain.", "authors": "Raval NR, Johansen A, Donovan LL, Ros NF, Ozenne B, Hansen HD, Knudsen GM.", "journal": "International Journal of Molecular Sciences", "publication_date": "2021-01-14", "publication_year": 2021, "doi": "10.3390/ijms22020835", "pubmed_id": "33467676", "openalex_id": "https://openalex.org/W3108222140", "source_url": "https://doi.org/10.3390/ijms22020835", "substance_tags": "psilocybin", "topic_tags": "Depression,Neuroplasticity,Receptor Pharmacology", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-04 07:00:38", "bibtex": null, "source_record_id": "PMID:33467676", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.3390/ijms22020835", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:33467676", "source_url": "https://doi.org/10.3390/ijms22020835", "doi": "10.3390/ijms22020835", "pmid": "33467676", "publication_date": "2021-01-14", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 2200, "title": "Classic serotonergic psychedelics for mood and depressive symptoms: a meta-analysis of mood disorder patients and healthy participants.", "authors": "Galvão-Coelho NL, Marx W, Gonzalez M, Sinclair J, de Manincor M, Perkins D, Sarris J.", "journal": null, "publication_date": "2021-01-10", "publication_year": 2021, "doi": "10.1007/s00213-020-05719-1", "pubmed_id": "33427944", "openalex_id": null, "source_url": "https://doi.org/10.1007/s00213-020-05719-1", "substance_tags": "psilocybin", "topic_tags": "Depression,Receptor Pharmacology,Clinical Trial,Randomized Controlled Trial,Meta-Analysis,Review Article,Healthy Volunteers", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-01 11:22:06", "bibtex": null, "source_record_id": "PMID:33427944", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1007/s00213-020-05719-1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:33427944", "source_url": "https://doi.org/10.1007/s00213-020-05719-1", "doi": "10.1007/s00213-020-05719-1", "pmid": "33427944", "publication_date": "2021-01-10", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 5130, "title": "Study: Psilocybin enhances therapy in patients with major depression", "authors": "", "journal": "The Brown University Psychopharmacology Update", "publication_date": "2021-01-06", "publication_year": 2021, "doi": "10.1002/pu.30675", "pubmed_id": null, "openalex_id": "https://openalex.org/W4245208197", "source_url": "https://doi.org/10.1002/pu.30675", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Randomized Controlled Trial,Treatment-Resistant Depression", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:52:00", "last_checked": "2026-07-04 07:00:38", "bibtex": null, "source_record_id": "DOI:10.1002/pu.30675", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1002/pu.30675", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1002/pu.30675", "source_url": "https://doi.org/10.1002/pu.30675", "doi": "10.1002/pu.30675", "pmid": "", "publication_date": "2021-01-06", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3556, "title": "Psilocybin-assisted Group Therapy for Demoralization in Long-term AIDS Survivors", "authors": "Joshua Woolley", "journal": "ClinicalTrials.gov", "publication_date": "2021-01-06", "publication_year": 2021, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT02950467", "substance_tags": "psilocybin", "topic_tags": "Depression,End-of-Life Distress", "study_type": "Other", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT02950467", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT02950467", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT02950467", "source_url": "https://clinicaltrials.gov/study/NCT02950467", "doi": "", "pmid": "", "publication_date": "2021-01-06", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 5145, "title": "Psilocybin therapy appears as effective as escitalopram, small study finds", "authors": "", "journal": "Pharmaceutical journal/˜The œpharmaceutical journal", "publication_date": "2020-12-31", "publication_year": 2020, "doi": "10.1211/pj.2021.1.91592", "pubmed_id": null, "openalex_id": "https://openalex.org/W4246962837", "source_url": "https://doi.org/10.1211/pj.2021.1.91592", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Receptor Pharmacology,Clinical Trial", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:52:00", "last_checked": "2026-07-04 07:00:38", "bibtex": null, "source_record_id": "DOI:10.1211/pj.2021.1.91592", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1211/pj.2021.1.91592", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1211/pj.2021.1.91592", "source_url": "https://doi.org/10.1211/pj.2021.1.91592", "doi": "10.1211/pj.2021.1.91592", "pmid": "", "publication_date": "2020-12-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 5141, "title": "Unmet need in depression: Psilocybin, a breakthrough treatment option", "authors": "Yogesh Kumar Chahar", "journal": "International Journal of Advanced Research in Medicine", "publication_date": "2020-12-31", "publication_year": 2020, "doi": "10.22271/27069567.2021.v3.i1f.159", "pubmed_id": null, "openalex_id": "https://openalex.org/W3164081616", "source_url": "https://doi.org/10.22271/27069567.2021.v3.i1f.159", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Review Article,Safety", "study_type": "Review Article", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:52:00", "last_checked": "2026-07-04 07:00:38", "bibtex": null, "source_record_id": "DOI:10.22271/27069567.2021.v3.i1f.159", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.22271/27069567.2021.v3.i1f.159", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.22271/27069567.2021.v3.i1f.159", "source_url": "https://doi.org/10.22271/27069567.2021.v3.i1f.159", "doi": "10.22271/27069567.2021.v3.i1f.159", "pmid": "", "publication_date": "2020-12-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 5140, "title": "We Need a Cole Memorandum for Magic Mushrooms", "authors": "Robert A. Mikos", "journal": "SSRN Electronic Journal", "publication_date": "2020-12-31", "publication_year": 2020, "doi": null, "pubmed_id": null, "openalex_id": "https://openalex.org/W3162478297", "source_url": "https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3839551", "substance_tags": "psilocybin", "topic_tags": "Depression", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:52:00", "last_checked": "2026-07-04 07:00:38", "bibtex": null, "source_record_id": "https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3839551", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3839551", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3839551", "source_url": "https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3839551", "doi": "", "pmid": "", "publication_date": "2020-12-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 5132, "title": "Preclinical Behavioral Assessment of Chronic, Intermittent Low-Dose Psilocybin in Rodent Models of Depression and Anxiety", "authors": "Harmony I. Risca", "journal": null, "publication_date": "2020-12-31", "publication_year": 2020, "doi": null, "pubmed_id": null, "openalex_id": "https://openalex.org/W3209570117", "source_url": "https://scholarworks.wmich.edu/cgi/viewcontent.cgi?article=4777&context=dissertations", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Receptor Pharmacology,Animal Study", "study_type": "Animal Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:52:00", "last_checked": "2026-07-04 07:00:38", "bibtex": null, "source_record_id": "https://scholarworks.wmich.edu/cgi/viewcontent.cgi?article=4777&context=dissertations", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "https://scholarworks.wmich.edu/cgi/viewcontent.cgi?article=4777&context=dissertations", "source_url": "https://scholarworks.wmich.edu/cgi/viewcontent.cgi?article=4777&context=dissertations", "doi": "", "pmid": "", "publication_date": "2020-12-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 2213, "title": "How ecstasy and psilocybin are shaking up psychiatry.", "authors": "Tullis P.", "journal": "Nature", "publication_date": "2020-12-31", "publication_year": 2020, "doi": "10.1038/d41586-021-00187-9", "pubmed_id": "33505033", "openalex_id": "https://openalex.org/W3125143320", "source_url": "https://doi.org/10.1038/d41586-021-00187-9", "substance_tags": "psilocybin", "topic_tags": "Depression,Neuroplasticity,Receptor Pharmacology,Clinical Trial", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-04 07:00:38", "bibtex": null, "source_record_id": "PMID:33505033", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:33505033", "source_url": "https://doi.org/10.1038/d41586-021-00187-9", "doi": "10.1038/d41586-021-00187-9", "pmid": "33505033", "publication_date": "2020-12-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 2211, "title": "Psychedelic Medicines in Major Depression: Progress and Future Challenges.", "authors": "Bouso JC, Ona G, Dos Santos RG, Hallak JEC.", "journal": null, "publication_date": "2020-12-31", "publication_year": 2020, "doi": "10.1007/978-981-33-6044-0_26", "pubmed_id": "33834416", "openalex_id": null, "source_url": "https://doi.org/10.1007/978-981-33-6044-0_26", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-01 11:22:06", "bibtex": null, "source_record_id": "PMID:33834416", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1007/978-981-33-6044-0_26", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:33834416", "source_url": "https://doi.org/10.1007/978-981-33-6044-0_26", "doi": "10.1007/978-981-33-6044-0_26", "pmid": "33834416", "publication_date": "2020-12-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 2208, "title": "A Trip Through Employment Law: Protecting Therapeutic Psilocybin Users in the Workplace.", "authors": "Sheppard B.", "journal": "PubMed", "publication_date": "2020-12-31", "publication_year": 2020, "doi": null, "pubmed_id": "35026878", "openalex_id": "https://openalex.org/W4206882396", "source_url": "https://europepmc.org/article/MED/35026878", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Headache / Migraine", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-04 07:00:38", "bibtex": null, "source_record_id": "PMID:35026878", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://europepmc.org/article/MED/35026878", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:35026878", "source_url": "https://europepmc.org/article/MED/35026878", "doi": "", "pmid": "35026878", "publication_date": "2020-12-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 2197, "title": "What is the clinical evidence on psilocybin for the treatment of psychiatric disorders? A systematic review.", "authors": "Castro Santos H, Gama Marques J.", "journal": null, "publication_date": "2020-12-31", "publication_year": 2020, "doi": "10.1097/j.pbj.0000000000000128", "pubmed_id": "33884324", "openalex_id": null, "source_url": "https://doi.org/10.1097/j.pbj.0000000000000128", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,OCD,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Randomized Controlled Trial,Systematic Review,Review Article", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-01 11:22:03", "bibtex": null, "source_record_id": "PMID:33884324", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1097/j.pbj.0000000000000128", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:33884324", "source_url": "https://doi.org/10.1097/j.pbj.0000000000000128", "doi": "10.1097/j.pbj.0000000000000128", "pmid": "33884324", "publication_date": "2020-12-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 2167, "title": "Ethical Concerns about Psilocybin Intellectual Property.", "authors": "Gerber K, Flores IG, Ruiz AC, Ali I, Ginsberg NL, Schenberg EE.", "journal": "ACS Pharmacology & Translational Science", "publication_date": "2020-12-31", "publication_year": 2020, "doi": "10.1021/acsptsci.0c00171", "pubmed_id": "33860186", "openalex_id": "https://openalex.org/W3114414169", "source_url": "https://doi.org/10.1021/acsptsci.0c00171", "substance_tags": "psilocybin", "topic_tags": "Depression", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-04 07:00:38", "bibtex": null, "source_record_id": "PMID:33860186", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1021/acsptsci.0c00171", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:33860186", "source_url": "https://doi.org/10.1021/acsptsci.0c00171", "doi": "10.1021/acsptsci.0c00171", "pmid": "33860186", "publication_date": "2020-12-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 2133, "title": "Examining the Potential Synergistic Effects Between Mindfulness Training and Psychedelic-Assisted Therapy.", "authors": "Eleftheriou ME, Thomas E", "journal": "Frontiers in psychiatry", "publication_date": "2020-12-31", "publication_year": 2020, "doi": "10.3389/fpsyt.2021.707057", "pubmed_id": "34456763", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/34456763/", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Wellbeing,Healthy Volunteers", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-01 11:20:39", "bibtex": null, "source_record_id": "PMID:34456763", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/34456763/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:34456763", "source_url": "https://pubmed.ncbi.nlm.nih.gov/34456763/", "doi": "10.3389/fpsyt.2021.707057", "pmid": "34456763", "publication_date": "2020-12-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1896, "title": "Psychedelics and Other Psychoplastogens for Treating Mental Illness.", "authors": "Vargas MV, Meyer R, Avanes AA, Rus M, Olson DE", "journal": "Frontiers in psychiatry", "publication_date": "2020-12-31", "publication_year": 2020, "doi": "10.3389/fpsyt.2021.727117", "pubmed_id": "34671279", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/34671279/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Neuroplasticity", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:06", "last_checked": "2026-07-01 11:20:39", "bibtex": null, "source_record_id": "PMID:34671279", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/34671279/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:34671279", "source_url": "https://pubmed.ncbi.nlm.nih.gov/34671279/", "doi": "10.3389/fpsyt.2021.727117", "pmid": "34671279", "publication_date": "2020-12-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1889, "title": "Translating Psychedelic Therapies From Clinical Trials to Community Clinics: Building Bridges and Addressing Potential Challenges Ahead.", "authors": "Williams ML, Korevaar D, Harvey R, Fitzgerald PB, Liknaitzky P, O'Carroll S, Puspanathan P, Ross M, Strauss N, Bennett-Levy J", "journal": "Frontiers in psychiatry", "publication_date": "2020-12-31", "publication_year": 2020, "doi": "10.3389/fpsyt.2021.737738", "pubmed_id": "34803761", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/34803761/", "substance_tags": "psilocybin", "topic_tags": "Depression,Creativity,Clinical Trial,Healthcare Workers,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:06", "last_checked": "2026-07-01 11:20:39", "bibtex": null, "source_record_id": "PMID:34803761", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/34803761/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:34803761", "source_url": "https://pubmed.ncbi.nlm.nih.gov/34803761/", "doi": "10.3389/fpsyt.2021.737738", "pmid": "34803761", "publication_date": "2020-12-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1872, "title": "Psychedelic Therapy's Transdiagnostic Effects: A Research Domain Criteria (RDoC) Perspective.", "authors": "Kelly JR, Gillan CM, Prenderville J, Kelly C, Harkin A, Clarke G, O'Keane V", "journal": "Frontiers in psychiatry", "publication_date": "2020-12-31", "publication_year": 2020, "doi": "10.3389/fpsyt.2021.800072", "pubmed_id": "34975593", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/34975593/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,OCD,Eating Disorders,Pharmacology,Mechanism of Action,Emotional Processing,Review Article,Treatment-Resistant Depression", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:20:39", "bibtex": null, "source_record_id": "PMID:34975593", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/34975593/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:34975593", "source_url": "https://pubmed.ncbi.nlm.nih.gov/34975593/", "doi": "10.3389/fpsyt.2021.800072", "pmid": "34975593", "publication_date": "2020-12-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1836, "title": "Psychedelic Mushrooms in the USA: Knowledge, Patterns of Use, and Association With Health Outcomes.", "authors": "Matzopoulos R, Morlock R, Morlock A, Lerer B, Lerer L", "journal": "Frontiers in psychiatry", "publication_date": "2020-12-31", "publication_year": 2020, "doi": "10.3389/fpsyt.2021.780696", "pubmed_id": "35046855", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/35046855/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Wellbeing,Observational Study", "study_type": "Observational Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:20:39", "bibtex": null, "source_record_id": "PMID:35046855", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/35046855/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:35046855", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35046855/", "doi": "10.3389/fpsyt.2021.780696", "pmid": "35046855", "publication_date": "2020-12-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 2183, "title": "A Dendrite-Focused Framework for Understanding the Actions of Ketamine and Psychedelics.", "authors": "Savalia NK, Shao LX, Kwan AC.", "journal": null, "publication_date": "2020-12-20", "publication_year": 2020, "doi": "10.1016/j.tins.2020.11.008", "pubmed_id": "33358035", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.tins.2020.11.008", "substance_tags": "psilocybin", "topic_tags": "Depression,Neuroplasticity,Receptor Pharmacology,Toxicity", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-01 11:22:06", "bibtex": null, "source_record_id": "PMID:33358035", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.tins.2020.11.008", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:33358035", "source_url": "https://doi.org/10.1016/j.tins.2020.11.008", "doi": "10.1016/j.tins.2020.11.008", "pmid": "33358035", "publication_date": "2020-12-20", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 2221, "title": "Effects and safety of Psilocybe cubensis and Panaeolus cyanescens magic mushroom extracts on endothelin-1-induced hypertrophy and cell injury in cardiomyocytes", "authors": "Sanah Malomile Nkadimeng, Christiaan M.L. Steinmann, J.N. Eloff", "journal": "Scientific Reports", "publication_date": "2020-12-17", "publication_year": 2020, "doi": "10.1038/s41598-020-79328-5", "pubmed_id": "33339902", "openalex_id": "https://openalex.org/W3115524456", "source_url": "https://doi.org/10.1038/s41598-020-79328-5", "substance_tags": "psilocybin", "topic_tags": "Depression,Receptor Pharmacology,Safety", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-04 07:00:38", "bibtex": null, "source_record_id": "PMID:33339902", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1038/s41598-020-79328-5", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:33339902", "source_url": "https://doi.org/10.1038/s41598-020-79328-5", "doi": "10.1038/s41598-020-79328-5", "pmid": "33339902", "publication_date": "2020-12-17", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 2210, "title": "People of color in North America report improvements in racial trauma and mental health symptoms following psychedelic experiences", "authors": "Monnica T. Williams, Alan K. Davis, Yitong Xin, Nathan D. Sepeda, Pamela Colón Grigas, Sinead M. Sinnott, Angela M. Haeny", "journal": "Drugs Education Prevention and Policy", "publication_date": "2020-12-09", "publication_year": 2020, "doi": "10.1080/09687637.2020.1854688", "pubmed_id": "34349358", "openalex_id": "https://openalex.org/W3112172827", "source_url": "https://doi.org/10.1080/09687637.2020.1854688", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Pharmacology,Mystical Experience,Observational Study", "study_type": "Observational Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-04 07:00:38", "bibtex": null, "source_record_id": "PMID:34349358", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1080/09687637.2020.1854688", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:34349358", "source_url": "https://doi.org/10.1080/09687637.2020.1854688", "doi": "10.1080/09687637.2020.1854688", "pmid": "34349358", "publication_date": "2020-12-09", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 2170, "title": "Psilocybin-Assisted Group Therapy and Attachment: Observed Reduction in Attachment Anxiety and Influences of Attachment Insecurity on the Psilocybin Experience", "authors": "Christopher S. Stauffer, B. Anderson, Kile Ortigo, Joshua Woolley", "journal": "ACS Pharmacology & Translational Science", "publication_date": "2020-12-08", "publication_year": 2020, "doi": "10.1021/acsptsci.0c00169", "pubmed_id": "33860182", "openalex_id": "https://openalex.org/W3112557491", "source_url": "https://doi.org/10.1021/acsptsci.0c00169", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Mystical Experience,Treatment-Resistant Depression,Safety", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-04 07:00:38", "bibtex": null, "source_record_id": "PMID:33860182", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1021/acsptsci.0c00169", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:33860182", "source_url": "https://doi.org/10.1021/acsptsci.0c00169", "doi": "10.1021/acsptsci.0c00169", "pmid": "33860182", "publication_date": "2020-12-08", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3491, "title": "Effects of Serotonin Transporter Inhibition on the Subjective Response to Psilocybin in Healthy Subjects", "authors": "University Hospital, Basel, Switzerland", "journal": "ClinicalTrials.gov", "publication_date": "2020-11-30", "publication_year": 2020, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT03912974", "substance_tags": "psilocybin", "topic_tags": "Depression,Neuroplasticity,Receptor Pharmacology,Consciousness,Safety", "study_type": "Other", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT03912974", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT03912974", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT03912974", "source_url": "https://clinicaltrials.gov/study/NCT03912974", "doi": "", "pmid": "", "publication_date": "2020-11-30", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 2201, "title": "Therapeutic effects of classic serotonergic psychedelics: A systematic review of modern-era clinical studies.", "authors": "Andersen KAA, Carhart-Harris R, Nutt DJ, Erritzoe D.", "journal": null, "publication_date": "2020-11-30", "publication_year": 2020, "doi": "10.1111/acps.13249", "pubmed_id": "33125716", "openalex_id": null, "source_url": "https://doi.org/10.1111/acps.13249", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,OCD,Systematic Review,Review Article,Safety,Adverse Events", "study_type": "Systematic Review", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-01 11:22:06", "bibtex": null, "source_record_id": "PMID:33125716", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1111/acps.13249", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:33125716", "source_url": "https://doi.org/10.1111/acps.13249", "doi": "10.1111/acps.13249", "pmid": "33125716", "publication_date": "2020-11-30", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3271, "title": "A Single Dose of Psilocybin Increases Synaptic Density and Decreases 5-HT2A Receptor Density in the Pig Brain", "authors": "Raval NR, Johansen A, Donovan LL, Ros NF, Ozenne B, Hansen HD, Knudsen GM.", "journal": "Preprints.org", "publication_date": "2020-11-29", "publication_year": 2020, "doi": "10.20944/preprints202011.0742.v1", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.20944/preprints202011.0742.v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Neuroplasticity,Receptor Pharmacology", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "preprint", "date_added": "2026-07-01 11:03:49", "last_checked": "2026-07-01 11:22:03", "bibtex": null, "source_record_id": "DOI:10.20944/preprints202011.0742.v1", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.20944/preprints202011.0742.v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "DOI:10.20944/preprints202011.0742.v1", "source_url": "https://doi.org/10.20944/preprints202011.0742.v1", "doi": "10.20944/preprints202011.0742.v1", "pmid": "", "publication_date": "2020-11-29", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 2199, "title": "Hallucinogens in Mental Health: Preclinical and Clinical Studies on LSD, Psilocybin, MDMA, and Ketamine.", "authors": "De Gregorio D, Aguilar-Valles A, Preller KH, Heifets BD, Hibicke M, Mitchell J, Gobbi G.", "journal": null, "publication_date": "2020-11-29", "publication_year": 2020, "doi": "10.1523/jneurosci.1659-20.2020", "pubmed_id": "33257322", "openalex_id": null, "source_url": "https://doi.org/10.1523/jneurosci.1659-20.2020", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Pharmacology,Randomized Controlled Trial,Review Article,Animal Study", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-01 11:22:04", "bibtex": null, "source_record_id": "PMID:33257322", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1523/jneurosci.1659-20.2020", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:33257322", "source_url": "https://doi.org/10.1523/jneurosci.1659-20.2020", "doi": "10.1523/jneurosci.1659-20.2020", "pmid": "33257322", "publication_date": "2020-11-29", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 2186, "title": "[Ketamine, psilocybin, and rapid acting antidepressant: new promise for psychiatry?]", "authors": "Bottemanne H, Claret A, Fossati P.", "journal": null, "publication_date": "2020-11-11", "publication_year": 2020, "doi": "10.1016/j.encep.2020.08.006", "pubmed_id": "33190819", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.encep.2020.08.006", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Receptor Pharmacology,Biomarkers,Healthcare Workers", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-01 11:22:04", "bibtex": null, "source_record_id": "PMID:33190819", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.encep.2020.08.006", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:33190819", "source_url": "https://doi.org/10.1016/j.encep.2020.08.006", "doi": "10.1016/j.encep.2020.08.006", "pmid": "33190819", "publication_date": "2020-11-11", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 2187, "title": "Transcriptional regulation in the rat prefrontal cortex and hippocampus after a single administration of psilocybin", "authors": "Oskar Hougaard Jefsen, Betina Elfving, Gregers Wegener, Heidi Kaastrup Müller", "journal": "Journal of Psychopharmacology", "publication_date": "2020-11-03", "publication_year": 2020, "doi": "10.1177/0269881120959614", "pubmed_id": "33143539", "openalex_id": "https://openalex.org/W3094714065", "source_url": "https://doi.org/10.1177/0269881120959614", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,OCD,Neuroplasticity,Receptor Pharmacology,Animal Study,Treatment-Resistant Depression", "study_type": "Animal Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-04 07:00:39", "bibtex": null, "source_record_id": "PMID:33143539", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1177/0269881120959614", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:33143539", "source_url": "https://doi.org/10.1177/0269881120959614", "doi": "10.1177/0269881120959614", "pmid": "33143539", "publication_date": "2020-11-03", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 2160, "title": "Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder", "authors": "Alan K. Davis, Frederick S. Barrett, Darrick G. May, Mary P Cosimano, Nathan D. Sepeda, Matthew W. Johnson, Patrick H. Finan, Roland R. Griffiths", "journal": "JAMA Psychiatry", "publication_date": "2020-11-03", "publication_year": 2020, "doi": "10.1001/jamapsychiatry.2020.3285", "pubmed_id": "33146667", "openalex_id": "https://openalex.org/W3096208965", "source_url": "https://doi.org/10.1001/jamapsychiatry.2020.3285", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Consciousness,Clinical Trial,Randomized Controlled Trial,Treatment-Resistant Depression", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-04 07:00:39", "bibtex": null, "source_record_id": "PMID:33146667", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1001/jamapsychiatry.2020.3285", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:33146667", "source_url": "https://doi.org/10.1001/jamapsychiatry.2020.3285", "doi": "10.1001/jamapsychiatry.2020.3285", "pmid": "33146667", "publication_date": "2020-11-03", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3402, "title": "A Meta-Analysis of Placebo-Controlled Trials of Psychedelic-Assisted Therapy", "authors": "Luoma JB, Chwyl C, Bathje G, Davis AK, Lancelotta RL.", "journal": "PsyArXiv", "publication_date": "2020-10-27", "publication_year": 2020, "doi": "10.31234/osf.io/nhbjk", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.31234/osf.io/nhbjk", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,End-of-Life Distress,Clinical Trial,Meta-Analysis", "study_type": "Meta-Analysis", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:52", "last_checked": "2026-07-01 11:22:06", "bibtex": null, "source_record_id": "DOI:10.31234/osf.io/nhbjk", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://doi.org/10.31234/osf.io/nhbjk", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "DOI:10.31234/osf.io/nhbjk", "source_url": "https://doi.org/10.31234/osf.io/nhbjk", "doi": "10.31234/osf.io/nhbjk", "pmid": "", "publication_date": "2020-10-27", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3429, "title": "Effects of Psilocybin on Anxiety and Psychosocial Distress in Cancer Patients", "authors": "NYU Langone Health", "journal": "ClinicalTrials.gov", "publication_date": "2020-10-19", "publication_year": 2020, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT00957359", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Chronic Pain,Mechanism of Action,Consciousness,Emotional Processing,Spirituality,Mystical Experience,Review Article,Cancer Patients,Safety", "study_type": "Review Article", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT00957359", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT00957359", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT00957359", "source_url": "https://clinicaltrials.gov/study/NCT00957359", "doi": "", "pmid": "", "publication_date": "2020-10-19", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3831, "title": "The Role of Psychedelics and Counseling in Mental Health Treatment", "authors": "Russ Curtis, Lisen C. Roberts, Elizabeth Graves, Heather Thompson Rainey, D. D. Wynn, Daphne Krantz, Verena Wieloch", "journal": "Journal of Mental Health Counseling", "publication_date": "2020-09-30", "publication_year": 2020, "doi": "10.17744/mehc.42.4.03", "pubmed_id": null, "openalex_id": "https://openalex.org/W3094549229", "source_url": "https://doi.org/10.17744/mehc.42.4.03", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Receptor Pharmacology,Clinical Trial", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-02 20:42:13", "last_checked": "2026-07-04 07:00:39", "bibtex": null, "source_record_id": "DOI:10.17744/mehc.42.4.03", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.17744/mehc.42.4.03", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.17744/mehc.42.4.03", "source_url": "https://doi.org/10.17744/mehc.42.4.03", "doi": "10.17744/mehc.42.4.03", "pmid": "", "publication_date": "2020-09-30", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 2242, "title": "Efficacy of psychedelic treatments on depressive symptoms: A meta-analysis.", "authors": "Romeo B, Karila L, Martelli C, Benyamina A", "journal": "Journal of psychopharmacology (Oxford, England)", "publication_date": "2020-09-30", "publication_year": 2020, "doi": "10.1177/0269881120919957", "pubmed_id": "32448048", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/32448048/", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Receptor Pharmacology,Meta-Analysis", "study_type": "Meta-Analysis", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-01 11:20:39", "bibtex": null, "source_record_id": "PMID:32448048", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/32448048/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:32448048", "source_url": "https://pubmed.ncbi.nlm.nih.gov/32448048/", "doi": "10.1177/0269881120919957", "pmid": "32448048", "publication_date": "2020-09-30", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3834, "title": "Wait for the Science Before Widespread Use of Psilocybin", "authors": "Nicole Harrington Cirino", "journal": "Psychiatric News", "publication_date": "2020-09-28", "publication_year": 2020, "doi": "10.1176/appi.pn.2020.10a32", "pubmed_id": null, "openalex_id": "https://openalex.org/W3091539953", "source_url": "https://doi.org/10.1176/appi.pn.2020.10a32", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Safety,Drug Interactions", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-02 20:42:13", "last_checked": "2026-07-04 07:00:39", "bibtex": null, "source_record_id": "DOI:10.1176/appi.pn.2020.10a32", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1176/appi.pn.2020.10a32", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1176/appi.pn.2020.10a32", "source_url": "https://doi.org/10.1176/appi.pn.2020.10a32", "doi": "10.1176/appi.pn.2020.10a32", "pmid": "", "publication_date": "2020-09-28", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 2238, "title": "Psilocybin-assisted group therapy for demoralized older long-term AIDS survivor men: An open-label safety and feasibility pilot study", "authors": "B. Anderson, Alicia Danforth, Prof Robert Daroff, Christopher S. Stauffer, Eve Ekman, Gabrielle Agin-Liebes, Alexander Trope, Matthew Tyler Boden, James Dilley, Jennifer Mitchell, Joshua Woolley", "journal": "EClinicalMedicine", "publication_date": "2020-09-23", "publication_year": 2020, "doi": "10.1016/j.eclinm.2020.100538", "pubmed_id": "33150319", "openalex_id": "https://openalex.org/W3087859780", "source_url": "https://doi.org/10.1016/j.eclinm.2020.100538", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Chronic Pain,Veterans,Safety,Adverse Events,Toxicity", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-04 07:00:39", "bibtex": null, "source_record_id": "PMID:33150319", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1016/j.eclinm.2020.100538", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:33150319", "source_url": "https://doi.org/10.1016/j.eclinm.2020.100538", "doi": "10.1016/j.eclinm.2020.100538", "pmid": "33150319", "publication_date": "2020-09-23", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 2219, "title": "Efficacy of Psychoactive Drugs for the Treatment of Posttraumatic Stress Disorder: A Systematic Review of MDMA, Ketamine, LSD and Psilocybin.", "authors": "Varker T, Watson L, Gibson K, Forbes D, O'Donnell ML.", "journal": null, "publication_date": "2020-09-14", "publication_year": 2020, "doi": "10.1080/02791072.2020.1817639", "pubmed_id": "32931403", "openalex_id": null, "source_url": "https://doi.org/10.1080/02791072.2020.1817639", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Randomized Controlled Trial,Systematic Review,Review Article,Observational Study", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-01 11:22:03", "bibtex": null, "source_record_id": "PMID:32931403", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1080/02791072.2020.1817639", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:32931403", "source_url": "https://doi.org/10.1080/02791072.2020.1817639", "doi": "10.1080/02791072.2020.1817639", "pmid": "32931403", "publication_date": "2020-09-14", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 2246, "title": "Total Recall: Lateral Habenula and Psychedelics in the Study of Depression and Comorbid Brain Disorders.", "authors": "Vitkauskas M, Mathuru AS.", "journal": null, "publication_date": "2020-09-06", "publication_year": 2020, "doi": "10.3390/ijms21186525", "pubmed_id": "32906643", "openalex_id": null, "source_url": "https://doi.org/10.3390/ijms21186525", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging,Aging,Clinical Trial,Review Article", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-01 11:22:06", "bibtex": null, "source_record_id": "PMID:32906643", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.3390/ijms21186525", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:32906643", "source_url": "https://doi.org/10.3390/ijms21186525", "doi": "10.3390/ijms21186525", "pmid": "32906643", "publication_date": "2020-09-06", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 2247, "title": "Psilocybin as a New Approach to Treat Depression and Anxiety in the Context of Life-Threatening Diseases-A Systematic Review and Meta-Analysis of Clinical Trials.", "authors": "Vargas AS, Luís Â, Barroso M, Gallardo E, Pereira L.", "journal": null, "publication_date": "2020-09-04", "publication_year": 2020, "doi": "10.3390/biomedicines8090331", "pubmed_id": "32899469", "openalex_id": null, "source_url": "https://doi.org/10.3390/biomedicines8090331", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Clinical Trial,Meta-Analysis,Systematic Review,Review Article,Safety", "study_type": "Meta-Analysis", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-01 11:22:03", "bibtex": null, "source_record_id": "PMID:32899469", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.3390/biomedicines8090331", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:32899469", "source_url": "https://doi.org/10.3390/biomedicines8090331", "doi": "10.3390/biomedicines8090331", "pmid": "32899469", "publication_date": "2020-09-04", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 2248, "title": "Psilocybin Can Diminish Depression", "authors": "Teresa Kay Jones, Steven Lippmann", "journal": "The Primary Care Companion For CNS Disorders", "publication_date": "2020-09-01", "publication_year": 2020, "doi": "10.4088/pcc.19br02580", "pubmed_id": "32898345", "openalex_id": "https://openalex.org/W3082563060", "source_url": "https://doi.org/10.4088/pcc.19br02580", "substance_tags": "psilocybin", "topic_tags": "Depression", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-04 07:00:39", "bibtex": null, "source_record_id": "PMID:32898345", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:32898345", "source_url": "https://doi.org/10.4088/pcc.19br02580", "doi": "10.4088/pcc.19br02580", "pmid": "32898345", "publication_date": "2020-09-01", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 2249, "title": "Psychedelic Treatments for Psychiatric Disorders: A Systematic Review and Thematic Synthesis of Patient Experiences in Qualitative Studies.", "authors": "Breeksema JJ, Niemeijer AR, Krediet E, Vermetten E, Schoevers RA.", "journal": null, "publication_date": "2020-08-31", "publication_year": 2020, "doi": "10.1007/s40263-020-00748-y", "pubmed_id": "32803732", "openalex_id": null, "source_url": "https://doi.org/10.1007/s40263-020-00748-y", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Eating Disorders,Pharmacology,Emotional Processing,Systematic Review,Review Article", "study_type": "Systematic Review", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-01 11:22:06", "bibtex": null, "source_record_id": "PMID:32803732", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1007/s40263-020-00748-y", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:32803732", "source_url": "https://doi.org/10.1007/s40263-020-00748-y", "doi": "10.1007/s40263-020-00748-y", "pmid": "32803732", "publication_date": "2020-08-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 2256, "title": "Phytochemical, Cytotoxicity, Antioxidant and Anti-Inflammatory Effects of Psilocybe Natalensis Magic Mushroom", "authors": "Sanah Malomile Nkadimeng, Alice Nabatanzi, Christiaan M.L. Steinmann, J.N. Eloff", "journal": "Plants", "publication_date": "2020-08-30", "publication_year": 2020, "doi": "10.3390/plants9091127", "pubmed_id": "32878164", "openalex_id": "https://openalex.org/W3081977832", "source_url": "https://doi.org/10.3390/plants9091127", "substance_tags": "psilocybin", "topic_tags": "Depression,Pharmacology,In Vitro Study,Toxicity,Inflammation", "study_type": "In Vitro Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-04 07:00:39", "bibtex": null, "source_record_id": "PMID:32878164", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.3390/plants9091127", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:32878164", "source_url": "https://doi.org/10.3390/plants9091127", "doi": "10.3390/plants9091127", "pmid": "32878164", "publication_date": "2020-08-30", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 2257, "title": "The therapeutic potential of microdosing psychedelics in depression.", "authors": "Kuypers KPC.", "journal": null, "publication_date": "2020-08-26", "publication_year": 2020, "doi": "10.1177/2045125320950567", "pubmed_id": "32922736", "openalex_id": null, "source_url": "https://doi.org/10.1177/2045125320950567", "substance_tags": "psilocybin", "topic_tags": "Depression,Microdosing,Review Article,Healthy Volunteers", "study_type": "Review Article", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-01 11:22:05", "bibtex": null, "source_record_id": "PMID:32922736", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1177/2045125320950567", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:32922736", "source_url": "https://doi.org/10.1177/2045125320950567", "doi": "10.1177/2045125320950567", "pmid": "32922736", "publication_date": "2020-08-26", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 2229, "title": "P300-mediated modulations in self-other processing under psychedelic psilocybin are related to connectedness and changed meaning: A window into the self-other overlap", "authors": "Lukasz Smigielski, Michael Kometer, Milan Scheidegger, Cornelia Stress, Katrin H. Preller, Thomas Koenig, Franz X. Vollenweider", "journal": "Human Brain Mapping", "publication_date": "2020-08-20", "publication_year": 2020, "doi": "10.1002/hbm.25174", "pubmed_id": "32820851", "openalex_id": "https://openalex.org/W3080679302", "source_url": "https://doi.org/10.1002/hbm.25174", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Brain Imaging,Mechanism of Action,Receptor Pharmacology,Aging", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-04 07:00:39", "bibtex": null, "source_record_id": "PMID:32820851", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1002/hbm.25174", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:32820851", "source_url": "https://doi.org/10.1002/hbm.25174", "doi": "10.1002/hbm.25174", "pmid": "32820851", "publication_date": "2020-08-20", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 2151, "title": "Psychedelic science in post-COVID-19 psychiatry", "authors": "John R. Kelly, Matthew Crockett, Laith Alexander, Martin Haran, Amanda Baker, Lisa M. Burke, Christine Brennan, Veronica O’Keane", "journal": "Irish Journal of Psychological Medicine", "publication_date": "2020-08-18", "publication_year": 2020, "doi": "10.1017/ipm.2020.94", "pubmed_id": "32811575", "openalex_id": "https://openalex.org/W3054886531", "source_url": "https://doi.org/10.1017/ipm.2020.94", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Randomized Controlled Trial,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-04 07:00:39", "bibtex": null, "source_record_id": "PMID:32811575", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1017/ipm.2020.94", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:32811575", "source_url": "https://doi.org/10.1017/ipm.2020.94", "doi": "10.1017/ipm.2020.94", "pmid": "32811575", "publication_date": "2020-08-18", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3839, "title": "Oregon's Pioneering Effort to Enact State Law to Allow Access to Psilocybin", "authors": "James D. Tucker", "journal": "SSRN Electronic Journal", "publication_date": "2020-08-13", "publication_year": 2020, "doi": null, "pubmed_id": null, "openalex_id": "https://openalex.org/W3157248359", "source_url": "https://papers.ssrn.com/sol3/Delivery.cfm/SSRN_ID3783484_code4550530.pdf?abstractid=3783484&mirid=1", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Spirituality", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-02 20:42:13", "last_checked": "2026-07-04 07:00:39", "bibtex": null, "source_record_id": "https://papers.ssrn.com/sol3/Delivery.cfm/SSRN_ID3783484_code4550530.pdf?abstractid=3783484&mirid=1", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://papers.ssrn.com/sol3/Delivery.cfm/SSRN_ID3783484_code4550530.pdf?abstractid=3783484&mirid=1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "https://papers.ssrn.com/sol3/Delivery.cfm/SSRN_ID3783484_code4550530.pdf?abstractid=3783484&mirid=1", "source_url": "https://papers.ssrn.com/sol3/Delivery.cfm/SSRN_ID3783484_code4550530.pdf?abstractid=3783484&mirid=1", "doi": "", "pmid": "", "publication_date": "2020-08-13", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3778, "title": "The Yale Manual for Psilocybin-Assisted Therapy of Depression (using Acceptance and Commitment Therapy as a Therapeutic Frame)", "authors": "Guss J, Krause R, Sloshower J.", "journal": "PsyArXiv", "publication_date": "2020-08-12", "publication_year": 2020, "doi": "10.31234/osf.io/u6v9y", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.31234/osf.io/u6v9y", "substance_tags": "psilocybin", "topic_tags": "Depression", "study_type": "Other", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:10:21", "last_checked": "2026-07-01 11:22:03", "bibtex": null, "source_record_id": "DOI:10.31234/osf.io/u6v9y", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://doi.org/10.31234/osf.io/u6v9y", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "DOI:10.31234/osf.io/u6v9y", "source_url": "https://doi.org/10.31234/osf.io/u6v9y", "doi": "10.31234/osf.io/u6v9y", "pmid": "", "publication_date": "2020-08-12", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3276, "title": "The Yale Manual for Psilocybin-Assisted Therapy of Depression (using Acceptance and Commitment Therapy as a Therapeutic Frame)", "authors": "", "journal": "PsyArXiv", "publication_date": "2020-08-12", "publication_year": 2020, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://osf.io/preprints/psyarxiv/u6v9y_v1", "substance_tags": "psilocybin", "topic_tags": "Depression", "study_type": "Other", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:49", "last_checked": "2026-07-01 11:22:30", "bibtex": null, "source_record_id": "https://osf.io/preprints/psyarxiv/u6v9y_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/u6v9y_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "https://osf.io/preprints/psyarxiv/u6v9y_v1", "source_url": "https://osf.io/preprints/psyarxiv/u6v9y_v1", "doi": "", "pmid": "", "publication_date": "2020-08-12", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3842, "title": "4 Psychedelics: therapeutic mechanisms", "authors": "Robin Carhart-Harris", "journal": "Journal of Neurology Neurosurgery & Psychiatry", "publication_date": "2020-07-19", "publication_year": 2020, "doi": "10.1136/jnnp-2020-bnpa.4", "pubmed_id": null, "openalex_id": "https://openalex.org/W3044110502", "source_url": "https://doi.org/10.1136/jnnp-2020-bnpa.4", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging,Pharmacology,Mechanism of Action,Receptor Pharmacology,Aging,Clinical Trial,Treatment-Resistant Depression", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-02 20:42:13", "last_checked": "2026-07-04 07:00:39", "bibtex": null, "source_record_id": "DOI:10.1136/jnnp-2020-bnpa.4", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1136/jnnp-2020-bnpa.4", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1136/jnnp-2020-bnpa.4", "source_url": "https://doi.org/10.1136/jnnp-2020-bnpa.4", "doi": "10.1136/jnnp-2020-bnpa.4", "pmid": "", "publication_date": "2020-07-19", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3404, "title": "A Meta-Analysis of Placebo-Controlled Trials of Psychedelic-Assisted Therapy", "authors": "Luoma JB.", "journal": "PsyArXiv", "publication_date": "2020-06-11", "publication_year": 2020, "doi": "10.31234/osf.io/sgujx", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.31234/osf.io/sgujx", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,End-of-Life Distress,Clinical Trial,Meta-Analysis", "study_type": "Meta-Analysis", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:52", "last_checked": "2026-07-01 11:22:06", "bibtex": null, "source_record_id": "DOI:10.31234/osf.io/sgujx", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://doi.org/10.31234/osf.io/sgujx", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "DOI:10.31234/osf.io/sgujx", "source_url": "https://doi.org/10.31234/osf.io/sgujx", "doi": "10.31234/osf.io/sgujx", "pmid": "", "publication_date": "2020-06-11", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3848, "title": "Journal Digest: Home Environment; Postpartum Mental Illness; Placebo in Psychedelic Study; Single Gene Mutation; Topiramate", "authors": "Nick Zagorski", "journal": "Psychiatric News", "publication_date": "2020-05-27", "publication_year": 2020, "doi": "10.1176/appi.pn.2020.6a34", "pubmed_id": null, "openalex_id": "https://openalex.org/W3033314635", "source_url": "https://doi.org/10.1176/appi.pn.2020.6a34", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Eating Disorders,Brain Imaging,Pharmacology,Consciousness,Aging,Creativity,Case Report,Observational Study,Healthcare Workers,Safety,Adverse Events", "study_type": "Case Report", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-02 20:42:13", "last_checked": "2026-07-04 07:00:39", "bibtex": null, "source_record_id": "DOI:10.1176/appi.pn.2020.6a34", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1176/appi.pn.2020.6a34", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1176/appi.pn.2020.6a34", "source_url": "https://doi.org/10.1176/appi.pn.2020.6a34", "doi": "10.1176/appi.pn.2020.6a34", "pmid": "", "publication_date": "2020-05-27", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 2233, "title": "Me, myself, bye: regional alterations in glutamate and the experience of ego dissolution with psilocybin", "authors": "Natasha L. Mason, Kim P. C. Kuypers, Felix Müller, Johannes T. Reckweg, Desmond H. Y. Tse, Stefan W. Toennes, Nadia R. P. W. Hutten, Jacobus F.A. Jansen, Peter Stiers, Amanda Feilding, Johannes G. Ramaekers", "journal": "Neuropsychopharmacology", "publication_date": "2020-05-22", "publication_year": 2020, "doi": "10.1038/s41386-020-0718-8", "pubmed_id": "32446245", "openalex_id": "https://openalex.org/W3027590463", "source_url": "https://doi.org/10.1038/s41386-020-0718-8", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging,Mechanism of Action,Receptor Pharmacology,Aging,Clinical Trial,Animal Study", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-04 07:00:39", "bibtex": null, "source_record_id": "PMID:32446245", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1038/s41386-020-0718-8", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:32446245", "source_url": "https://doi.org/10.1038/s41386-020-0718-8", "doi": "10.1038/s41386-020-0718-8", "pmid": "32446245", "publication_date": "2020-05-22", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 2243, "title": "Psilocybin: from ancient magic to modern medicine.", "authors": "Nichols DE.", "journal": null, "publication_date": "2020-05-11", "publication_year": 2020, "doi": "10.1038/s41429-020-0311-8", "pubmed_id": "32398764", "openalex_id": null, "source_url": "https://doi.org/10.1038/s41429-020-0311-8", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-01 11:22:03", "bibtex": null, "source_record_id": "PMID:32398764", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1038/s41429-020-0311-8", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:32398764", "source_url": "https://doi.org/10.1038/s41429-020-0311-8", "doi": "10.1038/s41429-020-0311-8", "pmid": "32398764", "publication_date": "2020-05-11", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3854, "title": "Binding Interactions of Psilocin and Serotonin in the 5-HT2A Receptor", "authors": "Katie R. Barnes, Stephanie N. Lewis", "journal": "VTechWorks (Virginia Tech)", "publication_date": "2020-05-04", "publication_year": 2020, "doi": null, "pubmed_id": null, "openalex_id": "https://openalex.org/W3048778283", "source_url": "http://hdl.handle.net/10919/99299", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Mechanism of Action,Receptor Pharmacology,Emotional Processing,Drug Interactions", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-02 20:42:13", "last_checked": "2026-07-04 07:00:39", "bibtex": null, "source_record_id": "http://hdl.handle.net/10919/99299", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://hdl.handle.net/10919/99299", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "http://hdl.handle.net/10919/99299", "source_url": "http://hdl.handle.net/10919/99299", "doi": "", "pmid": "", "publication_date": "2020-05-04", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 2279, "title": "Perceived outcomes of psychedelic microdosing as self-managed therapies for mental and substance use disorders.", "authors": "Lea T, Amada N, Jungaberle H, Schecke H, Scherbaum N, Klein M", "journal": "Psychopharmacology", "publication_date": "2020-04-30", "publication_year": 2020, "doi": "10.1007/s00213-020-05477-0", "pubmed_id": "32043165", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/32043165/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Microdosing,Clinical Trial,Observational Study", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-01 11:20:39", "bibtex": null, "source_record_id": "PMID:32043165", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/32043165/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:32043165", "source_url": "https://pubmed.ncbi.nlm.nih.gov/32043165/", "doi": "10.1007/s00213-020-05477-0", "pmid": "32043165", "publication_date": "2020-04-30", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3451, "title": "Pharmacokinetics of Psilocybin in Normal Adult Volunteers", "authors": "University of Wisconsin, Madison", "journal": "ClinicalTrials.gov", "publication_date": "2020-04-14", "publication_year": 2020, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT02163707", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Pharmacology,Clinical Trial", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT02163707", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT02163707", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT02163707", "source_url": "https://clinicaltrials.gov/study/NCT02163707", "doi": "", "pmid": "", "publication_date": "2020-04-14", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3858, "title": "Psychedelics for Psychiatric Disorders: More Research Needed", "authors": "Nick Zagorski", "journal": "Psychiatric News", "publication_date": "2020-04-12", "publication_year": 2020, "doi": "10.1176/appi.pn.2020.4a14", "pubmed_id": null, "openalex_id": "https://openalex.org/W3017294991", "source_url": "https://doi.org/10.1176/appi.pn.2020.4a14", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Pharmacology,Receptor Pharmacology,Biomarkers,Clinical Trial,Review Article,Cancer Patients", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-02 20:42:13", "last_checked": "2026-07-04 07:00:39", "bibtex": null, "source_record_id": "DOI:10.1176/appi.pn.2020.4a14", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1176/appi.pn.2020.4a14", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1176/appi.pn.2020.4a14", "source_url": "https://doi.org/10.1176/appi.pn.2020.4a14", "doi": "10.1176/appi.pn.2020.4a14", "pmid": "", "publication_date": "2020-04-12", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 2036, "title": "Exposure-Response Analysis to Assess the Concentration-QTc Relationship of Psilocybin/Psilocin", "authors": "Elyes Dahmane, Paul R. Hutson, Jogarao Gobburu", "journal": "Clinical Pharmacology in Drug Development", "publication_date": "2020-04-05", "publication_year": 2020, "doi": "10.1002/cpdd.796", "pubmed_id": "32250059", "openalex_id": "https://openalex.org/W3014341075", "source_url": "https://doi.org/10.1002/cpdd.796", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Pharmacology,Receptor Pharmacology,Clinical Trial", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:52:05", "last_checked": "2026-07-04 07:00:39", "bibtex": null, "source_record_id": "PMID:32250059", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1002/cpdd.796", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:32250059", "source_url": "https://doi.org/10.1002/cpdd.796", "doi": "10.1002/cpdd.796", "pmid": "32250059", "publication_date": "2020-04-05", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3859, "title": "One Dose of Psilocybin in Late Adolescence Mitigates Deleterious Effects of Developmental Stress on Cognition and Behavioral Despair in Adult Female Rats", "authors": "Meghan Hibicke, Charles D. Nichols", "journal": "The FASEB Journal", "publication_date": "2020-03-31", "publication_year": 2020, "doi": "10.1096/fasebj.2020.34.s1.02912", "pubmed_id": null, "openalex_id": "https://openalex.org/W3016993897", "source_url": "https://doi.org/10.1096/fasebj.2020.34.s1.02912", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Receptor Pharmacology,Adolescents", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-02 20:42:13", "last_checked": "2026-07-04 07:00:39", "bibtex": null, "source_record_id": "DOI:10.1096/fasebj.2020.34.s1.02912", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1096/fasebj.2020.34.s1.02912", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1096/fasebj.2020.34.s1.02912", "source_url": "https://doi.org/10.1096/fasebj.2020.34.s1.02912", "doi": "10.1096/fasebj.2020.34.s1.02912", "pmid": "", "publication_date": "2020-03-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 2284, "title": "Psychedelic Psychiatry’s Brave New World", "authors": "David Nutt, David Erritzøe, Robin Carhart-Harris", "journal": "Cell", "publication_date": "2020-03-31", "publication_year": 2020, "doi": "10.1016/j.cell.2020.03.020", "pubmed_id": "32243793", "openalex_id": "https://openalex.org/W3015140823", "source_url": "https://doi.org/10.1016/j.cell.2020.03.020", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Receptor Pharmacology", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-02 20:42:13", "bibtex": null, "source_record_id": "PMID:32243793", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:32243793", "source_url": "https://doi.org/10.1016/j.cell.2020.03.020", "doi": "10.1016/j.cell.2020.03.020", "pmid": "32243793", "publication_date": "2020-03-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 2288, "title": "Depression, Mindfulness, and Psilocybin: Possible Complementary Effects of Mindfulness Meditation and Psilocybin in the Treatment of Depression. A Review.", "authors": "Heuschkel K, Kuypers KPC.", "journal": null, "publication_date": "2020-03-30", "publication_year": 2020, "doi": "10.3389/fpsyt.2020.00224", "pubmed_id": "32296353", "openalex_id": null, "source_url": "https://doi.org/10.3389/fpsyt.2020.00224", "substance_tags": "psilocybin", "topic_tags": "Depression,Neuroplasticity,Mechanism of Action,Biomarkers,Review Article,Immune Function", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-01 11:22:03", "bibtex": null, "source_record_id": "PMID:32296353", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.3389/fpsyt.2020.00224", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:32296353", "source_url": "https://doi.org/10.3389/fpsyt.2020.00224", "doi": "10.3389/fpsyt.2020.00224", "pmid": "32296353", "publication_date": "2020-03-30", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3861, "title": "Long-Term Analysis of Psilocybin in Cancer Patients With Distress", "authors": "Richard Simoneaux", "journal": "Oncology Times", "publication_date": "2020-03-25", "publication_year": 2020, "doi": "10.1097/01.cot.0000660232.19098.7f", "pubmed_id": null, "openalex_id": "https://openalex.org/W3013419105", "source_url": "https://doi.org/10.1097/01.cot.0000660232.19098.7f", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Wellbeing,Spirituality,Mystical Experience,Cancer Patients", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-02 20:42:13", "last_checked": "2026-07-04 07:00:39", "bibtex": null, "source_record_id": "DOI:10.1097/01.cot.0000660232.19098.7f", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1097/01.cot.0000660232.19098.7f", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1097/01.cot.0000660232.19098.7f", "source_url": "https://doi.org/10.1097/01.cot.0000660232.19098.7f", "doi": "10.1097/01.cot.0000660232.19098.7f", "pmid": "", "publication_date": "2020-03-25", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 2271, "title": "Long-term effects of psychedelic drugs: A systematic review.", "authors": "Aday JS, Mitzkovitz CM, Bloesch EK, Davoli CC, Davis AK.", "journal": null, "publication_date": "2020-03-15", "publication_year": 2020, "doi": "10.1016/j.neubiorev.2020.03.017", "pubmed_id": "32194129", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.neubiorev.2020.03.017", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Wellbeing,Personality Change,Emotional Processing,Spirituality,Mystical Experience,Systematic Review,Review Article,Adverse Events", "study_type": "Systematic Review", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-01 11:22:06", "bibtex": null, "source_record_id": "PMID:32194129", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.neubiorev.2020.03.017", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:32194129", "source_url": "https://doi.org/10.1016/j.neubiorev.2020.03.017", "doi": "10.1016/j.neubiorev.2020.03.017", "pmid": "32194129", "publication_date": "2020-03-15", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 2290, "title": "Natural Psychoplastogens As Antidepressant Agents.", "authors": "Benko J, Vranková S.", "journal": null, "publication_date": "2020-03-04", "publication_year": 2020, "doi": "10.3390/molecules25051172", "pubmed_id": "32150976", "openalex_id": null, "source_url": "https://doi.org/10.3390/molecules25051172", "substance_tags": "psilocybin", "topic_tags": "Depression,Pharmacology,Mechanism of Action,Animal Study,Adverse Events", "study_type": "Animal Study", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-01 11:22:06", "bibtex": null, "source_record_id": "PMID:32150976", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.3390/molecules25051172", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:32150976", "source_url": "https://doi.org/10.3390/molecules25051172", "doi": "10.3390/molecules25051172", "pmid": "32150976", "publication_date": "2020-03-04", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 2289, "title": "Psychedelics, but Not Ketamine, Produce Persistent Antidepressant-like Effects in a Rodent Experimental System for the Study of Depression", "authors": "Meghan Hibicke, Alexus N. Landry, Hannah M. Kramer, Zoe K. Talman, Charles D. Nichols", "journal": "ACS Chemical Neuroscience", "publication_date": "2020-03-04", "publication_year": 2020, "doi": "10.1021/acschemneuro.9b00493", "pubmed_id": "32133835", "openalex_id": "https://openalex.org/W3010499243", "source_url": "https://doi.org/10.1021/acschemneuro.9b00493", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Pharmacology,Receptor Pharmacology,Clinical Trial,Animal Study", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-04 07:00:39", "bibtex": null, "source_record_id": "PMID:32133835", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1021/acschemneuro.9b00493", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:32133835", "source_url": "https://doi.org/10.1021/acschemneuro.9b00493", "doi": "10.1021/acschemneuro.9b00493", "pmid": "32133835", "publication_date": "2020-03-04", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 2283, "title": "Psilocybin Therapeutic Research: The Present and Future Paradigm", "authors": "Robert B. Kargbo", "journal": "ACS Medicinal Chemistry Letters", "publication_date": "2020-03-01", "publication_year": 2020, "doi": "10.1021/acsmedchemlett.0c00048", "pubmed_id": "32292538", "openalex_id": "https://openalex.org/W3009264042", "source_url": "https://doi.org/10.1021/acsmedchemlett.0c00048", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Pharmacology,Safety", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-04 07:00:39", "bibtex": null, "source_record_id": "PMID:32292538", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1021/acsmedchemlett.0c00048", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:32292538", "source_url": "https://doi.org/10.1021/acsmedchemlett.0c00048", "doi": "10.1021/acsmedchemlett.0c00048", "pmid": "32292538", "publication_date": "2020-03-01", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 2265, "title": "Scalable Hybrid Synthetic/Biocatalytic Route to Psilocybin", "authors": "Janis Fricke, Robert B. Kargbo, Lars Regestein, Claudius Lenz, Gundela Peschel, Miriam A. Rosenbaum, Alexander M. Sherwood, Dirk Hoffmeister", "journal": "Chemistry - A European Journal", "publication_date": "2020-02-25", "publication_year": 2020, "doi": "10.1002/chem.202000134", "pubmed_id": "32101345", "openalex_id": "https://openalex.org/W3007311584", "source_url": "https://doi.org/10.1002/chem.202000134", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Pharmacology,Clinical Trial,Treatment-Resistant Depression", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-04 07:00:39", "bibtex": null, "source_record_id": "PMID:32101345", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1002/chem.202000134", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:32101345", "source_url": "https://doi.org/10.1002/chem.202000134", "doi": "10.1002/chem.202000134", "pmid": "32101345", "publication_date": "2020-02-25", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 2209, "title": "Psychedelics and Psychedelic-Assisted Psychotherapy.", "authors": "Reiff CM, Richman EE, Nemeroff CB, Carpenter LL, Widge AS, Rodriguez CI, Kalin NH, McDonald WM, the Work Group on Biomarkers and Novel Treatments, a Division of the American Psychiatric Association Council of Research.", "journal": "Diseño interior", "publication_date": "2020-02-25", "publication_year": 2020, "doi": "10.1176/appi.ajp.2019.19010035", "pubmed_id": null, "openalex_id": "https://openalex.org/W32098487", "source_url": "https://doi.org/10.1176/appi.ajp.2019.19010035", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,End-of-Life Distress,Brain Imaging,Aging,Clinical Trial,Review Article,Observational Study,Cancer Patients,Treatment-Resistant Depression", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-04 07:00:41", "bibtex": null, "source_record_id": "DOI:10.1176/appi.ajp.2019.19010035", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1176/appi.ajp.2019.19010035", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "DOI:10.1176/appi.ajp.2019.19010035", "source_url": "https://doi.org/10.1176/appi.ajp.2019.19010035", "doi": "10.1176/appi.ajp.2019.19010035", "pmid": "", "publication_date": "2020-02-25", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 2295, "title": "Self-reported negative outcomes of psilocybin users: A quantitative textual analysis", "authors": "Bheatrix Bienemann, Nina Stamato Ruschel, Maria Luiza Pesse Campos, Marco Aurélio Negreiros, Daniel C. Mograbi", "journal": "PLoS ONE", "publication_date": "2020-02-20", "publication_year": 2020, "doi": "10.1371/journal.pone.0229067", "pubmed_id": "32084160", "openalex_id": "https://openalex.org/W3007379062", "source_url": "https://doi.org/10.1371/journal.pone.0229067", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Treatment-Resistant Depression,Safety,Toxicity", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-04 07:00:39", "bibtex": null, "source_record_id": "PMID:32084160", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1371/journal.pone.0229067", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:32084160", "source_url": "https://doi.org/10.1371/journal.pone.0229067", "doi": "10.1371/journal.pone.0229067", "pmid": "32084160", "publication_date": "2020-02-20", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1083, "title": "Rethinking Therapeutic Strategies for Anorexia Nervosa: Insights From Psychedelic Medicine and Animal Models.", "authors": "Foldi CJ, Liknaitzky P, Williams M, Oldfield BJ.", "journal": null, "publication_date": "2020-02-03", "publication_year": 2020, "doi": "10.3389/fnins.2020.00043", "pubmed_id": "32116500", "openalex_id": null, "source_url": "https://doi.org/10.3389/fnins.2020.00043", "substance_tags": "psilocybin", "topic_tags": "Depression,Eating Disorders,Pharmacology,Mechanism of Action,Clinical Trial,Animal Study,Treatment-Resistant Depression", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:05", "bibtex": null, "source_record_id": "PMID:32116500", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.3389/fnins.2020.00043", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:32116500", "source_url": "https://doi.org/10.3389/fnins.2020.00043", "doi": "10.3389/fnins.2020.00043", "pmid": "32116500", "publication_date": "2020-02-03", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3869, "title": "LSD und Psilocybin als Selbstmedikation", "authors": "", "journal": "Suchttherapie", "publication_date": "2020-01-31", "publication_year": 2020, "doi": "10.1055/a-1085-0309", "pubmed_id": null, "openalex_id": "https://openalex.org/W4255701151", "source_url": "https://doi.org/10.1055/a-1085-0309", "substance_tags": "psilocybin", "topic_tags": "Depression,Receptor Pharmacology,Microdosing", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-02 20:42:13", "last_checked": "2026-07-04 07:00:39", "bibtex": null, "source_record_id": "DOI:10.1055/a-1085-0309", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1055/a-1085-0309", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1055/a-1085-0309", "source_url": "https://doi.org/10.1055/a-1085-0309", "doi": "10.1055/a-1085-0309", "pmid": "", "publication_date": "2020-01-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 2282, "title": "A review of emerging therapeutic potential of psychedelic drugs in the treatment of psychiatric illnesses.", "authors": "Chi T, Gold JA.", "journal": null, "publication_date": "2020-01-30", "publication_year": 2020, "doi": "10.1016/j.jns.2020.116715", "pubmed_id": "32044687", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.jns.2020.116715", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,End-of-Life Distress,Review Article,Treatment-Resistant Depression,Safety", "study_type": "Review Article", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-01 11:22:06", "bibtex": null, "source_record_id": "PMID:32044687", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.jns.2020.116715", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:32044687", "source_url": "https://doi.org/10.1016/j.jns.2020.116715", "doi": "10.1016/j.jns.2020.116715", "pmid": "32044687", "publication_date": "2020-01-30", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3872, "title": "Psychedelic therapy: Fresh promise for mental health", "authors": "Heidi Bush", "journal": "Mental Health Weekly", "publication_date": "2020-01-23", "publication_year": 2020, "doi": "10.1002/mhw.32207", "pubmed_id": null, "openalex_id": "https://openalex.org/W3001867576", "source_url": "https://doi.org/10.1002/mhw.32207", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Pharmacology,Receptor Pharmacology", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-02 20:42:13", "last_checked": "2026-07-04 07:00:39", "bibtex": null, "source_record_id": "DOI:10.1002/mhw.32207", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1002/mhw.32207", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1002/mhw.32207", "source_url": "https://doi.org/10.1002/mhw.32207", "doi": "10.1002/mhw.32207", "pmid": "", "publication_date": "2020-01-23", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 2300, "title": "Therapeutic mechanisms of psilocybin: Changes in amygdala and prefrontal functional connectivity during emotional processing after psilocybin for treatment-resistant depression", "authors": "Lea J. Mertens, Matthew B. Wall, Leor Roseman, Lysia Demetriou, David Nutt, Robin Carhart-Harris", "journal": "Journal of Psychopharmacology", "publication_date": "2020-01-15", "publication_year": 2020, "doi": "10.1177/0269881119895520", "pubmed_id": "31941394", "openalex_id": "https://openalex.org/W3000549374", "source_url": "https://doi.org/10.1177/0269881119895520", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Brain Imaging,Mechanism of Action,Aging,Emotional Processing,Treatment-Resistant Depression,Toxicity,Drug Interactions", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-04 07:00:39", "bibtex": null, "source_record_id": "PMID:31941394", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1177/0269881119895520", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:31941394", "source_url": "https://doi.org/10.1177/0269881119895520", "doi": "10.1177/0269881119895520", "pmid": "31941394", "publication_date": "2020-01-15", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 2302, "title": "Long-term follow-up of psilocybin-assisted psychotherapy for psychiatric and existential distress in patients with life-threatening cancer", "authors": "Gabrielle Agin-Liebes, Tara C. Malone, Matthew M. Yalch, Sarah E. Mennenga, Katherine Ponte, Jeffrey Guss, Anthony P. Bossis, Jim Grigsby, Stacy M. Fischer, Stephen Ross", "journal": "Journal of Psychopharmacology", "publication_date": "2020-01-08", "publication_year": 2020, "doi": "10.1177/0269881119897615", "pubmed_id": "31916890", "openalex_id": "https://openalex.org/W3000636165", "source_url": "https://doi.org/10.1177/0269881119897615", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Chronic Pain,Wellbeing,Emotional Processing,Spirituality,Randomized Controlled Trial,Cancer Patients", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-04 07:00:39", "bibtex": null, "source_record_id": "PMID:31916890", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1177/0269881119897615", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:31916890", "source_url": "https://doi.org/10.1177/0269881119897615", "doi": "10.1177/0269881119897615", "pmid": "31916890", "publication_date": "2020-01-08", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 2301, "title": "The experimental effects of psilocybin on symptoms of anxiety and depression: A meta-analysis.", "authors": "Goldberg SB, Pace BT, Nicholas CR, Raison CL, Hutson PR.", "journal": null, "publication_date": "2020-01-01", "publication_year": 2020, "doi": "10.1016/j.psychres.2020.112749", "pubmed_id": "31931272", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.psychres.2020.112749", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Randomized Controlled Trial,Meta-Analysis,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-01 11:22:03", "bibtex": null, "source_record_id": "PMID:31931272", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.psychres.2020.112749", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:31931272", "source_url": "https://doi.org/10.1016/j.psychres.2020.112749", "doi": "10.1016/j.psychres.2020.112749", "pmid": "31931272", "publication_date": "2020-01-01", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3897, "title": "Is Psilocybin an Effective Treatment to Reduce Depression and Anxiety in Cancer Patients with a Diagnosis of an Anxiety Disorder, Mood Disorder, And/Or Stress Disorder?", "authors": "Brooke Reichenbach", "journal": "Digital Commons - PCOM (Philadelphia College of Osteopathic Medicine)", "publication_date": "2019-12-31", "publication_year": 2019, "doi": null, "pubmed_id": null, "openalex_id": "https://openalex.org/W3137131474", "source_url": "https://digitalcommons.pcom.edu/pa_systematic_reviews/531", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Systematic Review,Review Article,Cancer Patients", "study_type": "Systematic Review", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-02 20:42:13", "last_checked": "2026-07-04 07:00:39", "bibtex": null, "source_record_id": "https://digitalcommons.pcom.edu/pa_systematic_reviews/531", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://digitalcommons.pcom.edu/pa_systematic_reviews/531", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "https://digitalcommons.pcom.edu/pa_systematic_reviews/531", "source_url": "https://digitalcommons.pcom.edu/pa_systematic_reviews/531", "doi": "", "pmid": "", "publication_date": "2019-12-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3893, "title": "Psilocybin and LSD in the Treatment of Depression and Anxiety", "authors": "Marcus Allgulin", "journal": "Diva portal (Dalarna University Library)", "publication_date": "2019-12-31", "publication_year": 2019, "doi": null, "pubmed_id": null, "openalex_id": "https://openalex.org/W3093826296", "source_url": "http://urn.kb.se/resolve?urn=urn:nbn:se:his:diva-18843", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Mechanism of Action,Receptor Pharmacology,Default Mode Network,Consciousness,Mystical Experience,Review Article", "study_type": "Review Article", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-02 20:42:13", "last_checked": "2026-07-04 07:00:39", "bibtex": null, "source_record_id": "http://urn.kb.se/resolve?urn=urn:nbn:se:his:diva-18843", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://urn.kb.se/resolve?urn=urn:nbn:se:his:diva-18843", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "http://urn.kb.se/resolve?urn=urn:nbn:se:his:diva-18843", "source_url": "http://urn.kb.se/resolve?urn=urn:nbn:se:his:diva-18843", "doi": "", "pmid": "", "publication_date": "2019-12-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3892, "title": "Psychedelics: A Window To Mental Illness; Psilocybin And Depression", "authors": "Kiomary Rivera Quintana", "journal": null, "publication_date": "2019-12-31", "publication_year": 2019, "doi": null, "pubmed_id": null, "openalex_id": "https://openalex.org/W3091996077", "source_url": "https://nsuworks.nova.edu/cgi/viewcontent.cgi?article=1000&context=hpd_corx_stuarticles", "substance_tags": "psilocybin", "topic_tags": "Depression", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-02 20:42:13", "last_checked": "2026-07-04 07:00:39", "bibtex": null, "source_record_id": "https://nsuworks.nova.edu/cgi/viewcontent.cgi?article=1000&context=hpd_corx_stuarticles", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "https://nsuworks.nova.edu/cgi/viewcontent.cgi?article=1000&context=hpd_corx_stuarticles", "source_url": "https://nsuworks.nova.edu/cgi/viewcontent.cgi?article=1000&context=hpd_corx_stuarticles", "doi": "", "pmid": "", "publication_date": "2019-12-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3891, "title": "The Therapeutic Potential of Psilocybin and 3,4-Methylenedioxymethamphetamine in the Treatment of Depression and Post-Traumatic Stress Disorder", "authors": "Sofia Gyllvik", "journal": "Diva portal (Dalarna University Library)", "publication_date": "2019-12-31", "publication_year": 2019, "doi": null, "pubmed_id": null, "openalex_id": "https://openalex.org/W3083741926", "source_url": "http://urn.kb.se/resolve?urn=urn:nbn:se:his:diva-18729", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Mechanism of Action,Clinical Trial,Review Article,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-02 20:42:13", "last_checked": "2026-07-04 07:00:39", "bibtex": null, "source_record_id": "http://urn.kb.se/resolve?urn=urn:nbn:se:his:diva-18729", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://urn.kb.se/resolve?urn=urn:nbn:se:his:diva-18729", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "http://urn.kb.se/resolve?urn=urn:nbn:se:his:diva-18729", "source_url": "http://urn.kb.se/resolve?urn=urn:nbn:se:his:diva-18729", "doi": "", "pmid": "", "publication_date": "2019-12-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3889, "title": "Psilocybin's effects on the brain and implications for depression treatment", "authors": "Katariina Sarajärvi", "journal": "Epubl LTU", "publication_date": "2019-12-31", "publication_year": 2019, "doi": null, "pubmed_id": null, "openalex_id": "https://openalex.org/W3046649178", "source_url": "http://urn.kb.se/resolve?urn=urn:nbn:se:ltu:diva-79481", "substance_tags": "psilocybin", "topic_tags": "Depression,Receptor Pharmacology,Consciousness,Wellbeing,Adverse Events", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-02 20:42:13", "last_checked": "2026-07-04 07:00:39", "bibtex": null, "source_record_id": "http://urn.kb.se/resolve?urn=urn:nbn:se:ltu:diva-79481", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://urn.kb.se/resolve?urn=urn:nbn:se:ltu:diva-79481", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "http://urn.kb.se/resolve?urn=urn:nbn:se:ltu:diva-79481", "source_url": "http://urn.kb.se/resolve?urn=urn:nbn:se:ltu:diva-79481", "doi": "", "pmid": "", "publication_date": "2019-12-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3885, "title": "The Efficacy of Psilocybin Compared to Selective Serotonin Reuptake Inhibitors in the Treatment of Adults with Major Depressive Disorder", "authors": "Krista Worden", "journal": null, "publication_date": "2019-12-31", "publication_year": 2019, "doi": null, "pubmed_id": null, "openalex_id": "https://openalex.org/W3021977779", "source_url": "https://scholarworks.arcadia.edu/showcase/2020/pa/60/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Pharmacology,Receptor Pharmacology", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-02 20:42:13", "last_checked": "2026-07-04 07:00:39", "bibtex": null, "source_record_id": "https://scholarworks.arcadia.edu/showcase/2020/pa/60/", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "https://scholarworks.arcadia.edu/showcase/2020/pa/60/", "source_url": "https://scholarworks.arcadia.edu/showcase/2020/pa/60/", "doi": "", "pmid": "", "publication_date": "2019-12-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3884, "title": "Psilocybin may help cancer patients with depression and anxiety for years", "authors": "Laura Sanders", "journal": "Access Science", "publication_date": "2019-12-31", "publication_year": 2019, "doi": null, "pubmed_id": null, "openalex_id": "https://openalex.org/W3005367189", "source_url": "https://www.accessscience.com/content/psilocybin-may-help-cancer-patients-with-depression-and-anxiety-for-years/SN2002031", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Cancer Patients", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-02 20:42:13", "last_checked": "2026-07-04 07:00:39", "bibtex": null, "source_record_id": "https://www.accessscience.com/content/psilocybin-may-help-cancer-patients-with-depression-and-anxiety-for-years/SN2002031", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "https://www.accessscience.com/content/psilocybin-may-help-cancer-patients-with-depression-and-anxiety-for-years/SN2002031", "source_url": "https://www.accessscience.com/content/psilocybin-may-help-cancer-patients-with-depression-and-anxiety-for-years/SN2002031", "doi": "", "pmid": "", "publication_date": "2019-12-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3883, "title": "Development of an improved psilocybin synthesis", "authors": "Reham Shaba", "journal": "Uppsala University Publications (Uppsala University)", "publication_date": "2019-12-31", "publication_year": 2019, "doi": null, "pubmed_id": null, "openalex_id": "https://openalex.org/W3089446948", "source_url": "http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-420295", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Anxiety,Addiction,Clinical Trial,Observational Study", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-02 20:42:13", "last_checked": "2026-07-04 07:00:39", "bibtex": null, "source_record_id": "http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-420295", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-420295", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-420295", "source_url": "http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-420295", "doi": "", "pmid": "", "publication_date": "2019-12-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 2309, "title": "[Psychedelics for existential distress in terminally ill patients].", "authors": "Nina Schimmel, Joost J. Breeksema, Jolien K. E. Veraart, W van den Brink, Robert A. Schoevers", "journal": "PubMed", "publication_date": "2019-12-31", "publication_year": 2019, "doi": null, "pubmed_id": "32816294", "openalex_id": "https://openalex.org/W3080105950", "source_url": "https://pubmed.ncbi.nlm.nih.gov/32816294", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Wellbeing,Spirituality,Mystical Experience", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-04 07:00:39", "bibtex": null, "source_record_id": "PMID:32816294", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/32816294", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:32816294", "source_url": "https://pubmed.ncbi.nlm.nih.gov/32816294", "doi": "", "pmid": "32816294", "publication_date": "2019-12-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 2287, "title": "Psychedelic Microdosing: A Subreddit Analysis.", "authors": "Lea T, Amada N, Jungaberle H", "journal": "Journal of psychoactive drugs", "publication_date": "2019-12-31", "publication_year": 2019, "doi": "10.1080/02791072.2019.1683260", "pubmed_id": "31648596", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/31648596/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Microdosing,Wellbeing,Creativity,Safety,Drug Interactions", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-01 11:20:39", "bibtex": null, "source_record_id": "PMID:31648596", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/31648596/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:31648596", "source_url": "https://pubmed.ncbi.nlm.nih.gov/31648596/", "doi": "10.1080/02791072.2019.1683260", "pmid": "31648596", "publication_date": "2019-12-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3902, "title": "Structure Based Drug Design towards Exploring Potential Anti-Psychotic and Anti-Depressant Activity of Possible Stiff Base of Psilocybin", "authors": "Krishna Kumar Varshney", "journal": "SSRN Electronic Journal", "publication_date": "2019-12-29", "publication_year": 2019, "doi": null, "pubmed_id": null, "openalex_id": "https://openalex.org/W3135591988", "source_url": "https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3528349", "substance_tags": "psilocybin", "topic_tags": "Depression,Pharmacology,Receptor Pharmacology,Toxicity,Drug Interactions", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-02 20:42:13", "last_checked": "2026-07-04 07:00:39", "bibtex": null, "source_record_id": "https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3528349", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3528349", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3528349", "source_url": "https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3528349", "doi": "", "pmid": "", "publication_date": "2019-12-29", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 2291, "title": "The relationship between subjective effects induced by a single dose of ketamine and treatment response in patients with major depressive disorder: A systematic review.", "authors": "Mathai DS, Meyer MJ, Storch EA, Kosten TR.", "journal": null, "publication_date": "2019-12-13", "publication_year": 2019, "doi": "10.1016/j.jad.2019.12.023", "pubmed_id": "32056741", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.jad.2019.12.023", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Consciousness,Systematic Review,Review Article,Healthcare Workers", "study_type": "Systematic Review", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-01 11:22:06", "bibtex": null, "source_record_id": "PMID:32056741", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.jad.2019.12.023", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:32056741", "source_url": "https://doi.org/10.1016/j.jad.2019.12.023", "doi": "10.1016/j.jad.2019.12.023", "pmid": "32056741", "publication_date": "2019-12-13", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3285, "title": "Mapping Psilocybin-Assisted Therapies: A Scoping Review", "authors": "Shore R, Ioudovski P, Goldie C, McKeown S, Dumont E, Queen’s University, Kingston On.", "journal": "medRxiv", "publication_date": "2019-12-11", "publication_year": 2019, "doi": "10.1101/2019.12.04.19013896", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.1101/2019.12.04.19013896", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,OCD,End-of-Life Distress,Headache / Migraine,Clinical Trial,Randomized Controlled Trial,Review Article,Safety", "study_type": "Randomized Controlled Trial", "source_name": "medRxiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:49", "last_checked": "2026-07-01 11:22:03", "bibtex": null, "source_record_id": "DOI:10.1101/2019.12.04.19013896", "abstract_available": true, "abstract_source": "medRxiv", "abstract_source_url": "https://doi.org/10.1101/2019.12.04.19013896", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "medRxiv", "source_record_id": "DOI:10.1101/2019.12.04.19013896", "source_url": "https://doi.org/10.1101/2019.12.04.19013896", "doi": "10.1101/2019.12.04.19013896", "pmid": "", "publication_date": "2019-12-11", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 2362, "title": "[Neurotrophic mechanisms of psychedelic therapy].", "authors": "Corne R, Mongeau R.", "journal": null, "publication_date": "2019-12-11", "publication_year": 2019, "doi": "10.1051/jbio/2019015", "pubmed_id": "31829932", "openalex_id": null, "source_url": "https://doi.org/10.1051/jbio/2019015", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Addiction,Mechanism of Action,Receptor Pharmacology,Aging,Review Article,Toxicity", "study_type": "Review Article", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-01 11:22:06", "bibtex": null, "source_record_id": "PMID:31829932", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1051/jbio/2019015", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:31829932", "source_url": "https://doi.org/10.1051/jbio/2019015", "doi": "10.1051/jbio/2019015", "pmid": "31829932", "publication_date": "2019-12-11", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 2313, "title": "Therapeutic use of serotoninergic hallucinogens: A review of the evidence and of the biological and psychological mechanisms.", "authors": "Dos Santos RG, Hallak JEC.", "journal": null, "publication_date": "2019-12-02", "publication_year": 2019, "doi": "10.1016/j.neubiorev.2019.12.001", "pubmed_id": "31809772", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.neubiorev.2019.12.001", "substance_tags": "psilocybin", "topic_tags": "Depression,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Personality Change,Emotional Processing,Review Article", "study_type": "Review Article", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-01 11:22:06", "bibtex": null, "source_record_id": "PMID:31809772", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.neubiorev.2019.12.001", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:31809772", "source_url": "https://doi.org/10.1016/j.neubiorev.2019.12.001", "doi": "10.1016/j.neubiorev.2019.12.001", "pmid": "31809772", "publication_date": "2019-12-02", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3905, "title": "P.609 Therapeutic mechanisms of psychedelic drugs: Changes in amygdala and prefrontal functional connectivity during emotional processing after psilocybin for treatment-resistant depression", "authors": "Laura Mertens, M.B. Wall, L. Roseman, L. Demetriou, D.J. Nutt, R.L. Carhart-Harris", "journal": "European Neuropsychopharmacology", "publication_date": "2019-11-30", "publication_year": 2019, "doi": "10.1016/j.euroneuro.2019.09.593", "pubmed_id": null, "openalex_id": "https://openalex.org/W4248055189", "source_url": "https://doi.org/10.1016/j.euroneuro.2019.09.593", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Emotional Processing,Clinical Trial,Treatment-Resistant Depression", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-02 20:42:13", "last_checked": "2026-07-04 07:00:39", "bibtex": null, "source_record_id": "DOI:10.1016/j.euroneuro.2019.09.593", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.euroneuro.2019.09.593", "source_url": "https://doi.org/10.1016/j.euroneuro.2019.09.593", "doi": "10.1016/j.euroneuro.2019.09.593", "pmid": "", "publication_date": "2019-11-30", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 2318, "title": "Twenty percent better with 20 micrograms? A qualitative study of psychedelic microdosing self-rapports and discussions on YouTube", "authors": "Martin Andersson, Anette Kjellgren", "journal": "Harm Reduction Journal", "publication_date": "2019-11-27", "publication_year": 2019, "doi": "10.1186/s12954-019-0333-3", "pubmed_id": "31779667", "openalex_id": "https://openalex.org/W2991503240", "source_url": "https://doi.org/10.1186/s12954-019-0333-3", "substance_tags": "psilocybin", "topic_tags": "Depression,Pharmacology,Receptor Pharmacology,Microdosing,Emotional Processing,Safety,Toxicity,Drug Interactions", "study_type": "Qualitative Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-04 07:00:39", "bibtex": null, "source_record_id": "PMID:31779667", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1186/s12954-019-0333-3", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:31779667", "source_url": "https://doi.org/10.1186/s12954-019-0333-3", "doi": "10.1186/s12954-019-0333-3", "pmid": "31779667", "publication_date": "2019-11-27", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 2292, "title": "Psilocybin-assisted therapy for depression: How do we advance the field?", "authors": "Sally Meikle, Paul Liknaitzky, Susan L. Rossell, Margaret Ross, Nigel Strauss, Neil Thomas, Greg Murray, M.L. Williams, David Castle", "journal": "Australian & New Zealand Journal of Psychiatry", "publication_date": "2019-11-21", "publication_year": 2019, "doi": "10.1177/0004867419888575", "pubmed_id": "31752499", "openalex_id": "https://openalex.org/W2989680519", "source_url": "https://doi.org/10.1177/0004867419888575", "substance_tags": "psilocybin", "topic_tags": "Depression,Pharmacology,Mechanism of Action,Receptor Pharmacology,Adverse Events", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-04 07:00:39", "bibtex": null, "source_record_id": "PMID:31752499", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1177/0004867419888575", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:31752499", "source_url": "https://doi.org/10.1177/0004867419888575", "doi": "10.1177/0004867419888575", "pmid": "31752499", "publication_date": "2019-11-21", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3913, "title": "Psilocybin-assisted therapy of major depressive disorder using Acceptance and Commitment Therapy as a therapeutic frame", "authors": "Jordan Sloshower, Jeffrey Guss, Robert Krause, Ryan Wallace, Monnica T. Williams, Sara Reed, Matthew D. Skinta", "journal": "Journal of Contextual Behavioral Science", "publication_date": "2019-11-04", "publication_year": 2019, "doi": "10.1016/j.jcbs.2019.11.002", "pubmed_id": null, "openalex_id": "https://openalex.org/W2984820573", "source_url": "https://doi.org/10.1016/j.jcbs.2019.11.002", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Receptor Pharmacology", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-02 20:42:13", "last_checked": "2026-07-04 07:00:39", "bibtex": null, "source_record_id": "DOI:10.1016/j.jcbs.2019.11.002", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.jcbs.2019.11.002", "source_url": "https://doi.org/10.1016/j.jcbs.2019.11.002", "doi": "10.1016/j.jcbs.2019.11.002", "pmid": "", "publication_date": "2019-11-04", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3915, "title": "Johns Hopkins Opens Research Center on Psychedelics", "authors": "Nick Zagorski", "journal": "Psychiatric News", "publication_date": "2019-10-27", "publication_year": 2019, "doi": "10.1176/appi.pn.2019.10a16", "pubmed_id": null, "openalex_id": "https://openalex.org/W2982427347", "source_url": "https://doi.org/10.1176/appi.pn.2019.10a16", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Eating Disorders,Consciousness,Biomarkers,Clinical Trial,Healthcare Workers,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-02 20:42:13", "last_checked": "2026-07-04 07:00:39", "bibtex": null, "source_record_id": "DOI:10.1176/appi.pn.2019.10a16", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1176/appi.pn.2019.10a16", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1176/appi.pn.2019.10a16", "source_url": "https://doi.org/10.1176/appi.pn.2019.10a16", "doi": "10.1176/appi.pn.2019.10a16", "pmid": "", "publication_date": "2019-10-27", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 2322, "title": "Serotonergic hallucinogens/psychedelics could be promising treatments for depressive and anxiety disorders in end-stage cancer.", "authors": "Dos Santos RG, Bouso JC, Hallak JEC.", "journal": null, "publication_date": "2019-10-27", "publication_year": 2019, "doi": "10.1186/s12888-019-2288-z", "pubmed_id": "31660905", "openalex_id": null, "source_url": "https://doi.org/10.1186/s12888-019-2288-z", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Spirituality,Clinical Trial,Review Article,Cancer Patients", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-01 11:22:06", "bibtex": null, "source_record_id": "PMID:31660905", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1186/s12888-019-2288-z", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:31660905", "source_url": "https://doi.org/10.1186/s12888-019-2288-z", "doi": "10.1186/s12888-019-2288-z", "pmid": "31660905", "publication_date": "2019-10-27", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3917, "title": "Psilocybin for Depression in People With Mild Cognitive Impairment or Early Alzheimer's Disease", "authors": "Kernel Networks Inc.", "journal": "Case Medical Research", "publication_date": "2019-10-09", "publication_year": 2019, "doi": "10.31525/ct1-nct04123314", "pubmed_id": null, "openalex_id": "https://openalex.org/W4247147096", "source_url": "https://doi.org/10.31525/ct1-nct04123314", "substance_tags": "psilocybin", "topic_tags": "Depression", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-02 20:42:13", "last_checked": "2026-07-04 07:00:39", "bibtex": null, "source_record_id": "DOI:10.31525/ct1-nct04123314", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.31525/ct1-nct04123314", "source_url": "https://doi.org/10.31525/ct1-nct04123314", "doi": "10.31525/ct1-nct04123314", "pmid": "", "publication_date": "2019-10-09", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3918, "title": "Modified E. coli pump out psilocybin", "authors": "Megha Satyanarayana", "journal": "C&EN Global Enterprise", "publication_date": "2019-10-06", "publication_year": 2019, "doi": "10.1021/cen-09739-scicon9", "pubmed_id": null, "openalex_id": "https://openalex.org/W2981873322", "source_url": "https://doi.org/10.1021/cen-09739-scicon9", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Pharmacology,Mechanism of Action,Clinical Trial", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-02 20:42:13", "last_checked": "2026-07-04 07:00:39", "bibtex": null, "source_record_id": "DOI:10.1021/cen-09739-scicon9", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1021/cen-09739-scicon9", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1021/cen-09739-scicon9", "source_url": "https://doi.org/10.1021/cen-09739-scicon9", "doi": "10.1021/cen-09739-scicon9", "pmid": "", "publication_date": "2019-10-06", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 1633, "title": "The psychedelic renaissance: the next trip for psychiatry?", "authors": "Kelly JR, Baker A, Babiker M, Burke L, Brennan C, O'Keane V.", "journal": null, "publication_date": "2019-09-22", "publication_year": 2019, "doi": "10.1017/ipm.2019.39", "pubmed_id": "31543078", "openalex_id": null, "source_url": "https://doi.org/10.1017/ipm.2019.39", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Neuroplasticity,Default Mode Network,Randomized Controlled Trial,Treatment-Resistant Depression", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:05", "bibtex": null, "source_record_id": "PMID:31543078", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1017/ipm.2019.39", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:31543078", "source_url": "https://doi.org/10.1017/ipm.2019.39", "doi": "10.1017/ipm.2019.39", "pmid": "31543078", "publication_date": "2019-09-22", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3920, "title": "Psilocybin for depression: Considerations for clinical trial design", "authors": "Kelley C. O’Donnell, Sarah E. Mennenga, Michael P. Bogenschutz", "journal": "Journal of Psychedelic Studies", "publication_date": "2019-08-31", "publication_year": 2019, "doi": "10.1556/2054.2019.026", "pubmed_id": null, "openalex_id": "https://openalex.org/W2974814938", "source_url": "https://doi.org/10.1556/2054.2019.026", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Receptor Pharmacology,Clinical Trial,Review Article,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-02 20:42:13", "last_checked": "2026-07-04 07:00:39", "bibtex": null, "source_record_id": "DOI:10.1556/2054.2019.026", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1556/2054.2019.026", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1556/2054.2019.026", "source_url": "https://doi.org/10.1556/2054.2019.026", "doi": "10.1556/2054.2019.026", "pmid": "", "publication_date": "2019-08-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3287, "title": "Psilocybin exerts distinct effects on resting state networks associated with serotonin and dopamine in mice", "authors": "Grandjean J, Buehlmann D, Buerge M, Sigrist H, Seifritz E, Vollenweider FX, Pryce CR, Rudin M.", "journal": "bioRxiv", "publication_date": "2019-08-31", "publication_year": 2019, "doi": "10.1101/751255", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.1101/751255", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging,Mechanism of Action,Receptor Pharmacology,Default Mode Network,Animal Study,Drug Interactions", "study_type": "Animal Study", "source_name": "bioRxiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:49", "last_checked": "2026-07-01 11:22:03", "bibtex": null, "source_record_id": "DOI:10.1101/751255", "abstract_available": true, "abstract_source": "bioRxiv", "abstract_source_url": "https://doi.org/10.1101/751255", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "bioRxiv", "source_record_id": "DOI:10.1101/751255", "source_url": "https://doi.org/10.1101/751255", "doi": "10.1101/751255", "pmid": "", "publication_date": "2019-08-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 2330, "title": "Hallucinogens and Their Therapeutic Use: A Literature Review.", "authors": "Begola MJ, Schillerstrom JE.", "journal": null, "publication_date": "2019-08-31", "publication_year": 2019, "doi": "10.1097/pra.0000000000000409", "pubmed_id": "31505518", "openalex_id": null, "source_url": "https://doi.org/10.1097/pra.0000000000000409", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Review Article,Safety", "study_type": "Review Article", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-01 11:22:06", "bibtex": null, "source_record_id": "PMID:31505518", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1097/pra.0000000000000409", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:31505518", "source_url": "https://doi.org/10.1097/pra.0000000000000409", "doi": "10.1097/pra.0000000000000409", "pmid": "31505518", "publication_date": "2019-08-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3923, "title": "Beyond Cannabis: Psychedelic Decriminalization and Social Justice", "authors": "Dustin Marlan", "journal": "eYLS (Yale Law School)", "publication_date": "2019-08-14", "publication_year": 2019, "doi": null, "pubmed_id": null, "openalex_id": "https://openalex.org/W2969663209", "source_url": "https://lawcommons.lclark.edu/lclr/vol23/iss3/4", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Consciousness,Wellbeing", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-02 20:42:13", "last_checked": "2026-07-04 07:00:39", "bibtex": null, "source_record_id": "https://lawcommons.lclark.edu/lclr/vol23/iss3/4", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://lawcommons.lclark.edu/lclr/vol23/iss3/4", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "https://lawcommons.lclark.edu/lclr/vol23/iss3/4", "source_url": "https://lawcommons.lclark.edu/lclr/vol23/iss3/4", "doi": "", "pmid": "", "publication_date": "2019-08-14", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 2320, "title": "Classical psychedelics for the treatment of depression and anxiety: A systematic review.", "authors": "Muttoni S, Ardissino M, John C.", "journal": null, "publication_date": "2019-07-29", "publication_year": 2019, "doi": "10.1016/j.jad.2019.07.076", "pubmed_id": "31382100", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.jad.2019.07.076", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Headache / Migraine,Clinical Trial,Systematic Review,Review Article,Safety", "study_type": "Systematic Review", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-01 11:22:06", "bibtex": null, "source_record_id": "PMID:31382100", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.jad.2019.07.076", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:31382100", "source_url": "https://doi.org/10.1016/j.jad.2019.07.076", "doi": "10.1016/j.jad.2019.07.076", "pmid": "31382100", "publication_date": "2019-07-29", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 2363, "title": "Psychedelic drugs-a new era in psychiatry?", "authors": "David Nutt", "journal": "Dialogues in Clinical Neuroscience", "publication_date": "2019-06-29", "publication_year": 2019, "doi": "10.31887/dcns.2019.21.2/dnutt", "pubmed_id": "31636488", "openalex_id": "https://openalex.org/W2985843276", "source_url": "https://doi.org/10.31887/dcns.2019.21.2/dnutt", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Receptor Pharmacology,Treatment-Resistant Depression,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-04 07:00:39", "bibtex": null, "source_record_id": "PMID:31636488", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.31887/dcns.2019.21.2/dnutt", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:31636488", "source_url": "https://doi.org/10.31887/dcns.2019.21.2/dnutt", "doi": "10.31887/dcns.2019.21.2/dnutt", "pmid": "31636488", "publication_date": "2019-06-29", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3926, "title": "The Potential of Psilocybin Administration in Terminal Cancer Patients", "authors": "Richard Simoneaux", "journal": "Oncology Times", "publication_date": "2019-06-27", "publication_year": 2019, "doi": "10.1097/01.cot.0000574916.46844.cf", "pubmed_id": null, "openalex_id": "https://openalex.org/W2956046898", "source_url": "https://doi.org/10.1097/01.cot.0000574916.46844.cf", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Anxiety,Addiction,End-of-Life Distress,Chronic Pain,Pharmacology,Receptor Pharmacology,Consciousness,Clinical Trial,Cancer Patients,Treatment-Resistant Depression,Healthcare Workers,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-02 20:42:13", "last_checked": "2026-07-04 07:00:39", "bibtex": null, "source_record_id": "DOI:10.1097/01.cot.0000574916.46844.cf", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1097/01.cot.0000574916.46844.cf", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1097/01.cot.0000574916.46844.cf", "source_url": "https://doi.org/10.1097/01.cot.0000574916.46844.cf", "doi": "10.1097/01.cot.0000574916.46844.cf", "pmid": "", "publication_date": "2019-06-27", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 2319, "title": "Enzymatic Route toward 6-Methylated Baeocystin and Psilocybin", "authors": "Janis Fricke, Alexander M. Sherwood, Robert B. Kargbo, Andrew Orry, Felix Blei, Andreas Naschberger, Bernhard Rupp, Dirk Hoffmeister", "journal": "ChemBioChem", "publication_date": "2019-05-30", "publication_year": 2019, "doi": "10.1002/cbic.201900358", "pubmed_id": "31150155", "openalex_id": "https://openalex.org/W2948005519", "source_url": "https://doi.org/10.1002/cbic.201900358", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Pharmacology,Epigenetics,Clinical Trial", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-04 07:00:39", "bibtex": null, "source_record_id": "PMID:31150155", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1002/cbic.201900358", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:31150155", "source_url": "https://doi.org/10.1002/cbic.201900358", "doi": "10.1002/cbic.201900358", "pmid": "31150155", "publication_date": "2019-05-30", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 2334, "title": "Psilocybin lacks antidepressant-like effect in the Flinders Sensitive Line rat", "authors": "Oskar Hougaard Jefsen, Kristoffer Højgaard, Sofie Laage Christiansen, Betina Elfving, David Nutt, Gregers Wegener, Heidi Kaastrup Müller", "journal": "Acta Neuropsychiatrica", "publication_date": "2019-05-19", "publication_year": 2019, "doi": "10.1017/neu.2019.15", "pubmed_id": "31106729", "openalex_id": "https://openalex.org/W2945318261", "source_url": "https://doi.org/10.1017/neu.2019.15", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Pharmacology,Receptor Pharmacology,Animal Study,Treatment-Resistant Depression,Toxicity", "study_type": "Animal Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-04 07:00:39", "bibtex": null, "source_record_id": "PMID:31106729", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1017/neu.2019.15", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:31106729", "source_url": "https://doi.org/10.1017/neu.2019.15", "doi": "10.1017/neu.2019.15", "pmid": "31106729", "publication_date": "2019-05-19", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3935, "title": "T137. Psilocybin-Assisted Group Therapy for Demoralization in Long-Term AIDS Survivors", "authors": "B. Anderson, Alicia Danforth, Robert B. Daroff, Christopher S. Stauffer, James Dilley, Jennifer Mitchell, Joshua Woolley", "journal": "Biological Psychiatry", "publication_date": "2019-04-30", "publication_year": 2019, "doi": "10.1016/j.biopsych.2019.03.460", "pubmed_id": null, "openalex_id": "https://openalex.org/W2946285292", "source_url": "https://doi.org/10.1016/j.biopsych.2019.03.460", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-02 20:42:13", "last_checked": "2026-07-04 07:00:39", "bibtex": null, "source_record_id": "DOI:10.1016/j.biopsych.2019.03.460", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.biopsych.2019.03.460", "source_url": "https://doi.org/10.1016/j.biopsych.2019.03.460", "doi": "10.1016/j.biopsych.2019.03.460", "pmid": "", "publication_date": "2019-04-30", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 2348, "title": "Serotonergic hallucinogens and recognition of facial emotion expressions: a systematic review of the literature.", "authors": "Rocha JM, Osório FL, Crippa JAS, Bouso JC, Rossi GN, Hallak JEC, Dos Santos RG.", "journal": null, "publication_date": "2019-04-25", "publication_year": 2019, "doi": "10.1177/2045125319845774", "pubmed_id": "31065350", "openalex_id": null, "source_url": "https://doi.org/10.1177/2045125319845774", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Emotional Processing,Systematic Review,Review Article", "study_type": "Systematic Review", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-01 11:22:05", "bibtex": null, "source_record_id": "PMID:31065350", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1177/2045125319845774", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:31065350", "source_url": "https://doi.org/10.1177/2045125319845774", "doi": "10.1177/2045125319845774", "pmid": "31065350", "publication_date": "2019-04-25", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 2987, "title": "Rapid-acting antidepressants.", "authors": "Witkin JM, Martin AE, Golani LK, Xu NZ, Smith JL.", "journal": null, "publication_date": "2019-04-23", "publication_year": 2019, "doi": "10.1016/bs.apha.2019.03.002", "pubmed_id": "31378256", "openalex_id": null, "source_url": "https://doi.org/10.1016/bs.apha.2019.03.002", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Receptor Pharmacology,Animal Study,Adverse Events", "study_type": "Animal Study", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 07:01:03", "last_checked": "2026-07-01 11:22:06", "bibtex": null, "source_record_id": "PMID:31378256", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/bs.apha.2019.03.002", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:31378256", "source_url": "https://doi.org/10.1016/bs.apha.2019.03.002", "doi": "10.1016/bs.apha.2019.03.002", "pmid": "31378256", "publication_date": "2019-04-23", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3938, "title": "Attitudes Toward Medical Psychedelics", "authors": "McKenna Silva", "journal": "Dominican Scholar (Dominican University of California)", "publication_date": "2019-04-17", "publication_year": 2019, "doi": null, "pubmed_id": null, "openalex_id": "https://openalex.org/W2936920827", "source_url": "https://scholar.dominican.edu/scw/SCW2019/conference-presentations-exhibits-and-performances/83", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Receptor Pharmacology,Wellbeing,Spirituality,Observational Study", "study_type": "Observational Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-02 20:42:13", "last_checked": "2026-07-04 07:00:39", "bibtex": null, "source_record_id": "https://scholar.dominican.edu/scw/SCW2019/conference-presentations-exhibits-and-performances/83", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://scholar.dominican.edu/scw/SCW2019/conference-presentations-exhibits-and-performances/83", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "https://scholar.dominican.edu/scw/SCW2019/conference-presentations-exhibits-and-performances/83", "source_url": "https://scholar.dominican.edu/scw/SCW2019/conference-presentations-exhibits-and-performances/83", "doi": "", "pmid": "", "publication_date": "2019-04-17", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3940, "title": "Psychedelics Improve the Mental Health of Rats", "authors": "Meghan Hibicke, Alexus N. Landry, Zoe K. Talman, Charles D. Nichols", "journal": "The FASEB Journal", "publication_date": "2019-03-31", "publication_year": 2019, "doi": "10.1096/fasebj.2019.33.1_supplement.666.1", "pubmed_id": null, "openalex_id": "https://openalex.org/W3175025894", "source_url": "https://doi.org/10.1096/fasebj.2019.33.1_supplement.666.1", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Pharmacology,Receptor Pharmacology,Clinical Trial,Animal Study", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-02 20:42:13", "last_checked": "2026-07-04 07:00:39", "bibtex": null, "source_record_id": "DOI:10.1096/fasebj.2019.33.1_supplement.666.1", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1096/fasebj.2019.33.1_supplement.666.1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1096/fasebj.2019.33.1_supplement.666.1", "source_url": "https://doi.org/10.1096/fasebj.2019.33.1_supplement.666.1", "doi": "10.1096/fasebj.2019.33.1_supplement.666.1", "pmid": "", "publication_date": "2019-03-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 2351, "title": "The Past and Future of Psychedelic Science: An Introduction to This Issue", "authors": "Richard Doblin, Merete Bruun Christiansen, Lisa Jerome, Brad Burge", "journal": "Journal of Psychoactive Drugs", "publication_date": "2019-03-14", "publication_year": 2019, "doi": "10.1080/02791072.2019.1606472", "pubmed_id": "31132970", "openalex_id": "https://openalex.org/W2947995541", "source_url": "https://doi.org/10.1080/02791072.2019.1606472", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Receptor Pharmacology,Creativity,Spirituality,Mystical Experience,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-04 07:00:39", "bibtex": null, "source_record_id": "PMID:31132970", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1080/02791072.2019.1606472", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:31132970", "source_url": "https://doi.org/10.1080/02791072.2019.1606472", "doi": "10.1080/02791072.2019.1606472", "pmid": "31132970", "publication_date": "2019-03-14", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3942, "title": "A Study of Psilocybin for Major Depressive Disorder (MDD)", "authors": "Kernel Networks Inc.", "journal": "Case Medical Research", "publication_date": "2019-03-06", "publication_year": 2019, "doi": "10.31525/ct1-nct03866174", "pubmed_id": null, "openalex_id": "https://openalex.org/W4235066019", "source_url": "https://doi.org/10.31525/ct1-nct03866174", "substance_tags": "psilocybin", "topic_tags": "Depression", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-02 20:42:13", "last_checked": "2026-07-04 07:00:39", "bibtex": null, "source_record_id": "DOI:10.31525/ct1-nct03866174", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.31525/ct1-nct03866174", "source_url": "https://doi.org/10.31525/ct1-nct03866174", "doi": "10.31525/ct1-nct03866174", "pmid": "", "publication_date": "2019-03-06", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3943, "title": "Is Psychedelic Medicine on the Horizon?", "authors": "Nick Zagorski", "journal": "Psychiatric News", "publication_date": "2019-02-27", "publication_year": 2019, "doi": "10.1176/appi.pn.2019.1b1", "pubmed_id": null, "openalex_id": "https://openalex.org/W2918650357", "source_url": "https://doi.org/10.1176/appi.pn.2019.1b1", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,End-of-Life Distress,Consciousness,Review Article,Case Report,Observational Study,Cancer Patients,Treatment-Resistant Depression,Safety", "study_type": "Review Article", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-02 20:42:13", "last_checked": "2026-07-04 07:00:39", "bibtex": null, "source_record_id": "DOI:10.1176/appi.pn.2019.1b1", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1176/appi.pn.2019.1b1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1176/appi.pn.2019.1b1", "source_url": "https://doi.org/10.1176/appi.pn.2019.1b1", "doi": "10.1176/appi.pn.2019.1b1", "pmid": "", "publication_date": "2019-02-27", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 2354, "title": "Sub-Acute Effects of Psilocybin on Empathy, Creative Thinking, and Subjective Well-Being", "authors": "Natasha L. Mason, Elisabeth Mischler, Malin V. Uthaug, Kim P. C. Kuypers", "journal": "Journal of Psychoactive Drugs", "publication_date": "2019-02-25", "publication_year": 2019, "doi": "10.1080/02791072.2019.1580804", "pubmed_id": "30905276", "openalex_id": "https://openalex.org/W2917218353", "source_url": "https://doi.org/10.1080/02791072.2019.1580804", "substance_tags": "psilocybin", "topic_tags": "Depression,Wellbeing,Emotional Processing,Creativity,Drug Interactions", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-04 07:00:39", "bibtex": null, "source_record_id": "PMID:30905276", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1080/02791072.2019.1580804", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:30905276", "source_url": "https://doi.org/10.1080/02791072.2019.1580804", "doi": "10.1080/02791072.2019.1580804", "pmid": "30905276", "publication_date": "2019-02-25", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 2344, "title": "Effects of acute and repeated treatment with serotonin 5-HT2A receptor agonist hallucinogens on intracranial self-stimulation in rats.", "authors": "Farhana Sakloth, Elizabeth Leggett, Megan J. Moerke, E. Andrew Townsend, Matthew L. Banks, S. Stevens Negus", "journal": "Experimental and Clinical Psychopharmacology", "publication_date": "2019-01-09", "publication_year": 2019, "doi": "10.1037/pha0000253", "pubmed_id": "30628811", "openalex_id": "https://openalex.org/W2909121609", "source_url": "https://doi.org/10.1037/pha0000253", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Pharmacology,Receptor Pharmacology,Microdosing,Animal Study", "study_type": "Animal Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-04 07:00:39", "bibtex": null, "source_record_id": "PMID:30628811", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1037/pha0000253", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:30628811", "source_url": "https://doi.org/10.1037/pha0000253", "doi": "10.1037/pha0000253", "pmid": "30628811", "publication_date": "2019-01-09", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 2343, "title": "Pharmacological interventions targeting anhedonia in patients with major depressive disorder: A systematic review.", "authors": "Cao B, Zhu J, Zuckerman H, Rosenblat JD, Brietzke E, Pan Z, Subramanieapillai M, Park C, Lee Y, McIntyre RS.", "journal": null, "publication_date": "2019-01-02", "publication_year": 2019, "doi": "10.1016/j.pnpbp.2019.01.002", "pubmed_id": "30611836", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.pnpbp.2019.01.002", "substance_tags": "psilocybin", "topic_tags": "Depression,Systematic Review,Review Article", "study_type": "Systematic Review", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-01 11:22:06", "bibtex": null, "source_record_id": "PMID:30611836", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.pnpbp.2019.01.002", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:30611836", "source_url": "https://doi.org/10.1016/j.pnpbp.2019.01.002", "doi": "10.1016/j.pnpbp.2019.01.002", "pmid": "30611836", "publication_date": "2019-01-02", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3732, "title": "Microdosing psychedelics: personality, mental health, and creativity differences in microdosers.", "authors": "Anderson T, Petranker R, Rosenbaum D, Weissman CR, Dinh-Williams LA, Hui K, Hapke E, Farb NAS.", "journal": null, "publication_date": "2019-01-01", "publication_year": 2019, "doi": "10.1007/s00213-018-5106-2", "pubmed_id": "30604183", "openalex_id": null, "source_url": "https://doi.org/10.1007/s00213-018-5106-2", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Microdosing,Wellbeing,Personality Change,Emotional Processing,Creativity,Observational Study,Safety", "study_type": "Observational Study", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 11:08:44", "last_checked": "2026-07-01 11:22:06", "bibtex": null, "source_record_id": "PMID:30604183", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1007/s00213-018-5106-2", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:30604183", "source_url": "https://doi.org/10.1007/s00213-018-5106-2", "doi": "10.1007/s00213-018-5106-2", "pmid": "30604183", "publication_date": "2019-01-01", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3958, "title": "THE POTENTIAL THERAPEUTIC VALUE OF PSILOCYBIN: In Relation to Depression", "authors": "Isabella Stendahl", "journal": "Diva portal (Dalarna University Library)", "publication_date": "2018-12-31", "publication_year": 2018, "doi": null, "pubmed_id": null, "openalex_id": "https://openalex.org/W3045370936", "source_url": "http://urn.kb.se/resolve?urn=urn:nbn:se:his:diva-17749", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,OCD,Headache / Migraine,Brain Imaging,Mechanism of Action,Aging,Emotional Processing,Creativity", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-02 20:42:13", "last_checked": "2026-07-04 07:00:39", "bibtex": null, "source_record_id": "http://urn.kb.se/resolve?urn=urn:nbn:se:his:diva-17749", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://urn.kb.se/resolve?urn=urn:nbn:se:his:diva-17749", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "http://urn.kb.se/resolve?urn=urn:nbn:se:his:diva-17749", "source_url": "http://urn.kb.se/resolve?urn=urn:nbn:se:his:diva-17749", "doi": "", "pmid": "", "publication_date": "2018-12-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3957, "title": "Serotonergic Psychoactive Compounds as a Treatment for Addiction, Anxiety, and Depression: Their Efficacy and Legality", "authors": "William G. Crane", "journal": "Furman University Scholar Exchange (Furman University)", "publication_date": "2018-12-31", "publication_year": 2018, "doi": null, "pubmed_id": null, "openalex_id": "https://openalex.org/W3005336267", "source_url": "https://scholarexchange.furman.edu/furmanengaged/2019/all/522", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Receptor Pharmacology", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-02 20:42:13", "last_checked": "2026-07-04 07:00:39", "bibtex": null, "source_record_id": "https://scholarexchange.furman.edu/furmanengaged/2019/all/522", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://scholarexchange.furman.edu/furmanengaged/2019/all/522", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "https://scholarexchange.furman.edu/furmanengaged/2019/all/522", "source_url": "https://scholarexchange.furman.edu/furmanengaged/2019/all/522", "doi": "", "pmid": "", "publication_date": "2018-12-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3952, "title": "Psilocybin induces aberrant prediction error processing for tactile mismatch responses", "authors": "P. Dürler", "journal": "European Neuropsychopharmacology", "publication_date": "2018-12-31", "publication_year": 2018, "doi": "10.1016/j.euroneuro.2018.11.477", "pubmed_id": null, "openalex_id": "https://openalex.org/W2912928498", "source_url": "https://doi.org/10.1016/j.euroneuro.2018.11.477", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Receptor Pharmacology", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-02 20:42:13", "last_checked": "2026-07-04 07:00:39", "bibtex": null, "source_record_id": "DOI:10.1016/j.euroneuro.2018.11.477", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.euroneuro.2018.11.477", "source_url": "https://doi.org/10.1016/j.euroneuro.2018.11.477", "doi": "10.1016/j.euroneuro.2018.11.477", "pmid": "", "publication_date": "2018-12-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3947, "title": "2018: A watershed year for psychedelic science", "authors": "Jacob S. Aday, Christopher C. Davoli, Emily K. Bloesch", "journal": "Drug Science Policy and Law", "publication_date": "2018-12-31", "publication_year": 2018, "doi": "10.1177/2050324519872284", "pubmed_id": null, "openalex_id": "https://openalex.org/W2971831602", "source_url": "https://doi.org/10.1177/2050324519872284", "substance_tags": "psilocybin", "topic_tags": "Depression,Pharmacology,Treatment-Resistant Depression", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-02 20:42:13", "last_checked": "2026-07-04 07:00:39", "bibtex": null, "source_record_id": "DOI:10.1177/2050324519872284", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1177/2050324519872284", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1177/2050324519872284", "source_url": "https://doi.org/10.1177/2050324519872284", "doi": "10.1177/2050324519872284", "pmid": "", "publication_date": "2018-12-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 2353, "title": "Might Microdosing Psychedelics Be Safe and Beneficial? An Initial Exploration.", "authors": "Fadiman J, Korb S", "journal": "Journal of psychoactive drugs", "publication_date": "2018-12-31", "publication_year": 2018, "doi": "10.1080/02791072.2019.1593561", "pubmed_id": "30925850", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/30925850/", "substance_tags": "psilocybin", "topic_tags": "Depression,Headache / Migraine,Microdosing,Emotional Processing", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-01 11:20:40", "bibtex": null, "source_record_id": "PMID:30925850", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/30925850/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:30925850", "source_url": "https://pubmed.ncbi.nlm.nih.gov/30925850/", "doi": "10.1080/02791072.2019.1593561", "pmid": "30925850", "publication_date": "2018-12-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 2329, "title": "Self-Rated Effectiveness of Microdosing With Psychedelics for Mental and Physical Health Problems Among Microdosers.", "authors": "Hutten NRPW, Mason NL, Dolder PC, Kuypers KPC", "journal": "Frontiers in psychiatry", "publication_date": "2018-12-31", "publication_year": 2018, "doi": "10.3389/fpsyt.2019.00672", "pubmed_id": "31572246", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/31572246/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Chronic Pain,Microdosing,Clinical Trial,Randomized Controlled Trial", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-01 11:20:40", "bibtex": null, "source_record_id": "PMID:31572246", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/31572246/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:31572246", "source_url": "https://pubmed.ncbi.nlm.nih.gov/31572246/", "doi": "10.3389/fpsyt.2019.00672", "pmid": "31572246", "publication_date": "2018-12-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 2347, "title": "Classic psychedelics: An integrative review of epidemiology, therapeutics, mystical experience, and brain network function.", "authors": "Johnson MW, Hendricks PS, Barrett FS, Griffiths RR.", "journal": null, "publication_date": "2018-12-03", "publication_year": 2018, "doi": "10.1016/j.pharmthera.2018.11.010", "pubmed_id": "30521880", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.pharmthera.2018.11.010", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,End-of-Life Distress,Brain Imaging,Mechanism of Action,Receptor Pharmacology,Consciousness,Aging,Mystical Experience,Review Article,Healthy Volunteers", "study_type": "Review Article", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-01 11:22:06", "bibtex": null, "source_record_id": "PMID:30521880", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.pharmthera.2018.11.010", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:30521880", "source_url": "https://doi.org/10.1016/j.pharmthera.2018.11.010", "doi": "10.1016/j.pharmthera.2018.11.010", "pmid": "30521880", "publication_date": "2018-12-03", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 2361, "title": "Production Options for Psilocybin: Making of the Magic.", "authors": "Fricke J, Lenz C, Wick J, Blei F, Hoffmeister D.", "journal": "Chemistry - A European Journal", "publication_date": "2018-11-14", "publication_year": 2018, "doi": "10.1002/chem.201802758", "pubmed_id": "30011099", "openalex_id": "https://openalex.org/W2884828036", "source_url": "https://doi.org/10.1002/chem.201802758", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Anxiety,Pharmacology,Clinical Trial,In Vitro Study", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-04 07:00:40", "bibtex": null, "source_record_id": "PMID:30011099", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1002/chem.201802758", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:30011099", "source_url": "https://doi.org/10.1002/chem.201802758", "doi": "10.1002/chem.201802758", "pmid": "30011099", "publication_date": "2018-11-14", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 2371, "title": "Psychedelic drugs in the treatment of anxiety, depression and addiction.", "authors": "Kvam TM, Stewart LH, Andreassen OA.", "journal": null, "publication_date": "2018-11-11", "publication_year": 2018, "doi": "10.4045/tidsskr.17.1110", "pubmed_id": "30421744", "openalex_id": null, "source_url": "https://doi.org/10.4045/tidsskr.17.1110", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,OCD,Biomarkers,Animal Study", "study_type": "Animal Study", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-01 11:22:06", "bibtex": null, "source_record_id": "PMID:30421744", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.4045/tidsskr.17.1110", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:30421744", "source_url": "https://doi.org/10.4045/tidsskr.17.1110", "doi": "10.4045/tidsskr.17.1110", "pmid": "30421744", "publication_date": "2018-11-11", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3405, "title": "Microdosing Psychedelics: Personality, mental health, and creativity differences in microdosers", "authors": "Anderson T, Petranker R, Rosenbaum D, Weissman C, Dinh-Williams L, Hui K, Hapke E, Farb NAS.", "journal": "PsyArXiv", "publication_date": "2018-11-01", "publication_year": 2018, "doi": "10.31234/osf.io/gk4jd", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.31234/osf.io/gk4jd", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Microdosing,Wellbeing,Personality Change,Emotional Processing,Creativity,Safety", "study_type": "Other", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:52", "last_checked": "2026-07-01 11:22:06", "bibtex": null, "source_record_id": "DOI:10.31234/osf.io/gk4jd", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://doi.org/10.31234/osf.io/gk4jd", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "DOI:10.31234/osf.io/gk4jd", "source_url": "https://doi.org/10.31234/osf.io/gk4jd", "doi": "10.31234/osf.io/gk4jd", "pmid": "", "publication_date": "2018-11-01", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 2360, "title": "Microdosing Psychedelics: Personality, mental health, and creativity differences in microdosers", "authors": "", "journal": "PsyArXiv", "publication_date": "2018-11-01", "publication_year": 2018, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://osf.io/preprints/psyarxiv/gk4jd_v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Microdosing,Wellbeing,Personality Change,Emotional Processing,Creativity,Safety", "study_type": "Other", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-01 11:22:30", "bibtex": null, "source_record_id": "https://osf.io/preprints/psyarxiv/gk4jd_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/gk4jd_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "https://osf.io/preprints/psyarxiv/gk4jd_v1", "source_url": "https://osf.io/preprints/psyarxiv/gk4jd_v1", "doi": "", "pmid": "", "publication_date": "2018-11-01", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 2385, "title": "More Realistic Forecasting of Future Life Events After Psilocybin for Treatment-Resistant Depression.", "authors": "Lyons T, Carhart-Harris RL.", "journal": "Frontiers in Psychology", "publication_date": "2018-10-11", "publication_year": 2018, "doi": "10.3389/fpsyg.2018.01721", "pubmed_id": "30369890", "openalex_id": "https://openalex.org/W2889504249", "source_url": "https://doi.org/10.3389/fpsyg.2018.01721", "substance_tags": "psilocybin", "topic_tags": "Depression,Personality Change,Treatment-Resistant Depression", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-04 07:00:39", "bibtex": null, "source_record_id": "PMID:30369890", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.3389/fpsyg.2018.01721", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:30369890", "source_url": "https://doi.org/10.3389/fpsyg.2018.01721", "doi": "10.3389/fpsyg.2018.01721", "pmid": "30369890", "publication_date": "2018-10-11", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 2380, "title": "DARK Classics in Chemical Neuroscience: Ibogaine.", "authors": "Wasko MJ, Witt-Enderby PA, Surratt CK.", "journal": null, "publication_date": "2018-10-08", "publication_year": 2018, "doi": "10.1021/acschemneuro.8b00294", "pubmed_id": "30216039", "openalex_id": null, "source_url": "https://doi.org/10.1021/acschemneuro.8b00294", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Receptor Pharmacology,Clinical Trial,Animal Study,Toxicity", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-01 11:22:06", "bibtex": null, "source_record_id": "PMID:30216039", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1021/acschemneuro.8b00294", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:30216039", "source_url": "https://doi.org/10.1021/acschemneuro.8b00294", "doi": "10.1021/acschemneuro.8b00294", "pmid": "30216039", "publication_date": "2018-10-08", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 5157, "title": "Serotonin, psychedelics and psychiatry", "authors": "Robin Carhart-Harris", "journal": "World Psychiatry", "publication_date": "2018-09-06", "publication_year": 2018, "doi": "10.1002/wps.20555", "pubmed_id": "30192100", "openalex_id": "https://openalex.org/W2891343109", "source_url": "https://doi.org/10.1002/wps.20555", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Neuroplasticity,Neurogenesis,Pharmacology,Mechanism of Action,Receptor Pharmacology,Emotional Processing,Randomized Controlled Trial,Safety", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:52:01", "last_checked": "2026-07-04 07:00:39", "bibtex": null, "source_record_id": "PMID:30192100", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1002/wps.20555", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:30192100", "source_url": "https://doi.org/10.1002/wps.20555", "doi": "10.1002/wps.20555", "pmid": "30192100", "publication_date": "2018-09-06", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 2433, "title": "d-Lysergic acid diethylamide, psilocybin, and other classic hallucinogens: Mechanism of action and potential therapeutic applications in mood disorders.", "authors": "De Gregorio D, Enns JP, Nuñez NA, Posa L, Gobbi G.", "journal": null, "publication_date": "2018-08-30", "publication_year": 2018, "doi": "10.1016/bs.pbr.2018.07.008", "pubmed_id": "30471683", "openalex_id": null, "source_url": "https://doi.org/10.1016/bs.pbr.2018.07.008", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Pharmacology,Mechanism of Action,Receptor Pharmacology,Review Article", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-01 11:22:04", "bibtex": null, "source_record_id": "PMID:30471683", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/bs.pbr.2018.07.008", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:30471683", "source_url": "https://doi.org/10.1016/bs.pbr.2018.07.008", "doi": "10.1016/bs.pbr.2018.07.008", "pmid": "30471683", "publication_date": "2018-08-30", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 2389, "title": "Efficacy, tolerability, and safety of serotonergic psychedelics for the management of mood, anxiety, and substance-use disorders: a systematic review of systematic reviews.", "authors": "Dos Santos RG, Bouso JC, Alcázar-Córcoles MÁ, Hallak JEC.", "journal": null, "publication_date": "2018-08-22", "publication_year": 2018, "doi": "10.1080/17512433.2018.1511424", "pubmed_id": "30102078", "openalex_id": null, "source_url": "https://doi.org/10.1080/17512433.2018.1511424", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Receptor Pharmacology,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Cancer Patients,Treatment-Resistant Depression,Safety", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-01 11:22:06", "bibtex": null, "source_record_id": "PMID:30102078", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1080/17512433.2018.1511424", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:30102078", "source_url": "https://doi.org/10.1080/17512433.2018.1511424", "doi": "10.1080/17512433.2018.1511424", "pmid": "30102078", "publication_date": "2018-08-22", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 2395, "title": "Psychedelics as anti-inflammatory agents.", "authors": "Flanagan TW, Nichols CD.", "journal": "International Review of Psychiatry", "publication_date": "2018-08-12", "publication_year": 2018, "doi": "10.1080/09540261.2018.1481827", "pubmed_id": "30102081", "openalex_id": "https://openalex.org/W2886249511", "source_url": "https://doi.org/10.1080/09540261.2018.1481827", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,OCD,Mechanism of Action,Receptor Pharmacology,Review Article,Animal Study,Inflammation", "study_type": "Review Article", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-04 07:00:40", "bibtex": null, "source_record_id": "PMID:30102081", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1080/09540261.2018.1481827", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:30102081", "source_url": "https://doi.org/10.1080/09540261.2018.1481827", "doi": "10.1080/09540261.2018.1481827", "pmid": "30102081", "publication_date": "2018-08-12", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 2394, "title": "Therapeutic use of classic psychedelics to treat cancer-related psychiatric distress.", "authors": "Ross S.", "journal": null, "publication_date": "2018-08-12", "publication_year": 2018, "doi": "10.1080/09540261.2018.1482261", "pubmed_id": "30102082", "openalex_id": null, "source_url": "https://doi.org/10.1080/09540261.2018.1482261", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Receptor Pharmacology,Clinical Trial,Randomized Controlled Trial,Review Article,Cancer Patients", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-01 11:22:06", "bibtex": null, "source_record_id": "PMID:30102082", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1080/09540261.2018.1482261", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:30102082", "source_url": "https://doi.org/10.1080/09540261.2018.1482261", "doi": "10.1080/09540261.2018.1482261", "pmid": "30102082", "publication_date": "2018-08-12", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 5158, "title": "The Utility of Psilocybin in Managing Anxiety and Depression in Cancer Patients", "authors": "Chu Hsien Lim, Brian D. Kangas, Jack Bergman", "journal": "Biochemistry and Molecular Biology Education", "publication_date": "2018-07-31", "publication_year": 2018, "doi": null, "pubmed_id": null, "openalex_id": "https://openalex.org/W2900545389", "source_url": "https://www.jyi.org/2018-august/2018/7/6/the-utility-of-psilocybin-in-managing-anxiety-and-depression-in-cancer-patients", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Aging,Cancer Patients", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:52:01", "last_checked": "2026-07-04 07:00:39", "bibtex": null, "source_record_id": "https://www.jyi.org/2018-august/2018/7/6/the-utility-of-psilocybin-in-managing-anxiety-and-depression-in-cancer-patients", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "https://www.jyi.org/2018-august/2018/7/6/the-utility-of-psilocybin-in-managing-anxiety-and-depression-in-cancer-patients", "source_url": "https://www.jyi.org/2018-august/2018/7/6/the-utility-of-psilocybin-in-managing-anxiety-and-depression-in-cancer-patients", "doi": "", "pmid": "", "publication_date": "2018-07-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3290, "title": "Convergent evolution of psilocybin biosynthesis by psychedelic mushrooms", "authors": "Awan AR, Winter JM, Turner D, Shaw WM, Suz LM, Bradshaw AJ, Ellis T, Dentinger BT.", "journal": "bioRxiv", "publication_date": "2018-07-24", "publication_year": 2018, "doi": "10.1101/374199", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.1101/374199", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,End-of-Life Distress,Genomics,Transcriptomics", "study_type": "Other", "source_name": "bioRxiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:50", "last_checked": "2026-07-01 11:22:03", "bibtex": null, "source_record_id": "DOI:10.1101/374199", "abstract_available": true, "abstract_source": "bioRxiv", "abstract_source_url": "https://doi.org/10.1101/374199", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "bioRxiv", "source_record_id": "DOI:10.1101/374199", "source_url": "https://doi.org/10.1101/374199", "doi": "10.1101/374199", "pmid": "", "publication_date": "2018-07-24", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3553, "title": "Psychopharmacology of Psilocybin in Cancer Patients", "authors": "Johns Hopkins University", "journal": "ClinicalTrials.gov", "publication_date": "2018-07-18", "publication_year": 2018, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT00465595", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Pharmacology,Consciousness,Spirituality,Healthy Volunteers,Cancer Patients", "study_type": "Other", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT00465595", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT00465595", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT00465595", "source_url": "https://clinicaltrials.gov/study/NCT00465595", "doi": "", "pmid": "", "publication_date": "2018-07-18", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 2382, "title": "DARK Classics in Chemical Neuroscience: Psilocybin.", "authors": "Geiger HA, Wurst MG, Daniels RN.", "journal": null, "publication_date": "2018-07-15", "publication_year": 2018, "doi": "10.1021/acschemneuro.8b00186", "pubmed_id": "29956917", "openalex_id": null, "source_url": "https://doi.org/10.1021/acschemneuro.8b00186", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Addiction,End-of-Life Distress,Pharmacology,Review Article,Cancer Patients", "study_type": "Review Article", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-01 11:22:02", "bibtex": null, "source_record_id": "PMID:29956917", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1021/acschemneuro.8b00186", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:29956917", "source_url": "https://doi.org/10.1021/acschemneuro.8b00186", "doi": "10.1021/acschemneuro.8b00186", "pmid": "29956917", "publication_date": "2018-07-15", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 2396, "title": "Biocatalytic Production of Psilocybin and Derivatives in Tryptophan Synthase-Enhanced Reactions.", "authors": "Blei F, Baldeweg F, Fricke J, Hoffmeister D.", "journal": "Chemistry - A European Journal", "publication_date": "2018-06-18", "publication_year": 2018, "doi": "10.1002/chem.201801047", "pubmed_id": "29750381", "openalex_id": "https://openalex.org/W2802656036", "source_url": "https://doi.org/10.1002/chem.201801047", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Receptor Pharmacology,In Vitro Study", "study_type": "In Vitro Study", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-04 07:00:40", "bibtex": null, "source_record_id": "PMID:29750381", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1002/chem.201801047", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:29750381", "source_url": "https://doi.org/10.1002/chem.201801047", "doi": "10.1002/chem.201801047", "pmid": "29750381", "publication_date": "2018-06-18", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 2374, "title": "Effects of psilocybin therapy on personality structure.", "authors": "Erritzoe D, Roseman L, Nour MM, MacLean K, Kaelen M, Nutt DJ, Carhart-Harris RL.", "journal": "Acta Psychiatrica Scandinavica", "publication_date": "2018-06-18", "publication_year": 2018, "doi": "10.1111/acps.12904", "pubmed_id": "29923178", "openalex_id": "https://openalex.org/W2807534705", "source_url": "https://doi.org/10.1111/acps.12904", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Consciousness,Personality Change,Treatment-Resistant Depression", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-04 07:00:40", "bibtex": null, "source_record_id": "PMID:29923178", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1111/acps.12904", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:29923178", "source_url": "https://doi.org/10.1111/acps.12904", "doi": "10.1111/acps.12904", "pmid": "29923178", "publication_date": "2018-06-18", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 2411, "title": "Lysergic acid diethylamide and psilocybin for the management of patients with persistent pain: a potential role?", "authors": "Whelan A, Johnson MI.", "journal": null, "publication_date": "2018-05-02", "publication_year": 2018, "doi": "10.2217/pmt-2017-0068", "pubmed_id": "29722608", "openalex_id": null, "source_url": "https://doi.org/10.2217/pmt-2017-0068", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Chronic Pain,Receptor Pharmacology,Systematic Review,Review Article", "study_type": "Systematic Review", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-01 11:22:04", "bibtex": null, "source_record_id": "PMID:29722608", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.2217/pmt-2017-0068", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:29722608", "source_url": "https://doi.org/10.2217/pmt-2017-0068", "doi": "10.2217/pmt-2017-0068", "pmid": "29722608", "publication_date": "2018-05-02", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 2413, "title": "Individual Experiences in Four Cancer Patients Following Psilocybin-Assisted Psychotherapy.", "authors": "Malone TC, Mennenga SE, Guss J, Podrebarac SK, Owens LT, Bossis AP, Belser AB, Agin-Liebes G, Bogenschutz MP, Ross S.", "journal": "Frontiers in Pharmacology", "publication_date": "2018-04-02", "publication_year": 2018, "doi": "10.3389/fphar.2018.00256", "pubmed_id": "29666578", "openalex_id": "https://openalex.org/W2796179442", "source_url": "https://doi.org/10.3389/fphar.2018.00256", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Wellbeing,Spirituality,Cancer Patients,Healthcare Workers", "study_type": "Qualitative Study", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-04 07:00:40", "bibtex": null, "source_record_id": "PMID:29666578", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.3389/fphar.2018.00256", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:29666578", "source_url": "https://doi.org/10.3389/fphar.2018.00256", "doi": "10.3389/fphar.2018.00256", "pmid": "29666578", "publication_date": "2018-04-02", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 2416, "title": "Natural speech algorithm applied to baseline interview data can predict which patients will respond to psilocybin for treatment-resistant depression.", "authors": "Carrillo F, Sigman M, Fernández Slezak D, Ashton P, Fitzgerald L, Stroud J, Nutt DJ, Carhart-Harris RL.", "journal": "Journal of Affective Disorders", "publication_date": "2018-03-31", "publication_year": 2018, "doi": "10.1016/j.jad.2018.01.006", "pubmed_id": "29407543", "openalex_id": "https://openalex.org/W2790056169", "source_url": "https://doi.org/10.1016/j.jad.2018.01.006", "substance_tags": "psilocybin", "topic_tags": "Depression,Treatment-Resistant Depression", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-04 07:00:40", "bibtex": null, "source_record_id": "PMID:29407543", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.jad.2018.01.006", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:29407543", "source_url": "https://doi.org/10.1016/j.jad.2018.01.006", "doi": "10.1016/j.jad.2018.01.006", "pmid": "29407543", "publication_date": "2018-03-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 2407, "title": "Out of the box: A psychedelic model to study the creative mind.", "authors": "Kuypers KPC.", "journal": "Medical Hypotheses", "publication_date": "2018-03-22", "publication_year": 2018, "doi": "10.1016/j.mehy.2018.03.010", "pubmed_id": "29685188", "openalex_id": "https://openalex.org/W2790867612", "source_url": "https://doi.org/10.1016/j.mehy.2018.03.010", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Brain Imaging,Aging,Creativity,Healthy Volunteers", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-04 07:00:40", "bibtex": null, "source_record_id": "PMID:29685188", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.mehy.2018.03.010", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:29685188", "source_url": "https://doi.org/10.1016/j.mehy.2018.03.010", "doi": "10.1016/j.mehy.2018.03.010", "pmid": "29685188", "publication_date": "2018-03-22", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 5164, "title": "Alteration of Depressive-like Behaviors by Psilocybe cubensis Alkaloid Extract in Mice: the Role of Glutamate Pathway", "authors": "Elaheh Mahmoudi, Mehrdad Faizi, Reza Hajiaghaee, Ali Razmi", "journal": "DOAJ (DOAJ: Directory of Open Access Journals)", "publication_date": "2018-02-28", "publication_year": 2018, "doi": "10.22127/rjp.2018.58486", "pubmed_id": null, "openalex_id": "https://openalex.org/W2791918973", "source_url": "https://doaj.org/article/6982e7d479cc425db4622ec49357f976", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Pharmacology,Mechanism of Action,Receptor Pharmacology,Animal Study,Drug Interactions", "study_type": "Animal Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:52:02", "last_checked": "2026-07-04 07:00:40", "bibtex": null, "source_record_id": "DOI:10.22127/rjp.2018.58486", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doaj.org/article/6982e7d479cc425db4622ec49357f976", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.22127/rjp.2018.58486", "source_url": "https://doaj.org/article/6982e7d479cc425db4622ec49357f976", "doi": "10.22127/rjp.2018.58486", "pmid": "", "publication_date": "2018-02-28", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 2384, "title": "Dark Classics in Chemical Neuroscience: Lysergic Acid Diethylamide (LSD).", "authors": "Nichols DE.", "journal": null, "publication_date": "2018-02-28", "publication_year": 2018, "doi": "10.1021/acschemneuro.8b00043", "pubmed_id": "29461039", "openalex_id": null, "source_url": "https://doi.org/10.1021/acschemneuro.8b00043", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Brain Imaging,Receptor Pharmacology,Consciousness,Aging,Clinical Trial,Adverse Events", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-01 11:22:06", "bibtex": null, "source_record_id": "PMID:29461039", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1021/acschemneuro.8b00043", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:29461039", "source_url": "https://doi.org/10.1021/acschemneuro.8b00043", "doi": "10.1021/acschemneuro.8b00043", "pmid": "29461039", "publication_date": "2018-02-28", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 2425, "title": "The hidden therapist: evidence for a central role of music in psychedelic therapy.", "authors": "Kaelen M, Giribaldi B, Raine J, Evans L, Timmerman C, Rodriguez N, Roseman L, Feilding A, Nutt D, Carhart-Harris R.", "journal": "Psychopharmacology", "publication_date": "2018-02-01", "publication_year": 2018, "doi": "10.1007/s00213-017-4820-5", "pubmed_id": "29396616", "openalex_id": "https://openalex.org/W2784069100", "source_url": "https://doi.org/10.1007/s00213-017-4820-5", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Emotional Processing,Mystical Experience,Treatment-Resistant Depression,Safety", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-04 07:00:40", "bibtex": null, "source_record_id": "PMID:29396616", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1007/s00213-017-4820-5", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:29396616", "source_url": "https://doi.org/10.1007/s00213-017-4820-5", "doi": "10.1007/s00213-017-4820-5", "pmid": "29396616", "publication_date": "2018-02-01", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 5167, "title": "Can psychedelic drug help with depression?", "authors": "Jessica Hamzelou", "journal": "The New Scientist", "publication_date": "2018-01-31", "publication_year": 2018, "doi": "10.1016/s0262-4079(18)30332-4", "pubmed_id": null, "openalex_id": "https://openalex.org/W2793677349", "source_url": "https://doi.org/10.1016/s0262-4079(18)30332-4", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:52:02", "last_checked": "2026-07-04 06:52:02", "bibtex": null, "source_record_id": "DOI:10.1016/s0262-4079(18)30332-4", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/s0262-4079(18)30332-4", "source_url": "https://doi.org/10.1016/s0262-4079(18)30332-4", "doi": "10.1016/s0262-4079(18)30332-4", "pmid": "", "publication_date": "2018-01-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 2417, "title": "Taking Psychedelics Seriously.", "authors": "Byock I.", "journal": null, "publication_date": "2018-01-21", "publication_year": 2018, "doi": "10.1089/jpm.2017.0684", "pubmed_id": "29356590", "openalex_id": null, "source_url": "https://doi.org/10.1089/jpm.2017.0684", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Emotional Processing,Spirituality,Treatment-Resistant Depression,Healthcare Workers,Safety", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-01 11:22:06", "bibtex": null, "source_record_id": "PMID:29356590", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1089/jpm.2017.0684", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:29356590", "source_url": "https://doi.org/10.1089/jpm.2017.0684", "doi": "10.1089/jpm.2017.0684", "pmid": "29356590", "publication_date": "2018-01-21", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 2431, "title": "Quality of Acute Psychedelic Experience Predicts Therapeutic Efficacy of Psilocybin for Treatment-Resistant Depression.", "authors": "Roseman L, Nutt DJ, Carhart-Harris RL.", "journal": "Frontiers in Pharmacology", "publication_date": "2018-01-16", "publication_year": 2018, "doi": "10.3389/fphar.2017.00974", "pubmed_id": "29387009", "openalex_id": "https://openalex.org/W2792444257", "source_url": "https://doi.org/10.3389/fphar.2017.00974", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Consciousness,Mystical Experience,Clinical Trial,Randomized Controlled Trial,Treatment-Resistant Depression,Drug Interactions", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-04 07:00:40", "bibtex": null, "source_record_id": "PMID:29387009", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.3389/fphar.2017.00974", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:29387009", "source_url": "https://doi.org/10.3389/fphar.2017.00974", "doi": "10.3389/fphar.2017.00974", "pmid": "29387009", "publication_date": "2018-01-16", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 2405, "title": "Increased nature relatedness and decreased authoritarian political views after psilocybin for treatment-resistant depression.", "authors": "Lyons T, Carhart-Harris RL.", "journal": "Journal of Psychopharmacology", "publication_date": "2018-01-16", "publication_year": 2018, "doi": "10.1177/0269881117748902", "pubmed_id": "29338538", "openalex_id": "https://openalex.org/W2784860341", "source_url": "https://doi.org/10.1177/0269881117748902", "substance_tags": "psilocybin", "topic_tags": "Depression,Personality Change,Observational Study,Treatment-Resistant Depression", "study_type": "Observational Study", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-04 07:00:40", "bibtex": null, "source_record_id": "PMID:29338538", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1177/0269881117748902", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:29338538", "source_url": "https://doi.org/10.1177/0269881117748902", "doi": "10.1177/0269881117748902", "pmid": "29338538", "publication_date": "2018-01-16", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 5179, "title": "Mikrodosering av lysergsyradietylamid och psilocybin och dess effekter på psykisk hälsa", "authors": "Anisha Lela Larsson", "journal": "KTH Publication Database DiVA (KTH Royal Institute of Technology)", "publication_date": "2017-12-31", "publication_year": 2017, "doi": null, "pubmed_id": null, "openalex_id": "https://openalex.org/W3101603169", "source_url": "http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-358476", "substance_tags": "psilocybin", "topic_tags": "Depression,Animal Study", "study_type": "Animal Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:52:02", "last_checked": "2026-07-04 07:00:40", "bibtex": null, "source_record_id": "http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-358476", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-358476", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-358476", "source_url": "http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-358476", "doi": "", "pmid": "", "publication_date": "2017-12-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 2442, "title": "Classic Hallucinogens and Mystical Experiences: Phenomenology and Neural Correlates.", "authors": "Barrett FS, Griffiths RR.", "journal": null, "publication_date": "2017-12-31", "publication_year": 2017, "doi": "10.1007/7854_2017_474", "pubmed_id": "28401522", "openalex_id": null, "source_url": "https://doi.org/10.1007/7854_2017_474", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Default Mode Network,Mystical Experience,Review Article,Observational Study,Healthy Volunteers", "study_type": "Review Article", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-01 11:22:06", "bibtex": null, "source_record_id": "PMID:28401522", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1007/7854_2017_474", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:28401522", "source_url": "https://doi.org/10.1007/7854_2017_474", "doi": "10.1007/7854_2017_474", "pmid": "28401522", "publication_date": "2017-12-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 2441, "title": "Therapeutic Applications of Classic Hallucinogens.", "authors": "Bogenschutz MP, Ross S.", "journal": null, "publication_date": "2017-12-31", "publication_year": 2017, "doi": "10.1007/7854_2016_464", "pubmed_id": "28512684", "openalex_id": null, "source_url": "https://doi.org/10.1007/7854_2016_464", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,End-of-Life Distress,Mechanism of Action,Receptor Pharmacology,Aging,Clinical Trial,Review Article,Observational Study,In Vitro Study,Safety", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-01 11:22:06", "bibtex": null, "source_record_id": "PMID:28512684", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1007/7854_2016_464", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:28512684", "source_url": "https://doi.org/10.1007/7854_2016_464", "doi": "10.1007/7854_2016_464", "pmid": "28512684", "publication_date": "2017-12-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 2440, "title": "The Effects of Hallucinogens on Gene Expression.", "authors": "Martin DA, Nichols CD.", "journal": null, "publication_date": "2017-12-31", "publication_year": 2017, "doi": "10.1007/7854_2017_479", "pubmed_id": "28677095", "openalex_id": null, "source_url": "https://doi.org/10.1007/7854_2017_479", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Neuroplasticity,Brain Imaging,Mechanism of Action,Receptor Pharmacology,Default Mode Network,Aging,Mystical Experience,Review Article", "study_type": "Review Article", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-01 11:22:06", "bibtex": null, "source_record_id": "PMID:28677095", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1007/7854_2017_479", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:28677095", "source_url": "https://doi.org/10.1007/7854_2017_479", "doi": "10.1007/7854_2017_479", "pmid": "28677095", "publication_date": "2017-12-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 2436, "title": "Novel psychotherapeutics - a cautiously optimistic focus on Hallucinogens.", "authors": "Sherwood AM, Prisinzano TE", "journal": "Expert review of clinical pharmacology", "publication_date": "2017-12-31", "publication_year": 2017, "doi": "10.1080/17512433.2018.1415755", "pubmed_id": "29224406", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/29224406/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-01 11:20:40", "bibtex": null, "source_record_id": "PMID:29224406", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:29224406", "source_url": "https://pubmed.ncbi.nlm.nih.gov/29224406/", "doi": "10.1080/17512433.2018.1415755", "pmid": "29224406", "publication_date": "2017-12-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 2435, "title": "Serotonergic Psychedelics: Experimental Approaches for Assessing Mechanisms of Action.", "authors": "Canal CE.", "journal": null, "publication_date": "2017-12-31", "publication_year": 2017, "doi": "10.1007/164_2018_107", "pubmed_id": "29532180", "openalex_id": "https://openalex.org/W2789541163", "source_url": "https://doi.org/10.1007/164_2018_107", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging,Pharmacology,Mechanism of Action,Receptor Pharmacology,Aging,Clinical Trial,Animal Study,Treatment-Resistant Depression", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-01 11:22:06", "bibtex": null, "source_record_id": "PMID:29532180", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1007/164_2018_107", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:29532180", "source_url": "https://doi.org/10.1007/164_2018_107", "doi": "10.1007/164_2018_107", "pmid": "29532180", "publication_date": "2017-12-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 2365, "title": "Rapid-Acting Antidepressants.", "authors": "Witkin JM, Knutson DE, Rodriguez GJ, Shi S.", "journal": null, "publication_date": "2017-12-31", "publication_year": 2017, "doi": "10.2174/1381612824666180730104707", "pubmed_id": "30058481", "openalex_id": null, "source_url": "https://doi.org/10.2174/1381612824666180730104707", "substance_tags": "psilocybin", "topic_tags": "Depression,Receptor Pharmacology,Review Article,Animal Study", "study_type": "Review Article", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-01 11:22:06", "bibtex": null, "source_record_id": "PMID:30058481", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.2174/1381612824666180730104707", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:30058481", "source_url": "https://doi.org/10.2174/1381612824666180730104707", "doi": "10.2174/1381612824666180730104707", "pmid": "30058481", "publication_date": "2017-12-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 2376, "title": "Increased amygdala responses to emotional faces after psilocybin for treatment-resistant depression.", "authors": "Roseman L, Demetriou L, Wall MB, Nutt DJ, Carhart-Harris RL.", "journal": "Neuropharmacology", "publication_date": "2017-12-26", "publication_year": 2017, "doi": "10.1016/j.neuropharm.2017.12.041", "pubmed_id": "29288686", "openalex_id": "https://openalex.org/W2781340150", "source_url": "https://doi.org/10.1016/j.neuropharm.2017.12.041", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging,Aging,Emotional Processing,Randomized Controlled Trial,Treatment-Resistant Depression", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-04 07:00:40", "bibtex": null, "source_record_id": "PMID:29288686", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.neuropharm.2017.12.041", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:29288686", "source_url": "https://doi.org/10.1016/j.neuropharm.2017.12.041", "doi": "10.1016/j.neuropharm.2017.12.041", "pmid": "29288686", "publication_date": "2017-12-26", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 3631, "title": "Psilocybin and Depression - Assessing the Long-term Effects of a Single Administration of Psilocybin on the Psychiatric Symptoms and Brain Activity of Patients With Severe Depression", "authors": "University of Helsinki", "journal": "ClinicalTrials.gov", "publication_date": "2017-12-20", "publication_year": 2017, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT03380442", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging,Mechanism of Action,Biomarkers,Aging,Emotional Processing", "study_type": "Other", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:34", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT03380442", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT03380442", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT03380442", "source_url": "https://clinicaltrials.gov/study/NCT03380442", "doi": "", "pmid": "", "publication_date": "2017-12-20", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 5181, "title": "„Terapia szokowa”, czyli agoniści receptor 5-HT2A w leczeniu depresji i lęku", "authors": "Joanna Stefaniuk", "journal": "CeON Repository (Centre for Evaluation in Education and Science)", "publication_date": "2017-11-30", "publication_year": 2017, "doi": null, "pubmed_id": null, "openalex_id": "https://openalex.org/W2771603125", "source_url": "https://depot.ceon.pl/handle/123456789/13483", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Pharmacology,Mechanism of Action,Receptor Pharmacology,Emotional Processing,Safety", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:52:02", "last_checked": "2026-07-04 07:00:40", "bibtex": null, "source_record_id": "https://depot.ceon.pl/handle/123456789/13483", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://depot.ceon.pl/handle/123456789/13483", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "https://depot.ceon.pl/handle/123456789/13483", "source_url": "https://depot.ceon.pl/handle/123456789/13483", "doi": "", "pmid": "", "publication_date": "2017-11-30", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 2446, "title": "Pharmacokinetics of Escalating Doses of Oral Psilocybin in Healthy Adults.", "authors": "Brown RT, Nicholas CR, Cozzi NV, Gassman MC, Cooper KM, Muller D, Thomas CD, Hetzel SJ, Henriquez KM, Ribaudo AS, Hutson PR.", "journal": "Clinical Pharmacokinetics", "publication_date": "2017-11-30", "publication_year": 2017, "doi": "10.1007/s40262-017-0540-6", "pubmed_id": "28353056", "openalex_id": "https://openalex.org/W2600624779", "source_url": "https://doi.org/10.1007/s40262-017-0540-6", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Addiction,Pharmacology,Clinical Trial,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-04 07:00:40", "bibtex": null, "source_record_id": "PMID:28353056", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1007/s40262-017-0540-6", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:28353056", "source_url": "https://doi.org/10.1007/s40262-017-0540-6", "doi": "10.1007/s40262-017-0540-6", "pmid": "28353056", "publication_date": "2017-11-30", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 2447, "title": "The \"Endless Trip\" among the NPS Users: Psychopathology and Psychopharmacology in the Hallucinogen-Persisting Perception Disorder. A Systematic Review.", "authors": "Orsolini L, Papanti GD, De Berardis D, Guirguis A, Corkery JM, Schifano F.", "journal": null, "publication_date": "2017-11-19", "publication_year": 2017, "doi": "10.3389/fpsyt.2017.00240", "pubmed_id": "29209235", "openalex_id": null, "source_url": "https://doi.org/10.3389/fpsyt.2017.00240", "substance_tags": "psilocybin", "topic_tags": "Depression,Pharmacology,Systematic Review,Review Article,Safety", "study_type": "Systematic Review", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-01 11:22:06", "bibtex": null, "source_record_id": "PMID:29209235", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.3389/fpsyt.2017.00240", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:29209235", "source_url": "https://doi.org/10.3389/fpsyt.2017.00240", "doi": "10.3389/fpsyt.2017.00240", "pmid": "29209235", "publication_date": "2017-11-19", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 2427, "title": "Psilocybin with psychological support for treatment-resistant depression: six-month follow-up.", "authors": "Carhart-Harris RL, Bolstridge M, Day CMJ, Rucker J, Watts R, Erritzoe DE, Kaelen M, Giribaldi B, Bloomfield M, Pilling S, Rickard JA, Forbes B, Feilding A, Taylor D, Curran HV, Nutt DJ.", "journal": "Psychopharmacology", "publication_date": "2017-11-07", "publication_year": 2017, "doi": "10.1007/s00213-017-4771-x", "pubmed_id": "29119217", "openalex_id": "https://openalex.org/W2767530231", "source_url": "https://doi.org/10.1007/s00213-017-4771-x", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-04 07:00:40", "bibtex": null, "source_record_id": "PMID:29119217", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1007/s00213-017-4771-x", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:29119217", "source_url": "https://doi.org/10.1007/s00213-017-4771-x", "doi": "10.1007/s00213-017-4771-x", "pmid": "29119217", "publication_date": "2017-11-07", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 5185, "title": "Can Psilocybin Treat Severe Depression", "authors": "Barbara Geller", "journal": "Journal watch", "publication_date": "2017-11-02", "publication_year": 2017, "doi": "10.1056/nejm-jw.na45292", "pubmed_id": null, "openalex_id": "https://openalex.org/W2766340631", "source_url": "https://www.jwatch.org/na45292/2017/11/03/can-psilocybin-treat-severe-depression", "substance_tags": "psilocybin", "topic_tags": "Depression,Spirituality", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:52:02", "last_checked": "2026-07-04 07:00:40", "bibtex": null, "source_record_id": "DOI:10.1056/nejm-jw.na45292", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://www.jwatch.org/na45292/2017/11/03/can-psilocybin-treat-severe-depression", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1056/nejm-jw.na45292", "source_url": "https://www.jwatch.org/na45292/2017/11/03/can-psilocybin-treat-severe-depression", "doi": "10.1056/nejm-jw.na45292", "pmid": "", "publication_date": "2017-11-02", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 2429, "title": "Psilocybin with psychological support improves emotional face recognition in treatment-resistant depression.", "authors": "Stroud JB, Freeman TP, Leech R, Hindocha C, Lawn W, Nutt DJ, Curran HV, Carhart-Harris RL.", "journal": "Psychopharmacology", "publication_date": "2017-10-29", "publication_year": 2017, "doi": "10.1007/s00213-017-4754-y", "pubmed_id": "29085980", "openalex_id": "https://openalex.org/W2767171514", "source_url": "https://doi.org/10.1007/s00213-017-4754-y", "substance_tags": "psilocybin", "topic_tags": "Depression,Emotional Processing,Treatment-Resistant Depression,Drug Interactions", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-04 07:00:40", "bibtex": null, "source_record_id": "PMID:29085980", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1007/s00213-017-4754-y", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:29085980", "source_url": "https://doi.org/10.1007/s00213-017-4754-y", "doi": "10.1007/s00213-017-4754-y", "pmid": "29085980", "publication_date": "2017-10-29", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 2452, "title": "Psilocybin for treatment-resistant depression: fMRI-measured brain mechanisms.", "authors": "Carhart-Harris RL, Roseman L, Bolstridge M, Demetriou L, Pannekoek JN, Wall MB, Tanner M, Kaelen M, McGonigle J, Murphy K, Leech R, Curran HV, Nutt DJ.", "journal": "Scientific Reports", "publication_date": "2017-10-12", "publication_year": 2017, "doi": "10.1038/s41598-017-13282-7", "pubmed_id": "29030624", "openalex_id": "https://openalex.org/W2762746674", "source_url": "https://doi.org/10.1038/s41598-017-13282-7", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging,Mechanism of Action,Receptor Pharmacology,Default Mode Network,Aging,Treatment-Resistant Depression", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-04 07:00:40", "bibtex": null, "source_record_id": "PMID:29030624", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1038/s41598-017-13282-7", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:29030624", "source_url": "https://doi.org/10.1038/s41598-017-13282-7", "doi": "10.1038/s41598-017-13282-7", "pmid": "29030624", "publication_date": "2017-10-12", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 2449, "title": "Psychedelic Drugs in Biomedicine.", "authors": "Kyzar EJ, Nichols CD, Gainetdinov RR, Nichols DE, Kalueff AV.", "journal": null, "publication_date": "2017-09-21", "publication_year": 2017, "doi": "10.1016/j.tips.2017.08.003", "pubmed_id": "28947075", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.tips.2017.08.003", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Brain Imaging,Mechanism of Action,Aging,Clinical Trial,Animal Study,Safety", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-01 11:22:06", "bibtex": null, "source_record_id": "PMID:28947075", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.tips.2017.08.003", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:28947075", "source_url": "https://doi.org/10.1016/j.tips.2017.08.003", "doi": "10.1016/j.tips.2017.08.003", "pmid": "28947075", "publication_date": "2017-09-21", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 2424, "title": "Serotonergic hallucinogens in the treatment of anxiety and depression in patients suffering from a life-threatening disease: A systematic review.", "authors": "Reiche S, Hermle L, Gutwinski S, Jungaberle H, Gasser P, Majić T.", "journal": null, "publication_date": "2017-09-21", "publication_year": 2017, "doi": "10.1016/j.pnpbp.2017.09.012", "pubmed_id": "28947181", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.pnpbp.2017.09.012", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Receptor Pharmacology,Clinical Trial,Randomized Controlled Trial,Systematic Review,Review Article,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-01 11:22:06", "bibtex": null, "source_record_id": "PMID:28947181", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.pnpbp.2017.09.012", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:28947181", "source_url": "https://doi.org/10.1016/j.pnpbp.2017.09.012", "doi": "10.1016/j.pnpbp.2017.09.012", "pmid": "28947181", "publication_date": "2017-09-21", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 5189, "title": "Google Trends Analyses and Case Report: A Persistently Dilated Pupil in Psychedelics’ User", "authors": "Ahmed Al-Imam", "journal": "Global Journal of Health Science", "publication_date": "2017-09-17", "publication_year": 2017, "doi": "10.5539/gjhs.v9n11p168", "pubmed_id": null, "openalex_id": "https://openalex.org/W2754605292", "source_url": "https://doi.org/10.5539/gjhs.v9n11p168", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging,Receptor Pharmacology,Case Report,Toxicity", "study_type": "Case Report", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:52:02", "last_checked": "2026-07-04 07:00:40", "bibtex": null, "source_record_id": "DOI:10.5539/gjhs.v9n11p168", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.5539/gjhs.v9n11p168", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.5539/gjhs.v9n11p168", "source_url": "https://doi.org/10.5539/gjhs.v9n11p168", "doi": "10.5539/gjhs.v9n11p168", "pmid": "", "publication_date": "2017-09-17", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 5191, "title": "‘Magic mushroom’ enzyme mystery solved", "authors": "STEVE RITTER", "journal": "C&EN Global Enterprise", "publication_date": "2017-08-20", "publication_year": 2017, "doi": "10.1021/cen-09533-notw1", "pubmed_id": null, "openalex_id": "https://openalex.org/W2746206207", "source_url": "https://doi.org/10.1021/cen-09533-notw1", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Mechanism of Action", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:52:02", "last_checked": "2026-07-04 07:00:40", "bibtex": null, "source_record_id": "DOI:10.1021/cen-09533-notw1", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1021/cen-09533-notw1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1021/cen-09533-notw1", "source_url": "https://doi.org/10.1021/cen-09533-notw1", "doi": "10.1021/cen-09533-notw1", "pmid": "", "publication_date": "2017-08-20", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 2479, "title": "Could Hallucinogens Induce Permanent Pupillary Changes in (Ab)users? A Case Report from New Zealand.", "authors": "Al-Imam A.", "journal": "Case Reports in Neurological Medicine", "publication_date": "2017-08-16", "publication_year": 2017, "doi": "10.1155/2017/2503762", "pubmed_id": "28948056", "openalex_id": "https://openalex.org/W2748929572", "source_url": "https://doi.org/10.1155/2017/2503762", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging,Case Report", "study_type": "Case Report", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-04 07:00:40", "bibtex": null, "source_record_id": "PMID:28948056", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1155/2017/2503762", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:28948056", "source_url": "https://doi.org/10.1155/2017/2503762", "doi": "10.1155/2017/2503762", "pmid": "28948056", "publication_date": "2017-08-16", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 2467, "title": "Potential Therapeutic Effects of Psilocybin.", "authors": "Johnson MW, Griffiths RR.", "journal": null, "publication_date": "2017-06-30", "publication_year": 2017, "doi": "10.1007/s13311-017-0542-y", "pubmed_id": "28585222", "openalex_id": null, "source_url": "https://doi.org/10.1007/s13311-017-0542-y", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Mechanism of Action,Review Article,Cancer Patients,Treatment-Resistant Depression,Safety", "study_type": "Review Article", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-01 11:22:04", "bibtex": null, "source_record_id": "PMID:28585222", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1007/s13311-017-0542-y", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:28585222", "source_url": "https://doi.org/10.1007/s13311-017-0542-y", "doi": "10.1007/s13311-017-0542-y", "pmid": "28585222", "publication_date": "2017-06-30", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 2466, "title": "[Psychotherapy with Adjuvant use of Serotonergic Psychoactive Substances: Possibilities and Challenges].", "authors": "Majić T, Jungaberle H, Jungaberle H, Schmidt TT, Zeuch A, Hermle L, Gallinat J.", "journal": null, "publication_date": "2017-06-30", "publication_year": 2017, "doi": "10.1055/s-0043-103085", "pubmed_id": "28768346", "openalex_id": null, "source_url": "https://doi.org/10.1055/s-0043-103085", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,OCD,End-of-Life Distress,Receptor Pharmacology,Safety", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-01 11:22:06", "bibtex": null, "source_record_id": "PMID:28768346", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1055/s-0043-103085", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:28768346", "source_url": "https://doi.org/10.1055/s-0043-103085", "doi": "10.1055/s-0043-103085", "pmid": "28768346", "publication_date": "2017-06-30", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 5202, "title": "Patients’ Accounts of Increased “Connectedness” and “Acceptance” After Psilocybin for Treatment-Resistant Depression", "authors": "Rosalind Watts, Camilla Day, Jacob Krzanowski, David Nutt, Robin Carhart-Harris", "journal": "Journal of Humanistic Psychology", "publication_date": "2017-06-18", "publication_year": 2017, "doi": "10.1177/0022167817709585", "pubmed_id": null, "openalex_id": "https://openalex.org/W2644260506", "source_url": "https://doi.org/10.1177/0022167817709585", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Emotional Processing,Treatment-Resistant Depression", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:52:02", "last_checked": "2026-07-04 07:00:40", "bibtex": null, "source_record_id": "DOI:10.1177/0022167817709585", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1177/0022167817709585", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1177/0022167817709585", "source_url": "https://doi.org/10.1177/0022167817709585", "doi": "10.1177/0022167817709585", "pmid": "", "publication_date": "2017-06-18", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 5203, "title": "Cancer at the Dinner Table: Experiences of Psilocybin-Assisted Psychotherapy for the Treatment of Cancer-Related Distress", "authors": "Thomas Cody Swift, Alexander Belser, Gabrielle Agin-Liebes, Neşe Devenot, Sara Terrana, Harris L. Friedman, Jeffrey Guss, Anthony P. Bossis, Stephen Ross", "journal": "Journal of Humanistic Psychology", "publication_date": "2017-06-13", "publication_year": 2017, "doi": "10.1177/0022167817715966", "pubmed_id": null, "openalex_id": "https://openalex.org/W2626493232", "source_url": "https://doi.org/10.1177/0022167817715966", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Mechanism of Action,Emotional Processing,Spirituality,Randomized Controlled Trial,Cancer Patients", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:52:02", "last_checked": "2026-07-04 07:00:40", "bibtex": null, "source_record_id": "DOI:10.1177/0022167817715966", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1177/0022167817715966", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1177/0022167817715966", "source_url": "https://doi.org/10.1177/0022167817715966", "doi": "10.1177/0022167817715966", "pmid": "", "publication_date": "2017-06-13", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 2470, "title": "Psilocybin-assisted therapy for anxiety and depression: implications for euthanasia.", "authors": "Strauss N.", "journal": "The Medical Journal of Australia", "publication_date": "2017-05-31", "publication_year": 2017, "doi": "10.5694/mja17.00081", "pubmed_id": "28918722", "openalex_id": "https://openalex.org/W2625663774", "source_url": "https://doi.org/10.5694/mja17.00081", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Randomized Controlled Trial", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-04 07:00:40", "bibtex": null, "source_record_id": "PMID:28918722", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:28918722", "source_url": "https://doi.org/10.5694/mja17.00081", "doi": "10.5694/mja17.00081", "pmid": "28918722", "publication_date": "2017-05-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 2450, "title": "Psilocybin-Assisted Therapy: A Review of a Novel Treatment for Psychiatric Disorders.", "authors": "Thomas K, Malcolm B, Lastra D.", "journal": null, "publication_date": "2017-05-07", "publication_year": 2017, "doi": "10.1080/02791072.2017.1320734", "pubmed_id": "28481178", "openalex_id": null, "source_url": "https://doi.org/10.1080/02791072.2017.1320734", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Receptor Pharmacology,Default Mode Network,Clinical Trial,Review Article,Safety", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-01 11:22:04", "bibtex": null, "source_record_id": "PMID:28481178", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1080/02791072.2017.1320734", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:28481178", "source_url": "https://doi.org/10.1080/02791072.2017.1320734", "doi": "10.1080/02791072.2017.1320734", "pmid": "28481178", "publication_date": "2017-05-07", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 2456, "title": "The Therapeutic Potential of Psychedelic Drugs: Past, Present, and Future.", "authors": "Carhart-Harris RL, Goodwin GM.", "journal": null, "publication_date": "2017-04-25", "publication_year": 2017, "doi": "10.1038/npp.2017.84", "pubmed_id": "28443617", "openalex_id": null, "source_url": "https://doi.org/10.1038/npp.2017.84", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging,Aging,Clinical Trial", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-01 11:22:06", "bibtex": null, "source_record_id": "PMID:28443617", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1038/npp.2017.84", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:28443617", "source_url": "https://doi.org/10.1038/npp.2017.84", "doi": "10.1038/npp.2017.84", "pmid": "28443617", "publication_date": "2017-04-25", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 5208, "title": "Anti-inflammatory effects of serotonin 5-HT2A receptor activation in ovalbumin-induced allergic asthma models", "authors": "Thomas W. Flanagan, Melaine N. Sebastian, Charles D. Nichols", "journal": "The FASEB Journal", "publication_date": "2017-03-31", "publication_year": 2017, "doi": "10.1096/fasebj.31.1_supplement.820.4", "pubmed_id": null, "openalex_id": "https://openalex.org/W2970574043", "source_url": "https://doi.org/10.1096/fasebj.31.1_supplement.820.4", "substance_tags": "psilocybin", "topic_tags": "Depression,Pharmacology,Receptor Pharmacology,Biomarkers,Clinical Trial,Inflammation,Immune Function", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:52:02", "last_checked": "2026-07-04 07:00:40", "bibtex": null, "source_record_id": "DOI:10.1096/fasebj.31.1_supplement.820.4", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1096/fasebj.31.1_supplement.820.4", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1096/fasebj.31.1_supplement.820.4", "source_url": "https://doi.org/10.1096/fasebj.31.1_supplement.820.4", "doi": "10.1096/fasebj.31.1_supplement.820.4", "pmid": "", "publication_date": "2017-03-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 2473, "title": "Ayahuasca, dimethyltryptamine, and psychosis: a systematic review of human studies.", "authors": "Dos Santos RG, Bouso JC, Hallak JEC.", "journal": null, "publication_date": "2017-02-22", "publication_year": 2017, "doi": "10.1177/2045125316689030", "pubmed_id": "28540034", "openalex_id": null, "source_url": "https://doi.org/10.1177/2045125316689030", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Receptor Pharmacology,Systematic Review,Review Article,Case Report", "study_type": "Systematic Review", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-01 11:22:06", "bibtex": null, "source_record_id": "PMID:28540034", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1177/2045125316689030", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:28540034", "source_url": "https://doi.org/10.1177/2045125316689030", "doi": "10.1177/2045125316689030", "pmid": "28540034", "publication_date": "2017-02-22", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 2474, "title": "The fibrinolytic system: A new target for treatment of depression with psychedelics.", "authors": "Idell RD, Florova G, Komissarov AA, Shetty S, Girard RB, Idell S.", "journal": null, "publication_date": "2017-01-22", "publication_year": 2017, "doi": "10.1016/j.mehy.2017.01.013", "pubmed_id": "28236848", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.mehy.2017.01.013", "substance_tags": "psilocybin", "topic_tags": "Depression,Neuroplasticity,Neurogenesis,Receptor Pharmacology,Inflammation", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-01 11:22:06", "bibtex": null, "source_record_id": "PMID:28236848", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.mehy.2017.01.013", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:28236848", "source_url": "https://doi.org/10.1016/j.mehy.2017.01.013", "doi": "10.1016/j.mehy.2017.01.013", "pmid": "28236848", "publication_date": "2017-01-22", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 2468, "title": "An online survey of tobacco smoking cessation associated with naturalistic psychedelic use.", "authors": "Johnson MW, Garcia-Romeu A, Johnson PS, Griffiths RR.", "journal": "Journal of Psychopharmacology", "publication_date": "2017-01-17", "publication_year": 2017, "doi": "10.1177/0269881116684335", "pubmed_id": "28095732", "openalex_id": "https://openalex.org/W2573408014", "source_url": "https://doi.org/10.1177/0269881116684335", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Mechanism of Action,Emotional Processing,Spirituality,Observational Study", "study_type": "Observational Study", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-04 07:00:40", "bibtex": null, "source_record_id": "PMID:28095732", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1177/0269881116684335", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:28095732", "source_url": "https://doi.org/10.1177/0269881116684335", "doi": "10.1177/0269881116684335", "pmid": "28095732", "publication_date": "2017-01-17", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 5224, "title": "Magic mushrooms as a treatment for depression", "authors": "", "journal": "Clinical pharmacist", "publication_date": "2016-12-31", "publication_year": 2016, "doi": "10.1211/cp.2017.20204046", "pubmed_id": null, "openalex_id": "https://openalex.org/W4248666216", "source_url": "https://doi.org/10.1211/cp.2017.20204046", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging,Mechanism of Action,Aging,Treatment-Resistant Depression", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:52:03", "last_checked": "2026-07-04 07:00:40", "bibtex": null, "source_record_id": "DOI:10.1211/cp.2017.20204046", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1211/cp.2017.20204046", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1211/cp.2017.20204046", "source_url": "https://doi.org/10.1211/cp.2017.20204046", "doi": "10.1211/cp.2017.20204046", "pmid": "", "publication_date": "2016-12-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 5221, "title": "Lysergsyradietylamid (LSD) och psilocybin vid depression och ångestsjukdom: En litteraturstudie om effekter och biverkningar av LSD- och psilocybin-assisterad psykoterapi", "authors": "Natalie Engström", "journal": "KTH Publication Database DiVA (KTH Royal Institute of Technology)", "publication_date": "2016-12-31", "publication_year": 2016, "doi": null, "pubmed_id": null, "openalex_id": "https://openalex.org/W3047601216", "source_url": "http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-136681", "substance_tags": "psilocybin", "topic_tags": "Depression", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:52:03", "last_checked": "2026-07-04 07:00:40", "bibtex": null, "source_record_id": "http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-136681", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-136681", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-136681", "source_url": "http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-136681", "doi": "", "pmid": "", "publication_date": "2016-12-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 5217, "title": "Maddening Therapies: How Hallucinogens Morphed into Novel Treatments", "authors": "Henry A. Nasrallah", "journal": "Current psychiatry", "publication_date": "2016-12-31", "publication_year": 2016, "doi": null, "pubmed_id": null, "openalex_id": "https://openalex.org/W2992985834", "source_url": "https://www.questia.com/library/journal/1G1-480992660/maddening-therapies-how-hallucinogens-morphed-into", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Chronic Pain,Brain Imaging,Pharmacology,Aging,Wellbeing,Creativity,Review Article,Treatment-Resistant Depression,Immune Function", "study_type": "Review Article", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:52:03", "last_checked": "2026-07-04 07:00:40", "bibtex": null, "source_record_id": "https://www.questia.com/library/journal/1G1-480992660/maddening-therapies-how-hallucinogens-morphed-into", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://www.questia.com/library/journal/1G1-480992660/maddening-therapies-how-hallucinogens-morphed-into", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "https://www.questia.com/library/journal/1G1-480992660/maddening-therapies-how-hallucinogens-morphed-into", "source_url": "https://www.questia.com/library/journal/1G1-480992660/maddening-therapies-how-hallucinogens-morphed-into", "doi": "", "pmid": "", "publication_date": "2016-12-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 5215, "title": "Narrative therapy-assisted psilocybin use for treatment of depression", "authors": "Carlyn Delavan", "journal": null, "publication_date": "2016-12-31", "publication_year": 2016, "doi": null, "pubmed_id": null, "openalex_id": "https://openalex.org/W2797914777", "source_url": "https://digitalcommons.spu.edu/spfc_research_conference/spfc_conf_2017/spfc_conf_2017_events/43/", "substance_tags": "psilocybin", "topic_tags": "Depression", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:52:03", "last_checked": "2026-07-04 07:00:40", "bibtex": null, "source_record_id": "https://digitalcommons.spu.edu/spfc_research_conference/spfc_conf_2017/spfc_conf_2017_events/43/", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "https://digitalcommons.spu.edu/spfc_research_conference/spfc_conf_2017/spfc_conf_2017_events/43/", "source_url": "https://digitalcommons.spu.edu/spfc_research_conference/spfc_conf_2017/spfc_conf_2017_events/43/", "doi": "", "pmid": "", "publication_date": "2016-12-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 2477, "title": "Psychedelics as Medicines: An Emerging New Paradigm.", "authors": "Nichols DE, Johnson MW, Nichols CD.", "journal": null, "publication_date": "2016-12-25", "publication_year": 2016, "doi": "10.1002/cpt.557", "pubmed_id": "28019026", "openalex_id": null, "source_url": "https://doi.org/10.1002/cpt.557", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,OCD,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Inflammation", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-01 11:22:06", "bibtex": null, "source_record_id": "PMID:28019026", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1002/cpt.557", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:28019026", "source_url": "https://doi.org/10.1002/cpt.557", "doi": "10.1002/cpt.557", "pmid": "28019026", "publication_date": "2016-12-25", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 5225, "title": "Psilocybin to Manage Cancer-Related Depression", "authors": "Bobby Lazzara", "journal": null, "publication_date": "2016-12-20", "publication_year": 2016, "doi": null, "pubmed_id": null, "openalex_id": "https://openalex.org/W2936772948", "source_url": "https://www.endocrinologynetwork.com/hormone-related-cancers/psilocybin-manage-cancer-related-depression", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Review Article,Cancer Patients", "study_type": "Review Article", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:52:03", "last_checked": "2026-07-04 07:00:40", "bibtex": null, "source_record_id": "https://www.endocrinologynetwork.com/hormone-related-cancers/psilocybin-manage-cancer-related-depression", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://www.endocrinologynetwork.com/hormone-related-cancers/psilocybin-manage-cancer-related-depression", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "https://www.endocrinologynetwork.com/hormone-related-cancers/psilocybin-manage-cancer-related-depression", "source_url": "https://www.endocrinologynetwork.com/hormone-related-cancers/psilocybin-manage-cancer-related-depression", "doi": "", "pmid": "", "publication_date": "2016-12-20", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 2496, "title": "Psilocybin for anxiety and depression in cancer care? Lessons from the past and prospects for the future.", "authors": "Nutt D.", "journal": null, "publication_date": "2016-11-30", "publication_year": 2016, "doi": "10.1177/0269881116675754", "pubmed_id": "27909163", "openalex_id": null, "source_url": "https://doi.org/10.1177/0269881116675754", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-01 11:22:06", "bibtex": null, "source_record_id": "PMID:27909163", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:27909163", "source_url": "https://doi.org/10.1177/0269881116675754", "doi": "10.1177/0269881116675754", "pmid": "27909163", "publication_date": "2016-11-30", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 2495, "title": "Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial.", "authors": "Ross S, Bossis A, Guss J, Agin-Liebes G, Malone T, Cohen B, Mennenga SE, Belser A, Kalliontzi K, Babb J, Su Z, Corby P, Schmidt BL.", "journal": "Journal of Psychopharmacology", "publication_date": "2016-11-30", "publication_year": 2016, "doi": "10.1177/0269881116675512", "pubmed_id": "27909164", "openalex_id": "https://openalex.org/W2559739670", "source_url": "https://doi.org/10.1177/0269881116675512", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Wellbeing,Spirituality,Mystical Experience,Randomized Controlled Trial,Observational Study,Cancer Patients", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-04 07:00:40", "bibtex": null, "source_record_id": "PMID:27909164", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1177/0269881116675512", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:27909164", "source_url": "https://doi.org/10.1177/0269881116675512", "doi": "10.1177/0269881116675512", "pmid": "27909164", "publication_date": "2016-11-30", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 2494, "title": "Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial.", "authors": "Griffiths RR, Johnson MW, Carducci MA, Umbricht A, Richards WA, Richards BD, Cosimano MP, Klinedinst MA.", "journal": "Journal of Psychopharmacology", "publication_date": "2016-11-30", "publication_year": 2016, "doi": "10.1177/0269881116675513", "pubmed_id": "27909165", "openalex_id": "https://openalex.org/W2558412547", "source_url": "https://doi.org/10.1177/0269881116675513", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Wellbeing,Spirituality,Mystical Experience,Observational Study,Cancer Patients,Healthcare Workers", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-04 07:00:40", "bibtex": null, "source_record_id": "PMID:27909165", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1177/0269881116675513", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:27909165", "source_url": "https://doi.org/10.1177/0269881116675513", "doi": "10.1177/0269881116675513", "pmid": "27909165", "publication_date": "2016-11-30", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 2490, "title": "Psilocybin for depression and anxiety associated with life-threatening illnesses.", "authors": "McCorvy JD, Olsen RH, Roth BL.", "journal": null, "publication_date": "2016-11-30", "publication_year": 2016, "doi": "10.1177/0269881116675771", "pubmed_id": "27909171", "openalex_id": null, "source_url": "https://doi.org/10.1177/0269881116675771", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-01 11:22:06", "bibtex": null, "source_record_id": "PMID:27909171", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:27909171", "source_url": "https://doi.org/10.1177/0269881116675771", "doi": "10.1177/0269881116675771", "pmid": "27909171", "publication_date": "2016-11-30", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 2498, "title": "The Challenging Experience Questionnaire: Characterization of challenging experiences with psilocybin mushrooms.", "authors": "Barrett FS, Bradstreet MP, Leoutsakos JS, Johnson MW, Griffiths RR.", "journal": "Journal of Psychopharmacology", "publication_date": "2016-11-16", "publication_year": 2016, "doi": "10.1177/0269881116678781", "pubmed_id": "27856683", "openalex_id": "https://openalex.org/W2549202270", "source_url": "https://doi.org/10.1177/0269881116678781", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Consciousness,Wellbeing,Emotional Processing,Spirituality,Case Report,Observational Study,Safety", "study_type": "Case Report", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-04 07:00:40", "bibtex": null, "source_record_id": "PMID:27856683", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1177/0269881116678781", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:27856683", "source_url": "https://doi.org/10.1177/0269881116678781", "doi": "10.1177/0269881116678781", "pmid": "27856683", "publication_date": "2016-11-16", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 2497, "title": "Psychedelics in the treatment of unipolar mood disorders: a systematic review.", "authors": "Rucker JJ, Jelen LA, Flynn S, Frowde KD, Young AH.", "journal": null, "publication_date": "2016-11-16", "publication_year": 2016, "doi": "10.1177/0269881116679368", "pubmed_id": "27856684", "openalex_id": null, "source_url": "https://doi.org/10.1177/0269881116679368", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Systematic Review,Review Article,Healthcare Workers,Safety", "study_type": "Systematic Review", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-01 11:22:06", "bibtex": null, "source_record_id": "PMID:27856684", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1177/0269881116679368", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:27856684", "source_url": "https://doi.org/10.1177/0269881116679368", "doi": "10.1177/0269881116679368", "pmid": "27856684", "publication_date": "2016-11-16", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 2481, "title": "Role of psilocybin in the treatment of depression.", "authors": "Mahapatra A, Gupta R.", "journal": "Therapeutic Advances in Psychopharmacology", "publication_date": "2016-10-26", "publication_year": 2016, "doi": "10.1177/2045125316676092", "pubmed_id": "28101325", "openalex_id": "https://openalex.org/W2542493272", "source_url": "https://doi.org/10.1177/2045125316676092", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Receptor Pharmacology,Wellbeing", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-04 07:00:40", "bibtex": null, "source_record_id": "PMID:28101325", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1177/2045125316676092", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:28101325", "source_url": "https://doi.org/10.1177/2045125316676092", "doi": "10.1177/2045125316676092", "pmid": "28101325", "publication_date": "2016-10-26", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 5231, "title": "Psilocybin as an alternative medicine for patients suffering from depression", "authors": "Karolina Dydak, Mariola Śliwińska-Mossoń, Halina Milnerowicz", "journal": "Psychiatria i Psychologia Kliniczna", "publication_date": "2016-09-29", "publication_year": 2016, "doi": "10.15557/pipk.2016.0023", "pubmed_id": null, "openalex_id": "https://openalex.org/W2572466674", "source_url": "https://doi.org/10.15557/pipk.2016.0023", "substance_tags": "psilocybin", "topic_tags": "Depression,Receptor Pharmacology", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:52:03", "last_checked": "2026-07-04 07:00:40", "bibtex": null, "source_record_id": "DOI:10.15557/pipk.2016.0023", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.15557/pipk.2016.0023", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.15557/pipk.2016.0023", "source_url": "https://doi.org/10.15557/pipk.2016.0023", "doi": "10.15557/pipk.2016.0023", "pmid": "", "publication_date": "2016-09-29", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 5233, "title": "Psilocybin zur Behandlung der therapieresistenten Depression", "authors": "", "journal": "PSYCH up2date", "publication_date": "2016-09-07", "publication_year": 2016, "doi": "10.1055/s-0042-110896", "pubmed_id": null, "openalex_id": "https://openalex.org/W4252759495", "source_url": "https://doi.org/10.1055/s-0042-110896", "substance_tags": "psilocybin", "topic_tags": "Depression,Pharmacology", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:52:03", "last_checked": "2026-07-04 07:00:40", "bibtex": null, "source_record_id": "DOI:10.1055/s-0042-110896", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1055/s-0042-110896", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1055/s-0042-110896", "source_url": "https://doi.org/10.1055/s-0042-110896", "doi": "10.1055/s-0042-110896", "pmid": "", "publication_date": "2016-09-07", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 2505, "title": "Psilocybin: panacea or placebo?", "authors": "Hendrie C, Pickles A.", "journal": null, "publication_date": "2016-08-31", "publication_year": 2016, "doi": "10.1016/s2215-0366(16)30103-1", "pubmed_id": "27568263", "openalex_id": null, "source_url": "https://doi.org/10.1016/s2215-0366(16)30103-1", "substance_tags": "psilocybin", "topic_tags": "Depression", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-01 11:22:06", "bibtex": null, "source_record_id": "PMID:27568263", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:27568263", "source_url": "https://doi.org/10.1016/s2215-0366(16)30103-1", "doi": "10.1016/s2215-0366(16)30103-1", "pmid": "27568263", "publication_date": "2016-08-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 2504, "title": "Question-based Drug Development for psilocybin.", "authors": "Dijkstra FM, Jacobs GE, Cohen AF.", "journal": null, "publication_date": "2016-08-31", "publication_year": 2016, "doi": "10.1016/s2215-0366(16)30214-0", "pubmed_id": "27568265", "openalex_id": null, "source_url": "https://doi.org/10.1016/s2215-0366(16)30214-0", "substance_tags": "psilocybin", "topic_tags": "Depression", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-01 11:22:06", "bibtex": null, "source_record_id": "PMID:27568265", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:27568265", "source_url": "https://doi.org/10.1016/s2215-0366(16)30214-0", "doi": "10.1016/s2215-0366(16)30214-0", "pmid": "27568265", "publication_date": "2016-08-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 2486, "title": "Return of the psychedelics: Psilocybin for treatment resistant depression.", "authors": "Patra S.", "journal": null, "publication_date": "2016-08-22", "publication_year": 2016, "doi": "10.1016/j.ajp.2016.08.010", "pubmed_id": "27931907", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.ajp.2016.08.010", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Brain Imaging,Mechanism of Action,Aging,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-01 11:22:04", "bibtex": null, "source_record_id": "PMID:27931907", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.ajp.2016.08.010", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:27931907", "source_url": "https://doi.org/10.1016/j.ajp.2016.08.010", "doi": "10.1016/j.ajp.2016.08.010", "pmid": "27931907", "publication_date": "2016-08-22", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 2478, "title": "Psilocybin for treating substance use disorders?", "authors": "de Veen BT, Schellekens AF, Verheij MM, Homberg JR.", "journal": null, "publication_date": "2016-08-11", "publication_year": 2016, "doi": "10.1080/14737175.2016.1220834", "pubmed_id": "27684102", "openalex_id": null, "source_url": "https://doi.org/10.1080/14737175.2016.1220834", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Mechanism of Action,Receptor Pharmacology,Emotional Processing,Review Article,Safety,Toxicity", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-01 11:22:04", "bibtex": null, "source_record_id": "PMID:27684102", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1080/14737175.2016.1220834", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:27684102", "source_url": "https://doi.org/10.1080/14737175.2016.1220834", "doi": "10.1080/14737175.2016.1220834", "pmid": "27684102", "publication_date": "2016-08-11", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 2524, "title": "Treating Addiction: Perspectives from EEG and Imaging Studies on Psychedelics.", "authors": "Tófoli LF, de Araujo DB.", "journal": null, "publication_date": "2016-07-24", "publication_year": 2016, "doi": "10.1016/bs.irn.2016.06.005", "pubmed_id": "27503452", "openalex_id": null, "source_url": "https://doi.org/10.1016/bs.irn.2016.06.005", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Brain Imaging,Aging,Review Article", "study_type": "Review Article", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-01 11:22:06", "bibtex": null, "source_record_id": "PMID:27503452", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/bs.irn.2016.06.005", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:27503452", "source_url": "https://doi.org/10.1016/bs.irn.2016.06.005", "doi": "10.1016/bs.irn.2016.06.005", "pmid": "27503452", "publication_date": "2016-07-24", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 2508, "title": "Antidepressant, Antipsychotic, and Hallucinogen Drugs for the Treatment of Psychiatric Disorders: A Convergence at the Serotonin-2A Receptor.", "authors": "Howland RH.", "journal": "Journal of Psychosocial Nursing and Mental Health Services", "publication_date": "2016-06-30", "publication_year": 2016, "doi": "10.3928/02793695-20160616-09", "pubmed_id": "27362381", "openalex_id": "https://openalex.org/W2470545286", "source_url": "https://doi.org/10.3928/02793695-20160616-09", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Receptor Pharmacology,Clinical Trial,Drug Interactions", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-04 07:00:40", "bibtex": null, "source_record_id": "PMID:27362381", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.3928/02793695-20160616-09", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:27362381", "source_url": "https://doi.org/10.3928/02793695-20160616-09", "doi": "10.3928/02793695-20160616-09", "pmid": "27362381", "publication_date": "2016-06-30", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 2512, "title": "Magic mushroom compound is a potential treatment for patients with major depression.", "authors": "", "journal": "Nursing standard (Royal College of Nursing (Great Britain): 1987)", "publication_date": "2016-06-07", "publication_year": 2016, "doi": "10.7748/ns.30.41.15.s18", "pubmed_id": "27286599", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/27286599/", "substance_tags": "psilocybin", "topic_tags": "Depression", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-01 11:20:40", "bibtex": null, "source_record_id": "PMID:27286599", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/27286599/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:27286599", "source_url": "https://pubmed.ncbi.nlm.nih.gov/27286599/", "doi": "10.7748/ns.30.41.15.s18", "pmid": "27286599", "publication_date": "2016-06-07", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 5243, "title": "A Phenomenological Examination of Psilocybin and its Positive and Persisting Aftereffects", "authors": "Joseph A. Zamaria", "journal": "NeuroQuantology", "publication_date": "2016-05-23", "publication_year": 2016, "doi": "10.14704/nq.2016.14.2.943", "pubmed_id": null, "openalex_id": "https://openalex.org/W77478258", "source_url": "https://doi.org/10.14704/nq.2016.14.2.943", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,OCD,Consciousness,Emotional Processing,Spirituality", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:52:03", "last_checked": "2026-07-04 07:00:40", "bibtex": null, "source_record_id": "DOI:10.14704/nq.2016.14.2.943", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.14704/nq.2016.14.2.943", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.14704/nq.2016.14.2.943", "source_url": "https://doi.org/10.14704/nq.2016.14.2.943", "doi": "10.14704/nq.2016.14.2.943", "pmid": "", "publication_date": "2016-05-23", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 2515, "title": "Sixty seconds on... psilocybin.", "authors": "Hawkes N.", "journal": "BMJ", "publication_date": "2016-05-17", "publication_year": 2016, "doi": "10.1136/bmj.i2775", "pubmed_id": "27194646", "openalex_id": "https://openalex.org/W2407293282", "source_url": "https://doi.org/10.1136/bmj.i2775", "substance_tags": "psilocybin", "topic_tags": "Depression", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-04 07:00:40", "bibtex": null, "source_record_id": "PMID:27194646", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:27194646", "source_url": "https://doi.org/10.1136/bmj.i2775", "doi": "10.1136/bmj.i2775", "pmid": "27194646", "publication_date": "2016-05-17", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 2511, "title": "Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study.", "authors": "Carhart-Harris RL, Bolstridge M, Rucker J, Day CM, Erritzoe D, Kaelen M, Bloomfield M, Rickard JA, Forbes B, Feilding A, Taylor D, Pilling S, Curran VH, Nutt DJ.", "journal": "The Lancet Psychiatry", "publication_date": "2016-05-16", "publication_year": 2016, "doi": "10.1016/s2215-0366(16)30065-7", "pubmed_id": "27210031", "openalex_id": "https://openalex.org/W2396675581", "source_url": "https://doi.org/10.1016/s2215-0366(16)30065-7", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,OCD,End-of-Life Distress,Headache / Migraine,Receptor Pharmacology,Randomized Controlled Trial,Treatment-Resistant Depression,Safety,Adverse Events", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-04 07:00:40", "bibtex": null, "source_record_id": "PMID:27210031", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/s2215-0366(16)30065-7", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:27210031", "source_url": "https://doi.org/10.1016/s2215-0366(16)30065-7", "doi": "10.1016/s2215-0366(16)30065-7", "pmid": "27210031", "publication_date": "2016-05-16", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 2510, "title": "Altered states: psilocybin for treatment-resistant depression.", "authors": "Cowen P.", "journal": null, "publication_date": "2016-05-16", "publication_year": 2016, "doi": "10.1016/s2215-0366(16)30087-6", "pubmed_id": "27210032", "openalex_id": null, "source_url": "https://doi.org/10.1016/s2215-0366(16)30087-6", "substance_tags": "psilocybin", "topic_tags": "Depression,Treatment-Resistant Depression", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-01 11:22:06", "bibtex": null, "source_record_id": "PMID:27210032", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:27210032", "source_url": "https://doi.org/10.1016/s2215-0366(16)30087-6", "doi": "10.1016/s2215-0366(16)30087-6", "pmid": "27210032", "publication_date": "2016-05-16", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 2519, "title": "Psychedelics.", "authors": "Nichols DE.", "journal": null, "publication_date": "2016-03-31", "publication_year": 2016, "doi": "10.1124/pr.115.011478", "pubmed_id": "26841800", "openalex_id": null, "source_url": "https://doi.org/10.1124/pr.115.011478", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Brain Imaging,Receptor Pharmacology,Default Mode Network,Aging,Clinical Trial,Cancer Patients", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-01 11:22:06", "bibtex": null, "source_record_id": "PMID:26841800", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1124/pr.115.011478", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:26841800", "source_url": "https://doi.org/10.1124/pr.115.011478", "doi": "10.1124/pr.115.011478", "pmid": "26841800", "publication_date": "2016-03-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 2502, "title": "Exploring Hallucinogen Pharmacology and Psychedelic Medicine with Zebrafish Models.", "authors": "Kyzar EJ, Kalueff AV.", "journal": null, "publication_date": "2016-03-21", "publication_year": 2016, "doi": "10.1089/zeb.2016.1251", "pubmed_id": "27002655", "openalex_id": null, "source_url": "https://doi.org/10.1089/zeb.2016.1251", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Pharmacology,Animal Study", "study_type": "Animal Study", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-01 11:22:06", "bibtex": null, "source_record_id": "PMID:27002655", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1089/zeb.2016.1251", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:27002655", "source_url": "https://doi.org/10.1089/zeb.2016.1251", "doi": "10.1089/zeb.2016.1251", "pmid": "27002655", "publication_date": "2016-03-21", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 2513, "title": "Antidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): a systematic review of clinical trials published in the last 25 years.", "authors": "Dos Santos RG, Osório FL, Crippa JA, Riba J, Zuardi AW, Hallak JE.", "journal": null, "publication_date": "2016-03-17", "publication_year": 2016, "doi": "10.1177/2045125316638008", "pubmed_id": "27354908", "openalex_id": null, "source_url": "https://doi.org/10.1177/2045125316638008", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,End-of-Life Distress,Clinical Trial,Systematic Review,Review Article,Treatment-Resistant Depression", "study_type": "Systematic Review", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-01 11:22:05", "bibtex": null, "source_record_id": "PMID:27354908", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1177/2045125316638008", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:27354908", "source_url": "https://doi.org/10.1177/2045125316638008", "doi": "10.1177/2045125316638008", "pmid": "27354908", "publication_date": "2016-03-17", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 5248, "title": "The “Endless Trip”: Psychopathology and psychopharmacology in the Hallucinogen Persisting Perception Disorder (HPPD)", "authors": "Laura Orsolini, Alessandro Valchera, Duccio Papanti, R. Vecchiotti, Domenico De Berardis", "journal": "European Psychiatry", "publication_date": "2016-02-29", "publication_year": 2016, "doi": "10.1016/j.eurpsy.2016.01.1060", "pubmed_id": null, "openalex_id": "https://openalex.org/W2376514477", "source_url": "https://doi.org/10.1016/j.eurpsy.2016.01.1060", "substance_tags": "psilocybin", "topic_tags": "Depression,Pharmacology,Receptor Pharmacology,Review Article,Case Report,Safety,Toxicity", "study_type": "Review Article", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:52:03", "last_checked": "2026-07-04 07:00:40", "bibtex": null, "source_record_id": "DOI:10.1016/j.eurpsy.2016.01.1060", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1016/j.eurpsy.2016.01.1060", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.eurpsy.2016.01.1060", "source_url": "https://doi.org/10.1016/j.eurpsy.2016.01.1060", "doi": "10.1016/j.eurpsy.2016.01.1060", "pmid": "", "publication_date": "2016-02-29", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 5256, "title": "Psilocybin shows potential as treatment for depression", "authors": "", "journal": "Pharmaceutical journal/˜The œpharmaceutical journal", "publication_date": "2015-12-31", "publication_year": 2015, "doi": "10.1211/pj.2016.20201222", "pubmed_id": null, "openalex_id": "https://openalex.org/W4248672862", "source_url": "https://doi.org/10.1211/pj.2016.20201222", "substance_tags": "psilocybin", "topic_tags": "Depression", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:52:03", "last_checked": "2026-07-04 07:00:40", "bibtex": null, "source_record_id": "DOI:10.1211/pj.2016.20201222", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1211/pj.2016.20201222", "source_url": "https://doi.org/10.1211/pj.2016.20201222", "doi": "10.1211/pj.2016.20201222", "pmid": "", "publication_date": "2015-12-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 5255, "title": "Psilocybin shows potential as treatment for depression", "authors": "", "journal": "Clinical pharmacist", "publication_date": "2015-12-31", "publication_year": 2015, "doi": "10.1211/cp.2016.20201222", "pubmed_id": null, "openalex_id": "https://openalex.org/W4245491510", "source_url": "https://doi.org/10.1211/cp.2016.20201222", "substance_tags": "psilocybin", "topic_tags": "Depression", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:52:03", "last_checked": "2026-07-04 07:00:40", "bibtex": null, "source_record_id": "DOI:10.1211/cp.2016.20201222", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1211/cp.2016.20201222", "source_url": "https://doi.org/10.1211/cp.2016.20201222", "doi": "10.1211/cp.2016.20201222", "pmid": "", "publication_date": "2015-12-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 5263, "title": "P.1.i.005 The 5-HT2A/1A agonist psilocybin reduces social pain and enhances empathy in healthy volunteers", "authors": "Katrin H. Preller, Thomas Pokorny, Rainer Krähenmann, Milan Scheidegger, I. Dziobek, Philipp Stämpfli, F.X. Vollenweider", "journal": "European Neuropsychopharmacology", "publication_date": "2015-08-31", "publication_year": 2015, "doi": "10.1016/s0924-977x(15)30364-3", "pubmed_id": null, "openalex_id": "https://openalex.org/W2513457040", "source_url": "https://doi.org/10.1016/s0924-977x(15)30364-3", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Chronic Pain,Pharmacology,Receptor Pharmacology,Healthy Volunteers", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:52:04", "last_checked": "2026-07-04 07:00:40", "bibtex": null, "source_record_id": "DOI:10.1016/s0924-977x(15)30364-3", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/s0924-977x(15)30364-3", "source_url": "https://doi.org/10.1016/s0924-977x(15)30364-3", "doi": "10.1016/s0924-977x(15)30364-3", "pmid": "", "publication_date": "2015-08-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 2542, "title": "Psychedelics not linked to mental health problems or suicidal behavior: a population study.", "authors": "Johansen PØ, Krebs TS.", "journal": "Journal of Psychopharmacology", "publication_date": "2015-03-04", "publication_year": 2015, "doi": "10.1177/0269881114568039", "pubmed_id": "25744618", "openalex_id": "https://openalex.org/W2097999899", "source_url": "https://doi.org/10.1177/0269881114568039", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Adolescents,Safety,Adverse Events", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-04 07:00:40", "bibtex": null, "source_record_id": "PMID:25744618", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1177/0269881114568039", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:25744618", "source_url": "https://doi.org/10.1177/0269881114568039", "doi": "10.1177/0269881114568039", "pmid": "25744618", "publication_date": "2015-03-04", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 5268, "title": "5HT2a Receptors - a New Target for Depression?", "authors": "D.J. Nutt", "journal": "European Psychiatry", "publication_date": "2015-02-28", "publication_year": 2015, "doi": "10.1016/s0924-9338(15)30027-4", "pubmed_id": null, "openalex_id": "https://openalex.org/W562065783", "source_url": "https://doi.org/10.1016/s0924-9338(15)30027-4", "substance_tags": "psilocybin", "topic_tags": "Depression,Receptor Pharmacology,Default Mode Network", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:52:04", "last_checked": "2026-07-04 07:00:40", "bibtex": null, "source_record_id": "DOI:10.1016/s0924-9338(15)30027-4", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1016/s0924-9338(15)30027-4", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/s0924-9338(15)30027-4", "source_url": "https://doi.org/10.1016/s0924-9338(15)30027-4", "doi": "10.1016/s0924-9338(15)30027-4", "pmid": "", "publication_date": "2015-02-28", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 5267, "title": "The Effect of 5-HT2A/1a Agonist Treatment On Social Cognition, Empathy, and Social Decision-making", "authors": "Katrin H. Preller, Thomas Pokorny, Rainer Krähenmann, I. Dziobek, Philipp Stämpfli, F.X. Vollenweider", "journal": "European Psychiatry", "publication_date": "2015-02-28", "publication_year": 2015, "doi": "10.1016/s0924-9338(15)30017-1", "pubmed_id": null, "openalex_id": "https://openalex.org/W563138297", "source_url": "https://doi.org/10.1016/s0924-9338(15)30017-1", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Chronic Pain,Brain Imaging,Receptor Pharmacology,Emotional Processing,Healthy Volunteers,Drug Interactions", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:52:04", "last_checked": "2026-07-04 07:00:40", "bibtex": null, "source_record_id": "DOI:10.1016/s0924-9338(15)30017-1", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1016/s0924-9338(15)30017-1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/s0924-9338(15)30017-1", "source_url": "https://doi.org/10.1016/s0924-9338(15)30017-1", "doi": "10.1016/s0924-9338(15)30017-1", "pmid": "", "publication_date": "2015-02-28", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 2558, "title": "Classical hallucinogens as antidepressants? A review of pharmacodynamics and putative clinical roles.", "authors": "Baumeister D, Barnes G, Giaroli G, Tracy D", "journal": "Therapeutic advances in psychopharmacology", "publication_date": "2014-07-31", "publication_year": 2014, "doi": "10.1177/2045125314527985", "pubmed_id": "25083275", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/25083275/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Pharmacology,Mechanism of Action,Receptor Pharmacology,Consciousness,Spirituality,Clinical Trial,Review Article,Safety,Toxicity", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-01 11:20:40", "bibtex": null, "source_record_id": "PMID:25083275", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/25083275/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:25083275", "source_url": "https://pubmed.ncbi.nlm.nih.gov/25083275/", "doi": "10.1177/2045125314527985", "pmid": "25083275", "publication_date": "2014-07-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 2530, "title": "Psilocybin-Induced Decrease in Amygdala Reactivity Correlates with Enhanced Positive Mood in Healthy Volunteers.", "authors": "Kraehenmann R, Preller KH, Scheidegger M, Pokorny T, Bosch OG, Seifritz E, Vollenweider FX.", "journal": "Biological Psychiatry", "publication_date": "2014-04-25", "publication_year": 2014, "doi": "10.1016/j.biopsych.2014.04.010", "pubmed_id": "24882567", "openalex_id": "https://openalex.org/W2093203605", "source_url": "https://doi.org/10.1016/j.biopsych.2014.04.010", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Brain Imaging,Receptor Pharmacology,Aging,Emotional Processing,Healthy Volunteers", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-04 07:00:41", "bibtex": null, "source_record_id": "PMID:24882567", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.biopsych.2014.04.010", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:24882567", "source_url": "https://doi.org/10.1016/j.biopsych.2014.04.010", "doi": "10.1016/j.biopsych.2014.04.010", "pmid": "24882567", "publication_date": "2014-04-25", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 2567, "title": "The Heffter Research Institute: past and hopeful future.", "authors": "Nichols DE.", "journal": "Journal of Psychoactive Drugs", "publication_date": "2013-12-31", "publication_year": 2013, "doi": "10.1080/02791072.2014.873688", "pubmed_id": "24830182", "openalex_id": "https://openalex.org/W1982006269", "source_url": "https://doi.org/10.1080/02791072.2014.873688", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,OCD,End-of-Life Distress,Clinical Trial,Cancer Patients", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-04 07:00:41", "bibtex": null, "source_record_id": "PMID:24830182", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1080/02791072.2014.873688", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:24830182", "source_url": "https://doi.org/10.1080/02791072.2014.873688", "doi": "10.1080/02791072.2014.873688", "pmid": "24830182", "publication_date": "2013-12-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 2579, "title": "Psychedelics and mental health: a population study.", "authors": "Krebs TS, Johansen PØ.", "journal": "PLoS ONE", "publication_date": "2013-08-18", "publication_year": 2013, "doi": "10.1371/journal.pone.0063972", "pubmed_id": "23976938", "openalex_id": "https://openalex.org/W2014761647", "source_url": "https://doi.org/10.1371/journal.pone.0063972", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Observational Study,Adolescents,Safety", "study_type": "Observational Study", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-04 07:00:41", "bibtex": null, "source_record_id": "PMID:23976938", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1371/journal.pone.0063972", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:23976938", "source_url": "https://doi.org/10.1371/journal.pone.0063972", "doi": "10.1371/journal.pone.0063972", "pmid": "23976938", "publication_date": "2013-08-18", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 2578, "title": "Psychiatry's next top model: cause for a re-think on drug models of psychosis and other psychiatric disorders.", "authors": "Carhart-Harris RL, Brugger S, Nutt DJ, Stone JM.", "journal": "Journal of Psychopharmacology", "publication_date": "2013-06-18", "publication_year": 2013, "doi": "10.1177/0269881113494107", "pubmed_id": "23784738", "openalex_id": "https://openalex.org/W1982429022", "source_url": "https://doi.org/10.1177/0269881113494107", "substance_tags": "psilocybin", "topic_tags": "Depression", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-04 07:00:41", "bibtex": null, "source_record_id": "PMID:23784738", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1177/0269881113494107", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:23784738", "source_url": "https://doi.org/10.1177/0269881113494107", "doi": "10.1177/0269881113494107", "pmid": "23784738", "publication_date": "2013-06-18", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 2591, "title": "Single treatments that have lasting effects: some thoughts on the antidepressant effects of ketamine and botulinum toxin and the anxiolytic effect of psilocybin.", "authors": "Young SN.", "journal": "Фундаментальные исследования (Fundamental Research)", "publication_date": "2013-02-28", "publication_year": 2013, "doi": "10.1503/jpn.120128", "pubmed_id": null, "openalex_id": "https://openalex.org/W23171696", "source_url": "https://doi.org/10.1503/jpn.120128", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Mechanism of Action,Clinical Trial,Animal Study", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-04 07:00:41", "bibtex": null, "source_record_id": "DOI:10.1503/jpn.120128", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1503/jpn.120128", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "DOI:10.1503/jpn.120128", "source_url": "https://doi.org/10.1503/jpn.120128", "doi": "10.1503/jpn.120128", "pmid": "", "publication_date": "2013-02-28", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 5313, "title": "Activation of Serotonin 2A Receptors Underlies the Psilocybin-Induced Effects on α Oscillations, N170 Visual-Evoked Potentials, and Visual Hallucinations", "authors": "Kometer, Michael, Schmidt, André, Jäncke, Lutz, Vollenweider, Franz X", "journal": "Open MIND", "publication_date": "2012-12-31", "publication_year": 2012, "doi": null, "pubmed_id": null, "openalex_id": "https://openalex.org/W6929930661", "source_url": "https://openalex.org/W6929930661", "substance_tags": "psilocybin", "topic_tags": "Depression,Receptor Pharmacology,Genomics", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:52:04", "last_checked": "2026-07-04 07:00:41", "bibtex": null, "source_record_id": "https://openalex.org/W6929930661", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "https://openalex.org/W6929930661", "source_url": "https://openalex.org/W6929930661", "doi": "", "pmid": "", "publication_date": "2012-12-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 2598, "title": "Illicit use of LSD or psilocybin, but not MDMA or nonpsychedelic drugs, is associated with mystical experiences in a dose-dependent manner.", "authors": "Lyvers M, Meester M.", "journal": "Journal of Psychoactive Drugs", "publication_date": "2012-10-31", "publication_year": 2012, "doi": "10.1080/02791072.2012.736842", "pubmed_id": "23457892", "openalex_id": "https://openalex.org/W2135643379", "source_url": "https://doi.org/10.1080/02791072.2012.736842", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Consciousness,Emotional Processing,Spirituality,Mystical Experience,Observational Study,Adolescents", "study_type": "Observational Study", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-04 07:00:41", "bibtex": null, "source_record_id": "PMID:23457892", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1080/02791072.2012.736842", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:23457892", "source_url": "https://doi.org/10.1080/02791072.2012.736842", "doi": "10.1080/02791072.2012.736842", "pmid": "23457892", "publication_date": "2012-10-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 2597, "title": "Psilocybin biases facial recognition, goal-directed behavior, and mood state toward positive relative to negative emotions through different serotonergic subreceptors.", "authors": "Kometer M, Schmidt A, Bachmann R, Studerus E, Seifritz E, Vollenweider FX.", "journal": "Biological Psychiatry", "publication_date": "2012-05-09", "publication_year": 2012, "doi": "10.1016/j.biopsych.2012.04.005", "pubmed_id": "22578254", "openalex_id": "https://openalex.org/W1974074998", "source_url": "https://doi.org/10.1016/j.biopsych.2012.04.005", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Receptor Pharmacology,Emotional Processing", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-04 07:00:41", "bibtex": null, "source_record_id": "PMID:22578254", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.biopsych.2012.04.005", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:22578254", "source_url": "https://doi.org/10.1016/j.biopsych.2012.04.005", "doi": "10.1016/j.biopsych.2012.04.005", "pmid": "22578254", "publication_date": "2012-05-09", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 2605, "title": "Neuroimaging: a scanner, colourfully.", "authors": "Roiser JP, Rees G.", "journal": null, "publication_date": "2012-03-31", "publication_year": 2012, "doi": "10.1016/j.cub.2012.02.033", "pubmed_id": "22497939", "openalex_id": "https://openalex.org/W2082661311", "source_url": "https://doi.org/10.1016/j.cub.2012.02.033", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging,Aging,Emotional Processing", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-01 11:22:06", "bibtex": null, "source_record_id": "PMID:22497939", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.cub.2012.02.033", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:22497939", "source_url": "https://doi.org/10.1016/j.cub.2012.02.033", "doi": "10.1016/j.cub.2012.02.033", "pmid": "22497939", "publication_date": "2012-03-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 2627, "title": "Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer.", "authors": "Grob CS, Danforth AL, Chopra GS, Hagerty M, McKay CR, Halberstadt AL, Greer GR.", "journal": "Archives of General Psychiatry", "publication_date": "2010-09-05", "publication_year": 2010, "doi": "10.1001/archgenpsychiatry.2010.116", "pubmed_id": "20819978", "openalex_id": "https://openalex.org/W2161555895", "source_url": "https://doi.org/10.1001/archgenpsychiatry.2010.116", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Aging,Personality Change,Safety,Adverse Events", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-04 07:00:41", "bibtex": null, "source_record_id": "PMID:20819978", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1001/archgenpsychiatry.2010.116", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:20819978", "source_url": "https://doi.org/10.1001/archgenpsychiatry.2010.116", "doi": "10.1001/archgenpsychiatry.2010.116", "pmid": "20819978", "publication_date": "2010-09-05", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 2649, "title": "Chemical interactions with pyramidal neurons in layer 5 of the cerebral cortex: control of pain and anxiety.", "authors": "Adams JD.", "journal": null, "publication_date": "2008-12-31", "publication_year": 2008, "doi": "10.2174/092986709789057626", "pubmed_id": "19799545", "openalex_id": null, "source_url": "https://doi.org/10.2174/092986709789057626", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Chronic Pain,Neuroplasticity,Receptor Pharmacology,Review Article,Drug Interactions", "study_type": "Review Article", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-01 11:22:07", "bibtex": null, "source_record_id": "PMID:19799545", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.2174/092986709789057626", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:19799545", "source_url": "https://doi.org/10.2174/092986709789057626", "doi": "10.2174/092986709789057626", "pmid": "19799545", "publication_date": "2008-12-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 5381, "title": "Involvement of 5-HT2A Receptor in the Regulation of Hippocampal-Dependent Learning and Neurogenesis", "authors": "Briony J. Catlow", "journal": "Digital Commons - University of South Florida (University of South Florida)", "publication_date": "2007-12-31", "publication_year": 2007, "doi": null, "pubmed_id": null, "openalex_id": "https://openalex.org/W1522661265", "source_url": "https://digitalcommons.usf.edu/etd/166", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Neuroplasticity,Neurogenesis,Pharmacology,Mechanism of Action,Receptor Pharmacology", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:52:06", "last_checked": "2026-07-04 07:00:41", "bibtex": null, "source_record_id": "https://digitalcommons.usf.edu/etd/166", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://digitalcommons.usf.edu/etd/166", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "https://digitalcommons.usf.edu/etd/166", "source_url": "https://digitalcommons.usf.edu/etd/166", "doi": "", "pmid": "", "publication_date": "2007-12-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 5407, "title": "Psychopathological effects of S-ketamine and dimethyltryptamine (DMT) in humans: a double-blind, cross-over human experimental study of the NMDA antagonist and the 5HT2A agonist model of psychosis", "authors": "Euphrosyne Gouzoulis-Mayfrank, Anna Neukirch, Karsten Heekeren", "journal": "Pharmacopsychiatry", "publication_date": "2005-08-31", "publication_year": 2005, "doi": "10.1055/s-2005-918695", "pubmed_id": null, "openalex_id": "https://openalex.org/W2331400020", "source_url": "https://doi.org/10.1055/s-2005-918695", "substance_tags": "psilocybin", "topic_tags": "Depression,Pharmacology,Receptor Pharmacology,Healthy Volunteers", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:52:06", "last_checked": "2026-07-04 07:00:41", "bibtex": null, "source_record_id": "DOI:10.1055/s-2005-918695", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1055/s-2005-918695", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1055/s-2005-918695", "source_url": "https://doi.org/10.1055/s-2005-918695", "doi": "10.1055/s-2005-918695", "pmid": "", "publication_date": "2005-08-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 2691, "title": "Hallucinogen persisting perception disorder after psilocybin consumption: a case study.", "authors": "Espiard ML, Lecardeur L, Abadie P, Halbecq I, Dollfus S.", "journal": "European Psychiatry", "publication_date": "2005-07-31", "publication_year": 2005, "doi": "10.1016/j.eurpsy.2005.04.008", "pubmed_id": "15963699", "openalex_id": "https://openalex.org/W2106188235", "source_url": "https://doi.org/10.1016/j.eurpsy.2005.04.008", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Adolescents", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-04 07:00:41", "bibtex": null, "source_record_id": "PMID:15963699", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.eurpsy.2005.04.008", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:15963699", "source_url": "https://doi.org/10.1016/j.eurpsy.2005.04.008", "doi": "10.1016/j.eurpsy.2005.04.008", "pmid": "15963699", "publication_date": "2005-07-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 5421, "title": "Designer Hallucinogens", "authors": "Leon Gussow", "journal": "Emergency Medicine News", "publication_date": "2003-11-30", "publication_year": 2003, "doi": "10.1097/00132981-200312000-00015", "pubmed_id": null, "openalex_id": "https://openalex.org/W2319772829", "source_url": "https://doi.org/10.1097/00132981-200312000-00015", "substance_tags": "psilocybin", "topic_tags": "Depression,Receptor Pharmacology,Toxicity", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:52:06", "last_checked": "2026-07-04 06:52:06", "bibtex": null, "source_record_id": "DOI:10.1097/00132981-200312000-00015", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1097/00132981-200312000-00015", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1097/00132981-200312000-00015", "source_url": "https://doi.org/10.1097/00132981-200312000-00015", "doi": "10.1097/00132981-200312000-00015", "pmid": "", "publication_date": "2003-11-30", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 5422, "title": "P.6.057 Effects of 2A receptor challenge by psilocybin on cognitive performance and neuroendocrine measures in healthy humans: A serotonin model of psychosis", "authors": "Felix Hasler, Ulrike Grimberg, Martin Benz, F.X. Vollenweider", "journal": "European Neuropsychopharmacology", "publication_date": "2003-09-30", "publication_year": 2003, "doi": "10.1016/s0924-977x(03)92355-8", "pubmed_id": null, "openalex_id": "https://openalex.org/W2051778190", "source_url": "https://doi.org/10.1016/s0924-977x(03)92355-8", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Pharmacology,Receptor Pharmacology", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:52:06", "last_checked": "2026-07-04 06:52:06", "bibtex": null, "source_record_id": "DOI:10.1016/s0924-977x(03)92355-8", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/s0924-977x(03)92355-8", "source_url": "https://doi.org/10.1016/s0924-977x(03)92355-8", "doi": "10.1016/s0924-977x(03)92355-8", "pmid": "", "publication_date": "2003-09-30", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 2815, "title": "Chloroquine psychosis: a chemical psychosis?", "authors": "Mohan D, Mohandas E, Rajat R.", "journal": null, "publication_date": "1981-10-31", "publication_year": 1981, "doi": null, "pubmed_id": "7310924", "openalex_id": "https://openalex.org/W48775267", "source_url": "https://europepmc.org/article/MED/7310924", "substance_tags": "psilocybin", "topic_tags": "Depression,Adolescents", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:15", "last_checked": "2026-07-01 11:22:07", "bibtex": null, "source_record_id": "PMID:7310924", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://europepmc.org/article/MED/7310924", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:7310924", "source_url": "https://europepmc.org/article/MED/7310924", "doi": "", "pmid": "7310924", "publication_date": "1981-10-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 2819, "title": "Dissociations between the effects of hallucinogenic drugs on behavior and raphe unit activity in freely moving cats.", "authors": "Trulson ME, Heym J, Jacobs BL.", "journal": null, "publication_date": "1981-05-31", "publication_year": 1981, "doi": "10.1016/0006-8993(81)90507-2", "pubmed_id": "6114779", "openalex_id": null, "source_url": "https://doi.org/10.1016/0006-8993(81)90507-2", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Brain Imaging,Receptor Pharmacology", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:15", "last_checked": "2026-07-01 11:22:07", "bibtex": null, "source_record_id": "PMID:6114779", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/0006-8993(81)90507-2", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:6114779", "source_url": "https://doi.org/10.1016/0006-8993(81)90507-2", "doi": "10.1016/0006-8993(81)90507-2", "pmid": "6114779", "publication_date": "1981-05-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 5554, "title": "Psilocybin-induced Autonomic, Perceptual, and Behavioral Change", "authors": "R Fischer, Diana Warshay", "journal": "Pharmacopsychiatry", "publication_date": "1968-10-31", "publication_year": 1968, "doi": "10.1055/s-0028-1094227", "pubmed_id": null, "openalex_id": "https://openalex.org/W2047529423", "source_url": "https://doi.org/10.1055/s-0028-1094227", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Receptor Pharmacology,Personality Change", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:52:09", "last_checked": "2026-07-04 06:52:09", "bibtex": null, "source_record_id": "DOI:10.1055/s-0028-1094227", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1055/s-0028-1094227", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1055/s-0028-1094227", "source_url": "https://doi.org/10.1055/s-0028-1094227", "doi": "10.1055/s-0028-1094227", "pmid": "", "publication_date": "1968-10-31", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 2914, "title": "[CLINICAL AND PSYCHOPATHOLOGICAL STUDY OF PSILOCYBIN].", "authors": "REDA GC, VELLA G, CANCRINI L, D AGOSTINO E.", "journal": null, "publication_date": "1964-02-29", "publication_year": 1964, "doi": null, "pubmed_id": "14144273", "openalex_id": "https://openalex.org/W2419461447", "source_url": "https://europepmc.org/article/MED/14144273", "substance_tags": "psilocybin", "topic_tags": "Depression,Pharmacology,Consciousness,Personality Change,Toxicity", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:15", "last_checked": "2026-07-01 11:22:07", "bibtex": null, "source_record_id": "PMID:14144273", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:14144273", "source_url": "https://europepmc.org/article/MED/14144273", "doi": "", "pmid": "14144273", "publication_date": "1964-02-29", "importer_version": "2.1.1", "text_redistributed": false } }, { "id": 2953, "title": "[Clinical experiences with psilocybin (CY39 Sandoz)].", "authors": "SERCL M, KOVARIK J, JAROS O.", "journal": null, "publication_date": "1960-12-31", "publication_year": 1960, "doi": null, "pubmed_id": "13910754", "openalex_id": "https://openalex.org/W2438505389", "source_url": "https://europepmc.org/article/MED/13910754", "substance_tags": "psilocybin", "topic_tags": "Depression", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:15", "last_checked": "2026-07-01 11:22:07", "bibtex": null, "source_record_id": "PMID:13910754", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:13910754", "source_url": "https://europepmc.org/article/MED/13910754", "doi": "", "pmid": "13910754", "publication_date": "1960-12-31", "importer_version": "2.1.1", "text_redistributed": false } } ] }